Harmonized Variable,Harmonized Variable Description,SNOMED CT ID,NINDS CDE ID,Studies Mapped,Missing Samples (%)_x,Study Mapped,Variable Field Name,Variable Description,Missing Samples (%)_y,dataset,var,Study,Variable name,Variable description,dbGaP Study Accession,Variable accession,Dataset accession,Dataset name,phv,values,studyId,dtId,varId,is_categorical,is_continuous,columnmeta_is_stigmatized,columnmeta_name,description,columnmeta_min,HPDS_PATH,derived_group_id,columnmeta_hpds_path,columnmeta_var_id,columnmeta_var_group_description,derived_var_description,derived_variable_level_data,data_hierarchy,derived_group_description,columnmeta_max,columnmeta_description,derived_study_id,hashed_var_id,columnmeta_data_type,derived_var_id,columnmeta_study_id,is_stigmatized,derived_var_name,derived_study_abv_name,derived_study_description,columnmeta_var_group_id,derived_group_name,columnmeta_HPDS_PATH,min,max
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,,-,-,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,,-,-,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.afinc,Incident AF,2.1927486,afincps13,afinc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.afinc,Incident AF,2.1927486,afincps13,afinc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.afinc,Incident AF,2.1927486,afincps13,afinc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.afinc,Incident AF,2.1927486,afincps13,afinc,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.ttaf,time to incident af,2.1927486,afincps13,ttaf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.ttaf,time to incident af,2.1927486,afincps13,ttaf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.ttaf,time to incident af,2.1927486,afincps13,ttaf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,afincps13.ttaf,time to incident af,2.1927486,afincps13,ttaf,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,anut2.sodi,sodium (mg),-,anut2,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,Sodium [mg] [Nutrients. Visit 3],phs000280.v8.p2,phv00208588.v2.p2,pht004139.v3.p2,NUTV3,phv00208588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,anut2.sodi,sodium (mg),-,anut2,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,Sodium [mg] [Nutrients. Visit 2],phs000280.v8.p2,phv00208361.v2.p2,pht004137.v3.p2,NUTV2,phv00208361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,anut2.sodi,sodium (mg),-,anut2,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,"Sodium [mg] [Nutrients, ANUT. Visit 1]",phs000280.v8.p2,phv00203258.v2.p2,pht004036.v3.p2,ANUT2,phv00203258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib11.af,Atrial fibrillation,-,atrfib11,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB11. Visit 1],phs000280.v8.p2,phv00203303.v2.p2,pht004037.v4.p2,ATRFIB11,phv00203303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib11.af,Atrial fibrillation,-,atrfib11,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB21. Visit 2],phs000280.v8.p2,phv00203306.v2.p2,pht004038.v4.p2,ATRFIB21,phv00203306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib11.af,Atrial fibrillation,-,atrfib11,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB31. Visit 3],phs000280.v8.p2,phv00203309.v2.p2,pht004039.v4.p2,ATRFIB31,phv00203309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib11.af,Atrial fibrillation,-,atrfib11,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB41. Visit 4],phs000280.v8.p2,phv00203312.v2.p2,pht004040.v4.p2,ATRFIB41,phv00203312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib21.af,Atrial fibrillation,-,atrfib21,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB41. Visit 4],phs000280.v8.p2,phv00203312.v2.p2,pht004040.v4.p2,ATRFIB41,phv00203312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib21.af,Atrial fibrillation,-,atrfib21,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB31. Visit 3],phs000280.v8.p2,phv00203309.v2.p2,pht004039.v4.p2,ATRFIB31,phv00203309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib21.af,Atrial fibrillation,-,atrfib21,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB21. Visit 2],phs000280.v8.p2,phv00203306.v2.p2,pht004038.v4.p2,ATRFIB21,phv00203306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib21.af,Atrial fibrillation,-,atrfib21,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB11. Visit 1],phs000280.v8.p2,phv00203303.v2.p2,pht004037.v4.p2,ATRFIB11,phv00203303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib31.af,Atrial fibrillation,-,atrfib31,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB21. Visit 2],phs000280.v8.p2,phv00203306.v2.p2,pht004038.v4.p2,ATRFIB21,phv00203306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib31.af,Atrial fibrillation,-,atrfib31,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB31. Visit 3],phs000280.v8.p2,phv00203309.v2.p2,pht004039.v4.p2,ATRFIB31,phv00203309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib31.af,Atrial fibrillation,-,atrfib31,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB41. Visit 4],phs000280.v8.p2,phv00203312.v2.p2,pht004040.v4.p2,ATRFIB41,phv00203312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib31.af,Atrial fibrillation,-,atrfib31,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB11. Visit 1],phs000280.v8.p2,phv00203303.v2.p2,pht004037.v4.p2,ATRFIB11,phv00203303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib41.af,Atrial fibrillation,-,atrfib41,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB11. Visit 1],phs000280.v8.p2,phv00203303.v2.p2,pht004037.v4.p2,ATRFIB11,phv00203303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib41.af,Atrial fibrillation,-,atrfib41,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB21. Visit 2],phs000280.v8.p2,phv00203306.v2.p2,pht004038.v4.p2,ATRFIB21,phv00203306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib41.af,Atrial fibrillation,-,atrfib41,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB31. Visit 3],phs000280.v8.p2,phv00203309.v2.p2,pht004039.v4.p2,ATRFIB31,phv00203309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,atrfib41.af,Atrial fibrillation,-,atrfib41,af,Atherosclerosis Risk in Communities (ARIC) Cohort,af,Atrial fibrillation [Atrial Fibrillation. ATRFIB41. Visit 4],phs000280.v8.p2,phv00203312.v2.p2,pht004040.v4.p2,ATRFIB41,phv00203312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,REGARDS,baseline_calculated_variables.AFIB_ECG,-,-,baseline_calculated_variables,AFIB_ECG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,REGARDS,baseline_calculated_variables.AFIB_SR,-,-,baseline_calculated_variables,AFIB_SR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Atherosclerosis Risk in Communities (ARIC) Cohort,Age,Age at Contact [Annual Follow-up Questionnaire Form. AFU],phs000280.v8.p2,phv00294816.v5.p2,pht006416.v5.p2,afucomposite30ps1,phv00294816,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Atherosclerosis Risk in Communities (ARIC) Cohort,AGE,Age at discharge/death for cohort event use V5 DOB,phs000280.v8.p2,phv00419796.v3.p2,pht009477.v3.p2,HFCOCCPS18,phv00419796,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Hispanic Community Health Study /Study of Latinos (HCHS/SOL),AGE,Age,phs000810.v2.p2,phv00226251.v2.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,phv00226251,[],phs000810,pht004715,phv00226251,False,True,True,AGE,Age,18.0,\phs000810\pht004715\phv00226251\AGE\,pht004715.v1,\phs000810\pht004715\phv00226251\AGE\,phv00226251,"Subject ID, age, gender, study ID, year lived in USA, Hispanic/Latino background, education and occupation, household ID, family origin, marital status, height, weight, BMI, blood cell count, blood pressure, apnea/hypopnea, blood oxygen level, waist-to-Hip ration, asthma, diabetes, cancer, teeth, pregnancy, heart disease, chronic kidney disease, ECG, spirometry, physical activity, smoking, and treatment of participants involved in the ""Hispanic Community Health Study /Study of Latinos (HCHS/SOL)"" project.",Age,{},,"Subject ID, age, gender, study ID, year lived in USA, Hispanic/Latino background, education and occupation, household ID, family origin, marital status, height, weight, BMI, blood cell count, blood pressure, apnea/hypopnea, blood oxygen level, waist-to-Hip ration, asthma, diabetes, cancer, teeth, pregnancy, heart disease, chronic kidney disease, ECG, spirometry, physical activity, smoking, and treatment of participants involved in the ""Hispanic Community Health Study /Study of Latinos (HCHS/SOL)"" project.",76.0,Age,phs000810.v1,c6ad0299c6540a5b1bbaa62f2f2af135e0a2e85541e2688810fcfc5256000ad7,continuous,phv00226251.v1,phs000810,True,AGE,HCHSSOL,Hispanic Community Health Study /Study of Latinos (HCHS/SOL),pht004715,HCHS_SOL_Cohort_Subject_Phenotypes,\phs000810\pht004715\phv00226251\AGE\,18.0,76.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Framingham Cohort,AGE,Age of participant at the time of the neuropsychological test,phs000007.v33.p14,phv00253991.v5.p14,pht004374.v7.p14,vr_np_2018_a_1185s,phv00253991,[],phs000007,pht004374,phv00253991,False,True,True,AGE,Age of participant at the time of the neuropsychological test,25.0,\phs000007\pht004374\phv00253991\AGE\,pht004374.v5,\phs000007\pht004374\phv00253991\AGE\,phv00253991,"Neuropsychology Test Scores, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), 1999 - 2018. The primary objective of the MRI and Cognitive study was to establish baseline measures of brain morphology and cognitive function in the Original cohort survivors. This dataset contains all NP measures for participants in any of the FHS cohorts. The study comprised of a 50-90 minute neuropsychological test battery that also included some measures of physical functioning. This is NOT an adjudicated diagnosis and should not be used as such in ANY analysis under any circumstance. Please refer to the dementia review dataset for adjudicated dementia diagnosis outcomes.",Age of participant at the time of the neuropsychological test,{},,"Neuropsychology Test Scores, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), 1999 - 2018. The primary objective of the MRI and Cognitive study was to establish baseline measures of brain morphology and cognitive function in the Original cohort survivors. This dataset contains all NP measures for participants in any of the FHS cohorts. The study comprised of a 50-90 minute neuropsychological test battery that also included some measures of physical functioning. This is NOT an adjudicated diagnosis and should not be used as such in ANY analysis under any circumstance. Please refer to the dementia review dataset for adjudicated dementia diagnosis outcomes.",104.0,Age of participant at the time of the neuropsychological test,phs000007.v31,a9cf0b028aa8b15c5253ffdaa5f7d0106574d84959986c33ccd128f217593c2d,continuous,phv00253991.v3,phs000007,True,AGE,FHS,Framingham Cohort,pht004374,vr_np_2018_a_1185s,\phs000007\pht004374\phv00253991\AGE\,25.0,104.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Women's Health Initiative,AGE,Age at screening,phs000200.v12.p3,phv00078437.v6.p3,pht000998.v6.p3,f2_rel1,phv00078437,[],phs000200,pht000998,phv00078437,False,True,True,AGE,Age at screening,49.0,\phs000200\pht000998\phv00078437\AGE\,pht000998.v6,\phs000200\pht000998\phv00078437\AGE\,phv00078437,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",Age at screening,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",81.0,Age at screening,phs000200.v12,68a9f5b827311d33a4499bc3c98d409b40b446bdbdd33a5cdada3f71f4d0925e,continuous,phv00078437.v6,phs000200,True,AGE,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078437\AGE\,49.0,81.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age,DIETARY AGE CATEGORY EXAM 5,phs000209.v13.p3,phv00218304.v1.p3,pht004317.v1.p3,MESA_exam5dietnutrients,phv00218304,"['50-59', '60-69', '70 or +']",phs000209,pht004317,phv00218304,True,False,False,age,DIETARY AGE CATEGORY EXAM 5,,\phs000209\pht004317\phv00218304\age\,pht004317.v1,\phs000209\pht004317\phv00218304\age\,phv00218304,,DIETARY AGE CATEGORY EXAM 5,{},,,,DIETARY AGE CATEGORY EXAM 5,phs000209.v13,ac944dc504f3357a08d7925266e7b1a78b60b960f79f6cb63c11f1ad37e1c844,categorical,phv00218304.v1,phs000209,False,age,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht004317,MESA_exam5dietnutrients,\phs000209\pht004317\phv00218304\age\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age,AGE,phs000209.v13.p3,phv00175875.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175875,[],phs000209,pht003087,phv00175875,False,True,False,age,AGE,45.0,\phs000209\pht003087\phv00175875\age\,pht003087.v1,\phs000209\pht003087\phv00175875\age\,phv00175875,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,AGE,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,84.0,AGE,phs000209.v13,2b62119652a07dced93c7ca76ba34a67f3956ebd42d1a64bcd2ef6c4f2a0b09c,continuous,phv00175875.v1,phs000209,False,age,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175875\age\,45.0,84.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Jackson Heart Study (JHS) Cohort,age,Age in Years,phs000286.v7.p2,phv00401379.v2.p2,pht008731.v2.p2,analysis3,phv00401379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Jackson Heart Study (JHS) Cohort,age,Age in Years,phs000286.v7.p2,phv00401282.v2.p2,pht008730.v2.p2,analysis2,phv00401282,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,REGARDS,baseline_calculated_variables.AGE,-,-,baseline_calculated_variables,AGE,Jackson Heart Study (JHS) Cohort,age,Age in Years,phs000286.v7.p2,phv00401085.v2.p2,pht008729.v2.p2,analysis1,phv00401085,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,REGARDS,baseline_calculated_variables.ALC_DRINKS_WK,-,1.961368983,baseline_calculated_variables,ALC_DRINKS_WK,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,REGARDS,baseline_calculated_variables.CAD_SR_ECG,-,-,baseline_calculated_variables,CAD_SR_ECG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,REGARDS,baseline_calculated_variables.CAD_SR_ECG,-,-,baseline_calculated_variables,CAD_SR_ECG,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,REGARDS,baseline_calculated_variables.CREATININE_SERUM,-,4.323625882,baseline_calculated_variables,CREATININE_SERUM,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Jackson Heart Study (JHS) Cohort,dbp,Diastolic Blood Pressure (mmHg),phs000286.v7.p2,phv00401410.v1.p2,pht008731.v2.p2,analysis3,phv00401410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Jackson Heart Study (JHS) Cohort,dbp,Diastolic Blood Pressure (mmHg),phs000286.v7.p2,phv00401309.v1.p2,pht008730.v2.p2,analysis2,phv00401309,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure,phs000007.v33.p14,phv00476659.v2.p14,pht010745.v2.p14,t_tonla_ex08_1b_1232s,phv00476659,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure - mmHg,phs000007.v33.p14,phv00476781.v2.p14,pht010746.v2.p14,t_tonla_ex09_1b_1233s,phv00476781,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure,phs000007.v33.p14,phv00476584.v1.p14,pht010744.v1.p14,t_tonla_ex02_3b_1235s,phv00476584,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,dbp,Diastolic blood pressure entered by technician,phs000007.v33.p14,phv00072660.v7.p14,pht000748.v8.p14,t_pat_ex08_1b_0230s,phv00072660,[],phs000007,pht000748,phv00072660,False,True,False,dbp,Diastolic blood pressure entered by technician,41.0,\phs000007\pht000748\phv00072660\dbp\,pht000748.v6,\phs000007\pht000748\phv00072660\dbp\,phv00072660,"Peripheral Arterial Tone, Original Cohort Exam 28, Offspring Cohort Exam 8",Diastolic blood pressure entered by technician,{},,"Peripheral Arterial Tone, Original Cohort Exam 28, Offspring Cohort Exam 8",112.0,Diastolic blood pressure entered by technician,phs000007.v31,650de5aaaea24927c97c390be9faef6f5028bd4530ca99855f005e7fff6e4f65,continuous,phv00072660.v5,phs000007,False,dbp,FHS,Framingham Cohort,pht000748,pat1_8s,\phs000007\pht000748\phv00072660\dbp\,41.0,112.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Diastolic blood pressure entered by technician,phs000007.v33.p14,phv00066713.v7.p14,pht000673.v8.p14,t_pat_2005_m_0259s,phv00066713,[],phs000007,pht000673,phv00066713,False,True,False,DBP,"DIASTOLIC BLOOD PRESSURE ENTERED BY TECHNICIAN, MMHG",46.0,\phs000007\pht000673\phv00066713\DBP\,pht000673.v7,\phs000007\pht000673\phv00066713\DBP\,phv00066713,"Peripheral Arterial Tone, Original Cohort Exam 28, Generation 3, and New Offspring Spouse Cohorts Exam 1","DIASTOLIC BLOOD PRESSURE ENTERED BY TECHNICIAN, MMHG",{},,"Peripheral Arterial Tone, Original Cohort Exam 28, Generation 3, and New Offspring Spouse Cohorts Exam 1",80.0,"DIASTOLIC BLOOD PRESSURE ENTERED BY TECHNICIAN, MMHG",phs000007.v31,0d4ee96721b2806651a8fad31af99ba9b138e874c9a9205a1bc12a1eb3f03687,continuous,phv00066713.v6,phs000007,False,DBP,FHS,Framingham Cohort,pht000673,pat_2005s,\phs000007\pht000673\phv00066713\DBP\,46.0,80.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure (from tonometry worksheet),phs000007.v33.p14,phv00024866.v2.p14,pht000211.v5.p14,t_tonla_ex26_0_1229s,phv00024866,[],phs000007,pht000211,phv00024866,False,True,False,dbp,BRACHIAL DIASTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG),38.0,\phs000007\pht000211\phv00024866\dbp\,pht000211.v4,\phs000007\pht000211\phv00024866\dbp\,phv00024866,"Vascular Tonometry, Original Cohort Exam 26",BRACHIAL DIASTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG),{},,"Vascular Tonometry, Original Cohort Exam 26",112.0,BRACHIAL DIASTOLIC PRESSURE (FROM TONOMETRY DATA) (MMHG),phs000007.v31,c146b7fd870f22fdea0e4225e2b3b09426df705cdd65b86845a7196191b5ba35,continuous,phv00024866.v1,phs000007,False,dbp,FHS,Framingham Cohort,pht000211,ton0_26s,\phs000007\pht000211\phv00024866\dbp\,38.0,112.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure,phs000007.v33.p14,phv00024825.v7.p14,pht000210.v8.p14,t_tonla_ex01_3b_1234s,phv00024825,[],phs000007,pht000210,phv00024825,False,True,False,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),42.0,\phs000007\pht000210\phv00024825\dbp\,pht000210.v7,\phs000007\pht000210\phv00024825\dbp\,phv00024825,"Non-Invasive Vascular Tonometry, Generation 3 Cohort Exam 1",BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),{},,"Non-Invasive Vascular Tonometry, Generation 3 Cohort Exam 1",114.0,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),phs000007.v31,0d565c5bf3a1345b02d948121081c0a64c6efc123c177cac68f6bd6652fb1963,continuous,phv00024825.v6,phs000007,False,dbp,FHS,Framingham Cohort,pht000210,ton3_1s,\phs000007\pht000210\phv00024825\dbp\,42.0,114.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,DBP,Brachial diastolic pressure,phs000007.v33.p14,phv00024779.v8.p14,pht000209.v9.p14,t_tonla_ex07_1b_1231s,phv00024779,[],phs000007,pht000209,phv00024779,False,True,False,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONDBP),37.0,\phs000007\pht000209\phv00024779\dbp\,pht000209.v7,\phs000007\pht000209\phv00024779\dbp\,phv00024779,"Non-Invasive Vascular Tonometry, Offspring Cohort Exam 7",BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONDBP),{},,"Non-Invasive Vascular Tonometry, Offspring Cohort Exam 7",115.0,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA) (OLD NAME: TONDBP),phs000007.v31,c034a0fa5e28e843267b38c77560a5174668678e1961d628e7318a2d09990782,continuous,phv00024779.v6,phs000007,False,dbp,FHS,Framingham Cohort,pht000209,ton1_7s,\phs000007\pht000209\phv00024779\dbp\,37.0,115.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),phs000007.v33.p14,phv00024480.v8.p14,pht000195.v9.p14,brach1_7s,phv00024480,[],phs000007,pht000195,phv00024480,False,True,False,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),37.0,\phs000007\pht000195\phv00024480\dbp\,pht000195.v7,\phs000007\pht000195\phv00024480\dbp\,phv00024480,"Non-invasive Vascular Brachial Test, Offspring Cohort Exam 7",BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),{},,"Non-invasive Vascular Brachial Test, Offspring Cohort Exam 7",115.0,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),phs000007.v31,3e70e9e34c2efb3fa461b4951607fbfaabf38b89010b676a0e5649f978eef197,continuous,phv00024480.v6,phs000007,False,dbp,FHS,Framingham Cohort,pht000195,brach1_7s,\phs000007\pht000195\phv00024480\dbp\,37.0,115.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Jackson Heart Study (JHS) Cohort,dbp,Diastolic Blood Pressure (mmHg),phs000286.v7.p2,phv00401119.v1.p2,pht008729.v2.p2,analysis1,phv00401119,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,REGARDS,baseline_calculated_variables.DBP,-,0.288241726,baseline_calculated_variables,DBP,Framingham Cohort,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),phs000007.v33.p14,phv00024413.v7.p14,pht000194.v9.p14,brach3_1s,phv00024413,[],phs000007,pht000194,phv00024413,False,True,False,dbp,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),42.0,\phs000007\pht000194\phv00024413\dbp\,pht000194.v7,\phs000007\pht000194\phv00024413\dbp\,phv00024413,"Non-invasive Vascular Brachial Test, Generation 3 Cohort Exam 1",BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),{},,"Non-invasive Vascular Brachial Test, Generation 3 Cohort Exam 1",114.0,BRACHIAL DIASTOLIC PRESSURE (MMHG)(FROM TONOMETRY DATA),phs000007.v31,4d04533962be0756014d4aa8fea1d2c4bbfa5caca3e0d0c50e0a2b6fac27e620,continuous,phv00024413.v6,phs000007,False,dbp,FHS,Framingham Cohort,pht000194,brach3_1s,\phs000007\pht000194\phv00024413\dbp\,42.0,114.0
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,REGARDS,baseline_calculated_variables.DIABETES_MEDS_SR_INSULIN,-,-,baseline_calculated_variables,DIABETES_MEDS_SR_INSULIN,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,REGARDS,baseline_calculated_variables.DIABETES_SR,-,-,baseline_calculated_variables,DIABETES_SR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,REGARDS,baseline_calculated_variables.DIAB_SRMED_GLU,-,-,baseline_calculated_variables,DIAB_SRMED_GLU,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,REGARDS,baseline_calculated_variables.ED_CAT,-,-,baseline_calculated_variables,ED_CAT,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Framingham Cohort,glucose,Glucose Sample type: EDTA plasma,phs000007.v33.p14,phv00462195.v1.p14,pht010726.v1.p14,l_fhslab_ex03_3b_1170s,phv00462195,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Jackson Heart Study (JHS) Cohort,GLUCOSE,Glucose mg/dL [Visit 1],phs000286.v7.p2,phv00127613.v2.p2,pht001959.v2.p2,loca,phv00127613,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucose,GLUCOSE,phs000209.v13.p3,phv00175887.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175887,[],phs000209,pht003087,phv00175887,False,True,False,glucose,GLUCOSE,72.0,\phs000209\pht003087\phv00175887\glucose\,pht003087.v1,\phs000209\pht003087\phv00175887\glucose\,phv00175887,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,GLUCOSE,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,268.0,GLUCOSE,phs000209.v13,4b08e9d1b44d962cc1e86fc5c568646f37c6a848d9a64923fc7fd9f09d69ed87,continuous,phv00175887.v1,phs000209,False,glucose,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175887\glucose\,72.0,268.0
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Framingham Cohort,GLUCOSE,Glucose (sample type: plasma),phs000007.v33.p14,phv00275416.v2.p14,pht006011.v2.p14,l_fhslab_ex03_7_0267s,phv00275416,[],phs000007,pht006011,phv00275416,False,True,True,GLUCOSE,Glucose (sample type: plasma),68.0,\phs000007\pht006011\phv00275416\GLUCOSE\,pht006011.v1,\phs000007\pht006011\phv00275416\GLUCOSE\,phv00275416,"Routine Blood Work Processed at Framingham, Omni 1 Exam 3",Glucose (sample type: plasma),{},,"Routine Blood Work Processed at Framingham, Omni 1 Exam 3",319.0,Glucose (sample type: plasma),phs000007.v31,3cdd710e1b3a7d891af8778a9a4734dd872a207e66f248cb8b882b043f15b2f7,continuous,phv00275416.v1,phs000007,True,GLUCOSE,FHS,Framingham Cohort,pht006011,l_fhslab_ex03_7_0267s,\phs000007\pht006011\phv00275416\GLUCOSE\,68.0,319.0
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Framingham Cohort,GLUCOSE,"Glucose, plasma",phs000007.v33.p14,phv00071893.v7.p14,pht000742.v8.p14,fhslab1_8s,phv00071893,[],phs000007,pht000742,phv00071893,False,True,False,GLUCOSE,"Glucose, plasma",36.0,\phs000007\pht000742\phv00071893\GLUCOSE\,pht000742.v6,\phs000007\pht000742\phv00071893\GLUCOSE\,phv00071893,"FHS Clinic Lab Assays Processed on Site, Offspring Cohort Exam 8","Glucose, plasma",{},,"FHS Clinic Lab Assays Processed on Site, Offspring Cohort Exam 8",339.0,"Glucose, plasma",phs000007.v31,37064dc760041d5dd6f1104e1c8b69ab7776e0dc0346fa6e4968649a3ae2c4bc,continuous,phv00071893.v5,phs000007,False,GLUCOSE,FHS,Framingham Cohort,pht000742,fhslab1_8s,\phs000007\pht000742\phv00071893\GLUCOSE\,36.0,339.0
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Framingham Cohort,GLUCOSE,Glucose (HILIC) (sample type: urine),phs000007.v33.p14,phv00219360.v2.p14,pht004362.v2.p14,l_umtbl_ex06_1_0742s,phv00219360,[],phs000007,pht004362,phv00219360,False,True,True,GLUCOSE,Glucose (HILIC) (sample type: urine),477.4,\phs000007\pht004362\phv00219360\GLUCOSE\,pht004362.v1,\phs000007\pht004362\phv00219360\GLUCOSE\,phv00219360,"Urine Metabolomics, Offspring Exam 6. This was a nested case control study. All participants were free of CKD at baseline. Half developed CKD at follow-up (exam 8); cases and controls were age-sex matched",Glucose (HILIC) (sample type: urine),{},,"Urine Metabolomics, Offspring Exam 6. This was a nested case control study. All participants were free of CKD at baseline. Half developed CKD at follow-up (exam 8); cases and controls were age-sex matched",63226.3,Glucose (HILIC) (sample type: urine),phs000007.v31,a1b53fce857b76c3dde9c0158751494f9ec31503ee911a1b6cd4e92bae0326c2,continuous,phv00219360.v1,phs000007,True,GLUCOSE,FHS,Framingham Cohort,pht004362,l_umtbl_ex06_1_0742s,\phs000007\pht004362\phv00219360\GLUCOSE\,477.4,63226.3
GLUCOSE,-,-,-,ARICREGARDS,0.33,REGARDS,baseline_calculated_variables.GLUCOSE,-,4.330252129,baseline_calculated_variables,GLUCOSE,Framingham Cohort,Glucose,Glucose,phs000007.v33.p14,phv00255372.v4.p14,pht005144.v4.p14,l_mtbnegam1_ex01_3_0956s,phv00255372,[],phs000007,pht005144,phv00255372,False,True,False,Glucose,Glucose,0.6016943753,\phs000007\pht005144\phv00255372\Glucose\,pht005144.v3,\phs000007\pht005144\phv00255372\Glucose\,phv00255372,"Negatively Charged Polar Metabolomics - Amide - Installment 1, Generation 3 Exam 1. High throughput metabolite profiling was performed on plasma specimens. The concentration of plasma metabolites was assessed using a liquid chromatography/tandem mass spectrometry (LC/MS/MS) platform with HILIC Amide chromatography. In the dataset, each metabolite value represents the plasma concentration of an analyte (in this case, metabolite) that was assayed. There are a total of 79 metabolites.",Glucose,{},,"Negatively Charged Polar Metabolomics - Amide - Installment 1, Generation 3 Exam 1. High throughput metabolite profiling was performed on plasma specimens. The concentration of plasma metabolites was assessed using a liquid chromatography/tandem mass spectrometry (LC/MS/MS) platform with HILIC Amide chromatography. In the dataset, each metabolite value represents the plasma concentration of an analyte (in this case, metabolite) that was assayed. There are a total of 79 metabolites.",2.2229373078,Glucose,phs000007.v31,2f4e334925e98aa2ac05db9a928838641fdfcc2919bbed53c17c660f98377c64,continuous,phv00255372.v3,phs000007,False,Glucose,FHS,Framingham Cohort,pht005144,l_mtbnegam1_ex01_3_0956s,\phs000007\pht005144\phv00255372\Glucose\,0.6016943753,2.2229373078
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,REGARDS,baseline_calculated_variables.INCOME,-,12.35794984,baseline_calculated_variables,INCOME,Hispanic Community Health Study /Study of Latinos (HCHS/SOL),INCOME,Yearly Household Income (ECEA3 and ECEA4),phs000810.v2.p2,phv00526188.v1.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,phv00526188,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,REGARDS,baseline_calculated_variables.INCOME,-,12.35794984,baseline_calculated_variables,INCOME,Jackson Heart Study (JHS) Cohort,Income,Income Status,phs000286.v7.p2,phv00401229.v2.p2,pht008729.v2.p2,analysis1,phv00401229,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,REGARDS,baseline_calculated_variables.INCOME,-,12.35794984,baseline_calculated_variables,INCOME,Women's Health Initiative,INCOME,Total family income (before taxes),phs000200.v12.p3,phv00078409.v6.p3,pht000997.v6.p3,f20_rel1,phv00078409,"['$10,000 to $19,999', '$100,000 to $149,999', '$150,000 or more', '$20,000 to $34,999', '$35,000 to $49,999', '$50,000 to $74,999', '$75,000 to $99,999', ""Don't know"", 'Less than $10,000']",phs000200,pht000997,phv00078409,True,False,False,INCOME,Total family income (before taxes),,\phs000200\pht000997\phv00078409\INCOME\,pht000997.v6,\phs000200\pht000997\phv00078409\INCOME\,phv00078409,"Form 20 - Personal Information --education; employment status; occupation; marital status; partner's education, employment status, occupation; total family income; recent history of mammogram, pelvic exam, endometrial aspiration; insurance coverage; serve in armed services. This self-administered questionnaire was required for all OS participants.",Total family income (before taxes),{},,"Form 20 - Personal Information --education; employment status; occupation; marital status; partner's education, employment status, occupation; total family income; recent history of mammogram, pelvic exam, endometrial aspiration; insurance coverage; serve in armed services. This self-administered questionnaire was required for all OS participants.",,Total family income (before taxes),phs000200.v12,59def3df0ad0a2ebcaa070956971d5b12888b8b7da4db923f70615c46a080695,categorical,phv00078409.v6,phs000200,False,INCOME,WHI,Women's Health Initiative,pht000997,f20_rel1,\phs000200\pht000997\phv00078409\INCOME\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,REGARDS,baseline_calculated_variables.LVH_12,-,-,baseline_calculated_variables,LVH_12,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,REGARDS,baseline_calculated_variables.REG_ASA,-,-,baseline_calculated_variables,REG_ASA,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,REGARDS,baseline_calculated_variables.STROKE_SR,-,-,baseline_calculated_variables,STROKE_SR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,REGARDS,baseline_calculated_variables.STROKE_SR,-,-,baseline_calculated_variables,STROKE_SR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,REGARDS,baseline_calculated_variables.TIA_SR,-,-,baseline_calculated_variables,TIA_SR,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,ARIC,chm.chm21,"Creatinine, Serum (mg/dL)",0.609652837,chm,chm21,Atherosclerosis Risk in Communities (ARIC) Cohort,CHM21,"Creatinine, serum [Clinical Chemistry Lab. CHM. Visit 5]",phs000280.v8.p2,phv00295246.v2.p2,pht006427.v2.p2,CHM,phv00295246,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,ARIC,chma.chma09,CREATININE (MG-DL) Q9,-,chma,chma09,Atherosclerosis Risk in Communities (ARIC) Cohort,CHMA09,Creatinine (mg/dL). Q9 [Clinical Chemistry Lab. CHMA. Visit 1],phs000280.v8.p2,phv00203867.v2.p2,pht004051.v3.p2,CHMA,phv00203867,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,chmb.chmb07,GLUCOSE (mg per dL) DEC PT REQ Q7,-,chmb,chmb07,Atherosclerosis Risk in Communities (ARIC) Cohort,CHMB07,Glucose (mg Per dL) Dec Pt Req. Q7 [Clinical Chemistry Lab. CHMB. Visit 2],phs000280.v8.p2,phv00203882.v2.p2,pht004052.v3.p2,CHMB,phv00203882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,ARIC,chmb.chmb08,CREATININE (mg per dL) DEC PT REQ Q8,-,chmb,chmb08,Atherosclerosis Risk in Communities (ARIC) Cohort,CHMB08,Creatinine (mg Per dL) Dec Pt Req. Q8 [Clinical Chemistry Lab. CHMB. Visit 2],phs000280.v8.p2,phv00203883.v2.p2,pht004052.v3.p2,CHMB,phv00203883,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,ARIC,derive13.aspirincode01,"Used Aspirin-containing analgesics (at Visit 1) in last 2 weeks (0=No, 1=Yes), based on 2004 Med Code",0.866435617,derive13,aspirincode01,Atherosclerosis Risk in Communities (ARIC) Cohort,ASPIRINCODE01,"Used aspirin-containing analgesics (at visit 1) in last 2 weeks (0=no, 1=yes), based on 2004 Med code [Cohort. Visit 1]",phs000280.v8.p2,phv00204694.v2.p2,pht004063.v3.p2,DERIVE13,phv00204694,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,ARIC,derive13.cholmdcode01,Cholesterol lowering medication w/in 2wks: Using 2004 Med Code -V1,0.759797387,derive13,cholmdcode01,Atherosclerosis Risk in Communities (ARIC) Cohort,CHOLMDCODE01,"Cholesterol lowering medication in past 2 weeks: using 2004 Med. code, visit 1 [Cohort. Visit 1]",phs000280.v8.p2,phv00204802.v2.p2,pht004063.v3.p2,DERIVE13,phv00204802,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,ARIC,derive13.clvh01,LVH present by cornell definition,-,derive13,clvh01,Atherosclerosis Risk in Communities (ARIC) Cohort,CLVH01,LVH present by Cornell definition [Cohort. Visit 1],phs000280.v8.p2,phv00204700.v2.p2,pht004063.v3.p2,DERIVE13,phv00204700,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FASTING_12HR,-,-,-,ARIC,0.66,ARIC,derive13.fast1202,FASTING TIME OF 12 HOURS OR MORE,0.459877366,derive13,fast1202,Atherosclerosis Risk in Communities (ARIC) Cohort,FAST1202,Fasting time of 12 hours or more [Cohort. Visit 1],phs000280.v8.p2,phv00204733.v2.p2,pht004063.v3.p2,DERIVE13,phv00204733,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,derive13.glucos01,DERIVED GLUCOSE VALUE in mg/dl,0.913089843,derive13,glucos01,Atherosclerosis Risk in Communities (ARIC) Cohort,GLUCOS01,DERIVED GLUCOSE VALUE in mg/dl,phs000280.v8.p2,phv00519794.v1.p2,pht012853.v1.p2,V1_V5_ANALYTES,phv00519794,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,derive13.glucos01,DERIVED GLUCOSE VALUE in mg/dl,0.913089843,derive13,glucos01,Atherosclerosis Risk in Communities (ARIC) Cohort,GLUCOS01,Derived glucose value in mg/dL [Cohort. Visit 1],phs000280.v8.p2,phv00204730.v2.p2,pht004063.v3.p2,DERIVE13,phv00204730,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.pad02,"PAD V1, Def 2 (same for both genders)",3.692348707,derive13,pad02,Atherosclerosis Risk in Communities (ARIC) Cohort,pad02,"Pad02 (peripheral artery disease, visit 1, definition 2, Ankle Brachial Index <.9 for both genders) [Ankle Brachial BP Index. ABI04. Visit 1]",phs000280.v8.p2,phv00202847.v2.p2,pht004027.v3.p2,ABI04,phv00202847,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.pad02,"PAD V1, Def 2 (same for both genders)",3.692348707,derive13,pad02,Atherosclerosis Risk in Communities (ARIC) Cohort,PAD02,"Peripheral artery disease visit 1, definition 2 - same for both genders [Cohort. Visit 1]",phs000280.v8.p2,phv00204795.v2.p2,pht004063.v3.p2,DERIVE13,phv00204795,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at Visit 1,phs000280.v8.p2,phv00506149.v1.p2,pht006443.v5.p2,INCps18,phv00506149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.prevhf01,Prevalent HF at Visit 1,1.832844575,derive13,prevhf01,Atherosclerosis Risk in Communities (ARIC) Cohort,PREVHF01,Prevalent heart failure at baseline [Cohort. Visit 1],phs000280.v8.p2,phv00204697.v2.p2,pht004063.v3.p2,DERIVE13,phv00204697,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.prvchd05,PREVALENT CORONARY HEART DISEASE,2.19941349,derive13,prvchd05,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD05,Prevalent coronary heart disease [Cohort. Visit 1],phs000280.v8.p2,phv00204706.v2.p2,pht004063.v3.p2,DERIVE13,phv00204706,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.prvchd05,PREVALENT CORONARY HEART DISEASE,2.19941349,derive13,prvchd05,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD05,PREVALENT CORONARY HEART DISEASE,phs000280.v8.p2,phv00506159.v1.p2,pht006443.v5.p2,INCps18,phv00506159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prvchd05,PREVALENT CORONARY HEART DISEASE,2.19941349,derive13,prvchd05,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD05,PREVALENT CORONARY HEART DISEASE,phs000280.v8.p2,phv00506159.v1.p2,pht006443.v5.p2,INCps18,phv00506159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.prvchd05,PREVALENT CORONARY HEART DISEASE,2.19941349,derive13,prvchd05,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD05,Prevalent coronary heart disease [Cohort. Visit 1],phs000280.v8.p2,phv00204706.v2.p2,pht004063.v3.p2,DERIVE13,phv00204706,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive13.rangna01,ROSE ANGINA,0.239936017,derive13,rangna01,Atherosclerosis Risk in Communities (ARIC) Cohort,RANGNA01,Rose angina [Cohort. Visit 1],phs000280.v8.p2,phv00204724.v2.p2,pht004063.v3.p2,DERIVE13,phv00204724,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.rangna01,ROSE ANGINA,0.239936017,derive13,rangna01,Atherosclerosis Risk in Communities (ARIC) Cohort,RANGNA01,Rose angina [Cohort. Visit 1],phs000280.v8.p2,phv00204724.v2.p2,pht004063.v3.p2,DERIVE13,phv00204724,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.roseic03,"ROSE INTERMITTENT CLAUDICATION, DEF. 3",0.299920021,derive13,roseic03,Atherosclerosis Risk in Communities (ARIC) Cohort,ROSEIC03,Rose intermittent claudication [Cohort. Visit 1],phs000280.v8.p2,phv00204747.v2.p2,pht004063.v3.p2,DERIVE13,phv00204747,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive13.roseic03,"ROSE INTERMITTENT CLAUDICATION, DEF. 3",0.299920021,derive13,roseic03,Atherosclerosis Risk in Communities (ARIC) Cohort,ROSEIC03,Rose intermittent claudication [Cohort. Visit 1],phs000280.v8.p2,phv00204747.v2.p2,pht004063.v3.p2,DERIVE13,phv00204747,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,ARIC,derive13.symchd03,SYMPTOMATIC CORONARY HEART DISEASE,1.073047187,derive13,symchd03,Atherosclerosis Risk in Communities (ARIC) Cohort,SYMCHD03,Symptomatic coronary heart disease [Cohort. Visit 1],phs000280.v8.p2,phv00204751.v2.p2,pht004063.v3.p2,DERIVE13,phv00204751,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,ARIC,derive13.v1age01,AGE AT VISIT 1,-,derive13,v1age01,Atherosclerosis Risk in Communities (ARIC) Cohort,V1AGE01,Age at visit 1 [Cohort. Visit 1],phs000280.v8.p2,phv00204712.v2.p2,pht004063.v3.p2,DERIVE13,phv00204712,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,ARIC,derive2_10.aspirincode21,"Used Aspirin-containing analgesics (at Visit 2) in last 2 weeks (0=No, 1=Yes), based on 2004 Med Code",0.323410511,derive2_10,aspirincode21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,ARIC,derive2_10.cholmdcode21,Cholesterol lowering medication w/in 2wks: Using 2004 Med Code -V2,0.308710033,derive2_10,cholmdcode21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,ARIC,derive2_10.clvh21,LVH present by cornell definition,-,derive2_10,clvh21,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FASTING_12HR,-,-,-,ARIC,0.66,ARIC,derive2_10.fast1223,"V2 Fast 12 Hrs or More, Definition 2",0.308710033,derive2_10,fast1223,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,ARIC,derive2_10.v2age22,Age at Visit 2,-,derive2_10,v2age22,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,derive2_10.v2days,DAYS SINCE EXAM 1,-,derive2_10,v2days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,ARIC,derive37.aspirincode31,"Used Aspirin-containing analgesics (at Visit 3) in last 2 weeks (0=No, 1=Yes), based on 2004 Med Code",0.262596422,derive37,aspirincode31,Atherosclerosis Risk in Communities (ARIC) Cohort,ASPIRINCODE31,"Used aspirin-containing analgesics (at visit 3) in last 2 weeks (0=no, 1=yes), based on 2004 Med. code [Cohort. Visit 3]",phs000280.v8.p2,phv00204825.v2.p2,pht004064.v3.p2,DERIVE37,phv00204825,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,ARIC,derive37.cholmdcode31,Cholesterol lowering medication w/in 2wks: Using 2004 Med Code -V3,0.205153455,derive37,cholmdcode31,Atherosclerosis Risk in Communities (ARIC) Cohort,CHOLMDCODE31,"Cholesterol lowering medication within 2 wks.: using 2004 Med. Code, visit 3 [Cohort. Visit 3]",phs000280.v8.p2,phv00204917.v2.p2,pht004064.v3.p2,DERIVE37,phv00204917,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,ARIC,derive37.clvh31,LVH present by cornell definition,-,derive37,clvh31,Atherosclerosis Risk in Communities (ARIC) Cohort,CLVH31,LVH present by Cornell definition [Cohort. Visit 3],phs000280.v8.p2,phv00204830.v2.p2,pht004064.v3.p2,DERIVE37,phv00204830,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,ARIC,derive37.diabts34,Diabetes Using Lower Cutpoint 126 mg/dL,0.623666503,derive37,diabts34,Atherosclerosis Risk in Communities (ARIC) Cohort,DIABTS34,Diabetes using lower cut point 126 [mg/dL] [Cohort. Visit 3],phs000280.v8.p2,phv00204899.v2.p2,pht004064.v3.p2,DERIVE37,phv00204899,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FASTING_12HR,-,-,-,ARIC,0.66,ARIC,derive37.fast1234,Fasting Time of 12 Hours or More,0.812407681,derive37,fast1234,Atherosclerosis Risk in Communities (ARIC) Cohort,FAST1234,Fasting time of 12 hours or more [Cohort. Visit 3],phs000280.v8.p2,phv00204903.v2.p2,pht004064.v3.p2,DERIVE37,phv00204903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive37.pad32,"PAD V3, Def 2 (same for both genders)",65.00082061,derive37,pad32,Atherosclerosis Risk in Communities (ARIC) Cohort,pad32,"Peripheral artery disease, version 3 (definition 2), Ankle Brachial Index less than 0.9 for both genders [Ankle Brachial BP Index. ABI34. Visit 3]",phs000280.v8.p2,phv00202856.v2.p2,pht004028.v3.p2,ABI34,phv00202856,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive37.pad32,"PAD V3, Def 2 (same for both genders)",65.00082061,derive37,pad32,Atherosclerosis Risk in Communities (ARIC) Cohort,PAD32,"PAD visit 3, definition 2 (same for both genders) [Cohort. Visit 3]",phs000280.v8.p2,phv00204906.v2.p2,pht004064.v3.p2,DERIVE37,phv00204906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive37.prvchd33,"Prevalent CHD at V3, definition 3",2.067946824,derive37,prvchd33,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD33,"Prevalent coronary heart disease at visit 3, definition 3 [Cohort. Visit 3]",phs000280.v8.p2,phv00204911.v2.p2,pht004064.v3.p2,DERIVE37,phv00204911,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,ARIC,derive37.v3age31,Age at Visit 3,-,derive37,v3age31,Atherosclerosis Risk in Communities (ARIC) Cohort,V3AGE31,Age at visit 3 [Cohort. Visit 3],phs000280.v8.p2,phv00204871.v2.p2,pht004064.v3.p2,DERIVE37,phv00204871,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive37.v3days,DAYS SINCE EXAM 1,-,derive37,v3days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive37.v3days,DAYS SINCE EXAM 1,-,derive37,v3days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,derive37.v3days,DAYS SINCE EXAM 1,-,derive37,v3days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,ARIC,derive47.aspirincode41,"Used Aspirin-containing analgesics (at Visit 4) in last 2 weeks (0=No, 1=Yes), based on 2004 Med Code",0.409649522,derive47,aspirincode41,Atherosclerosis Risk in Communities (ARIC) Cohort,ASPIRINCODE41,"Used Aspirin-Containing Analgesics (At Visit 4) In Last 2 Weeks (0=no, 1=yes), Based On 2004 Med Code [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00511950.v1.p2,pht012813.v1.p2,DERIVE48,phv00511950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,ARIC,derive47.cholmdcode41,Cholesterol lowering medication w/in 2wks: Using 2004 Med Code -V4,0.391442877,derive47,cholmdcode41,Atherosclerosis Risk in Communities (ARIC) Cohort,CHOLMDCODE41,"Cholesterol Lowering Medication Within 2wks: Using 2004 Med Code -V3 [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00512034.v1.p2,pht012813.v1.p2,DERIVE48,phv00512034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,ARIC,derive47.clvh41,LVH present by cornell definition,-,derive47,clvh41,Atherosclerosis Risk in Communities (ARIC) Cohort,CLVH41,"LVH Present By Cornell Definition [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00511955.v1.p2,pht012813.v1.p2,DERIVE48,phv00511955,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,ARIC,derive47.diabts42,Diabetes Using Lower Cutpoint 126 mg/dL,1.201638598,derive47,diabts42,Atherosclerosis Risk in Communities (ARIC) Cohort,DIABTS42,"Diabetes Using Lower Cut point 126 Mg/dL [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00511979.v1.p2,pht012813.v1.p2,DERIVE48,phv00511979,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive47.pad42,"PAD V4, Def 2 (same for both genders)",44.86117433,derive47,pad42,Atherosclerosis Risk in Communities (ARIC) Cohort,PAD42,"Pad V4, Definition 2 (Same For Both Genders) [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00512021.v1.p2,pht012813.v1.p2,DERIVE48,phv00512021,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive47.pad42,"PAD V4, Def 2 (same for both genders)",44.86117433,derive47,pad42,Atherosclerosis Risk in Communities (ARIC) Cohort,pad42,"PAD42 [peripheral artery disease, visit 4 (definition 2) , Ankle Brachial Index less than .9 for both genders] [Ankle Brachial BP Index. ABI44. Visit 4]",phs000280.v8.p2,phv00202866.v2.p2,pht004029.v3.p2,ABI44,phv00202866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive47.prvchd43,"Prevalent CHD at V4, definition 3",1.957214383,derive47,prvchd43,Atherosclerosis Risk in Communities (ARIC) Cohort,PRVCHD43,"Prevalent Coronary Heart Disease At V4, Definition 3 [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00512028.v1.p2,pht012813.v1.p2,DERIVE48,phv00512028,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,ARIC,derive47.v4age41,Age at Visit 4,-,derive47,v4age41,Atherosclerosis Risk in Communities (ARIC) Cohort,V4AGE41,"Age At Visit 4 [Derived Variable Dataset, visit 4]",phs000280.v8.p2,phv00511996.v1.p2,pht012813.v1.p2,DERIVE48,phv00511996,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,ARIC,derive47.v4days,DAYS SINCE EXAM 1,-,derive47,v4days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,derive47.v4days,DAYS SINCE EXAM 1,-,derive47,v4days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,derive47.v4days,DAYS SINCE EXAM 1,-,derive47,v4days,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,ARIC,derive51.diabts54,V5 Diabetes - Lower Cutpoint 126 mg/dL,3.591905565,derive51,diabts54,Atherosclerosis Risk in Communities (ARIC) Cohort,DIABTS54,Diabetes - Lower Cutpoint 126 mg/dL [Cohort Visit Derived Variables. Visit 5],phs000280.v8.p2,phv00512061.v1.p2,pht012814.v1.p2,DERIVE53,phv00512061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,ARIC,derive51.v5age52,Corrected Visit 5 age,-,derive51,v5age52,Atherosclerosis Risk in Communities (ARIC) Cohort,V5AGE52,Corrected Visit 5 age [Cohort Visit Derived Variables. Visit 5],phs000280.v8.p2,phv00512053.v1.p2,pht012814.v1.p2,DERIVE53,phv00512053,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtia.dtia09,CONSUMED APPLES OR PEARS Q9,-,dtia,dtia09,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA09,"[Fruits]. In the past year, how often on average did you consume... Fresh apples or pears; 1. Q9 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205068.v2.p2,pht004068.v3.p2,dtia,phv00205068,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtia.dtia10,CONSUMED ORANGES Q10,-,dtia,dtia10,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA10,"[Fruits]. In the past year, how often on average did you consume... Oranges; 1. Q10 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205069.v2.p2,pht004068.v3.p2,dtia,phv00205069,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtia.dtia12,CONSUMED PEACHES APRICOTS PLUMS Q12,-,dtia,dtia12,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA12,"[Fruits]. In the past year, how often on average did you consume... Peaches, apricots, plums; 1 fresh or 1/2 c. canned or dried. Q12 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205071.v2.p2,pht004068.v3.p2,dtia,phv00205071,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtia.dtia13,CONSUMED BANANAS Q13,-,dtia,dtia13,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA13,"[Fruits]. In the past year, how often on average did you consume... Bananas; 1. Q13 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205072.v2.p2,pht004068.v3.p2,dtia,phv00205072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtia.dtia14,CONSUMED OTHER FRUITS Q14,-,dtia,dtia14,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA14,"[Fruits]. In the past year, how often on average did you consume... Other fruits; 1 fresh or 1/2 c. canned, including fruit cocktail. Q14 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205073.v2.p2,pht004068.v3.p2,dtia,phv00205073,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia15,CONSUMED STRING OR GREEN BEANS Q15,-,dtia,dtia15,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA15,"[Vegetables]. In the past year, how often on average did you consume... String or green beans; 1/2 c. Q15 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205074.v2.p2,pht004068.v3.p2,dtia,phv00205074,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia16,CONSUMED BROCCOLI Q16,-,dtia,dtia16,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA16,"[Vegetables]. In the past year, how often on average did you consume... Broccoli; 1/2 c. Q16 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205075.v2.p2,pht004068.v3.p2,dtia,phv00205075,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia17,"CABBAGE, CAULIFLWR,BUS SPROUT Q17",-,dtia,dtia17,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA17,"[Vegetables]. In the past year, how often on average did you consume... Cabbage, cauliflower, brussels sprouts; 1/2 c. Q17 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205076.v2.p2,pht004068.v3.p2,dtia,phv00205076,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia18,CONSUMED CARROTS Q18,-,dtia,dtia18,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA18,"[Vegetables]. In the past year, how often on average did you consume... Carrots; 1 whole or 1/2 c. cooked. Q18 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205077.v2.p2,pht004068.v3.p2,dtia,phv00205077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia19,CONSUMED CORN Q19,-,dtia,dtia19,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA19,"[Vegetables]. In the past year, how often on average did you consume... Corn; 1 ear or 1/2 c. Q19 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205078.v2.p2,pht004068.v3.p2,dtia,phv00205078,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia20,"SPINACH, COLLARDS, GREENS Q20",-,dtia,dtia20,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA20,"[Vegetables]. In the past year, how often on average did you consume... Spinach, collards, or other greens, but do not include lettuce; 1/2 c. Q20 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205079.v2.p2,pht004068.v3.p2,dtia,phv00205079,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia21,CONSUMED PEAS OR LIMA BEANS Q21,-,dtia,dtia21,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA21,"[Vegetables]. In the past year, how often on average did you consume... Peas or lima beans; 1/2 c. fresh, frozen or canned. Q21 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205080.v2.p2,pht004068.v3.p2,dtia,phv00205080,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia22,CONSUMED DARK YELLOW SQUASH Q22,-,dtia,dtia22,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA22,"[Vegetables]. In the past year, how often on average did you consume... Dark yellow, winter squash such as acorn, butternut; 1/2 c. Q22 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205081.v2.p2,pht004068.v3.p2,dtia,phv00205081,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia23,CONSUMED SWEET POTATOES Q23,-,dtia,dtia23,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA23,"[Vegetables]. In the past year, how often on average did you consume... Sweet potatoes; 1/2 c. Q23 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205082.v2.p2,pht004068.v3.p2,dtia,phv00205082,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia24,CONSUMED BEANS OR LENTILS Q24,-,dtia,dtia24,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA24,"[Vegetables]. In the past year, how often on average did you consume... Baked beans or lentils, dried cooked or canned, such as pinto, black eye, baked beans; 1/2 c. Q24 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205083.v2.p2,pht004068.v3.p2,dtia,phv00205083,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtia.dtia25,CONSUMED TOMATOES Q25,-,dtia,dtia25,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA25,"[Vegetables]. In the past year, how often on average did you consume... Tomatoes; 1, or tomato juice; 4 oz. Q25 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205084.v2.p2,pht004068.v3.p2,dtia,phv00205084,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,dtia.dtia90,DRINK ALCOHOLIC BEVERAGE Q90,-,dtia,dtia90,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA90,"[Alcohol]. I am going to ask you about wine, beer, and drinks made with hard liquor because these are the three major types of alcoholic beverages. Do you presently drink alcoholic beverages? Q90 [Dietary Intake Form. DTIA. Visit 1]",phs000280.v8.p2,phv00205157.v2.p2,pht004068.v3.p2,dtia,phv00205157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,dtia.dtia96,NO OF GLASSES WINE CONSUMED P WK Q96,43.73831776,dtia,dtia96,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA96,[Alcohol]. How many glasses of wine do you usually have per week? (4 oz. glasses; round down). Q96 [Dietary Intake Form. DTIA. Visit 1],phs000280.v8.p2,phv00205167.v2.p2,pht004068.v3.p2,dtia,phv00205167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,dtia.dtia97,NO OF CANS OF BEER CONSUMED P WK Q97,43.71161549,dtia,dtia97,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA97,[Alcohol]. How many bottles of cans of beer do you usually have per week? (12 oz. bottles or cans; round down). Q97 [Dietary Intake Form. DTIA. Visit 1],phs000280.v8.p2,phv00205168.v2.p2,pht004068.v3.p2,dtia,phv00205168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,dtia.dtia98,NO OF HARD LIQUOR DRINKS PER WK Q98,43.76502003,dtia,dtia98,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIA98,[Alcohol]. How many drinks of hard liquor do you usually have per week? (1 1/2 oz. shots; round down). Q98 [Dietary Intake Form. DTIA. Visit 1],phs000280.v8.p2,phv00205169.v2.p2,pht004068.v3.p2,dtia,phv00205169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtic04.dtic10,CONSUMED ORANGES Q10,-,dtic04,dtic10,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC10,"[Fruits]. In the past year, how often on average did you consume... Oranges; 1. Q10 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205289.v2.p2,pht004070.v3.p2,DTIC04,phv00205289,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtic04.dtic12,CONSUMED PEACHES APRICOTS PLUMS Q12,-,dtic04,dtic12,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC12,"[Fruits]. In the past year, how often on average did you consume... Peaches, apricots or plums; 1 fresh or 1/2 c. canned or dried. Q12 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205291.v2.p2,pht004070.v3.p2,DTIC04,phv00205291,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtic04.dtic13,CONSUMED BANANAS Q13,-,dtic04,dtic13,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC13,"[Fruits]. In the past year, how often on average did you consume... Bananas; 1. Q13 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205292.v2.p2,pht004070.v3.p2,DTIC04,phv00205292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtic04.dtic14,CONSUMED OTHER FRUITS Q14,-,dtic04,dtic14,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC14,"[Fruits]. In the past year, how often on average did you consume... Other fruits; 1 fresh or 1/2 c. canned, including fruit cocktail. Q14 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205293.v2.p2,pht004070.v3.p2,DTIC04,phv00205293,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic15,CONSUMED STRING OR GREEN BEANS Q15,-,dtic04,dtic15,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC15,"[Fruits]. In the past year, how often on average did you consume... String beans or green beans; 1/2 c. Q15 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205294.v2.p2,pht004070.v3.p2,DTIC04,phv00205294,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic16,CONSUMED BROCCOLI Q16,-,dtic04,dtic16,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC16,"[Fruits]. In the past year, how often on average did you consume... Broccoli; 1/2 c. Q16 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205295.v2.p2,pht004070.v3.p2,DTIC04,phv00205295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic17,"CABBAGE, CAULIFLWR, BRUS SPROUTS Q17",-,dtic04,dtic17,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC17,"[Fruits]. In the past year, how often on average did you consume... Cabbage, cauliflower, Brussels sprouts; 1/2 c. Q17 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205296.v2.p2,pht004070.v3.p2,DTIC04,phv00205296,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic18,CONSUMED CARROTS Q18,-,dtic04,dtic18,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC18,"[Fruits]. In the past year, how often on average did you consume... Carrots; 1 whole or 1/2 c. cooked. Q18 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205297.v2.p2,pht004070.v3.p2,DTIC04,phv00205297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic19,CONSUMED CORN Q19,-,dtic04,dtic19,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC19,"[Fruits]. In the past year, how often on average did you consume... Corn; 1 ear or 1/2 c. Q19 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205298.v2.p2,pht004070.v3.p2,DTIC04,phv00205298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic20,"SPINACH, COLLARDS, GREENS Q20",-,dtic04,dtic20,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC20,"[Fruits]. In the past year, how often on average did you consume... Spinach, collards or other greens, but do not include lettuce; 1/2 c. Q20 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205299.v2.p2,pht004070.v3.p2,DTIC04,phv00205299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic21,CONSUMED PEAS OR LIMA BEANS Q21,-,dtic04,dtic21,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC21,"[Fruits]. In the past year, how often on average did you consume... Peas or lima beans; 1/2 c. fresh, frozen or canned. Q21 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205300.v2.p2,pht004070.v3.p2,DTIC04,phv00205300,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic22,CONSUMED DARK YELLOW SQUASH Q22,-,dtic04,dtic22,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC22,"[Fruits]. In the past year, how often on average did you consume... Dark yellow, winter squash such as acorn, butternut; 1/2 c. Q22 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205301.v2.p2,pht004070.v3.p2,DTIC04,phv00205301,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic23,CONSUMED SWEET POTATOES Q23,-,dtic04,dtic23,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC23,"[Fruits]. In the past year, how often on average did you consume... Sweet potatoes; 1/2 c. Q23 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205302.v2.p2,pht004070.v3.p2,DTIC04,phv00205302,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic24,CONSUMED BEANS OR LENTILS Q24,-,dtic04,dtic24,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC24,"[Fruits]. In the past year, how often on average did you consume... Beans or lentils, dried cooked, or canned, such as pinto, black eye, baked beans; 1/2 c. Q24 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205303.v2.p2,pht004070.v3.p2,DTIC04,phv00205303,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,ARIC,dtic04.dtic25,CONSUMED TOMATOES Q25,-,dtic04,dtic25,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC25,"[Fruits]. In the past year, how often on average did you consume... Tomatoes; 1, or tomato juice; 4 oz. Q25 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205304.v2.p2,pht004070.v3.p2,DTIC04,phv00205304,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,ARIC,dtic04.dtic9,CONSUMED APPLES OR PEARS Q9,-,dtic04,dtic9,Atherosclerosis Risk in Communities (ARIC) Cohort,DTIC9,"[Fruits]. In the past year, how often on average did you consume... Fresh apples or pears; 1. Q9 [Dietary Intake Form. DTIC04. Visit 3]",phs000280.v8.p2,phv00205288.v2.p2,pht004070.v3.p2,DTIC04,phv00205288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex08_1_0005d.h011,Number aspirins taken regularly,0.167504188,e_exam_ex08_1_0005d,h011,Framingham Cohort,h011,Medical History - Medications: Number of aspirins taken regularly,phs000007.v33.p14,phv00251272.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251272,"['1', '2', '3', '4', 'H010 = 0']",phs000007,pht004815,phv00251272,True,False,False,h011,Medical History - Medications: Number of aspirins taken regularly,,\phs000007\pht004815\phv00251272\h011\,pht004815.v1,\phs000007\pht004815\phv00251272\h011\,phv00251272,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Medical History - Medications: Number of aspirins taken regularly,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Medical History - Medications: Number of aspirins taken regularly,phs000007.v31,b15ee6068592380ce45020aa4d520318c55187643d2ac380c5c6fdd5b53d12fd,categorical,phv00251272.v1,phs000007,False,h011,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251272\h011\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex08_1_0005d.h011,Number aspirins taken regularly,0.167504188,e_exam_ex08_1_0005d,h011,Framingham Cohort,H011,"IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY",phs000007.v33.p14,phv00072054.v7.p14,pht000747.v8.p14,ex1_8s,phv00072054,"['1', '10', '15', '2', '3', '4', '5', '6', '7', '8', 'DOES NOT TAKE ASPIRIN REGULARLY']",phs000007,pht000747,phv00072054,True,False,False,H011,"IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY",,\phs000007\pht000747\phv00072054\H011\,pht000747.v6,\phs000007\pht000747\phv00072054\H011\,phv00072054,"Clinic Exam, Offspring Cohort Exam 8","IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY",{},,"Clinic Exam, Offspring Cohort Exam 8",,"IF TAKING ASPIRIN, NUMBER OF ASPIRINS TAKEN REGULARLY",phs000007.v31,f3aa5f31b91498cadc1cc9ffde40bb11e90debdd30b2e17f2c1e1d8ce44bfb7b,categorical,phv00072054.v5,phs000007,False,H011,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072054\H011\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex08_1_0005d.h012,Aspirin Frequency per,0.201005025,e_exam_ex08_1_0005d,h012,Framingham Cohort,H012,"IF TAKING ASPIRIN, FREQUENCY PER",phs000007.v33.p14,phv00072055.v7.p14,pht000747.v8.p14,ex1_8s,phv00072055,"['DAY', 'DOES NOT TAKE ASPIRIN REGULARLY', 'MONTH', 'WEEK', 'YEAR']",phs000007,pht000747,phv00072055,True,False,False,H012,"IF TAKING ASPIRIN, FREQUENCY PER",,\phs000007\pht000747\phv00072055\H012\,pht000747.v6,\phs000007\pht000747\phv00072055\H012\,phv00072055,"Clinic Exam, Offspring Cohort Exam 8","IF TAKING ASPIRIN, FREQUENCY PER",{},,"Clinic Exam, Offspring Cohort Exam 8",,"IF TAKING ASPIRIN, FREQUENCY PER",phs000007.v31,f5e3660c776891df60f3fc30ccc0fb038bf618dea95cc043674af1daf1aaa3ca,categorical,phv00072055.v5,phs000007,False,H012,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072055\H012\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex08_1_0005d.h012,Aspirin Frequency per,0.201005025,e_exam_ex08_1_0005d,h012,Framingham Cohort,h012,Medical History - Medications: Aspirin frequency per,phs000007.v33.p14,phv00251273.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251273,"['Day', 'H010 = 0', 'Month', 'Week']",phs000007,pht004815,phv00251273,True,False,False,h012,Medical History - Medications: Aspirin frequency per,,\phs000007\pht004815\phv00251273\h012\,pht004815.v1,\phs000007\pht004815\phv00251273\h012\,phv00251273,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Medical History - Medications: Aspirin frequency per,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Medical History - Medications: Aspirin frequency per,phs000007.v31,f8184ca06812675d019620f961972d844057d2664e41aa70fd2bb1c848f5baef,categorical,phv00251273.v1,phs000007,False,h012,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251273\h012\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,e_exam_ex08_1_0005d.h309,ECG - RHYTHM,0.033500838,e_exam_ex08_1_0005d,h309,Framingham Cohort,H309,ECG: RHYTHM PREDOMINANT,phs000007.v33.p14,phv00072266.v7.p14,pht000747.v8.p14,ex1_8s,phv00072266,[],phs000007,pht000747,phv00072266,False,True,False,H309,ECG: RHYTHM PREDOMINANT,0.0,\phs000007\pht000747\phv00072266\H309\,pht000747.v6,\phs000007\pht000747\phv00072266\H309\,phv00072266,"Clinic Exam, Offspring Cohort Exam 8",ECG: RHYTHM PREDOMINANT,{},,"Clinic Exam, Offspring Cohort Exam 8",1.0,ECG: RHYTHM PREDOMINANT,phs000007.v31,893245ecf74b89b0b68a222615652fadd991532582aa055db1e032630301516a,continuous,phv00072266.v5,phs000007,False,H309,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072266\H309\,0.0,1.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,e_exam_ex08_1_0005d.h309,ECG - RHYTHM,0.033500838,e_exam_ex08_1_0005d,h309,Framingham Cohort,h309,Electrocardiograph - Part I: Rhythm - predominant,phs000007.v33.p14,phv00251462.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251462,"['Atrial fibrillation / atrial flutter', 'Normal sinus, (including s.tach, s.brady, s arrhy, 1 degree AV block)', 'Other or combination of above', 'Paced']",phs000007,pht004815,phv00251462,True,False,False,h309,Electrocardiograph - Part I: Rhythm - predominant,,\phs000007\pht004815\phv00251462\h309\,pht004815.v1,\phs000007\pht004815\phv00251462\h309\,phv00251462,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Electrocardiograph - Part I: Rhythm - predominant,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Electrocardiograph - Part I: Rhythm - predominant,phs000007.v31,d4106e3cdeeecd32de0327c2152dd39aaab10ff658a6728d2f7d79d1e508b3a4,categorical,phv00251462.v1,phs000007,False,h309,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251462\h309\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h339,CDI - RHEUMATIC HEART DISEASE,0.201005025,e_exam_ex08_1_0005d,h339,Framingham Cohort,h339,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Rheumatic Heart Disease,phs000007.v33.p14,phv00251492.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251492,['No'],phs000007,pht004815,phv00251492,True,False,False,h339,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Rheumatic Heart Disease,,\phs000007\pht004815\phv00251492\h339\,pht004815.v1,\phs000007\pht004815\phv00251492\h339\,phv00251492,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Rheumatic Heart Disease,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Rheumatic Heart Disease,phs000007.v31,57d099c3ba65a547ca498a9b08c882efa80af90e91ddddab582458231e85b607,categorical,phv00251492.v1,phs000007,False,h339,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251492\h339\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h339,CDI - RHEUMATIC HEART DISEASE,0.201005025,e_exam_ex08_1_0005d,h339,Framingham Cohort,H339,CLINICAL DIAGNOSTIC IMPRESSION: RHEUMATIC HEART DISEASE,phs000007.v33.p14,phv00072296.v7.p14,pht000747.v8.p14,ex1_8s,phv00072296,"['MAYBE', 'NO', 'YES']",phs000007,pht000747,phv00072296,True,False,False,H339,CLINICAL DIAGNOSTIC IMPRESSION: RHEUMATIC HEART DISEASE,,\phs000007\pht000747\phv00072296\H339\,pht000747.v6,\phs000007\pht000747\phv00072296\H339\,phv00072296,"Clinic Exam, Offspring Cohort Exam 8",CLINICAL DIAGNOSTIC IMPRESSION: RHEUMATIC HEART DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 8",,CLINICAL DIAGNOSTIC IMPRESSION: RHEUMATIC HEART DISEASE,phs000007.v31,f917e592e8d72853c7286a1d1d2ee1f5e7d46d98cda49b84cb96735e9adff9e2,categorical,phv00072296.v5,phs000007,False,H339,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072296\H339\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h340,CDI - AORTIC VALVE DISEASE,0.167504188,e_exam_ex08_1_0005d,h340,Framingham Cohort,h340,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Aortic Valve Disease,phs000007.v33.p14,phv00251493.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251493,"['Maybe', 'No', 'Yes']",phs000007,pht004815,phv00251493,True,False,False,h340,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Aortic Valve Disease,,\phs000007\pht004815\phv00251493\h340\,pht004815.v1,\phs000007\pht004815\phv00251493\h340\,phv00251493,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Aortic Valve Disease,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Aortic Valve Disease,phs000007.v31,4695753d252ea47287bd1f3ebef54dc1dfc9f0285ca41a34d3373f1e036c3356,categorical,phv00251493.v1,phs000007,False,h340,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251493\h340\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h340,CDI - AORTIC VALVE DISEASE,0.167504188,e_exam_ex08_1_0005d,h340,Framingham Cohort,H340,CLINICAL DIAGNOSTIC IMPRESSION: AORTIC VALVE DISEASE,phs000007.v33.p14,phv00072297.v7.p14,pht000747.v8.p14,ex1_8s,phv00072297,"['MAYBE', 'NO', 'YES']",phs000007,pht000747,phv00072297,True,False,False,H340,CLINICAL DIAGNOSTIC IMPRESSION: AORTIC VALVE DISEASE,,\phs000007\pht000747\phv00072297\H340\,pht000747.v6,\phs000007\pht000747\phv00072297\H340\,phv00072297,"Clinic Exam, Offspring Cohort Exam 8",CLINICAL DIAGNOSTIC IMPRESSION: AORTIC VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 8",,CLINICAL DIAGNOSTIC IMPRESSION: AORTIC VALVE DISEASE,phs000007.v31,46d1bb60a63f4a76d14b9cd5ae1e8ec99de0e5480a9d85278711e28598756915,categorical,phv00072297.v5,phs000007,False,H340,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072297\H340\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h341,CDI - MITRAL VALVE DISEASE,0.167504188,e_exam_ex08_1_0005d,h341,Framingham Cohort,H341,CLINICAL DIAGNOSTIC IMPRESSION: MITRAL VALVE DISEASE,phs000007.v33.p14,phv00072298.v7.p14,pht000747.v8.p14,ex1_8s,phv00072298,"['MAYBE', 'NO', 'YES']",phs000007,pht000747,phv00072298,True,False,False,H341,CLINICAL DIAGNOSTIC IMPRESSION: MITRAL VALVE DISEASE,,\phs000007\pht000747\phv00072298\H341\,pht000747.v6,\phs000007\pht000747\phv00072298\H341\,phv00072298,"Clinic Exam, Offspring Cohort Exam 8",CLINICAL DIAGNOSTIC IMPRESSION: MITRAL VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 8",,CLINICAL DIAGNOSTIC IMPRESSION: MITRAL VALVE DISEASE,phs000007.v31,0dacd2c18da6350af4627dec4f6a4c6714ddcc8ebf5ee05f829b0ae414811b1e,categorical,phv00072298.v5,phs000007,False,H341,FHS,Framingham Cohort,pht000747,ex1_8s,\phs000007\pht000747\phv00072298\H341\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,e_exam_ex08_1_0005d.h341,CDI - MITRAL VALVE DISEASE,0.167504188,e_exam_ex08_1_0005d,h341,Framingham Cohort,h341,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Mitral Valve Disease,phs000007.v33.p14,phv00251494.v2.p14,pht004815.v2.p14,e_exam_ex03_7_0426s,phv00251494,"['Maybe', 'No', 'Yes']",phs000007,pht004815,phv00251494,True,False,False,h341,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Mitral Valve Disease,,\phs000007\pht004815\phv00251494\h341\,pht004815.v1,\phs000007\pht004815\phv00251494\h341\,phv00251494,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Mitral Valve Disease,{},,"Omni 1 Clinic Exam 3: Interview, Physical Exam, ECG",,Clinical Diagnostic Impression - Part I: Heart Diagnoses First Examiner Opinions: Mitral Valve Disease,phs000007.v31,19b2f510c1ba1d8a01c4c2a1384d4dd55a8f40f08952a69eba65b3646fd9c0d1,categorical,phv00251494.v1,phs000007,False,h341,FHS,Framingham Cohort,pht004815,e_exam_ex03_7_0426s,\phs000007\pht004815\phv00251494\h341\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex09_1b_0844d.j011,"MEDS - ASPIR, # OF",0.558243394,e_exam_ex09_1b_0844d,j011,Framingham Cohort,j011,Medical History - Medications: Number of aspirins taken regularly,phs000007.v33.p14,phv00254020.v4.p14,pht005140.v4.p14,e_exam_ex09_1b_0844s,phv00254020,[],phs000007,pht005140,phv00254020,False,True,False,j011,Medical History - Medications: Number of aspirins taken regularly,0.0,\phs000007\pht005140\phv00254020\j011\,pht005140.v2,\phs000007\pht005140\phv00254020\j011\,phv00254020,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.",Medical History - Medications: Number of aspirins taken regularly,{},,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.",20.0,Medical History - Medications: Number of aspirins taken regularly,phs000007.v31,364459969b030505c0d934b428dd8dedd45bdd67a3dd6da3808a98d96abda030,continuous,phv00254020.v2,phs000007,False,j011,FHS,Framingham Cohort,pht005140,e_exam_ex09_1b_0844s,\phs000007\pht005140\phv00254020\j011\,0.0,20.0
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,e_exam_ex09_1b_0844d.j012,"MEDS - ASPIR, PER DY/WK/MO/YR",0.632675847,e_exam_ex09_1b_0844d,j012,Framingham Cohort,j012,"Medical History - Medications: Aspirin frequency per (day, week, month, year)",phs000007.v33.p14,phv00254021.v4.p14,pht005140.v4.p14,e_exam_ex09_1b_0844s,phv00254021,"['Day', 'Month', 'No aspirin taken regularly', 'Week', 'Year']",phs000007,pht005140,phv00254021,True,False,False,j012,"Medical History - Medications: Aspirin frequency per (day, week, month, year)",,\phs000007\pht005140\phv00254021\j012\,pht005140.v2,\phs000007\pht005140\phv00254021\j012\,phv00254021,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.","Medical History - Medications: Aspirin frequency per (day, week, month, year)",{},,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.",,"Medical History - Medications: Aspirin frequency per (day, week, month, year)",phs000007.v31,fe7a7b30aeeffd28c93fdcc9b9e8a93cfce488218b80e77d07ac7daac461e0e2,categorical,phv00254021.v2,phs000007,False,j012,FHS,Framingham Cohort,pht005140,e_exam_ex09_1b_0844s,\phs000007\pht005140\phv00254021\j012\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,e_exam_ex09_1b_0844d.j364,ECG - RHYTHM,0.148864905,e_exam_ex09_1b_0844d,j364,Framingham Cohort,j364,Electrocardiograph-Part I: Rhythm--predominant,phs000007.v33.p14,phv00254211.v4.p14,pht005140.v4.p14,e_exam_ex09_1b_0844s,phv00254211,"['2nd degree AV block, Mobitz 1 (Wenckebach)', '3rd degree AV block / AV dissociation', 'Atrial fibrillation / atrial flutter', 'Nodal', 'Normal sinus, (including s. tach, s. brady, s arrhy, 1 degree AV block)', 'Other or combination of above', 'Paced']",phs000007,pht005140,phv00254211,True,False,False,j364,Electrocardiograph-Part I: Rhythm--predominant,,\phs000007\pht005140\phv00254211\j364\,pht005140.v2,\phs000007\pht005140\phv00254211\j364\,phv00254211,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.",Electrocardiograph-Part I: Rhythm--predominant,{},,"Clinic Exam: Interview, Physical Exam, ECG, Offspring Exam 9 and Omni 1 Exam 4. Surviving Offspring and Omni Group 1 participants were invited to attend clinic examination 9/4 respectively. Participants who declined a clinic examination were offered a visit in their personal residence or nursing home. The examination included a physician-administered medical history interview (or for examinations that occurred outside the research clinic, a technician-administered interview), technician-administered questionnaires to assess cognitive and physical function, and clinical measurements (anthropometric measurements, ECG and physical performance measures). In addition participants underwent ankle-brachial blood pressure testing and pulmonary function testing. Participants completed self-administered questionnaires that asked about diet, sleep and health.",,Electrocardiograph-Part I: Rhythm--predominant,phs000007.v31,36559606fff901922f38676935f058bccd0b94d097137771e75ad9830bf03c2b,categorical,phv00254211.v2,phs000007,False,j364,FHS,Framingham Cohort,pht005140,e_exam_ex09_1b_0844s,\phs000007\pht005140\phv00254211\j364\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_1d_v3.a158,ATRIAL FIBRILLATION,0.040096231,ex1_1d_v3,a158,Framingham Cohort,A158,ATRIAL FIBRILLATION,phs000007.v33.p14,phv00007660.v8.p14,pht000030.v10.p14,ex1_1s,phv00007660,"['no', 'yes']",phs000007,pht000030,phv00007660,True,False,False,A158,ATRIAL FIBRILLATION,,\phs000007\pht000030\phv00007660\A158\,pht000030.v8,\phs000007\pht000030\phv00007660\A158\,phv00007660,"Clinic Exam, Offspring Cohort Exam 1",ATRIAL FIBRILLATION,{},,"Clinic Exam, Offspring Cohort Exam 1",,ATRIAL FIBRILLATION,phs000007.v31,d22dcd401120809ddc1d95a15297edd902be6c1b50c5c8d0b3b563abfa4f14e8,categorical,phv00007660.v6,phs000007,False,A158,FHS,Framingham Cohort,pht000030,ex1_1s,\phs000007\pht000030\phv00007660\A158\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_1d_v3.a80,ANTI-CHOLESTEROL AGENTS,0.481154772,ex1_1d_v3,a80,Framingham Cohort,A80,ANTI-CHOLESTEROL AGENTS,phs000007.v33.p14,phv00007593.v8.p14,pht000030.v10.p14,ex1_1s,phv00007593,"['no', 'yes (not now)', 'yes (now)']",phs000007,pht000030,phv00007593,True,False,False,A80,ANTI-CHOLESTEROL AGENTS,,\phs000007\pht000030\phv00007593\A80\,pht000030.v8,\phs000007\pht000030\phv00007593\A80\,phv00007593,"Clinic Exam, Offspring Cohort Exam 1",ANTI-CHOLESTEROL AGENTS,{},,"Clinic Exam, Offspring Cohort Exam 1",,ANTI-CHOLESTEROL AGENTS,phs000007.v31,27c9635d1f558e73476fc0983f8f276f8cd596248b114f88e00a14ca705b8d20,categorical,phv00007593.v6,phs000007,False,A80,FHS,Framingham Cohort,pht000030,ex1_1s,\phs000007\pht000030\phv00007593\A80\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_1d_v3.a80,ANTI-CHOLESTEROL AGENTS,0.481154772,ex1_1d_v3,a80,Framingham Cohort,A80,ANTI-CHOLESTEROL AGENTS,phs000007.v33.p14,phv00007593.v8.p14,pht000030.v10.p14,ex1_1s,phv00007593,"['no', 'yes (not now)', 'yes (now)']",phs000007,pht000030,phv00007593,True,False,False,A80,ANTI-CHOLESTEROL AGENTS,,\phs000007\pht000030\phv00007593\A80\,pht000030.v8,\phs000007\pht000030\phv00007593\A80\,phv00007593,"Clinic Exam, Offspring Cohort Exam 1",ANTI-CHOLESTEROL AGENTS,{},,"Clinic Exam, Offspring Cohort Exam 1",,ANTI-CHOLESTEROL AGENTS,phs000007.v31,27c9635d1f558e73476fc0983f8f276f8cd596248b114f88e00a14ca705b8d20,categorical,phv00007593.v6,phs000007,False,A80,FHS,Framingham Cohort,pht000030,ex1_1s,\phs000007\pht000030\phv00007593\A80\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_2d_v3.b269,D205-026-ATRIAL-FIBRILLATION,0.319829424,ex1_2d_v3,b269,Framingham Cohort,B269,ECG: ATRIAL FIBRILLATION,phs000007.v33.p14,phv00007901.v8.p14,pht000031.v10.p14,ex1_2s,phv00007901,"['NO', 'YES']",phs000007,pht000031,phv00007901,True,False,False,B269,ECG: ATRIAL FIBRILLATION,,\phs000007\pht000031\phv00007901\B269\,pht000031.v8,\phs000007\pht000031\phv00007901\B269\,phv00007901,"Clinic Exam, Offspring Cohort Exam 2",ECG: ATRIAL FIBRILLATION,{},,"Clinic Exam, Offspring Cohort Exam 2",,ECG: ATRIAL FIBRILLATION,phs000007.v31,d791d599f97f17cbef68ac0e8d05ab55b8e86267acb93731e43a946a87b70723,categorical,phv00007901.v6,phs000007,False,B269,FHS,Framingham Cohort,pht000031,ex1_2s,\phs000007\pht000031\phv00007901\B269\,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,Framingham,ex1_2d_v3.b43,D201-099-YEARS-EDUCATION,0.159914712,ex1_2d_v3,b43,Framingham Cohort,B43,YEARS EDUCATION,phs000007.v33.p14,phv00007693.v8.p14,pht000031.v10.p14,ex1_2s,phv00007693,[],phs000007,pht000031,phv00007693,False,True,True,B43,YEARS EDUCATION,1.0,\phs000007\pht000031\phv00007693\B43\,pht000031.v8,\phs000007\pht000031\phv00007693\B43\,phv00007693,"Clinic Exam, Offspring Cohort Exam 2",YEARS EDUCATION,{},,"Clinic Exam, Offspring Cohort Exam 2",30.0,YEARS EDUCATION,phs000007.v31,580398ed613ed6ee8d70ac0979d08f1950d6ef02c854014fd619400172f9d6c6,continuous,phv00007693.v6,phs000007,True,B43,FHS,Framingham Cohort,pht000031,ex1_2s,\phs000007\pht000031\phv00007693\B43\,1.0,30.0
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_2d_v3.b61,D202-016-ANTI-CHOLESTEROL,0.053304904,ex1_2d_v3,b61,Framingham Cohort,B61,ANTI-CHOLESTEROL AGENT,phs000007.v33.p14,phv00007711.v8.p14,pht000031.v10.p14,ex1_2s,phv00007711,"['NO', 'YES (NOT NOW)', 'YES (NOW)']",phs000007,pht000031,phv00007711,True,False,False,B61,ANTI-CHOLESTEROL AGENT,,\phs000007\pht000031\phv00007711\B61\,pht000031.v8,\phs000007\pht000031\phv00007711\B61\,phv00007711,"Clinic Exam, Offspring Cohort Exam 2",ANTI-CHOLESTEROL AGENT,{},,"Clinic Exam, Offspring Cohort Exam 2",,ANTI-CHOLESTEROL AGENT,phs000007.v31,edcebb7282cdc2abf8ab5379489a2da1e970a63af061e3f2d5d9731d5a972dea,categorical,phv00007711.v6,phs000007,False,B61,FHS,Framingham Cohort,pht000031,ex1_2s,\phs000007\pht000031\phv00007711\B61\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_2d_v3.b68,D202-23-INSULIN,0.026652452,ex1_2d_v3,b68,Framingham Cohort,B68,INSULIN,phs000007.v33.p14,phv00007718.v8.p14,pht000031.v10.p14,ex1_2s,phv00007718,"['NO', 'YES (20+)', 'YES (<20)', 'YES (NOT NOW)']",phs000007,pht000031,phv00007718,True,False,False,B68,INSULIN,,\phs000007\pht000031\phv00007718\B68\,pht000031.v8,\phs000007\pht000031\phv00007718\B68\,phv00007718,"Clinic Exam, Offspring Cohort Exam 2",INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 2",,INSULIN,phs000007.v31,ba3a3b1173d94127f04a110ed415f8f19219b735c482771946ad4375296b1abc,categorical,phv00007718.v6,phs000007,False,B68,FHS,Framingham Cohort,pht000031,ex1_2s,\phs000007\pht000031\phv00007718\B68\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_3d_v1.c26,ANTI CHOLESTEROL DRUGS,0.026581606,ex1_3d_v1,c26,Framingham Cohort,C26,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",phs000007.v33.p14,phv00008401.v8.p14,pht000032.v9.p14,ex1_3s,phv00008401,"['MAYBE', 'NO', 'YES (NOT NOW)', 'YES (NOW)']",phs000007,pht000032,phv00008401,True,False,False,C26,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",,\phs000007\pht000032\phv00008401\C26\,pht000032.v7,\phs000007\pht000032\phv00008401\C26\,phv00008401,"Clinic Exam, Offspring Cohort Exam 3","ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",{},,"Clinic Exam, Offspring Cohort Exam 3",,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",phs000007.v31,90dbcd2b4d865f8c459b30cbbb5791b3f2d6323960328f877ce5b4c33ceedfaa,categorical,phv00008401.v6,phs000007,False,C26,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008401\C26\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_3d_v1.c29,INSULIN,-,ex1_3d_v1,c29,Framingham Cohort,C29,INSULIN,phs000007.v33.p14,phv00008404.v8.p14,pht000032.v9.p14,ex1_3s,phv00008404,"['NO', 'YES (NOT NOW)', 'YES (NOW)']",phs000007,pht000032,phv00008404,True,False,False,C29,INSULIN,,\phs000007\pht000032\phv00008404\C29\,pht000032.v7,\phs000007\pht000032\phv00008404\C29\,phv00008404,"Clinic Exam, Offspring Cohort Exam 3",INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 3",,INSULIN,phs000007.v31,41e9747ec579f831250fb42136231c994248f43e02759f781aed112352a84996,categorical,phv00008404.v6,phs000007,False,C29,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008404\C29\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_3d_v1.c302,ATRIAL FIBRILLATION ON ECG,0.132908028,ex1_3d_v1,c302,Framingham Cohort,C302,ECG: ATRIAL FIBRILLATION,phs000007.v33.p14,phv00008646.v8.p14,pht000032.v9.p14,ex1_3s,phv00008646,"['NO', 'YES']",phs000007,pht000032,phv00008646,True,False,False,C302,ECG: ATRIAL FIBRILLATION,,\phs000007\pht000032\phv00008646\C302\,pht000032.v7,\phs000007\pht000032\phv00008646\C302\,phv00008646,"Clinic Exam, Offspring Cohort Exam 3",ECG: ATRIAL FIBRILLATION,{},,"Clinic Exam, Offspring Cohort Exam 3",,ECG: ATRIAL FIBRILLATION,phs000007.v31,a5f87edee5879b2e77d25c44d885b8f9f9a8907a3f8f8884fd286c8148e866ea,categorical,phv00008646.v6,phs000007,False,C302,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008646\C302\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_3d_v1.c339,CDI: RHEUMATIC HEART DISEASE,0.053163211,ex1_3d_v1,c339,Framingham Cohort,C339,CDI: RHEUMATIC HEART DISEASE,phs000007.v33.p14,phv00008680.v8.p14,pht000032.v9.p14,ex1_3s,phv00008680,"['MAYBE', 'NO', 'YES']",phs000007,pht000032,phv00008680,True,False,False,C339,CDI: RHEUMATIC HEART DISEASE,,\phs000007\pht000032\phv00008680\C339\,pht000032.v7,\phs000007\pht000032\phv00008680\C339\,phv00008680,"Clinic Exam, Offspring Cohort Exam 3",CDI: RHEUMATIC HEART DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 3",,CDI: RHEUMATIC HEART DISEASE,phs000007.v31,8bfb93e30bb5884f673c7efae0e20595f4f2892a9e906fa1f4518cefd8a2cc75,categorical,phv00008680.v6,phs000007,False,C339,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008680\C339\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_3d_v1.c340,CDI: AORTIC VALVE DISEASE,0.079744817,ex1_3d_v1,c340,Framingham Cohort,C340,CDI: AORTIC VALVE DISEASE,phs000007.v33.p14,phv00008681.v8.p14,pht000032.v9.p14,ex1_3s,phv00008681,"['MAYBE', 'NO', 'YES']",phs000007,pht000032,phv00008681,True,False,False,C340,CDI: AORTIC VALVE DISEASE,,\phs000007\pht000032\phv00008681\C340\,pht000032.v7,\phs000007\pht000032\phv00008681\C340\,phv00008681,"Clinic Exam, Offspring Cohort Exam 3",CDI: AORTIC VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 3",,CDI: AORTIC VALVE DISEASE,phs000007.v31,e01f929601133531816a4685220a5b0b97f2e60b62c2d0418b0e946f5d93642e,categorical,phv00008681.v6,phs000007,False,C340,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008681\C340\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_3d_v1.c341,CDI: MITRAL VALVE DISEASE,0.053163211,ex1_3d_v1,c341,Framingham Cohort,C341,CDI: MITRAL VALVE DISEASE,phs000007.v33.p14,phv00008682.v8.p14,pht000032.v9.p14,ex1_3s,phv00008682,"['MAYBE', 'NO', 'YES']",phs000007,pht000032,phv00008682,True,False,False,C341,CDI: MITRAL VALVE DISEASE,,\phs000007\pht000032\phv00008682\C341\,pht000032.v7,\phs000007\pht000032\phv00008682\C341\,phv00008682,"Clinic Exam, Offspring Cohort Exam 3",CDI: MITRAL VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 3",,CDI: MITRAL VALVE DISEASE,phs000007.v31,58f209abdb7a2fc9b31ddfb8025ed741b0300a60d6f2c31ac574099f6c4ce79e,categorical,phv00008682.v6,phs000007,False,C341,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008682\C341\,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,ex1_3d_v1.c452,Total Alcohol Consumption,0.292397661,ex1_3d_v1,c452,Framingham Cohort,C452,TOTAL ALCOHOL CONSUMPTION,phs000007.v33.p14,phv00008741.v8.p14,pht000032.v9.p14,ex1_3s,phv00008741,[],phs000007,pht000032,phv00008741,False,True,False,C452,TOTAL ALCOHOL CONSUMPTION,0.0,\phs000007\pht000032\phv00008741\C452\,pht000032.v7,\phs000007\pht000032\phv00008741\C452\,phv00008741,"Clinic Exam, Offspring Cohort Exam 3",TOTAL ALCOHOL CONSUMPTION,{},,"Clinic Exam, Offspring Cohort Exam 3",54.0,TOTAL ALCOHOL CONSUMPTION,phs000007.v31,1ba0274db090f160e9a072772c893e59fc4a567932fe463a4bec4799a3ab792a,continuous,phv00008741.v6,phs000007,False,C452,FHS,Framingham Cohort,pht000032,ex1_3s,\phs000007\pht000032\phv00008741\C452\,0.0,54.0
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_4d_v1.d030,ANTI CHOLESTEROL DRUGS,0.230650948,ex1_4d_v1,d030,Framingham Cohort,D030,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",phs000007.v33.p14,phv00008800.v8.p14,pht000033.v11.p14,ex1_4s,phv00008800,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000033,phv00008800,True,False,False,D030,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",,\phs000007\pht000033\phv00008800\D030\,pht000033.v9,\phs000007\pht000033\phv00008800\D030\,phv00008800,"Clinic Exam, Offspring Cohort Exam 4","ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",{},,"Clinic Exam, Offspring Cohort Exam 4",,"ANTI CHOLESTEROL DRUGS (RESINS, FIBRATES, ETC.)",phs000007.v31,fa93c71b29d4a28a9281ff5bee1f4457682b4e69556b4881e3f00652cfcd154f,categorical,phv00008800.v6,phs000007,False,D030,FHS,Framingham Cohort,pht000033,ex1_4s,\phs000007\pht000033\phv00008800\D030\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_4d_v1.d035,INSULIN,0.230650948,ex1_4d_v1,d035,Framingham Cohort,D035,INSULIN,phs000007.v33.p14,phv00008805.v8.p14,pht000033.v11.p14,ex1_4s,phv00008805,"['NO', 'YES, NOW']",phs000007,pht000033,phv00008805,True,False,False,D035,INSULIN,,\phs000007\pht000033\phv00008805\D035\,pht000033.v9,\phs000007\pht000033\phv00008805\D035\,phv00008805,"Clinic Exam, Offspring Cohort Exam 4",INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 4",,INSULIN,phs000007.v31,62ce3df9abcf0b275e442de631702f746c7fc3699065275574cd81f0de2618fd,categorical,phv00008805.v6,phs000007,False,D035,FHS,Framingham Cohort,pht000033,ex1_4s,\phs000007\pht000033\phv00008805\D035\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_4d_v1.d306,ECG-ATRIAL FIBRILLATION,0.128139416,ex1_4d_v1,d306,Framingham Cohort,D306,ECG: ATRIAL FIBRILLATION,phs000007.v33.p14,phv00009042.v8.p14,pht000033.v11.p14,ex1_4s,phv00009042,"['NO', 'YES']",phs000007,pht000033,phv00009042,True,False,False,D306,ECG: ATRIAL FIBRILLATION,,\phs000007\pht000033\phv00009042\D306\,pht000033.v9,\phs000007\pht000033\phv00009042\D306\,phv00009042,"Clinic Exam, Offspring Cohort Exam 4",ECG: ATRIAL FIBRILLATION,{},,"Clinic Exam, Offspring Cohort Exam 4",,ECG: ATRIAL FIBRILLATION,phs000007.v31,276ecc016e2128b74aca8686adf1a351db2297c4c5be9040d41e45a4d9db0ee2,categorical,phv00009042.v6,phs000007,False,D306,FHS,Framingham Cohort,pht000033,ex1_4s,\phs000007\pht000033\phv00009042\D306\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e218,NUMBER OF ASPIRINS PER TIME INTERVAL,0.569414317,ex1_5d_v1,e218,Framingham Cohort,E218,NUMBER OF ASPIRINS PER TIME INTERVAL,phs000007.v33.p14,phv00009171.v8.p14,pht000034.v10.p14,ex1_5s,phv00009171,"['1', '10', '12', '14', '15', '16', '18', '2', '20', '21', '24', '25', '3', '30', '32', '33', '36', '4', '40', '45', '5', '50', '6', '60', '7', '8', '9', '90', 'NONE']",phs000007,pht000034,phv00009171,True,False,False,E218,NUMBER OF ASPIRINS PER TIME INTERVAL,,\phs000007\pht000034\phv00009171\E218\,pht000034.v8,\phs000007\pht000034\phv00009171\E218\,phv00009171,"Clinic Exam, Offspring Cohort Exam 5",NUMBER OF ASPIRINS PER TIME INTERVAL,{},,"Clinic Exam, Offspring Cohort Exam 5",,NUMBER OF ASPIRINS PER TIME INTERVAL,phs000007.v31,ea6d97e1f28d9c7f28f63aa91895f00d2bc0c004ed7feda2a9cd0cf97d5f470f,categorical,phv00009171.v6,phs000007,False,E218,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009171\E218\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e218,NUMBER OF ASPIRINS PER TIME INTERVAL,0.569414317,ex1_5d_v1,e218,Framingham Cohort,e218,Medical History - Cardiovascular Medications: Number of aspirins,phs000007.v33.p14,phv00461381.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461381,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e219,TIME INTERVAL FOR ASPIRIN TAKEN,0.921908894,ex1_5d_v1,e219,Framingham Cohort,E219,TIME INTERVAL FOR ASPIRIN TAKEN,phs000007.v33.p14,phv00009172.v8.p14,pht000034.v10.p14,ex1_5s,phv00009172,"['DAY', 'MONTH', 'NEVER', 'WEEK', 'YEAR']",phs000007,pht000034,phv00009172,True,False,False,E219,TIME INTERVAL FOR ASPIRIN TAKEN,,\phs000007\pht000034\phv00009172\E219\,pht000034.v8,\phs000007\pht000034\phv00009172\E219\,phv00009172,"Clinic Exam, Offspring Cohort Exam 5",TIME INTERVAL FOR ASPIRIN TAKEN,{},,"Clinic Exam, Offspring Cohort Exam 5",,TIME INTERVAL FOR ASPIRIN TAKEN,phs000007.v31,d8d21d01fd200c95628c3ea6e0a14a549a3ef19a8b51b1c6d3355290c90a4d7a,categorical,phv00009172.v6,phs000007,False,E219,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009172\E219\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e219,TIME INTERVAL FOR ASPIRIN TAKEN,0.921908894,ex1_5d_v1,e219,Framingham Cohort,e219,Medical History - Cardiovascular Medications: Time interval for aspirin taken,phs000007.v33.p14,phv00461382.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461382,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e245,ANTI CHOLESTEROL DRUGS-RESINS,0.027114968,ex1_5d_v1,e245,Framingham Cohort,E245,ANTI CHOLESTEROL DRUGS-RESINS,phs000007.v33.p14,phv00009198.v8.p14,pht000034.v10.p14,ex1_5s,phv00009198,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009198,True,False,False,E245,ANTI CHOLESTEROL DRUGS-RESINS,,\phs000007\pht000034\phv00009198\E245\,pht000034.v8,\phs000007\pht000034\phv00009198\E245\,phv00009198,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-RESINS,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-RESINS,phs000007.v31,ada19125aebc29e9cbe936081a82fa558c298218750a1cdaf407351525519a26,categorical,phv00009198.v6,phs000007,False,E245,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009198\E245\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e245,ANTI CHOLESTEROL DRUGS-RESINS,0.027114968,ex1_5d_v1,e245,Framingham Cohort,e245,"Medical History - Other Medications: Anti cholesterol drugs (Resins, e.g. Questran, Colestid)",phs000007.v33.p14,phv00461408.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e246,ANTI CHOLESTEROL DRUGS-NIACIN,0.027114968,ex1_5d_v1,e246,Framingham Cohort,e246,Medical History - Other Medications: Anti cholesterol drugs (Niacin or Nicotinic Acid),phs000007.v33.p14,phv00461409.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e246,ANTI CHOLESTEROL DRUGS-NIACIN,0.027114968,ex1_5d_v1,e246,Framingham Cohort,E246,ANTI CHOLESTEROL DRUGS-NIACIN,phs000007.v33.p14,phv00009199.v8.p14,pht000034.v10.p14,ex1_5s,phv00009199,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009199,True,False,False,E246,ANTI CHOLESTEROL DRUGS-NIACIN,,\phs000007\pht000034\phv00009199\E246\,pht000034.v8,\phs000007\pht000034\phv00009199\E246\,phv00009199,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-NIACIN,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-NIACIN,phs000007.v31,588044848bb10c7cbc09d69996969399efd61ca3e1678066b0cc078cfcd858da,categorical,phv00009199.v6,phs000007,False,E246,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009199\E246\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e247,ANTI CHOLESTEROL DRUGS-FIBRATES,0.027114968,ex1_5d_v1,e247,Framingham Cohort,e247,"Medical History - Other Medications: Anti cholesterol drugs (Fibrates, e.g. Gemfibrozil)",phs000007.v33.p14,phv00461410.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e247,ANTI CHOLESTEROL DRUGS-FIBRATES,0.027114968,ex1_5d_v1,e247,Framingham Cohort,E247,ANTI CHOLESTEROL DRUGS-FIBRATES,phs000007.v33.p14,phv00009200.v8.p14,pht000034.v10.p14,ex1_5s,phv00009200,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009200,True,False,False,E247,ANTI CHOLESTEROL DRUGS-FIBRATES,,\phs000007\pht000034\phv00009200\E247\,pht000034.v8,\phs000007\pht000034\phv00009200\E247\,phv00009200,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-FIBRATES,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-FIBRATES,phs000007.v31,2c5e53ba83b18d34f12558c15c45b6c2b6598bc54ab6a42c64c91b671d67ca10,categorical,phv00009200.v6,phs000007,False,E247,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009200\E247\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e247,ANTI CHOLESTEROL DRUGS-FIBRATES,0.027114968,ex1_5d_v1,e247,Framingham Cohort,E247,ANTI CHOLESTEROL DRUGS-FIBRATES,phs000007.v33.p14,phv00009200.v8.p14,pht000034.v10.p14,ex1_5s,phv00009200,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009200,True,False,False,E247,ANTI CHOLESTEROL DRUGS-FIBRATES,,\phs000007\pht000034\phv00009200\E247\,pht000034.v8,\phs000007\pht000034\phv00009200\E247\,phv00009200,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-FIBRATES,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-FIBRATES,phs000007.v31,2c5e53ba83b18d34f12558c15c45b6c2b6598bc54ab6a42c64c91b671d67ca10,categorical,phv00009200.v6,phs000007,False,E247,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009200\E247\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e247,ANTI CHOLESTEROL DRUGS-FIBRATES,0.027114968,ex1_5d_v1,e247,Framingham Cohort,e247,"Medical History - Other Medications: Anti cholesterol drugs (Fibrates, e.g. Gemfibrozil)",phs000007.v33.p14,phv00461410.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461410,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e248,ANTI CHOLESTEROL DRUGS-STATINS,0.027114968,ex1_5d_v1,e248,Framingham Cohort,E248,ANTI CHOLESTEROL DRUGS-STATINS,phs000007.v33.p14,phv00009201.v8.p14,pht000034.v10.p14,ex1_5s,phv00009201,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009201,True,False,False,E248,ANTI CHOLESTEROL DRUGS-STATINS,,\phs000007\pht000034\phv00009201\E248\,pht000034.v8,\phs000007\pht000034\phv00009201\E248\,phv00009201,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-STATINS,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-STATINS,phs000007.v31,e05eebdd436384cfaeec98cc70e079bd02f7de5f8d7c25636c149d1bfcb7ee18,categorical,phv00009201.v6,phs000007,False,E248,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009201\E248\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e248,ANTI CHOLESTEROL DRUGS-STATINS,0.027114968,ex1_5d_v1,e248,Framingham Cohort,e248,"Medical History - Other Medications: Anti cholesterol drugs (Statins, e.g. Lovastatin, Pravastatin)",phs000007.v33.p14,phv00461411.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461411,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e249,ANTI CHOLESTEROL DRUGS-OTHER,0.054229935,ex1_5d_v1,e249,Framingham Cohort,E249,ANTI CHOLESTEROL DRUGS-OTHER,phs000007.v33.p14,phv00009202.v8.p14,pht000034.v10.p14,ex1_5s,phv00009202,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009202,True,False,False,E249,ANTI CHOLESTEROL DRUGS-OTHER,,\phs000007\pht000034\phv00009202\E249\,pht000034.v8,\phs000007\pht000034\phv00009202\E249\,phv00009202,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-OTHER,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-OTHER,phs000007.v31,6d849197ee90cdf321d92b5fe752470cbdb2da3109614187c753a5ca236e354e,categorical,phv00009202.v6,phs000007,False,E249,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009202\E249\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e249,ANTI CHOLESTEROL DRUGS-OTHER,0.054229935,ex1_5d_v1,e249,Framingham Cohort,E249,ANTI CHOLESTEROL DRUGS-OTHER,phs000007.v33.p14,phv00009202.v8.p14,pht000034.v10.p14,ex1_5s,phv00009202,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009202,True,False,False,E249,ANTI CHOLESTEROL DRUGS-OTHER,,\phs000007\pht000034\phv00009202\E249\,pht000034.v8,\phs000007\pht000034\phv00009202\E249\,phv00009202,"Clinic Exam, Offspring Cohort Exam 5",ANTI CHOLESTEROL DRUGS-OTHER,{},,"Clinic Exam, Offspring Cohort Exam 5",,ANTI CHOLESTEROL DRUGS-OTHER,phs000007.v31,6d849197ee90cdf321d92b5fe752470cbdb2da3109614187c753a5ca236e354e,categorical,phv00009202.v6,phs000007,False,E249,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009202\E249\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_5d_v1.e249,ANTI CHOLESTEROL DRUGS-OTHER,0.054229935,ex1_5d_v1,e249,Framingham Cohort,e249,Medical History - Other Medications: Anti cholesterol drugs (Other),phs000007.v33.p14,phv00461412.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461412,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e249,ANTI CHOLESTEROL DRUGS-OTHER,0.054229935,ex1_5d_v1,e249,Framingham Cohort,e249,Medical History - Other Medications: Anti cholesterol drugs (Other),phs000007.v33.p14,phv00461412.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461412,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e254,INSULIN,0.027114968,ex1_5d_v1,e254,Framingham Cohort,E254,INSULIN,phs000007.v33.p14,phv00009207.v8.p14,pht000034.v10.p14,ex1_5s,phv00009207,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000034,phv00009207,True,False,False,E254,INSULIN,,\phs000007\pht000034\phv00009207\E254\,pht000034.v8,\phs000007\pht000034\phv00009207\E254\,phv00009207,"Clinic Exam, Offspring Cohort Exam 5",INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 5",,INSULIN,phs000007.v31,f092b36e97322c8f76bff8d9a7f264b97767eb848b7513d78521acf6d67bb10a,categorical,phv00009207.v6,phs000007,False,E254,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009207\E254\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e254,INSULIN,0.027114968,ex1_5d_v1,e254,Framingham Cohort,e254,Medical History - Other Medications: Insulin,phs000007.v33.p14,phv00461417.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461417,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_5d_v1.e254,INSULIN,0.027114968,ex1_5d_v1,e254,Framingham Cohort,E254,"DEFINITIVE EXAM: DIABETIC RETINOPATHY SUSPECTS: ALL SINGLE CAPITAL LETTERS REFER TO STANDARD DIABETIC RETINOPATHY PHOTOS - TYPE OF CHANGE: HEMORRHAGES AND MICROANEURYSMS (A,B), O.S., BLANK = DOES NOT MEET REFERRAL CRITERIA FOR DIABETIC RETINOPATHY (2583)",phs000007.v33.p14,phv00054875.v1.p14,pht000390.v2.p14,eye0_1975s,phv00054875,"['<A', '>=A<B', '>=B', 'ABSENT', 'DIABETIC RETINOPATHY SUSPECT, NOT EXAMINED', 'QUESTIONABLE', 'UNKNOWN, OR EYE NOT EXAMINED (2)']",phs000007,pht000390,phv00054875,True,False,True,E254,"DEFINITIVE EXAM: DIABETIC RETINOPATHY SUSPECTS: ALL SINGLE CAPITAL LETTERS REFER TO STANDARD DIABETIC RETINOPATHY PHOTOS - TYPE OF CHANGE: HEMORRHAGES AND MICROANEURYSMS (A,B), O.S., BLANK = DOES NOT MEET REFERRAL CRITERIA FOR DIABETIC RETINOPATHY (2583)",,\phs000007\pht000390\phv00054875\E254\,pht000390.v2,\phs000007\pht000390\phv00054875\E254\,phv00054875,"Eye Examination, Original Cohort 1973 - 1975","DEFINITIVE EXAM: DIABETIC RETINOPATHY SUSPECTS: ALL SINGLE CAPITAL LETTERS REFER TO STANDARD DIABETIC RETINOPATHY PHOTOS - TYPE OF CHANGE: HEMORRHAGES AND MICROANEURYSMS (A,B), O.S., BLANK = DOES NOT MEET REFERRAL CRITERIA FOR DIABETIC RETINOPATHY (2583)",{},,"Eye Examination, Original Cohort 1973 - 1975",,"DEFINITIVE EXAM: DIABETIC RETINOPATHY SUSPECTS: ALL SINGLE CAPITAL LETTERS REFER TO STANDARD DIABETIC RETINOPATHY PHOTOS - TYPE OF CHANGE: HEMORRHAGES AND MICROANEURYSMS (A,B), O.S., BLANK = DOES NOT MEET REFERRAL CRITERIA FOR DIABETIC RETINOPATHY (2583)",phs000007.v31,6140d18fbde32ae570904daa498893cfd8b316124c99fd9055335914c94c817f,categorical,phv00054875.v1,phs000007,True,E254,FHS,Framingham Cohort,pht000390,eye0_1975s,\phs000007\pht000390\phv00054875\E254\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_5d_v1.e589,ECG-RHYTHM,0.027114968,ex1_5d_v1,e589,Framingham Cohort,E589,ECG: RHYTHM,phs000007.v33.p14,phv00009494.v8.p14,pht000034.v10.p14,ex1_5s,phv00009494,"['2ND DEGREE AV BLOCK, MOBITZ I (WENCKEBACH)', '3RD DEGREE AV BLOCK/AV DISSOCIATION', 'ATRIAL FIBRILLATION/ATRIAL FLUTTER', 'NODAL', 'NORMAL SINUS', 'OTHER OR COMBINATION OF ABOVE (LIST)', 'PACED', 'SINUS RHYTHM  WITH 1ST DEGREE AV BLOCK (PR INVERVAL > = .20 SEC)']",phs000007,pht000034,phv00009494,True,False,False,E589,ECG: RHYTHM,,\phs000007\pht000034\phv00009494\E589\,pht000034.v8,\phs000007\pht000034\phv00009494\E589\,phv00009494,"Clinic Exam, Offspring Cohort Exam 5",ECG: RHYTHM,{},,"Clinic Exam, Offspring Cohort Exam 5",,ECG: RHYTHM,phs000007.v31,81af8ddab3773d403d2cd7d15f20c38e913a08e3ad604cacb4bb35ecbf6cb23f,categorical,phv00009494.v6,phs000007,False,E589,FHS,Framingham Cohort,pht000034,ex1_5s,\phs000007\pht000034\phv00009494\E589\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_5d_v1.e589,ECG-RHYTHM,0.027114968,ex1_5d_v1,e589,Framingham Cohort,e589,Electrocardiograph - Part I: Rhythm,phs000007.v33.p14,phv00461686.v2.p14,pht006006.v5.p14,e_exam_ex01_72_0652s,phv00461686,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f181,NUMBER OF ASPIRINS TAKEN REGULARLY,0.35180299,ex1_6d_v1,f181,Framingham Cohort,F181,NUMBER OF ASPIRIN TAKEN REGULARLY,phs000007.v33.p14,phv00009671.v8.p14,pht000035.v11.p14,ex1_6s,phv00009671,"['1', '10', '12', '15', '16', '2', '20', '3', '4', '5', '6', '7', '8', '9', 'DOES NOT TAKE ASPIRIN REGULARLY']",phs000007,pht000035,phv00009671,True,False,False,F181,NUMBER OF ASPIRIN TAKEN REGULARLY,,\phs000007\pht000035\phv00009671\F181\,pht000035.v9,\phs000007\pht000035\phv00009671\F181\,phv00009671,"Clinic Exam, Offspring Cohort Exam 6",NUMBER OF ASPIRIN TAKEN REGULARLY,{},,"Clinic Exam, Offspring Cohort Exam 6",,NUMBER OF ASPIRIN TAKEN REGULARLY,phs000007.v31,03f4f4a69cb8fd1dbb5c1307df6ed430e7bd8ed75691484b3d2b515fe1c6daf8,categorical,phv00009671.v6,phs000007,False,F181,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009671\F181\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f181,NUMBER OF ASPIRINS TAKEN REGULARLY,0.35180299,ex1_6d_v1,f181,Atherosclerosis Risk in Communities (ARIC) Cohort,F181,"Fatty acid 18:1 [g] [Nutrients, ANUT. Visit 1]",phs000280.v8.p2,phv00203247.v2.p2,pht004036.v3.p2,ANUT2,phv00203247,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f181,NUMBER OF ASPIRINS TAKEN REGULARLY,0.35180299,ex1_6d_v1,f181,Atherosclerosis Risk in Communities (ARIC) Cohort,F181,Fatty acid 18:1 [g] [Nutrients. Visit 2],phs000280.v8.p2,phv00208349.v2.p2,pht004137.v3.p2,NUTV2,phv00208349,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f181,NUMBER OF ASPIRINS TAKEN REGULARLY,0.35180299,ex1_6d_v1,f181,Atherosclerosis Risk in Communities (ARIC) Cohort,F181,Fatty acid 18:1 [g] [Nutrients. Visit 3],phs000280.v8.p2,phv00208576.v2.p2,pht004139.v3.p2,NUTV3,phv00208576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f182,ASPIRIN FREQUENCY,0.322486075,ex1_6d_v1,f182,Framingham Cohort,F182,ASPIRIN FREQUENCY,phs000007.v33.p14,phv00009672.v8.p14,pht000035.v11.p14,ex1_6s,phv00009672,"['DAY', 'MONTH', 'NEVER', 'WEEK', 'YEAR']",phs000007,pht000035,phv00009672,True,False,False,F182,ASPIRIN FREQUENCY,,\phs000007\pht000035\phv00009672\F182\,pht000035.v9,\phs000007\pht000035\phv00009672\F182\,phv00009672,"Clinic Exam, Offspring Cohort Exam 6",ASPIRIN FREQUENCY,{},,"Clinic Exam, Offspring Cohort Exam 6",,ASPIRIN FREQUENCY,phs000007.v31,db3a087b65d16c4851d7e1930326164c821b8d1ef7f0bf80743cc9264c0db997,categorical,phv00009672.v6,phs000007,False,F182,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009672\F182\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f182,ASPIRIN FREQUENCY,0.322486075,ex1_6d_v1,f182,Atherosclerosis Risk in Communities (ARIC) Cohort,F182,Fatty acid 18:2 [g] [Nutrients. Visit 2],phs000280.v8.p2,phv00208351.v2.p2,pht004137.v3.p2,NUTV2,phv00208351,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f182,ASPIRIN FREQUENCY,0.322486075,ex1_6d_v1,f182,Atherosclerosis Risk in Communities (ARIC) Cohort,F182,Fatty acid 18:2 [g] [Nutrients. Visit 3],phs000280.v8.p2,phv00208578.v2.p2,pht004139.v3.p2,NUTV3,phv00208578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f182,ASPIRIN FREQUENCY,0.322486075,ex1_6d_v1,f182,Atherosclerosis Risk in Communities (ARIC) Cohort,F182,"Fatty acid 18:2 [g] [Nutrients, ANUT. Visit 1]",phs000280.v8.p2,phv00203249.v2.p2,pht004036.v3.p2,ANUT2,phv00203249,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_6d_v1.f209,MEDS - ANTI-CHOL -RESINS,0.029316916,ex1_6d_v1,f209,Framingham Cohort,F209,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v33.p14,phv00009699.v8.p14,pht000035.v11.p14,ex1_6s,phv00009699,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009699,True,False,False,F209,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",,\phs000007\pht000035\phv00009699\F209\,pht000035.v9,\phs000007\pht000035\phv00009699\F209\,phv00009699,"Clinic Exam, Offspring Cohort Exam 6","MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",{},,"Clinic Exam, Offspring Cohort Exam 6",,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v31,d43a0f10ee5752f9b73760f4720f19fc43d0234f7c60772e48b5d36e9cf28b34,categorical,phv00009699.v6,phs000007,False,F209,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009699\F209\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f209,MEDS - ANTI-CHOL -RESINS,0.029316916,ex1_6d_v1,f209,Framingham Cohort,F209,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v33.p14,phv00009699.v8.p14,pht000035.v11.p14,ex1_6s,phv00009699,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009699,True,False,False,F209,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",,\phs000007\pht000035\phv00009699\F209\,pht000035.v9,\phs000007\pht000035\phv00009699\F209\,phv00009699,"Clinic Exam, Offspring Cohort Exam 6","MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",{},,"Clinic Exam, Offspring Cohort Exam 6",,"MEDICATIONS: ANTI CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v31,d43a0f10ee5752f9b73760f4720f19fc43d0234f7c60772e48b5d36e9cf28b34,categorical,phv00009699.v6,phs000007,False,F209,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009699\F209\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f210,MEDS - ANTI-CHOL -NIACIN/NICOTINIC ACID,0.029316916,ex1_6d_v1,f210,Framingham Cohort,F210,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v33.p14,phv00009700.v8.p14,pht000035.v11.p14,ex1_6s,phv00009700,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009700,True,False,False,F210,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),,\phs000007\pht000035\phv00009700\F210\,pht000035.v9,\phs000007\pht000035\phv00009700\F210\,phv00009700,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v31,0dd87007f2c4f6716cb6bfbe950cd7b87a5c8a07abf1e219f790d99dde04778b,categorical,phv00009700.v6,phs000007,False,F210,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009700\F210\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_6d_v1.f210,MEDS - ANTI-CHOL -NIACIN/NICOTINIC ACID,0.029316916,ex1_6d_v1,f210,Framingham Cohort,F210,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v33.p14,phv00009700.v8.p14,pht000035.v11.p14,ex1_6s,phv00009700,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009700,True,False,False,F210,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),,\phs000007\pht000035\phv00009700\F210\,pht000035.v9,\phs000007\pht000035\phv00009700\F210\,phv00009700,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: ANTI CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v31,0dd87007f2c4f6716cb6bfbe950cd7b87a5c8a07abf1e219f790d99dde04778b,categorical,phv00009700.v6,phs000007,False,F210,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009700\F210\,,
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f211,MEDS - ANTI-CHOL -FIBRATES,0.029316916,ex1_6d_v1,f211,Framingham Cohort,F211,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v33.p14,phv00009701.v8.p14,pht000035.v11.p14,ex1_6s,phv00009701,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009701,True,False,False,F211,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),,\phs000007\pht000035\phv00009701\F211\,pht000035.v9,\phs000007\pht000035\phv00009701\F211\,phv00009701,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v31,e9dcf66e57bcc1b4f663e3201502c4685226e9360dc2b5259df93913028293f2,categorical,phv00009701.v6,phs000007,False,F211,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009701\F211\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_6d_v1.f211,MEDS - ANTI-CHOL -FIBRATES,0.029316916,ex1_6d_v1,f211,Framingham Cohort,F211,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v33.p14,phv00009701.v8.p14,pht000035.v11.p14,ex1_6s,phv00009701,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009701,True,False,False,F211,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),,\phs000007\pht000035\phv00009701\F211\,pht000035.v9,\phs000007\pht000035\phv00009701\F211\,phv00009701,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: ANTI CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v31,e9dcf66e57bcc1b4f663e3201502c4685226e9360dc2b5259df93913028293f2,categorical,phv00009701.v6,phs000007,False,F211,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009701\F211\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_6d_v1.f213,MEDS - ANTI-CHOL -OTHER,0.029316916,ex1_6d_v1,f213,Framingham Cohort,F213,MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER,phs000007.v33.p14,phv00009703.v8.p14,pht000035.v11.p14,ex1_6s,phv00009703,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009703,True,False,False,F213,MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER,,\phs000007\pht000035\phv00009703\F213\,pht000035.v9,\phs000007\pht000035\phv00009703\F213\,phv00009703,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER,{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: ANTI CHOLESTEROL DRUGS - OTHER,phs000007.v31,4b709d414b20a034827ac07072f71b3291c9ca994b484fecd5321f473032427c,categorical,phv00009703.v6,phs000007,False,F213,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009703\F213\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_6d_v1.f218,MEDS - INSULIN,0.205218411,ex1_6d_v1,f218,Framingham Cohort,F218,MEDICATIONS: INSULIN,phs000007.v33.p14,phv00009708.v8.p14,pht000035.v11.p14,ex1_6s,phv00009708,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000035,phv00009708,True,False,False,F218,MEDICATIONS: INSULIN,,\phs000007\pht000035\phv00009708\F218\,pht000035.v9,\phs000007\pht000035\phv00009708\F218\,phv00009708,"Clinic Exam, Offspring Cohort Exam 6",MEDICATIONS: INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 6",,MEDICATIONS: INSULIN,phs000007.v31,7c02225c6de418672fa29bff2242230f86b0fa9b3c9abba9bfdce65a2ad49ec7,categorical,phv00009708.v6,phs000007,False,F218,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00009708\F218\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_6d_v1.f584,ECG-RHYTHM,-,ex1_6d_v1,f584,Framingham Cohort,F584,RHYTHM,phs000007.v33.p14,phv00010008.v8.p14,pht000035.v11.p14,ex1_6s,phv00010008,"['3RD DEGREE AV BLOCK/AV DISSOCIATION', 'ATRIAL FIBRILLATION/ATRIAL FLUTTER', 'NODAL', 'NORMAL SINUS', 'OTHER OR COMBINATION OF ABOVE', 'PACED']",phs000007,pht000035,phv00010008,True,False,False,F584,RHYTHM,,\phs000007\pht000035\phv00010008\F584\,pht000035.v9,\phs000007\pht000035\phv00010008\F584\,phv00010008,"Clinic Exam, Offspring Cohort Exam 6",RHYTHM,{},,"Clinic Exam, Offspring Cohort Exam 6",,RHYTHM,phs000007.v31,da3efbcb652a9a480c2d9b7f1950918ccd6dbf6bde13eeef6e1f39026729d052,categorical,phv00010008.v6,phs000007,False,F584,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00010008\F584\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_6d_v1.f617,CDI-RHEUMATIC HEART DISEASE,1.34857813,ex1_6d_v1,f617,Framingham Cohort,F617,CDI: RHEUMATIC HEART DISEASE,phs000007.v33.p14,phv00010038.v8.p14,pht000035.v11.p14,ex1_6s,phv00010038,"['MAYBE', 'NO', 'YES']",phs000007,pht000035,phv00010038,True,False,False,F617,CDI: RHEUMATIC HEART DISEASE,,\phs000007\pht000035\phv00010038\F617\,pht000035.v9,\phs000007\pht000035\phv00010038\F617\,phv00010038,"Clinic Exam, Offspring Cohort Exam 6",CDI: RHEUMATIC HEART DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 6",,CDI: RHEUMATIC HEART DISEASE,phs000007.v31,c0a9fe6be17adda4d94bfdc9cf2b17047988d9bf78aecc6bfca977eb26cf0afa,categorical,phv00010038.v6,phs000007,False,F617,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00010038\F617\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_6d_v1.f618,CDI-AORTIC VALVE DISEASE,1.34857813,ex1_6d_v1,f618,Framingham Cohort,F618,CDI: AORTIC VALVE DISEASE,phs000007.v33.p14,phv00010039.v8.p14,pht000035.v11.p14,ex1_6s,phv00010039,"['MAYBE', 'NO', 'YES']",phs000007,pht000035,phv00010039,True,False,False,F618,CDI: AORTIC VALVE DISEASE,,\phs000007\pht000035\phv00010039\F618\,pht000035.v9,\phs000007\pht000035\phv00010039\F618\,phv00010039,"Clinic Exam, Offspring Cohort Exam 6",CDI: AORTIC VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 6",,CDI: AORTIC VALVE DISEASE,phs000007.v31,7a12ba96dfede952678975c772506f16b205e8c52769cf384fc5ee28baa6f33a,categorical,phv00010039.v6,phs000007,False,F618,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00010039\F618\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,Framingham,ex1_6d_v1.f619,CDI-MITRAL VALVE DISEASE,1.377895045,ex1_6d_v1,f619,Framingham Cohort,F619,CDI: MITRAL VALVE DISEASE,phs000007.v33.p14,phv00010040.v8.p14,pht000035.v11.p14,ex1_6s,phv00010040,"['MAYBE', 'NO', 'YES']",phs000007,pht000035,phv00010040,True,False,False,F619,CDI: MITRAL VALVE DISEASE,,\phs000007\pht000035\phv00010040\F619\,pht000035.v9,\phs000007\pht000035\phv00010040\F619\,phv00010040,"Clinic Exam, Offspring Cohort Exam 6",CDI: MITRAL VALVE DISEASE,{},,"Clinic Exam, Offspring Cohort Exam 6",,CDI: MITRAL VALVE DISEASE,phs000007.v31,375f0f45710d59fae9d763452d3342667ab3646380d4da5c0ade151171e157a8,categorical,phv00010040.v6,phs000007,False,F619,FHS,Framingham Cohort,pht000035,ex1_6s,\phs000007\pht000035\phv00010040\F619\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g038,NUMBER OF ASPIRINS TAKEN REGULARLY,0.115074799,ex1_7d_v2,g038,Framingham Cohort,g038,Medical History - Aspirin: Number aspirin taken regularly,phs000007.v33.p14,phv00250755.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250755,"['0 or (G037 = 0)', '1', '10', '2', '3', '4', '5', '8']",phs000007,pht004814,phv00250755,True,False,False,g038,Medical History - Aspirin: Number aspirin taken regularly,,\phs000007\pht004814\phv00250755\g038\,pht004814.v1,\phs000007\pht004814\phv00250755\g038\,phv00250755,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Aspirin: Number aspirin taken regularly,{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Aspirin: Number aspirin taken regularly,phs000007.v31,c7ae7ca3326f7e8f475764c16bad6daac3dc6d45ad38cd0c465845cf84a35ab6,categorical,phv00250755.v1,phs000007,False,g038,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250755\g038\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g038,NUMBER OF ASPIRINS TAKEN REGULARLY,0.115074799,ex1_7d_v2,g038,Framingham Cohort,G038,ASPIRIN: NUMBER TAKEN REGULARLY,phs000007.v33.p14,phv00010181.v8.p14,pht000036.v11.p14,ex1_7s,phv00010181,"['1', '10', '12', '15', '18', '2', '3', '4', '5', '6', '7', '8', '91', 'DOES NOT TAKE ASPIRIN REGULARLY']",phs000007,pht000036,phv00010181,True,False,False,G038,ASPIRIN: NUMBER TAKEN REGULARLY,,\phs000007\pht000036\phv00010181\G038\,pht000036.v9,\phs000007\pht000036\phv00010181\G038\,phv00010181,"Clinic Exam, Offspring Cohort Exam 7",ASPIRIN: NUMBER TAKEN REGULARLY,{},,"Clinic Exam, Offspring Cohort Exam 7",,ASPIRIN: NUMBER TAKEN REGULARLY,phs000007.v31,f46fffa29ff52d7228ba784a8d8c160b4ad9ade0677c31618591d0e3672ed0a8,categorical,phv00010181.v6,phs000007,False,G038,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010181\G038\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g039,ASPIRIN FREQUENCY,0.172612198,ex1_7d_v2,g039,Framingham Cohort,G039,ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY,phs000007.v33.p14,phv00010182.v8.p14,pht000036.v11.p14,ex1_7s,phv00010182,"['DAY', 'MONTH', 'NEVER', 'WEEK', 'YEAR']",phs000007,pht000036,phv00010182,True,False,False,G039,ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY,,\phs000007\pht000036\phv00010182\G039\,pht000036.v9,\phs000007\pht000036\phv00010182\G039\,phv00010182,"Clinic Exam, Offspring Cohort Exam 7",ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY,{},,"Clinic Exam, Offspring Cohort Exam 7",,ASPIRIN: ASPIRIN FREQUENCY - NUMBER TAKEN REGULARLY,phs000007.v31,56ce0205000291bc9bb8384d04ec6f033fb5116865633a511e6a33ed77f58d60,categorical,phv00010182.v6,phs000007,False,G039,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010182\G039\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g039,ASPIRIN FREQUENCY,0.172612198,ex1_7d_v2,g039,Framingham Cohort,g039,Medical History - Aspirin: Aspirin frequency - number taken regularly,phs000007.v33.p14,phv00250756.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250756,"['Day', 'Month', 'Never or (G037 = 0)', 'Week', 'Year']",phs000007,pht004814,phv00250756,True,False,False,g039,Medical History - Aspirin: Aspirin frequency - number taken regularly,,\phs000007\pht004814\phv00250756\g039\,pht004814.v1,\phs000007\pht004814\phv00250756\g039\,phv00250756,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Aspirin: Aspirin frequency - number taken regularly,{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Aspirin: Aspirin frequency - number taken regularly,phs000007.v31,12e9517e5f6a541f57bf0a3287624b55d952182447440d14cee6c276427ce45c,categorical,phv00250756.v1,phs000007,False,g039,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250756\g039\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g041,MEDS - ANTI-CHOL - RESINS,0.115074799,ex1_7d_v2,g041,Framingham Cohort,g041,"Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid)",phs000007.v33.p14,phv00250758.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250758,['No'],phs000007,pht004814,phv00250758,True,False,False,g041,"Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid)",,\phs000007\pht004814\phv00250758\g041\,pht004814.v1,\phs000007\pht004814\phv00250758\g041\,phv00250758,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG","Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid)",{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,"Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Resins-e.g. Questran, Colestid)",phs000007.v31,e3362306fd7a4036824cd1c3851f75910c006b348f7d6f94301a9995f659cd59,categorical,phv00250758.v1,phs000007,False,g041,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250758\g041\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g041,MEDS - ANTI-CHOL - RESINS,0.115074799,ex1_7d_v2,g041,Framingham Cohort,G041,"NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v33.p14,phv00010184.v8.p14,pht000036.v11.p14,ex1_7s,phv00010184,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000036,phv00010184,True,False,False,G041,"NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",,\phs000007\pht000036\phv00010184\G041\,pht000036.v9,\phs000007\pht000036\phv00010184\G041\,phv00010184,"Clinic Exam, Offspring Cohort Exam 7","NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",{},,"Clinic Exam, Offspring Cohort Exam 7",,"NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (RESINS - E.G. QUESTRAN, COLESTID)",phs000007.v31,e0bf557f62a0cfa6c32d12408631d0613db83582e985a6aa613a27e23a85cdc6,categorical,phv00010184.v6,phs000007,False,G041,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010184\G041\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g042,MEDS - ANTI-CHOL - NIACIN/NICOTINIC ACID,0.115074799,ex1_7d_v2,g042,Framingham Cohort,g042,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid),phs000007.v33.p14,phv00250759.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250759,"['No', 'Yes, now']",phs000007,pht004814,phv00250759,True,False,False,g042,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid),,\phs000007\pht004814\phv00250759\g042\,pht004814.v1,\phs000007\pht004814\phv00250759\g042\,phv00250759,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid),{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Niacin or Nicotinic acid),phs000007.v31,7bf8ab2109a01b0a807bc2de63659c04faa9c40d8de456bea2fffcd821353dd0,categorical,phv00250759.v1,phs000007,False,g042,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250759\g042\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g042,MEDS - ANTI-CHOL - NIACIN/NICOTINIC ACID,0.115074799,ex1_7d_v2,g042,Framingham Cohort,G042,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v33.p14,phv00010185.v8.p14,pht000036.v11.p14,ex1_7s,phv00010185,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000036,phv00010185,True,False,False,G042,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),,\phs000007\pht000036\phv00010185\G042\,pht000036.v9,\phs000007\pht000036\phv00010185\G042\,phv00010185,"Clinic Exam, Offspring Cohort Exam 7",NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),{},,"Clinic Exam, Offspring Cohort Exam 7",,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (NIACIN OR NICOTINIC ACID),phs000007.v31,c47fb7db0538c48a14e826a8852434fb179fa397609af1597d0bd59aa62fef9c,categorical,phv00010185.v6,phs000007,False,G042,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010185\G042\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g043,MEDS - ANTI-CHOL - FIBRATES,0.115074799,ex1_7d_v2,g043,Framingham Cohort,g043,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil),phs000007.v33.p14,phv00250760.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250760,"['No', 'Yes, now']",phs000007,pht004814,phv00250760,True,False,False,g043,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil),,\phs000007\pht004814\phv00250760\g043\,pht004814.v1,\phs000007\pht004814\phv00250760\g043\,phv00250760,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil),{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (Fibrates-e.g. Gemfibrozil),phs000007.v31,370b3dd9b8364498d689c1527e091d356506c817ed28c687e60293b2c322c12b,categorical,phv00250760.v1,phs000007,False,g043,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250760\g043\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g043,MEDS - ANTI-CHOL - FIBRATES,0.115074799,ex1_7d_v2,g043,Framingham Cohort,G043,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v33.p14,phv00010186.v8.p14,pht000036.v11.p14,ex1_7s,phv00010186,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000036,phv00010186,True,False,False,G043,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),,\phs000007\pht000036\phv00010186\G043\,pht000036.v9,\phs000007\pht000036\phv00010186\G043\,phv00010186,"Clinic Exam, Offspring Cohort Exam 7",NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),{},,"Clinic Exam, Offspring Cohort Exam 7",,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (FIBRATES - E.G. GEMFIBROZIL),phs000007.v31,a1fcfe7e0af7d1d17a10d622f0a97df190e1dcc50c48f8e57027d30b3a8bb8b9,categorical,phv00010186.v6,phs000007,False,G043,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010186\G043\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g045,MEDS - ANTI-CHOL - OTHER,0.115074799,ex1_7d_v2,g045,Framingham Cohort,g045,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify),phs000007.v33.p14,phv00250762.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250762,"['No', 'Yes, not now']",phs000007,pht004814,phv00250762,True,False,False,g045,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify),,\phs000007\pht004814\phv00250762\g045\,pht004814.v1,\phs000007\pht004814\phv00250762\g045\,phv00250762,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify),{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Interim Non-cardiovascular Medications I: Anti cholesterol drugs (other-specify),phs000007.v31,545f6edfbd7cbb95dfc07939b9455ae9052b5bf5c50eb087c4ec8eb10ad7fd5d,categorical,phv00250762.v1,phs000007,False,g045,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250762\g045\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,ex1_7d_v2.g045,MEDS - ANTI-CHOL - OTHER,0.115074799,ex1_7d_v2,g045,Framingham Cohort,G045,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY),phs000007.v33.p14,phv00010188.v8.p14,pht000036.v11.p14,ex1_7s,phv00010188,"['NO', 'YES, NOW']",phs000007,pht000036,phv00010188,True,False,False,G045,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY),,\phs000007\pht000036\phv00010188\G045\,pht000036.v9,\phs000007\pht000036\phv00010188\G045\,phv00010188,"Clinic Exam, Offspring Cohort Exam 7",NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY),{},,"Clinic Exam, Offspring Cohort Exam 7",,NON-CARDIOVASCULAR MEDICATIONS: ANTI-CHOLESTEROL DRUGS (OTHER - SPECIFY),phs000007.v31,e00c5beafa62409e9effcd5b1bfeac79b1659409f88276d235d56654b060405c,categorical,phv00010188.v6,phs000007,False,G045,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010188\G045\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g050,MEDS - INSULIN,0.057537399,ex1_7d_v2,g050,Framingham Cohort,G050,NON-CARDIOVASCULAR MEDICATIONS: INSULIN,phs000007.v33.p14,phv00010193.v8.p14,pht000036.v11.p14,ex1_7s,phv00010193,"['NO', 'YES, NOT NOW', 'YES, NOW']",phs000007,pht000036,phv00010193,True,False,False,G050,NON-CARDIOVASCULAR MEDICATIONS: INSULIN,,\phs000007\pht000036\phv00010193\G050\,pht000036.v9,\phs000007\pht000036\phv00010193\G050\,phv00010193,"Clinic Exam, Offspring Cohort Exam 7",NON-CARDIOVASCULAR MEDICATIONS: INSULIN,{},,"Clinic Exam, Offspring Cohort Exam 7",,NON-CARDIOVASCULAR MEDICATIONS: INSULIN,phs000007.v31,b9a5d79b2a4152f8f71b068d79dff0fe92ba23f46ad79ab863e2efc342571e2c,categorical,phv00010193.v6,phs000007,False,G050,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010193\G050\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,ex1_7d_v2.g050,MEDS - INSULIN,0.057537399,ex1_7d_v2,g050,Framingham Cohort,g050,Medical History - Interim Non-cardiovascular Medications I: Insulin,phs000007.v33.p14,phv00250767.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00250767,"['No', 'Yes, now']",phs000007,pht004814,phv00250767,True,False,False,g050,Medical History - Interim Non-cardiovascular Medications I: Insulin,,\phs000007\pht004814\phv00250767\g050\,pht004814.v1,\phs000007\pht004814\phv00250767\g050\,phv00250767,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Medical History - Interim Non-cardiovascular Medications I: Insulin,{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",,Medical History - Interim Non-cardiovascular Medications I: Insulin,phs000007.v31,e2abd748606016f180ed242cbe54ab3096f212ec2c591591764420c2d47675c8,categorical,phv00250767.v1,phs000007,False,g050,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00250767\g050\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_7d_v2.g362,ECG - RHYTHM,0.086306099,ex1_7d_v2,g362,Framingham Cohort,G362,ECG: RHYTHM PREDOMINANT,phs000007.v33.p14,phv00010441.v8.p14,pht000036.v11.p14,ex1_7s,phv00010441,"['2ND DEGREE AV BLOCK, MOBITZ II', 'ATRIAL FIBRILLATION/ATRIAL FLUTTER', 'NORMAL SINUS (INCLUDING S. TACH., S. BRADY., S. ARRH., 1ST DEGREE AV BLOCK)', 'OTHER COMBINATION OF ABOVE', 'PACED']",phs000007,pht000036,phv00010441,True,False,False,G362,ECG: RHYTHM PREDOMINANT,,\phs000007\pht000036\phv00010441\G362\,pht000036.v9,\phs000007\pht000036\phv00010441\G362\,phv00010441,"Clinic Exam, Offspring Cohort Exam 7",ECG: RHYTHM PREDOMINANT,{},,"Clinic Exam, Offspring Cohort Exam 7",,ECG: RHYTHM PREDOMINANT,phs000007.v31,21fe37fcbe1d6c7bfb4044c184d802bc18e79cdbf18545ae54948f67f13d16a8,categorical,phv00010441.v6,phs000007,False,G362,FHS,Framingham Cohort,pht000036,ex1_7s,\phs000007\pht000036\phv00010441\G362\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,Framingham,ex1_7d_v2.g362,ECG - RHYTHM,0.086306099,ex1_7d_v2,g362,Framingham Cohort,g362,Electrocardiograph - Part I: Rhythm - predominant,phs000007.v33.p14,phv00251002.v2.p14,pht004814.v2.p14,e_exam_ex02_7_0003s,phv00251002,[],phs000007,pht004814,phv00251002,False,True,False,g362,Electrocardiograph - Part I: Rhythm - predominant,0.0,\phs000007\pht004814\phv00251002\g362\,pht004814.v1,\phs000007\pht004814\phv00251002\g362\,phv00251002,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",Electrocardiograph - Part I: Rhythm - predominant,{},,"Omni 1 Clinic Exam 2: Interview, Physical Exam, ECG",1.0,Electrocardiograph - Part I: Rhythm - predominant,phs000007.v31,b2994db9e61018070a49f356d3770eb009f751f6b0912fdce3c75498dffca78f,continuous,phv00251002.v1,phs000007,False,g362,FHS,Framingham Cohort,pht004814,e_exam_ex02_7_0003s,\phs000007\pht004814\phv00251002\g362\,0.0,1.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,REGARDS,ffq_analyzed.FRUITSRV,-,-,ffq_analyzed,FRUITSRV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,REGARDS,ffq_analyzed.SODIUM,-,-,ffq_analyzed,SODIUM,Jackson Heart Study (JHS) Cohort,SODIUM,Sodium mmol/L [Visit 1],phs000286.v7.p2,phv00127618.v2.p2,pht001959.v2.p2,loca,phv00127618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,REGARDS,ffq_analyzed.SODIUM,-,-,ffq_analyzed,SODIUM,Atherosclerosis Risk in Communities (ARIC) Cohort,SODIUM,Sodium mg [Vitamin and Nutrient Measurements. VITNUT01. Visit 3],phs000280.v8.p2,phv00217437.v2.p2,pht004239.v3.p2,VITNUT01,phv00217437,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,REGARDS,ffq_analyzed.SODIUM,-,-,ffq_analyzed,SODIUM,Women's Health Initiative,SODIUM,"""F136 Sodium",phs000200.v12.p3,phv00283658.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283658,[],phs000200,pht006223,phv00283658,False,True,False,SODIUM,"""F136 Sodium",50.0,\phs000200\pht006223\phv00283658\SODIUM\,pht006223.v2,\phs000200\pht006223\phv00283658\SODIUM\,phv00283658,,"""F136 Sodium",{},,,168.0,"""F136 Sodium",phs000200.v12,b8dcddb15026662f191129d832746bee954289c8094e4c6774cdd2e84d41ef42,continuous,phv00283658.v2,phs000200,False,SODIUM,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283658\SODIUM\,50.0,168.0
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,REGARDS,ffq_analyzed.SODIUM,-,-,ffq_analyzed,SODIUM,Atherosclerosis Risk in Communities (ARIC) Cohort,Sodium,Sodium (mmol/L),phs000280.v8.p2,phv00519776.v1.p2,pht012851.v1.p2,UC7236_V5_ELECTROLYTES_P,phv00519776,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,REGARDS,ffq_analyzed.VEGSRV,-,-,ffq_analyzed,VEGSRV,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,hhxc04.hhxc1,REPORT ROSE ANGINA IN AFU? Q1,-,hhxc04,hhxc1,Atherosclerosis Risk in Communities (ARIC) Cohort,HHXC1,[AFU chest pain confirmation]. Did the participant report positive Rose angina in the Annual Follow-up call preceding this visit? Q1 [Health/Medical History. HHXC04. Visit 3],phs000280.v8.p2,phv00207159.v2.p2,pht004104.v3.p2,HHXC04,phv00207159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,hhxc04.hhxc1,REPORT ROSE ANGINA IN AFU? Q1,-,hhxc04,hhxc1,Atherosclerosis Risk in Communities (ARIC) Cohort,HHXC1,[AFU chest pain confirmation]. Did the participant report positive Rose angina in the Annual Follow-up call preceding this visit? Q1 [Health/Medical History. HHXC04. Visit 3],phs000280.v8.p2,phv00207159.v2.p2,pht004104.v3.p2,HHXC04,phv00207159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,hhxd04.hhxd1,REPORT ROSE ANGINA IN AFU? Q1,-,hhxd04,hhxd1,Atherosclerosis Risk in Communities (ARIC) Cohort,HHXD1,[AFU chest pain confirmation]. Did the participant report positive Rose angina in the Annual Follow-up call preceding this visit? Q1 [Health/Medical History. HHXD04. Visit 4],phs000280.v8.p2,phv00207199.v2.p2,pht004106.v3.p2,HHXD04,phv00207199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,hhxd04.hhxd1,REPORT ROSE ANGINA IN AFU? Q1,-,hhxd04,hhxd1,Atherosclerosis Risk in Communities (ARIC) Cohort,HHXD1,[AFU chest pain confirmation]. Did the participant report positive Rose angina in the Annual Follow-up call preceding this visit? Q1 [Health/Medical History. HHXD04. Visit 4],phs000280.v8.p2,phv00207199.v2.p2,pht004106.v3.p2,HHXD04,phv00207199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,ARIC,hom.hom54,HIGHEST EDUCATION COMPLETED Q54,0.14665689,hom,hom54,Atherosclerosis Risk in Communities (ARIC) Cohort,HOM54,Highest grade or year of school completed. Q54 [Home Interview. HOM. Visit 1],phs000280.v8.p2,phv00207396.v2.p2,pht004111.v3.p2,HOM,phv00207396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,ARIC,hom.hom62,COMBINED FAMILY INCOME GROUP Q62,5.659622692,hom,hom62,Atherosclerosis Risk in Communities (ARIC) Cohort,HOM62,Total combined family income for the past 12 months. Q62 [Home Interview. HOM. Visit 1],phs000280.v8.p2,phv00207402.v2.p2,pht004111.v3.p2,HOM,phv00207402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.c7_futimehf,Follow-up time for INCHF18 in days,6.671554252,incps18,c7_futimehf,Atherosclerosis Risk in Communities (ARIC) Cohort,C7_FUTIMEHF,Follow-up time for INCHF18 in days,phs000280.v8.p2,phv00296633.v5.p2,pht006443.v5.p2,INCps18,phv00296633,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DEATH_IND,Death indicator,-,-,ARICFraminghamMESA,1.79,ARIC,incps18.dead18,Dead by 2018 from DTH/NDI/AFU,-,incps18,dead18,Atherosclerosis Risk in Communities (ARIC) Cohort,DEAD18,Dead by 2018 from DTH/NDI/AFU,phs000280.v8.p2,phv00506161.v1.p2,pht006443.v5.p2,INCps18,phv00506161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.fuproc18,Follow up time for PROC18 (days),-,incps18,fuproc18,Atherosclerosis Risk in Communities (ARIC) Cohort,FUPROC18,Follow up time for PROC18,phs000280.v8.p2,phv00506166.v1.p2,pht006443.v5.p2,INCps18,phv00506166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.fuproc18,Follow up time for PROC18 (days),-,incps18,fuproc18,Atherosclerosis Risk in Communities (ARIC) Cohort,FUPROC18,Follow up time for PROC18,phs000280.v8.p2,phv00506166.v1.p2,pht006443.v5.p2,INCps18,phv00506166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.fuproc18,Follow up time for PROC18 (days),-,incps18,fuproc18,Atherosclerosis Risk in Communities (ARIC) Cohort,FUPROC18,Follow up time for PROC18,phs000280.v8.p2,phv00506166.v1.p2,pht006443.v5.p2,INCps18,phv00506166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,ARIC,incps18.inchf18,Incident HF (from discharge codes),6.671554252,incps18,inchf18,Atherosclerosis Risk in Communities (ARIC) Cohort,INCHF18,Incident of heart failure (from discharge codes),phs000280.v8.p2,phv00506150.v1.p2,pht006443.v5.p2,INCps18,phv00506150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.proc18,Cardiac Procedures,-,incps18,proc18,Atherosclerosis Risk in Communities (ARIC) Cohort,PROC18,Cardiac Procedures,phs000280.v8.p2,phv00506155.v1.p2,pht006443.v5.p2,INCps18,phv00506155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.proc18,Cardiac Procedures,-,incps18,proc18,Atherosclerosis Risk in Communities (ARIC) Cohort,PROC18,Cardiac Procedures,phs000280.v8.p2,phv00506155.v1.p2,pht006443.v5.p2,INCps18,phv00506155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,ARIC,incps18.proc18,Cardiac Procedures,-,incps18,proc18,Atherosclerosis Risk in Communities (ARIC) Cohort,PROC18,Cardiac Procedures,phs000280.v8.p2,phv00506155.v1.p2,pht006443.v5.p2,INCps18,phv00506155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,lip.lip23,Fasting Glucose (mg/dL),5.536742296,lip,lip23,Atherosclerosis Risk in Communities (ARIC) Cohort,LIP23,Fasting glucose [Central Lab Data],phs000280.v8.p2,phv00296695.v2.p2,pht006444.v2.p2,LIP,phv00296695,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,lipc04.lipc4a,GLUCOSE (VALUE IN MG/DL) Q4A,-,lipc04,lipc4a,Atherosclerosis Risk in Communities (ARIC) Cohort,LIPC4A,Glucose (value in mg/dL) Q4a [Lipid Lab. LIPC04. Visit 3],phs000280.v8.p2,phv00207663.v2.p2,pht004123.v3.p2,LIPC04,phv00207663,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
GLUCOSE,-,-,-,ARICREGARDS,0.33,ARIC,lipd04.lipd4a,FASTING GLUCOSE (VALUE) Q4A,0.009175154,lipd04,lipd4a,Atherosclerosis Risk in Communities (ARIC) Cohort,LIPD4A,Fasting glucose (value). Q4a [Lipid Lab. LIPD04. Visit 4],phs000280.v8.p2,phv00207678.v2.p2,pht004124.v3.p2,LIPD04,phv00207678,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae1dres20220813.afib1c,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,0.719107719,mesae1dres20220813,afib1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib1c,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,phs000209.v13.p3,phv00084553.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084553,"['NO', 'YES']",phs000209,pht001116,phv00084553,True,False,False,afib1c,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,,\phs000209\pht001116\phv00084553\afib1c\,pht001116.v10,\phs000209\pht001116\phv00084553\afib1c\,phv00084553,,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,{},,,,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,phs000209.v13,c25a05dbc3fc2ee32f60b9e78eca2edf72b49fe6155cb22cf1c7a06a20d693ee,categorical,phv00084553.v2,phs000209,False,afib1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084553\afib1c\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae1dres20220813.afib1c,ATRIAL FIBRILLATION / FLUTTER BY NOVACODE,0.719107719,mesae1dres20220813,afib1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib1c,ECG ATRIAL FIBRILLATION,phs000209.v13.p3,phv00082843.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082843,['NO'],phs000209,pht001111,phv00082843,True,False,False,afib1c,ECG ATRIAL FIBRILLATION,,\phs000209\pht001111\phv00082843\afib1c\,pht001111.v4,\phs000209\pht001111\phv00082843\afib1c\,phv00082843,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",ECG ATRIAL FIBRILLATION,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,ECG ATRIAL FIBRILLATION,phs000209.v13,b386aea1a1cde4f8e9e9fe9b80a66aaf1cce61947496f3cdccf7f1b21ba14dce,categorical,phv00082843.v1,phs000209,False,afib1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082843\afib1c\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae1dres20220813.age1c,AGE,-,mesae1dres20220813,age1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age1c,AGE,phs000209.v13.p3,phv00084442.v3.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084442,[],phs000209,pht001116,phv00084442,False,True,False,age1c,AGE,44.0,\phs000209\pht001116\phv00084442\age1c\,pht001116.v10,\phs000209\pht001116\phv00084442\age1c\,phv00084442,,AGE,{},,,84.0,AGE,phs000209.v13,924df3f6ed9f4c05b9d75ab4ce88c3980ebf87998f41eb53b768b544cc41b538,continuous,phv00084442.v3,phs000209,False,age1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084442\age1c\,44.0,84.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae1dres20220813.age1c,AGE,-,mesae1dres20220813,age1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age1c,AGE,phs000209.v13.p3,phv00082639.v2.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082639,[],phs000209,pht001111,phv00082639,False,True,False,age1c,AGE,50.0,\phs000209\pht001111\phv00082639\age1c\,pht001111.v4,\phs000209\pht001111\phv00082639\age1c\,phv00082639,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",AGE,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",87.0,AGE,phs000209.v13,8465cda9405149ef0a1b1a862ade267ef9467c05929ffc07d77437886b911567,continuous,phv00082639.v2,phs000209,False,age1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082639\age1c\,50.0,87.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae1dres20220813.age1c,AGE,-,mesae1dres20220813,age1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age1c,AGE,phs000209.v13.p3,phv00175854.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175854,"['45', '46', '47', '48', '49', '50', '51', '52', '53', '54', '55', '56', '57', '58', '59', '60', '61', '62', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '84']",phs000209,pht003087,phv00175854,True,False,False,age1c,AGE,,\phs000209\pht003087\phv00175854\age1c\,pht003087.v1,\phs000209\pht003087\phv00175854\age1c\,phv00175854,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,AGE,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,,AGE,phs000209.v13,6d8596dce20c590ed9ad7dc900f09c88936a42798557651abd77dbcef5d6c9b0,categorical,phv00175854.v1,phs000209,False,age1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175854\age1c\,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,MESA,mesae1dres20220813.alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),21.44115057,mesae1dres20220813,alcwk1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),phs000209.v13.p3,phv00085609.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085609,"['0', '1', '10', '11', '12', '13', '14', '15', '16', '17', '18', '19', '2', '20', '21', '22', '23', '24', '25', '28', '3', '30', '32', '35', '36', '4', '40', '42', '45', '48', '49', '5', '50', '56', '6', '60', '64', '7', '70', '72', '8', '84', '85', '9', '99']",phs000209,pht001116,phv00085609,True,False,False,alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),,\phs000209\pht001116\phv00085609\alcwk1c\,pht001116.v10,\phs000209\pht001116\phv00085609\alcwk1c\,phv00085609,,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),{},,,,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),phs000209.v13,220f842f9bdc7ccfb52e03e693eda7481814dd3afd7d4d99ab0904d13fce7350,categorical,phv00085609.v2,phs000209,False,alcwk1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085609\alcwk1c\,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,MESA,mesae1dres20220813.alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),21.44115057,mesae1dres20220813,alcwk1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),phs000209.v13.p3,phv00083279.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083279,"['0', '1', '10', '12', '14', '15', '17', '18', '2', '20', '21', '25', '28', '3', '30', '4', '5', '50', '6', '60', '7', '77', '8', '9']",phs000209,pht001111,phv00083279,True,False,False,alcwk1c,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),,\phs000209\pht001111\phv00083279\alcwk1c\,pht001111.v4,\phs000209\pht001111\phv00083279\alcwk1c\,phv00083279,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,# DRINKS PER WEEK (CURRENT AND FORMER DRINKERS),phs000209.v13,14776638f02a87dda71bef2e6b70b27218965d82734518fe3b628fc5918b999d,categorical,phv00083279.v1,phs000209,False,alcwk1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083279\alcwk1c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae1dres20220813.asa1c,Aspirin from 280804 (anti-inflam agents),0.044027003,mesae1dres20220813,asa1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa1c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00085341.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085341,"['NO', 'YES']",phs000209,pht001116,phv00085341,True,False,False,asa1c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht001116\phv00085341\asa1c\,pht001116.v10,\phs000209\pht001116\phv00085341\asa1c\,phv00085341,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,f34f020ad12096fd6772607679273c888b93f9c5c111ab9a23dc7756d942cac7,categorical,phv00085341.v2,phs000209,False,asa1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085341\asa1c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae1dres20220813.asa1c,Aspirin from 280804 (anti-inflam agents),0.044027003,mesae1dres20220813,asa1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa1c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00083096.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083096,"['NO', 'YES']",phs000209,pht001111,phv00083096,True,False,False,asa1c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht001111\phv00083096\asa1c\,pht001111.v4,\phs000209\pht001111\phv00083096\asa1c\,phv00083096,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,3c6d3d80416f407dd798c140379283320d64f21916bde792021272f2609f8e2e,categorical,phv00083096.v1,phs000209,False,asa1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083096\asa1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.basq1c,Bile-acid sequestrants,0.044027003,mesae1dres20220813,basq1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq1c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00083097.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083097,"['NO', 'YES']",phs000209,pht001111,phv00083097,True,False,False,basq1c,BILE-ACID SEQUESTRANTS,,\phs000209\pht001111\phv00083097\basq1c\,pht001111.v4,\phs000209\pht001111\phv00083097\basq1c\,phv00083097,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",BILE-ACID SEQUESTRANTS,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,BILE-ACID SEQUESTRANTS,phs000209.v13,fb821cfeebeed03d5ab0c9eac67cf83b4340a714c949d960718c4ac124854de8,categorical,phv00083097.v1,phs000209,False,basq1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083097\basq1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.basq1c,Bile-acid sequestrants,0.044027003,mesae1dres20220813,basq1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq1c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00085342.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085342,"['NO', 'YES']",phs000209,pht001116,phv00085342,True,False,False,basq1c,BILE-ACID SEQUESTRANTS,,\phs000209\pht001116\phv00085342\basq1c\,pht001116.v10,\phs000209\pht001116\phv00085342\basq1c\,phv00085342,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,d7c8ee9a7cbc5c975a5a3303f55dcf7d7fc8f05795848f897826522ecff31f20,categorical,phv00085342.v2,phs000209,False,basq1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085342\basq1c\,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,MESA,mesae1dres20220813.creatin1,CREATININE (mg/dl),0.366891694,mesae1dres20220813,creatin1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,creatin1,CREATININE (mg/dl),phs000209.v13.p3,phv00082955.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082955,[],phs000209,pht001111,phv00082955,False,True,False,creatin1,CREATININE (mg/dl),0.5185,\phs000209\pht001111\phv00082955\creatin1\,pht001111.v4,\phs000209\pht001111\phv00082955\creatin1\,phv00082955,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",CREATININE (mg/dl),{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",2.0116,CREATININE (mg/dl),phs000209.v13,bba884d177c04fd9b1109a4164654349db24184e1a705247d24d9514affac2d3,continuous,phv00082955.v1,phs000209,False,creatin1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082955\creatin1\,0.5185,2.0116
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,MESA,mesae1dres20220813.creatin1,CREATININE (mg/dl),0.366891694,mesae1dres20220813,creatin1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,creatin1,CREATININE (mg/dl),phs000209.v13.p3,phv00084973.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084973,[],phs000209,pht001116,phv00084973,False,True,False,creatin1,CREATININE (mg/dl),0.2,\phs000209\pht001116\phv00084973\creatin1\,pht001116.v10,\phs000209\pht001116\phv00084973\creatin1\,phv00084973,,CREATININE (mg/dl),{},,,10.0,CREATININE (mg/dl),phs000209.v13,3795c52f0768ac05d8212c50d292514dcedb696a76cad7f6b7c47efb43a93b64,continuous,phv00084973.v2,phs000209,False,creatin1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084973\creatin1\,0.2,10.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae1dres20220813.dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),0.044027003,mesae1dres20220813,dbp1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00083411.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083411,[],phs000209,pht001111,phv00083411,False,True,False,dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),46.5,\phs000209\pht001111\phv00083411\dbp1c\,pht001111.v4,\phs000209\pht001111\phv00083411\dbp1c\,phv00083411,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",106.5,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,b10deb765462ddda1b757b43f59eaadb4b270dca9b6c48398a62c0ad80a72650,continuous,phv00083411.v1,phs000209,False,dbp1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083411\dbp1c\,46.5,106.5
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae1dres20220813.dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),0.044027003,mesae1dres20220813,dbp1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00085741.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085741,[],phs000209,pht001116,phv00085741,False,True,False,dbp1c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),37.0,\phs000209\pht001116\phv00085741\dbp1c\,pht001116.v10,\phs000209\pht001116\phv00085741\dbp1c\,phv00085741,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,,118.5,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,b825473f2c69c45cf6d60f72054751cbaa019e4c9e967c46f6347f4fcfa2cb90,continuous,phv00085741.v2,phs000209,False,dbp1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085741\dbp1c\,37.0,118.5
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae1dres20220813.dm031c,Exam 1 Diabetes mellitus by 2003 ADA fasting criteria algorithm,0.352216026,mesae1dres20220813,dm031c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm031c,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13.p3,phv00084456.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084456,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht001116,phv00084456,True,False,False,dm031c,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,,\phs000209\pht001116\phv00084456\dm031c\,pht001116.v10,\phs000209\pht001116\phv00084456\dm031c\,phv00084456,,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,{},,,,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13,ce6d320750917196871dece55b2cbcde87591510719aa81c3f529c4f2d7a5d8e,categorical,phv00084456.v2,phs000209,False,dm031c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084456\dm031c\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae1dres20220813.dm031c,Exam 1 Diabetes mellitus by 2003 ADA fasting criteria algorithm,0.352216026,mesae1dres20220813,dm031c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm031c,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13.p3,phv00082652.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082652,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht001111,phv00082652,True,False,False,dm031c,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,,\phs000209\pht001111\phv00082652\dm031c\,pht001111.v4,\phs000209\pht001111\phv00082652\dm031c\,phv00082652,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,EXAM 1 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13,bda748526cded4bfbeb0dde9e70a5396a47c8eed5d1c91db216f518880b2d2d0,categorical,phv00082652.v1,phs000209,False,dm031c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082652\dm031c\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,MESA,mesae1dres20220813.ecglvh1c,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,0.719107719,mesae1dres20220813,ecglvh1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ecglvh1c,ECG LEFT VENTRICULAR HYPERTROPHY,phs000209.v13.p3,phv00082842.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082842,"['NO', 'YES']",phs000209,pht001111,phv00082842,True,False,False,ecglvh1c,ECG LEFT VENTRICULAR HYPERTROPHY,,\phs000209\pht001111\phv00082842\ecglvh1c\,pht001111.v4,\phs000209\pht001111\phv00082842\ecglvh1c\,phv00082842,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",ECG LEFT VENTRICULAR HYPERTROPHY,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,ECG LEFT VENTRICULAR HYPERTROPHY,phs000209.v13,aca54cb59644ff3edff9e5e18be57c107010bf0d9b023c679316641ae0821ea3,categorical,phv00082842.v1,phs000209,False,ecglvh1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082842\ecglvh1c\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,MESA,mesae1dres20220813.ecglvh1c,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,0.719107719,mesae1dres20220813,ecglvh1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ecglvh1c,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13.p3,phv00084552.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084552,"['NO', 'YES']",phs000209,pht001116,phv00084552,True,False,False,ecglvh1c,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,,\phs000209\pht001116\phv00084552\ecglvh1c\,pht001116.v10,\phs000209\pht001116\phv00084552\ecglvh1c\,phv00084552,,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,{},,,,LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13,a4e309e1e2e5f631fb903c612a9e44a51e3ea23ae31e68594290914dc6b5fcb6,categorical,phv00084552.v2,phs000209,False,ecglvh1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084552\ecglvh1c\,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,MESA,mesae1dres20220813.educ1,EDUCATION: HIGHEST LEVEL COMPLETED,0.337540358,mesae1dres20220813,educ1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13.p3,phv00085554.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085554,"['ASSOCIATE DEGREE', ""BACHELOR'S DEGREE"", 'COMPLETED HIGH SCHOOL/GED', 'GRADES 1-8', 'GRADES 9-11', 'GRADUATE OR PROFESSIONAL SCHOOL', 'NO SCHOOLING', 'SOME COLLEGE BUT NO DEGREE', 'TECHNICAL SCHOOL CERTIFICATE']",phs000209,pht001116,phv00085554,True,False,True,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,,\phs000209\pht001116\phv00085554\educ1\,pht001116.v10,\phs000209\pht001116\phv00085554\educ1\,phv00085554,,EDUCATION: HIGHEST LEVEL COMPLETED,{},,,,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13,6dd47ce9b67df304c0585842e134ef5a01616e68bf17394e198df7cc8b67c663,categorical,phv00085554.v2,phs000209,True,educ1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085554\educ1\,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,MESA,mesae1dres20220813.educ1,EDUCATION: HIGHEST LEVEL COMPLETED,0.337540358,mesae1dres20220813,educ1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13.p3,phv00175873.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175873,"['ASSOCIATE DEGREE', ""BACHELOR'S DEGREE"", 'COMPLETED HIGH SCHOOL/GED', 'GRADES 1-8', 'GRADES 9-11', 'GRADUATE OR PROFESSIONAL SCHOOL', 'NO SCHOOLING', 'SOME COLLEGE BUT NO DEGREE', 'TECHNICAL SCHOOL CERTIFICATE']",phs000209,pht003087,phv00175873,True,False,True,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,,\phs000209\pht003087\phv00175873\educ1\,pht003087.v1,\phs000209\pht003087\phv00175873\educ1\,phv00175873,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,EDUCATION: HIGHEST LEVEL COMPLETED,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13,05fd83fed275f2d68f804967774f3d823303de75311e9c2af00adba56c6cb5e9,categorical,phv00175873.v1,phs000209,True,educ1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175873\educ1\,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,MESA,mesae1dres20220813.educ1,EDUCATION: HIGHEST LEVEL COMPLETED,0.337540358,mesae1dres20220813,educ1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13.p3,phv00083223.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083223,"['ASSOCIATE DEGREE', ""BACHELOR'S DEGREE"", 'COMPLETED HIGH SCHOOL/GED', 'GRADES 1-8', 'GRADES 9-11', 'GRADUATE OR PROFESSIONAL SCHOOL', 'SOME COLLEGE BUT NO DEGREE', 'TECHNICAL SCHOOL CERTIFICATE']",phs000209,pht001111,phv00083223,True,False,True,educ1,EDUCATION: HIGHEST LEVEL COMPLETED,,\phs000209\pht001111\phv00083223\educ1\,pht001111.v4,\phs000209\pht001111\phv00083223\educ1\,phv00083223,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",EDUCATION: HIGHEST LEVEL COMPLETED,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,EDUCATION: HIGHEST LEVEL COMPLETED,phs000209.v13,8e535f1dff936caad6a6410251443fdc2630ba0258dd0c6545766881ea32587a,categorical,phv00083223.v1,phs000209,True,educ1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083223\educ1\,,
EDUCLEV,"Education level (1=Less than High School, 2=High School, 3=Some College, 4=College)",276031006,C00012,ARICFraminghamMESAREGARDS,1.45,MESA,mesae1dres20220813.educ1,EDUCATION: HIGHEST LEVEL COMPLETED,0.337540358,mesae1dres20220813,educ1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,educ1,EDUCATION: HIGHEST LEVEL COMPLETED AT BASELINE MESA EXAM,phs000209.v13.p3,phv00219019.v1.p3,pht004326.v1.p3,MESA_AncilMesaStressWave1,phv00219019,"['ASSOCIATE DEGREE', ""BACHELOR'S DEGREE"", 'COMPLETED HIGH SCHOOL/GED', 'GRADES 1-8', 'GRADES 9-11', 'GRADUATE, PROFESSIONAL SCHOOL', 'NO SCHOOLING', 'SOME COLLEGE BUT NO DEGREE', 'TECHNICAL SCHOOL CERTIFICATE']",phs000209,pht004326,phv00219019,True,False,True,educ1,EDUCATION: HIGHEST LEVEL COMPLETED AT BASELINE MESA EXAM,,\phs000209\pht004326\phv00219019\educ1\,pht004326.v1,\phs000209\pht004326\phv00219019\educ1\,phv00219019,,EDUCATION: HIGHEST LEVEL COMPLETED AT BASELINE MESA EXAM,{},,,,EDUCATION: HIGHEST LEVEL COMPLETED AT BASELINE MESA EXAM,phs000209.v13,b5fd641282887ce31e65fd7a5eb28c0337212a7b022a10bef5311441bd8cc8a4,categorical,phv00219019.v1,phs000209,True,educ1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht004326,MESA_AncilMesaStressWave1,\phs000209\pht004326\phv00219019\educ1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.fibr1c,Fibrates,0.044027003,mesae1dres20220813,fibr1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr1c,FIBRATES,phs000209.v13.p3,phv00085359.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085359,"['NO', 'YES']",phs000209,pht001116,phv00085359,True,False,False,fibr1c,FIBRATES,,\phs000209\pht001116\phv00085359\fibr1c\,pht001116.v10,\phs000209\pht001116\phv00085359\fibr1c\,phv00085359,,FIBRATES,{},,,,FIBRATES,phs000209.v13,db0cf23e50cf2a276641f772814aceae7457b7348a7d179276dac1c378223149,categorical,phv00085359.v2,phs000209,False,fibr1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085359\fibr1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.fibr1c,Fibrates,0.044027003,mesae1dres20220813,fibr1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr1c,FIBRATES,phs000209.v13.p3,phv00083114.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083114,"['NO', 'YES']",phs000209,pht001111,phv00083114,True,False,False,fibr1c,FIBRATES,,\phs000209\pht001111\phv00083114\fibr1c\,pht001111.v4,\phs000209\pht001111\phv00083114\fibr1c\,phv00083114,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",FIBRATES,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,FIBRATES,phs000209.v13,53976b15bad21146692c285a55fc672a5dae34655ae87185e602b19c8288d003,categorical,phv00083114.v1,phs000209,False,fibr1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083114\fibr1c\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae1dres20220813.glucos1c,Exam 1 Fasting Glucose- Calibrated,0.366891694,mesae1dres20220813,glucos1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos1c,FASTING GLUCOSE CALIBRATED (mg/dl),phs000209.v13.p3,phv00082953.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082953,[],phs000209,pht001111,phv00082953,False,True,False,glucos1c,FASTING GLUCOSE CALIBRATED (mg/dl),64.0,\phs000209\pht001111\phv00082953\glucos1c\,pht001111.v4,\phs000209\pht001111\phv00082953\glucos1c\,phv00082953,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",FASTING GLUCOSE CALIBRATED (mg/dl),{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",331.0,FASTING GLUCOSE CALIBRATED (mg/dl),phs000209.v13,c8db3846eb7d8d8aad3d76fa5c1c25553a492e775c1c260a0a852740d1350b15,continuous,phv00082953.v1,phs000209,False,glucos1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082953\glucos1c\,64.0,331.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae1dres20220813.glucos1c,Exam 1 Fasting Glucose- Calibrated,0.366891694,mesae1dres20220813,glucos1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos1c,EXAM 1 FASTING GLUCOSE- CALIBRATED,phs000209.v13.p3,phv00084969.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084969,[],phs000209,pht001116,phv00084969,False,True,False,glucos1c,EXAM 1 FASTING GLUCOSE- CALIBRATED,38.0,\phs000209\pht001116\phv00084969\glucos1c\,pht001116.v10,\phs000209\pht001116\phv00084969\glucos1c\,phv00084969,,EXAM 1 FASTING GLUCOSE- CALIBRATED,{},,,507.0,EXAM 1 FASTING GLUCOSE- CALIBRATED,phs000209.v13,c3dc6da3fdd03288825361351a45d6b0dae2c97ad645b8e9a2d1b5106c1da5fc,continuous,phv00084969.v2,phs000209,False,glucos1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084969\glucos1c\,38.0,507.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae1dres20220813.glucos1c,Exam 1 Fasting Glucose- Calibrated,0.366891694,mesae1dres20220813,glucos1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos1c,EXAM 1 FASTING GLUCOSE- CALIBRATED,phs000209.v13.p3,phv00175863.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175863,"['100', '101', '102', '104', '106', '111', '114', '115', '117', '118', '122', '123', '124', '127', '130', '131', '133', '142', '152', '155', '164', '171', '175', '178', '180', '203', '224', '235', '237', '242', '246', '250', '268', '72', '73', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94', '95', '96', '97', '98', '99']",phs000209,pht003087,phv00175863,True,False,False,glucos1c,EXAM 1 FASTING GLUCOSE- CALIBRATED,,\phs000209\pht003087\phv00175863\glucos1c\,pht003087.v1,\phs000209\pht003087\phv00175863\glucos1c\,phv00175863,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,EXAM 1 FASTING GLUCOSE- CALIBRATED,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,,EXAM 1 FASTING GLUCOSE- CALIBRATED,phs000209.v13,a136fab26d8622b7e745c0dc9df355c3b91e7ebb0f686d936e633de89242e751,categorical,phv00175863.v1,phs000209,False,glucos1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175863\glucos1c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae1dres20220813.htn1c,Hypertension by JNC VI (1997) criteria,-,mesae1dres20220813,htn1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13.p3,phv00175865.v1.p3,pht003087.v1.p3,MESA_AncilMesaCTRead185,phv00175865,"['NO', 'YES']",phs000209,pht003087,phv00175865,True,False,False,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,,\phs000209\pht003087\phv00175865\htn1c\,pht003087.v1,\phs000209\pht003087\phv00175865\htn1c\,phv00175865,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,HYPERTENSION BY JNC VI (1997) CRITERIA,{},,MESA Lung CT Read 185: Lung CT reads for 185 case-control subjects who had A1AT measured from the MESA Lung Cohort.,,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13,07e65c560c6b53018c1c92043ae229ca5c128f702ccfa9d4a84133c103a138ba,categorical,phv00175865.v1,phs000209,False,htn1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003087,MESA_AncilMesaCTRead185,\phs000209\pht003087\phv00175865\htn1c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae1dres20220813.htn1c,Hypertension by JNC VI (1997) criteria,-,mesae1dres20220813,htn1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13.p3,phv00084459.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00084459,"['NO', 'YES']",phs000209,pht001116,phv00084459,True,False,False,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,,\phs000209\pht001116\phv00084459\htn1c\,pht001116.v10,\phs000209\pht001116\phv00084459\htn1c\,phv00084459,,HYPERTENSION BY JNC VI (1997) CRITERIA,{},,,,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13,00481139bdc2615ce6fc51c1d5e05c509a77e0258816fa7716b48263a3fa7dd7,categorical,phv00084459.v2,phs000209,False,htn1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00084459\htn1c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae1dres20220813.htn1c,Hypertension by JNC VI (1997) criteria,-,mesae1dres20220813,htn1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13.p3,phv00082655.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082655,"['NO', 'YES']",phs000209,pht001111,phv00082655,True,False,False,htn1c,HYPERTENSION BY JNC VI (1997) CRITERIA,,\phs000209\pht001111\phv00082655\htn1c\,pht001111.v4,\phs000209\pht001111\phv00082655\htn1c\,phv00082655,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",HYPERTENSION BY JNC VI (1997) CRITERIA,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,HYPERTENSION BY JNC VI (1997) CRITERIA,phs000209.v13,28478e4a3ff1359100c6e347f16a4368fdf42eacafdf39686211a6a70289c173,categorical,phv00082655.v1,phs000209,False,htn1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082655\htn1c\,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,MESA,mesae1dres20220813.income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",4.006457294,mesae1dres20220813,income1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",phs000209.v13.p3,phv00083226.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083226,"['$100000 OR MORE', '$12,000 - 15,999', '$16,000 - 19,999', '$20,000 - 24,999', '$25,000 - 29,999', '$30,000 - 34,999', '$35,000 - 39,999', '$40,000 - 49,999', '$5,000 - 7,999', '$50,000 - 74,999', '$75,000 - 99,999,', '$8,000 - 11,999', '< $5,000']",phs000209,pht001111,phv00083226,True,False,False,income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",,\phs000209\pht001111\phv00083226\income1\,pht001111.v4,\phs000209\pht001111\phv00083226\income1\,phv00083226,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.","TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",phs000209.v13,d529b2e72016fd308ce3a51b45cb00c454c58631182326fd3ecc4e6260edf6f4,categorical,phv00083226.v1,phs000209,False,income1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083226\income1\,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,MESA,mesae1dres20220813.income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",4.006457294,mesae1dres20220813,income1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",phs000209.v13.p3,phv00085558.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085558,"['$100,000 +', '$12,000 - 15,999', '$16,000 - 19,999', '$20,000 - 24,999', '$25,000 - 29,999', '$30,000 - 34,999', '$35,000 - 39,999', '$40,000 - 49,999', '$5,000 - 7,999', '$50,000 - 74,999', '$75,000 - 99,999', '$8,000 - 11,999', '< $5,000']",phs000209,pht001116,phv00085558,True,False,False,income1,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",,\phs000209\pht001116\phv00085558\income1\,pht001116.v10,\phs000209\pht001116\phv00085558\income1\,phv00085558,,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",{},,,,"TOTAL GROSS FAMILY INCOME, PAST 12 MONTHS",phs000209.v13,43bb0837e516726ea170df2c55b6e10388ea872ec89afda78b5aaeba879db85e,categorical,phv00085558.v2,phs000209,False,income1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085558\income1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae1dres20220813.insln1c,Insulins,0.044027003,mesae1dres20220813,insln1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln1c,INSULINS,phs000209.v13.p3,phv00083119.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083119,"['NO', 'YES']",phs000209,pht001111,phv00083119,True,False,False,insln1c,INSULINS,,\phs000209\pht001111\phv00083119\insln1c\,pht001111.v4,\phs000209\pht001111\phv00083119\insln1c\,phv00083119,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",INSULINS,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,INSULINS,phs000209.v13,a3e8992b4908f3d8e18572c6e53ac890e98e3af2083b95b3157f7625ae86229a,categorical,phv00083119.v1,phs000209,False,insln1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083119\insln1c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae1dres20220813.insln1c,Insulins,0.044027003,mesae1dres20220813,insln1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln1c,INSULINS,phs000209.v13.p3,phv00085364.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085364,"['NO', 'YES']",phs000209,pht001116,phv00085364,True,False,False,insln1c,INSULINS,,\phs000209\pht001116\phv00085364\insln1c\,pht001116.v10,\phs000209\pht001116\phv00085364\insln1c\,phv00085364,,INSULINS,{},,,,INSULINS,phs000209.v13,1d3ed1777997bfb63c2dc70dbba8688c75ebb40f9ef7c09512b3d4bbcc3d2611,categorical,phv00085364.v2,phs000209,False,insln1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085364\insln1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.mlpd1c,Miscellaneous lipid-lowering drugs,0.044027003,mesae1dres20220813,mlpd1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd1c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00083127.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083127,"['NO', 'YES']",phs000209,pht001111,phv00083127,True,False,False,mlpd1c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht001111\phv00083127\mlpd1c\,pht001111.v4,\phs000209\pht001111\phv00083127\mlpd1c\,phv00083127,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",MISCELLANEOUS LIPID-LOWERING DRUGS,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,51081adcac4045d6e891785669054e72ac9319dad3f6cf72ad47ef7f69747a3d,categorical,phv00083127.v1,phs000209,False,mlpd1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083127\mlpd1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.mlpd1c,Miscellaneous lipid-lowering drugs,0.044027003,mesae1dres20220813,mlpd1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd1c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00085372.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085372,['NO'],phs000209,pht001116,phv00085372,True,False,False,mlpd1c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht001116\phv00085372\mlpd1c\,pht001116.v10,\phs000209\pht001116\phv00085372\mlpd1c\,phv00085372,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,7643de3bfa424ddd13b0dd4506bd0f1dc1224f4d8eae878c84bb948365030c19,categorical,phv00085372.v2,phs000209,False,mlpd1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085372\mlpd1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.niac1c,Niacin and nictotinic acid,0.044027003,mesae1dres20220813,niac1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac1c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00083128.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083128,"['NO', 'YES']",phs000209,pht001111,phv00083128,True,False,False,niac1c,NIACIN AND NICOTINIC ACID,,\phs000209\pht001111\phv00083128\niac1c\,pht001111.v4,\phs000209\pht001111\phv00083128\niac1c\,phv00083128,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",NIACIN AND NICOTINIC ACID,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,NIACIN AND NICOTINIC ACID,phs000209.v13,cab2957cb1a184ae16b8514da65120f20186fa5e1d5409932525be3fcced1493,categorical,phv00083128.v1,phs000209,False,niac1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083128\niac1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.niac1c,Niacin and nictotinic acid,0.044027003,mesae1dres20220813,niac1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac1c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00085373.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085373,"['NO', 'YES']",phs000209,pht001116,phv00085373,True,False,False,niac1c,NIACIN AND NICOTINIC ACID,,\phs000209\pht001116\phv00085373\niac1c\,pht001116.v10,\phs000209\pht001116\phv00085373\niac1c\,phv00085373,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,0caa3c8332e04ceb04d62804d42ec35eb357d44b82ad19d662f81df0015cb0ea,categorical,phv00085373.v2,phs000209,False,niac1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085373\niac1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.prob1c,Probucol,0.044027003,mesae1dres20220813,prob1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob1c,PROBUCOL,phs000209.v13.p3,phv00083143.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00083143,['NO'],phs000209,pht001111,phv00083143,True,False,False,prob1c,PROBUCOL,,\phs000209\pht001111\phv00083143\prob1c\,pht001111.v4,\phs000209\pht001111\phv00083143\prob1c\,phv00083143,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",PROBUCOL,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,PROBUCOL,phs000209.v13,47a5b447f07e2031db930992063ae1da1c76c572d3b0e15f731be05ef7223f21,categorical,phv00083143.v1,phs000209,False,prob1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00083143\prob1c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae1dres20220813.prob1c,Probucol,0.044027003,mesae1dres20220813,prob1c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob1c,PROBUCOL,phs000209.v13.p3,phv00085388.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085388,['NO'],phs000209,pht001116,phv00085388,True,False,False,prob1c,PROBUCOL,,\phs000209\pht001116\phv00085388\prob1c\,pht001116.v10,\phs000209\pht001116\phv00085388\prob1c\,phv00085388,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,a3efef2ec17eb7815c99bd587be38df16f6774e83a024a1a4534adc827dc5cc1,categorical,phv00085388.v2,phs000209,False,prob1c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085388\prob1c\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,MESA,mesae1dres20220813.rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,0.014675668,mesae1dres20220813,rheuhv1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,phs000209.v13.p3,phv00082985.v1.p3,pht001111.v4.p3,MESA_AirNRExamMain,phv00082985,"['DO NOT KNOW', 'NO', 'YES']",phs000209,pht001111,phv00082985,True,False,False,rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,,\phs000209\pht001111\phv00082985\rheuhv1\,pht001111.v4,\phs000209\pht001111\phv00082985\rheuhv1\,phv00082985,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",RHEUMATIC HEART DISEASE: SELF-REPORT,{},,"MESA Air Exam Main Dataset: The MESA Air Exam is an ancillary exam of the MESA Study. There are no overlaps in subjects in between MESA Classic Exam datasets, MESA Family Exam datasets, and MESA AIR Exam datasets. However, many of the phenotype measurements are shared betweeen the MESA Classic and MESA Air Exams. Variables included in the MESA Air Exam are those from standard questionnaires, clinical and laboratory measurements. The questionnaires include variables of demography, socioeconomic and psychosocial status, medical and family history, medication use, dietary and alcohol intakes, smoking, and physical activity. The clinical measurements include anthropometry, blood pressure, ankle/brachial blood pressure indices, ECG, coronary calcium determination, arterial wave forms, and flow-dependent brachial artery vasodilation. Laboratory measurements include various lipids, cytokines, adhesion molecules, NO, and hemostasis/fibrinolysis markers.",,RHEUMATIC HEART DISEASE: SELF-REPORT,phs000209.v13,44d7c9f9d65a54cdaba8bc636cf285beab1a46c431c8d6db6e1cfdba7c05746a,categorical,phv00082985.v1,phs000209,False,rheuhv1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001111,MESA_AirNRExamMain,\phs000209\pht001111\phv00082985\rheuhv1\,,
VALVDIS,"Valvular heart disease (0=No, 1=Yes)",368009,C22435,FraminghamMESA,2.56,MESA,mesae1dres20220813.rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,0.014675668,mesae1dres20220813,rheuhv1,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,phs000209.v13.p3,phv00085221.v2.p3,pht001116.v10.p3,MESA_Exam1Main,phv00085221,"['DO NOT KNOW', 'NO', 'YES']",phs000209,pht001116,phv00085221,True,False,False,rheuhv1,RHEUMATIC HEART DISEASE: SELF-REPORT,,\phs000209\pht001116\phv00085221\rheuhv1\,pht001116.v10,\phs000209\pht001116\phv00085221\rheuhv1\,phv00085221,,RHEUMATIC HEART DISEASE: SELF-REPORT,{},,,,RHEUMATIC HEART DISEASE: SELF-REPORT,phs000209.v13,967cb919fee31d060a3a370693f7ced243877488af0cc1f0d70a2c66bc7e4219,categorical,phv00085221.v2,phs000209,False,rheuhv1,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001116,MESA_Exam1Main,\phs000209\pht001116\phv00085221\rheuhv1\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae1dres20220813.whoros1c,WHO ROSE Intermittent Claudication,9.054886997,mesae1dres20220813,whoros1c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae2dres06222012.age2c,AGE AT EXAM 2,8.526562959,mesae2dres06222012,age2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age2c,AGE AT EXAM 2,phs000209.v13.p3,phv00085773.v3.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085773,"['46', '47', '48', '49', '50', '51', '52', '53', '54', '55', '56', '57', '58', '59', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87']",phs000209,pht001118,phv00085773,True,False,False,age2c,AGE AT EXAM 2,,\phs000209\pht001118\phv00085773\age2c\,pht001118.v8,\phs000209\pht001118\phv00085773\age2c\,phv00085773,,AGE AT EXAM 2,{},,,,AGE AT EXAM 2,phs000209.v13,602747151fe485cce921078f65875755a7506469c30a9c83c2c792fc9f5a2453,categorical,phv00085773.v3,phs000209,False,age2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085773\age2c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae2dres06222012.asa2c,Aspirin from 280804 (anti-inflam agents),12.35691224,mesae2dres06222012,asa2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa2c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00086003.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086003,"['NO', 'YES']",phs000209,pht001118,phv00086003,True,False,False,asa2c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht001118\phv00086003\asa2c\,pht001118.v8,\phs000209\pht001118\phv00086003\asa2c\,phv00086003,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,b25814481a9e8c643aa6ab8756c38602f02270abdf65c595b887a28098a214a5,categorical,phv00086003.v2,phs000209,False,asa2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086003\asa2c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae2dres06222012.basq2c,Bile-acid sequestrants,12.35691224,mesae2dres06222012,basq2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq2c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00086028.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086028,"['NO', 'YES']",phs000209,pht001118,phv00086028,True,False,False,basq2c,BILE-ACID SEQUESTRANTS,,\phs000209\pht001118\phv00086028\basq2c\,pht001118.v8,\phs000209\pht001118\phv00086028\basq2c\,phv00086028,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,41e3ad2b30f66837cc4e712158ea8100c5955de11d541fad5a65a818c9aa494a,categorical,phv00086028.v2,phs000209,False,basq2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086028\basq2c\,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae2dres06222012.dbp2c,Seated Diastolic Blood Pressure (mmHg),8.570589962,mesae2dres06222012,dbp2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp2c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00086225.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086225,"['100', '100.5', '101', '101.5', '102', '102.5', '103', '103.5', '104', '106', '106.5', '108', '112', '112.5', '114', '116.5', '118.5', '38', '38.5', '39', '40.5', '42', '43', '43.5', '44', '44.5', '45', '45.5', '46', '46.5', '47', '47.5', '48', '48.5', '49', '49.5', '50', '50.5', '51', '51.5', '52', '52.5', '53', '53.5', '54', '54.5', '55', '55.5', '56', '56.5', '57', '57.5', '58', '58.5', '59', '59.5', '60', '60.5', '61', '61.5', '62', '62.5', '63', '63.5', '64', '64.5', '65', '65.5', '66', '66.5', '67', '67.5', '68', '68.5', '69', '69.5', '70', '70.5', '71', '71.5', '72', '72.5', '73', '73.5', '74', '74.5', '75', '75.5', '76', '76.5', '77', '77.5', '78', '78.5', '79', '79.5', '80', '80.5', '81', '81.5', '82', '82.5', '83', '83.5', '84', '84.5', '85', '85.5', '86', '86.5', '87', '87.5', '88', '88.5', '89', '89.5', '90', '90.5', '91', '91.5', '92', '92.5', '93', '93.5', '94', '94.5', '95', '95.5', '96', '96.5', '97', '97.5', '98', '98.5', '99', '99.5']",phs000209,pht001118,phv00086225,True,False,False,dbp2c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),,\phs000209\pht001118\phv00086225\dbp2c\,pht001118.v8,\phs000209\pht001118\phv00086225\dbp2c\,phv00086225,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,5edaec38af901f57d6a2c10a343f78895151b7b48b5e926c99dc09ca1bcb2adc,categorical,phv00086225.v2,phs000209,False,dbp2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086225\dbp2c\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae2dres06222012.dm032c,Exam 2 Diabetes mellitus by 2003 ADA fasting criteria algorithm,9.186968007,mesae2dres06222012,dm032c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm032c,EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13.p3,phv00085794.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085794,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht001118,phv00085794,True,False,False,dm032c,EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,,\phs000209\pht001118\phv00085794\dm032c\,pht001118.v8,\phs000209\pht001118\phv00085794\dm032c\,phv00085794,,EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,{},,,,EXAM 2 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13,4856066f79c92cb66ea6cf6f4deba4bbd3f881a453c0da2391aa4dd0ae66175a,categorical,phv00085794.v2,phs000209,False,dm032c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085794\dm032c\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesae2dres06222012.e12dyc,"Time between exam visits, in days",8.526562959,mesae2dres06222012,e12dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13.p3,phv00085786.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085786,"['1000', '1005', '1007', '1012', '1014', '1019', '1023', '1029', '1033', '1048', '1064', '1075', '1086', '1093', '1099', '1100', '1113', '1120', '1125', '1133', '1143', '1154', '1161', '1205', '1224', '319', '385', '386', '387', '388', '393', '394', '395', '398', '402', '405', '406', '407', '408', '410', '411', '412', '413', '414', '415', '416', '417', '418', '419', '420', '421', '422', '423', '424', '425', '426', '427', '428', '429', '430', '431', '432', '433', '434', '435', '436', '437', '438', '439', '440', '441', '442', '443', '444', '445', '446', '447', '448', '449', '450', '451', '452', '453', '454', '455', '456', '457', '458', '459', '460', '461', '462', '463', '464', '465', '466', '467', '468', '469', '470', '471', '472', '473', '474', '475', '476', '477', '478', '479', '480', '481', '482', '483', '484', '485', '486', '487', '488', '489', '490', '491', '492', '493', '494', '495', '496', '497', '498', '499', '500', '501', '502', '503', '504', '505', '506', '507', '508', '509', '510', '511', '512', '513', '514', '515', '516', '517', '518', '519', '520', '521', '522', '523', '524', '525', '526', '527', '528', '529', '530', '531', '532', '533', '534', '535', '536', '537', '538', '539', '540', '541', '542', '543', '544', '545', '546', '547', '548', '549', '550', '551', '552', '553', '554', '555', '556', '557', '558', '559', '560', '561', '562', '563', '564', '565', '566', '567', '568', '569', '570', '571', '572', '573', '574', '575', '576', '577', '578', '579', '580', '581', '582', '583', '584', '585', '586', '587', '588', '589', '590', '591', '592', '593', '594', '595', '596', '597', '598', '599', '600', '601', '602', '603', '604', '605', '606', '607', '608', '609', '610', '611', '612', '613', '614', '615', '616', '617', '618', '619', '620', '621', '622', '623', '624', '625', '626', '627', '628', '629', '630', '631', '632', '633', '634', '635', '636', '637', '638', '639', '640', '641', '642', '643', '644', '645', '646', '647', '648', '649', '650', '651', '652', '653', '654', '655', '656', '657', '658', '659', '660', '661', '662', '663', '664', '665', '666', '667', '668', '669', '670', '671', '672', '673', '674', '675', '676', '677', '678', '679', '680', '681', '682', '683', '684', '685', '686', '687', '688', '689', '690', '691', '692', '693', '694', '695', '696', '697', '698', '699', '700', '701', '702', '703', '704', '705', '706', '707', '708', '709', '710', '711', '712', '713', '714', '715', '716', '717', '718', '719', '720', '721', '722', '723', '724', '725', '726', '727', '728', '729', '730', '731', '732', '733', '734', '735', '736', '737', '738', '739', '740', '741', '742', '743', '744', '745', '746', '747', '748', '749', '750', '751', '752', '753', '754', '755', '756', '757', '758', '759', '760', '761', '762', '763', '764', '765', '766', '767', '768', '769', '770', '771', '772', '773', '774', '775', '776', '777', '778', '779', '780', '781', '782', '783', '784', '785', '786', '787', '788', '789', '791', '792', '793', '794', '796', '797', '798', '799', '800', '801', '802', '803', '804', '805', '806', '807', '809', '810', '811', '812', '813', '814', '816', '817', '818', '819', '820', '822', '825', '826', '827', '828', '829', '830', '832', '836', '837', '838', '839', '840', '841', '842', '843', '845', '847', '849', '850', '851', '852', '854', '855', '856', '857', '859', '860', '861', '862', '863', '864', '868', '870', '871', '872', '875', '876', '878', '879', '881', '882', '885', '886', '887', '888', '890', '891', '894', '896', '899', '903', '905', '906', '908', '910', '916', '917', '918', '923', '924', '925', '929', '930', '931', '935', '940', '941', '942', '945', '947', '950', '952', '958', '961', '964', '966', '968', '973', '976', '977', '978', '980', '982', '985', '994', '995']",phs000209,pht001118,phv00085786,True,False,False,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",,\phs000209\pht001118\phv00085786\E12DyC\,pht001118.v8,\phs000209\pht001118\phv00085786\E12DyC\,phv00085786,,"TIME BETWEEN EXAM VISITS, IN DAYS",{},,,,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13,a898cd22c023601dd60c16c197a154bbf72f9add1fba244d06872231a40ade70,categorical,phv00085786.v2,phs000209,False,E12DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085786\E12DyC\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae2dres06222012.e12dyc,"Time between exam visits, in days",8.526562959,mesae2dres06222012,e12dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13.p3,phv00085786.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085786,"['1000', '1005', '1007', '1012', '1014', '1019', '1023', '1029', '1033', '1048', '1064', '1075', '1086', '1093', '1099', '1100', '1113', '1120', '1125', '1133', '1143', '1154', '1161', '1205', '1224', '319', '385', '386', '387', '388', '393', '394', '395', '398', '402', '405', '406', '407', '408', '410', '411', '412', '413', '414', '415', '416', '417', '418', '419', '420', '421', '422', '423', '424', '425', '426', '427', '428', '429', '430', '431', '432', '433', '434', '435', '436', '437', '438', '439', '440', '441', '442', '443', '444', '445', '446', '447', '448', '449', '450', '451', '452', '453', '454', '455', '456', '457', '458', '459', '460', '461', '462', '463', '464', '465', '466', '467', '468', '469', '470', '471', '472', '473', '474', '475', '476', '477', '478', '479', '480', '481', '482', '483', '484', '485', '486', '487', '488', '489', '490', '491', '492', '493', '494', '495', '496', '497', '498', '499', '500', '501', '502', '503', '504', '505', '506', '507', '508', '509', '510', '511', '512', '513', '514', '515', '516', '517', '518', '519', '520', '521', '522', '523', '524', '525', '526', '527', '528', '529', '530', '531', '532', '533', '534', '535', '536', '537', '538', '539', '540', '541', '542', '543', '544', '545', '546', '547', '548', '549', '550', '551', '552', '553', '554', '555', '556', '557', '558', '559', '560', '561', '562', '563', '564', '565', '566', '567', '568', '569', '570', '571', '572', '573', '574', '575', '576', '577', '578', '579', '580', '581', '582', '583', '584', '585', '586', '587', '588', '589', '590', '591', '592', '593', '594', '595', '596', '597', '598', '599', '600', '601', '602', '603', '604', '605', '606', '607', '608', '609', '610', '611', '612', '613', '614', '615', '616', '617', '618', '619', '620', '621', '622', '623', '624', '625', '626', '627', '628', '629', '630', '631', '632', '633', '634', '635', '636', '637', '638', '639', '640', '641', '642', '643', '644', '645', '646', '647', '648', '649', '650', '651', '652', '653', '654', '655', '656', '657', '658', '659', '660', '661', '662', '663', '664', '665', '666', '667', '668', '669', '670', '671', '672', '673', '674', '675', '676', '677', '678', '679', '680', '681', '682', '683', '684', '685', '686', '687', '688', '689', '690', '691', '692', '693', '694', '695', '696', '697', '698', '699', '700', '701', '702', '703', '704', '705', '706', '707', '708', '709', '710', '711', '712', '713', '714', '715', '716', '717', '718', '719', '720', '721', '722', '723', '724', '725', '726', '727', '728', '729', '730', '731', '732', '733', '734', '735', '736', '737', '738', '739', '740', '741', '742', '743', '744', '745', '746', '747', '748', '749', '750', '751', '752', '753', '754', '755', '756', '757', '758', '759', '760', '761', '762', '763', '764', '765', '766', '767', '768', '769', '770', '771', '772', '773', '774', '775', '776', '777', '778', '779', '780', '781', '782', '783', '784', '785', '786', '787', '788', '789', '791', '792', '793', '794', '796', '797', '798', '799', '800', '801', '802', '803', '804', '805', '806', '807', '809', '810', '811', '812', '813', '814', '816', '817', '818', '819', '820', '822', '825', '826', '827', '828', '829', '830', '832', '836', '837', '838', '839', '840', '841', '842', '843', '845', '847', '849', '850', '851', '852', '854', '855', '856', '857', '859', '860', '861', '862', '863', '864', '868', '870', '871', '872', '875', '876', '878', '879', '881', '882', '885', '886', '887', '888', '890', '891', '894', '896', '899', '903', '905', '906', '908', '910', '916', '917', '918', '923', '924', '925', '929', '930', '931', '935', '940', '941', '942', '945', '947', '950', '952', '958', '961', '964', '966', '968', '973', '976', '977', '978', '980', '982', '985', '994', '995']",phs000209,pht001118,phv00085786,True,False,False,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",,\phs000209\pht001118\phv00085786\E12DyC\,pht001118.v8,\phs000209\pht001118\phv00085786\E12DyC\,phv00085786,,"TIME BETWEEN EXAM VISITS, IN DAYS",{},,,,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13,a898cd22c023601dd60c16c197a154bbf72f9add1fba244d06872231a40ade70,categorical,phv00085786.v2,phs000209,False,E12DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085786\E12DyC\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae2dres06222012.e12dyc,"Time between exam visits, in days",8.526562959,mesae2dres06222012,e12dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13.p3,phv00085786.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085786,"['1000', '1005', '1007', '1012', '1014', '1019', '1023', '1029', '1033', '1048', '1064', '1075', '1086', '1093', '1099', '1100', '1113', '1120', '1125', '1133', '1143', '1154', '1161', '1205', '1224', '319', '385', '386', '387', '388', '393', '394', '395', '398', '402', '405', '406', '407', '408', '410', '411', '412', '413', '414', '415', '416', '417', '418', '419', '420', '421', '422', '423', '424', '425', '426', '427', '428', '429', '430', '431', '432', '433', '434', '435', '436', '437', '438', '439', '440', '441', '442', '443', '444', '445', '446', '447', '448', '449', '450', '451', '452', '453', '454', '455', '456', '457', '458', '459', '460', '461', '462', '463', '464', '465', '466', '467', '468', '469', '470', '471', '472', '473', '474', '475', '476', '477', '478', '479', '480', '481', '482', '483', '484', '485', '486', '487', '488', '489', '490', '491', '492', '493', '494', '495', '496', '497', '498', '499', '500', '501', '502', '503', '504', '505', '506', '507', '508', '509', '510', '511', '512', '513', '514', '515', '516', '517', '518', '519', '520', '521', '522', '523', '524', '525', '526', '527', '528', '529', '530', '531', '532', '533', '534', '535', '536', '537', '538', '539', '540', '541', '542', '543', '544', '545', '546', '547', '548', '549', '550', '551', '552', '553', '554', '555', '556', '557', '558', '559', '560', '561', '562', '563', '564', '565', '566', '567', '568', '569', '570', '571', '572', '573', '574', '575', '576', '577', '578', '579', '580', '581', '582', '583', '584', '585', '586', '587', '588', '589', '590', '591', '592', '593', '594', '595', '596', '597', '598', '599', '600', '601', '602', '603', '604', '605', '606', '607', '608', '609', '610', '611', '612', '613', '614', '615', '616', '617', '618', '619', '620', '621', '622', '623', '624', '625', '626', '627', '628', '629', '630', '631', '632', '633', '634', '635', '636', '637', '638', '639', '640', '641', '642', '643', '644', '645', '646', '647', '648', '649', '650', '651', '652', '653', '654', '655', '656', '657', '658', '659', '660', '661', '662', '663', '664', '665', '666', '667', '668', '669', '670', '671', '672', '673', '674', '675', '676', '677', '678', '679', '680', '681', '682', '683', '684', '685', '686', '687', '688', '689', '690', '691', '692', '693', '694', '695', '696', '697', '698', '699', '700', '701', '702', '703', '704', '705', '706', '707', '708', '709', '710', '711', '712', '713', '714', '715', '716', '717', '718', '719', '720', '721', '722', '723', '724', '725', '726', '727', '728', '729', '730', '731', '732', '733', '734', '735', '736', '737', '738', '739', '740', '741', '742', '743', '744', '745', '746', '747', '748', '749', '750', '751', '752', '753', '754', '755', '756', '757', '758', '759', '760', '761', '762', '763', '764', '765', '766', '767', '768', '769', '770', '771', '772', '773', '774', '775', '776', '777', '778', '779', '780', '781', '782', '783', '784', '785', '786', '787', '788', '789', '791', '792', '793', '794', '796', '797', '798', '799', '800', '801', '802', '803', '804', '805', '806', '807', '809', '810', '811', '812', '813', '814', '816', '817', '818', '819', '820', '822', '825', '826', '827', '828', '829', '830', '832', '836', '837', '838', '839', '840', '841', '842', '843', '845', '847', '849', '850', '851', '852', '854', '855', '856', '857', '859', '860', '861', '862', '863', '864', '868', '870', '871', '872', '875', '876', '878', '879', '881', '882', '885', '886', '887', '888', '890', '891', '894', '896', '899', '903', '905', '906', '908', '910', '916', '917', '918', '923', '924', '925', '929', '930', '931', '935', '940', '941', '942', '945', '947', '950', '952', '958', '961', '964', '966', '968', '973', '976', '977', '978', '980', '982', '985', '994', '995']",phs000209,pht001118,phv00085786,True,False,False,E12DyC,"TIME BETWEEN EXAM VISITS, IN DAYS",,\phs000209\pht001118\phv00085786\E12DyC\,pht001118.v8,\phs000209\pht001118\phv00085786\E12DyC\,phv00085786,,"TIME BETWEEN EXAM VISITS, IN DAYS",{},,,,"TIME BETWEEN EXAM VISITS, IN DAYS",phs000209.v13,a898cd22c023601dd60c16c197a154bbf72f9add1fba244d06872231a40ade70,categorical,phv00085786.v2,phs000209,False,E12DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085786\E12DyC\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae2dres06222012.fibr2c,Fibrates,12.35691224,mesae2dres06222012,fibr2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr2c,FIBRATES,phs000209.v13.p3,phv00086041.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086041,"['NO', 'YES']",phs000209,pht001118,phv00086041,True,False,False,fibr2c,FIBRATES,,\phs000209\pht001118\phv00086041\fibr2c\,pht001118.v8,\phs000209\pht001118\phv00086041\fibr2c\,phv00086041,,FIBRATES,{},,,,FIBRATES,phs000209.v13,4e67ba212b49338eefe6fcaebd0514c671b9fe36c8e37e596633e6551268e534,categorical,phv00086041.v2,phs000209,False,fibr2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086041\fibr2c\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae2dres06222012.glucos2c,FASTING GLUCOSE (mg/dL) CALIBRATED,9.245670678,mesae2dres06222012,glucos2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos2c,EXAM 2 FASTING GLUCOSE- CALIBRATED,phs000209.v13.p3,phv00085932.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085932,"['100', '101', '102', '103', '104', '105', '106', '107', '108', '109', '110', '111', '112', '113', '114', '115', '116', '117', '118', '119', '120', '121', '122', '123', '124', '125', '126', '127', '128', '129', '130', '131', '132', '133', '134', '135', '136', '137', '138', '139', '140', '141', '142', '143', '144', '145', '146', '147', '148', '149', '150', '151', '152', '153', '154', '155', '156', '157', '158', '159', '160', '161', '162', '163', '164', '165', '166', '167', '168', '169', '170', '171', '172', '173', '174', '175', '176', '177', '178', '179', '180', '181', '182', '183', '184', '185', '186', '187', '188', '189', '190', '191', '192', '193', '195', '196', '198', '199', '200', '201', '202', '203', '205', '206', '209', '210', '211', '212', '213', '214', '217', '218', '219', '221', '222', '223', '225', '227', '228', '231', '232', '233', '234', '235', '236', '237', '240', '241', '243', '244', '245', '246', '247', '249', '251', '253', '254', '255', '259', '260', '262', '264', '269', '270', '271', '273', '275', '277', '278', '279', '280', '281', '282', '283', '284', '285', '286', '287', '288', '289', '291', '292', '293', '296', '301', '303', '312', '313', '318', '320', '322', '324', '325', '327', '337', '338', '340', '365', '379', '380', '426', '49', '58', '60', '61', '62', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94', '95', '96', '97', '98', '99']",phs000209,pht001118,phv00085932,True,False,False,glucos2c,EXAM 2 FASTING GLUCOSE- CALIBRATED,,\phs000209\pht001118\phv00085932\glucos2c\,pht001118.v8,\phs000209\pht001118\phv00085932\glucos2c\,phv00085932,,EXAM 2 FASTING GLUCOSE- CALIBRATED,{},,,,EXAM 2 FASTING GLUCOSE- CALIBRATED,phs000209.v13,e34319e9a57e3a9fb15286abd5a48f7970696bdecfe521b9a750e75b89611eae,categorical,phv00085932.v2,phs000209,False,glucos2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085932\glucos2c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae2dres06222012.htn2c,"Hypertension by JNC VI (1997) criteria, Exam 2",9.451130026,mesae2dres06222012,htn2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn2c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2",phs000209.v13.p3,phv00085797.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00085797,"['NO', 'YES']",phs000209,pht001118,phv00085797,True,False,False,htn2c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2",,\phs000209\pht001118\phv00085797\htn2c\,pht001118.v8,\phs000209\pht001118\phv00085797\htn2c\,phv00085797,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2",{},,,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 2",phs000209.v13,ce8bbd55e22b4b3ab9cd4842794d36e658229f092f2a5276db5ca562f40bbe8b,categorical,phv00085797.v2,phs000209,False,htn2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00085797\htn2c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae2dres06222012.insln2c,Insulins,12.35691224,mesae2dres06222012,insln2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln2c,INSULINS,phs000209.v13.p3,phv00086008.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086008,"['NO', 'YES']",phs000209,pht001118,phv00086008,True,False,False,insln2c,INSULINS,,\phs000209\pht001118\phv00086008\insln2c\,pht001118.v8,\phs000209\pht001118\phv00086008\insln2c\,phv00086008,,INSULINS,{},,,,INSULINS,phs000209.v13,f60f5586a68e6d002c6d8b65904fc3576251e0f071b7c988de3935919f6a53ab,categorical,phv00086008.v2,phs000209,False,insln2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086008\insln2c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae2dres06222012.mlpd2c,Miscellaneous lipid-lowering drugs,12.35691224,mesae2dres06222012,mlpd2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd2c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00086010.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086010,"['NO', 'YES']",phs000209,pht001118,phv00086010,True,False,False,mlpd2c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht001118\phv00086010\mlpd2c\,pht001118.v8,\phs000209\pht001118\phv00086010\mlpd2c\,phv00086010,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,9c4ca43a3c3521f61000fc4a2a7c5dde67f61ee1994cfd7e628d17e389ab3097,categorical,phv00086010.v2,phs000209,False,mlpd2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086010\mlpd2c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae2dres06222012.niac2c,Niacin and nictotinic acid,12.35691224,mesae2dres06222012,niac2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac2c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00086052.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086052,"['NO', 'YES']",phs000209,pht001118,phv00086052,True,False,False,niac2c,NIACIN AND NICOTINIC ACID,,\phs000209\pht001118\phv00086052\niac2c\,pht001118.v8,\phs000209\pht001118\phv00086052\niac2c\,phv00086052,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,5cab7834a7188c48fd0e995856a4fe6a5136a70162cb435d05aaa5add2924539,categorical,phv00086052.v2,phs000209,False,niac2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086052\niac2c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae2dres06222012.prob2c,Probucol,12.35691224,mesae2dres06222012,prob2c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob2c,PROBUCOL,phs000209.v13.p3,phv00086066.v2.p3,pht001118.v8.p3,MESA_Exam2Main,phv00086066,['NO'],phs000209,pht001118,phv00086066,True,False,False,prob2c,PROBUCOL,,\phs000209\pht001118\phv00086066\prob2c\,pht001118.v8,\phs000209\pht001118\phv00086066\prob2c\,phv00086066,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,c2e1dec170331d79ca03597c6f6d52ee257e0b368eecde65311b48e779fea7c7,categorical,phv00086066.v2,phs000209,False,prob2c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001118,MESA_Exam2Main,\phs000209\pht001118\phv00086066\prob2c\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae2dres06222012.whoros2c,WHO ROSE Intermittent Claudication,14.26474905,mesae2dres06222012,whoros2c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae3dres06222012.age3c,AGE AT EXAM3,12.72380393,mesae3dres06222012,age3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age3c,AGE AT EXAM3,phs000209.v13.p3,phv00086259.v4.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086259,"['47', '48', '49', '50', '51', '52', '53', '54', '55', '56', '57', '58', '59', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88']",phs000209,pht001119,phv00086259,True,False,False,age3c,AGE AT EXAM3,,\phs000209\pht001119\phv00086259\age3c\,pht001119.v8,\phs000209\pht001119\phv00086259\age3c\,phv00086259,,AGE AT EXAM3,{},,,,AGE AT EXAM3,phs000209.v13,49807e4d19892687617752e463733544df8daea8afbccd0b29beafca04fccee7,categorical,phv00086259.v4,phs000209,False,age3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086259\age3c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae3dres06222012.asa3c,Aspirin from 280804 (anti-inflam agents),14.22072204,mesae3dres06222012,asa3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa3c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00086485.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086485,"['NO', 'YES']",phs000209,pht001119,phv00086485,True,False,False,asa3c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht001119\phv00086485\asa3c\,pht001119.v8,\phs000209\pht001119\phv00086485\asa3c\,phv00086485,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,30811e92887c49a0f18c46fd331b30f91c5123345c39a8f66cdc8da0b756c49a,categorical,phv00086485.v2,phs000209,False,asa3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086485\asa3c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.basq3c,Bile-acid sequestrants,14.22072204,mesae3dres06222012,basq3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq3c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00086510.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086510,"['NO', 'YES']",phs000209,pht001119,phv00086510,True,False,False,basq3c,BILE-ACID SEQUESTRANTS,,\phs000209\pht001119\phv00086510\basq3c\,pht001119.v8,\phs000209\pht001119\phv00086510\basq3c\,phv00086510,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,27a20f0fbf6a548ce9bbe7f8507f1fd4ddc3031fc34d0856e7a59459000cef5e,categorical,phv00086510.v2,phs000209,False,basq3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086510\basq3c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.basq4c,-,-,mesae3dres06222012,basq4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq4c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00086947.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086947,"['NO', 'YES']",phs000209,pht001120,phv00086947,True,False,False,basq4c,BILE-ACID SEQUESTRANTS,,\phs000209\pht001120\phv00086947\basq4c\,pht001120.v10,\phs000209\pht001120\phv00086947\basq4c\,phv00086947,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,e9118a5ff6e46eeb0b7a707e127e81156c0d613cd90546f7197dd382e0caebd6,categorical,phv00086947.v2,phs000209,False,basq4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086947\basq4c\,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,MESA,mesae3dres06222012.creatin3,CREATININE (mg/dl),13.604344,mesae3dres06222012,creatin3,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,creatin3,CREATININE (mg/dl),phs000209.v13.p3,phv00086403.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086403,"['.4', '.5', '.6', '.7', '.8', '.9', '1', '1.1', '1.2', '1.3', '1.4', '1.5', '1.6', '1.7', '1.8', '1.9', '2', '2.1', '2.2', '2.3', '2.4', '2.5', '2.6', '2.7', '2.8', '2.9', '3', '3.1', '3.2', '3.4', '3.7', '4', '4.8', '6.2', '7.1', '7.4']",phs000209,pht001119,phv00086403,True,False,False,creatin3,CREATININE (mg/dl),,\phs000209\pht001119\phv00086403\creatin3\,pht001119.v8,\phs000209\pht001119\phv00086403\creatin3\,phv00086403,,CREATININE (mg/dl),{},,,,CREATININE (mg/dl),phs000209.v13,075717c942a3107da8e237c9480ef0d9ba4a421a31f5a0ac10afd1683d75466c,categorical,phv00086403.v2,phs000209,False,creatin3,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086403\creatin3\,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae3dres06222012.dbp3c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),12.88523628,mesae3dres06222012,dbp3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp3c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00086708.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086708,"['100.5', '101', '101.5', '102', '104.5', '107', '108.5', '109.5', '112', '115', '34.5', '37', '38.5', '40.5', '42', '42.5', '43.5', '44', '44.5', '45', '45.5', '46', '46.5', '47', '47.5', '48', '48.5', '49', '49.5', '50', '50.5', '51', '51.5', '52', '52.5', '53', '53.5', '54', '54.5', '55', '55.5', '56', '56.5', '57', '57.5', '58', '58.5', '59', '59.5', '60', '60.5', '61', '61.5', '62', '62.5', '63', '63.5', '64', '64.5', '65', '65.5', '66', '66.5', '67', '67.5', '68', '68.5', '69', '69.5', '70', '70.5', '71', '71.5', '72', '72.5', '73', '73.5', '74', '74.5', '75', '75.5', '76', '76.5', '77', '77.5', '78', '78.5', '79', '79.5', '80', '80.5', '81', '81.5', '82', '82.5', '83', '83.5', '84', '84.5', '85', '85.5', '86', '86.5', '87', '87.5', '88', '88.5', '89', '89.5', '90', '90.5', '91', '91.5', '92', '92.5', '93', '93.5', '94', '94.5', '95', '95.5', '96', '96.5', '97', '97.5', '98', '98.5', '99', '99.5']",phs000209,pht001119,phv00086708,True,False,False,dbp3c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),,\phs000209\pht001119\phv00086708\dbp3c\,pht001119.v8,\phs000209\pht001119\phv00086708\dbp3c\,phv00086708,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,8202ac1c2979fa129160d20eb97dec8dac5315dd0f23a8225ae0fad69019e0b5,categorical,phv00086708.v2,phs000209,False,dbp3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086708\dbp3c\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae3dres06222012.dm033c,Exam 3 Diabetes mellitus by 2003 ADA fasting criteria algorithm,13.47226299,mesae3dres06222012,dm033c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm033c,EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13.p3,phv00086279.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086279,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht001119,phv00086279,True,False,False,dm033c,EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,,\phs000209\pht001119\phv00086279\dm033c\,pht001119.v8,\phs000209\pht001119\phv00086279\dm033c\,phv00086279,,EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,{},,,,EXAM 3 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13,ad449d3429a3f2dd6f54586e7597d1c44124761e49a9b123669b9e1eebaa4e45,categorical,phv00086279.v2,phs000209,False,dm033c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086279\dm033c\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae3dres06222012.e13dyc,"Time between first and third visits, in days",12.72380393,mesae3dres06222012,e13dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13.p3,phv00086272.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086272,"['1000', '1001', '1002', '1003', '1004', '1005', '1006', '1007', '1008', '1009', '1010', '1011', '1012', '1013', '1014', '1015', '1016', '1017', '1018', '1019', '1020', '1021', '1022', '1023', '1024', '1025', '1026', '1027', '1028', '1029', '1030', '1031', '1032', '1033', '1034', '1035', '1036', '1037', '1038', '1039', '1040', '1041', '1042', '1043', '1044', '1045', '1046', '1047', '1048', '1049', '1050', '1051', '1052', '1053', '1054', '1055', '1056', '1057', '1058', '1059', '1060', '1061', '1062', '1063', '1064', '1065', '1066', '1067', '1068', '1069', '1070', '1071', '1072', '1073', '1074', '1075', '1076', '1077', '1078', '1079', '1080', '1081', '1082', '1083', '1084', '1085', '1086', '1087', '1088', '1089', '1090', '1091', '1092', '1093', '1094', '1095', '1096', '1097', '1098', '1099', '1100', '1101', '1102', '1103', '1104', '1105', '1106', '1107', '1108', '1109', '1110', '1111', '1112', '1113', '1114', '1115', '1116', '1117', '1118', '1119', '1120', '1121', '1122', '1123', '1124', '1125', '1126', '1127', '1128', '1129', '1130', '1131', '1132', '1133', '1134', '1135', '1136', '1137', '1138', '1139', '1140', '1141', '1142', '1143', '1144', '1145', '1146', '1147', '1148', '1149', '1150', '1151', '1152', '1153', '1154', '1155', '1156', '1157', '1158', '1159', '1160', '1161', '1162', '1163', '1164', '1165', '1166', '1167', '1168', '1169', '1170', '1171', '1172', '1173', '1174', '1175', '1176', '1177', '1178', '1179', '1180', '1181', '1182', '1183', '1184', '1185', '1186', '1187', '1188', '1189', '1190', '1191', '1192', '1193', '1194', '1195', '1196', '1197', '1198', '1199', '1200', '1201', '1202', '1203', '1204', '1205', '1206', '1207', '1208', '1209', '1210', '1211', '1212', '1213', '1214', '1215', '1216', '1217', '1218', '1219', '1220', '1221', '1222', '1223', '1224', '1225', '1226', '1227', '1228', '1229', '1230', '1231', '1232', '1233', '1234', '1235', '1236', '1237', '1238', '1239', '1240', '1241', '1242', '1243', '1244', '1245', '1246', '1247', '1248', '1249', '1250', '1251', '1252', '1253', '1254', '1255', '1256', '1257', '1258', '1259', '1260', '1261', '1262', '1263', '1264', '1265', '1266', '1267', '1268', '1269', '1270', '1271', '1272', '1273', '1274', '1275', '1276', '1277', '1278', '1279', '1280', '1281', '1282', '1283', '1284', '1285', '1286', '1287', '1288', '1289', '1290', '1291', '1292', '1293', '1294', '1295', '1296', '1297', '1298', '1299', '1300', '1301', '1302', '1303', '1304', '1305', '1306', '1307', '1308', '1309', '1310', '1311', '1312', '1313', '1314', '1315', '1316', '1317', '1318', '1319', '1320', '1321', '1322', '1323', '1324', '1325', '1326', '1327', '1328', '1329', '1330', '1331', '1332', '1333', '1334', '1335', '1336', '1337', '1338', '1339', '1340', '1341', '1342', '1343', '1344', '1345', '1346', '1348', '1349', '1350', '1351', '1353', '1354', '1355', '1357', '1358', '1359', '1360', '1361', '1362', '1363', '1364', '1365', '1367', '1368', '1369', '1370', '1372', '1373', '1374', '1375', '1376', '1377', '1378', '1379', '1380', '1381', '1382', '1383', '1384', '1385', '1386', '1387', '1388', '1389', '1390', '1392', '1393', '1395', '1399', '1400', '1401', '1402', '1403', '1405', '1406', '1407', '1408', '1410', '1411', '1412', '1413', '1414', '1415', '1416', '1417', '1418', '1419', '1420', '1421', '1422', '1423', '1424', '1425', '1426', '1428', '1429', '1430', '1432', '1433', '1435', '1436', '1438', '1439', '1440', '1441', '1442', '1443', '1444', '1446', '1450', '1451', '1453', '1454', '1455', '1456', '1457', '1458', '1459', '1460', '1462', '1464', '1466', '1470', '1471', '1474', '1479', '1480', '1481', '1484', '1485', '1486', '1489', '1491', '1492', '1493', '1495', '1499', '1501', '1506', '1508', '1512', '1513', '1514', '1517', '1518', '1519', '1520', '1521', '1525', '1526', '1527', '1533', '1537', '1539', '1542', '1546', '1549', '1558', '1560', '1561', '1563', '1564', '1569', '1570', '1576', '1582', '1586', '1591', '1599', '1603', '1606', '1611', '1612', '1631', '1632', '1633', '1637', '1645', '1646', '1654', '1655', '1674', '1678', '1686', '1691', '1715', '1717', '1722', '1725', '1740', '1742', '1743', '1744', '1746', '1755', '1762', '1772', '717', '759', '793', '815', '817', '868', '900', '907', '918', '922', '928', '929', '930', '933', '937', '938', '944', '945', '953', '954', '956', '957', '960', '961', '963', '965', '968', '969', '970', '973', '975', '976', '977', '978', '979', '980', '981', '982', '983', '984', '985', '986', '987', '988', '989', '990', '991', '992', '993', '994', '995', '996', '997', '998', '999']",phs000209,pht001119,phv00086272,True,False,False,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",,\phs000209\pht001119\phv00086272\E13DyC\,pht001119.v8,\phs000209\pht001119\phv00086272\E13DyC\,phv00086272,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13,64bce358c9c8c289b5c7780831aab253c2f7a057cedeefcc880b02defbb99211,categorical,phv00086272.v2,phs000209,False,E13DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086272\E13DyC\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae3dres06222012.e13dyc,"Time between first and third visits, in days",12.72380393,mesae3dres06222012,e13dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13.p3,phv00086272.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086272,"['1000', '1001', '1002', '1003', '1004', '1005', '1006', '1007', '1008', '1009', '1010', '1011', '1012', '1013', '1014', '1015', '1016', '1017', '1018', '1019', '1020', '1021', '1022', '1023', '1024', '1025', '1026', '1027', '1028', '1029', '1030', '1031', '1032', '1033', '1034', '1035', '1036', '1037', '1038', '1039', '1040', '1041', '1042', '1043', '1044', '1045', '1046', '1047', '1048', '1049', '1050', '1051', '1052', '1053', '1054', '1055', '1056', '1057', '1058', '1059', '1060', '1061', '1062', '1063', '1064', '1065', '1066', '1067', '1068', '1069', '1070', '1071', '1072', '1073', '1074', '1075', '1076', '1077', '1078', '1079', '1080', '1081', '1082', '1083', '1084', '1085', '1086', '1087', '1088', '1089', '1090', '1091', '1092', '1093', '1094', '1095', '1096', '1097', '1098', '1099', '1100', '1101', '1102', '1103', '1104', '1105', '1106', '1107', '1108', '1109', '1110', '1111', '1112', '1113', '1114', '1115', '1116', '1117', '1118', '1119', '1120', '1121', '1122', '1123', '1124', '1125', '1126', '1127', '1128', '1129', '1130', '1131', '1132', '1133', '1134', '1135', '1136', '1137', '1138', '1139', '1140', '1141', '1142', '1143', '1144', '1145', '1146', '1147', '1148', '1149', '1150', '1151', '1152', '1153', '1154', '1155', '1156', '1157', '1158', '1159', '1160', '1161', '1162', '1163', '1164', '1165', '1166', '1167', '1168', '1169', '1170', '1171', '1172', '1173', '1174', '1175', '1176', '1177', '1178', '1179', '1180', '1181', '1182', '1183', '1184', '1185', '1186', '1187', '1188', '1189', '1190', '1191', '1192', '1193', '1194', '1195', '1196', '1197', '1198', '1199', '1200', '1201', '1202', '1203', '1204', '1205', '1206', '1207', '1208', '1209', '1210', '1211', '1212', '1213', '1214', '1215', '1216', '1217', '1218', '1219', '1220', '1221', '1222', '1223', '1224', '1225', '1226', '1227', '1228', '1229', '1230', '1231', '1232', '1233', '1234', '1235', '1236', '1237', '1238', '1239', '1240', '1241', '1242', '1243', '1244', '1245', '1246', '1247', '1248', '1249', '1250', '1251', '1252', '1253', '1254', '1255', '1256', '1257', '1258', '1259', '1260', '1261', '1262', '1263', '1264', '1265', '1266', '1267', '1268', '1269', '1270', '1271', '1272', '1273', '1274', '1275', '1276', '1277', '1278', '1279', '1280', '1281', '1282', '1283', '1284', '1285', '1286', '1287', '1288', '1289', '1290', '1291', '1292', '1293', '1294', '1295', '1296', '1297', '1298', '1299', '1300', '1301', '1302', '1303', '1304', '1305', '1306', '1307', '1308', '1309', '1310', '1311', '1312', '1313', '1314', '1315', '1316', '1317', '1318', '1319', '1320', '1321', '1322', '1323', '1324', '1325', '1326', '1327', '1328', '1329', '1330', '1331', '1332', '1333', '1334', '1335', '1336', '1337', '1338', '1339', '1340', '1341', '1342', '1343', '1344', '1345', '1346', '1348', '1349', '1350', '1351', '1353', '1354', '1355', '1357', '1358', '1359', '1360', '1361', '1362', '1363', '1364', '1365', '1367', '1368', '1369', '1370', '1372', '1373', '1374', '1375', '1376', '1377', '1378', '1379', '1380', '1381', '1382', '1383', '1384', '1385', '1386', '1387', '1388', '1389', '1390', '1392', '1393', '1395', '1399', '1400', '1401', '1402', '1403', '1405', '1406', '1407', '1408', '1410', '1411', '1412', '1413', '1414', '1415', '1416', '1417', '1418', '1419', '1420', '1421', '1422', '1423', '1424', '1425', '1426', '1428', '1429', '1430', '1432', '1433', '1435', '1436', '1438', '1439', '1440', '1441', '1442', '1443', '1444', '1446', '1450', '1451', '1453', '1454', '1455', '1456', '1457', '1458', '1459', '1460', '1462', '1464', '1466', '1470', '1471', '1474', '1479', '1480', '1481', '1484', '1485', '1486', '1489', '1491', '1492', '1493', '1495', '1499', '1501', '1506', '1508', '1512', '1513', '1514', '1517', '1518', '1519', '1520', '1521', '1525', '1526', '1527', '1533', '1537', '1539', '1542', '1546', '1549', '1558', '1560', '1561', '1563', '1564', '1569', '1570', '1576', '1582', '1586', '1591', '1599', '1603', '1606', '1611', '1612', '1631', '1632', '1633', '1637', '1645', '1646', '1654', '1655', '1674', '1678', '1686', '1691', '1715', '1717', '1722', '1725', '1740', '1742', '1743', '1744', '1746', '1755', '1762', '1772', '717', '759', '793', '815', '817', '868', '900', '907', '918', '922', '928', '929', '930', '933', '937', '938', '944', '945', '953', '954', '956', '957', '960', '961', '963', '965', '968', '969', '970', '973', '975', '976', '977', '978', '979', '980', '981', '982', '983', '984', '985', '986', '987', '988', '989', '990', '991', '992', '993', '994', '995', '996', '997', '998', '999']",phs000209,pht001119,phv00086272,True,False,False,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",,\phs000209\pht001119\phv00086272\E13DyC\,pht001119.v8,\phs000209\pht001119\phv00086272\E13DyC\,phv00086272,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13,64bce358c9c8c289b5c7780831aab253c2f7a057cedeefcc880b02defbb99211,categorical,phv00086272.v2,phs000209,False,E13DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086272\E13DyC\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesae3dres06222012.e13dyc,"Time between first and third visits, in days",12.72380393,mesae3dres06222012,e13dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13.p3,phv00086272.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086272,"['1000', '1001', '1002', '1003', '1004', '1005', '1006', '1007', '1008', '1009', '1010', '1011', '1012', '1013', '1014', '1015', '1016', '1017', '1018', '1019', '1020', '1021', '1022', '1023', '1024', '1025', '1026', '1027', '1028', '1029', '1030', '1031', '1032', '1033', '1034', '1035', '1036', '1037', '1038', '1039', '1040', '1041', '1042', '1043', '1044', '1045', '1046', '1047', '1048', '1049', '1050', '1051', '1052', '1053', '1054', '1055', '1056', '1057', '1058', '1059', '1060', '1061', '1062', '1063', '1064', '1065', '1066', '1067', '1068', '1069', '1070', '1071', '1072', '1073', '1074', '1075', '1076', '1077', '1078', '1079', '1080', '1081', '1082', '1083', '1084', '1085', '1086', '1087', '1088', '1089', '1090', '1091', '1092', '1093', '1094', '1095', '1096', '1097', '1098', '1099', '1100', '1101', '1102', '1103', '1104', '1105', '1106', '1107', '1108', '1109', '1110', '1111', '1112', '1113', '1114', '1115', '1116', '1117', '1118', '1119', '1120', '1121', '1122', '1123', '1124', '1125', '1126', '1127', '1128', '1129', '1130', '1131', '1132', '1133', '1134', '1135', '1136', '1137', '1138', '1139', '1140', '1141', '1142', '1143', '1144', '1145', '1146', '1147', '1148', '1149', '1150', '1151', '1152', '1153', '1154', '1155', '1156', '1157', '1158', '1159', '1160', '1161', '1162', '1163', '1164', '1165', '1166', '1167', '1168', '1169', '1170', '1171', '1172', '1173', '1174', '1175', '1176', '1177', '1178', '1179', '1180', '1181', '1182', '1183', '1184', '1185', '1186', '1187', '1188', '1189', '1190', '1191', '1192', '1193', '1194', '1195', '1196', '1197', '1198', '1199', '1200', '1201', '1202', '1203', '1204', '1205', '1206', '1207', '1208', '1209', '1210', '1211', '1212', '1213', '1214', '1215', '1216', '1217', '1218', '1219', '1220', '1221', '1222', '1223', '1224', '1225', '1226', '1227', '1228', '1229', '1230', '1231', '1232', '1233', '1234', '1235', '1236', '1237', '1238', '1239', '1240', '1241', '1242', '1243', '1244', '1245', '1246', '1247', '1248', '1249', '1250', '1251', '1252', '1253', '1254', '1255', '1256', '1257', '1258', '1259', '1260', '1261', '1262', '1263', '1264', '1265', '1266', '1267', '1268', '1269', '1270', '1271', '1272', '1273', '1274', '1275', '1276', '1277', '1278', '1279', '1280', '1281', '1282', '1283', '1284', '1285', '1286', '1287', '1288', '1289', '1290', '1291', '1292', '1293', '1294', '1295', '1296', '1297', '1298', '1299', '1300', '1301', '1302', '1303', '1304', '1305', '1306', '1307', '1308', '1309', '1310', '1311', '1312', '1313', '1314', '1315', '1316', '1317', '1318', '1319', '1320', '1321', '1322', '1323', '1324', '1325', '1326', '1327', '1328', '1329', '1330', '1331', '1332', '1333', '1334', '1335', '1336', '1337', '1338', '1339', '1340', '1341', '1342', '1343', '1344', '1345', '1346', '1348', '1349', '1350', '1351', '1353', '1354', '1355', '1357', '1358', '1359', '1360', '1361', '1362', '1363', '1364', '1365', '1367', '1368', '1369', '1370', '1372', '1373', '1374', '1375', '1376', '1377', '1378', '1379', '1380', '1381', '1382', '1383', '1384', '1385', '1386', '1387', '1388', '1389', '1390', '1392', '1393', '1395', '1399', '1400', '1401', '1402', '1403', '1405', '1406', '1407', '1408', '1410', '1411', '1412', '1413', '1414', '1415', '1416', '1417', '1418', '1419', '1420', '1421', '1422', '1423', '1424', '1425', '1426', '1428', '1429', '1430', '1432', '1433', '1435', '1436', '1438', '1439', '1440', '1441', '1442', '1443', '1444', '1446', '1450', '1451', '1453', '1454', '1455', '1456', '1457', '1458', '1459', '1460', '1462', '1464', '1466', '1470', '1471', '1474', '1479', '1480', '1481', '1484', '1485', '1486', '1489', '1491', '1492', '1493', '1495', '1499', '1501', '1506', '1508', '1512', '1513', '1514', '1517', '1518', '1519', '1520', '1521', '1525', '1526', '1527', '1533', '1537', '1539', '1542', '1546', '1549', '1558', '1560', '1561', '1563', '1564', '1569', '1570', '1576', '1582', '1586', '1591', '1599', '1603', '1606', '1611', '1612', '1631', '1632', '1633', '1637', '1645', '1646', '1654', '1655', '1674', '1678', '1686', '1691', '1715', '1717', '1722', '1725', '1740', '1742', '1743', '1744', '1746', '1755', '1762', '1772', '717', '759', '793', '815', '817', '868', '900', '907', '918', '922', '928', '929', '930', '933', '937', '938', '944', '945', '953', '954', '956', '957', '960', '961', '963', '965', '968', '969', '970', '973', '975', '976', '977', '978', '979', '980', '981', '982', '983', '984', '985', '986', '987', '988', '989', '990', '991', '992', '993', '994', '995', '996', '997', '998', '999']",phs000209,pht001119,phv00086272,True,False,False,E13DyC,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",,\phs000209\pht001119\phv00086272\E13DyC\,pht001119.v8,\phs000209\pht001119\phv00086272\E13DyC\,phv00086272,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND THIRD VISITS, IN DAYS",phs000209.v13,64bce358c9c8c289b5c7780831aab253c2f7a057cedeefcc880b02defbb99211,categorical,phv00086272.v2,phs000209,False,E13DyC,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086272\E13DyC\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.fibr3c,Fibrates,14.22072204,mesae3dres06222012,fibr3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr3c,FIBRATES,phs000209.v13.p3,phv00086523.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086523,"['NO', 'YES']",phs000209,pht001119,phv00086523,True,False,False,fibr3c,FIBRATES,,\phs000209\pht001119\phv00086523\fibr3c\,pht001119.v8,\phs000209\pht001119\phv00086523\fibr3c\,phv00086523,,FIBRATES,{},,,,FIBRATES,phs000209.v13,17af62a07c683a2bd05310a8914c831b3ac80b6b15cee6077c7ca0912569657a,categorical,phv00086523.v2,phs000209,False,fibr3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086523\fibr3c\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae3dres06222012.glucos3c,FASTING GLUCOSE (mg/dL) CALIBRATED,13.604344,mesae3dres06222012,glucos3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos3c,EXAM 3 FASTING GLUCOSE- CALIBRATED,phs000209.v13.p3,phv00086415.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086415,"['100', '101', '102', '103', '104', '105', '106', '107', '108', '109', '110', '111', '112', '113', '114', '115', '116', '117', '118', '119', '120', '121', '122', '123', '124', '125', '126', '127', '128', '129', '130', '131', '132', '133', '134', '135', '136', '137', '138', '139', '140', '141', '142', '143', '144', '145', '146', '147', '148', '149', '150', '151', '152', '153', '154', '155', '156', '157', '158', '159', '160', '161', '162', '163', '164', '166', '167', '168', '169', '170', '171', '172', '173', '175', '176', '177', '178', '179', '181', '182', '183', '186', '187', '188', '189', '190', '192', '193', '194', '195', '196', '197', '199', '200', '201', '202', '203', '204', '205', '206', '210', '211', '212', '213', '216', '217', '218', '219', '220', '221', '222', '223', '225', '226', '227', '228', '229', '232', '233', '234', '236', '238', '239', '240', '248', '253', '256', '257', '258', '259', '262', '267', '270', '274', '275', '277', '278', '280', '281', '282', '287', '296', '299', '301', '315', '320', '324', '327', '328', '334', '348', '355', '360', '40', '41', '44', '50', '61', '62', '63', '64', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94', '95', '96', '97', '98', '99']",phs000209,pht001119,phv00086415,True,False,False,glucos3c,EXAM 3 FASTING GLUCOSE- CALIBRATED,,\phs000209\pht001119\phv00086415\glucos3c\,pht001119.v8,\phs000209\pht001119\phv00086415\glucos3c\,phv00086415,,EXAM 3 FASTING GLUCOSE- CALIBRATED,{},,,,EXAM 3 FASTING GLUCOSE- CALIBRATED,phs000209.v13,4f04ef039212b7a5ad23bb6cf953e1ba1af9d8da240f748d2fa60692cb68ca12,categorical,phv00086415.v2,phs000209,False,glucos3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086415\glucos3c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae3dres06222012.htn3c,"Hypertension by JNC VI (1997) criteria, Exam 3",13.42823598,mesae3dres06222012,htn3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn3c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3",phs000209.v13.p3,phv00086282.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086282,"['NO', 'YES']",phs000209,pht001119,phv00086282,True,False,False,htn3c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3",,\phs000209\pht001119\phv00086282\htn3c\,pht001119.v8,\phs000209\pht001119\phv00086282\htn3c\,phv00086282,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3",{},,,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 3",phs000209.v13,990084df353cf4890b06874e18415437ef0dced9d938aac0c47b836eb00150dd,categorical,phv00086282.v2,phs000209,False,htn3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086282\htn3c\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae3dres06222012.htnmed3c,Any hypertension medication,14.22072204,mesae3dres06222012,htnmed3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htnmed3c,ANY HYPERTENSION MEDICATION,phs000209.v13.p3,phv00086496.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086496,"['NO', 'YES']",phs000209,pht001119,phv00086496,True,False,False,htnmed3c,ANY HYPERTENSION MEDICATION,,\phs000209\pht001119\phv00086496\htnmed3c\,pht001119.v8,\phs000209\pht001119\phv00086496\htnmed3c\,phv00086496,,ANY HYPERTENSION MEDICATION,{},,,,ANY HYPERTENSION MEDICATION,phs000209.v13,3e74715c9f73b3a3faa075a2f423b1a19cde5395a22644dcc2a6f20a7748f494,categorical,phv00086496.v2,phs000209,False,htnmed3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086496\htnmed3c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae3dres06222012.insln3c,Insulins,14.22072204,mesae3dres06222012,insln3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln3c,INSULINS,phs000209.v13.p3,phv00086490.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086490,"['NO', 'YES']",phs000209,pht001119,phv00086490,True,False,False,insln3c,INSULINS,,\phs000209\pht001119\phv00086490\insln3c\,pht001119.v8,\phs000209\pht001119\phv00086490\insln3c\,phv00086490,,INSULINS,{},,,,INSULINS,phs000209.v13,98085d55c544122c34cfcba54509395d9101232f7b1af5c57ad0bca2931596fe,categorical,phv00086490.v2,phs000209,False,insln3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086490\insln3c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.mlpd3c,Miscellaneous lipid-lowering drugs,14.22072204,mesae3dres06222012,mlpd3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd3c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00086492.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086492,"['NO', 'YES']",phs000209,pht001119,phv00086492,True,False,False,mlpd3c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht001119\phv00086492\mlpd3c\,pht001119.v8,\phs000209\pht001119\phv00086492\mlpd3c\,phv00086492,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,ba090b597ffca070a7f20fac11708fa58377162b4d4adb7a061177cbf212bda7,categorical,phv00086492.v2,phs000209,False,mlpd3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086492\mlpd3c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.niac3c,Niacin and nictotinic acid,14.22072204,mesae3dres06222012,niac3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac3c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00086534.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086534,"['NO', 'YES']",phs000209,pht001119,phv00086534,True,False,False,niac3c,NIACIN AND NICOTINIC ACID,,\phs000209\pht001119\phv00086534\niac3c\,pht001119.v8,\phs000209\pht001119\phv00086534\niac3c\,phv00086534,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,98a62b2bf23c35e6c64dc4d86bb98843582b69105f99fd75df0939cec1d95e94,categorical,phv00086534.v2,phs000209,False,niac3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086534\niac3c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae3dres06222012.prob3c,Probucol,14.22072204,mesae3dres06222012,prob3c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob3c,PROBUCOL,phs000209.v13.p3,phv00086548.v2.p3,pht001119.v8.p3,MESA_Exam3Main,phv00086548,['NO'],phs000209,pht001119,phv00086548,True,False,False,prob3c,PROBUCOL,,\phs000209\pht001119\phv00086548\prob3c\,pht001119.v8,\phs000209\pht001119\phv00086548\prob3c\,phv00086548,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,13ce304ad2cf778238c32cdda0fbf35c21a2b41d4ffebfb0a2fb8cb498414fa3,categorical,phv00086548.v2,phs000209,False,prob3c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001119,MESA_Exam3Main,\phs000209\pht001119\phv00086548\prob3c\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae4dres06222012.age4c,Age at exam 4,14.61696507,mesae4dres06222012,age4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age4c,AGE AT EXAM 4,phs000209.v13.p3,phv00086727.v3.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086727,"['49', '50', '51', '52', '53', '54', '55', '56', '57', '58', '59', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90']",phs000209,pht001120,phv00086727,True,False,False,age4c,AGE AT EXAM 4,,\phs000209\pht001120\phv00086727\age4c\,pht001120.v10,\phs000209\pht001120\phv00086727\age4c\,phv00086727,,AGE AT EXAM 4,{},,,,AGE AT EXAM 4,phs000209.v13,5477e51077c51a365500f28a2448ec0a100ef414a4e1bf72eac28d435caddd19,categorical,phv00086727.v3,phs000209,False,age4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086727\age4c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae4dres06222012.asa4c,Aspirin from 280804 (anti-inflam agents),17.36131494,mesae4dres06222012,asa4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa4c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00086922.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086922,"['NO', 'YES']",phs000209,pht001120,phv00086922,True,False,False,asa4c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht001120\phv00086922\asa4c\,pht001120.v10,\phs000209\pht001120\phv00086922\asa4c\,phv00086922,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,82fb0dab59a5571febe103a5bb0154bf8cf67887f7417b54e205d44adf265015,categorical,phv00086922.v2,phs000209,False,asa4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086922\asa4c\,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,MESA,mesae4dres06222012.creatin4,Creatinine (mg/dl),17.31728794,mesae4dres06222012,creatin4,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,creatin4,CREATININE (mg/dl),phs000209.v13.p3,phv00086835.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086835,"['.4', '.5', '.6', '.7', '.8', '.9', '1', '1.1', '1.2', '1.3', '1.4', '1.5', '1.6', '1.7', '1.8', '1.9', '2', '2.1', '2.2', '2.3', '2.4', '2.5', '2.6', '2.8', '2.9', '3', '3.1', '3.5', '3.6', '3.8', '3.9', '4', '4.5', '4.7', '5.3', '5.6', '5.7', '6.7', '7.3']",phs000209,pht001120,phv00086835,True,False,False,creatin4,CREATININE (mg/dl),,\phs000209\pht001120\phv00086835\creatin4\,pht001120.v10,\phs000209\pht001120\phv00086835\creatin4\,phv00086835,,CREATININE (mg/dl),{},,,,CREATININE (mg/dl),phs000209.v13,3ce652d4a20eda76bdb2b2fa1d256bd926399182f350c22aaa1abf997ceb086c,categorical,phv00086835.v2,phs000209,False,creatin4,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086835\creatin4\,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae4dres06222012.dbp4c,Seated diastolic blood pressure (mmhg),16.3780452,mesae4dres06222012,dbp4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp4c,SEATED DIASTOLIC BLOOD PRESSURE (mmhg),phs000209.v13.p3,phv00087030.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00087030,"['100', '100.5', '101', '101.5', '102', '102.5', '103', '105', '108', '108.5', '109.5', '113.5', '118', '129.5', '41', '41.5', '42', '43', '43.5', '44', '44.5', '45', '45.5', '46', '46.5', '47', '47.5', '48', '48.5', '49', '49.5', '50', '50.5', '51', '51.5', '52', '52.5', '53', '53.5', '54', '54.5', '55', '55.5', '56', '56.5', '57', '57.5', '58', '58.5', '59', '59.5', '60', '60.5', '61', '61.5', '62', '62.5', '63', '63.5', '64', '64.5', '65', '65.5', '66', '66.5', '67', '67.5', '68', '68.5', '69', '69.5', '70', '70.5', '71', '71.5', '72', '72.5', '73', '73.5', '74', '74.5', '75', '75.5', '76', '76.5', '77', '77.5', '78', '78.5', '79', '79.5', '80', '80.5', '81', '81.5', '82', '82.5', '83', '83.5', '84', '84.5', '85', '85.5', '86', '86.5', '87', '87.5', '88', '88.5', '89', '89.5', '90', '90.5', '91', '91.5', '92', '92.5', '93', '93.5', '94', '94.5', '95', '95.5', '96', '96.5', '97', '97.5', '98', '98.5', '99', '99.5']",phs000209,pht001120,phv00087030,True,False,False,dbp4c,SEATED DIASTOLIC BLOOD PRESSURE (mmhg),,\phs000209\pht001120\phv00087030\dbp4c\,pht001120.v10,\phs000209\pht001120\phv00087030\dbp4c\,phv00087030,,SEATED DIASTOLIC BLOOD PRESSURE (mmhg),{},,,,SEATED DIASTOLIC BLOOD PRESSURE (mmhg),phs000209.v13,d1471e8824e0ec039e737d8ced24f69a49329ae09d4518551118fd84e938da8a,categorical,phv00087030.v2,phs000209,False,dbp4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00087030\dbp4c\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae4dres06222012.dm034c,Exam 4 Diabetes mellitus by 2003 ADA fasting criteria algorithm,16.90636924,mesae4dres06222012,dm034c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm034c,EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13.p3,phv00086746.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086746,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht001120,phv00086746,True,False,False,dm034c,EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,,\phs000209\pht001120\phv00086746\dm034c\,pht001120.v10,\phs000209\pht001120\phv00086746\dm034c\,phv00086746,,EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,{},,,,EXAM 4 DIABETES MELLITUS BY 2003 ADA FASTING CRITERIA ALGORITHM,phs000209.v13,69f95e7002b1958aa6f77e88eed627d8c754df58b0c9c3c848b67a2e042b0ff2,categorical,phv00086746.v2,phs000209,False,dm034c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086746\dm034c\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae4dres06222012.e14dyc,"Time between first and fourth visits, in days",14.61696507,mesae4dres06222012,e14dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13.p3,phv00086740.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086740,"['1218', '1259', '1345', '1365', '1392', '1428', '1432', '1440', '1442', '1455', '1457', '1464', '1469', '1470', '1475', '1476', '1479', '1480', '1481', '1488', '1490', '1491', '1496', '1497', '1498', '1499', '1500', '1501', '1503', '1505', '1509', '1511', '1512', '1514', '1517', '1518', '1519', '1521', '1522', '1524', '1526', '1527', '1533', '1534', '1535', '1538', '1539', '1540', '1541', '1543', '1544', '1545', '1546', '1548', '1549', '1550', '1551', '1552', '1553', '1554', '1555', '1556', '1557', '1558', '1559', '1560', '1561', '1562', '1563', '1564', '1566', '1567', '1568', '1569', '1570', '1571', '1572', '1573', '1574', '1575', '1576', '1577', '1578', '1579', '1580', '1581', '1582', '1583', '1584', '1585', '1586', '1587', '1588', '1589', '1590', '1591', '1592', '1593', '1594', '1595', '1596', '1597', '1598', '1599', '1600', '1601', '1602', '1603', '1604', '1605', '1606', '1607', '1608', '1609', '1610', '1611', '1612', '1613', '1614', '1615', '1616', '1617', '1618', '1619', '1620', '1621', '1622', '1623', '1624', '1625', '1626', '1627', '1628', '1629', '1630', '1631', '1632', '1633', '1634', '1635', '1636', '1637', '1638', '1639', '1640', '1641', '1642', '1643', '1644', '1645', '1646', '1647', '1648', '1649', '1650', '1651', '1652', '1653', '1654', '1655', '1656', '1657', '1658', '1659', '1660', '1661', '1662', '1663', '1664', '1665', '1666', '1667', '1668', '1669', '1670', '1671', '1672', '1673', '1674', '1675', '1676', '1677', '1678', '1679', '1680', '1681', '1682', '1683', '1684', '1685', '1686', '1687', '1688', '1689', '1690', '1691', '1692', '1693', '1694', '1695', '1696', '1697', '1698', '1699', '1700', '1701', '1702', '1703', '1704', '1705', '1706', '1707', '1708', '1709', '1710', '1711', '1712', '1713', '1714', '1715', '1716', '1717', '1718', '1719', '1720', '1721', '1722', '1723', '1724', '1725', '1726', '1727', '1728', '1729', '1730', '1731', '1732', '1733', '1734', '1735', '1736', '1737', '1738', '1739', '1740', '1741', '1742', '1743', '1744', '1745', '1746', '1747', '1748', '1749', '1750', '1751', '1752', '1753', '1754', '1755', '1756', '1757', '1758', '1759', '1760', '1761', '1762', '1763', '1764', '1765', '1766', '1767', '1768', '1769', '1770', '1771', '1772', '1773', '1774', '1775', '1776', '1777', '1778', '1779', '1780', '1781', '1782', '1783', '1784', '1785', '1786', '1787', '1788', '1789', '1790', '1791', '1792', '1793', '1794', '1795', '1796', '1797', '1798', '1799', '1800', '1801', '1802', '1803', '1804', '1805', '1806', '1807', '1808', '1809', '1810', '1811', '1812', '1813', '1814', '1815', '1816', '1817', '1818', '1819', '1820', '1821', '1822', '1823', '1824', '1825', '1826', '1827', '1828', '1829', '1830', '1831', '1832', '1833', '1834', '1835', '1836', '1837', '1838', '1839', '1840', '1841', '1842', '1843', '1844', '1845', '1846', '1847', '1848', '1849', '1850', '1851', '1852', '1853', '1854', '1855', '1856', '1857', '1858', '1859', '1860', '1861', '1862', '1863', '1864', '1865', '1866', '1867', '1868', '1869', '1870', '1871', '1872', '1873', '1874', '1875', '1876', '1877', '1878', '1879', '1880', '1881', '1882', '1883', '1884', '1885', '1886', '1887', '1888', '1889', '1890', '1891', '1892', '1893', '1894', '1895', '1896', '1897', '1898', '1899', '1900', '1901', '1902', '1903', '1904', '1905', '1906', '1907', '1908', '1909', '1911', '1912', '1913', '1914', '1915', '1916', '1917', '1918', '1919', '1920', '1921', '1922', '1923', '1925', '1926', '1927', '1928', '1929', '1930', '1931', '1932', '1933', '1934', '1935', '1936', '1937', '1938', '1939', '1940', '1942', '1943', '1944', '1945', '1946', '1947', '1948', '1949', '1950', '1951', '1953', '1954', '1955', '1956', '1957', '1958', '1959', '1960', '1961', '1962', '1963', '1964', '1965', '1966', '1967', '1968', '1969', '1970', '1971', '1972', '1973', '1975', '1976', '1977', '1978', '1979', '1980', '1981', '1984', '1985', '1986', '1987', '1988', '1989', '1990', '1991', '1992', '1994', '1995', '1996', '1997', '1999', '2001', '2002', '2003', '2004', '2005', '2006', '2007', '2008', '2009', '2010', '2012', '2013', '2014', '2015', '2016', '2018', '2020', '2021', '2022', '2023', '2024', '2026', '2027', '2029', '2030', '2031', '2033', '2034', '2035', '2037', '2038', '2039', '2041', '2042', '2043', '2044', '2045', '2046', '2047', '2048', '2049', '2050', '2051', '2053', '2054', '2055', '2057', '2058', '2059', '2060', '2061', '2062', '2065', '2066', '2069', '2071', '2072', '2073', '2074', '2076', '2078', '2079', '2081', '2082', '2083', '2084', '2085', '2086', '2087', '2088', '2091', '2092', '2093', '2095', '2099', '2100', '2102', '2103', '2104', '2107', '2110', '2111', '2112', '2114', '2117', '2118', '2119', '2125', '2127', '2130', '2131', '2133', '2136', '2137', '2138', '2139', '2140', '2143', '2144', '2145', '2146', '2147', '2149', '2150', '2152', '2153', '2154', '2156', '2158', '2160', '2169', '2170', '2172', '2173', '2175', '2178', '2179', '2181', '2183', '2184', '2185', '2189', '2191', '2193', '2194', '2197', '2198', '2201', '2202', '2205', '2206', '2211', '2214', '2215', '2217', '2218', '2221', '2223', '2225', '2226', '2229', '2232', '2233', '2236', '2237', '2242', '2247', '2254', '2255', '2261', '2267', '2269', '2272', '2273', '2276', '2277', '2283', '2286', '2288', '2293', '2314', '2324', '2335', '2349', '2354', '2355', '2357', '2362', '2368', '2403', '2404', '2406', '2422', '2430']",phs000209,pht001120,phv00086740,True,False,False,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",,\phs000209\pht001120\phv00086740\e14dyc\,pht001120.v10,\phs000209\pht001120\phv00086740\e14dyc\,phv00086740,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13,8c8b8db9ecb90e2b236152e98d2ac84b8a0e0895dc0757dba21d20e54dcfb802,categorical,phv00086740.v2,phs000209,False,e14dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086740\e14dyc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesae4dres06222012.e14dyc,"Time between first and fourth visits, in days",14.61696507,mesae4dres06222012,e14dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13.p3,phv00086740.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086740,"['1218', '1259', '1345', '1365', '1392', '1428', '1432', '1440', '1442', '1455', '1457', '1464', '1469', '1470', '1475', '1476', '1479', '1480', '1481', '1488', '1490', '1491', '1496', '1497', '1498', '1499', '1500', '1501', '1503', '1505', '1509', '1511', '1512', '1514', '1517', '1518', '1519', '1521', '1522', '1524', '1526', '1527', '1533', '1534', '1535', '1538', '1539', '1540', '1541', '1543', '1544', '1545', '1546', '1548', '1549', '1550', '1551', '1552', '1553', '1554', '1555', '1556', '1557', '1558', '1559', '1560', '1561', '1562', '1563', '1564', '1566', '1567', '1568', '1569', '1570', '1571', '1572', '1573', '1574', '1575', '1576', '1577', '1578', '1579', '1580', '1581', '1582', '1583', '1584', '1585', '1586', '1587', '1588', '1589', '1590', '1591', '1592', '1593', '1594', '1595', '1596', '1597', '1598', '1599', '1600', '1601', '1602', '1603', '1604', '1605', '1606', '1607', '1608', '1609', '1610', '1611', '1612', '1613', '1614', '1615', '1616', '1617', '1618', '1619', '1620', '1621', '1622', '1623', '1624', '1625', '1626', '1627', '1628', '1629', '1630', '1631', '1632', '1633', '1634', '1635', '1636', '1637', '1638', '1639', '1640', '1641', '1642', '1643', '1644', '1645', '1646', '1647', '1648', '1649', '1650', '1651', '1652', '1653', '1654', '1655', '1656', '1657', '1658', '1659', '1660', '1661', '1662', '1663', '1664', '1665', '1666', '1667', '1668', '1669', '1670', '1671', '1672', '1673', '1674', '1675', '1676', '1677', '1678', '1679', '1680', '1681', '1682', '1683', '1684', '1685', '1686', '1687', '1688', '1689', '1690', '1691', '1692', '1693', '1694', '1695', '1696', '1697', '1698', '1699', '1700', '1701', '1702', '1703', '1704', '1705', '1706', '1707', '1708', '1709', '1710', '1711', '1712', '1713', '1714', '1715', '1716', '1717', '1718', '1719', '1720', '1721', '1722', '1723', '1724', '1725', '1726', '1727', '1728', '1729', '1730', '1731', '1732', '1733', '1734', '1735', '1736', '1737', '1738', '1739', '1740', '1741', '1742', '1743', '1744', '1745', '1746', '1747', '1748', '1749', '1750', '1751', '1752', '1753', '1754', '1755', '1756', '1757', '1758', '1759', '1760', '1761', '1762', '1763', '1764', '1765', '1766', '1767', '1768', '1769', '1770', '1771', '1772', '1773', '1774', '1775', '1776', '1777', '1778', '1779', '1780', '1781', '1782', '1783', '1784', '1785', '1786', '1787', '1788', '1789', '1790', '1791', '1792', '1793', '1794', '1795', '1796', '1797', '1798', '1799', '1800', '1801', '1802', '1803', '1804', '1805', '1806', '1807', '1808', '1809', '1810', '1811', '1812', '1813', '1814', '1815', '1816', '1817', '1818', '1819', '1820', '1821', '1822', '1823', '1824', '1825', '1826', '1827', '1828', '1829', '1830', '1831', '1832', '1833', '1834', '1835', '1836', '1837', '1838', '1839', '1840', '1841', '1842', '1843', '1844', '1845', '1846', '1847', '1848', '1849', '1850', '1851', '1852', '1853', '1854', '1855', '1856', '1857', '1858', '1859', '1860', '1861', '1862', '1863', '1864', '1865', '1866', '1867', '1868', '1869', '1870', '1871', '1872', '1873', '1874', '1875', '1876', '1877', '1878', '1879', '1880', '1881', '1882', '1883', '1884', '1885', '1886', '1887', '1888', '1889', '1890', '1891', '1892', '1893', '1894', '1895', '1896', '1897', '1898', '1899', '1900', '1901', '1902', '1903', '1904', '1905', '1906', '1907', '1908', '1909', '1911', '1912', '1913', '1914', '1915', '1916', '1917', '1918', '1919', '1920', '1921', '1922', '1923', '1925', '1926', '1927', '1928', '1929', '1930', '1931', '1932', '1933', '1934', '1935', '1936', '1937', '1938', '1939', '1940', '1942', '1943', '1944', '1945', '1946', '1947', '1948', '1949', '1950', '1951', '1953', '1954', '1955', '1956', '1957', '1958', '1959', '1960', '1961', '1962', '1963', '1964', '1965', '1966', '1967', '1968', '1969', '1970', '1971', '1972', '1973', '1975', '1976', '1977', '1978', '1979', '1980', '1981', '1984', '1985', '1986', '1987', '1988', '1989', '1990', '1991', '1992', '1994', '1995', '1996', '1997', '1999', '2001', '2002', '2003', '2004', '2005', '2006', '2007', '2008', '2009', '2010', '2012', '2013', '2014', '2015', '2016', '2018', '2020', '2021', '2022', '2023', '2024', '2026', '2027', '2029', '2030', '2031', '2033', '2034', '2035', '2037', '2038', '2039', '2041', '2042', '2043', '2044', '2045', '2046', '2047', '2048', '2049', '2050', '2051', '2053', '2054', '2055', '2057', '2058', '2059', '2060', '2061', '2062', '2065', '2066', '2069', '2071', '2072', '2073', '2074', '2076', '2078', '2079', '2081', '2082', '2083', '2084', '2085', '2086', '2087', '2088', '2091', '2092', '2093', '2095', '2099', '2100', '2102', '2103', '2104', '2107', '2110', '2111', '2112', '2114', '2117', '2118', '2119', '2125', '2127', '2130', '2131', '2133', '2136', '2137', '2138', '2139', '2140', '2143', '2144', '2145', '2146', '2147', '2149', '2150', '2152', '2153', '2154', '2156', '2158', '2160', '2169', '2170', '2172', '2173', '2175', '2178', '2179', '2181', '2183', '2184', '2185', '2189', '2191', '2193', '2194', '2197', '2198', '2201', '2202', '2205', '2206', '2211', '2214', '2215', '2217', '2218', '2221', '2223', '2225', '2226', '2229', '2232', '2233', '2236', '2237', '2242', '2247', '2254', '2255', '2261', '2267', '2269', '2272', '2273', '2276', '2277', '2283', '2286', '2288', '2293', '2314', '2324', '2335', '2349', '2354', '2355', '2357', '2362', '2368', '2403', '2404', '2406', '2422', '2430']",phs000209,pht001120,phv00086740,True,False,False,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",,\phs000209\pht001120\phv00086740\e14dyc\,pht001120.v10,\phs000209\pht001120\phv00086740\e14dyc\,phv00086740,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13,8c8b8db9ecb90e2b236152e98d2ac84b8a0e0895dc0757dba21d20e54dcfb802,categorical,phv00086740.v2,phs000209,False,e14dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086740\e14dyc\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae4dres06222012.e14dyc,"Time between first and fourth visits, in days",14.61696507,mesae4dres06222012,e14dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13.p3,phv00086740.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086740,"['1218', '1259', '1345', '1365', '1392', '1428', '1432', '1440', '1442', '1455', '1457', '1464', '1469', '1470', '1475', '1476', '1479', '1480', '1481', '1488', '1490', '1491', '1496', '1497', '1498', '1499', '1500', '1501', '1503', '1505', '1509', '1511', '1512', '1514', '1517', '1518', '1519', '1521', '1522', '1524', '1526', '1527', '1533', '1534', '1535', '1538', '1539', '1540', '1541', '1543', '1544', '1545', '1546', '1548', '1549', '1550', '1551', '1552', '1553', '1554', '1555', '1556', '1557', '1558', '1559', '1560', '1561', '1562', '1563', '1564', '1566', '1567', '1568', '1569', '1570', '1571', '1572', '1573', '1574', '1575', '1576', '1577', '1578', '1579', '1580', '1581', '1582', '1583', '1584', '1585', '1586', '1587', '1588', '1589', '1590', '1591', '1592', '1593', '1594', '1595', '1596', '1597', '1598', '1599', '1600', '1601', '1602', '1603', '1604', '1605', '1606', '1607', '1608', '1609', '1610', '1611', '1612', '1613', '1614', '1615', '1616', '1617', '1618', '1619', '1620', '1621', '1622', '1623', '1624', '1625', '1626', '1627', '1628', '1629', '1630', '1631', '1632', '1633', '1634', '1635', '1636', '1637', '1638', '1639', '1640', '1641', '1642', '1643', '1644', '1645', '1646', '1647', '1648', '1649', '1650', '1651', '1652', '1653', '1654', '1655', '1656', '1657', '1658', '1659', '1660', '1661', '1662', '1663', '1664', '1665', '1666', '1667', '1668', '1669', '1670', '1671', '1672', '1673', '1674', '1675', '1676', '1677', '1678', '1679', '1680', '1681', '1682', '1683', '1684', '1685', '1686', '1687', '1688', '1689', '1690', '1691', '1692', '1693', '1694', '1695', '1696', '1697', '1698', '1699', '1700', '1701', '1702', '1703', '1704', '1705', '1706', '1707', '1708', '1709', '1710', '1711', '1712', '1713', '1714', '1715', '1716', '1717', '1718', '1719', '1720', '1721', '1722', '1723', '1724', '1725', '1726', '1727', '1728', '1729', '1730', '1731', '1732', '1733', '1734', '1735', '1736', '1737', '1738', '1739', '1740', '1741', '1742', '1743', '1744', '1745', '1746', '1747', '1748', '1749', '1750', '1751', '1752', '1753', '1754', '1755', '1756', '1757', '1758', '1759', '1760', '1761', '1762', '1763', '1764', '1765', '1766', '1767', '1768', '1769', '1770', '1771', '1772', '1773', '1774', '1775', '1776', '1777', '1778', '1779', '1780', '1781', '1782', '1783', '1784', '1785', '1786', '1787', '1788', '1789', '1790', '1791', '1792', '1793', '1794', '1795', '1796', '1797', '1798', '1799', '1800', '1801', '1802', '1803', '1804', '1805', '1806', '1807', '1808', '1809', '1810', '1811', '1812', '1813', '1814', '1815', '1816', '1817', '1818', '1819', '1820', '1821', '1822', '1823', '1824', '1825', '1826', '1827', '1828', '1829', '1830', '1831', '1832', '1833', '1834', '1835', '1836', '1837', '1838', '1839', '1840', '1841', '1842', '1843', '1844', '1845', '1846', '1847', '1848', '1849', '1850', '1851', '1852', '1853', '1854', '1855', '1856', '1857', '1858', '1859', '1860', '1861', '1862', '1863', '1864', '1865', '1866', '1867', '1868', '1869', '1870', '1871', '1872', '1873', '1874', '1875', '1876', '1877', '1878', '1879', '1880', '1881', '1882', '1883', '1884', '1885', '1886', '1887', '1888', '1889', '1890', '1891', '1892', '1893', '1894', '1895', '1896', '1897', '1898', '1899', '1900', '1901', '1902', '1903', '1904', '1905', '1906', '1907', '1908', '1909', '1911', '1912', '1913', '1914', '1915', '1916', '1917', '1918', '1919', '1920', '1921', '1922', '1923', '1925', '1926', '1927', '1928', '1929', '1930', '1931', '1932', '1933', '1934', '1935', '1936', '1937', '1938', '1939', '1940', '1942', '1943', '1944', '1945', '1946', '1947', '1948', '1949', '1950', '1951', '1953', '1954', '1955', '1956', '1957', '1958', '1959', '1960', '1961', '1962', '1963', '1964', '1965', '1966', '1967', '1968', '1969', '1970', '1971', '1972', '1973', '1975', '1976', '1977', '1978', '1979', '1980', '1981', '1984', '1985', '1986', '1987', '1988', '1989', '1990', '1991', '1992', '1994', '1995', '1996', '1997', '1999', '2001', '2002', '2003', '2004', '2005', '2006', '2007', '2008', '2009', '2010', '2012', '2013', '2014', '2015', '2016', '2018', '2020', '2021', '2022', '2023', '2024', '2026', '2027', '2029', '2030', '2031', '2033', '2034', '2035', '2037', '2038', '2039', '2041', '2042', '2043', '2044', '2045', '2046', '2047', '2048', '2049', '2050', '2051', '2053', '2054', '2055', '2057', '2058', '2059', '2060', '2061', '2062', '2065', '2066', '2069', '2071', '2072', '2073', '2074', '2076', '2078', '2079', '2081', '2082', '2083', '2084', '2085', '2086', '2087', '2088', '2091', '2092', '2093', '2095', '2099', '2100', '2102', '2103', '2104', '2107', '2110', '2111', '2112', '2114', '2117', '2118', '2119', '2125', '2127', '2130', '2131', '2133', '2136', '2137', '2138', '2139', '2140', '2143', '2144', '2145', '2146', '2147', '2149', '2150', '2152', '2153', '2154', '2156', '2158', '2160', '2169', '2170', '2172', '2173', '2175', '2178', '2179', '2181', '2183', '2184', '2185', '2189', '2191', '2193', '2194', '2197', '2198', '2201', '2202', '2205', '2206', '2211', '2214', '2215', '2217', '2218', '2221', '2223', '2225', '2226', '2229', '2232', '2233', '2236', '2237', '2242', '2247', '2254', '2255', '2261', '2267', '2269', '2272', '2273', '2276', '2277', '2283', '2286', '2288', '2293', '2314', '2324', '2335', '2349', '2354', '2355', '2357', '2362', '2368', '2403', '2404', '2406', '2422', '2430']",phs000209,pht001120,phv00086740,True,False,False,e14dyc,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",,\phs000209\pht001120\phv00086740\e14dyc\,pht001120.v10,\phs000209\pht001120\phv00086740\e14dyc\,phv00086740,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FOURTH VISITS, IN DAYS",phs000209.v13,8c8b8db9ecb90e2b236152e98d2ac84b8a0e0895dc0757dba21d20e54dcfb802,categorical,phv00086740.v2,phs000209,False,e14dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086740\e14dyc\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae4dres06222012.fibr4c,Fibrates,17.36131494,mesae4dres06222012,fibr4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr4c,FIBRATES,phs000209.v13.p3,phv00086960.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086960,"['NO', 'YES']",phs000209,pht001120,phv00086960,True,False,False,fibr4c,FIBRATES,,\phs000209\pht001120\phv00086960\fibr4c\,pht001120.v10,\phs000209\pht001120\phv00086960\fibr4c\,phv00086960,,FIBRATES,{},,,,FIBRATES,phs000209.v13,3eb7d55abe95039eee90320a0c65979ac28401dbec3a2df5216d0738c3165971,categorical,phv00086960.v2,phs000209,False,fibr4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086960\fibr4c\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae4dres06222012.glucos4c,Fasting Glucose (mg/dL) Calibrated,17.31728794,mesae4dres06222012,glucos4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucos4c,EXAM 4 FASTING GLUCOSE- CALIBRATED,phs000209.v13.p3,phv00086834.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086834,"['100', '101', '102', '103', '104', '105', '106', '107', '108', '109', '110', '111', '112', '113', '114', '115', '116', '117', '118', '119', '120', '121', '122', '123', '124', '125', '126', '127', '128', '129', '130', '131', '132', '133', '134', '135', '136', '137', '138', '139', '140', '141', '142', '143', '144', '145', '146', '147', '148', '149', '150', '151', '152', '153', '154', '155', '156', '157', '158', '159', '160', '161', '162', '163', '164', '165', '166', '167', '168', '169', '170', '171', '172', '173', '174', '175', '176', '177', '178', '179', '182', '183', '184', '186', '189', '190', '191', '192', '193', '194', '195', '196', '197', '198', '199', '200', '201', '202', '203', '204', '205', '206', '207', '208', '209', '211', '213', '215', '216', '218', '219', '222', '223', '225', '227', '230', '232', '233', '235', '236', '238', '240', '241', '242', '243', '244', '245', '248', '254', '256', '258', '259', '261', '263', '265', '266', '267', '273', '274', '276', '277', '281', '285', '286', '287', '292', '295', '301', '302', '305', '307', '309', '314', '318', '319', '321', '329', '331', '334', '345', '348', '35', '359', '394', '397', '42', '472', '48', '55', '57', '60', '61', '62', '64', '65', '67', '68', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94', '95', '96', '97', '98', '99']",phs000209,pht001120,phv00086834,True,False,False,glucos4c,EXAM 4 FASTING GLUCOSE- CALIBRATED,,\phs000209\pht001120\phv00086834\glucos4c\,pht001120.v10,\phs000209\pht001120\phv00086834\glucos4c\,phv00086834,,EXAM 4 FASTING GLUCOSE- CALIBRATED,{},,,,EXAM 4 FASTING GLUCOSE- CALIBRATED,phs000209.v13,07130a07f770e1e39003e7605b6322dbaf927d1160faf95745eeacd43113f1ec,categorical,phv00086834.v2,phs000209,False,glucos4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086834\glucos4c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae4dres06222012.htn4c,"Hypertension by JNC VI (1997) criteria, Exam 4",16.40739654,mesae4dres06222012,htn4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn4c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4",phs000209.v13.p3,phv00086749.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086749,"['NO', 'YES']",phs000209,pht001120,phv00086749,True,False,False,htn4c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4",,\phs000209\pht001120\phv00086749\htn4c\,pht001120.v10,\phs000209\pht001120\phv00086749\htn4c\,phv00086749,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4",{},,,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 4",phs000209.v13,8caa95e74a5a314413cd6f0524cda1559bd1046b9807bb54ff9633f35872b6c7,categorical,phv00086749.v2,phs000209,False,htn4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086749\htn4c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae4dres06222012.insln4c,Insulins,17.36131494,mesae4dres06222012,insln4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln4c,INSULINS,phs000209.v13.p3,phv00086927.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086927,"['NO', 'YES']",phs000209,pht001120,phv00086927,True,False,False,insln4c,INSULINS,,\phs000209\pht001120\phv00086927\insln4c\,pht001120.v10,\phs000209\pht001120\phv00086927\insln4c\,phv00086927,,INSULINS,{},,,,INSULINS,phs000209.v13,803c85e0698adb8564a61e823449490e6175ebb14fe75a64ea049b037c336308,categorical,phv00086927.v2,phs000209,False,insln4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086927\insln4c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae4dres06222012.mlpd4c,Miscellaneous lipid-lowering drugs,17.36131494,mesae4dres06222012,mlpd4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd4c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00086929.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086929,"['NO', 'YES']",phs000209,pht001120,phv00086929,True,False,False,mlpd4c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht001120\phv00086929\mlpd4c\,pht001120.v10,\phs000209\pht001120\phv00086929\mlpd4c\,phv00086929,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,0ba4e9824963e5ce0fd53504380765730036f1840c58689f04bd93c75e7e74c3,categorical,phv00086929.v2,phs000209,False,mlpd4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086929\mlpd4c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae4dres06222012.niac4c,Niacin and nictotinic acid,17.36131494,mesae4dres06222012,niac4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac4c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00086971.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086971,"['NO', 'YES']",phs000209,pht001120,phv00086971,True,False,False,niac4c,NIACIN AND NICOTINIC ACID,,\phs000209\pht001120\phv00086971\niac4c\,pht001120.v10,\phs000209\pht001120\phv00086971\niac4c\,phv00086971,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,64ce6699ef9386e246e86382bcca5ce9326ce7a8a216a8da60c3ee894893f82c,categorical,phv00086971.v2,phs000209,False,niac4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086971\niac4c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae4dres06222012.prob4c,Probucol,17.36131494,mesae4dres06222012,prob4c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob4c,PROBUCOL,phs000209.v13.p3,phv00086985.v2.p3,pht001120.v10.p3,MESA_Exam4Main,phv00086985,['NO'],phs000209,pht001120,phv00086985,True,False,False,prob4c,PROBUCOL,,\phs000209\pht001120\phv00086985\prob4c\,pht001120.v10,\phs000209\pht001120\phv00086985\prob4c\,phv00086985,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,1d767b9a2ed68df62d6977c4642abbacb7304b687ba6c6dc5da095c738c85c0d,categorical,phv00086985.v2,phs000209,False,prob4c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001120,MESA_Exam4Main,\phs000209\pht001120\phv00086985\prob4c\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae4dres06222012.whoros4c,WHO ROSE Intermittent Claudication,21.16231289,mesae4dres06222012,whoros4c,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae5_drepos_20220820.afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,2.184054283,mesae5_drepos_20220820,afib5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,phs000209.v13.p3,phv00176548.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176548,"['NO', 'YES']",phs000209,pht003091,phv00176548,True,False,False,afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,,\phs000209\pht003091\phv00176548\afib5c\,pht003091.v3,\phs000209\pht003091\phv00176548\afib5c\,phv00176548,,ECG ATRIAL FIBRILLATION / FLUTTER,{},,,,ECG ATRIAL FIBRILLATION / FLUTTER,phs000209.v13,d76bc471f0887deba5032e49780fcf26405faf4b87b0c79e83a5cbec7b6f9c76,categorical,phv00176548.v1,phs000209,False,afib5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176548\afib5c\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae5_drepos_20220820.afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,2.184054283,mesae5_drepos_20220820,afib5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,phs000209.v13.p3,phv00175125.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175125,"['NO', 'YES']",phs000209,pht003086,phv00175125,True,False,False,afib5c,ECG ATRIAL FIBRILLATION / FLUTTER,,\phs000209\pht003086\phv00175125\afib5c\,pht003086.v3,\phs000209\pht003086\phv00175125\afib5c\,phv00175125,,ECG ATRIAL FIBRILLATION / FLUTTER,{},,,,ECG ATRIAL FIBRILLATION / FLUTTER,phs000209.v13,2803b55c59ca5f1463f93de795b1ea98ecb2fa84c61c43bb179f3192714d39f7,categorical,phv00175125.v1,phs000209,False,afib5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175125\afib5c\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae5_drepos_20220820.age5c,AGE AT EXAM 5,-,mesae5_drepos_20220820,age5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age5c,AGE AT EXAM 5,phs000209.v13.p3,phv00176011.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176011,"['53', '54', '55', '56', '57', '58', '59', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '70', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94']",phs000209,pht003091,phv00176011,True,False,False,age5c,AGE AT EXAM 5,,\phs000209\pht003091\phv00176011\age5c\,pht003091.v3,\phs000209\pht003091\phv00176011\age5c\,phv00176011,,AGE AT EXAM 5,{},,,,AGE AT EXAM 5,phs000209.v13,868d259d5fe94d16a48515b5aa705f9c8c36dd2a67ec0ea352644a6f9cf9cb87,categorical,phv00176011.v1,phs000209,False,age5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176011\age5c\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,MESA,mesae5_drepos_20220820.age5c,AGE AT EXAM 5,-,mesae5_drepos_20220820,age5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age5c,AGE AT EXAM 5,phs000209.v13.p3,phv00174588.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174588,[],phs000209,pht003086,phv00174588,False,True,False,age5c,AGE AT EXAM 5,54.0,\phs000209\pht003086\phv00174588\age5c\,pht003086.v3,\phs000209\pht003086\phv00174588\age5c\,phv00174588,,AGE AT EXAM 5,{},,,92.0,AGE AT EXAM 5,phs000209.v13,2098e779e40cc294d86bab44491b4d274521e572dd3e1156f7101e3f04bf4496,continuous,phv00174588.v1,phs000209,False,age5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174588\age5c\,54.0,92.0
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae5_drepos_20220820.asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),0.169635284,mesae5_drepos_20220820,asa5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00176765.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176765,"['NO', 'YES']",phs000209,pht003091,phv00176765,True,False,False,asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht003091\phv00176765\asa5c\,pht003091.v3,\phs000209\pht003091\phv00176765\asa5c\,phv00176765,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,b5b8ced1cd3a6276e540a28e870da65eb507a0a8144504e09168e79940aeb479,categorical,phv00176765.v1,phs000209,False,asa5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176765\asa5c\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,MESA,mesae5_drepos_20220820.asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),0.169635284,mesae5_drepos_20220820,asa5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13.p3,phv00175342.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175342,"['NO', 'YES']",phs000209,pht003086,phv00175342,True,False,False,asa5c,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),,\phs000209\pht003086\phv00175342\asa5c\,pht003086.v3,\phs000209\pht003086\phv00175342\asa5c\,phv00175342,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),{},,,,ASPIRIN FROM 280804 (ANTI-INFLAM AGENTS),phs000209.v13,c6ecafeaefed7f8c8ab3febbed33d225fb30b6177dd1bd34d85a4b74162f1fa1,categorical,phv00175342.v1,phs000209,False,asa5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175342\asa5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.basq5c,BILE-ACID SEQUESTRANTS,0.169635284,mesae5_drepos_20220820,basq5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq5c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00176766.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176766,"['NO', 'YES']",phs000209,pht003091,phv00176766,True,False,False,basq5c,BILE-ACID SEQUESTRANTS,,\phs000209\pht003091\phv00176766\basq5c\,pht003091.v3,\phs000209\pht003091\phv00176766\basq5c\,phv00176766,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,e37d530ea4e11db299fc5f309495fa773247054fed45f8713f0213594a11bc53,categorical,phv00176766.v1,phs000209,False,basq5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176766\basq5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.basq5c,BILE-ACID SEQUESTRANTS,0.169635284,mesae5_drepos_20220820,basq5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,basq5c,BILE-ACID SEQUESTRANTS,phs000209.v13.p3,phv00175343.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175343,"['NO', 'YES']",phs000209,pht003086,phv00175343,True,False,False,basq5c,BILE-ACID SEQUESTRANTS,,\phs000209\pht003086\phv00175343\basq5c\,pht003086.v3,\phs000209\pht003086\phv00175343\basq5c\,phv00175343,,BILE-ACID SEQUESTRANTS,{},,,,BILE-ACID SEQUESTRANTS,phs000209.v13,59dfd9d69b3d09a97c37a9969708648018d04f01869e6e9790283bd7e0429a6e,categorical,phv00175343.v1,phs000209,False,basq5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175343\basq5c\,,
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,MESA,mesae5_drepos_20220820.creatnn5,CREATININE,95.41984733,mesae5_drepos_20220820,creatnn5,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae5_drepos_20220820.dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),1.335877863,mesae5_drepos_20220820,dbp5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00177036.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00177036,"['100', '100.5', '102', '104', '106.5', '109.5', '112', '113', '123', '36.5', '40.5', '42', '42.5', '43', '43.5', '44', '44.5', '45', '45.5', '46', '46.5', '47', '47.5', '48', '48.5', '49', '49.5', '50', '50.5', '51', '51.5', '52', '52.5', '53', '53.5', '54', '54.5', '55', '55.5', '56', '56.5', '57', '57.5', '58', '58.5', '59', '59.5', '60', '60.5', '61', '61.5', '62', '62.5', '63', '63.5', '64', '64.5', '65', '65.5', '66', '66.5', '67', '67.5', '68', '68.5', '69', '69.5', '70', '70.5', '71', '71.5', '72', '72.5', '73', '73.5', '74', '74.5', '75', '75.5', '76', '76.5', '77', '77.5', '78', '78.5', '79', '79.5', '80', '80.5', '81', '81.5', '82', '82.5', '83', '83.5', '84', '84.5', '85', '85.5', '86', '86.5', '87', '87.5', '88', '88.5', '89', '89.5', '90', '90.5', '91', '91.5', '92', '92.5', '93', '93.5', '94', '94.5', '95.5', '96', '96.5', '97', '97.5', '98', '98.5', '99', '99.5']",phs000209,pht003091,phv00177036,True,False,False,dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),,\phs000209\pht003091\phv00177036\dbp5c\,pht003091.v3,\phs000209\pht003091\phv00177036\dbp5c\,phv00177036,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,eab3a2148d2932121494066ae0d10c3280ed614792df17a1ddb085901790325e,categorical,phv00177036.v1,phs000209,False,dbp5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00177036\dbp5c\,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,MESA,mesae5_drepos_20220820.dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),1.335877863,mesae5_drepos_20220820,dbp5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13.p3,phv00175602.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175602,[],phs000209,pht003086,phv00175602,False,True,False,dbp5c,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),43.5,\phs000209\pht003086\phv00175602\dbp5c\,pht003086.v3,\phs000209\pht003086\phv00175602\dbp5c\,phv00175602,,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),{},,,95.0,SEATED DIASTOLIC BLOOD PRESSURE (mmHg),phs000209.v13,04fe1b96b635019e758162d810ed23ebc3a5b0d369c74d64062d8d90ed4fcba1,continuous,phv00175602.v1,phs000209,False,dbp5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175602\dbp5c\,43.5,95.0
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae5_drepos_20220820.dm035c,DIABETES 2003 ADA FASTING CRITERIA,2.565733673,mesae5_drepos_20220820,dm035c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm035c,DIABETES 2003 ADA FASTING CRITERIA,phs000209.v13.p3,phv00176017.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176017,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht003091,phv00176017,True,False,False,dm035c,DIABETES 2003 ADA FASTING CRITERIA,,\phs000209\pht003091\phv00176017\dm035c\,pht003091.v3,\phs000209\pht003091\phv00176017\dm035c\,phv00176017,,DIABETES 2003 ADA FASTING CRITERIA,{},,,,DIABETES 2003 ADA FASTING CRITERIA,phs000209.v13,cddfbcbc35e6b970dfe103d5dd64b65ae9fe458572a5a941d6926c61a1b15819,categorical,phv00176017.v1,phs000209,False,dm035c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176017\dm035c\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,MESA,mesae5_drepos_20220820.dm035c,DIABETES 2003 ADA FASTING CRITERIA,2.565733673,mesae5_drepos_20220820,dm035c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dm035c,DIABETES 2003 ADA FASTING CRITERIA,phs000209.v13.p3,phv00174594.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174594,"['IFG', 'NORMAL', 'TREATED DIABETES', 'UNTREATED DIABETES']",phs000209,pht003086,phv00174594,True,False,False,dm035c,DIABETES 2003 ADA FASTING CRITERIA,,\phs000209\pht003086\phv00174594\dm035c\,pht003086.v3,\phs000209\pht003086\phv00174594\dm035c\,phv00174594,,DIABETES 2003 ADA FASTING CRITERIA,{},,,,DIABETES 2003 ADA FASTING CRITERIA,phs000209.v13,43d5a2b779678445ff3208bf2bf0f39569bbe7b9b399050d7b86e48a7be6a25b,categorical,phv00174594.v1,phs000209,False,dm035c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174594\dm035c\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00176013.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176013,"['2909', '2950', '2952', '2957', '2970', '2972', '2973', '2996', '3000', '3011', '3019', '3025', '3031', '3037', '3038', '3041', '3042', '3044', '3053', '3057', '3058', '3059', '3060', '3066', '3067', '3068', '3070', '3071', '3072', '3074', '3075', '3077', '3079', '3080', '3081', '3083', '3086', '3091', '3093', '3094', '3096', '3100', '3101', '3102', '3104', '3105', '3107', '3108', '3109', '3112', '3115', '3118', '3119', '3121', '3122', '3123', '3127', '3128', '3129', '3131', '3135', '3136', '3137', '3138', '3139', '3140', '3141', '3142', '3143', '3144', '3145', '3147', '3148', '3149', '3151', '3152', '3153', '3156', '3157', '3158', '3161', '3162', '3164', '3165', '3166', '3167', '3169', '3170', '3171', '3172', '3174', '3175', '3176', '3177', '3178', '3179', '3180', '3181', '3182', '3183', '3184', '3185', '3186', '3187', '3188', '3189', '3190', '3191', '3192', '3193', '3194', '3195', '3196', '3197', '3198', '3199', '3200', '3204', '3205', '3206', '3207', '3208', '3209', '3210', '3212', '3213', '3214', '3215', '3217', '3218', '3219', '3220', '3221', '3222', '3223', '3224', '3225', '3226', '3227', '3228', '3229', '3230', '3231', '3232', '3234', '3235', '3236', '3237', '3238', '3239', '3241', '3242', '3243', '3244', '3245', '3246', '3247', '3248', '3249', '3250', '3251', '3252', '3253', '3254', '3255', '3256', '3257', '3258', '3259', '3260', '3261', '3262', '3263', '3264', '3265', '3266', '3267', '3268', '3269', '3270', '3271', '3272', '3273', '3274', '3275', '3276', '3277', '3278', '3280', '3281', '3282', '3283', '3284', '3285', '3286', '3287', '3288', '3289', '3290', '3291', '3292', '3293', '3294', '3295', '3296', '3297', '3298', '3299', '3300', '3301', '3302', '3303', '3304', '3305', '3306', '3307', '3308', '3309', '3310', '3311', '3312', '3313', '3314', '3315', '3316', '3317', '3318', '3319', '3320', '3321', '3322', '3323', '3324', '3325', '3326', '3327', '3328', '3329', '3330', '3331', '3332', '3333', '3334', '3335', '3336', '3337', '3338', '3339', '3340', '3341', '3342', '3343', '3344', '3345', '3346', '3347', '3348', '3349', '3350', '3351', '3352', '3353', '3354', '3355', '3356', '3357', '3358', '3359', '3360', '3361', '3362', '3363', '3364', '3365', '3366', '3367', '3368', '3369', '3370', '3371', '3372', '3373', '3374', '3375', '3376', '3377', '3378', '3379', '3380', '3381', '3382', '3383', '3384', '3385', '3386', '3387', '3388', '3389', '3390', '3391', '3392', '3393', '3394', '3395', '3396', '3397', '3398', '3399', '3400', '3401', '3402', '3403', '3404', '3405', '3406', '3407', '3408', '3409', '3410', '3411', '3412', '3413', '3414', '3415', '3416', '3417', '3418', '3419', '3420', '3421', '3422', '3423', '3424', '3425', '3426', '3427', '3428', '3429', '3430', '3431', '3432', '3433', '3434', '3435', '3436', '3437', '3438', '3439', '3440', '3441', '3442', '3443', '3444', '3445', '3446', '3447', '3448', '3449', '3450', '3451', '3452', '3453', '3454', '3455', '3456', '3457', '3458', '3459', '3460', '3461', '3462', '3463', '3464', '3465', '3466', '3467', '3468', '3469', '3470', '3471', '3472', '3473', '3474', '3475', '3476', '3477', '3478', '3479', '3480', '3481', '3482', '3483', '3484', '3485', '3486', '3487', '3488', '3489', '3490', '3491', '3492', '3493', '3494', '3495', '3496', '3497', '3498', '3499', '3500', '3501', '3502', '3503', '3504', '3505', '3506', '3507', '3508', '3509', '3510', '3511', '3512', '3513', '3514', '3515', '3516', '3517', '3518', '3519', '3520', '3521', '3522', '3523', '3524', '3525', '3526', '3527', '3528', '3529', '3530', '3531', '3532', '3533', '3534', '3535', '3536', '3537', '3538', '3539', '3540', '3541', '3542', '3543', '3544', '3545', '3546', '3547', '3548', '3549', '3550', '3551', '3552', '3553', '3554', '3555', '3556', '3557', '3558', '3559', '3560', '3561', '3562', '3563', '3564', '3565', '3566', '3567', '3568', '3569', '3570', '3571', '3572', '3573', '3574', '3575', '3576', '3577', '3578', '3579', '3580', '3581', '3582', '3583', '3584', '3585', '3586', '3587', '3588', '3589', '3590', '3591', '3592', '3593', '3594', '3595', '3596', '3597', '3598', '3599', '3600', '3601', '3602', '3603', '3604', '3605', '3606', '3607', '3608', '3609', '3610', '3611', '3612', '3613', '3614', '3615', '3616', '3617', '3618', '3619', '3620', '3621', '3622', '3623', '3625', '3626', '3627', '3628', '3629', '3630', '3631', '3632', '3633', '3634', '3635', '3636', '3637', '3638', '3639', '3640', '3641', '3642', '3643', '3644', '3645', '3646', '3647', '3648', '3649', '3650', '3651', '3652', '3653', '3654', '3656', '3658', '3659', '3660', '3661', '3662', '3663', '3664', '3665', '3667', '3668', '3669', '3670', '3671', '3672', '3673', '3674', '3675', '3676', '3677', '3679', '3680', '3681', '3682', '3683', '3684', '3685', '3686', '3687', '3688', '3690', '3691', '3692', '3694', '3695', '3696', '3697', '3698', '3699', '3700', '3701', '3702', '3703', '3705', '3706', '3707', '3709', '3710', '3711', '3712', '3713', '3714', '3715', '3716', '3717', '3718', '3719', '3720', '3721', '3722', '3723', '3724', '3725', '3726', '3727', '3728', '3729', '3730', '3731', '3732', '3733', '3734', '3736', '3737', '3738', '3740', '3741', '3742', '3743', '3744', '3745', '3746', '3748', '3750', '3751', '3752', '3753', '3754', '3755', '3756', '3757', '3758', '3759', '3760', '3762', '3763', '3764', '3765', '3766', '3767', '3768', '3769', '3770', '3771', '3772', '3773', '3775', '3776', '3777', '3778', '3780', '3781', '3782', '3783', '3784', '3785', '3786', '3787', '3788', '3789', '3790', '3791', '3792', '3793', '3794', '3795', '3798', '3800', '3801', '3802', '3803', '3806', '3807', '3808', '3810', '3811', '3814', '3815', '3816', '3817', '3819', '3821', '3822', '3823', '3825', '3826', '3828', '3832', '3833', '3834', '3835', '3836', '3837', '3839', '3841', '3842', '3843', '3845', '3846', '3847', '3848', '3849', '3850', '3851', '3854', '3855', '3856', '3857', '3858', '3859', '3861', '3862', '3865', '3866', '3867', '3868', '3871', '3874', '3877', '3878', '3880', '3882', '3884', '3885', '3886', '3888', '3889', '3891', '3892', '3893', '3894', '3895', '3896', '3897', '3899', '3903', '3904', '3906', '3907', '3913', '3914', '3915', '3918', '3919', '3920', '3927', '3928', '3929', '3932', '3933', '3934', '3935', '3938', '3939', '3940', '3941', '3946', '3948', '3951', '3952', '3953', '3954', '3955', '3962', '3964', '3965', '3966', '3967', '3968', '3969', '3976', '3977', '3980', '3981', '3983', '3985', '3987', '3990', '3992', '3993', '3994', '3996', '3997', '3998', '3999', '4003', '4006', '4011', '4017', '4022', '4023', '4025', '4029', '4035', '4040', '4041', '4048', '4049', '4050', '4052', '4053', '4057', '4078', '4086']",phs000209,pht003091,phv00176013,True,False,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",,\phs000209\pht003091\phv00176013\e15dyc\,pht003091.v3,\phs000209\pht003091\phv00176013\e15dyc\,phv00176013,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,ec6d11782fa710d1d7d6523d6752eb88fdedd734e0e9426c01a27f17c672d66c,categorical,phv00176013.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176013\e15dyc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00174590.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174590,[],phs000209,pht003086,phv00174590,False,True,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",1566.0,\phs000209\pht003086\phv00174590\e15dyc\,pht003086.v3,\phs000209\pht003086\phv00174590\e15dyc\,phv00174590,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,2116.0,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,19944c8c97055e6a453b1b337bccfec9639ac16e7b32fa3b7670854d4a266e7b,continuous,phv00174590.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174590\e15dyc\,1566.0,2116.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00176013.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176013,"['2909', '2950', '2952', '2957', '2970', '2972', '2973', '2996', '3000', '3011', '3019', '3025', '3031', '3037', '3038', '3041', '3042', '3044', '3053', '3057', '3058', '3059', '3060', '3066', '3067', '3068', '3070', '3071', '3072', '3074', '3075', '3077', '3079', '3080', '3081', '3083', '3086', '3091', '3093', '3094', '3096', '3100', '3101', '3102', '3104', '3105', '3107', '3108', '3109', '3112', '3115', '3118', '3119', '3121', '3122', '3123', '3127', '3128', '3129', '3131', '3135', '3136', '3137', '3138', '3139', '3140', '3141', '3142', '3143', '3144', '3145', '3147', '3148', '3149', '3151', '3152', '3153', '3156', '3157', '3158', '3161', '3162', '3164', '3165', '3166', '3167', '3169', '3170', '3171', '3172', '3174', '3175', '3176', '3177', '3178', '3179', '3180', '3181', '3182', '3183', '3184', '3185', '3186', '3187', '3188', '3189', '3190', '3191', '3192', '3193', '3194', '3195', '3196', '3197', '3198', '3199', '3200', '3204', '3205', '3206', '3207', '3208', '3209', '3210', '3212', '3213', '3214', '3215', '3217', '3218', '3219', '3220', '3221', '3222', '3223', '3224', '3225', '3226', '3227', '3228', '3229', '3230', '3231', '3232', '3234', '3235', '3236', '3237', '3238', '3239', '3241', '3242', '3243', '3244', '3245', '3246', '3247', '3248', '3249', '3250', '3251', '3252', '3253', '3254', '3255', '3256', '3257', '3258', '3259', '3260', '3261', '3262', '3263', '3264', '3265', '3266', '3267', '3268', '3269', '3270', '3271', '3272', '3273', '3274', '3275', '3276', '3277', '3278', '3280', '3281', '3282', '3283', '3284', '3285', '3286', '3287', '3288', '3289', '3290', '3291', '3292', '3293', '3294', '3295', '3296', '3297', '3298', '3299', '3300', '3301', '3302', '3303', '3304', '3305', '3306', '3307', '3308', '3309', '3310', '3311', '3312', '3313', '3314', '3315', '3316', '3317', '3318', '3319', '3320', '3321', '3322', '3323', '3324', '3325', '3326', '3327', '3328', '3329', '3330', '3331', '3332', '3333', '3334', '3335', '3336', '3337', '3338', '3339', '3340', '3341', '3342', '3343', '3344', '3345', '3346', '3347', '3348', '3349', '3350', '3351', '3352', '3353', '3354', '3355', '3356', '3357', '3358', '3359', '3360', '3361', '3362', '3363', '3364', '3365', '3366', '3367', '3368', '3369', '3370', '3371', '3372', '3373', '3374', '3375', '3376', '3377', '3378', '3379', '3380', '3381', '3382', '3383', '3384', '3385', '3386', '3387', '3388', '3389', '3390', '3391', '3392', '3393', '3394', '3395', '3396', '3397', '3398', '3399', '3400', '3401', '3402', '3403', '3404', '3405', '3406', '3407', '3408', '3409', '3410', '3411', '3412', '3413', '3414', '3415', '3416', '3417', '3418', '3419', '3420', '3421', '3422', '3423', '3424', '3425', '3426', '3427', '3428', '3429', '3430', '3431', '3432', '3433', '3434', '3435', '3436', '3437', '3438', '3439', '3440', '3441', '3442', '3443', '3444', '3445', '3446', '3447', '3448', '3449', '3450', '3451', '3452', '3453', '3454', '3455', '3456', '3457', '3458', '3459', '3460', '3461', '3462', '3463', '3464', '3465', '3466', '3467', '3468', '3469', '3470', '3471', '3472', '3473', '3474', '3475', '3476', '3477', '3478', '3479', '3480', '3481', '3482', '3483', '3484', '3485', '3486', '3487', '3488', '3489', '3490', '3491', '3492', '3493', '3494', '3495', '3496', '3497', '3498', '3499', '3500', '3501', '3502', '3503', '3504', '3505', '3506', '3507', '3508', '3509', '3510', '3511', '3512', '3513', '3514', '3515', '3516', '3517', '3518', '3519', '3520', '3521', '3522', '3523', '3524', '3525', '3526', '3527', '3528', '3529', '3530', '3531', '3532', '3533', '3534', '3535', '3536', '3537', '3538', '3539', '3540', '3541', '3542', '3543', '3544', '3545', '3546', '3547', '3548', '3549', '3550', '3551', '3552', '3553', '3554', '3555', '3556', '3557', '3558', '3559', '3560', '3561', '3562', '3563', '3564', '3565', '3566', '3567', '3568', '3569', '3570', '3571', '3572', '3573', '3574', '3575', '3576', '3577', '3578', '3579', '3580', '3581', '3582', '3583', '3584', '3585', '3586', '3587', '3588', '3589', '3590', '3591', '3592', '3593', '3594', '3595', '3596', '3597', '3598', '3599', '3600', '3601', '3602', '3603', '3604', '3605', '3606', '3607', '3608', '3609', '3610', '3611', '3612', '3613', '3614', '3615', '3616', '3617', '3618', '3619', '3620', '3621', '3622', '3623', '3625', '3626', '3627', '3628', '3629', '3630', '3631', '3632', '3633', '3634', '3635', '3636', '3637', '3638', '3639', '3640', '3641', '3642', '3643', '3644', '3645', '3646', '3647', '3648', '3649', '3650', '3651', '3652', '3653', '3654', '3656', '3658', '3659', '3660', '3661', '3662', '3663', '3664', '3665', '3667', '3668', '3669', '3670', '3671', '3672', '3673', '3674', '3675', '3676', '3677', '3679', '3680', '3681', '3682', '3683', '3684', '3685', '3686', '3687', '3688', '3690', '3691', '3692', '3694', '3695', '3696', '3697', '3698', '3699', '3700', '3701', '3702', '3703', '3705', '3706', '3707', '3709', '3710', '3711', '3712', '3713', '3714', '3715', '3716', '3717', '3718', '3719', '3720', '3721', '3722', '3723', '3724', '3725', '3726', '3727', '3728', '3729', '3730', '3731', '3732', '3733', '3734', '3736', '3737', '3738', '3740', '3741', '3742', '3743', '3744', '3745', '3746', '3748', '3750', '3751', '3752', '3753', '3754', '3755', '3756', '3757', '3758', '3759', '3760', '3762', '3763', '3764', '3765', '3766', '3767', '3768', '3769', '3770', '3771', '3772', '3773', '3775', '3776', '3777', '3778', '3780', '3781', '3782', '3783', '3784', '3785', '3786', '3787', '3788', '3789', '3790', '3791', '3792', '3793', '3794', '3795', '3798', '3800', '3801', '3802', '3803', '3806', '3807', '3808', '3810', '3811', '3814', '3815', '3816', '3817', '3819', '3821', '3822', '3823', '3825', '3826', '3828', '3832', '3833', '3834', '3835', '3836', '3837', '3839', '3841', '3842', '3843', '3845', '3846', '3847', '3848', '3849', '3850', '3851', '3854', '3855', '3856', '3857', '3858', '3859', '3861', '3862', '3865', '3866', '3867', '3868', '3871', '3874', '3877', '3878', '3880', '3882', '3884', '3885', '3886', '3888', '3889', '3891', '3892', '3893', '3894', '3895', '3896', '3897', '3899', '3903', '3904', '3906', '3907', '3913', '3914', '3915', '3918', '3919', '3920', '3927', '3928', '3929', '3932', '3933', '3934', '3935', '3938', '3939', '3940', '3941', '3946', '3948', '3951', '3952', '3953', '3954', '3955', '3962', '3964', '3965', '3966', '3967', '3968', '3969', '3976', '3977', '3980', '3981', '3983', '3985', '3987', '3990', '3992', '3993', '3994', '3996', '3997', '3998', '3999', '4003', '4006', '4011', '4017', '4022', '4023', '4025', '4029', '4035', '4040', '4041', '4048', '4049', '4050', '4052', '4053', '4057', '4078', '4086']",phs000209,pht003091,phv00176013,True,False,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",,\phs000209\pht003091\phv00176013\e15dyc\,pht003091.v3,\phs000209\pht003091\phv00176013\e15dyc\,phv00176013,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,ec6d11782fa710d1d7d6523d6752eb88fdedd734e0e9426c01a27f17c672d66c,categorical,phv00176013.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176013\e15dyc\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00174590.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174590,[],phs000209,pht003086,phv00174590,False,True,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",1566.0,\phs000209\pht003086\phv00174590\e15dyc\,pht003086.v3,\phs000209\pht003086\phv00174590\e15dyc\,phv00174590,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,2116.0,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,19944c8c97055e6a453b1b337bccfec9639ac16e7b32fa3b7670854d4a266e7b,continuous,phv00174590.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174590\e15dyc\,1566.0,2116.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00174590.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174590,[],phs000209,pht003086,phv00174590,False,True,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",1566.0,\phs000209\pht003086\phv00174590\e15dyc\,pht003086.v3,\phs000209\pht003086\phv00174590\e15dyc\,phv00174590,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,2116.0,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,19944c8c97055e6a453b1b337bccfec9639ac16e7b32fa3b7670854d4a266e7b,continuous,phv00174590.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174590\e15dyc\,1566.0,2116.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesae5_drepos_20220820.e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",-,mesae5_drepos_20220820,e15dyc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13.p3,phv00176013.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176013,"['2909', '2950', '2952', '2957', '2970', '2972', '2973', '2996', '3000', '3011', '3019', '3025', '3031', '3037', '3038', '3041', '3042', '3044', '3053', '3057', '3058', '3059', '3060', '3066', '3067', '3068', '3070', '3071', '3072', '3074', '3075', '3077', '3079', '3080', '3081', '3083', '3086', '3091', '3093', '3094', '3096', '3100', '3101', '3102', '3104', '3105', '3107', '3108', '3109', '3112', '3115', '3118', '3119', '3121', '3122', '3123', '3127', '3128', '3129', '3131', '3135', '3136', '3137', '3138', '3139', '3140', '3141', '3142', '3143', '3144', '3145', '3147', '3148', '3149', '3151', '3152', '3153', '3156', '3157', '3158', '3161', '3162', '3164', '3165', '3166', '3167', '3169', '3170', '3171', '3172', '3174', '3175', '3176', '3177', '3178', '3179', '3180', '3181', '3182', '3183', '3184', '3185', '3186', '3187', '3188', '3189', '3190', '3191', '3192', '3193', '3194', '3195', '3196', '3197', '3198', '3199', '3200', '3204', '3205', '3206', '3207', '3208', '3209', '3210', '3212', '3213', '3214', '3215', '3217', '3218', '3219', '3220', '3221', '3222', '3223', '3224', '3225', '3226', '3227', '3228', '3229', '3230', '3231', '3232', '3234', '3235', '3236', '3237', '3238', '3239', '3241', '3242', '3243', '3244', '3245', '3246', '3247', '3248', '3249', '3250', '3251', '3252', '3253', '3254', '3255', '3256', '3257', '3258', '3259', '3260', '3261', '3262', '3263', '3264', '3265', '3266', '3267', '3268', '3269', '3270', '3271', '3272', '3273', '3274', '3275', '3276', '3277', '3278', '3280', '3281', '3282', '3283', '3284', '3285', '3286', '3287', '3288', '3289', '3290', '3291', '3292', '3293', '3294', '3295', '3296', '3297', '3298', '3299', '3300', '3301', '3302', '3303', '3304', '3305', '3306', '3307', '3308', '3309', '3310', '3311', '3312', '3313', '3314', '3315', '3316', '3317', '3318', '3319', '3320', '3321', '3322', '3323', '3324', '3325', '3326', '3327', '3328', '3329', '3330', '3331', '3332', '3333', '3334', '3335', '3336', '3337', '3338', '3339', '3340', '3341', '3342', '3343', '3344', '3345', '3346', '3347', '3348', '3349', '3350', '3351', '3352', '3353', '3354', '3355', '3356', '3357', '3358', '3359', '3360', '3361', '3362', '3363', '3364', '3365', '3366', '3367', '3368', '3369', '3370', '3371', '3372', '3373', '3374', '3375', '3376', '3377', '3378', '3379', '3380', '3381', '3382', '3383', '3384', '3385', '3386', '3387', '3388', '3389', '3390', '3391', '3392', '3393', '3394', '3395', '3396', '3397', '3398', '3399', '3400', '3401', '3402', '3403', '3404', '3405', '3406', '3407', '3408', '3409', '3410', '3411', '3412', '3413', '3414', '3415', '3416', '3417', '3418', '3419', '3420', '3421', '3422', '3423', '3424', '3425', '3426', '3427', '3428', '3429', '3430', '3431', '3432', '3433', '3434', '3435', '3436', '3437', '3438', '3439', '3440', '3441', '3442', '3443', '3444', '3445', '3446', '3447', '3448', '3449', '3450', '3451', '3452', '3453', '3454', '3455', '3456', '3457', '3458', '3459', '3460', '3461', '3462', '3463', '3464', '3465', '3466', '3467', '3468', '3469', '3470', '3471', '3472', '3473', '3474', '3475', '3476', '3477', '3478', '3479', '3480', '3481', '3482', '3483', '3484', '3485', '3486', '3487', '3488', '3489', '3490', '3491', '3492', '3493', '3494', '3495', '3496', '3497', '3498', '3499', '3500', '3501', '3502', '3503', '3504', '3505', '3506', '3507', '3508', '3509', '3510', '3511', '3512', '3513', '3514', '3515', '3516', '3517', '3518', '3519', '3520', '3521', '3522', '3523', '3524', '3525', '3526', '3527', '3528', '3529', '3530', '3531', '3532', '3533', '3534', '3535', '3536', '3537', '3538', '3539', '3540', '3541', '3542', '3543', '3544', '3545', '3546', '3547', '3548', '3549', '3550', '3551', '3552', '3553', '3554', '3555', '3556', '3557', '3558', '3559', '3560', '3561', '3562', '3563', '3564', '3565', '3566', '3567', '3568', '3569', '3570', '3571', '3572', '3573', '3574', '3575', '3576', '3577', '3578', '3579', '3580', '3581', '3582', '3583', '3584', '3585', '3586', '3587', '3588', '3589', '3590', '3591', '3592', '3593', '3594', '3595', '3596', '3597', '3598', '3599', '3600', '3601', '3602', '3603', '3604', '3605', '3606', '3607', '3608', '3609', '3610', '3611', '3612', '3613', '3614', '3615', '3616', '3617', '3618', '3619', '3620', '3621', '3622', '3623', '3625', '3626', '3627', '3628', '3629', '3630', '3631', '3632', '3633', '3634', '3635', '3636', '3637', '3638', '3639', '3640', '3641', '3642', '3643', '3644', '3645', '3646', '3647', '3648', '3649', '3650', '3651', '3652', '3653', '3654', '3656', '3658', '3659', '3660', '3661', '3662', '3663', '3664', '3665', '3667', '3668', '3669', '3670', '3671', '3672', '3673', '3674', '3675', '3676', '3677', '3679', '3680', '3681', '3682', '3683', '3684', '3685', '3686', '3687', '3688', '3690', '3691', '3692', '3694', '3695', '3696', '3697', '3698', '3699', '3700', '3701', '3702', '3703', '3705', '3706', '3707', '3709', '3710', '3711', '3712', '3713', '3714', '3715', '3716', '3717', '3718', '3719', '3720', '3721', '3722', '3723', '3724', '3725', '3726', '3727', '3728', '3729', '3730', '3731', '3732', '3733', '3734', '3736', '3737', '3738', '3740', '3741', '3742', '3743', '3744', '3745', '3746', '3748', '3750', '3751', '3752', '3753', '3754', '3755', '3756', '3757', '3758', '3759', '3760', '3762', '3763', '3764', '3765', '3766', '3767', '3768', '3769', '3770', '3771', '3772', '3773', '3775', '3776', '3777', '3778', '3780', '3781', '3782', '3783', '3784', '3785', '3786', '3787', '3788', '3789', '3790', '3791', '3792', '3793', '3794', '3795', '3798', '3800', '3801', '3802', '3803', '3806', '3807', '3808', '3810', '3811', '3814', '3815', '3816', '3817', '3819', '3821', '3822', '3823', '3825', '3826', '3828', '3832', '3833', '3834', '3835', '3836', '3837', '3839', '3841', '3842', '3843', '3845', '3846', '3847', '3848', '3849', '3850', '3851', '3854', '3855', '3856', '3857', '3858', '3859', '3861', '3862', '3865', '3866', '3867', '3868', '3871', '3874', '3877', '3878', '3880', '3882', '3884', '3885', '3886', '3888', '3889', '3891', '3892', '3893', '3894', '3895', '3896', '3897', '3899', '3903', '3904', '3906', '3907', '3913', '3914', '3915', '3918', '3919', '3920', '3927', '3928', '3929', '3932', '3933', '3934', '3935', '3938', '3939', '3940', '3941', '3946', '3948', '3951', '3952', '3953', '3954', '3955', '3962', '3964', '3965', '3966', '3967', '3968', '3969', '3976', '3977', '3980', '3981', '3983', '3985', '3987', '3990', '3992', '3993', '3994', '3996', '3997', '3998', '3999', '4003', '4006', '4011', '4017', '4022', '4023', '4025', '4029', '4035', '4040', '4041', '4048', '4049', '4050', '4052', '4053', '4057', '4078', '4086']",phs000209,pht003091,phv00176013,True,False,False,e15dyc,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",,\phs000209\pht003091\phv00176013\e15dyc\,pht003091.v3,\phs000209\pht003091\phv00176013\e15dyc\,phv00176013,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",{},,,,"TIME BETWEEN FIRST AND FIFTH VISITS, IN DAYS",phs000209.v13,ec6d11782fa710d1d7d6523d6752eb88fdedd734e0e9426c01a27f17c672d66c,categorical,phv00176013.v1,phs000209,False,e15dyc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176013\e15dyc\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,MESA,mesae5_drepos_20220820.ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,2.184054283,mesae5_drepos_20220820,ecglvh5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13.p3,phv00175124.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175124,"['NO', 'YES']",phs000209,pht003086,phv00175124,True,False,False,ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,,\phs000209\pht003086\phv00175124\ecglvh5c\,pht003086.v3,\phs000209\pht003086\phv00175124\ecglvh5c\,phv00175124,,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,{},,,,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13,265d27abbca78e042e7df2ade59effcc4a89bbe2a45f783a17547edd893b92f8,categorical,phv00175124.v1,phs000209,False,ecglvh5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175124\ecglvh5c\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,MESA,mesae5_drepos_20220820.ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,2.184054283,mesae5_drepos_20220820,ecglvh5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13.p3,phv00176547.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176547,"['NO', 'YES']",phs000209,pht003091,phv00176547,True,False,False,ecglvh5c,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,,\phs000209\pht003091\phv00176547\ecglvh5c\,pht003091.v3,\phs000209\pht003091\phv00176547\ecglvh5c\,phv00176547,,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,{},,,,ECG LEFT VENTRICULAR HYPERTROPHY BY NOVACODE,phs000209.v13,9d90428731efb30976d17bb3091826af04d629b24f1c7637859bfa56774e4b9a,categorical,phv00176547.v1,phs000209,False,ecglvh5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176547\ecglvh5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.fibr5c,FIBRATES,0.169635284,mesae5_drepos_20220820,fibr5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr5c,FIBRATES,phs000209.v13.p3,phv00176783.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176783,"['NO', 'YES']",phs000209,pht003091,phv00176783,True,False,False,fibr5c,FIBRATES,,\phs000209\pht003091\phv00176783\fibr5c\,pht003091.v3,\phs000209\pht003091\phv00176783\fibr5c\,phv00176783,,FIBRATES,{},,,,FIBRATES,phs000209.v13,7def5702c51a98502844db3d09fc7ee14340116f42807a734fbf09334f108d20,categorical,phv00176783.v1,phs000209,False,fibr5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176783\fibr5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.fibr5c,FIBRATES,0.169635284,mesae5_drepos_20220820,fibr5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,fibr5c,FIBRATES,phs000209.v13.p3,phv00175360.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175360,"['NO', 'YES']",phs000209,pht003086,phv00175360,True,False,False,fibr5c,FIBRATES,,\phs000209\pht003086\phv00175360\fibr5c\,pht003086.v3,\phs000209\pht003086\phv00175360\fibr5c\,phv00175360,,FIBRATES,{},,,,FIBRATES,phs000209.v13,5c90e404a8c86ebc9d5af1c50e59026b7cd12080f8631683dd2d9e065fe310b7,categorical,phv00175360.v1,phs000209,False,fibr5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175360\fibr5c\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae5_drepos_20220820.glucose5,FASTING GLUCOSE (mg/dl),2.735368957,mesae5_drepos_20220820,glucose5,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucose5,FASTING GLUCOSE (mg/dl),phs000209.v13.p3,phv00176663.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176663,"['100', '101', '102', '103', '104', '105', '106', '107', '108', '109', '110', '111', '112', '113', '114', '115', '116', '117', '118', '119', '120', '121', '122', '123', '124', '125', '126', '127', '128', '129', '130', '131', '132', '133', '134', '135', '136', '137', '138', '139', '140', '141', '142', '143', '144', '145', '146', '147', '148', '149', '150', '151', '152', '153', '154', '155', '156', '157', '158', '159', '160', '161', '162', '163', '164', '165', '166', '167', '168', '169', '170', '171', '172', '173', '174', '175', '176', '177', '178', '179', '181', '182', '183', '184', '185', '186', '188', '190', '191', '193', '195', '197', '200', '201', '202', '203', '204', '205', '206', '207', '209', '210', '212', '213', '214', '215', '216', '220', '221', '223', '230', '231', '233', '235', '242', '245', '249', '257', '260', '262', '263', '264', '266', '269', '270', '271', '275', '276', '281', '284', '285', '288', '290', '291', '296', '302', '307', '308', '311', '314', '319', '323', '328', '335', '338', '343', '351', '357', '359', '38', '387', '40', '401', '41', '44', '448', '58', '59', '60', '63', '64', '65', '66', '67', '68', '69', '71', '72', '73', '74', '75', '76', '77', '78', '79', '80', '81', '82', '83', '84', '85', '86', '87', '88', '89', '90', '91', '92', '93', '94', '95', '96', '97', '98', '99']",phs000209,pht003091,phv00176663,True,False,False,glucose5,FASTING GLUCOSE (mg/dl),,\phs000209\pht003091\phv00176663\glucose5\,pht003091.v3,\phs000209\pht003091\phv00176663\glucose5\,phv00176663,,FASTING GLUCOSE (mg/dl),{},,,,FASTING GLUCOSE (mg/dl),phs000209.v13,366b450438c0d5d23b3c3a53fb5e50a41fc9730349793923d504d7415d3364ad,categorical,phv00176663.v1,phs000209,False,glucose5,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176663\glucose5\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,MESA,mesae5_drepos_20220820.glucose5,FASTING GLUCOSE (mg/dl),2.735368957,mesae5_drepos_20220820,glucose5,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,glucose5,FASTING GLUCOSE (mg/dl),phs000209.v13.p3,phv00175240.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175240,[],phs000209,pht003086,phv00175240,False,True,False,glucose5,FASTING GLUCOSE (mg/dl),73.0,\phs000209\pht003086\phv00175240\glucose5\,pht003086.v3,\phs000209\pht003086\phv00175240\glucose5\,phv00175240,,FASTING GLUCOSE (mg/dl),{},,,237.0,FASTING GLUCOSE (mg/dl),phs000209.v13,58a88bc0a262885fdfe167dacfcb26f08d6f356037abc00599065d336735946e,continuous,phv00175240.v1,phs000209,False,glucose5,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175240\glucose5\,73.0,237.0
HYPT,-,-,-,MESA,1.25,MESA,mesae5_drepos_20220820.htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",1.335877863,mesae5_drepos_20220820,htn5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",phs000209.v13.p3,phv00174605.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174605,"['NO', 'YES']",phs000209,pht003086,phv00174605,True,False,False,htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",,\phs000209\pht003086\phv00174605\htn5c\,pht003086.v3,\phs000209\pht003086\phv00174605\htn5c\,phv00174605,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",{},,,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",phs000209.v13,fe92faf092f278564cb1ae3ca04577b40bb271f54ceb837426102fd91e4d9ac3,categorical,phv00174605.v1,phs000209,False,htn5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174605\htn5c\,,
HYPT,-,-,-,MESA,1.25,MESA,mesae5_drepos_20220820.htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",1.335877863,mesae5_drepos_20220820,htn5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",phs000209.v13.p3,phv00176028.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176028,"['NO', 'YES']",phs000209,pht003091,phv00176028,True,False,False,htn5c,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",,\phs000209\pht003091\phv00176028\htn5c\,pht003091.v3,\phs000209\pht003091\phv00176028\htn5c\,phv00176028,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",{},,,,"HYPERTENSION BY JNC VI (1997) CRITERIA, EXAM 5",phs000209.v13,a1e5f440919c30f722ab093604e91643dbecf3a52bd201deb296e93e391028d5,categorical,phv00176028.v1,phs000209,False,htn5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176028\htn5c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae5_drepos_20220820.insln5c,INSULINS,0.169635284,mesae5_drepos_20220820,insln5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln5c,INSULINS,phs000209.v13.p3,phv00176789.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176789,"['NO', 'YES']",phs000209,pht003091,phv00176789,True,False,False,insln5c,INSULINS,,\phs000209\pht003091\phv00176789\insln5c\,pht003091.v3,\phs000209\pht003091\phv00176789\insln5c\,phv00176789,,INSULINS,{},,,,INSULINS,phs000209.v13,ead95397f8a14804eacc0d46d32fb676750f381adf74118c8041a02918a5a1d1,categorical,phv00176789.v1,phs000209,False,insln5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176789\insln5c\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,MESA,mesae5_drepos_20220820.insln5c,INSULINS,0.169635284,mesae5_drepos_20220820,insln5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,insln5c,INSULINS,phs000209.v13.p3,phv00175366.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175366,"['NO', 'YES']",phs000209,pht003086,phv00175366,True,False,False,insln5c,INSULINS,,\phs000209\pht003086\phv00175366\insln5c\,pht003086.v3,\phs000209\pht003086\phv00175366\insln5c\,phv00175366,,INSULINS,{},,,,INSULINS,phs000209.v13,464bfd30ab69d1c1f9c86bd0122b88ffe93a390e306c4fedc956f182db356593,categorical,phv00175366.v1,phs000209,False,insln5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175366\insln5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,0.169635284,mesae5_drepos_20220820,mlpd5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00175374.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175374,"['NO', 'YES']",phs000209,pht003086,phv00175374,True,False,False,mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht003086\phv00175374\mlpd5c\,pht003086.v3,\phs000209\pht003086\phv00175374\mlpd5c\,phv00175374,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,cdcc47b255c00f90f7942c3d3373cc57ff6bec2bb94a390115d688560b4f9cee,categorical,phv00175374.v1,phs000209,False,mlpd5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175374\mlpd5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,0.169635284,mesae5_drepos_20220820,mlpd5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13.p3,phv00176797.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176797,"['NO', 'YES']",phs000209,pht003091,phv00176797,True,False,False,mlpd5c,MISCELLANEOUS LIPID-LOWERING DRUGS,,\phs000209\pht003091\phv00176797\mlpd5c\,pht003091.v3,\phs000209\pht003091\phv00176797\mlpd5c\,phv00176797,,MISCELLANEOUS LIPID-LOWERING DRUGS,{},,,,MISCELLANEOUS LIPID-LOWERING DRUGS,phs000209.v13,63b0e05d99b9c9a986d4a3dbb055570293763fefb738e11964b8dad337ee33ec,categorical,phv00176797.v1,phs000209,False,mlpd5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176797\mlpd5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.niac5c,NIACIN AND NICTOTINIC ACID,0.169635284,mesae5_drepos_20220820,niac5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac5c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00176798.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176798,"['NO', 'YES']",phs000209,pht003091,phv00176798,True,False,False,niac5c,NIACIN AND NICOTINIC ACID,,\phs000209\pht003091\phv00176798\niac5c\,pht003091.v3,\phs000209\pht003091\phv00176798\niac5c\,phv00176798,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,34783fb99c0c4773c5409d89a251e282f56f9333d89874c959b1c7425d9b7d38,categorical,phv00176798.v1,phs000209,False,niac5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176798\niac5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.niac5c,NIACIN AND NICTOTINIC ACID,0.169635284,mesae5_drepos_20220820,niac5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,niac5c,NIACIN AND NICOTINIC ACID,phs000209.v13.p3,phv00175375.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175375,"['NO', 'YES']",phs000209,pht003086,phv00175375,True,False,False,niac5c,NIACIN AND NICOTINIC ACID,,\phs000209\pht003086\phv00175375\niac5c\,pht003086.v3,\phs000209\pht003086\phv00175375\niac5c\,phv00175375,,NIACIN AND NICOTINIC ACID,{},,,,NIACIN AND NICOTINIC ACID,phs000209.v13,53c1f7fcd1d1ce3cf9680f2f3522fb2bd7595b9ba2c84e49f36bff1276a2e3b6,categorical,phv00175375.v1,phs000209,False,niac5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175375\niac5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.prob5c,PROBUCOL,0.169635284,mesae5_drepos_20220820,prob5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob5c,PROBUCOL,phs000209.v13.p3,phv00176813.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176813,['NO'],phs000209,pht003091,phv00176813,True,False,False,prob5c,PROBUCOL,,\phs000209\pht003091\phv00176813\prob5c\,pht003091.v3,\phs000209\pht003091\phv00176813\prob5c\,phv00176813,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,7bb981fcc2518e6d3f960432844374f66d9eeb0c9a7451cc0d0a88d0b2f96195,categorical,phv00176813.v1,phs000209,False,prob5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176813\prob5c\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,MESA,mesae5_drepos_20220820.prob5c,PROBUCOL,0.169635284,mesae5_drepos_20220820,prob5c,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prob5c,PROBUCOL,phs000209.v13.p3,phv00175390.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00175390,['NO'],phs000209,pht003086,phv00175390,True,False,False,prob5c,PROBUCOL,,\phs000209\pht003086\phv00175390\prob5c\,pht003086.v3,\phs000209\pht003086\phv00175390\prob5c\,phv00175390,,PROBUCOL,{},,,,PROBUCOL,phs000209.v13,d8c28475d7aadc428877a0457588ac24df61f487e65d48180fd6a4de35f7e724,categorical,phv00175390.v1,phs000209,False,prob5c,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00175390\prob5c\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Women's Health Initiative,AFIB,F136 Atrial fibrillation,phs000200.v12.p3,phv00283695.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283695,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283695,True,False,False,AFIB,F136 Atrial fibrillation,,\phs000200\pht006223\phv00283695\AFIB\,pht006223.v2,\phs000200\pht006223\phv00283695\AFIB\,phv00283695,,F136 Atrial fibrillation,{},,,,F136 Atrial fibrillation,phs000200.v12,2814a7cbebd182f97b93902594a6fb05335065ff377d823c92f26a3dd8ba67f7,categorical,phv00283695.v2,phs000200,False,AFIB,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283695\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,afib,A-fib/flutter,phs000287.v7.p1,phv00197387.v1.p1,pht003698.v2.p1,SHHS2_ecg,phv00197387,"['No', 'Yes']",phs000287,pht003698,phv00197387,True,False,False,afib,A-fib/flutter,,\phs000287\pht003698\phv00197387\afib\,pht003698.v2,\phs000287\pht003698\phv00197387\afib\,phv00197387,CARe_CHS_SHHS-2 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-2 (ECG),,A-fib/flutter,phs000287.v7,8cd93fceb542705298b9b25a5d8711ba94f3f73d63837906a74cfb11ceb5f801,categorical,phv00197387.v1,phs000287,False,afib,CHS,Cardiovascular Health Study (CHS) Cohort,pht003698,SHHS2_ecg,\phs000287\pht003698\phv00197387\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13.p3,phv00090303.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090303,"['NO', 'YES']",phs000209,pht001217,phv00090303,True,False,False,afib,ATRIAL FIBRILLATION DIAGNOSIS,,\phs000209\pht001217\phv00090303\afib\,pht001217.v5,\phs000209\pht001217\phv00090303\afib\,phv00090303,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION DIAGNOSIS,{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13,ff9488794481f86dbfaf4705d962089258a457e250cb1de60a891c8adff7e7b0,categorical,phv00090303.v5,phs000209,False,afib,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090303\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13.p3,phv00090303.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090303,"['NO', 'YES']",phs000209,pht001217,phv00090303,True,False,False,afib,ATRIAL FIBRILLATION DIAGNOSIS,,\phs000209\pht001217\phv00090303\afib\,pht001217.v5,\phs000209\pht001217\phv00090303\afib\,phv00090303,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION DIAGNOSIS,{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13,ff9488794481f86dbfaf4705d962089258a457e250cb1de60a891c8adff7e7b0,categorical,phv00090303.v5,phs000209,False,afib,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090303\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Women's Health Initiative,AFIB,F136 Atrial fibrillation,phs000200.v12.p3,phv00283695.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283695,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283695,True,False,False,AFIB,F136 Atrial fibrillation,,\phs000200\pht006223\phv00283695\AFIB\,pht006223.v2,\phs000200\pht006223\phv00283695\AFIB\,phv00283695,,F136 Atrial fibrillation,{},,,,F136 Atrial fibrillation,phs000200.v12,2814a7cbebd182f97b93902594a6fb05335065ff377d823c92f26a3dd8ba67f7,categorical,phv00283695.v2,phs000200,False,AFIB,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283695\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,A-fib/flutter,phs000287.v7.p1,phv00197352.v1.p1,pht003697.v2.p1,SHHS1_ecg,phv00197352,"['No', 'Yes']",phs000287,pht003697,phv00197352,True,False,False,AFIB,A-fib/flutter,,\phs000287\pht003697\phv00197352\AFIB\,pht003697.v2,\phs000287\pht003697\phv00197352\AFIB\,phv00197352,CARe_CHS_SHHS-1 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-1 (ECG),,A-fib/flutter,phs000287.v7,342a3cfb6a1eb1dab60e709fed17f1b2038fa47b3034b695bca106fbaee49ee5,categorical,phv00197352.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht003697,SHHS1_ecg,\phs000287\pht003697\phv00197352\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401458.v1.p2,pht008731.v2.p2,analysis3,phv00401458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401193.v1.p2,pht008729.v2.p2,analysis1,phv00401193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401193.v1.p2,pht008729.v2.p2,analysis1,phv00401193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401458.v1.p2,pht008731.v2.p2,analysis3,phv00401458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Women's Health Initiative,AFIB,F136 Atrial fibrillation,phs000200.v12.p3,phv00283695.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283695,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283695,True,False,False,AFIB,F136 Atrial fibrillation,,\phs000200\pht006223\phv00283695\AFIB\,pht006223.v2,\phs000200\pht006223\phv00283695\AFIB\,phv00283695,,F136 Atrial fibrillation,{},,,,F136 Atrial fibrillation,phs000200.v12,2814a7cbebd182f97b93902594a6fb05335065ff377d823c92f26a3dd8ba67f7,categorical,phv00283695.v2,phs000200,False,AFIB,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283695\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,A-fib/flutter,phs000287.v7.p1,phv00197352.v1.p1,pht003697.v2.p1,SHHS1_ecg,phv00197352,"['No', 'Yes']",phs000287,pht003697,phv00197352,True,False,False,AFIB,A-fib/flutter,,\phs000287\pht003697\phv00197352\AFIB\,pht003697.v2,\phs000287\pht003697\phv00197352\AFIB\,phv00197352,CARe_CHS_SHHS-1 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-1 (ECG),,A-fib/flutter,phs000287.v7,342a3cfb6a1eb1dab60e709fed17f1b2038fa47b3034b695bca106fbaee49ee5,categorical,phv00197352.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht003697,SHHS1_ecg,\phs000287\pht003697\phv00197352\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401193.v1.p2,pht008729.v2.p2,analysis1,phv00401193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,HAD ATRIAL FIBRILLATION,phs000287.v7.p1,phv00100324.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100324,"['No', 'Yes']",phs000287,pht001452,phv00100324,True,False,False,AFIB,HAD ATRIAL FIBRILLATION,,\phs000287\pht001452\phv00100324\AFIB\,pht001452.v1,\phs000287\pht001452\phv00100324\AFIB\,phv00100324,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),HAD ATRIAL FIBRILLATION,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),,HAD ATRIAL FIBRILLATION,phs000287.v7,fc75945f9cf3ce58842ba5bcb3a0f6958c87de6f44c2dbe157e90c6c1642e132,categorical,phv00100324.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100324\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,A-fib/flutter,phs000287.v7.p1,phv00197352.v1.p1,pht003697.v2.p1,SHHS1_ecg,phv00197352,"['No', 'Yes']",phs000287,pht003697,phv00197352,True,False,False,AFIB,A-fib/flutter,,\phs000287\pht003697\phv00197352\AFIB\,pht003697.v2,\phs000287\pht003697\phv00197352\AFIB\,phv00197352,CARe_CHS_SHHS-1 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-1 (ECG),,A-fib/flutter,phs000287.v7,342a3cfb6a1eb1dab60e709fed17f1b2038fa47b3034b695bca106fbaee49ee5,categorical,phv00197352.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht003697,SHHS1_ecg,\phs000287\pht003697\phv00197352\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,afib,A-fib/flutter,phs000287.v7.p1,phv00197387.v1.p1,pht003698.v2.p1,SHHS2_ecg,phv00197387,"['No', 'Yes']",phs000287,pht003698,phv00197387,True,False,False,afib,A-fib/flutter,,\phs000287\pht003698\phv00197387\afib\,pht003698.v2,\phs000287\pht003698\phv00197387\afib\,phv00197387,CARe_CHS_SHHS-2 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-2 (ECG),,A-fib/flutter,phs000287.v7,8cd93fceb542705298b9b25a5d8711ba94f3f73d63837906a74cfb11ceb5f801,categorical,phv00197387.v1,phs000287,False,afib,CHS,Cardiovascular Health Study (CHS) Cohort,pht003698,SHHS2_ecg,\phs000287\pht003698\phv00197387\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401193.v1.p2,pht008729.v2.p2,analysis1,phv00401193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401458.v1.p2,pht008731.v2.p2,analysis3,phv00401458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13.p3,phv00090303.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090303,"['NO', 'YES']",phs000209,pht001217,phv00090303,True,False,False,afib,ATRIAL FIBRILLATION DIAGNOSIS,,\phs000209\pht001217\phv00090303\afib\,pht001217.v5,\phs000209\pht001217\phv00090303\afib\,phv00090303,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION DIAGNOSIS,{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13,ff9488794481f86dbfaf4705d962089258a457e250cb1de60a891c8adff7e7b0,categorical,phv00090303.v5,phs000209,False,afib,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090303\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Women's Health Initiative,AFIB,F136 Atrial fibrillation,phs000200.v12.p3,phv00283695.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283695,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283695,True,False,False,AFIB,F136 Atrial fibrillation,,\phs000200\pht006223\phv00283695\AFIB\,pht006223.v2,\phs000200\pht006223\phv00283695\AFIB\,phv00283695,,F136 Atrial fibrillation,{},,,,F136 Atrial fibrillation,phs000200.v12,2814a7cbebd182f97b93902594a6fb05335065ff377d823c92f26a3dd8ba67f7,categorical,phv00283695.v2,phs000200,False,AFIB,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283695\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401458.v1.p2,pht008731.v2.p2,analysis3,phv00401458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,afib,A-fib/flutter,phs000287.v7.p1,phv00197387.v1.p1,pht003698.v2.p1,SHHS2_ecg,phv00197387,"['No', 'Yes']",phs000287,pht003698,phv00197387,True,False,False,afib,A-fib/flutter,,\phs000287\pht003698\phv00197387\afib\,pht003698.v2,\phs000287\pht003698\phv00197387\afib\,phv00197387,CARe_CHS_SHHS-2 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-2 (ECG),,A-fib/flutter,phs000287.v7,8cd93fceb542705298b9b25a5d8711ba94f3f73d63837906a74cfb11ceb5f801,categorical,phv00197387.v1,phs000287,False,afib,CHS,Cardiovascular Health Study (CHS) Cohort,pht003698,SHHS2_ecg,\phs000287\pht003698\phv00197387\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13.p3,phv00090303.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090303,"['NO', 'YES']",phs000209,pht001217,phv00090303,True,False,False,afib,ATRIAL FIBRILLATION DIAGNOSIS,,\phs000209\pht001217\phv00090303\afib\,pht001217.v5,\phs000209\pht001217\phv00090303\afib\,phv00090303,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION DIAGNOSIS,{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13,ff9488794481f86dbfaf4705d962089258a457e250cb1de60a891c8adff7e7b0,categorical,phv00090303.v5,phs000209,False,afib,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090303\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,HAD ATRIAL FIBRILLATION,phs000287.v7.p1,phv00100324.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100324,"['No', 'Yes']",phs000287,pht001452,phv00100324,True,False,False,AFIB,HAD ATRIAL FIBRILLATION,,\phs000287\pht001452\phv00100324\AFIB\,pht001452.v1,\phs000287\pht001452\phv00100324\AFIB\,phv00100324,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),HAD ATRIAL FIBRILLATION,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),,HAD ATRIAL FIBRILLATION,phs000287.v7,fc75945f9cf3ce58842ba5bcb3a0f6958c87de6f44c2dbe157e90c6c1642e132,categorical,phv00100324.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100324\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,A-fib/flutter,phs000287.v7.p1,phv00197352.v1.p1,pht003697.v2.p1,SHHS1_ecg,phv00197352,"['No', 'Yes']",phs000287,pht003697,phv00197352,True,False,False,AFIB,A-fib/flutter,,\phs000287\pht003697\phv00197352\AFIB\,pht003697.v2,\phs000287\pht003697\phv00197352\AFIB\,phv00197352,CARe_CHS_SHHS-1 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-1 (ECG),,A-fib/flutter,phs000287.v7,342a3cfb6a1eb1dab60e709fed17f1b2038fa47b3034b695bca106fbaee49ee5,categorical,phv00197352.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht003697,SHHS1_ecg,\phs000287\pht003697\phv00197352\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,HAD ATRIAL FIBRILLATION,phs000287.v7.p1,phv00100324.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100324,"['No', 'Yes']",phs000287,pht001452,phv00100324,True,False,False,AFIB,HAD ATRIAL FIBRILLATION,,\phs000287\pht001452\phv00100324\AFIB\,pht001452.v1,\phs000287\pht001452\phv00100324\AFIB\,phv00100324,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),HAD ATRIAL FIBRILLATION,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),,HAD ATRIAL FIBRILLATION,phs000287.v7,fc75945f9cf3ce58842ba5bcb3a0f6958c87de6f44c2dbe157e90c6c1642e132,categorical,phv00100324.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100324\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,A-fib/flutter,phs000287.v7.p1,phv00197352.v1.p1,pht003697.v2.p1,SHHS1_ecg,phv00197352,"['No', 'Yes']",phs000287,pht003697,phv00197352,True,False,False,AFIB,A-fib/flutter,,\phs000287\pht003697\phv00197352\AFIB\,pht003697.v2,\phs000287\pht003697\phv00197352\AFIB\,phv00197352,CARe_CHS_SHHS-1 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-1 (ECG),,A-fib/flutter,phs000287.v7,342a3cfb6a1eb1dab60e709fed17f1b2038fa47b3034b695bca106fbaee49ee5,categorical,phv00197352.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht003697,SHHS1_ecg,\phs000287\pht003697\phv00197352\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,afib,A-fib/flutter,phs000287.v7.p1,phv00197387.v1.p1,pht003698.v2.p1,SHHS2_ecg,phv00197387,"['No', 'Yes']",phs000287,pht003698,phv00197387,True,False,False,afib,A-fib/flutter,,\phs000287\pht003698\phv00197387\afib\,pht003698.v2,\phs000287\pht003698\phv00197387\afib\,phv00197387,CARe_CHS_SHHS-2 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-2 (ECG),,A-fib/flutter,phs000287.v7,8cd93fceb542705298b9b25a5d8711ba94f3f73d63837906a74cfb11ceb5f801,categorical,phv00197387.v1,phs000287,False,afib,CHS,Cardiovascular Health Study (CHS) Cohort,pht003698,SHHS2_ecg,\phs000287\pht003698\phv00197387\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401193.v1.p2,pht008729.v2.p2,analysis1,phv00401193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Jackson Heart Study (JHS) Cohort,Afib,Atrial Fibrillation,phs000286.v7.p2,phv00401458.v1.p2,pht008731.v2.p2,analysis3,phv00401458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afib,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13.p3,phv00090303.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090303,"['NO', 'YES']",phs000209,pht001217,phv00090303,True,False,False,afib,ATRIAL FIBRILLATION DIAGNOSIS,,\phs000209\pht001217\phv00090303\afib\,pht001217.v5,\phs000209\pht001217\phv00090303\afib\,phv00090303,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION DIAGNOSIS,{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,,ATRIAL FIBRILLATION DIAGNOSIS,phs000209.v13,ff9488794481f86dbfaf4705d962089258a457e250cb1de60a891c8adff7e7b0,categorical,phv00090303.v5,phs000209,False,afib,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090303\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,HAD ATRIAL FIBRILLATION,phs000287.v7.p1,phv00100324.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100324,"['No', 'Yes']",phs000287,pht001452,phv00100324,True,False,False,AFIB,HAD ATRIAL FIBRILLATION,,\phs000287\pht001452\phv00100324\AFIB\,pht001452.v1,\phs000287\pht001452\phv00100324\AFIB\,phv00100324,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),HAD ATRIAL FIBRILLATION,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),,HAD ATRIAL FIBRILLATION,phs000287.v7,fc75945f9cf3ce58842ba5bcb3a0f6958c87de6f44c2dbe157e90c6c1642e132,categorical,phv00100324.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100324\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Women's Health Initiative,AFIB,F136 Atrial fibrillation,phs000200.v12.p3,phv00283695.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283695,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283695,True,False,False,AFIB,F136 Atrial fibrillation,,\phs000200\pht006223\phv00283695\AFIB\,pht006223.v2,\phs000200\pht006223\phv00283695\AFIB\,phv00283695,,F136 Atrial fibrillation,{},,,,F136 Atrial fibrillation,phs000200.v12,2814a7cbebd182f97b93902594a6fb05335065ff377d823c92f26a3dd8ba67f7,categorical,phv00283695.v2,phs000200,False,AFIB,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283695\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AFIB,HAD ATRIAL FIBRILLATION,phs000287.v7.p1,phv00100324.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100324,"['No', 'Yes']",phs000287,pht001452,phv00100324,True,False,False,AFIB,HAD ATRIAL FIBRILLATION,,\phs000287\pht001452\phv00100324\AFIB\,pht001452.v1,\phs000287\pht001452\phv00100324\AFIB\,phv00100324,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),HAD ATRIAL FIBRILLATION,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),,HAD ATRIAL FIBRILLATION,phs000287.v7,fc75945f9cf3ce58842ba5bcb3a0f6958c87de6f44c2dbe157e90c6c1642e132,categorical,phv00100324.v1,phs000287,False,AFIB,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100324\AFIB\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afib,Atrial Fibrillation Diagnosis (via ICD10 Code),-,mesaevaffu10_drepos_2015416,afib,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,afib,A-fib/flutter,phs000287.v7.p1,phv00197387.v1.p1,pht003698.v2.p1,SHHS2_ecg,phv00197387,"['No', 'Yes']",phs000287,pht003698,phv00197387,True,False,False,afib,A-fib/flutter,,\phs000287\pht003698\phv00197387\afib\,pht003698.v2,\phs000287\pht003698\phv00197387\afib\,phv00197387,CARe_CHS_SHHS-2 (ECG),A-fib/flutter,{},,CARe_CHS_SHHS-2 (ECG),,A-fib/flutter,phs000287.v7,8cd93fceb542705298b9b25a5d8711ba94f3f73d63837906a74cfb11ceb5f801,categorical,phv00197387.v1,phs000287,False,afib,CHS,Cardiovascular Health Study (CHS) Cohort,pht003698,SHHS2_ecg,\phs000287\pht003698\phv00197387\afib\,,
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afibtt,Atrial Fibrillation (via ICD10 Code): Time from Baseline to Diagnosis (Days),0.058702671,mesaevaffu10_drepos_2015416,afibtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13.p3,phv00090304.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090304,[],phs000209,pht001217,phv00090304,False,True,False,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),0.0,\phs000209\pht001217\phv00090304\afibtt\,pht001217.v5,\phs000209\pht001217\phv00090304\afibtt\,phv00090304,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,3987.0,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13,0d41bf538dbff8e5361c1ba2ae63230166eefbb0fc0d71b216d26f79f0aaab69,continuous,phv00090304.v5,phs000209,False,afibtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090304\afibtt\,0.0,3987.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afibtt,Atrial Fibrillation (via ICD10 Code): Time from Baseline to Diagnosis (Days),0.058702671,mesaevaffu10_drepos_2015416,afibtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13.p3,phv00090304.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090304,[],phs000209,pht001217,phv00090304,False,True,False,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),0.0,\phs000209\pht001217\phv00090304\afibtt\,pht001217.v5,\phs000209\pht001217\phv00090304\afibtt\,phv00090304,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,3987.0,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13,0d41bf538dbff8e5361c1ba2ae63230166eefbb0fc0d71b216d26f79f0aaab69,continuous,phv00090304.v5,phs000209,False,afibtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090304\afibtt\,0.0,3987.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afibtt,Atrial Fibrillation (via ICD10 Code): Time from Baseline to Diagnosis (Days),0.058702671,mesaevaffu10_drepos_2015416,afibtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13.p3,phv00090304.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090304,[],phs000209,pht001217,phv00090304,False,True,False,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),0.0,\phs000209\pht001217\phv00090304\afibtt\,pht001217.v5,\phs000209\pht001217\phv00090304\afibtt\,phv00090304,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,3987.0,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13,0d41bf538dbff8e5361c1ba2ae63230166eefbb0fc0d71b216d26f79f0aaab69,continuous,phv00090304.v5,phs000209,False,afibtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090304\afibtt\,0.0,3987.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afibtt,Atrial Fibrillation (via ICD10 Code): Time from Baseline to Diagnosis (Days),0.058702671,mesaevaffu10_drepos_2015416,afibtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13.p3,phv00090304.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090304,[],phs000209,pht001217,phv00090304,False,True,False,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),0.0,\phs000209\pht001217\phv00090304\afibtt\,pht001217.v5,\phs000209\pht001217\phv00090304\afibtt\,phv00090304,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,3987.0,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13,0d41bf538dbff8e5361c1ba2ae63230166eefbb0fc0d71b216d26f79f0aaab69,continuous,phv00090304.v5,phs000209,False,afibtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090304\afibtt\,0.0,3987.0
AFIB,"Atrial fibrillation (0=No, 1=Yes)",49436004,C17466; C52619,ARICFraminghamMESAREGARDS,1.26,MESA,mesaevaffu10_drepos_2015416.afibtt,Atrial Fibrillation (via ICD10 Code): Time from Baseline to Diagnosis (Days),0.058702671,mesaevaffu10_drepos_2015416,afibtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13.p3,phv00090304.v5.p3,pht001217.v5.p3,MESA_MesaAfibEvents,phv00090304,[],phs000209,pht001217,phv00090304,False,True,False,afibtt,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),0.0,\phs000209\pht001217\phv00090304\afibtt\,pht001217.v5,\phs000209\pht001217\phv00090304\afibtt\,phv00090304,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),{},,MESA Atrial Fibrillation Dataset: This dataset contains phenotype variables for Atrial Fibrillation events from baseline until the participant's Follow-Up Interview.,3987.0,ATRIAL FIBRILLATION: TIME FROM BASELINE TO DIAGNOSIS (DAYS),phs000209.v13,0d41bf538dbff8e5361c1ba2ae63230166eefbb0fc0d71b216d26f79f0aaab69,continuous,phv00090304.v5,phs000209,False,afibtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001217,MESA_MesaAfibEvents,\phs000209\pht001217\phv00090304\afibtt\,0.0,3987.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ang,ANGINA PECTORIS,phs000209.v13.p3,phv00087859.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087859,"['NO', 'YES']",phs000209,pht001123,phv00087859,True,False,False,ang,ANGINA PECTORIS,,\phs000209\pht001123\phv00087859\ang\,pht001123.v7,\phs000209\pht001123\phv00087859\ang\,phv00087859,,ANGINA PECTORIS,{},,,,ANGINA PECTORIS,phs000209.v13,050fe6d74fcd697376bdd8f7cad665f7e83d6560696c7adc5b376f994a7e028f,categorical,phv00087859.v6,phs000209,False,ang,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087859\ang\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ang,Angina Pectoris,0.4549457,mesaevthr2015_drepos_20200330,ang,Framingham Cohort,ANG,ANG - OLINK CARDIOMETABOLIC(V.3602) - P03950 - OID01226 (Sample type: EDTA plasma),phs000007.v33.p14,phv00462297.v2.p14,pht010727.v2.p14,l_prothf_ex07_1_1148s,phv00462297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.angtt,Time to Angina or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,angtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087861.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087861,[],phs000209,pht001123,phv00087861,False,True,False,angtt,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087861\angtt\,pht001123.v7,\phs000209\pht001123\phv00087861\angtt\,phv00087861,,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO ANGINA OR LAST FOLLOW-UP (DAYS),phs000209.v13,0b886c7d8907c99815f319280e8b5a679e379c51f4dd8b535545fbd8b188e8cf,continuous,phv00087861.v6,phs000209,False,angtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087861\angtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbg,Coronary Bypass Graft (CBG),0.4549457,mesaevthr2015_drepos_20200330,cbg,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbg,CORONARY BYPASS GRAFT (CBG),phs000209.v13.p3,phv00087865.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087865,"['NO', 'YES']",phs000209,pht001123,phv00087865,True,False,False,cbg,CORONARY BYPASS GRAFT (CBG),,\phs000209\pht001123\phv00087865\cbg\,pht001123.v7,\phs000209\pht001123\phv00087865\cbg\,phv00087865,,CORONARY BYPASS GRAFT (CBG),{},,,,CORONARY BYPASS GRAFT (CBG),phs000209.v13,e671e4be2d996c6f1029548878272b2b7b540cc59a13119b0fbc67ee934729aa,categorical,phv00087865.v6,phs000209,False,cbg,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087865\cbg\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbg,Coronary Bypass Graft (CBG),0.4549457,mesaevthr2015_drepos_20200330,cbg,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbg,CORONARY BYPASS GRAFT (CBG),phs000209.v13.p3,phv00087865.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087865,"['NO', 'YES']",phs000209,pht001123,phv00087865,True,False,False,cbg,CORONARY BYPASS GRAFT (CBG),,\phs000209\pht001123\phv00087865\cbg\,pht001123.v7,\phs000209\pht001123\phv00087865\cbg\,phv00087865,,CORONARY BYPASS GRAFT (CBG),{},,,,CORONARY BYPASS GRAFT (CBG),phs000209.v13,e671e4be2d996c6f1029548878272b2b7b540cc59a13119b0fbc67ee934729aa,categorical,phv00087865.v6,phs000209,False,cbg,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087865\cbg\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbg,Coronary Bypass Graft (CBG),0.4549457,mesaevthr2015_drepos_20200330,cbg,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbg,CORONARY BYPASS GRAFT (CBG),phs000209.v13.p3,phv00087865.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087865,"['NO', 'YES']",phs000209,pht001123,phv00087865,True,False,False,cbg,CORONARY BYPASS GRAFT (CBG),,\phs000209\pht001123\phv00087865\cbg\,pht001123.v7,\phs000209\pht001123\phv00087865\cbg\,phv00087865,,CORONARY BYPASS GRAFT (CBG),{},,,,CORONARY BYPASS GRAFT (CBG),phs000209.v13,e671e4be2d996c6f1029548878272b2b7b540cc59a13119b0fbc67ee934729aa,categorical,phv00087865.v6,phs000209,False,cbg,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087865\cbg\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbg,Coronary Bypass Graft (CBG),0.4549457,mesaevthr2015_drepos_20200330,cbg,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbg,CORONARY BYPASS GRAFT (CBG),phs000209.v13.p3,phv00087865.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087865,"['NO', 'YES']",phs000209,pht001123,phv00087865,True,False,False,cbg,CORONARY BYPASS GRAFT (CBG),,\phs000209\pht001123\phv00087865\cbg\,pht001123.v7,\phs000209\pht001123\phv00087865\cbg\,phv00087865,,CORONARY BYPASS GRAFT (CBG),{},,,,CORONARY BYPASS GRAFT (CBG),phs000209.v13,e671e4be2d996c6f1029548878272b2b7b540cc59a13119b0fbc67ee934729aa,categorical,phv00087865.v6,phs000209,False,cbg,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087865\cbg\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbg,Coronary Bypass Graft (CBG),0.4549457,mesaevthr2015_drepos_20200330,cbg,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbg,CORONARY BYPASS GRAFT (CBG),phs000209.v13.p3,phv00087865.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087865,"['NO', 'YES']",phs000209,pht001123,phv00087865,True,False,False,cbg,CORONARY BYPASS GRAFT (CBG),,\phs000209\pht001123\phv00087865\cbg\,pht001123.v7,\phs000209\pht001123\phv00087865\cbg\,phv00087865,,CORONARY BYPASS GRAFT (CBG),{},,,,CORONARY BYPASS GRAFT (CBG),phs000209.v13,e671e4be2d996c6f1029548878272b2b7b540cc59a13119b0fbc67ee934729aa,categorical,phv00087865.v6,phs000209,False,cbg,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087865\cbg\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbgtt,Time to CBG or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,cbgtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087867.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087867,[],phs000209,pht001123,phv00087867,False,True,False,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087867\cbgtt\,pht001123.v7,\phs000209\pht001123\phv00087867\cbgtt\,phv00087867,,TIME TO CBG OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13,d5eeac89947650a858b266301746b11927fcfd51e21a8de36cb5c8510430a712,continuous,phv00087867.v6,phs000209,False,cbgtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087867\cbgtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbgtt,Time to CBG or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,cbgtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087867.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087867,[],phs000209,pht001123,phv00087867,False,True,False,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087867\cbgtt\,pht001123.v7,\phs000209\pht001123\phv00087867\cbgtt\,phv00087867,,TIME TO CBG OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13,d5eeac89947650a858b266301746b11927fcfd51e21a8de36cb5c8510430a712,continuous,phv00087867.v6,phs000209,False,cbgtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087867\cbgtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbgtt,Time to CBG or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,cbgtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087867.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087867,[],phs000209,pht001123,phv00087867,False,True,False,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087867\cbgtt\,pht001123.v7,\phs000209\pht001123\phv00087867\cbgtt\,phv00087867,,TIME TO CBG OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13,d5eeac89947650a858b266301746b11927fcfd51e21a8de36cb5c8510430a712,continuous,phv00087867.v6,phs000209,False,cbgtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087867\cbgtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbgtt,Time to CBG or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,cbgtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087867.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087867,[],phs000209,pht001123,phv00087867,False,True,False,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087867\cbgtt\,pht001123.v7,\phs000209\pht001123\phv00087867\cbgtt\,phv00087867,,TIME TO CBG OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13,d5eeac89947650a858b266301746b11927fcfd51e21a8de36cb5c8510430a712,continuous,phv00087867.v6,phs000209,False,cbgtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087867\cbgtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.cbgtt,Time to CBG or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,cbgtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087867.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087867,[],phs000209,pht001123,phv00087867,False,True,False,cbgtt,TIME TO CBG OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087867\cbgtt\,pht001123.v7,\phs000209\pht001123\phv00087867\cbgtt\,phv00087867,,TIME TO CBG OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CBG OR LAST FOLLOW-UP (DAYS),phs000209.v13,d5eeac89947650a858b266301746b11927fcfd51e21a8de36cb5c8510430a712,continuous,phv00087867.v6,phs000209,False,cbgtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087867\cbgtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,chf,Congestive Heart Failure (CHF) status,phs000007.v33.p14,phv00190816.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190816,"['No', 'Yes']",phs000007,pht003316,phv00190816,True,False,False,chf,Congestive Heart Failure (CHF) status,,\phs000007\pht003316\phv00190816\chf\,pht003316.v8,\phs000007\pht003316\phv00190816\chf\,phv00190816,,Congestive Heart Failure (CHF) status,{},,,,Congestive Heart Failure (CHF) status,phs000007.v31,7f60cac39040c99e10ae562b68b3e112c4b925e5405f5d8d125fcc4f6573c15f,categorical,phv00190816.v8,phs000007,False,chf,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190816\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chf,CONGESTIVE HEART FAILURE (CHF),phs000209.v13.p3,phv00087870.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087870,"['NO', 'YES']",phs000209,pht001123,phv00087870,True,False,False,chf,CONGESTIVE HEART FAILURE (CHF),,\phs000209\pht001123\phv00087870\chf\,pht001123.v7,\phs000209\pht001123\phv00087870\chf\,phv00087870,,CONGESTIVE HEART FAILURE (CHF),{},,,,CONGESTIVE HEART FAILURE (CHF),phs000209.v13,50fef1cfc20869a2debcaea9ae81e7317991b4ceb04669387976273ae0558252,categorical,phv00087870.v6,phs000209,False,chf,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087870\chf\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Framingham Cohort,CHF,CHF during interval since the prior parent exam,phs000007.v33.p14,phv00520263.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520263,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192996.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192996,['Yes'],phs000200,pht003405,phv00192996,True,False,False,CHF,CHF,,\phs000200\pht003405\phv00192996\CHF\,pht003405.v4,\phs000200\pht003405\phv00192996\CHF\,phv00192996,,CHF,{},,,,CHF,phs000200.v12,30a5a08d7942da1cf8c63e0a7097255b6378298b46537a4132443a03ae980a26,categorical,phv00192996.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192996\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00192489.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192489,"['No', 'Yes']",phs000200,pht003402,phv00192489,True,False,False,CHF,CHF,,\phs000200\pht003402\phv00192489\CHF\,pht003402.v4,\phs000200\pht003402\phv00192489\CHF\,phv00192489,,CHF,{},,,,CHF,phs000200.v12,1f2589ea264e32b4b0eb76bc700d47b8497217a62823e73c016a439a945b076d,categorical,phv00192489.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192489\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193166.v3.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193166,"['No', 'Yes']",phs000200,pht003407,phv00193166,True,False,False,CHF,CHF,,\phs000200\pht003407\phv00193166\CHF\,pht003407.v4,\phs000200\pht003407\phv00193166\CHF\,phv00193166,,CHF,{},,,,CHF,phs000200.v12,705f0addd0671232292a77b36eb8bec345ec3506d3b608f1e4ef2c357a4cf89d,categorical,phv00193166.v3,phs000200,False,CHF,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193166\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chf,Congestive Heart Failure (CHF),0.425594365,mesaevthr2015_drepos_20200330,chf,Women's Health Initiative,CHF,CHF,phs000200.v12.p3,phv00193053.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193053,['Yes'],phs000200,pht003406,phv00193053,True,False,False,CHF,CHF,,\phs000200\pht003406\phv00193053\CHF\,pht003406.v4,\phs000200\pht003406\phv00193053\CHF\,phv00193053,,CHF,{},,,,CHF,phs000200.v12,3eda27630db819bcc9c65063a78bb60174c36f308a89b3d11e2721f718b8f021,categorical,phv00193053.v4,phs000200,False,CHF,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193053\CHF\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.chftt,Time to CHF or End of Year 2015 (days),0.425594365,mesaevthr2015_drepos_20200330,chftt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087872.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087872,[],phs000209,pht001123,phv00087872,False,True,False,chftt,TIME TO CHF OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087872\chftt\,pht001123.v7,\phs000209\pht001123\phv00087872\chftt\,phv00087872,,TIME TO CHF OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO CHF OR LAST FOLLOW-UP (DAYS),phs000209.v13,d248b1500ab2e82f94cbbe3ecbca3f23661d8930447bcbfde9cd0516e941e640,continuous,phv00087872.v6,phs000209,False,chftt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087872\chftt\,0.0,4184.0
DEATH_IND,Death indicator,-,-,ARICFraminghamMESA,1.79,MESA,mesaevthr2015_drepos_20200330.dth,Death,0.308189023,mesaevthr2015_drepos_20200330,dth,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dth,DEATH,phs000209.v13.p3,phv00087882.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087882,"['NO', 'YES']",phs000209,pht001123,phv00087882,True,False,False,dth,DEATH,,\phs000209\pht001123\phv00087882\dth\,pht001123.v7,\phs000209\pht001123\phv00087882\dth\,phv00087882,,DEATH,{},,,,DEATH,phs000209.v13,525d14f9c841a5ae49cb720d661a77e845753dad1b2977df7816855d4f7dacf4,categorical,phv00087882.v6,phs000209,False,dth,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087882\dth\,,
DEATH_IND_T2,-,-,-,MESA,1.45,MESA,mesaevthr2015_drepos_20200330.dthtt,Time to All-Cause Death or End of Year 2015 (days),0.308189023,mesaevthr2015_drepos_20200330,dthtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,dthtt,TIME TO ALL-CAUSE DEATH OR LAST FU (DAYS),phs000209.v13.p3,phv00087885.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087885,[],phs000209,pht001123,phv00087885,False,True,False,dthtt,TIME TO ALL-CAUSE DEATH OR LAST FU (DAYS),62.0,\phs000209\pht001123\phv00087885\dthtt\,pht001123.v7,\phs000209\pht001123\phv00087885\dthtt\,phv00087885,,TIME TO ALL-CAUSE DEATH OR LAST FU (DAYS),{},,,4184.0,TIME TO ALL-CAUSE DEATH OR LAST FU (DAYS),phs000209.v13,9259f20b12b9691d566b316a8759fa3b6b43a4fb570444fad7f2017284629b64,continuous,phv00087885.v6,phs000209,False,dthtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087885\dthtt\,62.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,F136 MI,phs000200.v12.p3,phv00283702.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283702,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283702,True,False,False,MI,F136 MI,,\phs000200\pht006223\phv00283702\MI\,pht006223.v2,\phs000200\pht006223\phv00283702\MI\,phv00283702,,F136 MI,{},,,,F136 MI,phs000200.v12,06c25dfa724bf42cf04259492fb2f5b49c50f51f9c3cdf03ca91826117303609,categorical,phv00283702.v2,phs000200,False,MI,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283702\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mi,MYOCARDIAL INFARCTION (MI),phs000209.v13.p3,phv00087853.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087853,"['NO', 'YES']",phs000209,pht001123,phv00087853,True,False,False,mi,MYOCARDIAL INFARCTION (MI),,\phs000209\pht001123\phv00087853\mi\,pht001123.v7,\phs000209\pht001123\phv00087853\mi\,phv00087853,,MYOCARDIAL INFARCTION (MI),{},,,,MYOCARDIAL INFARCTION (MI),phs000209.v13,8ed28600cbd3ec217c530f8070422776f3cec00932a138a607ed6b133c7526a0,categorical,phv00087853.v6,phs000209,False,mi,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087853\mi\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,MI ever,phs000200.v12.p3,phv00078482.v6.p3,pht000998.v6.p3,f2_rel1,phv00078482,"['No', 'Yes']",phs000200,pht000998,phv00078482,True,False,False,MI,MI ever,,\phs000200\pht000998\phv00078482\MI\,pht000998.v6,\phs000200\pht000998\phv00078482\MI\,phv00078482,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",MI ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,MI ever,phs000200.v12,fce058fc3bae3d9cbf79b404c70cbc85c36e91fe29b6ea0cecbbc54678034668,categorical,phv00078482.v6,phs000200,False,MI,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078482\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192492.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192492,"['No', 'Yes']",phs000200,pht003402,phv00192492,True,False,False,MI,Clinical MI,,\phs000200\pht003402\phv00192492\MI\,pht003402.v4,\phs000200\pht003402\phv00192492\MI\,phv00192492,,Clinical MI,{},,,,Clinical MI,phs000200.v12,0420485dec1405b194ced703c83a2ede9cccd38dab02f54f537d4f61037fe8b2,categorical,phv00192492.v3,phs000200,False,MI,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192492\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Framingham Cohort,MI,MI during interval since the prior parent exam,phs000007.v33.p14,phv00520259.v1.p14,pht000396.v5.p14,t_sleephhs_1999_1b_1057s,phv00520259,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193169.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193169,"['No', 'Yes']",phs000200,pht003407,phv00193169,True,False,False,MI,Clinical MI,,\phs000200\pht003407\phv00193169\MI\,pht003407.v4,\phs000200\pht003407\phv00193169\MI\,phv00193169,,Clinical MI,{},,,,Clinical MI,phs000200.v12,a6916eca52b05acfcf93f0c8b785035bc0f44bdd5cb90c390329e393f12cbe9c,categorical,phv00193169.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193169\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Jackson Heart Study (JHS) Cohort,MI,MI Status,phs000286.v7.p2,phv00401061.v2.p2,pht008726.v2.p2,allevtchd,phv00401061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00193054.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193054,['Yes'],phs000200,pht003406,phv00193054,True,False,False,MI,Clinical MI,,\phs000200\pht003406\phv00193054\MI\,pht003406.v4,\phs000200\pht003406\phv00193054\MI\,phv00193054,,Clinical MI,{},,,,Clinical MI,phs000200.v12,5f637c22e4763f69ce6777f757a4a740943a6bcf23a93b1828d9fea204cc07c9,categorical,phv00193054.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193054\MI\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Women's Health Initiative,MI,Clinical MI,phs000200.v12.p3,phv00192997.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00192997,['Yes'],phs000200,pht003405,phv00192997,True,False,False,MI,Clinical MI,,\phs000200\pht003405\phv00192997\MI\,pht003405.v4,\phs000200\pht003405\phv00192997\MI\,phv00192997,,Clinical MI,{},,,,Clinical MI,phs000200.v12,be8168e1f291a4e4f46873333276532f7f06ff2702c0bbb9bdb292cff912ef6b,categorical,phv00192997.v4,phs000200,False,MI,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00192997\MI\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mi,Myocardial Infarction (MI),0.440270032,mesaevthr2015_drepos_20200330,mi,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,mi,Prevalent heart attacks,phs000287.v7.p1,phv00197703.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197703,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.mitt,Time to MI or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,mitt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087855.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087855,[],phs000209,pht001123,phv00087855,False,True,False,mitt,TIME TO MI OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087855\mitt\,pht001123.v7,\phs000209\pht001123\phv00087855\mitt\,phv00087855,,TIME TO MI OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO MI OR LAST FOLLOW-UP (DAYS),phs000209.v13,a44a6614e9e65b86173e98a73458ebab95c83c6acc2a8c541343e8b80228083e,continuous,phv00087855.v6,phs000209,False,mitt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087855\mitt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,MESA,mesaevthr2015_drepos_20200330.prebase,Type of pre-baseline event,-,mesaevthr2015_drepos_20200330,prebase,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,prebase,TYPE OF PRE-BASELINE EVENT,phs000209.v13.p3,phv00087850.v2.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087850,"['ang', 'chf', 'mi', 'pvd']",phs000209,pht001123,phv00087850,True,False,False,prebase,TYPE OF PRE-BASELINE EVENT,,\phs000209\pht001123\phv00087850\prebase\,pht001123.v7,\phs000209\pht001123\phv00087850\prebase\,phv00087850,,TYPE OF PRE-BASELINE EVENT,{},,,,TYPE OF PRE-BASELINE EVENT,phs000209.v13,9c43ecfbc5d389aa81a0c94587bace3a27d1680173399fb9d28e0c3f84a5e565,categorical,phv00087850.v2,phs000209,False,prebase,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087850\prebase\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193199,"['No', 'Yes']",phs000200,pht003407,phv00193199,True,False,False,PTCA,PTCA,,\phs000200\pht003407\phv00193199\PTCA\,pht003407.v4,\phs000200\pht003407\phv00193199\PTCA\,phv00193199,,PTCA,{},,,,PTCA,phs000200.v12,99b1af8df6a5ec2b7251623f616063b91c610ddebf7872c32a41fe137d7c73a0,categorical,phv00193199.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193199\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,F136 PTCA,phs000200.v12.p3,phv00283700.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283700,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283700,True,False,False,PTCA,F136 PTCA,,\phs000200\pht006223\phv00283700\PTCA\,pht006223.v2,\phs000200\pht006223\phv00283700\PTCA\,phv00283700,,F136 PTCA,{},,,,F136 PTCA,phs000200.v12,4f919eba5bc4366209631f24a7a907f138f28efacc813da3c51b62e0745f6e4f,categorical,phv00283700.v2,phs000200,False,PTCA,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283700\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193058.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193058,['Yes'],phs000200,pht003406,phv00193058,True,False,False,PTCA,PTCA,,\phs000200\pht003406\phv00193058\PTCA\,pht003406.v4,\phs000200\pht003406\phv00193058\PTCA\,phv00193058,,PTCA,{},,,,PTCA,phs000200.v12,2224ee54cac0ef632cedc954fc0c8486cbbcec7a3a127426e1a20ba50f284bcd,categorical,phv00193058.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193058\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193000.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00193000,['Yes'],phs000200,pht003405,phv00193000,True,False,False,PTCA,PTCA,,\phs000200\pht003405\phv00193000\PTCA\,pht003405.v4,\phs000200\pht003405\phv00193000\PTCA\,phv00193000,,PTCA,{},,,,PTCA,phs000200.v12,5f2a647ab5b390cd73eef590ff865f5934a00a98bf3e88184c3e851bdf8076fd,categorical,phv00193000.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00193000\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,Angioplasty of coronary arteries ever,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,phv00078536,"['No', 'Yes']",phs000200,pht000999,phv00078536,True,False,False,PTCA,Angioplasty of coronary arteries ever,,\phs000200\pht000999\phv00078536\PTCA\,pht000999.v6,\phs000200\pht000999\phv00078536\PTCA\,phv00078536,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Angioplasty of coronary arteries ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Angioplasty of coronary arteries ever,phs000200.v12,60826d9c286787f921243fb7c5b641740aa0ea7b13f0734a8a0a690076189b27,categorical,phv00078536.v6,phs000200,False,PTCA,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078536\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193199,"['No', 'Yes']",phs000200,pht003407,phv00193199,True,False,False,PTCA,PTCA,,\phs000200\pht003407\phv00193199\PTCA\,pht003407.v4,\phs000200\pht003407\phv00193199\PTCA\,phv00193199,,PTCA,{},,,,PTCA,phs000200.v12,99b1af8df6a5ec2b7251623f616063b91c610ddebf7872c32a41fe137d7c73a0,categorical,phv00193199.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193199\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,F136 PTCA,phs000200.v12.p3,phv00283700.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283700,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283700,True,False,False,PTCA,F136 PTCA,,\phs000200\pht006223\phv00283700\PTCA\,pht006223.v2,\phs000200\pht006223\phv00283700\PTCA\,phv00283700,,F136 PTCA,{},,,,F136 PTCA,phs000200.v12,4f919eba5bc4366209631f24a7a907f138f28efacc813da3c51b62e0745f6e4f,categorical,phv00283700.v2,phs000200,False,PTCA,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283700\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13.p3,phv00087862.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087862,"['NO', 'YES']",phs000209,pht001123,phv00087862,True,False,False,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",,\phs000209\pht001123\phv00087862\ptca\,pht001123.v7,\phs000209\pht001123\phv00087862\ptca\,phv00087862,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",{},,,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13,8db4e37a33c19c3121afd7344ca8fc1dea2b39578347edc4691c0d1e6d7ba8b4,categorical,phv00087862.v6,phs000209,False,ptca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087862\ptca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,F136 PTCA,phs000200.v12.p3,phv00283700.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283700,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283700,True,False,False,PTCA,F136 PTCA,,\phs000200\pht006223\phv00283700\PTCA\,pht006223.v2,\phs000200\pht006223\phv00283700\PTCA\,phv00283700,,F136 PTCA,{},,,,F136 PTCA,phs000200.v12,4f919eba5bc4366209631f24a7a907f138f28efacc813da3c51b62e0745f6e4f,categorical,phv00283700.v2,phs000200,False,PTCA,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283700\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193000.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00193000,['Yes'],phs000200,pht003405,phv00193000,True,False,False,PTCA,PTCA,,\phs000200\pht003405\phv00193000\PTCA\,pht003405.v4,\phs000200\pht003405\phv00193000\PTCA\,phv00193000,,PTCA,{},,,,PTCA,phs000200.v12,5f2a647ab5b390cd73eef590ff865f5934a00a98bf3e88184c3e851bdf8076fd,categorical,phv00193000.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00193000\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,Angioplasty of coronary arteries ever,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,phv00078536,"['No', 'Yes']",phs000200,pht000999,phv00078536,True,False,False,PTCA,Angioplasty of coronary arteries ever,,\phs000200\pht000999\phv00078536\PTCA\,pht000999.v6,\phs000200\pht000999\phv00078536\PTCA\,phv00078536,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Angioplasty of coronary arteries ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Angioplasty of coronary arteries ever,phs000200.v12,60826d9c286787f921243fb7c5b641740aa0ea7b13f0734a8a0a690076189b27,categorical,phv00078536.v6,phs000200,False,PTCA,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078536\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13.p3,phv00087862.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087862,"['NO', 'YES']",phs000209,pht001123,phv00087862,True,False,False,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",,\phs000209\pht001123\phv00087862\ptca\,pht001123.v7,\phs000209\pht001123\phv00087862\ptca\,phv00087862,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",{},,,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13,8db4e37a33c19c3121afd7344ca8fc1dea2b39578347edc4691c0d1e6d7ba8b4,categorical,phv00087862.v6,phs000209,False,ptca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087862\ptca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193058.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193058,['Yes'],phs000200,pht003406,phv00193058,True,False,False,PTCA,PTCA,,\phs000200\pht003406\phv00193058\PTCA\,pht003406.v4,\phs000200\pht003406\phv00193058\PTCA\,phv00193058,,PTCA,{},,,,PTCA,phs000200.v12,2224ee54cac0ef632cedc954fc0c8486cbbcec7a3a127426e1a20ba50f284bcd,categorical,phv00193058.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193058\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193000.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00193000,['Yes'],phs000200,pht003405,phv00193000,True,False,False,PTCA,PTCA,,\phs000200\pht003405\phv00193000\PTCA\,pht003405.v4,\phs000200\pht003405\phv00193000\PTCA\,phv00193000,,PTCA,{},,,,PTCA,phs000200.v12,5f2a647ab5b390cd73eef590ff865f5934a00a98bf3e88184c3e851bdf8076fd,categorical,phv00193000.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00193000\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193199,"['No', 'Yes']",phs000200,pht003407,phv00193199,True,False,False,PTCA,PTCA,,\phs000200\pht003407\phv00193199\PTCA\,pht003407.v4,\phs000200\pht003407\phv00193199\PTCA\,phv00193199,,PTCA,{},,,,PTCA,phs000200.v12,99b1af8df6a5ec2b7251623f616063b91c610ddebf7872c32a41fe137d7c73a0,categorical,phv00193199.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193199\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,F136 PTCA,phs000200.v12.p3,phv00283700.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283700,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283700,True,False,False,PTCA,F136 PTCA,,\phs000200\pht006223\phv00283700\PTCA\,pht006223.v2,\phs000200\pht006223\phv00283700\PTCA\,phv00283700,,F136 PTCA,{},,,,F136 PTCA,phs000200.v12,4f919eba5bc4366209631f24a7a907f138f28efacc813da3c51b62e0745f6e4f,categorical,phv00283700.v2,phs000200,False,PTCA,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283700\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,Angioplasty of coronary arteries ever,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,phv00078536,"['No', 'Yes']",phs000200,pht000999,phv00078536,True,False,False,PTCA,Angioplasty of coronary arteries ever,,\phs000200\pht000999\phv00078536\PTCA\,pht000999.v6,\phs000200\pht000999\phv00078536\PTCA\,phv00078536,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Angioplasty of coronary arteries ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Angioplasty of coronary arteries ever,phs000200.v12,60826d9c286787f921243fb7c5b641740aa0ea7b13f0734a8a0a690076189b27,categorical,phv00078536.v6,phs000200,False,PTCA,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078536\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00192519.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192519,"['No', 'Yes']",phs000200,pht003402,phv00192519,True,False,False,PTCA,PTCA,,\phs000200\pht003402\phv00192519\PTCA\,pht003402.v4,\phs000200\pht003402\phv00192519\PTCA\,phv00192519,,PTCA,{},,,,PTCA,phs000200.v12,0060b675a8cadb1cedbc7f9f3854eefbec1fd1f22346a28d7bc9f357466c7540,categorical,phv00192519.v3,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192519\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00192519.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192519,"['No', 'Yes']",phs000200,pht003402,phv00192519,True,False,False,PTCA,PTCA,,\phs000200\pht003402\phv00192519\PTCA\,pht003402.v4,\phs000200\pht003402\phv00192519\PTCA\,phv00192519,,PTCA,{},,,,PTCA,phs000200.v12,0060b675a8cadb1cedbc7f9f3854eefbec1fd1f22346a28d7bc9f357466c7540,categorical,phv00192519.v3,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192519\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,Angioplasty of coronary arteries ever,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,phv00078536,"['No', 'Yes']",phs000200,pht000999,phv00078536,True,False,False,PTCA,Angioplasty of coronary arteries ever,,\phs000200\pht000999\phv00078536\PTCA\,pht000999.v6,\phs000200\pht000999\phv00078536\PTCA\,phv00078536,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Angioplasty of coronary arteries ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Angioplasty of coronary arteries ever,phs000200.v12,60826d9c286787f921243fb7c5b641740aa0ea7b13f0734a8a0a690076189b27,categorical,phv00078536.v6,phs000200,False,PTCA,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078536\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193058.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193058,['Yes'],phs000200,pht003406,phv00193058,True,False,False,PTCA,PTCA,,\phs000200\pht003406\phv00193058\PTCA\,pht003406.v4,\phs000200\pht003406\phv00193058\PTCA\,phv00193058,,PTCA,{},,,,PTCA,phs000200.v12,2224ee54cac0ef632cedc954fc0c8486cbbcec7a3a127426e1a20ba50f284bcd,categorical,phv00193058.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193058\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13.p3,phv00087862.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087862,"['NO', 'YES']",phs000209,pht001123,phv00087862,True,False,False,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",,\phs000209\pht001123\phv00087862\ptca\,pht001123.v7,\phs000209\pht001123\phv00087862\ptca\,phv00087862,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",{},,,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13,8db4e37a33c19c3121afd7344ca8fc1dea2b39578347edc4691c0d1e6d7ba8b4,categorical,phv00087862.v6,phs000209,False,ptca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087862\ptca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,Angioplasty of coronary arteries ever,phs000200.v12.p3,phv00078536.v6.p3,pht000999.v6.p3,f30_rel2,phv00078536,"['No', 'Yes']",phs000200,pht000999,phv00078536,True,False,False,PTCA,Angioplasty of coronary arteries ever,,\phs000200\pht000999\phv00078536\PTCA\,pht000999.v6,\phs000200\pht000999\phv00078536\PTCA\,phv00078536,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Angioplasty of coronary arteries ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Angioplasty of coronary arteries ever,phs000200.v12,60826d9c286787f921243fb7c5b641740aa0ea7b13f0734a8a0a690076189b27,categorical,phv00078536.v6,phs000200,False,PTCA,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078536\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00192519.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192519,"['No', 'Yes']",phs000200,pht003402,phv00192519,True,False,False,PTCA,PTCA,,\phs000200\pht003402\phv00192519\PTCA\,pht003402.v4,\phs000200\pht003402\phv00192519\PTCA\,phv00192519,,PTCA,{},,,,PTCA,phs000200.v12,0060b675a8cadb1cedbc7f9f3854eefbec1fd1f22346a28d7bc9f357466c7540,categorical,phv00192519.v3,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192519\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193000.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00193000,['Yes'],phs000200,pht003405,phv00193000,True,False,False,PTCA,PTCA,,\phs000200\pht003405\phv00193000\PTCA\,pht003405.v4,\phs000200\pht003405\phv00193000\PTCA\,phv00193000,,PTCA,{},,,,PTCA,phs000200.v12,5f2a647ab5b390cd73eef590ff865f5934a00a98bf3e88184c3e851bdf8076fd,categorical,phv00193000.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00193000\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193058.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193058,['Yes'],phs000200,pht003406,phv00193058,True,False,False,PTCA,PTCA,,\phs000200\pht003406\phv00193058\PTCA\,pht003406.v4,\phs000200\pht003406\phv00193058\PTCA\,phv00193058,,PTCA,{},,,,PTCA,phs000200.v12,2224ee54cac0ef632cedc954fc0c8486cbbcec7a3a127426e1a20ba50f284bcd,categorical,phv00193058.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193058\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193199,"['No', 'Yes']",phs000200,pht003407,phv00193199,True,False,False,PTCA,PTCA,,\phs000200\pht003407\phv00193199\PTCA\,pht003407.v4,\phs000200\pht003407\phv00193199\PTCA\,phv00193199,,PTCA,{},,,,PTCA,phs000200.v12,99b1af8df6a5ec2b7251623f616063b91c610ddebf7872c32a41fe137d7c73a0,categorical,phv00193199.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193199\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,F136 PTCA,phs000200.v12.p3,phv00283700.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283700,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283700,True,False,False,PTCA,F136 PTCA,,\phs000200\pht006223\phv00283700\PTCA\,pht006223.v2,\phs000200\pht006223\phv00283700\PTCA\,phv00283700,,F136 PTCA,{},,,,F136 PTCA,phs000200.v12,4f919eba5bc4366209631f24a7a907f138f28efacc813da3c51b62e0745f6e4f,categorical,phv00283700.v2,phs000200,False,PTCA,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283700\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193000.v4.p3,pht003405.v4.p3,outc_cardio_cad_rel4,phv00193000,['Yes'],phs000200,pht003405,phv00193000,True,False,False,PTCA,PTCA,,\phs000200\pht003405\phv00193000\PTCA\,pht003405.v4,\phs000200\pht003405\phv00193000\PTCA\,phv00193000,,PTCA,{},,,,PTCA,phs000200.v12,5f2a647ab5b390cd73eef590ff865f5934a00a98bf3e88184c3e851bdf8076fd,categorical,phv00193000.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003405,outc_cardio_cad_rel4,\phs000200\pht003405\phv00193000\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193058.v4.p3,pht003406.v4.p3,outc_cardio_rel4,phv00193058,['Yes'],phs000200,pht003406,phv00193058,True,False,False,PTCA,PTCA,,\phs000200\pht003406\phv00193058\PTCA\,pht003406.v4,\phs000200\pht003406\phv00193058\PTCA\,phv00193058,,PTCA,{},,,,PTCA,phs000200.v12,2224ee54cac0ef632cedc954fc0c8486cbbcec7a3a127426e1a20ba50f284bcd,categorical,phv00193058.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003406,outc_cardio_rel4,\phs000200\pht003406\phv00193058\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00193199.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193199,"['No', 'Yes']",phs000200,pht003407,phv00193199,True,False,False,PTCA,PTCA,,\phs000200\pht003407\phv00193199\PTCA\,pht003407.v4,\phs000200\pht003407\phv00193199\PTCA\,phv00193199,,PTCA,{},,,,PTCA,phs000200.v12,99b1af8df6a5ec2b7251623f616063b91c610ddebf7872c32a41fe137d7c73a0,categorical,phv00193199.v4,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193199\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00192519.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192519,"['No', 'Yes']",phs000200,pht003402,phv00192519,True,False,False,PTCA,PTCA,,\phs000200\pht003402\phv00192519\PTCA\,pht003402.v4,\phs000200\pht003402\phv00192519\PTCA\,phv00192519,,PTCA,{},,,,PTCA,phs000200.v12,0060b675a8cadb1cedbc7f9f3854eefbec1fd1f22346a28d7bc9f357466c7540,categorical,phv00192519.v3,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192519\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13.p3,phv00087862.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087862,"['NO', 'YES']",phs000209,pht001123,phv00087862,True,False,False,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",,\phs000209\pht001123\phv00087862\ptca\,pht001123.v7,\phs000209\pht001123\phv00087862\ptca\,phv00087862,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",{},,,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13,8db4e37a33c19c3121afd7344ca8fc1dea2b39578347edc4691c0d1e6d7ba8b4,categorical,phv00087862.v6,phs000209,False,ptca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087862\ptca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13.p3,phv00087862.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087862,"['NO', 'YES']",phs000209,pht001123,phv00087862,True,False,False,ptca,"PTCA, COR. STENT, OR COR. ATHERECTOMY",,\phs000209\pht001123\phv00087862\ptca\,pht001123.v7,\phs000209\pht001123\phv00087862\ptca\,phv00087862,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",{},,,,"PTCA, COR. STENT, OR COR. ATHERECTOMY",phs000209.v13,8db4e37a33c19c3121afd7344ca8fc1dea2b39578347edc4691c0d1e6d7ba8b4,categorical,phv00087862.v6,phs000209,False,ptca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087862\ptca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptca,"PTCA, Cor. Stent, or Cor. Atherectomy",0.440270032,mesaevthr2015_drepos_20200330,ptca,Women's Health Initiative,PTCA,PTCA,phs000200.v12.p3,phv00192519.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192519,"['No', 'Yes']",phs000200,pht003402,phv00192519,True,False,False,PTCA,PTCA,,\phs000200\pht003402\phv00192519\PTCA\,pht003402.v4,\phs000200\pht003402\phv00192519\PTCA\,phv00192519,,PTCA,{},,,,PTCA,phs000200.v12,0060b675a8cadb1cedbc7f9f3854eefbec1fd1f22346a28d7bc9f357466c7540,categorical,phv00192519.v3,phs000200,False,PTCA,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192519\PTCA\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptcatt,Time to PTCA or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,ptcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087864.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087864,[],phs000209,pht001123,phv00087864,False,True,False,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087864\ptcatt\,pht001123.v7,\phs000209\pht001123\phv00087864\ptcatt\,phv00087864,,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,56c7baac4147746840e5d6719cee6eb0093e1c681d30d0010d0320da33e829f1,continuous,phv00087864.v6,phs000209,False,ptcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087864\ptcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptcatt,Time to PTCA or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,ptcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087864.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087864,[],phs000209,pht001123,phv00087864,False,True,False,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087864\ptcatt\,pht001123.v7,\phs000209\pht001123\phv00087864\ptcatt\,phv00087864,,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,56c7baac4147746840e5d6719cee6eb0093e1c681d30d0010d0320da33e829f1,continuous,phv00087864.v6,phs000209,False,ptcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087864\ptcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptcatt,Time to PTCA or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,ptcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087864.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087864,[],phs000209,pht001123,phv00087864,False,True,False,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087864\ptcatt\,pht001123.v7,\phs000209\pht001123\phv00087864\ptcatt\,phv00087864,,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,56c7baac4147746840e5d6719cee6eb0093e1c681d30d0010d0320da33e829f1,continuous,phv00087864.v6,phs000209,False,ptcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087864\ptcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptcatt,Time to PTCA or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,ptcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087864.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087864,[],phs000209,pht001123,phv00087864,False,True,False,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087864\ptcatt\,pht001123.v7,\phs000209\pht001123\phv00087864\ptcatt\,phv00087864,,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,56c7baac4147746840e5d6719cee6eb0093e1c681d30d0010d0320da33e829f1,continuous,phv00087864.v6,phs000209,False,ptcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087864\ptcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.ptcatt,Time to PTCA or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,ptcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087864.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087864,[],phs000209,pht001123,phv00087864,False,True,False,ptcatt,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087864\ptcatt\,pht001123.v7,\phs000209\pht001123\phv00087864\ptcatt\,phv00087864,,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PTCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,56c7baac4147746840e5d6719cee6eb0093e1c681d30d0010d0320da33e829f1,continuous,phv00087864.v6,phs000209,False,ptcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087864\ptcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvd,Peripheral Vascular Disease (PVD),0.513648371,mesaevthr2015_drepos_20200330,pvd,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvd,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13.p3,phv00087873.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087873,"['NO', 'YES']",phs000209,pht001123,phv00087873,True,False,False,pvd,PERIPHERAL VASCULAR DISEASE (PVD),,\phs000209\pht001123\phv00087873\pvd\,pht001123.v7,\phs000209\pht001123\phv00087873\pvd\,phv00087873,,PERIPHERAL VASCULAR DISEASE (PVD),{},,,,PERIPHERAL VASCULAR DISEASE (PVD),phs000209.v13,0248da0579684d54fbacbf43070a5a9369dde97f4a190bed301ef1dffdd8f2f2,categorical,phv00087873.v6,phs000209,False,pvd,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087873\pvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.pvdtt,Time to PVD or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,pvdtt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087875.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087875,[],phs000209,pht001123,phv00087875,False,True,False,pvdtt,TIME TO PVD OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087875\pvdtt\,pht001123.v7,\phs000209\pht001123\phv00087875\pvdtt\,phv00087875,,TIME TO PVD OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO PVD OR LAST FOLLOW-UP (DAYS),phs000209.v13,d417adeea97f50361205bdc6718cb1fe3eef485a382958591088843edfb7eccf,continuous,phv00087875.v6,phs000209,False,pvdtt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087875\pvdtt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rca,Resuscitated Cardiac Arrest,0.4549457,mesaevthr2015_drepos_20200330,rca,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rca,RESUSCITATED CARDIAC ARREST,phs000209.v13.p3,phv00087856.v5.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087856,"['NO', 'YES']",phs000209,pht001123,phv00087856,True,False,False,rca,RESUSCITATED CARDIAC ARREST,,\phs000209\pht001123\phv00087856\rca\,pht001123.v7,\phs000209\pht001123\phv00087856\rca\,phv00087856,,RESUSCITATED CARDIAC ARREST,{},,,,RESUSCITATED CARDIAC ARREST,phs000209.v13,cf3a93196f7c3ca5838acef6ec7b88a9332f3e70f9bb095fcae54b75e4b9686a,categorical,phv00087856.v5,phs000209,False,rca,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087856\rca\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,MESA,mesaevthr2015_drepos_20200330.rcatt,Time to RCA or End of Year 2015 (days),0.4549457,mesaevthr2015_drepos_20200330,rcatt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13.p3,phv00087858.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087858,[],phs000209,pht001123,phv00087858,False,True,False,rcatt,TIME TO RCA OR LAST FOLLOW-UP (DAYS),0.0,\phs000209\pht001123\phv00087858\rcatt\,pht001123.v7,\phs000209\pht001123\phv00087858\rcatt\,phv00087858,,TIME TO RCA OR LAST FOLLOW-UP (DAYS),{},,,4184.0,TIME TO RCA OR LAST FOLLOW-UP (DAYS),phs000209.v13,619fa03c8e195f55bafa110c922e55bf2f161cc0a697aadb7bd18d1d605833f0,continuous,phv00087858.v6,phs000209,False,rcatt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087858\rcatt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revc,Coronary Revascularization,0.440270032,mesaevthr2015_drepos_20200330,revc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revc,CORONARY REVASCULARIZATION,phs000209.v13.p3,phv00087894.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087894,"['NO', 'YES']",phs000209,pht001123,phv00087894,True,False,False,revc,CORONARY REVASCULARIZATION,,\phs000209\pht001123\phv00087894\revc\,pht001123.v7,\phs000209\pht001123\phv00087894\revc\,phv00087894,,CORONARY REVASCULARIZATION,{},,,,CORONARY REVASCULARIZATION,phs000209.v13,8160a7e0291859043def7c75a859e4b261ddd8d7c8bac01140f679aa50633a7e,categorical,phv00087894.v6,phs000209,False,revc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087894\revc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revc,Coronary Revascularization,0.440270032,mesaevthr2015_drepos_20200330,revc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revc,CORONARY REVASCULARIZATION,phs000209.v13.p3,phv00087894.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087894,"['NO', 'YES']",phs000209,pht001123,phv00087894,True,False,False,revc,CORONARY REVASCULARIZATION,,\phs000209\pht001123\phv00087894\revc\,pht001123.v7,\phs000209\pht001123\phv00087894\revc\,phv00087894,,CORONARY REVASCULARIZATION,{},,,,CORONARY REVASCULARIZATION,phs000209.v13,8160a7e0291859043def7c75a859e4b261ddd8d7c8bac01140f679aa50633a7e,categorical,phv00087894.v6,phs000209,False,revc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087894\revc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revc,Coronary Revascularization,0.440270032,mesaevthr2015_drepos_20200330,revc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revc,CORONARY REVASCULARIZATION,phs000209.v13.p3,phv00087894.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087894,"['NO', 'YES']",phs000209,pht001123,phv00087894,True,False,False,revc,CORONARY REVASCULARIZATION,,\phs000209\pht001123\phv00087894\revc\,pht001123.v7,\phs000209\pht001123\phv00087894\revc\,phv00087894,,CORONARY REVASCULARIZATION,{},,,,CORONARY REVASCULARIZATION,phs000209.v13,8160a7e0291859043def7c75a859e4b261ddd8d7c8bac01140f679aa50633a7e,categorical,phv00087894.v6,phs000209,False,revc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087894\revc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revc,Coronary Revascularization,0.440270032,mesaevthr2015_drepos_20200330,revc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revc,CORONARY REVASCULARIZATION,phs000209.v13.p3,phv00087894.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087894,"['NO', 'YES']",phs000209,pht001123,phv00087894,True,False,False,revc,CORONARY REVASCULARIZATION,,\phs000209\pht001123\phv00087894\revc\,pht001123.v7,\phs000209\pht001123\phv00087894\revc\,phv00087894,,CORONARY REVASCULARIZATION,{},,,,CORONARY REVASCULARIZATION,phs000209.v13,8160a7e0291859043def7c75a859e4b261ddd8d7c8bac01140f679aa50633a7e,categorical,phv00087894.v6,phs000209,False,revc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087894\revc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revc,Coronary Revascularization,0.440270032,mesaevthr2015_drepos_20200330,revc,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revc,CORONARY REVASCULARIZATION,phs000209.v13.p3,phv00087894.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087894,"['NO', 'YES']",phs000209,pht001123,phv00087894,True,False,False,revc,CORONARY REVASCULARIZATION,,\phs000209\pht001123\phv00087894\revc\,pht001123.v7,\phs000209\pht001123\phv00087894\revc\,phv00087894,,CORONARY REVASCULARIZATION,{},,,,CORONARY REVASCULARIZATION,phs000209.v13,8160a7e0291859043def7c75a859e4b261ddd8d7c8bac01140f679aa50633a7e,categorical,phv00087894.v6,phs000209,False,revc,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087894\revc\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revctt,Time to Cor. Revasc. or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,revctt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13.p3,phv00087895.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087895,[],phs000209,pht001123,phv00087895,False,True,False,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),0.0,\phs000209\pht001123\phv00087895\revctt\,pht001123.v7,\phs000209\pht001123\phv00087895\revctt\,phv00087895,,TIME TO COR. REVASC. OR LAST FU (DAYS),{},,,4184.0,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13,6f3c5d2aa2e29ca05fd145e263c46aff2f6a78d502a90a56916e376ac071b380,continuous,phv00087895.v6,phs000209,False,revctt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087895\revctt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revctt,Time to Cor. Revasc. or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,revctt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13.p3,phv00087895.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087895,[],phs000209,pht001123,phv00087895,False,True,False,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),0.0,\phs000209\pht001123\phv00087895\revctt\,pht001123.v7,\phs000209\pht001123\phv00087895\revctt\,phv00087895,,TIME TO COR. REVASC. OR LAST FU (DAYS),{},,,4184.0,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13,6f3c5d2aa2e29ca05fd145e263c46aff2f6a78d502a90a56916e376ac071b380,continuous,phv00087895.v6,phs000209,False,revctt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087895\revctt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revctt,Time to Cor. Revasc. or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,revctt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13.p3,phv00087895.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087895,[],phs000209,pht001123,phv00087895,False,True,False,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),0.0,\phs000209\pht001123\phv00087895\revctt\,pht001123.v7,\phs000209\pht001123\phv00087895\revctt\,phv00087895,,TIME TO COR. REVASC. OR LAST FU (DAYS),{},,,4184.0,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13,6f3c5d2aa2e29ca05fd145e263c46aff2f6a78d502a90a56916e376ac071b380,continuous,phv00087895.v6,phs000209,False,revctt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087895\revctt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revctt,Time to Cor. Revasc. or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,revctt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13.p3,phv00087895.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087895,[],phs000209,pht001123,phv00087895,False,True,False,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),0.0,\phs000209\pht001123\phv00087895\revctt\,pht001123.v7,\phs000209\pht001123\phv00087895\revctt\,phv00087895,,TIME TO COR. REVASC. OR LAST FU (DAYS),{},,,4184.0,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13,6f3c5d2aa2e29ca05fd145e263c46aff2f6a78d502a90a56916e376ac071b380,continuous,phv00087895.v6,phs000209,False,revctt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087895\revctt\,0.0,4184.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,MESA,mesaevthr2015_drepos_20200330.revctt,Time to Cor. Revasc. or End of Year 2015 (days),0.440270032,mesaevthr2015_drepos_20200330,revctt,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13.p3,phv00087895.v6.p3,pht001123.v7.p3,MESA_ThruYear2011Events,phv00087895,[],phs000209,pht001123,phv00087895,False,True,False,revctt,TIME TO COR. REVASC. OR LAST FU (DAYS),0.0,\phs000209\pht001123\phv00087895\revctt\,pht001123.v7,\phs000209\pht001123\phv00087895\revctt\,phv00087895,,TIME TO COR. REVASC. OR LAST FU (DAYS),{},,,4184.0,TIME TO COR. REVASC. OR LAST FU (DAYS),phs000209.v13,6f3c5d2aa2e29ca05fd145e263c46aff2f6a78d502a90a56916e376ac071b380,continuous,phv00087895.v6,phs000209,False,revctt,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht001123,MESA_ThruYear2011Events,\phs000209\pht001123\phv00087895\revctt\,0.0,4184.0
ANYCHOLMED,"Taking cholesterol lowering medication (0=No, 1=Yes)",-,C58967,ARICFraminghamMESAREGARDS,1.24,ARIC,msr.msrf33e,Medication taken for high blood cholesterol,-,msr,msrf33e,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,ARIC,msr.msrf34,Aspirin taken in last 4 weeks,-,msr,msrf34,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc10a,MEDICATION G NAME & CONCENTRATION Q10A,-,msrc04,msrc10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC10A,Medication name and concentration Q10 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208161.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc10a,MEDICATION G NAME & CONCENTRATION Q10A,-,msrc04,msrc10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC10A,[Medication records]. Medication name and concentration. Q10a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208034.v2.p2,pht004131.v3.p2,MSRC04,phv00208034,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc11a,MEDICATION H NAME & CONCENTRATION Q11A,-,msrc04,msrc11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC11A,[Medication records]. Medication name and concentration. Q11a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208037.v2.p2,pht004131.v3.p2,MSRC04,phv00208037,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc11a,MEDICATION H NAME & CONCENTRATION Q11A,-,msrc04,msrc11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC11A,Medication name and concentration. Q11 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208162.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc12a,MEDICATION I NAME & CONCENTRATION Q12A,-,msrc04,msrc12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC12A,[Medication records]. Medication name and concentration. Q12a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208040.v3.p2,pht004131.v3.p2,MSRC04,phv00208040,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc12a,MEDICATION I NAME & CONCENTRATION Q12A,-,msrc04,msrc12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC12A,Medication name and concentration. Q12 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208163.v3.p2,pht004134.v3.p2,MSRCOD36,phv00208163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc13a,MEDICATION J NAME & CONCENTRATION Q13A,-,msrc04,msrc13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC13A,Medication name and concentration. Q13 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208164.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc13a,MEDICATION J NAME & CONCENTRATION Q13A,-,msrc04,msrc13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC13A,[Medication records]. Medication name and concentration. Q13a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208043.v2.p2,pht004131.v3.p2,MSRC04,phv00208043,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc14a,MEDICATION K NAME & CONCENTRATION Q14A,-,msrc04,msrc14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC14A,[Medication records]. Medication name and concentration. Q14a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208046.v2.p2,pht004131.v3.p2,MSRC04,phv00208046,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc14a,MEDICATION K NAME & CONCENTRATION Q14A,-,msrc04,msrc14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC14A,Medication name and concentration. Q14 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208165.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208165,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc15a,MEDICATION L NAME & CONCENTRATION Q15A,-,msrc04,msrc15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC15A,[Medication records]. Medication name and concentration. Q15a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208049.v2.p2,pht004131.v3.p2,MSRC04,phv00208049,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc15a,MEDICATION L NAME & CONCENTRATION Q15A,-,msrc04,msrc15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC15A,Medication name and concentration. Q15 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208166.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc16a,MEDICATION M NAME & CONCENTRATION Q16A,-,msrc04,msrc16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC16A,[Medication records]. Medication name and concentration. Q16a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208052.v2.p2,pht004131.v3.p2,MSRC04,phv00208052,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc16a,MEDICATION M NAME & CONCENTRATION Q16A,-,msrc04,msrc16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC16A,Medication name and concentration. Q16 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208167.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc17a,MEDICATION N NAME & CONCENTRATION Q17A,-,msrc04,msrc17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC17A,[Medication records]. Medication name and concentration. Q17a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208055.v2.p2,pht004131.v3.p2,MSRC04,phv00208055,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc17a,MEDICATION N NAME & CONCENTRATION Q17A,-,msrc04,msrc17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC17A,Medication name and concentration. Q17 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208168.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc19a,MEDICATION P NAME & CONCENTRATION Q19A,-,msrc04,msrc19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC19A,Medication name and concentration. Q19 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208170.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208170,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc19a,MEDICATION P NAME & CONCENTRATION Q19A,-,msrc04,msrc19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC19A,[Medication records]. Medication name and concentration. Q19a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208061.v2.p2,pht004131.v3.p2,MSRC04,phv00208061,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc20a,MEDICATION Q NAME & CONCENTRATION Q20A,-,msrc04,msrc20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC20A,Medication name and concentration. Q20 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208171.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208171,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc20a,MEDICATION Q NAME & CONCENTRATION Q20A,-,msrc04,msrc20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC20A,[Medication records]. Medication name and concentration. Q20a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208064.v2.p2,pht004131.v3.p2,MSRC04,phv00208064,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc4a,MEDICATION A NAME & CONCENTATION Q4A,-,msrc04,msrc4a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC4A,[Medication records]. Medication name and concentration. Q4a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208016.v2.p2,pht004131.v3.p2,MSRC04,phv00208016,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc4a,MEDICATION A NAME & CONCENTATION Q4A,-,msrc04,msrc4a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC4A,Medication name and concentration. Q4 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208155.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc5a,MEDICATION B NAME & CONCENTRATION Q5A,-,msrc04,msrc5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC5A,[Medication records]. Medication name and concentration. Q5a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208019.v2.p2,pht004131.v3.p2,MSRC04,phv00208019,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc5a,MEDICATION B NAME & CONCENTRATION Q5A,-,msrc04,msrc5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC5A,Medication name and concentration. Q5 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208156.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc6a,MEDICATION C NAME & CONCENTRATION Q6A,-,msrc04,msrc6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC6A,[Medication records]. Medication name and concentration. Q6a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208022.v2.p2,pht004131.v3.p2,MSRC04,phv00208022,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc6a,MEDICATION C NAME & CONCENTRATION Q6A,-,msrc04,msrc6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC6A,Medication name and concentration. Q6 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208157.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc7a,MEDICATION D NAME & CONCENTRATION Q7A,-,msrc04,msrc7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC7A,[Medication records]. Medication name and concentration. Q7a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208025.v3.p2,pht004131.v3.p2,MSRC04,phv00208025,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc7a,MEDICATION D NAME & CONCENTRATION Q7A,-,msrc04,msrc7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC7A,Medication name and concentration. Q7 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208158.v3.p2,pht004134.v3.p2,MSRCOD36,phv00208158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc80a,-,-,msrc04,msrc80a,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc8a,MEDICATION E NAME & CONCENTRATION Q8A,-,msrc04,msrc8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC8A,Medication name and concentration. Q8 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208159.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc8a,MEDICATION E NAME & CONCENTRATION Q8A,-,msrc04,msrc8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC8A,[Medication records]. Medication name and concentration. Q8a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208028.v2.p2,pht004131.v3.p2,MSRC04,phv00208028,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc9a,MEDICATION F NAME & CONCENTRATION Q9A,-,msrc04,msrc9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC9A,Medication name and concentration. Q9 A [Medication Codes. MSRCOD36. Visit 3],phs000280.v8.p2,phv00208160.v2.p2,pht004134.v3.p2,MSRCOD36,phv00208160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrc04.msrc9a,MEDICATION F NAME & CONCENTRATION Q9A,-,msrc04,msrc9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRC9A,[Medication records]. Medication name and concentration. Q9a [Medication Survey Form. MSRC04. Visit 3],phs000280.v8.p2,phv00208031.v2.p2,pht004131.v3.p2,MSRC04,phv00208031,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04aa,MEDICATION & CONCENTRATION Q4M01A,-,msrcod07,msra04aa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04AA,Medication and concentration. Q4m01a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208085.v3.p2,pht004132.v3.p2,MSRCOD07,phv00208085,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04aa,MEDICATION & CONCENTRATION Q4M01A,-,msrcod07,msra04aa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04AA,[Medication records]. Medication name & concentration. Q4aa [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207842.v3.p2,pht004129.v3.p2,MSRA,phv00207842,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ba,MEDICATION & CONCENTRATION Q4M02A,-,msrcod07,msra04ba,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04BA,[Medication records]. Medication name & concentration.Q4ba [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207846.v3.p2,pht004129.v3.p2,MSRA,phv00207846,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ba,MEDICATION & CONCENTRATION Q4M02A,-,msrcod07,msra04ba,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04BA,Medication and concentration. Q4m02a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208086.v3.p2,pht004132.v3.p2,MSRCOD07,phv00208086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ca,MEDICATION & CONCENTRATION Q4M03A,-,msrcod07,msra04ca,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04CA,[Medication records]. Medication name & concentration. Q4ca [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207850.v2.p2,pht004129.v3.p2,MSRA,phv00207850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ca,MEDICATION & CONCENTRATION Q4M03A,-,msrcod07,msra04ca,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04CA,Medication and concentration. Q4m03a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208087.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208087,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04da,MEDICATION & CONCENTRATION Q4M04A,-,msrcod07,msra04da,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04DA,[Medication records]. Medication name & concentration. Q4da [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207854.v3.p2,pht004129.v3.p2,MSRA,phv00207854,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04da,MEDICATION & CONCENTRATION Q4M04A,-,msrcod07,msra04da,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04DA,Medication and concentration. Q4m04a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208088.v3.p2,pht004132.v3.p2,MSRCOD07,phv00208088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ea,MEDICATION & CONCENTRATION Q4M05A,-,msrcod07,msra04ea,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04EA,[Medication records]. Medication name & concentration. Q4ea [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207858.v3.p2,pht004129.v3.p2,MSRA,phv00207858,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ea,MEDICATION & CONCENTRATION Q4M05A,-,msrcod07,msra04ea,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04EA,Medication and concentration. Q4m05a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208089.v3.p2,pht004132.v3.p2,MSRCOD07,phv00208089,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04fa,MEDICATION & CONCENTRATION Q4M06A,-,msrcod07,msra04fa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04FA,[Medication records]. Medication name & concentration. Q4fa [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207862.v2.p2,pht004129.v3.p2,MSRA,phv00207862,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04fa,MEDICATION & CONCENTRATION Q4M06A,-,msrcod07,msra04fa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04FA,Medication and concentration. Q4m06a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208090.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ga,MEDICATION & CONCENTRATION Q4M07A,-,msrcod07,msra04ga,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04GA,[Medication records]. Medication name & concentration. Q4ga [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207866.v2.p2,pht004129.v3.p2,MSRA,phv00207866,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ga,MEDICATION & CONCENTRATION Q4M07A,-,msrcod07,msra04ga,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04GA,Medication and concentration. Q4m07a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208091.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ha,MEDICATION & CONCENTRATION Q4M08A,-,msrcod07,msra04ha,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04HA,[Medication records]. Medication name & concentration. Q4ha [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207870.v2.p2,pht004129.v3.p2,MSRA,phv00207870,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ha,MEDICATION & CONCENTRATION Q4M08A,-,msrcod07,msra04ha,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04HA,Medication and concentration. Q4m08a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208092.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208092,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ia,MEDICATION & CONCENTRATION Q4M09A,-,msrcod07,msra04ia,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04IA,[Medication records]. Medication name & concentration. Q4ia [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207874.v2.p2,pht004129.v3.p2,MSRA,phv00207874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ia,MEDICATION & CONCENTRATION Q4M09A,-,msrcod07,msra04ia,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04IA,Medication and concentration. Q4m09a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208093.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ja,MEDICATION & CONCENTRATION Q4M10A,-,msrcod07,msra04ja,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04JA,[Medication records]. Medication name & concentration. Q4ja [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207878.v2.p2,pht004129.v3.p2,MSRA,phv00207878,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ja,MEDICATION & CONCENTRATION Q4M10A,-,msrcod07,msra04ja,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04JA,Medication and concentration. Q4m10a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208094.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208094,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ka,MEDICATION & CONCENTRATION Q4M11A,-,msrcod07,msra04ka,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04KA,[Medication records]. Medication name & concentration. Q4ka [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207882.v3.p2,pht004129.v3.p2,MSRA,phv00207882,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ka,MEDICATION & CONCENTRATION Q4M11A,-,msrcod07,msra04ka,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04KA,Medication and concentration. Q4m11a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208095.v3.p2,pht004132.v3.p2,MSRCOD07,phv00208095,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04la,MEDICATION & CONCENTRATION Q4M12A,-,msrcod07,msra04la,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04LA,Medication and concentration. Q4m12a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208096.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208096,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04la,MEDICATION & CONCENTRATION Q4M12A,-,msrcod07,msra04la,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04LA,[Medication records]. Medication name & concentration. Q4la [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207886.v2.p2,pht004129.v3.p2,MSRA,phv00207886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ma,MEDICATION & CONCENTRATION Q4M13A,-,msrcod07,msra04ma,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04MA,[Medication records]. Medication name & concentration. Q4ma [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207890.v2.p2,pht004129.v3.p2,MSRA,phv00207890,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04ma,MEDICATION & CONCENTRATION Q4M13A,-,msrcod07,msra04ma,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04MA,Medication and concentration. Q4m13a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208097.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208097,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04na,MEDICATION & CONCENTRATION Q4M14A,-,msrcod07,msra04na,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04NA,[Medication records]. Medication name & concentration. Q4na [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207894.v2.p2,pht004129.v3.p2,MSRA,phv00207894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04na,MEDICATION & CONCENTRATION Q4M14A,-,msrcod07,msra04na,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04NA,Medication and concentration. Q4m14a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208098.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04oa,MEDICATION & CONCENTRATION Q4M15A,-,msrcod07,msra04oa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04OA,[Medication records]. Medication name & concentration. Q4oa [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207898.v2.p2,pht004129.v3.p2,MSRA,phv00207898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04oa,MEDICATION & CONCENTRATION Q4M15A,-,msrcod07,msra04oa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04OA,Medication and concentration. Q4m15a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208099.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208099,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04pa,MEDICATION & CONCENTRATION Q4M16A,-,msrcod07,msra04pa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04PA,[Medication records]. Medication name & concentration. Q4pa [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207902.v2.p2,pht004129.v3.p2,MSRA,phv00207902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04pa,MEDICATION & CONCENTRATION Q4M16A,-,msrcod07,msra04pa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04PA,Medication and concentration. Q4m16a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208100.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208100,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04qa,MEDICATION & CONCENTRATION Q4M17A,-,msrcod07,msra04qa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04QA,Medication and concentration. Q4m17a [Medication Codes. MSRCOD07. Visit 1],phs000280.v8.p2,phv00208101.v2.p2,pht004132.v3.p2,MSRCOD07,phv00208101,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod07.msra04qa,MEDICATION & CONCENTRATION Q4M17A,-,msrcod07,msra04qa,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRA04QA,[Medication records]. Medication name & concentration. Q4qa [Medication Survey Form. MSRA. Visit 1],phs000280.v8.p2,phv00207906.v2.p2,pht004129.v3.p2,MSRA,phv00207906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb04a,MEDICATION NAME & CONCENTRATION Q4A,-,msrcod26,msrb04a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB04A,[Medication records]. Medication name and concentration. Q4A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207929.v2.p2,pht004130.v3.p2,MSRB,phv00207929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb04a,MEDICATION NAME & CONCENTRATION Q4A,-,msrcod26,msrb04a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB04A,Medication name and concentration. Q4a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208120.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208120,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb05a,MEDICATION NAME & CONCENTRATION Q5A,-,msrcod26,msrb05a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB05A,[Medication records]. Medication name and concentration Q5A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207933.v2.p2,pht004130.v3.p2,MSRB,phv00207933,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb05a,MEDICATION NAME & CONCENTRATION Q5A,-,msrcod26,msrb05a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB05A,Medication name and concentration. Q5a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208121.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208121,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb06a,MEDICATION NAME & CONCENTRATION Q6A,-,msrcod26,msrb06a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB06A,[Medication records]. Medication name and concentration. Q6A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207937.v2.p2,pht004130.v3.p2,MSRB,phv00207937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb06a,MEDICATION NAME & CONCENTRATION Q6A,-,msrcod26,msrb06a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB06A,Medication name and concentration. Q6a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208122.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208122,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb07a,MEDICATION NAME & CONCENTRATION Q7A,-,msrcod26,msrb07a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB07A,[Medication records]. Medication name and concentration. Q7A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207941.v2.p2,pht004130.v3.p2,MSRB,phv00207941,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb07a,MEDICATION NAME & CONCENTRATION Q7A,-,msrcod26,msrb07a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB07A,Medication name and concentration. Q7a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208123.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208123,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb08a,MEDICATION NAME & CONCENTRATION Q8A,-,msrcod26,msrb08a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB08A,[Medication records]. Medication name and concentration. Q8A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207945.v2.p2,pht004130.v3.p2,MSRB,phv00207945,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb08a,MEDICATION NAME & CONCENTRATION Q8A,-,msrcod26,msrb08a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB08A,Medication name and concentration. Q8a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208124.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208124,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb09a,MEDICATION NAME & CONCENTRATION Q9A,-,msrcod26,msrb09a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB09A,[Medication records]. Medication name and concentration. Q9A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207949.v2.p2,pht004130.v3.p2,MSRB,phv00207949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb09a,MEDICATION NAME & CONCENTRATION Q9A,-,msrcod26,msrb09a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB09A,Medication name and concentration. Q9a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208125.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208125,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb10a,MEDICATION NAME & CONCENTRATION Q10A,-,msrcod26,msrb10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB10A,Medication name and concentration. Q10a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208126.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208126,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb10a,MEDICATION NAME & CONCENTRATION Q10A,-,msrcod26,msrb10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB10A,[Medication records]. Medication name and concentration. Q10A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207953.v2.p2,pht004130.v3.p2,MSRB,phv00207953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb11a,MEDICATION NAME & CONCENTRATION Q11A,-,msrcod26,msrb11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB11A,Medication name and concentration. Q11a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208127.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208127,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb11a,MEDICATION NAME & CONCENTRATION Q11A,-,msrcod26,msrb11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB11A,[Medication records]. Medication name and concentration. Q11A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207957.v2.p2,pht004130.v3.p2,MSRB,phv00207957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb12a,MEDICATION NAME & CONCENTRATION Q12A,-,msrcod26,msrb12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB12A,Medication name and concentration. Q12a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208128.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208128,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb12a,MEDICATION NAME & CONCENTRATION Q12A,-,msrcod26,msrb12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB12A,[Medication records]. Medication name and concentration. Q12A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207961.v2.p2,pht004130.v3.p2,MSRB,phv00207961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb13a,MEDICATION NAME & CONCENTRATION Q13A,-,msrcod26,msrb13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB13A,Medication name and concentration. Q13a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208129.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208129,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb13a,MEDICATION NAME & CONCENTRATION Q13A,-,msrcod26,msrb13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB13A,[Medication records]. Medication name and concentration. Q13A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207965.v2.p2,pht004130.v3.p2,MSRB,phv00207965,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb14a,MEDICATION NAME & CONCENTRATION Q14A,-,msrcod26,msrb14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB14A,Medication name and concentration. Q14a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208130.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb14a,MEDICATION NAME & CONCENTRATION Q14A,-,msrcod26,msrb14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB14A,[Medication records]. Medication name and concentration. Q14A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207969.v2.p2,pht004130.v3.p2,MSRB,phv00207969,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb15a,MEDICATION NAME & CONCENTRATION Q15A,-,msrcod26,msrb15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB15A,Medication name and concentration. Q15a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208131.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb15a,MEDICATION NAME & CONCENTRATION Q15A,-,msrcod26,msrb15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB15A,[Medication records]. Medication name and concentration. Q15A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207973.v2.p2,pht004130.v3.p2,MSRB,phv00207973,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb16a,MEDICATION NAME & CONCENTRATION Q16A,-,msrcod26,msrb16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB16A,Medication name and concentration. Q16a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208132.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208132,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb16a,MEDICATION NAME & CONCENTRATION Q16A,-,msrcod26,msrb16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB16A,[Medication records]. Medication name and concentration. Q16A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207977.v2.p2,pht004130.v3.p2,MSRB,phv00207977,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb17a,MEDICATION NAME & CONCENTRATION Q17A,-,msrcod26,msrb17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB17A,Medication name and concentration. Q17a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208133.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208133,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb17a,MEDICATION NAME & CONCENTRATION Q17A,-,msrcod26,msrb17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB17A,[Medication records]. Medication name and concentration. Q17A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207981.v2.p2,pht004130.v3.p2,MSRB,phv00207981,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb18a,MEDICATION NAME & CONCENTRATION Q18A,-,msrcod26,msrb18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB18A,[Medication records]. Medication name and concentration. Q18A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207985.v2.p2,pht004130.v3.p2,MSRB,phv00207985,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb18a,MEDICATION NAME & CONCENTRATION Q18A,-,msrcod26,msrb18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB18A,Medication name and concentration. Q18a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208134.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208134,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb19a,MEDICATION NAME & CONCENTRATION Q19A,-,msrcod26,msrb19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB19A,[Medication records]. Medication name and concentration. Q19A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207989.v2.p2,pht004130.v3.p2,MSRB,phv00207989,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb19a,MEDICATION NAME & CONCENTRATION Q19A,-,msrcod26,msrb19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB19A,Medication name and concentration. Q19a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208135.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208135,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb20a,MEDICATION NAME & CONCENTRATION Q20A,-,msrcod26,msrb20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB20A,[Medication records]. Medication name and concentration. Q20A [Medication Survey Form. MSRB. Visit 2],phs000280.v8.p2,phv00207993.v2.p2,pht004130.v3.p2,MSRB,phv00207993,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod26.msrb20a,MEDICATION NAME & CONCENTRATION Q20A,-,msrcod26,msrb20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRB20A,Medication name and concentration. Q20a [Medication Codes. MSRCOD26. Visit 2],phs000280.v8.p2,phv00208136.v2.p2,pht004133.v3.p2,MSRCOD26,phv00208136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod10a,Med 6: Scanned UPC med name,-,msrcod51,msrcod10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD10a,Med 6: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297144.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod10a,Med 6: Scanned UPC med name,-,msrcod51,msrcod10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD10a,Med 6: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507567.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod10a,Med 6: Scanned UPC med name,-,msrcod51,msrcod10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD10a,Med 6: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516444.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516444,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod11a,Med 7: Scanned UPC med name,-,msrcod51,msrcod11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD11a,Med 7: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297145.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297145,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod11a,Med 7: Scanned UPC med name,-,msrcod51,msrcod11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD11a,Med 7: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507568.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod11a,Med 7: Scanned UPC med name,-,msrcod51,msrcod11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD11a,Med 7: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516445.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516445,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod12a,Med 8: Scanned UPC med name,-,msrcod51,msrcod12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD12a,Med 8: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297146.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod12a,Med 8: Scanned UPC med name,-,msrcod51,msrcod12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD12a,Med 8: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507569.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507569,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod12a,Med 8: Scanned UPC med name,-,msrcod51,msrcod12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD12a,Med 8: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516446.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516446,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod13a,Med 9: Scanned UPC med name,-,msrcod51,msrcod13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD13a,Med 9: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516447.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516447,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod13a,Med 9: Scanned UPC med name,-,msrcod51,msrcod13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD13a,Med 9: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297147.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297147,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod13a,Med 9: Scanned UPC med name,-,msrcod51,msrcod13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD13a,Med 9: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507570.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507570,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod14a,Med 10: Scanned UPC med name,-,msrcod51,msrcod14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD14a,Med 10: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297148.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod14a,Med 10: Scanned UPC med name,-,msrcod51,msrcod14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD14a,Med 10: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507571.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507571,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod14a,Med 10: Scanned UPC med name,-,msrcod51,msrcod14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD14a,Med 10: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516448.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516448,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod15a,Med 11: Scanned UPC med name,-,msrcod51,msrcod15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD15a,Med 11: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516449.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod15a,Med 11: Scanned UPC med name,-,msrcod51,msrcod15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD15a,Med 11: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507572.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507572,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod15a,Med 11: Scanned UPC med name,-,msrcod51,msrcod15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD15a,Med 11: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297149.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297149,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod16a,Med 12: Scanned UPC med name,-,msrcod51,msrcod16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD16a,Med 12: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516450.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod16a,Med 12: Scanned UPC med name,-,msrcod51,msrcod16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD16a,Med 12: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507573.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod16a,Med 12: Scanned UPC med name,-,msrcod51,msrcod16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD16a,Med 12: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297150.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297150,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod17a,Med 13: Scanned UPC med name,-,msrcod51,msrcod17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD17a,Med 13: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516451.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516451,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod17a,Med 13: Scanned UPC med name,-,msrcod51,msrcod17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD17a,Med 13: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297151.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod17a,Med 13: Scanned UPC med name,-,msrcod51,msrcod17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD17a,Med 13: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507574.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507574,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod18a,Med 14: Scanned UPC med name,-,msrcod51,msrcod18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD18a,Med 14: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507575.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod18a,Med 14: Scanned UPC med name,-,msrcod51,msrcod18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD18a,Med 14: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297152.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297152,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod18a,Med 14: Scanned UPC med name,-,msrcod51,msrcod18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD18a,Med 14: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516452.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod19a,Med 15: Scanned UPC med name,-,msrcod51,msrcod19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD19a,Med 15: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297153.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod19a,Med 15: Scanned UPC med name,-,msrcod51,msrcod19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD19a,Med 15: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507576.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod19a,Med 15: Scanned UPC med name,-,msrcod51,msrcod19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD19a,Med 15: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516453.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516453,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod20a,Med 16: Scanned UPC med name,-,msrcod51,msrcod20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD20a,Med 16: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516454.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516454,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod20a,Med 16: Scanned UPC med name,-,msrcod51,msrcod20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD20a,Med 16: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507577.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507577,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod20a,Med 16: Scanned UPC med name,-,msrcod51,msrcod20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD20a,Med 16: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297154.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod21a,Med 17: Scanned UPC med name,-,msrcod51,msrcod21a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD21a,Med 17: Therapeutic Class Code [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516455.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516455,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod21a,Med 17: Scanned UPC med name,-,msrcod51,msrcod21a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD21a,Med 17: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297155.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297155,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod21a,Med 17: Scanned UPC med name,-,msrcod51,msrcod21a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD21a,Med 17: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507578.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507578,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod22a,Med 18: Scanned UPC med name,-,msrcod51,msrcod22a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD22a,Med 18: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516456.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516456,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod22a,Med 18: Scanned UPC med name,-,msrcod51,msrcod22a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD22a,Med 18: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507579.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507579,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod22a,Med 18: Scanned UPC med name,-,msrcod51,msrcod22a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD22a,Med 18: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297156.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297156,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod23a,Med 19: Scanned UPC med name,-,msrcod51,msrcod23a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD23a,Med 19: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297157.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod23a,Med 19: Scanned UPC med name,-,msrcod51,msrcod23a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD23a,Med 19: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507580.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507580,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod23a,Med 19: Scanned UPC med name,-,msrcod51,msrcod23a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD23a,Med 19: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516457.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516457,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod24a,Med 20: Scanned UPC med name,-,msrcod51,msrcod24a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD24a,Med 20: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297158.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297158,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod24a,Med 20: Scanned UPC med name,-,msrcod51,msrcod24a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD24a,Med 20: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507581.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507581,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod24a,Med 20: Scanned UPC med name,-,msrcod51,msrcod24a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD24a,Med 20: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516458.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516458,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod25a,Med 21: Scanned UPC med name,-,msrcod51,msrcod25a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD25a,Med 21: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297159.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297159,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod25a,Med 21: Scanned UPC med name,-,msrcod51,msrcod25a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD25a,Med 21: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507582.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507582,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod25a,Med 21: Scanned UPC med name,-,msrcod51,msrcod25a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD25a,Med 21: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516459.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516459,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod26a,Med 22: Scanned UPC med name,-,msrcod51,msrcod26a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD26a,Med 22: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516460.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516460,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod26a,Med 22: Scanned UPC med name,-,msrcod51,msrcod26a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD26a,Med 22: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507583.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507583,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod26a,Med 22: Scanned UPC med name,-,msrcod51,msrcod26a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD26a,Med 22: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297160.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297160,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod27a,Med 23: Scanned UPC med name,-,msrcod51,msrcod27a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD27a,Med 23: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297161.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod27a,Med 23: Scanned UPC med name,-,msrcod51,msrcod27a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD27a,Med 23: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516461.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516461,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod27a,Med 23: Scanned UPC med name,-,msrcod51,msrcod27a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD27a,Med 23: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507584.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507584,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod28a,Med 24: Scanned UPC med name,-,msrcod51,msrcod28a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD28a,Med 24: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507585.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507585,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod28a,Med 24: Scanned UPC med name,-,msrcod51,msrcod28a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD28a,Med 24: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516462.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516462,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod28a,Med 24: Scanned UPC med name,-,msrcod51,msrcod28a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD28a,Med 24: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297162.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod29a,Med 25: Scanned UPC med name,-,msrcod51,msrcod29a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD29a,Med 25: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297163.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297163,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod29a,Med 25: Scanned UPC med name,-,msrcod51,msrcod29a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD29a,Med 25: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507586.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507586,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod29a,Med 25: Scanned UPC med name,-,msrcod51,msrcod29a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD29a,Med 25: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516463.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516463,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod5a,Med 1: Scanned UPC med name,-,msrcod51,msrcod5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD5a,Med 1: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516439.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516439,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod5a,Med 1: Scanned UPC med name,-,msrcod51,msrcod5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD5a,Med 1: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507562.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod5a,Med 1: Scanned UPC med name,-,msrcod51,msrcod5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD5a,Med 1: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297139.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod6a,Med 2: Scanned UPC med name,-,msrcod51,msrcod6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD6a,Med 2: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297140.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod6a,Med 2: Scanned UPC med name,-,msrcod51,msrcod6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD6a,Med 2: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507563.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod6a,Med 2: Scanned UPC med name,-,msrcod51,msrcod6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD6a,Med 2: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516440.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516440,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod7a,Med 3: Scanned UPC med name,-,msrcod51,msrcod7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD7a,Med 3: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297141.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297141,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod7a,Med 3: Scanned UPC med name,-,msrcod51,msrcod7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD7a,Med 3: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507564.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod7a,Med 3: Scanned UPC med name,-,msrcod51,msrcod7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD7a,Med 3: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516441.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516441,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod8a,Med 4: Scanned UPC med name,-,msrcod51,msrcod8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD8a,Med 4: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507565.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod8a,Med 4: Scanned UPC med name,-,msrcod51,msrcod8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD8a,Med 4: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297142.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297142,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod8a,Med 4: Scanned UPC med name,-,msrcod51,msrcod8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD8a,Med 4: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516442.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516442,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod9a,Med 5: Scanned UPC med name,-,msrcod51,msrcod9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD9a,Med 5: Scanned UPC med name [Medication Codes. MSRCOD61. Visit 6],phs000280.v8.p2,phv00516443.v1.p2,pht012833.v1.p2,MSRCOD61,phv00516443,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod9a,Med 5: Scanned UPC med name,-,msrcod51,msrcod9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD9a,Med 5: scanned UPC med name [Medication Codes. MSRCOD51. Visit 5],phs000280.v8.p2,phv00297143.v2.p2,pht006454.v2.p2,MSRCOD51,phv00297143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrcod51.msrcod9a,Med 5: Scanned UPC med name,-,msrcod51,msrcod9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRCOD9a,Med 5: Scanned UPC med name [Medication Codes. MSRCOD71. Visit 7],phs000280.v8.p2,phv00507566.v1.p2,pht012512.v1.p2,MSRCOD71,phv00507566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd10a,MEDICATION G NAME Q10A,-,msrd04,msrd10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD10A,[Medication records]. Medication G name. Q10a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208252.v2.p2,pht004136.v3.p2,MSRD04,phv00208252,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd10a,MEDICATION G NAME Q10A,-,msrd04,msrd10a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD10A,Medication name. Q10a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208196.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208196,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd11a,MEDICATION H NAME Q11A,-,msrd04,msrd11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD11A,[Medication records]. Medication H name. Q11a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208256.v2.p2,pht004136.v3.p2,MSRD04,phv00208256,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd11a,MEDICATION H NAME Q11A,-,msrd04,msrd11a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD11A,Medication name. Q11a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208197.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208197,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd12a,MEDICATION I NAME Q12A,-,msrd04,msrd12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD12A,[Medication records]. Medication I name. Q12a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208260.v2.p2,pht004136.v3.p2,MSRD04,phv00208260,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd12a,MEDICATION I NAME Q12A,-,msrd04,msrd12a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD12A,Medication name. Q12a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208198.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208198,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd13a,MEDICATION J NAME Q13A,-,msrd04,msrd13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD13A,[Medication records]. Medication J name. Q13a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208264.v2.p2,pht004136.v3.p2,MSRD04,phv00208264,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd13a,MEDICATION J NAME Q13A,-,msrd04,msrd13a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD13A,Medication name. Q13a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208199.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208199,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd14a,MEDICATION K NAME Q14A,-,msrd04,msrd14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD14A,Medication name. Q14a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208200.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208200,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd14a,MEDICATION K NAME Q14A,-,msrd04,msrd14a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD14A,[Medication records]. Medication K name. Q14a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208268.v2.p2,pht004136.v3.p2,MSRD04,phv00208268,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd15a,MEDICATION L NAME Q15A,-,msrd04,msrd15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD15A,[Medication records]. Medication L name. Q15a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208272.v2.p2,pht004136.v3.p2,MSRD04,phv00208272,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd15a,MEDICATION L NAME Q15A,-,msrd04,msrd15a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD15A,Medication name. Q15a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208201.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208201,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd16a,MEDICATION M NAME Q16A,-,msrd04,msrd16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD16A,[Medication records]. Medication M name. Q16a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208276.v2.p2,pht004136.v3.p2,MSRD04,phv00208276,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd16a,MEDICATION M NAME Q16A,-,msrd04,msrd16a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD16A,Medication name. Q16a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208202.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208202,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd17a,MEDICATION N NAME Q17A,-,msrd04,msrd17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD17A,Medication name. Q17a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208203.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208203,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd17a,MEDICATION N NAME Q17A,-,msrd04,msrd17a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD17A,[Medication records]. Medication N name. Q17a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208280.v2.p2,pht004136.v3.p2,MSRD04,phv00208280,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd18a,MEDICATION O NAME Q18A,-,msrd04,msrd18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD18A,[Medication records]. Medication O name. Q18a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208284.v2.p2,pht004136.v3.p2,MSRD04,phv00208284,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd18a,MEDICATION O NAME Q18A,-,msrd04,msrd18a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD18A,Medication name. Q18a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208204.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208204,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd19a,MEDICATION P NAME Q19A,-,msrd04,msrd19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD19A,Medication name. Q19a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208205.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208205,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd19a,MEDICATION P NAME Q19A,-,msrd04,msrd19a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD19A,[Medication records]. Medication P name. Q19a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208288.v2.p2,pht004136.v3.p2,MSRD04,phv00208288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd20a,MEDICATION Q NAME Q20A,-,msrd04,msrd20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD20A,Medication name. Q20a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208206.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208206,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd20a,MEDICATION Q NAME Q20A,-,msrd04,msrd20a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD20A,[Medication records]. Medication Q name Q20a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208292.v2.p2,pht004136.v3.p2,MSRD04,phv00208292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd4a,MEDICATION A NAME Q4A,-,msrd04,msrd4a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD4A,[Medication records]. Medication A name. Q4a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208228.v2.p2,pht004136.v3.p2,MSRD04,phv00208228,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd4a,MEDICATION A NAME Q4A,-,msrd04,msrd4a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD4A,Medication name. Q4a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208190.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208190,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd5a,MEDICATION B NAME Q5A,-,msrd04,msrd5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD5A,[Medication records]. Medication B name. Q5a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208232.v2.p2,pht004136.v3.p2,MSRD04,phv00208232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd5a,MEDICATION B NAME Q5A,-,msrd04,msrd5a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD5A,Medication name. Q5a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208191.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208191,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd6a,MEDICATION C NAME Q6A,-,msrd04,msrd6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD6A,Medication name. Q6a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208192.v3.p2,pht004135.v3.p2,MSRCOD43,phv00208192,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd6a,MEDICATION C NAME Q6A,-,msrd04,msrd6a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD6A,[Medication records]. Medication C name. Q6a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208236.v3.p2,pht004136.v3.p2,MSRD04,phv00208236,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd7a,MEDICATION D NAME Q7A,-,msrd04,msrd7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD7A,[Medication records]. Medication D name. Q7a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208240.v2.p2,pht004136.v3.p2,MSRD04,phv00208240,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd7a,MEDICATION D NAME Q7A,-,msrd04,msrd7a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD7A,Medication name. Q7a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208193.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208193,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd8a,MEDICATION E NAME Q8A,-,msrd04,msrd8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD8A,[Medication records]. Medication E name. Q8a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208244.v2.p2,pht004136.v3.p2,MSRD04,phv00208244,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd8a,MEDICATION E NAME Q8A,-,msrd04,msrd8a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD8A,Medication name. Q8a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208194.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208194,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd9a,MEDICATION F NAME Q9A,-,msrd04,msrd9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD9A,[Medication records]. Medication F name. Q9a [Medication Survey Form. MSRD04. Visit 4],phs000280.v8.p2,phv00208248.v2.p2,pht004136.v3.p2,MSRD04,phv00208248,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,ARIC,msrd04.msrd9a,MEDICATION F NAME Q9A,-,msrd04,msrd9a,Atherosclerosis Risk in Communities (ARIC) Cohort,MSRD9A,Medication name. Q9a [Medication Codes. MSRCOD43. Visit 4],phs000280.v8.p2,phv00208195.v2.p2,pht004135.v3.p2,MSRCOD43,phv00208195,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,nutv3.sodi,sodium (mg),-,nutv3,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,Sodium [mg] [Nutrients. Visit 2],phs000280.v8.p2,phv00208361.v2.p2,pht004137.v3.p2,NUTV2,phv00208361,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,nutv3.sodi,sodium (mg),-,nutv3,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,Sodium [mg] [Nutrients. Visit 3],phs000280.v8.p2,phv00208588.v2.p2,pht004139.v3.p2,NUTV3,phv00208588,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,ARIC,nutv3.sodi,sodium (mg),-,nutv3,sodi,Atherosclerosis Risk in Communities (ARIC) Cohort,SODI,"Sodium [mg] [Nutrients, ANUT. Visit 1]",phs000280.v8.p2,phv00203258.v2.p2,pht004036.v3.p2,ANUT2,phv00203258,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,phxb04.phxb14,EVER CONSUMED ALCOHOLIC BEVERAGES Q14,-,phxb04,phxb14,Atherosclerosis Risk in Communities (ARIC) Cohort,PHXB14,[Alcohol]. Have you ever consumed alcoholic beverages? Q14 [Personal History form. PHXB04. Visit 4],phs000280.v8.p2,phv00209080.v2.p2,pht004146.v3.p2,PHXB04,phv00209080,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,phxb04.phxb15,DRINK ALCOHOL NOW Q15,-,phxb04,phxb15,Atherosclerosis Risk in Communities (ARIC) Cohort,PHXB15,[Alcohol]. Do you presently drink alcoholic beverages? Q15 [Personal History form. PHXB04. Visit 4],phs000280.v8.p2,phv00209081.v2.p2,pht004146.v3.p2,PHXB04,phv00209081,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,phxb04.phxb17a,USUAL # OF GLASSES WINE/WK Q17A,50.96950387,phxb04,phxb17a,Atherosclerosis Risk in Communities (ARIC) Cohort,PHXB17A,[Alcohol]. How many glasses of wine do you usually have per week? Q17a [Personal History form. PHXB04. Visit 4],phs000280.v8.p2,phv00209088.v2.p2,pht004146.v3.p2,PHXB04,phv00209088,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,phxb04.phxb18a,USUAL # OF BEERS PER WEEK Q18A,50.99681384,phxb04,phxb18a,Atherosclerosis Risk in Communities (ARIC) Cohort,PHXB18A,"[Alcohol]. How many glasses, bottles, or cans of beer do you usually have per week? Q18a [Personal History form. PHXB04. Visit 4]",phs000280.v8.p2,phv00209090.v2.p2,pht004146.v3.p2,PHXB04,phv00209090,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,ARIC,phxb04.phxb19a,USUAL # OF HARD LIQUOR DRINKS/WK Q19A,50.99681384,phxb04,phxb19a,Atherosclerosis Risk in Communities (ARIC) Cohort,PHXB19A,[Alcohol]. How many drinks of hard liquor do you usually have per week? Q19a [Personal History form. PHXB04. Visit 4],phs000280.v8.p2,phv00209091.v2.p2,pht004146.v3.p2,PHXB04,phv00209091,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS,phs000007.v33.p14,phv00476981.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00476981,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS,phs000007.v33.p14,phv00162172.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162172,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month', 'invalid data or other (missing data)']",phs000007,pht002350,phv00162172,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS,,\phs000007\pht002350\phv00162172\APPLE\,pht002350.v5,\phs000007\pht002350\phv00162172\APPLE\,phv00162172,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",FFQ: FRESH APPLES OR PEARS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",,FFQ: FRESH APPLES OR PEARS,phs000007.v31,c5ae9279f53e49f8bd6e2efa2e86e91d9a9e428257242a4f48f29a3cc2366f38,categorical,phv00162172.v5,phs000007,False,APPLE,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162172\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00172499.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172499,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '4 - 5 per day', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172499,True,False,False,Q_APPLE,FFQ: Fresh apples or pears,,\phs000007\pht002900\phv00172499\Q_APPLE\,pht002900.v3,\phs000007\pht002900\phv00172499\Q_APPLE\,phv00172499,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",FFQ: Fresh apples or pears,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,FFQ: Fresh apples or pears,phs000007.v31,635462ba26d91b0c99ea19f21865f205b097d87ff60859791f7319b650524ecc,categorical,phv00172499.v3,phs000007,False,Q_APPLE,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172499\Q_APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00068134.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00068134,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '4-5 PER DAY', '5-6 PER WEEK', '6+ PER DAY', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000680,phv00068134,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht000680\phv00068134\APPLE\,pht000680.v6,\phs000007\pht000680\phv00068134\APPLE\,phv00068134,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,dc356f41f6c1cdaca9fc0092d381dfeeae60f68fa93895659a5741ac77999cef,categorical,phv00068134.v5,phs000007,False,APPLE,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00068134\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00157445.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157445,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002151,phv00157445,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht002151\phv00157445\APPLE\,pht002151.v1,\phs000007\pht002151\phv00157445\APPLE\,phv00157445,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,b908ba4ca0eaabc660f4ddaf3b5df4f553b01f325ea606653d7ca4d42ee636bb,categorical,phv00157445.v1,phs000007,False,APPLE,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157445\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS,phs000007.v33.p14,phv00156812.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00156812,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Invalid data or other (missing data)', 'Never, or less than once per month']",phs000007,pht002150,phv00156812,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS,,\phs000007\pht002150\phv00156812\APPLE\,pht002150.v4,\phs000007\pht002150\phv00156812\APPLE\,phv00156812,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",FFQ: FRESH APPLES OR PEARS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",,FFQ: FRESH APPLES OR PEARS,phs000007.v31,dcdefa0b8fab0e6638764b4927e312ee9e8e491111744130a35fa9e762b2c0e6,categorical,phv00156812.v4,phs000007,False,APPLE,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00156812\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FRESH APPLE OR PEAR (1),phs000007.v33.p14,phv00070783.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070783,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070783,True,False,False,APPLE,FRESH APPLE OR PEAR (1),,\phs000007\pht000689\phv00070783\APPLE\,pht000689.v6,\phs000007\pht000689\phv00070783\APPLE\,phv00070783,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",FRESH APPLE OR PEAR (1),{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,FRESH APPLE OR PEAR (1),phs000007.v31,51ed3f91ea0f419d2838e64d05939fa91b67df8011439aa07d1d2c72ba1c52d1,categorical,phv00070783.v5,phs000007,False,APPLE,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070783\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00068869.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068869,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '4-5 PER DAY', '5-6 PER WEEK', '6+ PER DAY', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid data or other (missing data)']",phs000007,pht000682,phv00068869,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht000682\phv00068869\APPLE\,pht000682.v6,\phs000007\pht000682\phv00068869\APPLE\,phv00068869,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,b31f313ae77541b3b02666de19aa634f49c782f52d1a42fafa7d213f563de922,categorical,phv00068869.v5,phs000007,False,APPLE,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068869\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00068301.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068301,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '4-5 PER DAY', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000681,phv00068301,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht000681\phv00068301\APPLE\,pht000681.v6,\phs000007\pht000681\phv00068301\APPLE\,phv00068301,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,09e2daab44cb9431e6a618352ec70169e022757f8fab3d21c7a832faeed09ce7,categorical,phv00068301.v5,phs000007,False,APPLE,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068301\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS,phs000007.v33.p14,phv00477544.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00157922.v1.p14,pht002152.v2.p14,ffreq0_21s,phv00157922,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '4-5 PER DAY', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002152,phv00157922,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht002152\phv00157922\APPLE\,pht002152.v1,\phs000007\pht002152\phv00157922\APPLE\,phv00157922,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,33a846a8b21edfc1ed8a84734300a51b4d9c07039d34eaf568d7e7751d788bc5,categorical,phv00157922.v1,phs000007,False,APPLE,FHS,Framingham Cohort,pht002152,ffreq0_21s,\phs000007\pht002152\phv00157922\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00478107.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478107,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00158239.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158239,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002153,phv00158239,True,False,False,APPLE,FFQ: FRESH APPLES OR PEARS (1),,\phs000007\pht002153\phv00158239\APPLE\,pht002153.v1,\phs000007\pht002153\phv00158239\APPLE\,phv00158239,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",FFQ: FRESH APPLES OR PEARS (1),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",,FFQ: FRESH APPLES OR PEARS (1),phs000007.v31,e78f1d37aefc61767d10331fa8e65d2e01c423bf923ac00e3866012fae0fb7ad,categorical,phv00158239.v1,phs000007,False,APPLE,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158239\APPLE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00523706.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523706,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,apple,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00524068.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524068,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Women's Health Initiative,APPLE,"Item #1: Apples and pears, med serv/day",phs000200.v12.p3,phv00111744.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111744,[],phs000200,pht001517,phv00111744,False,True,False,APPLE,"Item #1: Apples and pears, med serv/day",0.0,\phs000200\pht001517\phv00111744\APPLE\,pht001517.v6,\phs000200\pht001517\phv00111744\APPLE\,phv00111744,Form 60 - Items and Food Groups,"Item #1: Apples and pears, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #1: Apples and pears, med serv/day",phs000200.v12,527ec988ce9ca7b4ef25a9967493785a408cbe0730a1140b598bc95c4fb6d262,continuous,phv00111744.v6,phs000200,False,APPLE,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111744\APPLE\,0.0,3.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.apple,FRESH APPLE OR PAIR,1.35209713,q_ffreq_ex03_1_0302d,apple,Framingham Cohort,APPLE,FFQ: FRESH APPLES OR PEARS (1),phs000007.v33.p14,phv00478715.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478715,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.avocados,ONE QUARTER OF AN AVOCADO,2.317880795,q_ffreq_ex03_1_0302d,avocados,Framingham Cohort,AVOCADOS,ONE QUARTER OF AN AVOCADO,phs000007.v33.p14,phv00070801.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070801,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070801,True,False,False,AVOCADOS,ONE QUARTER OF AN AVOCADO,,\phs000007\pht000689\phv00070801\AVOCADOS\,pht000689.v6,\phs000007\pht000689\phv00070801\AVOCADOS\,phv00070801,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",ONE QUARTER OF AN AVOCADO,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,ONE QUARTER OF AN AVOCADO,phs000007.v31,2fa66f73cab4b63b9159d583dbb4455c5f2eba5d56feaf14298d7616dd3c0833,categorical,phv00070801.v5,phs000007,False,AVOCADOS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070801\AVOCADOS\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.bananas,BANANAS,1.07615894,q_ffreq_ex03_1_0302d,bananas,Framingham Cohort,BANANAS,BANANAS (1),phs000007.v33.p14,phv00070793.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070793,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070793,True,False,False,BANANAS,BANANAS (1),,\phs000007\pht000689\phv00070793\BANANAS\,pht000689.v6,\phs000007\pht000689\phv00070793\BANANAS\,phv00070793,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",BANANAS (1),{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,BANANAS (1),phs000007.v31,03d26e9558625326e6bd4b9426f5c85a8bac617e144cfbc8e74b7d217fc4bb01,categorical,phv00070793.v5,phs000007,False,BANANAS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070793\BANANAS\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.blackber,"BLACKBERRIES,BLUEBERRIES,RASPBERRIES",1.655629139,q_ffreq_ex03_1_0302d,blackber,Framingham Cohort,BLACKBER,"CUP OF BLACKBERRIES, BLUEBERRIES, RASPBERRIES",phs000007.v33.p14,phv00070795.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070795,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070795,True,False,False,BLACKBER,"CUP OF BLACKBERRIES, BLUEBERRIES, RASPBERRIES",,\phs000007\pht000689\phv00070795\BLACKBER\,pht000689.v6,\phs000007\pht000689\phv00070795\BLACKBER\,phv00070795,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP OF BLACKBERRIES, BLUEBERRIES, RASPBERRIES",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP OF BLACKBERRIES, BLUEBERRIES, RASPBERRIES",phs000007.v31,50b7bf84b7d8a06831e1ce5479788f130f7f946f7d5170981078296fe5ebbd62,categorical,phv00070795.v5,phs000007,False,BLACKBER,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070795\BLACKBER\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.broccoli,HALF CUP BROCCOLI,1.379690949,q_ffreq_ex03_1_0302d,broccoli,Framingham Cohort,BROCCOLI,HALF CUP OF BROCCOLI,phs000007.v33.p14,phv00070803.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070803,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070803,True,False,False,BROCCOLI,HALF CUP OF BROCCOLI,,\phs000007\pht000689\phv00070803\BROCCOLI\,pht000689.v6,\phs000007\pht000689\phv00070803\BROCCOLI\,phv00070803,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF BROCCOLI,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF BROCCOLI,phs000007.v31,5855d288c23077abc412436e47195819f95f73c6cc66ee222caa94450e46a4e7,categorical,phv00070803.v5,phs000007,False,BROCCOLI,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070803\BROCCOLI\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.broccoli,HALF CUP BROCCOLI,1.379690949,q_ffreq_ex03_1_0302d,broccoli,Women's Health Initiative,BROCCOLI,"Item #26: Broccoli, med serv/day",phs000200.v12.p3,phv00111769.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111769,[],phs000200,pht001517,phv00111769,False,True,False,BROCCOLI,"Item #26: Broccoli, med serv/day",0.0,\phs000200\pht001517\phv00111769\BROCCOLI\,pht001517.v6,\phs000200\pht001517\phv00111769\BROCCOLI\,phv00111769,Form 60 - Items and Food Groups,"Item #26: Broccoli, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #26: Broccoli, med serv/day",phs000200.v12,dd60d323ad4618a28c9b95b4d3f6827539f1bbed78df65a90e42ce927ea7c65d,continuous,phv00111769.v6,phs000200,False,BROCCOLI,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111769\BROCCOLI\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.bruselsp,HALF CUP BRUSSEL SPROUTS,1.62803532,q_ffreq_ex03_1_0302d,bruselsp,Framingham Cohort,BRUSELSP,HALF CUP OF BRUSSEL SPROUTS,phs000007.v33.p14,phv00070806.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070806,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070806,True,False,False,BRUSELSP,HALF CUP OF BRUSSEL SPROUTS,,\phs000007\pht000689\phv00070806\BRUSELSP\,pht000689.v6,\phs000007\pht000689\phv00070806\BRUSELSP\,phv00070806,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF BRUSSEL SPROUTS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF BRUSSEL SPROUTS,phs000007.v31,1fffbaaa8ec503ac882f2afb021b6e274ad607a0287fd1b4d78c0787939c9815,categorical,phv00070806.v5,phs000007,False,BRUSELSP,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070806\BRUSELSP\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.cabbage,CABBAGE COLE SLAW OR SAUERKRAUT,1.655629139,q_ffreq_ex03_1_0302d,cabbage,Framingham Cohort,CABBAGE,CUP OF CABBAGE COLE SLAW OR SAUERKRAUT,phs000007.v33.p14,phv00070804.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070804,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070804,True,False,False,CABBAGE,CUP OF CABBAGE COLE SLAW OR SAUERKRAUT,,\phs000007\pht000689\phv00070804\CABBAGE\,pht000689.v6,\phs000007\pht000689\phv00070804\CABBAGE\,phv00070804,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",CUP OF CABBAGE COLE SLAW OR SAUERKRAUT,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,CUP OF CABBAGE COLE SLAW OR SAUERKRAUT,phs000007.v31,0230689593ba0f3bfdf085a49db0946324a31aaa1406da0ef5856c155de89ea6,categorical,phv00070804.v5,phs000007,False,CABBAGE,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070804\CABBAGE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.carrots,ONE WHOLE OR HALF CUP COOKED,0.965783665,q_ffreq_ex03_1_0302d,carrots,Framingham Cohort,CARROTS,ONE WHOLE OR HALF CUP OF COOKED CARROTS,phs000007.v33.p14,phv00070807.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070807,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070807,True,False,False,CARROTS,ONE WHOLE OR HALF CUP OF COOKED CARROTS,,\phs000007\pht000689\phv00070807\CARROTS\,pht000689.v6,\phs000007\pht000689\phv00070807\CARROTS\,phv00070807,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",ONE WHOLE OR HALF CUP OF COOKED CARROTS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,ONE WHOLE OR HALF CUP OF COOKED CARROTS,phs000007.v31,e3baa7bf07d9073a35348016f67b8cb9723a0ba2f1c60881ad88cbf325b1c23c,categorical,phv00070807.v5,phs000007,False,CARROTS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070807\CARROTS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.caulflwr,CAULIFLOWER-HALF CUP,1.710816777,q_ffreq_ex03_1_0302d,caulflwr,Framingham Cohort,CAULFLWR,"CAULIFLOWER, HALF CUP",phs000007.v33.p14,phv00070805.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070805,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070805,True,False,False,CAULFLWR,"CAULIFLOWER, HALF CUP",,\phs000007\pht000689\phv00070805\CAULFLWR\,pht000689.v6,\phs000007\pht000689\phv00070805\CAULFLWR\,phv00070805,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CAULIFLOWER, HALF CUP",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CAULIFLOWER, HALF CUP",phs000007.v31,c5993ed9a80635863a8c4253b84fe3913eb597a8d402ad1f9849f2166faea038,categorical,phv00070805.v5,phs000007,False,CAULFLWR,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070805\CAULFLWR\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.cherries,FRESH OR CANNED CHERRIES,1.931567329,q_ffreq_ex03_1_0302d,cherries,Framingham Cohort,CHERRIES,CUP OF FRESH OR CANNED CHERRIES,phs000007.v33.p14,phv00070799.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070799,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070799,True,False,False,CHERRIES,CUP OF FRESH OR CANNED CHERRIES,,\phs000007\pht000689\phv00070799\CHERRIES\,pht000689.v6,\phs000007\pht000689\phv00070799\CHERRIES\,phv00070799,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",CUP OF FRESH OR CANNED CHERRIES,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,CUP OF FRESH OR CANNED CHERRIES,phs000007.v31,16dc597cf1164236393eefc38ad14409f33e25cdb58206bf9f3e1727325f6c63,categorical,phv00070799.v5,phs000007,False,CHERRIES,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070799\CHERRIES\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00158262.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158262,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002153,phv00158262,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht002153\phv00158262\CORN\,pht002153.v1,\phs000007\pht002153\phv00158262\CORN\,phv00158262,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,7662570ac38fd692b7424763f5c3f9e71afd0b438f9d39636361d2783bfe892f,categorical,phv00158262.v1,phs000007,False,CORN,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158262\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN,phs000007.v33.p14,phv00162195.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162195,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month', 'invalid data or other (missing data)']",phs000007,pht002350,phv00162195,True,False,False,CORN,FFQ: CORN,,\phs000007\pht002350\phv00162195\CORN\,pht002350.v5,\phs000007\pht002350\phv00162195\CORN\,phv00162195,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",FFQ: CORN,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",,FFQ: CORN,phs000007.v31,78ada835a4ba15bc43a4e4212d7b8eabc48d89d89b1f19ecf597b8dbf8239405,categorical,phv00162195.v5,phs000007,False,CORN,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162195\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00523729.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523729,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00172525.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172525,"['1 - 3 per month', '1 per day', '1 per week', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172525,True,False,False,Q_CORN,"FFQ: Corn (1 ear), or frozen or canned (1/2 cup)",,\phs000007\pht002900\phv00172525\Q_CORN\,pht002900.v3,\phs000007\pht002900\phv00172525\Q_CORN\,phv00172525,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","FFQ: Corn (1 ear), or frozen or canned (1/2 cup)",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,"FFQ: Corn (1 ear), or frozen or canned (1/2 cup)",phs000007.v31,dc11a23bae3d1879e8c6af6ef88172115ec8c5757ac2f7a1cb3d13275c7a6c7b,categorical,phv00172525.v3,phs000007,False,Q_CORN,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172525\Q_CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN,phs000007.v33.p14,phv00477004.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477004,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00157945.v1.p14,pht002152.v2.p14,ffreq0_21s,phv00157945,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002152,phv00157945,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht002152\phv00157945\CORN\,pht002152.v1,\phs000007\pht002152\phv00157945\CORN\,phv00157945,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,f932ff9adf599a6bf8ddf1112b1c509f99e99d59327912c94cebdee5b81e3d59,categorical,phv00157945.v1,phs000007,False,CORN,FHS,Framingham Cohort,pht002152,ffreq0_21s,\phs000007\pht002152\phv00157945\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN,phs000007.v33.p14,phv00477567.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00478130.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478130,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00478741.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478741,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Women's Health Initiative,CORN,"Item #21: Corn and hominy, med serv/day",phs000200.v12.p3,phv00111764.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111764,[],phs000200,pht001517,phv00111764,False,True,False,CORN,"Item #21: Corn and hominy, med serv/day",0.0,\phs000200\pht001517\phv00111764\CORN\,pht001517.v6,\phs000200\pht001517\phv00111764\CORN\,phv00111764,Form 60 - Items and Food Groups,"Item #21: Corn and hominy, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #21: Corn and hominy, med serv/day",phs000200.v12,cf36ba8ba1249c7461889663d3085df237787824e5cf030fa9828ff1a48c094b,continuous,phv00111764.v6,phs000200,False,CORN,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111764\CORN\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00157468.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157468,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002151,phv00157468,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht002151\phv00157468\CORN\,pht002151.v1,\phs000007\pht002151\phv00157468\CORN\,phv00157468,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,93abd599a4608a286d82e9aa247da465c99eab9635ba4b03ebd4f94c8ca04aaf,categorical,phv00157468.v1,phs000007,False,CORN,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157468\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,corn,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00524093.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524093,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,"EAR OR HALF CUP OF CORN, (FROZEN, FRESH, CANNED)",phs000007.v33.p14,phv00070809.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070809,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070809,True,False,False,CORN,"EAR OR HALF CUP OF CORN, (FROZEN, FRESH, CANNED)",,\phs000007\pht000689\phv00070809\CORN\,pht000689.v6,\phs000007\pht000689\phv00070809\CORN\,phv00070809,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","EAR OR HALF CUP OF CORN, (FROZEN, FRESH, CANNED)",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"EAR OR HALF CUP OF CORN, (FROZEN, FRESH, CANNED)",phs000007.v31,cdae1874c2d19f198d6d6d24d658287b0fe31df0d9c90273efd43306913b3ab3,categorical,phv00070809.v5,phs000007,False,CORN,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070809\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00068892.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068892,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid data or other (missing data)']",phs000007,pht000682,phv00068892,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht000682\phv00068892\CORN\,pht000682.v6,\phs000007\pht000682\phv00068892\CORN\,phv00068892,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,89f053745e24b9150071a601f3d69cdde0a6e277a0f6f8df0f0bbb3cc69060a1,categorical,phv00068892.v5,phs000007,False,CORN,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068892\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00068324.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068324,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000681,phv00068324,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht000681\phv00068324\CORN\,pht000681.v6,\phs000007\pht000681\phv00068324\CORN\,phv00068324,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,2a2df69992e3ed4e115b53be92d49859e2a6efe463bab7ea0a023dc3e456eb0b,categorical,phv00068324.v5,phs000007,False,CORN,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068324\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v33.p14,phv00068160.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00068160,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000680,phv00068160,True,False,False,CORN,FFQ: CORN (1 EAR OR 1/2 CUP),,\phs000007\pht000680\phv00068160\CORN\,pht000680.v6,\phs000007\pht000680\phv00068160\CORN\,phv00068160,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",FFQ: CORN (1 EAR OR 1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",,FFQ: CORN (1 EAR OR 1/2 CUP),phs000007.v31,b54437101d229b4c87b6b9acbdaa5e895d713348322961fb70cc4d31894d3121,categorical,phv00068160.v5,phs000007,False,CORN,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00068160\CORN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.corn,EAR OR HALF CUP FROZEN,1.62803532,q_ffreq_ex03_1_0302d,corn,Framingham Cohort,CORN,FFQ: CORN,phs000007.v33.p14,phv00156835.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00156835,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '4 - 5 per day', '5 - 6 per week', 'Invalid data or other (missing data)', 'Never, or less than once per month']",phs000007,pht002150,phv00156835,True,False,False,CORN,FFQ: CORN,,\phs000007\pht002150\phv00156835\CORN\,pht002150.v4,\phs000007\pht002150\phv00156835\CORN\,phv00156835,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",FFQ: CORN,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",,FFQ: CORN,phs000007.v31,ae8c73ce445b90272acdf6bdfe7b5739ae3f93c7c2b980011f3c47c662b44c95,categorical,phv00156835.v4,phs000007,False,CORN,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00156835\CORN\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.dates,HALF CUP DATES OR FIGS,1.90397351,q_ffreq_ex03_1_0302d,dates,Framingham Cohort,DATES,HALF CUP OF DATES OR FIGS,phs000007.v33.p14,phv00070792.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070792,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070792,True,False,True,DATES,HALF CUP OF DATES OR FIGS,,\phs000007\pht000689\phv00070792\DATES\,pht000689.v6,\phs000007\pht000689\phv00070792\DATES\,phv00070792,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF DATES OR FIGS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF DATES OR FIGS,phs000007.v31,c21f3dbb352cd95129f2c9603436978529317bbc7781f9efc864b4cdf333c255,categorical,phv00070792.v5,phs000007,True,DATES,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070792\DATES\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.grapfrut,HALF GRAPEFRUIT OR GLASS JUICE,1.90397351,q_ffreq_ex03_1_0302d,grapfrut,Framingham Cohort,GRAPFRUT,HALF GRAPEFRUIT OR GLASS JUICE,phs000007.v33.p14,phv00070788.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070788,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070788,True,False,False,GRAPFRUT,HALF GRAPEFRUIT OR GLASS JUICE,,\phs000007\pht000689\phv00070788\GRAPFRUT\,pht000689.v6,\phs000007\pht000689\phv00070788\GRAPFRUT\,phv00070788,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF GRAPEFRUIT OR GLASS JUICE,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF GRAPEFRUIT OR GLASS JUICE,phs000007.v31,e91ac8118b249871696352126f260ec34f90d5c07b46845ee11ba72fb463e691,categorical,phv00070788.v5,phs000007,False,GRAPFRUT,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070788\GRAPFRUT\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.greenben,GREEN STRING BEANS OR ASPARAGUS,1.434878587,q_ffreq_ex03_1_0302d,greenben,Framingham Cohort,GREENBEN,GREEN OR STRING BEANS OR ASPARAGUS,phs000007.v33.p14,phv00070802.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070802,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070802,True,False,False,GREENBEN,GREEN OR STRING BEANS OR ASPARAGUS,,\phs000007\pht000689\phv00070802\GREENBEN\,pht000689.v6,\phs000007\pht000689\phv00070802\GREENBEN\,phv00070802,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",GREEN OR STRING BEANS OR ASPARAGUS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,GREEN OR STRING BEANS OR ASPARAGUS,phs000007.v31,541edd3f75c016ca173c1ca580a5d4e22bf19e2f2e6cb5964bd020e65c35d733,categorical,phv00070802.v5,phs000007,False,GREENBEN,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070802\GREENBEN\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.iceberg,CUP OF ICEBERG OR HEAD LETTUCE,1.490066225,q_ffreq_ex03_1_0302d,iceberg,Framingham Cohort,ICEBERG,CUP OF ICEBERG OR HEAD LETTUCE,phs000007.v33.p14,phv00070813.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070813,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070813,True,False,False,ICEBERG,CUP OF ICEBERG OR HEAD LETTUCE,,\phs000007\pht000689\phv00070813\ICEBERG\,pht000689.v6,\phs000007\pht000689\phv00070813\ICEBERG\,phv00070813,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",CUP OF ICEBERG OR HEAD LETTUCE,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,CUP OF ICEBERG OR HEAD LETTUCE,phs000007.v31,eb1a64df5aefcdda7220316b7f0b06f10caa02789ee46adabd37456f4d28ef45,categorical,phv00070813.v5,phs000007,False,ICEBERG,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070813\ICEBERG\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"CUP OF KALE, MUSTARD, CHARD, BEET OR OTHER GREENS",phs000007.v33.p14,phv00070812.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070812,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070812,True,False,False,KALE,"CUP OF KALE, MUSTARD, CHARD, BEET OR OTHER GREENS",,\phs000007\pht000689\phv00070812\KALE\,pht000689.v6,\phs000007\pht000689\phv00070812\KALE\,phv00070812,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP OF KALE, MUSTARD, CHARD, BEET OR OTHER GREENS",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP OF KALE, MUSTARD, CHARD, BEET OR OTHER GREENS",phs000007.v31,74be396a7da6b54bc3a28ffb660332a2ea41fbf5d050aa2e85b0bcdcf2a4c791,categorical,phv00070812.v5,phs000007,False,KALE,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070812\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v33.p14,phv00156844.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00156844,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Invalid data or other (missing data)', 'Never, or less than once per month']",phs000007,pht002150,phv00156844,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",,\phs000007\pht002150\phv00156844\KALE\,pht002150.v4,\phs000007\pht002150\phv00156844\KALE\,phv00156844,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","FFQ: KALE, MUSTARD, CHARD GREENS",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v31,41e9232636343b4dab6249c14a2924efb81eca0ac0c887a3f4bf919b4fcbfa5d,categorical,phv00156844.v4,phs000007,False,KALE,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00156844\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00157477.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157477,"['1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002151,phv00157477,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht002151\phv00157477\KALE\,pht002151.v1,\phs000007\pht002151\phv00157477\KALE\,phv00157477,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,467fa5997258ad1c84d9990674ada051bd3e59106bae24ee5c8031a4bc005676,categorical,phv00157477.v1,phs000007,False,KALE,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157477\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00157954.v1.p14,pht002152.v2.p14,ffreq0_21s,phv00157954,"['1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002152,phv00157954,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht002152\phv00157954\KALE\,pht002152.v1,\phs000007\pht002152\phv00157954\KALE\,phv00157954,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,229caac901ef877362e6c9d255ce161a5924c835b5e57fcb0162fe5aa5e40f7d,categorical,phv00157954.v1,phs000007,False,KALE,FHS,Framingham Cohort,pht002152,ffreq0_21s,\phs000007\pht002152\phv00157954\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00158271.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158271,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002153,phv00158271,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht002153\phv00158271\KALE\,pht002153.v1,\phs000007\pht002153\phv00158271\KALE\,phv00158271,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,5729287ebd1a04df2aced30fae42a248b368e4f9373d121469e7901d61011ec0,categorical,phv00158271.v1,phs000007,False,KALE,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158271\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v33.p14,phv00162204.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162204,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month', 'invalid data or other (missing data)']",phs000007,pht002350,phv00162204,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",,\phs000007\pht002350\phv00162204\KALE\,pht002350.v5,\phs000007\pht002350\phv00162204\KALE\,phv00162204,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","FFQ: KALE, MUSTARD, CHARD GREENS",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v31,239d6b1dce8a63e2c22f1879f9a94c7088d1cb82bf8a024d68e2ccb846e37beb,categorical,phv00162204.v5,phs000007,False,KALE,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162204\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v33.p14,phv00477576.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS",phs000007.v33.p14,phv00477013.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00478139.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478139,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD GREENS, OR CHARD (1/2 CUP)",phs000007.v33.p14,phv00478746.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478746,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MSTRD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00523738.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523738,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,kale,"FFQ: KALE, MUSTARD GREENS, OR CHARD (1/2 CUP)",phs000007.v33.p14,phv00524098.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524098,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD GREENS, OR CHARD (1/2 CUP)",phs000007.v33.p14,phv00172530.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172530,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172530,True,False,False,Q_KALE,"FFQ: Kale, mustard greens or chard",,\phs000007\pht002900\phv00172530\Q_KALE\,pht002900.v3,\phs000007\pht002900\phv00172530\Q_KALE\,phv00172530,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","FFQ: Kale, mustard greens or chard",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,"FFQ: Kale, mustard greens or chard",phs000007.v31,6815cf216eaa6315db1ba24295b0d5485e2c9986cfe54b263452027e2ae3d152,categorical,phv00172530.v3,phs000007,False,Q_KALE,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172530\Q_KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00068333.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068333,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000681,phv00068333,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht000681\phv00068333\KALE\,pht000681.v6,\phs000007\pht000681\phv00068333\KALE\,phv00068333,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,0117d0bb281631a6fa7d1f5306b4b573e41fb04446f43b2cd2c618246ebb8b6d,categorical,phv00068333.v5,phs000007,False,KALE,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068333\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00068901.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068901,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid data or other (missing data)']",phs000007,pht000682,phv00068901,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht000682\phv00068901\KALE\,pht000682.v6,\phs000007\pht000682\phv00068901\KALE\,phv00068901,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,05c11302ff88ef6eb8d3bc7eaebaef79f5442dd7380b8fe48015f933724c5ff6,categorical,phv00068901.v5,phs000007,False,KALE,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068901\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.kale,"KALE,MUSTARD,CHARD,BEET OR OTHER GREENS",2.786975717,q_ffreq_ex03_1_0302d,kale,Framingham Cohort,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v33.p14,phv00068163.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00068163,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000680,phv00068163,True,False,False,KALE,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",,\phs000007\pht000680\phv00068163\KALE\,pht000680.v6,\phs000007\pht000680\phv00068163\KALE\,phv00068163,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",,"FFQ: KALE, MUSTARD, CHARD GREENS (1/2 CUP)",phs000007.v31,33a97567ee7c3565cffa160e35a139a55e3f9ce712019ac1a33b82ad4aa2892a,categorical,phv00068163.v5,phs000007,False,KALE,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00068163\KALE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.lentils,"LENTILS, CHICK PEAS, KIDNEY,PINTO BEANS",2.124724062,q_ffreq_ex03_1_0302d,lentils,Framingham Cohort,LENTILS,"CUP LENTILS, CHICK PEAS, KIDNEY, PINTO BEANS",phs000007.v33.p14,phv00070823.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070823,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070823,True,False,True,LENTILS,"CUP LENTILS, CHICK PEAS, KIDNEY, PINTO BEANS",,\phs000007\pht000689\phv00070823\LENTILS\,pht000689.v6,\phs000007\pht000689\phv00070823\LENTILS\,phv00070823,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP LENTILS, CHICK PEAS, KIDNEY, PINTO BEANS",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP LENTILS, CHICK PEAS, KIDNEY, PINTO BEANS",phs000007.v31,72e87e46ddbdfb4a01e884a6684dd4d3350014126d9b4759387b871d97ba466e,categorical,phv00070823.v5,phs000007,True,LENTILS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070823\LENTILS\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.melon,CANTELOUPE OR HONEYDEW MELON-SLICE,1.379690949,q_ffreq_ex03_1_0302d,melon,Framingham Cohort,MELON,CANTELOUPE OR HONEYDEW MELON (SMALL SLICE),phs000007.v33.p14,phv00070796.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070796,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070796,True,False,False,MELON,CANTELOUPE OR HONEYDEW MELON (SMALL SLICE),,\phs000007\pht000689\phv00070796\MELON\,pht000689.v6,\phs000007\pht000689\phv00070796\MELON\,phv00070796,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",CANTELOUPE OR HONEYDEW MELON (SMALL SLICE),{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,CANTELOUPE OR HONEYDEW MELON (SMALL SLICE),phs000007.v31,8b30b74f05cf494c9726347d7056381d633e400244df801e03ba66b7ca818d25,categorical,phv00070796.v5,phs000007,False,MELON,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070796\MELON\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.orange,ORANGE OR TANGERINE,2.069536424,q_ffreq_ex03_1_0302d,orange,Framingham Cohort,ORANGE,ORANGE OR TANGERINE (1),phs000007.v33.p14,phv00070786.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070786,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070786,True,False,False,ORANGE,ORANGE OR TANGERINE (1),,\phs000007\pht000689\phv00070786\ORANGE\,pht000689.v6,\phs000007\pht000689\phv00070786\ORANGE\,phv00070786,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",ORANGE OR TANGERINE (1),{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,ORANGE OR TANGERINE (1),phs000007.v31,48199377afccc8be8fcc9ec68a6a929503f64ec21f9e45f39c328de838643ffe,categorical,phv00070786.v5,phs000007,False,ORANGE,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070786\ORANGE\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.orange,ORANGE OR TANGERINE,2.069536424,q_ffreq_ex03_1_0302d,orange,Women's Health Initiative,ORANGE,"Item #9: Oranges, grapefruit and tangerines, med serv/day",phs000200.v12.p3,phv00111752.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111752,[],phs000200,pht001517,phv00111752,False,True,False,ORANGE,"Item #9: Oranges, grapefruit and tangerines, med serv/day",0.0,\phs000200\pht001517\phv00111752\ORANGE\,pht001517.v6,\phs000200\pht001517\phv00111752\ORANGE\,phv00111752,Form 60 - Items and Food Groups,"Item #9: Oranges, grapefruit and tangerines, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #9: Oranges, grapefruit and tangerines, med serv/day",phs000200.v12,0d0dfdfafb487826eee4dabcc7563c40cc4986c893f6f2dec4e6e6f8bdbcb374,continuous,phv00111752.v6,phs000200,False,ORANGE,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111752\ORANGE\,0.0,3.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.papayas,HALF CUP PAPAYAS,1.90397351,q_ffreq_ex03_1_0302d,papayas,Framingham Cohort,PAPAYAS,HALF CUP OF PAPAYAS,phs000007.v33.p14,phv00070800.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070800,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070800,True,False,True,PAPAYAS,HALF CUP OF PAPAYAS,,\phs000007\pht000689\phv00070800\PAPAYAS\,pht000689.v6,\phs000007\pht000689\phv00070800\PAPAYAS\,phv00070800,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF PAPAYAS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF PAPAYAS,phs000007.v31,0c83aed3f95403b41b97a0cf5baca55c2655030a6ae499a8e7a2ef675b7d30ac,categorical,phv00070800.v5,phs000007,True,PAPAYAS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070800\PAPAYAS\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.peaches,"PEACHES,APRICOTS,PLUMS OR NECTARINES",1.379690949,q_ffreq_ex03_1_0302d,peaches,Framingham Cohort,PEACHES,"PEACHES, APRICOTS, PLUMS, NECTARINES (PIECE OR 1/2 CUP)",phs000007.v33.p14,phv00070789.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070789,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070789,True,False,False,PEACHES,"PEACHES, APRICOTS, PLUMS, NECTARINES (PIECE OR 1/2 CUP)",,\phs000007\pht000689\phv00070789\PEACHES\,pht000689.v6,\phs000007\pht000689\phv00070789\PEACHES\,phv00070789,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","PEACHES, APRICOTS, PLUMS, NECTARINES (PIECE OR 1/2 CUP)",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"PEACHES, APRICOTS, PLUMS, NECTARINES (PIECE OR 1/2 CUP)",phs000007.v31,79c9392f6a0b8e72053b5baf43a37c0c3634d2ef54b2885cd226c6c77223d8ca,categorical,phv00070789.v5,phs000007,False,PEACHES,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070789\PEACHES\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.peaches,"PEACHES,APRICOTS,PLUMS OR NECTARINES",1.379690949,q_ffreq_ex03_1_0302d,peaches,Framingham Cohort,PEACHES,FFQ: PEACHES OR PLUMS (1 FRESH OR 1/2 CUP CANNED),phs000007.v33.p14,phv00172508.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172508,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '4 - 5 per day', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172508,True,False,False,Q_PEACHES,FFQ: Peaches or plums (1 fresh or 1/2 cup canned),,\phs000007\pht002900\phv00172508\Q_PEACHES\,pht002900.v3,\phs000007\pht002900\phv00172508\Q_PEACHES\,phv00172508,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",FFQ: Peaches or plums (1 fresh or 1/2 cup canned),{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,FFQ: Peaches or plums (1 fresh or 1/2 cup canned),phs000007.v31,3d258d3c5d4ed7672528e0a80eeb52ba00e4c77fb2fd3db53849e6815b695ff0,categorical,phv00172508.v3,phs000007,False,Q_PEACHES,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172508\Q_PEACHES\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.peaches,"PEACHES,APRICOTS,PLUMS OR NECTARINES",1.379690949,q_ffreq_ex03_1_0302d,peaches,Framingham Cohort,PEACHES,FFQ: PEACHES OR PLUMS (1 FRESH OR 1/2 CUP CANNED),phs000007.v33.p14,phv00478724.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478724,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.peaches,"PEACHES,APRICOTS,PLUMS OR NECTARINES",1.379690949,q_ffreq_ex03_1_0302d,peaches,Framingham Cohort,peaches,FFQ: PEACHES OR PLUMS (1 FRESH OR 1/2 CUP CANNED),phs000007.v33.p14,phv00524077.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524077,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00068325.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068325,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000681,phv00068325,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht000681\phv00068325\PEAS\,pht000681.v6,\phs000007\pht000681\phv00068325\PEAS\,phv00068325,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,5f83d84efec3aaedff844a79dd6391fff9b6283214cd64f0afc01d42dfc0cbe4,categorical,phv00068325.v5,phs000007,False,PEAS,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068325\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00068893.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068893,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid data or other (missing data)']",phs000007,pht000682,phv00068893,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht000682\phv00068893\PEAS\,pht000682.v6,\phs000007\pht000682\phv00068893\PEAS\,phv00068893,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,7b112dc7c054441e34318b014ca5fbc968277176c1a7b3961497fe096d758ceb,categorical,phv00068893.v5,phs000007,False,PEAS,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068893\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00068166.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00068166,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000680,phv00068166,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht000680\phv00068166\PEAS\,pht000680.v6,\phs000007\pht000680\phv00068166\PEAS\,phv00068166,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,ec807843d60c404f1350c83d6c56e0a356fb8e1bdf3a7b8c36e88051e47d30cc,categorical,phv00068166.v5,phs000007,False,PEAS,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00068166\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS,phs000007.v33.p14,phv00156836.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00156836,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '4 - 5 per day', '5 - 6 per week', 'Invalid data or other (missing data)', 'Never, or less than once per month']",phs000007,pht002150,phv00156836,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS,,\phs000007\pht002150\phv00156836\PEAS\,pht002150.v4,\phs000007\pht002150\phv00156836\PEAS\,phv00156836,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",FFQ: PEAS OR LIMA BEANS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",,FFQ: PEAS OR LIMA BEANS,phs000007.v31,9ddaa2d0c3e4ef1ad5cbfd10c559039e4577ccde6a8c8757941813ad45611652,categorical,phv00156836.v4,phs000007,False,PEAS,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00156836\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00157469.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157469,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH']",phs000007,pht002151,phv00157469,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht002151\phv00157469\PEAS\,pht002151.v1,\phs000007\pht002151\phv00157469\PEAS\,phv00157469,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,5f1fa6e52efcd511f1239262c1e33e6378afa3b13d7e6b7cd763742be27b567b,categorical,phv00157469.v1,phs000007,False,PEAS,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157469\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS,phs000007.v33.p14,phv00477005.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477005,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00158263.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158263,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002153,phv00158263,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht002153\phv00158263\PEAS\,pht002153.v1,\phs000007\pht002153\phv00158263\PEAS\,phv00158263,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,897f92617354eb2f1ef93f1d8b403d27746b911929d4a7250ec70c666dd110d8,categorical,phv00158263.v1,phs000007,False,PEAS,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158263\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS,phs000007.v33.p14,phv00162196.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162196,"['1 - 3 per month', '1 per day', '1 per week', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month', 'invalid data or other (missing data)']",phs000007,pht002350,phv00162196,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS,,\phs000007\pht002350\phv00162196\PEAS\,pht002350.v5,\phs000007\pht002350\phv00162196\PEAS\,phv00162196,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",FFQ: PEAS OR LIMA BEANS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",,FFQ: PEAS OR LIMA BEANS,phs000007.v31,a5066f514f0d1577f5ac239fefa16a8f2c7e2eeca09014d22a9ac03077f1dbbb,categorical,phv00162196.v5,phs000007,False,PEAS,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162196\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,peas,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00524086.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524086,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00523730.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523730,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00478734.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478734,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00478131.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478131,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS,phs000007.v33.p14,phv00477568.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00157946.v1.p14,pht002152.v2.p14,ffreq0_21s,phv00157946,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-3 PER DAY', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH']",phs000007,pht002152,phv00157946,True,False,False,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),,\phs000007\pht002152\phv00157946\PEAS\,pht002152.v1,\phs000007\pht002152\phv00157946\PEAS\,phv00157946,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",FFQ: PEAS OR LIMA BEANS (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v31,ba0eae0d75da754121cd751f057c1654b2daab62bae4fc1b46915ab2959d1f6d,categorical,phv00157946.v1,phs000007,False,PEAS,FHS,Framingham Cohort,pht002152,ffreq0_21s,\phs000007\pht002152\phv00157946\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,FFQ: PEAS OR LIMA BEANS (1/2 CUP),phs000007.v33.p14,phv00172518.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172518,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172518,True,False,False,Q_PEAS,"FFQ: Peas or lima beans, fresh, frozen or canned",,\phs000007\pht002900\phv00172518\Q_PEAS\,pht002900.v3,\phs000007\pht002900\phv00172518\Q_PEAS\,phv00172518,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","FFQ: Peas or lima beans, fresh, frozen or canned",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,"FFQ: Peas or lima beans, fresh, frozen or canned",phs000007.v31,3478fb31d1f055e625e45ae7fe13fab91cc053ed494e3a2c7ebcd3bed92d1951,categorical,phv00172518.v3,phs000007,False,Q_PEAS,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172518\Q_PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peas,"PEAS,LIMA BEANS OR PEA PODS",1.766004415,q_ffreq_ex03_1_0302d,peas,Framingham Cohort,PEAS,"PEAS, LIMA BEANS OR PEA PODS (1/2 CUP)",phs000007.v33.p14,phv00070815.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070815,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070815,True,False,False,PEAS,"PEAS, LIMA BEANS OR PEA PODS (1/2 CUP)",,\phs000007\pht000689\phv00070815\PEAS\,pht000689.v6,\phs000007\pht000689\phv00070815\PEAS\,phv00070815,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","PEAS, LIMA BEANS OR PEA PODS (1/2 CUP)",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"PEAS, LIMA BEANS OR PEA PODS (1/2 CUP)",phs000007.v31,e42879ffb1df17266c0a258bb20815e53fe986c4f67839fd066f46c00993cf34,categorical,phv00070815.v5,phs000007,False,PEAS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070815\PEAS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peppers,GREEN OR RED PEPPERS-HALF CUP,2.317880795,q_ffreq_ex03_1_0302d,peppers,Framingham Cohort,peppers,FFQ: PEPPERS (3 SLICES),phs000007.v33.p14,phv00524104.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524104,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peppers,GREEN OR RED PEPPERS-HALF CUP,2.317880795,q_ffreq_ex03_1_0302d,peppers,Framingham Cohort,PEPPERS,GREEN OR RED PEPPERS-HALF CUP,phs000007.v33.p14,phv00070811.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070811,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070811,True,False,False,PEPPERS,GREEN OR RED PEPPERS-HALF CUP,,\phs000007\pht000689\phv00070811\PEPPERS\,pht000689.v6,\phs000007\pht000689\phv00070811\PEPPERS\,phv00070811,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",GREEN OR RED PEPPERS-HALF CUP,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,GREEN OR RED PEPPERS-HALF CUP,phs000007.v31,93440668e71b6e6e960261cc78002d337f1bce8a3ee1448f6f85dac367b85a8b,categorical,phv00070811.v5,phs000007,False,PEPPERS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070811\PEPPERS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peppers,GREEN OR RED PEPPERS-HALF CUP,2.317880795,q_ffreq_ex03_1_0302d,peppers,Framingham Cohort,PEPPERS,FFQ: PEPPERS (3 SLICES),phs000007.v33.p14,phv00478752.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478752,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.peppers,GREEN OR RED PEPPERS-HALF CUP,2.317880795,q_ffreq_ex03_1_0302d,peppers,Framingham Cohort,PEPPERS,FFQ: PEPPERS (3 SLICES),phs000007.v33.p14,phv00172536.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172536,"['1 - 3 per month', '1 per day', '1 per week', '2 - 3 per day', '2 - 4 per week', '4 - 5 per day', '5 - 6 per week', 'Never, or less than once per month']",phs000007,pht002900,phv00172536,True,False,False,Q_PEPPERS,"FFQ: Peppers - green, yellow or red",,\phs000007\pht002900\phv00172536\Q_PEPPERS\,pht002900.v3,\phs000007\pht002900\phv00172536\Q_PEPPERS\,phv00172536,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","FFQ: Peppers - green, yellow or red",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",,"FFQ: Peppers - green, yellow or red",phs000007.v31,357b977a58be2f023a9ec242bb2ffeb568c38e1e59d7132044939b575be297ce,categorical,phv00172536.v3,phs000007,False,Q_PEPPERS,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172536\Q_PEPPERS\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.pineappl,FRESH OR CANNED PINEAPPLE,1.766004415,q_ffreq_ex03_1_0302d,pineappl,Framingham Cohort,PINEAPPL,FRESH OR CANNED PINEAPPLE (1/2 CUP),phs000007.v33.p14,phv00070798.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070798,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070798,True,False,False,PINEAPPL,FRESH OR CANNED PINEAPPLE (1/2 CUP),,\phs000007\pht000689\phv00070798\PINEAPPL\,pht000689.v6,\phs000007\pht000689\phv00070798\PINEAPPL\,phv00070798,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",FRESH OR CANNED PINEAPPLE (1/2 CUP),{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,FRESH OR CANNED PINEAPPLE (1/2 CUP),phs000007.v31,c255523f55abc932cd87f3b537ccd406dc7477daf753094dcbf3cf326fb27b8b,categorical,phv00070798.v5,phs000007,False,PINEAPPL,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070798\PINEAPPL\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.prunes,HALF CUP RAISINS OR DRY APRICOTS,1.738410596,q_ffreq_ex03_1_0302d,prunes,Framingham Cohort,PRUNES,HALF CUP OF PRUNES OR DRY APRICOTS,phs000007.v33.p14,phv00070791.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070791,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070791,True,False,False,PRUNES,HALF CUP OF PRUNES OR DRY APRICOTS,,\phs000007\pht000689\phv00070791\PRUNES\,pht000689.v6,\phs000007\pht000689\phv00070791\PRUNES\,phv00070791,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF PRUNES OR DRY APRICOTS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF PRUNES OR DRY APRICOTS,phs000007.v31,2e9aa4cf4021a88aa8fdc92881693b0368ed295544e5247cd8a32a617f45e7cd,categorical,phv00070791.v5,phs000007,False,PRUNES,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070791\PRUNES\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.raisins,SMALL PACK RAISINS OR GRAPES,1.600441501,q_ffreq_ex03_1_0302d,raisins,Framingham Cohort,RAISINS,SMALL PACK OF RAISINS OR SMALL BUNCH OF GRAPES,phs000007.v33.p14,phv00070790.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070790,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070790,True,False,False,RAISINS,SMALL PACK OF RAISINS OR SMALL BUNCH OF GRAPES,,\phs000007\pht000689\phv00070790\RAISINS\,pht000689.v6,\phs000007\pht000689\phv00070790\RAISINS\,phv00070790,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",SMALL PACK OF RAISINS OR SMALL BUNCH OF GRAPES,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,SMALL PACK OF RAISINS OR SMALL BUNCH OF GRAPES,phs000007.v31,ca81cb4f26ff123e28b3cfb772297eaa45739d2cb40c8b35313ce4061ab6d2a0,categorical,phv00070790.v5,phs000007,False,RAISINS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070790\RAISINS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.romaine,"ESCAROLE,ROMAINE,WATERCRESS LEAFLETTUCE",2.73178808,q_ffreq_ex03_1_0302d,romaine,Framingham Cohort,ROMAINE,"CUP OF ESCAROLE, ROMAINE, WATERCRESS OR LEAF LETTUCE",phs000007.v33.p14,phv00070814.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070814,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070814,True,False,False,ROMAINE,"CUP OF ESCAROLE, ROMAINE, WATERCRESS OR LEAF LETTUCE",,\phs000007\pht000689\phv00070814\ROMAINE\,pht000689.v6,\phs000007\pht000689\phv00070814\ROMAINE\,phv00070814,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP OF ESCAROLE, ROMAINE, WATERCRESS OR LEAF LETTUCE",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP OF ESCAROLE, ROMAINE, WATERCRESS OR LEAF LETTUCE",phs000007.v31,af5f5cf0bbde47f0e324c993faaa1e5a40b0f9fc6254ae4230b518f27acc611e,categorical,phv00070814.v5,phs000007,False,ROMAINE,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070814\ROMAINE\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.spinach,HALF CUP SPINACH RAW OR COOKED,1.62803532,q_ffreq_ex03_1_0302d,spinach,Framingham Cohort,SPINACH,HALF CUP OF SPINACH RAW OR COOKED,phs000007.v33.p14,phv00070810.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070810,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070810,True,False,False,SPINACH,HALF CUP OF SPINACH RAW OR COOKED,,\phs000007\pht000689\phv00070810\SPINACH\,pht000689.v6,\phs000007\pht000689\phv00070810\SPINACH\,phv00070810,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF SPINACH RAW OR COOKED,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF SPINACH RAW OR COOKED,phs000007.v31,13b3c61706f4e1c92af79b785780c7c5e04f8f485f9134bf26b9acd9c809a4b4,categorical,phv00070810.v5,phs000007,False,SPINACH,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070810\SPINACH\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.strawber,"FRESH,FROZEN OR CANNED STRAWBERRIES",1.62803532,q_ffreq_ex03_1_0302d,strawber,Framingham Cohort,STRAWBER,"CUP OF FRESH, FROZEN OR CANNED STRAWBERRIES",phs000007.v33.p14,phv00070794.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070794,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070794,True,False,False,STRAWBER,"CUP OF FRESH, FROZEN OR CANNED STRAWBERRIES",,\phs000007\pht000689\phv00070794\STRAWBER\,pht000689.v6,\phs000007\pht000689\phv00070794\STRAWBER\,phv00070794,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP OF FRESH, FROZEN OR CANNED STRAWBERRIES",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP OF FRESH, FROZEN OR CANNED STRAWBERRIES",phs000007.v31,07514496391b21887b231b11fb9f9ff67949ed3cff17d9c2a493d4f7275a3409,categorical,phv00070794.v5,phs000007,False,STRAWBER,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070794\STRAWBER\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.strawber,"FRESH,FROZEN OR CANNED STRAWBERRIES",1.62803532,q_ffreq_ex03_1_0302d,strawber,Women's Health Initiative,STRAWBER,"Item #10: Strawberries and kiwi, med serv/day",phs000200.v12.p3,phv00111753.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111753,[],phs000200,pht001517,phv00111753,False,True,False,STRAWBER,"Item #10: Strawberries and kiwi, med serv/day",0.0,\phs000200\pht001517\phv00111753\STRAWBER\,pht001517.v6,\phs000200\pht001517\phv00111753\STRAWBER\,phv00111753,Form 60 - Items and Food Groups,"Item #10: Strawberries and kiwi, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #10: Strawberries and kiwi, med serv/day",phs000200.v12,3a8f17de62c0b4733efb4290ce86bacc4123d040bdee3d7a2ced1bbd58c35ac7,continuous,phv00111753.v6,phs000200,False,STRAWBER,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111753\STRAWBER\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.tomatoes,ONE TOMATO OR HALF CUP,1.407284768,q_ffreq_ex03_1_0302d,tomatoes,Framingham Cohort,TOMATOES,ONE TOMATO OR HALF CUP,phs000007.v33.p14,phv00070819.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070819,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '4 + TIMES PER DAY', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070819,True,False,False,TOMATOES,ONE TOMATO OR HALF CUP,,\phs000007\pht000689\phv00070819\TOMATOES\,pht000689.v6,\phs000007\pht000689\phv00070819\TOMATOES\,phv00070819,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",ONE TOMATO OR HALF CUP,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,ONE TOMATO OR HALF CUP,phs000007.v31,fe7c4bd0d711b6bdaf6ebfc6d32eafef67687a5e874dea8b96ac53957597eacc,categorical,phv00070819.v5,phs000007,False,TOMATOES,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070819\TOMATOES\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.watermel,SLICE OF WATERMELON,2.290286976,q_ffreq_ex03_1_0302d,watermel,Framingham Cohort,WATERMEL,SLICE OF WATERMELON,phs000007.v33.p14,phv00070797.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070797,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070797,True,False,False,WATERMEL,SLICE OF WATERMELON,,\phs000007\pht000689\phv00070797\WATERMEL\,pht000689.v6,\phs000007\pht000689\phv00070797\WATERMEL\,phv00070797,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",SLICE OF WATERMELON,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,SLICE OF WATERMELON,phs000007.v31,ff7e10570375d1c64cbb1e18e6948981d4caa2d05b5e9908e1381ea006303750,categorical,phv00070797.v5,phs000007,False,WATERMEL,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070797\WATERMEL\,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,q_ffreq_ex03_1_0302d.watermel,SLICE OF WATERMELON,2.290286976,q_ffreq_ex03_1_0302d,watermel,Women's Health Initiative,WATERMEL,"Item #5: Watermelon and red melon, med serv/day",phs000200.v12.p3,phv00111748.v6.p3,pht001517.v6.p3,f60_item_rel1,phv00111748,[],phs000200,pht001517,phv00111748,False,True,False,WATERMEL,"Item #5: Watermelon and red melon, med serv/day",0.0,\phs000200\pht001517\phv00111748\WATERMEL\,pht001517.v6,\phs000200\pht001517\phv00111748\WATERMEL\,phv00111748,Form 60 - Items and Food Groups,"Item #5: Watermelon and red melon, med serv/day",{},,Form 60 - Items and Food Groups,3.0,"Item #5: Watermelon and red melon, med serv/day",phs000200.v12,abd1d58d5cae5a24c0b0a752b4fa4867e9274dbfb43db0c640649d8b77e99dc9,continuous,phv00111748.v6,phs000200,False,WATERMEL,WHI,Women's Health Initiative,pht001517,f60_item_rel1,\phs000200\pht001517\phv00111748\WATERMEL\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.wintersq,YELLOW WINTER SQUASH OR PUMPKINS,1.766004415,q_ffreq_ex03_1_0302d,wintersq,Framingham Cohort,WINTERSQ,CUP OF YELLOW WINTER SQUASH OR PUMPKINS,phs000007.v33.p14,phv00070816.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070816,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070816,True,False,False,WINTERSQ,CUP OF YELLOW WINTER SQUASH OR PUMPKINS,,\phs000007\pht000689\phv00070816\WINTERSQ\,pht000689.v6,\phs000007\pht000689\phv00070816\WINTERSQ\,phv00070816,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",CUP OF YELLOW WINTER SQUASH OR PUMPKINS,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,CUP OF YELLOW WINTER SQUASH OR PUMPKINS,phs000007.v31,eb48f24c288e299e88a90e9b5bc4acccfc38fd1bfeb82033987c5a5d8007554b,categorical,phv00070816.v5,phs000007,False,WINTERSQ,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070816\WINTERSQ\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00158268.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158268,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002153,phv00158268,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht002153\phv00158268\YAMS\,pht002153.v1,\phs000007\pht002153\phv00158268\YAMS\,phv00158268,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,5282f27878bc42eb8c9feca9baa2f660ab06d42933f70a8a167bdede1b534e6c,categorical,phv00158268.v1,phs000007,False,YAMS,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158268\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00523735.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523735,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00157474.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157474,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002151,phv00157474,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht002151\phv00157474\YAMS\,pht002151.v1,\phs000007\pht002151\phv00157474\YAMS\,phv00157474,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,41a4e8d9a6bb84fadfc02be875f9a5699c07b0234d69c6f5e94a7a7c267af05d,categorical,phv00157474.v1,phs000007,False,YAMS,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157474\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES,phs000007.v33.p14,phv00162201.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162201,"['1 - 3 per month', '1 per day', '1 per week', '2 - 4 per week', '5 - 6 per week', 'Never, or less than once per month', 'invalid data or other (missing data)']",phs000007,pht002350,phv00162201,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES,,\phs000007\pht002350\phv00162201\YAMS\,pht002350.v5,\phs000007\pht002350\phv00162201\YAMS\,phv00162201,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",FFQ: YAMS OR SWEET POTATOES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",,FFQ: YAMS OR SWEET POTATOES,phs000007.v31,2d7cedfc783cebed6e6923e489d5e94da317f3e12e914f2312509ad6976ac8ed,categorical,phv00162201.v5,phs000007,False,YAMS,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162201\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES,phs000007.v33.p14,phv00477010.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477010,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES,phs000007.v33.p14,phv00477573.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00478136.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478136,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00157951.v1.p14,pht002152.v2.p14,ffreq0_21s,phv00157951,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht002152,phv00157951,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht002152\phv00157951\YAMS\,pht002152.v1,\phs000007\pht002152\phv00157951\YAMS\,phv00157951,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 21",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,3df98b65d5f242c13d87479778ec56c281fffa9acaac3d80480d7105559e99d8,categorical,phv00157951.v1,phs000007,False,YAMS,FHS,Framingham Cohort,pht002152,ffreq0_21s,\phs000007\pht002152\phv00157951\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,HALF CUP OF YAMS OR SWEET POTATOES,phs000007.v33.p14,phv00070818.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070818,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070818,True,False,False,YAMS,HALF CUP OF YAMS OR SWEET POTATOES,,\phs000007\pht000689\phv00070818\YAMS\,pht000689.v6,\phs000007\pht000689\phv00070818\YAMS\,phv00070818,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",HALF CUP OF YAMS OR SWEET POTATOES,{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,HALF CUP OF YAMS OR SWEET POTATOES,phs000007.v31,d6e06ac27583b7a8e87829fab357a1513010b8d6d927d7a87831e10407cff663,categorical,phv00070818.v5,phs000007,False,YAMS,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070818\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES,phs000007.v33.p14,phv00156841.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00156841,"['1 - 3 per month', '1 per day', '1 per week', '2 - 4 per week', '5 - 6 per week', 'Invalid data or other (missing data)', 'Never, or less than once per month']",phs000007,pht002150,phv00156841,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES,,\phs000007\pht002150\phv00156841\YAMS\,pht002150.v4,\phs000007\pht002150\phv00156841\YAMS\,phv00156841,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",FFQ: YAMS OR SWEET POTATOES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",,FFQ: YAMS OR SWEET POTATOES,phs000007.v31,4e0adab392f58057614e09f9eda6b045892539bf3046d7c765f7f16f96df03da,categorical,phv00156841.v4,phs000007,False,YAMS,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00156841\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00068898.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068898,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid data or other (missing data)']",phs000007,pht000682,phv00068898,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht000682\phv00068898\YAMS\,pht000682.v6,\phs000007\pht000682\phv00068898\YAMS\,phv00068898,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,2a71153037fe101519809fc506532ed3312c132e457444f45886bc4c744dbc1d,categorical,phv00068898.v5,phs000007,False,YAMS,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068898\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00068330.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068330,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000681,phv00068330,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht000681\phv00068330\YAMS\,pht000681.v6,\phs000007\pht000681\phv00068330\YAMS\,phv00068330,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,7045c479723b4bfb39141d055effcad37404428d8caeb95cb2d1356139acd329,categorical,phv00068330.v5,phs000007,False,YAMS,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068330\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.yams,HALF CUP YAMS OR SWEET POTATOES,2.262693157,q_ffreq_ex03_1_0302d,yams,Framingham Cohort,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v33.p14,phv00068169.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00068169,"['1 PER DAY', '1 PER WEEK', '1-3 PER MONTH', '2-4 PER WEEK', '5-6 PER WEEK', 'NEVER, OR LESS THAN ONCE PER MONTH', 'invalid writing or other (missing data)']",phs000007,pht000680,phv00068169,True,False,False,YAMS,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),,\phs000007\pht000680\phv00068169\YAMS\,pht000680.v6,\phs000007\pht000680\phv00068169\YAMS\,phv00068169,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",FFQ: YAMS OR SWEET POTATOES (1/2 CUP),{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",,FFQ: YAMS OR SWEET POTATOES (1/2 CUP),phs000007.v31,34fc058113304864e56bcace320528f1dc9ee266fd01d366b19a5f485619c2b0,categorical,phv00068169.v5,phs000007,False,YAMS,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00068169\YAMS\,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,q_ffreq_ex03_1_0302d.zucchini,"EGGPLANT,ZUCCHINI,OTHER SUMMER SQUASH",1.710816777,q_ffreq_ex03_1_0302d,zucchini,Framingham Cohort,ZUCCHINI,"CUP OF EGGPLANT, ZUCCHINI, OTHER SUMMER SQUASH",phs000007.v33.p14,phv00070817.v7.p14,pht000689.v8.p14,ffreq1_3s,phv00070817,"['1 PER WEEK [ABOUT ONCE A WEEK]', '1-3 TIMES PER MONTH', '2-3 TIMES PER DAY', '2-4 TIMES PER WEEK', '5-7 TIMES PER WEEK [ABOUT ONCE A DAY]', 'NEVER OR < 1 PER MONTH']",phs000007,pht000689,phv00070817,True,False,False,ZUCCHINI,"CUP OF EGGPLANT, ZUCCHINI, OTHER SUMMER SQUASH",,\phs000007\pht000689\phv00070817\ZUCCHINI\,pht000689.v6,\phs000007\pht000689\phv00070817\ZUCCHINI\,phv00070817,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.","CUP OF EGGPLANT, ZUCCHINI, OTHER SUMMER SQUASH",{},,"Food Frequency Questionnaire Data, Offspring Cohort Exam 3. This is based on a modified Willett questionnaire.",,"CUP OF EGGPLANT, ZUCCHINI, OTHER SUMMER SQUASH",phs000007.v31,d184995842edd94104ac11dcf07fea0efec8b9386b60f131890534c750a28e83,categorical,phv00070817.v5,phs000007,False,ZUCCHINI,FHS,Framingham Cohort,pht000689,ffreq1_3s,\phs000007\pht000689\phv00070817\ZUCCHINI\,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,Framingham,q_psych_ex03_1_0167d.py125,Current total family income/yr before tx,20.96008931,q_psych_ex03_1_0167d,py125,Framingham Cohort,PY125,WHAT IS YOUR CURRENT TOTAL FAMILY INCOME PER YEAR BEFORE TAXES?,phs000007.v33.p14,phv00022428.v8.p14,pht000100.v9.p14,psych1_3s,phv00022428,[],phs000007,pht000100,phv00022428,False,True,False,PY125,WHAT IS YOUR CURRENT TOTAL FAMILY INCOME PER YEAR BEFORE TAXES?,3.0,\phs000007\pht000100\phv00022428\PY125\,pht000100.v7,\phs000007\pht000100\phv00022428\PY125\,phv00022428,"Psychosocial Study, Offspring Cohort Exam 3",WHAT IS YOUR CURRENT TOTAL FAMILY INCOME PER YEAR BEFORE TAXES?,{},,"Psychosocial Study, Offspring Cohort Exam 3",12.0,WHAT IS YOUR CURRENT TOTAL FAMILY INCOME PER YEAR BEFORE TAXES?,phs000007.v31,8752e0f5708fb678ccc33f643a1305c7277583987016d19c58ef520868f2a4da,continuous,phv00022428.v6,phs000007,False,PY125,FHS,Framingham Cohort,pht000100,psych1_3s,\phs000007\pht000100\phv00022428\PY125\,3.0,12.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbp.sbp15,AVG: Diastolic (mmHg),0.690817186,sbp,sbp15,Atherosclerosis Risk in Communities (ARIC) Cohort,SBP15,"E. Average Blood Pressure/Pulse Rate. Q15. Avg: diastolic [Sitting Blood Pressure Form, SBP]",phs000280.v8.p2,phv00298044.v2.p2,pht006480.v2.p2,SBP,phv00298044,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbp.sbp15,AVG: Diastolic (mmHg),0.690817186,sbp,sbp15,Framingham Cohort,SBP15,"Average systolic blood pressure, Exam 15",phs000007.v33.p14,phv00370045.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370045,[],phs000007,pht007777,phv00370045,False,True,False,SBP15,"Average systolic blood pressure, Exam 15",91.0,\phs000007\pht007777\phv00370045\SBP15\,pht007777.v2,\phs000007\pht007777\phv00370045\SBP15\,phv00370045,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Average systolic blood pressure, Exam 15",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",253.0,"Average systolic blood pressure, Exam 15",phs000007.v31,69cd7dc40581325155301c8e04190db7e28f6187584a1cf4183cd8d4c36cff03,continuous,phv00370045.v1,phs000007,False,SBP15,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370045\SBP15\,91.0,253.0
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbpa02.sbpa22,2ND AND 3RD DIASTOLIC BP AVERAGE Q22,0.079984003,sbpa02,sbpa22,Atherosclerosis Risk in Communities (ARIC) Cohort,SBPA22,[Third blood pressure measurement]. 2nd and 3rd diastolic. Q22 [Siting Blood Pressure. SBPA. Visit 1],phs000280.v8.p2,phv00210291.v2.p2,pht004192.v3.p2,SBPA02,phv00210291,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbpb02.sbpb22,2ND AND 3RD DIASTOLIC BP AVERAGE Q22,0.029400956,sbpb02,sbpb22,Jackson Heart Study (JHS) Cohort,SBPB22,"Q22. G. Computed net average of first and second random zero blood pressure measurements. Systolic (Net Average Random Zero Measurement) [Visit 6] [Sitting Blood Pressure Form, SBP]",phs000286.v7.p2,phv00403819.v1.p2,pht008782.v1.p2,sbpb,phv00403819,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbpb02.sbpb22,2ND AND 3RD DIASTOLIC BP AVERAGE Q22,0.029400956,sbpb02,sbpb22,Atherosclerosis Risk in Communities (ARIC) Cohort,SBPB22,"Computed net average of second and third blood pressure measurements, diastolic. Q22 [Sitting Blood Pressure. SBPB02. Visit 2]",phs000280.v8.p2,phv00210317.v2.p2,pht004193.v3.p2,SBPB02,phv00210317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbpc04_02.sbpc23,2ND AND 3RD DIASTOLIC BP AVERAGE Q23,0.024624477,sbpc04_02,sbpc23,Atherosclerosis Risk in Communities (ARIC) Cohort,SBPC23,[Computed net average of second and third blood pressure measurements]. 2nd and 3rd diastolic blood pressure average. Q23 [Sitting Blood Pressure. SBPC04_02. Visit 3],phs000280.v8.p2,phv00210341.v2.p2,pht004194.v3.p2,SBPC04_02,phv00210341,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIABP,-,271650006,C01507,ARICMESAREGARDS,1.25,ARIC,sbpd04_02.sbpd20,1ST AND 2ND DIASTOLIC BP AVERAGE Q20,0.109239873,sbpd04_02,sbpd20,Atherosclerosis Risk in Communities (ARIC) Cohort,SBPD20,1st and 2nd diastolic blood pressure average. Q20 [Sitting Blood Pressure. SBPD04_02. Visit 4],phs000280.v8.p2,phv00210364.v2.p2,pht004195.v3.p2,SBPD04_02,phv00210364,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FAM_INCOME,Family income,224168007,-,ARICFraminghamMESAREGARDS,0.56,ARIC,sesa04.sesa6,HOUSEHOLD INCOME LAST YEAR Q6,-,sesa04,sesa6,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,ARIC,stroke01.stroke01,Stroke,-,stroke01,stroke01,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,STROKE01,STROKE,phs000287.v7.p1,phv00098822.v1.p1,pht001450.v1.p1,BASE1,phv00098822,"['NO', 'YES']",phs000287,pht001450,phv00098822,True,False,False,STROKE01,STROKE,,\phs000287\pht001450\phv00098822\STROKE01\,pht001450.v1,\phs000287\pht001450\phv00098822\STROKE01\,phv00098822,CARe_CHS_BASELINE - Medical History (1),STROKE,{},,CARe_CHS_BASELINE - Medical History (1),,STROKE,phs000287.v7,490b39417b72f2147ee0c228cbce39828ab374b8ee750edecc6f1adf590511ca,categorical,phv00098822.v1,phs000287,False,STROKE01,CHS,Cardiovascular Health Study (CHS) Cohort,pht001450,BASE1,\phs000287\pht001450\phv00098822\STROKE01\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,ARIC,stroke01.stroke01,Stroke,-,stroke01,stroke01,Atherosclerosis Risk in Communities (ARIC) Cohort,STROKE01,Stroke [Stroke. Visit 1],phs000280.v8.p2,phv00210409.v2.p2,pht004197.v3.p2,STROKE01,phv00210409,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,ARIC,stroke01.stroke01,Stroke,-,stroke01,stroke01,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,STROKE01,STROKE,phs000287.v7.p1,phv00105139.v1.p1,pht001490.v1.p1,YR5NEW,phv00105139,"['NO', 'YES']",phs000287,pht001490,phv00105139,True,False,False,STROKE01,STROKE,,\phs000287\pht001490\phv00105139\STROKE01\,pht001490.v1,\phs000287\pht001490\phv00105139\STROKE01\,phv00105139,CARe_CHS_YR5NEW - Medical History,STROKE,{},,CARe_CHS_YR5NEW - Medical History,,STROKE,phs000287.v7,e28fdd1dc52cdf31dd3a63d4301373abb9ad72ec54cffa697ecda1aa7f49d475,categorical,phv00105139.v1,phs000287,False,STROKE01,CHS,Cardiovascular Health Study (CHS) Cohort,pht001490,YR5NEW,\phs000287\pht001490\phv00105139\STROKE01\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,ARIC,stroke01.tia01,TIA,-,stroke01,tia01,Atherosclerosis Risk in Communities (ARIC) Cohort,TIA01,Transient ischemic attack [TIA] [Stroke. Visit 1],phs000280.v8.p2,phv00210408.v2.p2,pht004197.v3.p2,STROKE01,phv00210408,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Procedure date,phs000007.v33.p14,phv00054659.v3.p14,pht000386.v4.p14,vr_cabg_2007_m_0007s,phv00054659,[],phs000007,pht000386,phv00054659,False,True,True,procdate,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",-5957.0,\phs000007\pht000386\phv00054659\procdate\,pht000386.v3,\phs000007\pht000386\phv00054659\procdate\,phv00054659,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007","PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Coronary Artery Bypass Grafting (CABG) and Heart Valve Procedures, Original and Offspring Cohorts reviewed through 2007",20600.0,"PROCEDURE DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,72a5f2d424346e39d09657c7fd2b634e690ce38dce4bd48d244f8426557584bd,continuous,phv00054659.v2,phs000007,True,procdate,FHS,Framingham Cohort,pht000386,cabg_2007s,\phs000007\pht000386\phv00054659\procdate\,-5957.0,20600.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procdate,Date of cardiovascular procedure,-,vr_cvdproc_2020_a_1313d,procdate,Framingham Cohort,procdate,Date of cardiovascular procedure,phs000007.v33.p14,phv00054697.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054697,[],phs000007,pht000389,phv00054697,False,True,True,procdate,Date of cardiovascular procedure,-11348.0,\phs000007\pht000389\phv00054697\procdate\,pht000389.v11,\phs000007\pht000389\phv00054697\procdate\,phv00054697,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Date of cardiovascular procedure,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",23463.0,Date of cardiovascular procedure,phs000007.v31,f3130cd82c3be4c71dbe643f8a8b9382dedbeef6e0edf29e022f4968a1a687da,continuous,phv00054697.v9,phs000007,True,procdate,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054697\procdate\,-11348.0,23463.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_cvdproc_2020_a_1313d.procnum,PROCEDURE NUMBER,-,vr_cvdproc_2020_a_1313d,procnum,Framingham Cohort,PROCNUM,Cardiovascular procedure codes,phs000007.v33.p14,phv00054692.v11.p14,pht000389.v13.p14,vr_cvdproc_2020_a_1313s,phv00054692,"['Aorta and renal vascular imaging', 'Aorta surgery', 'CABG', 'Cardiac catheterization', 'Carotid artery surgery', 'Cerebral carotid vascular imaging', 'Femoral of lower extremity surgery', 'Heart valve procedure', 'Other cardiac surgery/ procedure', 'PCTA (Percutaneous transluminal coronary angioplasty)', 'Permanent pacemaker insertion', 'Surgical amputation']",phs000007,pht000389,phv00054692,True,False,False,procnum,Cardiovascular procedure codes,,\phs000007\pht000389\phv00054692\procnum\,pht000389.v11,\phs000007\pht000389\phv00054692\procnum\,phv00054692,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",Cardiovascular procedure codes,{},,"Cardiovascular Procedures, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts), cases reviewed through 2018. The CVD procedures data set consists of an extraction of procedure date and procedure number from several CVD procedures data collection sheets. The original CVD procedures sheets are completed at the time of cardiovascular endpoints review. Medical records are obtained on each procedure. Each procedure is coded by the endpoint review committee using medical records. This dataset is cumulative and replaces dataset vr_cvdproc_2016_a_1028s.",,Cardiovascular procedure codes,phs000007.v31,e64ab360a6f77a3860ac7d5711968f55ac93dc5727eede35cb5ced42c4921d92,categorical,phv00054692.v9,phs000007,False,procnum,FHS,Framingham Cohort,pht000389,vr_cvdproc_2018_a_1140s,\phs000007\pht000389\phv00054692\procnum\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab1,"Diabetes Mellitus Status, Exam 1",4.731355253,vr_diab_ex09_1_1002d,curr_diab1,Framingham Cohort,CURR_DIAB1,"Current Diabetes status (using 200 mg/dL), Exam 1",phs000007.v33.p14,phv00080829.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080829,"['No', 'Yes']",phs000007,pht000040,phv00080829,True,False,False,CURR_DIAB1,"Current Diabetes status (using 200 mg/dL), Exam 1",,\phs000007\pht000040\phv00080829\CURR_DIAB1\,pht000040.v5,\phs000007\pht000040\phv00080829\CURR_DIAB1\,phv00080829,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 1",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 1",phs000007.v31,4ad80d6fba70134477c371def32008b93043546a7ef64e64e6caa7a7982bda0a,categorical,phv00080829.v2,phs000007,False,CURR_DIAB1,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080829\CURR_DIAB1\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab1,"Diabetes Mellitus Status, Exam 1",4.731355253,vr_diab_ex09_1_1002d,curr_diab1,Framingham Cohort,CURR_DIAB1,"Diabetes Mellitus Status, Exam 1",phs000007.v33.p14,phv00523493.v1.p14,pht012905.v1.p14,vr_diab_ex04_7_1339s,phv00523493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab1,"Diabetes Mellitus Status, Exam 1",4.731355253,vr_diab_ex09_1_1002d,curr_diab1,Framingham Cohort,CURR_DIAB1,"Current Diabetes status, Exam 1",phs000007.v33.p14,phv00010791.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010791,"['No', 'Yes']",phs000007,pht000041,phv00010791,True,False,False,CURR_DIAB1,"Current Diabetes status, Exam 1",,\phs000007\pht000041\phv00010791\CURR_DIAB1\,pht000041.v7,\phs000007\pht000041\phv00010791\CURR_DIAB1\,phv00010791,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 1",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 1",phs000007.v31,08a30efd7e9c508f1052cd1056a207ded7a02d0aa3b1d1b491457cf1786e9110,categorical,phv00010791.v6,phs000007,False,CURR_DIAB1,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010791\CURR_DIAB1\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab1,"Diabetes Mellitus Status, Exam 1",4.731355253,vr_diab_ex09_1_1002d,curr_diab1,Framingham Cohort,CURR_DIAB1,"Diabetes Mellitus Status, Exam 1",phs000007.v33.p14,phv00369583.v3.p14,pht007775.v4.p14,vr_diab_ex03_3b_1312s,phv00369583,"['No', 'Yes']",phs000007,pht007775,phv00369583,True,False,False,CURR_DIAB1,"Current diabetes status, Exam 1",,\phs000007\pht007775\phv00369583\CURR_DIAB1\,pht007775.v2,\phs000007\pht007775\phv00369583\CURR_DIAB1\,phv00369583,"Diabetes (Derived), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. Current diabetes status is positive at a specific exam if a study participant reports they are under current treatment for diabetes or they have a blood glucose level of 200 mg/dL or greater. Current diabetes status can change from exam to exam.","Current diabetes status, Exam 1",{},,"Diabetes (Derived), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. Current diabetes status is positive at a specific exam if a study participant reports they are under current treatment for diabetes or they have a blood glucose level of 200 mg/dL or greater. Current diabetes status can change from exam to exam.",,"Current diabetes status, Exam 1",phs000007.v31,ac866460cb32878f84289906fc12b2660ce7e3254ad4e3e6de593a3f25cf9983,categorical,phv00369583.v2,phs000007,False,CURR_DIAB1,FHS,Framingham Cohort,pht007775,vr_diab_ex02_3b_0388s,\phs000007\pht007775\phv00369583\CURR_DIAB1\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab2,"Diabetes Mellitus Status, Exam 2",27.96712109,vr_diab_ex09_1_1002d,curr_diab2,Framingham Cohort,CURR_DIAB2,"Diabetes Mellitus Status, Exam 2",phs000007.v33.p14,phv00523494.v1.p14,pht012905.v1.p14,vr_diab_ex04_7_1339s,phv00523494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab2,"Diabetes Mellitus Status, Exam 2",27.96712109,vr_diab_ex09_1_1002d,curr_diab2,Framingham Cohort,CURR_DIAB2,"Diabetes Mellitus Status, Exam 2",phs000007.v33.p14,phv00369584.v3.p14,pht007775.v4.p14,vr_diab_ex03_3b_1312s,phv00369584,"['No', 'Yes']",phs000007,pht007775,phv00369584,True,False,False,CURR_DIAB2,"Current diabetes status, Exam 2",,\phs000007\pht007775\phv00369584\CURR_DIAB2\,pht007775.v2,\phs000007\pht007775\phv00369584\CURR_DIAB2\,phv00369584,"Diabetes (Derived), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. Current diabetes status is positive at a specific exam if a study participant reports they are under current treatment for diabetes or they have a blood glucose level of 200 mg/dL or greater. Current diabetes status can change from exam to exam.","Current diabetes status, Exam 2",{},,"Diabetes (Derived), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. Current diabetes status is positive at a specific exam if a study participant reports they are under current treatment for diabetes or they have a blood glucose level of 200 mg/dL or greater. Current diabetes status can change from exam to exam.",,"Current diabetes status, Exam 2",phs000007.v31,2ba730386095b6604612441987a228ca227c2079e8a0614d2322ea61a9d324d0,categorical,phv00369584.v2,phs000007,False,CURR_DIAB2,FHS,Framingham Cohort,pht007775,vr_diab_ex02_3b_0388s,\phs000007\pht007775\phv00369584\CURR_DIAB2\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab2,"Diabetes Mellitus Status, Exam 2",27.96712109,vr_diab_ex09_1_1002d,curr_diab2,Framingham Cohort,CURR_DIAB2,"Current Diabetes status (using 200 mg/dL), Exam 2",phs000007.v33.p14,phv00080830.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080830,"['No', 'Yes']",phs000007,pht000040,phv00080830,True,False,False,CURR_DIAB2,"Current Diabetes status (using 200 mg/dL), Exam 2",,\phs000007\pht000040\phv00080830\CURR_DIAB2\,pht000040.v5,\phs000007\pht000040\phv00080830\CURR_DIAB2\,phv00080830,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 2",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 2",phs000007.v31,e24571f2e9d04263709ab27f1aa7721e83ec6e0167fb98efcba91783362de69c,categorical,phv00080830.v2,phs000007,False,CURR_DIAB2,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080830\CURR_DIAB2\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab2,"Diabetes Mellitus Status, Exam 2",27.96712109,vr_diab_ex09_1_1002d,curr_diab2,Framingham Cohort,CURR_DIAB2,"Current Diabetes status, Exam 2",phs000007.v33.p14,phv00010792.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010792,"['No', 'Yes']",phs000007,pht000041,phv00010792,True,False,False,CURR_DIAB2,"Current Diabetes status, Exam 2",,\phs000007\pht000041\phv00010792\CURR_DIAB2\,pht000041.v7,\phs000007\pht000041\phv00010792\CURR_DIAB2\,phv00010792,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 2",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 2",phs000007.v31,18490fa7c380020ad9db79722e16f9892f665e4e314a2bd4a83e0849e9947080,categorical,phv00010792.v6,phs000007,False,CURR_DIAB2,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010792\CURR_DIAB2\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab3,"Diabetes Mellitus Status, Exam 3",27.12510024,vr_diab_ex09_1_1002d,curr_diab3,Framingham Cohort,CURR_DIAB3,"Diabetes Mellitus Status, Exam 3",phs000007.v33.p14,phv00520312.v1.p14,pht007775.v4.p14,vr_diab_ex03_3b_1312s,phv00520312,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab3,"Diabetes Mellitus Status, Exam 3",27.12510024,vr_diab_ex09_1_1002d,curr_diab3,Framingham Cohort,CURR_DIAB3,"Diabetes Mellitus Status, Exam 3",phs000007.v33.p14,phv00523495.v1.p14,pht012905.v1.p14,vr_diab_ex04_7_1339s,phv00523495,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab3,"Diabetes Mellitus Status, Exam 3",27.12510024,vr_diab_ex09_1_1002d,curr_diab3,Framingham Cohort,CURR_DIAB3,"Current Diabetes status (using 200 mg/dL), Exam 3",phs000007.v33.p14,phv00080831.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080831,"['No', 'Yes']",phs000007,pht000040,phv00080831,True,False,False,CURR_DIAB3,"Current Diabetes status (using 200 mg/dL), Exam 3",,\phs000007\pht000040\phv00080831\CURR_DIAB3\,pht000040.v5,\phs000007\pht000040\phv00080831\CURR_DIAB3\,phv00080831,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 3",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 3",phs000007.v31,238ad1da1a8940725d89b384be13fce121b49bbaed4b263d357d940a4bb1dea5,categorical,phv00080831.v2,phs000007,False,CURR_DIAB3,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080831\CURR_DIAB3\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab3,"Diabetes Mellitus Status, Exam 3",27.12510024,vr_diab_ex09_1_1002d,curr_diab3,Framingham Cohort,CURR_DIAB3,"Current Diabetes status, Exam 3",phs000007.v33.p14,phv00010793.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010793,"['No', 'Yes']",phs000007,pht000041,phv00010793,True,False,False,CURR_DIAB3,"Current Diabetes status, Exam 3",,\phs000007\pht000041\phv00010793\CURR_DIAB3\,pht000041.v7,\phs000007\pht000041\phv00010793\CURR_DIAB3\,phv00010793,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 3",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 3",phs000007.v31,f03665611f88b2d05bc3324a43f022e5057a5e6c44f461d69570931c7db28aee,categorical,phv00010793.v6,phs000007,False,CURR_DIAB3,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010793\CURR_DIAB3\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab4,"Diabetes Mellitus Status, Exam 4",23.65677626,vr_diab_ex09_1_1002d,curr_diab4,Framingham Cohort,CURR_DIAB4,"Current Diabetes status, Exam 4",phs000007.v33.p14,phv00010794.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010794,"['No', 'Yes']",phs000007,pht000041,phv00010794,True,False,False,CURR_DIAB4,"Current Diabetes status, Exam 4",,\phs000007\pht000041\phv00010794\CURR_DIAB4\,pht000041.v7,\phs000007\pht000041\phv00010794\CURR_DIAB4\,phv00010794,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 4",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 4",phs000007.v31,d57d0eed8224d48a5a461ff56307ffc7c7652699e6b7dd025c2993e6551e8e5d,categorical,phv00010794.v6,phs000007,False,CURR_DIAB4,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010794\CURR_DIAB4\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab4,"Diabetes Mellitus Status, Exam 4",23.65677626,vr_diab_ex09_1_1002d,curr_diab4,Framingham Cohort,CURR_DIAB4,"Current Diabetes status (using 200 mg/dL), Exam 4",phs000007.v33.p14,phv00080832.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080832,"['No', 'Yes']",phs000007,pht000040,phv00080832,True,False,False,CURR_DIAB4,"Current Diabetes status (using 200 mg/dL), Exam 4",,\phs000007\pht000040\phv00080832\CURR_DIAB4\,pht000040.v5,\phs000007\pht000040\phv00080832\CURR_DIAB4\,phv00080832,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 4",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 4",phs000007.v31,b1134c85e13b98c38a5d2388d46068d0170773f9c1b1ee144649550f573644ed,categorical,phv00080832.v2,phs000007,False,CURR_DIAB4,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080832\CURR_DIAB4\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab4,"Diabetes Mellitus Status, Exam 4",23.65677626,vr_diab_ex09_1_1002d,curr_diab4,Framingham Cohort,CURR_DIAB4,"Diabetes Mellitus Status, Exam 4",phs000007.v33.p14,phv00523496.v1.p14,pht012905.v1.p14,vr_diab_ex04_7_1339s,phv00523496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab5,"Diabetes Mellitus Status, Exam 5",26.64394547,vr_diab_ex09_1_1002d,curr_diab5,Framingham Cohort,CURR_DIAB5,"Current Diabetes status (using 200 mg/dL), Exam 5",phs000007.v33.p14,phv00080833.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080833,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab5,"Diabetes Mellitus Status, Exam 5",26.64394547,vr_diab_ex09_1_1002d,curr_diab5,Framingham Cohort,CURR_DIAB5,"Current Diabetes status, Exam 5",phs000007.v33.p14,phv00010795.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010795,"['No', 'Yes']",phs000007,pht000041,phv00010795,True,False,False,CURR_DIAB5,"Current Diabetes status, Exam 5",,\phs000007\pht000041\phv00010795\CURR_DIAB5\,pht000041.v7,\phs000007\pht000041\phv00010795\CURR_DIAB5\,phv00010795,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 5",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 5",phs000007.v31,354e56837e73a9ccb44d9b42b110c9213cf206ec005b9cef290dbd800a06ef0b,categorical,phv00010795.v6,phs000007,False,CURR_DIAB5,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010795\CURR_DIAB5\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab6,"Diabetes Mellitus Status, Exam 6",32.47794707,vr_diab_ex09_1_1002d,curr_diab6,Framingham Cohort,CURR_DIAB6,"Current Diabetes status (using 200 mg/dL), Exam 6",phs000007.v33.p14,phv00080834.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080834,"['No', 'Yes']",phs000007,pht000040,phv00080834,True,False,False,CURR_DIAB6,"Current Diabetes status (using 200 mg/dL), Exam 6",,\phs000007\pht000040\phv00080834\CURR_DIAB6\,pht000040.v5,\phs000007\pht000040\phv00080834\CURR_DIAB6\,phv00080834,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 6",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 6",phs000007.v31,a33d5853cedd26169154c8063e992f197d61ca585fc595f9adb73ee2b09b4150,categorical,phv00080834.v2,phs000007,False,CURR_DIAB6,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080834\CURR_DIAB6\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab6,"Diabetes Mellitus Status, Exam 6",32.47794707,vr_diab_ex09_1_1002d,curr_diab6,Framingham Cohort,CURR_DIAB6,"Current Diabetes status, Exam 6",phs000007.v33.p14,phv00010796.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010796,"['No', 'Yes']",phs000007,pht000041,phv00010796,True,False,False,CURR_DIAB6,"Current Diabetes status, Exam 6",,\phs000007\pht000041\phv00010796\CURR_DIAB6\,pht000041.v7,\phs000007\pht000041\phv00010796\CURR_DIAB6\,phv00010796,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 6",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 6",phs000007.v31,ac725a9808b78e8ba0fd9f9848dc6892dc63f7a5d6dd95f168cca7c60386b9d3,categorical,phv00010796.v6,phs000007,False,CURR_DIAB6,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010796\CURR_DIAB6\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab7,"Diabetes Mellitus Status, Exam 7",33.9414595,vr_diab_ex09_1_1002d,curr_diab7,Framingham Cohort,CURR_DIAB7,"Current Diabetes status (using 200 mg/dL), Exam 7",phs000007.v33.p14,phv00080835.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080835,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab7,"Diabetes Mellitus Status, Exam 7",33.9414595,vr_diab_ex09_1_1002d,curr_diab7,Framingham Cohort,CURR_DIAB7,"Current Diabetes status, Exam 7",phs000007.v33.p14,phv00010797.v8.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00010797,"['No', 'Yes']",phs000007,pht000041,phv00010797,True,False,False,CURR_DIAB7,"Current Diabetes status, Exam 7",,\phs000007\pht000041\phv00010797\CURR_DIAB7\,pht000041.v7,\phs000007\pht000041\phv00010797\CURR_DIAB7\,phv00010797,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 7",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 7",phs000007.v31,8db3cedceb1c4d5267d0b064903e8fc01cb0f017d191c8963deb5a75eccd1fd7,categorical,phv00010797.v6,phs000007,False,CURR_DIAB7,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00010797\CURR_DIAB7\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab8,"Diabetes Mellitus Status, Exam 8",42.26142743,vr_diab_ex09_1_1002d,curr_diab8,Framingham Cohort,CURR_DIAB8,"Current Diabetes status, Exam 8",phs000007.v33.p14,phv00369406.v3.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00369406,"['No', 'Yes']",phs000007,pht000041,phv00369406,True,False,False,CURR_DIAB8,"Current Diabetes status, Exam 8",,\phs000007\pht000041\phv00369406\CURR_DIAB8\,pht000041.v7,\phs000007\pht000041\phv00369406\CURR_DIAB8\,phv00369406,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 8",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 8",phs000007.v31,e375e4591fe4c6058efba1d55c8011ecc7b239662470fc3518a4814ec3784031,categorical,phv00369406.v1,phs000007,False,CURR_DIAB8,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00369406\CURR_DIAB8\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab8,"Diabetes Mellitus Status, Exam 8",42.26142743,vr_diab_ex09_1_1002d,curr_diab8,Framingham Cohort,CURR_DIAB8,"Current Diabetes status (using 200 mg/dL), Exam 8",phs000007.v33.p14,phv00080836.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080836,"['No', 'Yes']",phs000007,pht000040,phv00080836,True,False,False,CURR_DIAB8,"Current Diabetes status (using 200 mg/dL), Exam 8",,\phs000007\pht000040\phv00080836\CURR_DIAB8\,pht000040.v5,\phs000007\pht000040\phv00080836\CURR_DIAB8\,phv00080836,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 8",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 8",phs000007.v31,27833a272077710a1f01e56510e55c96c7c1598277b6a39d7b67fca6bc4beae7,categorical,phv00080836.v2,phs000007,False,CURR_DIAB8,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080836\CURR_DIAB8\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab9,"Diabetes Mellitus Status, Exam 9",54.83159583,vr_diab_ex09_1_1002d,curr_diab9,Framingham Cohort,CURR_DIAB9,"Current Diabetes status (using 200 mg/dL), Exam 9",phs000007.v33.p14,phv00080837.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080837,"['No', 'Yes']",phs000007,pht000040,phv00080837,True,False,False,CURR_DIAB9,"Current Diabetes status (using 200 mg/dL), Exam 9",,\phs000007\pht000040\phv00080837\CURR_DIAB9\,pht000040.v5,\phs000007\pht000040\phv00080837\CURR_DIAB9\,phv00080837,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Current Diabetes status (using 200 mg/dL), Exam 9",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",,"Current Diabetes status (using 200 mg/dL), Exam 9",phs000007.v31,a4058c356b0c9b2bc95c6c414d2327378378bdd07718a8040b37303a5c7f5e5f,categorical,phv00080837.v2,phs000007,False,CURR_DIAB9,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080837\CURR_DIAB9\,,
DIAB,"Diabetes(0=No, 1=Yes)",73211009,C17480,ARICFraminghamMESAREGARDS,1.32,Framingham,vr_diab_ex09_1_1002d.curr_diab9,"Diabetes Mellitus Status, Exam 9",54.83159583,vr_diab_ex09_1_1002d,curr_diab9,Framingham Cohort,CURR_DIAB9,"Current Diabetes status, Exam 9",phs000007.v33.p14,phv00369407.v3.p14,pht000041.v9.p14,vr_diab_ex09_1_1002s,phv00369407,"['No', 'Yes']",phs000007,pht000041,phv00369407,True,False,False,CURR_DIAB9,"Current Diabetes status, Exam 9",,\phs000007\pht000041\phv00369407\CURR_DIAB9\,pht000041.v7,\phs000007\pht000041\phv00369407\CURR_DIAB9\,phv00369407,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.","Current Diabetes status, Exam 9",{},,"Diabetes Mellitus Status, Offspring Cohort Exams 1 - 9. Variables include diabetes mellitus status, fasting blood glucose levels and treatment status for diabetes.",,"Current Diabetes status, Exam 9",phs000007.v31,ae5d7a51c28976dbd9e26a9881955e0aa79032cbd7466e6076c2105ba4c0c8da,categorical,phv00369407.v1,phs000007,False,CURR_DIAB9,FHS,Framingham Cohort,pht000041,vr_diab_ex09_1_1002s,\phs000007\pht000041\phv00369407\CURR_DIAB9\,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00477449.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00478012.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00478573.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00158504.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158504,[],phs000007,pht002153,phv00158504,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht002153\phv00158504\FFD114\,pht002153.v1,\phs000007\pht002153\phv00158504\FFD114\,phv00158504,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,1fa60c508b1e22d5cdc4ba2e835fc8f1e0db73876d430eb57e2fc517c65bd441,continuous,phv00158504.v1,phs000007,True,FFD114,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158504\FFD114\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00157701.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157701,[],phs000007,pht002151,phv00157701,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht002151\phv00157701\FFD114\,pht002151.v1,\phs000007\pht002151\phv00157701\FFD114\,phv00157701,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,db27c49de9785eb38f148d802411e8b2bc26c542168bf5bda70211687573da43,continuous,phv00157701.v1,phs000007,True,FFD114,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157701\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00070150.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070150,[],phs000007,pht000680,phv00070150,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000680\phv00070150\FFD114\,pht000680.v6,\phs000007\pht000680\phv00070150\FFD114\,phv00070150,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,a8be256ad6889d7f59f2c2bd2cb0336a203ea36e1eb6cdb0670f1b0af84ef7e0,continuous,phv00070150.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070150\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00069126.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069126,[],phs000007,pht000682,phv00069126,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000682\phv00069126\FFD114\,pht000682.v6,\phs000007\pht000682\phv00069126\FFD114\,phv00069126,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,d5d06579c9061e6db756dab3172c8f8517fda42d0debb340782ad9e2e9d9d0d5,continuous,phv00069126.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069126\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00157260.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157260,[],phs000007,pht002150,phv00157260,False,True,True,FFD114,DERIVED FIELD:BEER,0.0,\phs000007\pht002150\phv00157260\FFD114\,pht002150.v4,\phs000007\pht002150\phv00157260\FFD114\,phv00157260,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEER,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:BEER,phs000007.v31,1118bc50ecaeb49589a59c25a024075be4cc7458ecb63b14ddb616e3f69868c2,continuous,phv00157260.v4,phs000007,True,FFD114,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157260\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00162638.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162638,[],phs000007,pht002350,phv00162638,False,True,True,FFD114,DERIVED FIELD:BEER,0.0,\phs000007\pht002350\phv00162638\FFD114\,pht002350.v5,\phs000007\pht002350\phv00162638\FFD114\,phv00162638,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEER,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:BEER,phs000007.v31,74ee6d0f73cf34948f09457f252223dad0d03e4dc382a2c5fe2b91f954109e53,continuous,phv00162638.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162638\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,BEER,phs000007.v33.p14,phv00523956.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523956,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd114,BEER:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00068557.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068557,[],phs000007,pht000681,phv00068557,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000681\phv00068557\FFD114\,pht000681.v6,\phs000007\pht000681\phv00068557\FFD114\,phv00068557,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,2f5c7f194789f77b15a689d5a5d03bbad1c60dbcdaff4de3c60f8598d1b5f4ed,continuous,phv00068557.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068557\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00157702.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157702,[],phs000007,pht002151,phv00157702,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht002151\phv00157702\FFD115\,pht002151.v1,\phs000007\pht002151\phv00157702\FFD115\,phv00157702,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,f30e3c10c7bae7590edb3e8df039d3ea985c28fddbb4861f5b5ddbc8a3404388,continuous,phv00157702.v1,phs000007,True,FFD115,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157702\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00524617.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,RED WINE,phs000007.v33.p14,phv00523957.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00479230.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00158505.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158505,[],phs000007,pht002153,phv00158505,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht002153\phv00158505\FFD115\,pht002153.v1,\phs000007\pht002153\phv00158505\FFD115\,phv00158505,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,dd388c0334e96b8393d50833cc20d838f5fe1f77e27e8e7117d4f2ff4e48a108,continuous,phv00158505.v1,phs000007,True,FFD115,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158505\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00478013.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00478574.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478574,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00162639.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162639,[],phs000007,pht002350,phv00162639,False,True,True,FFD115,DERIVED FIELD:RED WINE,0.0,\phs000007\pht002350\phv00162639\FFD115\,pht002350.v5,\phs000007\pht002350\phv00162639\FFD115\,phv00162639,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:RED WINE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:RED WINE,phs000007.v31,4512c778ea2a9ba4f8593401fc38269b3d3a3e79bf66eedc26d9e2b372a8d884,continuous,phv00162639.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162639\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00068558.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068558,[],phs000007,pht000681,phv00068558,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000681\phv00068558\FFD115\,pht000681.v6,\phs000007\pht000681\phv00068558\FFD115\,phv00068558,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,30381d4eece831ff8f24a0c4007caf7d8f2a0834cbb3f09f0d81c56b0267c531,continuous,phv00068558.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068558\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00069127.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069127,[],phs000007,pht000682,phv00069127,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000682\phv00069127\FFD115\,pht000682.v6,\phs000007\pht000682\phv00069127\FFD115\,phv00069127,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,169fa874ef35e15aa15bb07ab4dff68ff88cf9f224074d786ff989f530f67d25,continuous,phv00069127.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069127\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00070151.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070151,[],phs000007,pht000680,phv00070151,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000680\phv00070151\FFD115\,pht000680.v6,\phs000007\pht000680\phv00070151\FFD115\,phv00070151,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,69702aad592a2eb281b7d6ce28bd9df95cd53b9cdc10e1d51589933e8d60f9e1,continuous,phv00070151.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070151\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00157261.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157261,[],phs000007,pht002150,phv00157261,False,True,True,FFD115,DERIVED FIELD:RED WINE,0.0,\phs000007\pht002150\phv00157261\FFD115\,pht002150.v4,\phs000007\pht002150\phv00157261\FFD115\,phv00157261,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:RED WINE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:RED WINE,phs000007.v31,2c43cec98c258ef0aa247d9c43f8ca1e613f4347d8040c8117a38b3f3641b91d,continuous,phv00157261.v4,phs000007,True,FFD115,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157261\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00173043.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173043,[],phs000007,pht002900,phv00173043,False,True,True,FFD115,Derived field: Red wine,0.0,\phs000007\pht002900\phv00173043\FFD115\,pht002900.v3,\phs000007\pht002900\phv00173043\FFD115\,phv00173043,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Red wine,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Red wine,phs000007.v31,897a7be1929114f6ed54b574021b25666d849a4d22959a574ea27206994d0c97,continuous,phv00173043.v3,phs000007,True,FFD115,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173043\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd115,RED WINE:(servings/week),0.525624179,vr_ffreq_ex06_1_0506d,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00477450.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,WHITE WINE,phs000007.v33.p14,phv00523958.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523958,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00524618.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00069128.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069128,[],phs000007,pht000682,phv00069128,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000682\phv00069128\FFD116\,pht000682.v6,\phs000007\pht000682\phv00069128\FFD116\,phv00069128,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,c94b6312f826e7d34a7b702feec5cff066ab4fabbb1d2c95c8b8c7148f21a81e,continuous,phv00069128.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069128\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00070152.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070152,[],phs000007,pht000680,phv00070152,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000680\phv00070152\FFD116\,pht000680.v6,\phs000007\pht000680\phv00070152\FFD116\,phv00070152,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,34b6e947e3b63e1a934f323d8a2ade05f53b107a0f5084ed188c047abc864b02,continuous,phv00070152.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070152\FFD116\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00478575.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00478014.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00477451.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477451,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00068559.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068559,[],phs000007,pht000681,phv00068559,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000681\phv00068559\FFD116\,pht000681.v6,\phs000007\pht000681\phv00068559\FFD116\,phv00068559,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,d72036b8d78f24b0c061b986c695c63408529f6be85e2054d92dd8d3c09efe6c,continuous,phv00068559.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068559\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00173044.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173044,[],phs000007,pht002900,phv00173044,False,True,True,FFD116,Derived field: White wine,0.0,\phs000007\pht002900\phv00173044\FFD116\,pht002900.v3,\phs000007\pht002900\phv00173044\FFD116\,phv00173044,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: White wine,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: White wine,phs000007.v31,1aa6adbb069211b5c40ff56d4fe2decd00202e5a413b47975e876dd5bdd48169,continuous,phv00173044.v3,phs000007,True,FFD116,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173044\FFD116\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00162640.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162640,[],phs000007,pht002350,phv00162640,False,True,True,FFD116,DERIVED FIELD:WHITE WINE,0.0,\phs000007\pht002350\phv00162640\FFD116\,pht002350.v5,\phs000007\pht002350\phv00162640\FFD116\,phv00162640,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WHITE WINE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:WHITE WINE,phs000007.v31,4b2b26d975530b9fd54a7a0cb655102eb52a70873527946dc549d199704c39e6,continuous,phv00162640.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162640\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00158506.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158506,[],phs000007,pht002153,phv00158506,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht002153\phv00158506\FFD116\,pht002153.v1,\phs000007\pht002153\phv00158506\FFD116\,phv00158506,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,d6855fba30973760015639ce6c196448935d635187aa61f9d858766e6c1fcc12,continuous,phv00158506.v1,phs000007,True,FFD116,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158506\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00157262.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157262,[],phs000007,pht002150,phv00157262,False,True,True,FFD116,DERIVED FIELD:WHITE WINE,0.0,\phs000007\pht002150\phv00157262\FFD116\,pht002150.v4,\phs000007\pht002150\phv00157262\FFD116\,phv00157262,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WHITE WINE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:WHITE WINE,phs000007.v31,0306be86fbae2fbe9196c0caffdd16133664e3519a4b8fbf736148659032a4c1,continuous,phv00157262.v4,phs000007,True,FFD116,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157262\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00157703.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157703,[],phs000007,pht002151,phv00157703,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht002151\phv00157703\FFD116\,pht002151.v1,\phs000007\pht002151\phv00157703\FFD116\,phv00157703,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,a885769bad8325ebdb79d9cb7dfa93a798ce9b5fd9cb08c3c3a93b8a7222a17c,continuous,phv00157703.v1,phs000007,True,FFD116,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157703\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd116,WHITE WINE:(servings/week),0.591327201,vr_ffreq_ex06_1_0506d,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00479231.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479231,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00478576.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00478015.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00157263.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157263,[],phs000007,pht002150,phv00157263,False,True,True,FFD117,DERIVED FIELD:LIQUOR,0.0,\phs000007\pht002150\phv00157263\FFD117\,pht002150.v4,\phs000007\pht002150\phv00157263\FFD117\,phv00157263,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:LIQUOR,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:LIQUOR,phs000007.v31,336361869c80c7dbfd84d5bc508ca544aedecfb5dd661ae1e84d020554ea35d1,continuous,phv00157263.v4,phs000007,True,FFD117,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157263\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00157704.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157704,[],phs000007,pht002151,phv00157704,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht002151\phv00157704\FFD117\,pht002151.v1,\phs000007\pht002151\phv00157704\FFD117\,phv00157704,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,0fd1578c5c436e32fc736d2458cef4ddf9231278746a07f72980df7f28cd014d,continuous,phv00157704.v1,phs000007,True,FFD117,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157704\FFD117\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00070153.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070153,[],phs000007,pht000680,phv00070153,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000680\phv00070153\FFD117\,pht000680.v6,\phs000007\pht000680\phv00070153\FFD117\,phv00070153,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,b1cadde8c2c5c63783d184f016570935bacaa9594d8d2dfef19b1f5c225226bc,continuous,phv00070153.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070153\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00069129.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069129,[],phs000007,pht000682,phv00069129,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000682\phv00069129\FFD117\,pht000682.v6,\phs000007\pht000682\phv00069129\FFD117\,phv00069129,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,53d53d04d2fd499ed4520c93bb5010ac90cc3d721584c9020e3fc5dab639510e,continuous,phv00069129.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069129\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,LIQUOR,phs000007.v33.p14,phv00523959.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00158507.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158507,[],phs000007,pht002153,phv00158507,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht002153\phv00158507\FFD117\,pht002153.v1,\phs000007\pht002153\phv00158507\FFD117\,phv00158507,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,5648cac741e364f2065b6f7a6cc5f0a0395d7e8db218264652d46b51e01de1f5,continuous,phv00158507.v1,phs000007,True,FFD117,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158507\FFD117\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00162641.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162641,[],phs000007,pht002350,phv00162641,False,True,True,FFD117,DERIVED FIELD:LIQUOR,0.0,\phs000007\pht002350\phv00162641\FFD117\,pht002350.v5,\phs000007\pht002350\phv00162641\FFD117\,phv00162641,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:LIQUOR,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:LIQUOR,phs000007.v31,955fc37c2f93e97ac55b75b42d3bc8012d25f322fa3f344e1982b63b627251c6,continuous,phv00162641.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162641\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00479232.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00173045.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173045,[],phs000007,pht002900,phv00173045,False,True,True,FFD117,Derived field: Liquor,0.0,\phs000007\pht002900\phv00173045\FFD117\,pht002900.v3,\phs000007\pht002900\phv00173045\FFD117\,phv00173045,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Liquor,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Liquor,phs000007.v31,021d8fb2f95c3a1698b3cbc57414e6153098f78614d3d501b3e57b48d9d31002,continuous,phv00173045.v3,phs000007,True,FFD117,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173045\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00524619.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00068560.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068560,[],phs000007,pht000681,phv00068560,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000681\phv00068560\FFD117\,pht000681.v6,\phs000007\pht000681\phv00068560\FFD117\,phv00068560,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,54f73fea724c26925c19695c838792a5a6cd22350f364c20e83e6806d98852cb,continuous,phv00068560.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068560\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex06_1_0506d.ffd117,LIQUOR:(servings/week),0.229960578,vr_ffreq_ex06_1_0506d,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00477452.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00524527.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00479140.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,RAISINS,phs000007.v33.p14,phv00523872.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523872,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00477928.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00477365.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00068473.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068473,[],phs000007,pht000681,phv00068473,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000681\phv00068473\FFD30\,pht000681.v6,\phs000007\pht000681\phv00068473\FFD30\,phv00068473,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,be49de00223c4ec07aa8c093ba00a8874c07cb9ac4aadf651f4985d3093e5cac,continuous,phv00068473.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068473\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00172953.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172953,[],phs000007,pht002900,phv00172953,False,True,False,FFD30,Derived field: Raisins or grapes,0.0,\phs000007\pht002900\phv00172953\FFD30\,pht002900.v3,\phs000007\pht002900\phv00172953\FFD30\,phv00172953,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Raisins or grapes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Raisins or grapes,phs000007.v31,d5c1a07452f1953a5e6e83cbd6dc46795b03b83fe9d208e3ce3dd33c3c8b015f,continuous,phv00172953.v3,phs000007,False,FFD30,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172953\FFD30\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00162554.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162554,[],phs000007,pht002350,phv00162554,False,True,False,FFD30,DERIVED FIELD:RAISINS,0.0,\phs000007\pht002350\phv00162554\FFD30\,pht002350.v5,\phs000007\pht002350\phv00162554\FFD30\,phv00162554,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:RAISINS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:RAISINS,phs000007.v31,6c1c26cf8f68e8dbf3e476b63162f6493658000a4fe0a934c0878b8e0e8dd5f7,continuous,phv00162554.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162554\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00069042.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069042,[],phs000007,pht000682,phv00069042,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000682\phv00069042\FFD30\,pht000682.v6,\phs000007\pht000682\phv00069042\FFD30\,phv00069042,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,2f8ce696e225dfc8e7a37e1cf0112cbd192bd9dd41d7b8ce0a15d05431ba4961,continuous,phv00069042.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069042\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00158420.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158420,[],phs000007,pht002153,phv00158420,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht002153\phv00158420\FFD30\,pht002153.v1,\phs000007\pht002153\phv00158420\FFD30\,phv00158420,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,f99797221f56d569434cb40309bc140df8d3241a5e29099117c70be2e33ab2c0,continuous,phv00158420.v1,phs000007,False,FFD30,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158420\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00157617.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157617,[],phs000007,pht002151,phv00157617,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht002151\phv00157617\FFD30\,pht002151.v1,\phs000007\pht002151\phv00157617\FFD30\,phv00157617,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,45537ab4ad44589e914f23a9399ba1939637bf681dd6844778b6b161c860f0b0,continuous,phv00157617.v1,phs000007,False,FFD30,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157617\FFD30\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00070066.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070066,[],phs000007,pht000680,phv00070066,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000680\phv00070066\FFD30\,pht000680.v6,\phs000007\pht000680\phv00070066\FFD30\,phv00070066,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,f09a6599e8c1cf8c64abb6d7ccdfe4302a2fdecc5f25ce148fd91c0916600f3b,continuous,phv00070066.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070066\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00157176.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157176,[],phs000007,pht002150,phv00157176,False,True,False,FFD30,DERIVED FIELD:RAISINS,0.0,\phs000007\pht002150\phv00157176\FFD30\,pht002150.v4,\phs000007\pht002150\phv00157176\FFD30\,phv00157176,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:RAISINS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:RAISINS,phs000007.v31,2d080857ade314a03e8901fca5a691becc0d3de98e8c48c37b1cd698b1ee13ea,continuous,phv00157176.v4,phs000007,False,FFD30,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157176\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd30,RAISINS:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00478489.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,PRUNES,phs000007.v33.p14,phv00523873.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00478490.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00477929.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00162555.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162555,[],phs000007,pht002350,phv00162555,False,True,False,FFD31,DERIVED FIELD:PRUNES,0.0,\phs000007\pht002350\phv00162555\FFD31\,pht002350.v5,\phs000007\pht002350\phv00162555\FFD31\,phv00162555,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PRUNES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:PRUNES,phs000007.v31,19cbe3fcd263200f95d070d348366b41e300ac3a28a4609875b69106f6764388,continuous,phv00162555.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162555\FFD31\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00158421.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158421,[],phs000007,pht002153,phv00158421,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht002153\phv00158421\FFD31\,pht002153.v1,\phs000007\pht002153\phv00158421\FFD31\,phv00158421,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,9d829a254ae2697ca62a229c302f3ecc0d82110b50d947e6955f21d2668fe7a1,continuous,phv00158421.v1,phs000007,False,FFD31,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158421\FFD31\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00157618.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157618,[],phs000007,pht002151,phv00157618,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht002151\phv00157618\FFD31\,pht002151.v1,\phs000007\pht002151\phv00157618\FFD31\,phv00157618,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,e1b32985c3cafcbaeac7e41d65a31b8726ee5de8022bf4cd28d3995639ad5b78,continuous,phv00157618.v1,phs000007,False,FFD31,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157618\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00157177.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157177,[],phs000007,pht002150,phv00157177,False,True,False,FFD31,DERIVED FIELD:PRUNES,0.0,\phs000007\pht002150\phv00157177\FFD31\,pht002150.v4,\phs000007\pht002150\phv00157177\FFD31\,phv00157177,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PRUNES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:PRUNES,phs000007.v31,543e9ab69eb1ed8d6ba460f1e636195d2adee5f946444aefe45ea30935ab09e8,continuous,phv00157177.v4,phs000007,False,FFD31,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157177\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00070067.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070067,[],phs000007,pht000680,phv00070067,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000680\phv00070067\FFD31\,pht000680.v6,\phs000007\pht000680\phv00070067\FFD31\,phv00070067,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,c48bd4cbbd2518e68a4ebca54ac41b908f136adb0ebd6d951a90bf195f16028a,continuous,phv00070067.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070067\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00069043.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069043,[],phs000007,pht000682,phv00069043,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000682\phv00069043\FFD31\,pht000682.v6,\phs000007\pht000682\phv00069043\FFD31\,phv00069043,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,217cd5c97101248ff7264b0315cdd2e3466c731e192474269dd3eebb4eb0e959,continuous,phv00069043.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069043\FFD31\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00068474.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068474,[],phs000007,pht000681,phv00068474,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000681\phv00068474\FFD31\,pht000681.v6,\phs000007\pht000681\phv00068474\FFD31\,phv00068474,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,6f83b7cc15bf1b18636fedac7f39d308601e8992454dfc8bf7598411edfe668d,continuous,phv00068474.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068474\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd31,PRUNES:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00477366.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00068475.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068475,[],phs000007,pht000681,phv00068475,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000681\phv00068475\FFD32\,pht000681.v6,\phs000007\pht000681\phv00068475\FFD32\,phv00068475,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,d68c6d4d0406eb63cabbf69e87e0cc9990cc9c66da76f6931ece5e13ae08ac99,continuous,phv00068475.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068475\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00069044.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069044,[],phs000007,pht000682,phv00069044,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000682\phv00069044\FFD32\,pht000682.v6,\phs000007\pht000682\phv00069044\FFD32\,phv00069044,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,376dd521f3f1d7a3f03337dc6567a8f78edef583e49340a32bea9142df664032,continuous,phv00069044.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069044\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00158422.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158422,[],phs000007,pht002153,phv00158422,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht002153\phv00158422\FFD32\,pht002153.v1,\phs000007\pht002153\phv00158422\FFD32\,phv00158422,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,516b994d306a118bd3861d65af73848e910daf6431dbba6bde1e794caa6403d3,continuous,phv00158422.v1,phs000007,False,FFD32,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158422\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00070068.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070068,[],phs000007,pht000680,phv00070068,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000680\phv00070068\FFD32\,pht000680.v6,\phs000007\pht000680\phv00070068\FFD32\,phv00070068,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,a2cd8145b51cad6b3b9427ac6b6f9f1261dfdfdecac6817370388bea6e4aa229,continuous,phv00070068.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070068\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00157178.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157178,[],phs000007,pht002150,phv00157178,False,True,False,FFD32,DERIVED FIELD:BANANAS,0.0,\phs000007\pht002150\phv00157178\FFD32\,pht002150.v4,\phs000007\pht002150\phv00157178\FFD32\,phv00157178,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BANANAS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BANANAS,phs000007.v31,2345889d9d90803c638ec75abcc0d49e793ded46823ca3c79cce40b1bd6900cf,continuous,phv00157178.v4,phs000007,False,FFD32,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157178\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00157619.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157619,[],phs000007,pht002151,phv00157619,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht002151\phv00157619\FFD32\,pht002151.v1,\phs000007\pht002151\phv00157619\FFD32\,phv00157619,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,f2df173e3f9ae6b20d2f7e95b28bc28d5be064c6d3c36c93647e96147ad10399,continuous,phv00157619.v1,phs000007,False,FFD32,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157619\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00162556.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162556,[],phs000007,pht002350,phv00162556,False,True,False,FFD32,DERIVED FIELD:BANANAS,0.0,\phs000007\pht002350\phv00162556\FFD32\,pht002350.v5,\phs000007\pht002350\phv00162556\FFD32\,phv00162556,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BANANAS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BANANAS,phs000007.v31,1c4ff3408fda6d4fc1fdc0bc17c095dceba5d0d12ec7bdcb94fcbf3a30045722,continuous,phv00162556.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162556\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,BANANAS,phs000007.v33.p14,phv00523874.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00477367.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477367,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00477930.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477930,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00478491.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00479143.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00524530.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd32,BANANAS:(servings/week),1.609724047,vr_ffreq_ex06_1_0506d,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00172956.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172956,[],phs000007,pht002900,phv00172956,False,True,False,FFD32,Derived field: Bananas,0.0,\phs000007\pht002900\phv00172956\FFD32\,pht002900.v3,\phs000007\pht002900\phv00172956\FFD32\,phv00172956,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Bananas,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Bananas,phs000007.v31,976af2eb6db825a29af00e1f704be42fb3a4070bdcabf4a90fb29851da7072a2,continuous,phv00172956.v3,phs000007,False,FFD32,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172956\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,CANTALOUPE,phs000007.v33.p14,phv00523875.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00479144.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00478492.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478492,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00477931.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00477368.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00172957.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172957,[],phs000007,pht002900,phv00172957,False,True,False,FFD33,Derived field: Cantaloupe,0.0,\phs000007\pht002900\phv00172957\FFD33\,pht002900.v3,\phs000007\pht002900\phv00172957\FFD33\,phv00172957,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cantaloupe,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Cantaloupe,phs000007.v31,5583becf69ba14da6f104cd78c493737ffd21fc69eca2e7fc0f3ba600116e6ce,continuous,phv00172957.v3,phs000007,False,FFD33,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172957\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00524531.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524531,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00158423.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158423,[],phs000007,pht002153,phv00158423,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht002153\phv00158423\FFD33\,pht002153.v1,\phs000007\pht002153\phv00158423\FFD33\,phv00158423,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,3ae3c6805679ff084e90bc9ecc5fccb5a5535d0e07a3b491c99f10292b9bbec7,continuous,phv00158423.v1,phs000007,False,FFD33,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158423\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00157620.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157620,[],phs000007,pht002151,phv00157620,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht002151\phv00157620\FFD33\,pht002151.v1,\phs000007\pht002151\phv00157620\FFD33\,phv00157620,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,5aaca17896fbd32741da0675ddabd821f9e66ae9e774d0c056e70ce89dde2302,continuous,phv00157620.v1,phs000007,False,FFD33,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157620\FFD33\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00157179.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157179,[],phs000007,pht002150,phv00157179,False,True,False,FFD33,DERIVED FIELD:CANTALOUPE,0.0,\phs000007\pht002150\phv00157179\FFD33\,pht002150.v4,\phs000007\pht002150\phv00157179\FFD33\,phv00157179,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CANTALOUPE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:CANTALOUPE,phs000007.v31,53bf60ccb09476213d4c0b17c108c21b2b5ad8097e009fd5f4cb0280547bed43,continuous,phv00157179.v4,phs000007,False,FFD33,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157179\FFD33\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00070069.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070069,[],phs000007,pht000680,phv00070069,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000680\phv00070069\FFD33\,pht000680.v6,\phs000007\pht000680\phv00070069\FFD33\,phv00070069,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,343e5aad482555ea3af002918d6bbaf9cabd25d83ba5b64cd8e42e0649b062b2,continuous,phv00070069.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070069\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00069045.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069045,[],phs000007,pht000682,phv00069045,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000682\phv00069045\FFD33\,pht000682.v6,\phs000007\pht000682\phv00069045\FFD33\,phv00069045,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,6ccb8b8957767e011560b3dd7d05974cc852fc011363380dfae40e8c1500dc3c,continuous,phv00069045.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069045\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00068476.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068476,[],phs000007,pht000681,phv00068476,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000681\phv00068476\FFD33\,pht000681.v6,\phs000007\pht000681\phv00068476\FFD33\,phv00068476,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,3f6ca7b0ff2bdc23cd5887c75f52503b8f4d62fdd61b2259f2e0afa026614a5c,continuous,phv00068476.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068476\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd33,CANTALOUPE:(servings/week),0.985545335,vr_ffreq_ex06_1_0506d,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00162557.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162557,[],phs000007,pht002350,phv00162557,False,True,False,FFD33,DERIVED FIELD:CANTALOUPE,0.0,\phs000007\pht002350\phv00162557\FFD33\,pht002350.v5,\phs000007\pht002350\phv00162557\FFD33\,phv00162557,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CANTALOUPE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:CANTALOUPE,phs000007.v31,aa1f34f9cbcb31b6356c3e404f549806f38e91d733a939d03a00322d3ad69f2a,continuous,phv00162557.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162557\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,WATERMELON,phs000007.v33.p14,phv00523876.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523876,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00478493.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00477932.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477932,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00477369.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00162558.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162558,[],phs000007,pht002350,phv00162558,False,True,False,FFD34,DERIVED FIELD:WATERMELON,0.0,\phs000007\pht002350\phv00162558\FFD34\,pht002350.v5,\phs000007\pht002350\phv00162558\FFD34\,phv00162558,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WATERMELON,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:WATERMELON,phs000007.v31,3ed7e5236a23088be0f1e3abd84040d3c831cd76286f1fee7e4190f23fde6ab2,continuous,phv00162558.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162558\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00158424.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158424,[],phs000007,pht002153,phv00158424,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht002153\phv00158424\FFD34\,pht002153.v1,\phs000007\pht002153\phv00158424\FFD34\,phv00158424,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,64206c630afb53c5e5cbf27fde6f51667b52504ed40838de10291f5baf866bf2,continuous,phv00158424.v1,phs000007,False,FFD34,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158424\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00157180.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157180,[],phs000007,pht002150,phv00157180,False,True,False,FFD34,DERIVED FIELD:WATERMELON,0.0,\phs000007\pht002150\phv00157180\FFD34\,pht002150.v4,\phs000007\pht002150\phv00157180\FFD34\,phv00157180,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WATERMELON,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:WATERMELON,phs000007.v31,ee5e015faa58e773bcf8cc48c03b18606cff5c8292bbf61d6ba1e61b685cc6ec,continuous,phv00157180.v4,phs000007,False,FFD34,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157180\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00070070.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070070,[],phs000007,pht000680,phv00070070,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000680\phv00070070\FFD34\,pht000680.v6,\phs000007\pht000680\phv00070070\FFD34\,phv00070070,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,89768909f3e72b5e62236000f4d6d4d45dd495d935db8a9c4702b773d1630cb9,continuous,phv00070070.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070070\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00069046.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069046,[],phs000007,pht000682,phv00069046,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000682\phv00069046\FFD34\,pht000682.v6,\phs000007\pht000682\phv00069046\FFD34\,phv00069046,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,16ece4d2ee001070614d0a5974ead7d3b2f13cdf412fc221fed2e0b5ba7c3f96,continuous,phv00069046.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069046\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00068477.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068477,[],phs000007,pht000681,phv00068477,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000681\phv00068477\FFD34\,pht000681.v6,\phs000007\pht000681\phv00068477\FFD34\,phv00068477,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,950d4fe76954abffcd38ae8ac5390a8a9bb6dd70a10ef25dc56099a233701a12,continuous,phv00068477.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068477\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd34,WATERMELON:(servings/week),1.806833114,vr_ffreq_ex06_1_0506d,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00157621.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157621,[],phs000007,pht002151,phv00157621,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht002151\phv00157621\FFD34\,pht002151.v1,\phs000007\pht002151\phv00157621\FFD34\,phv00157621,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,5fd21372dfa6ffe0b9b2b3275644ef8f340a6521f7e467fe8e916abbb3770b57,continuous,phv00157621.v1,phs000007,False,FFD34,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157621\FFD34\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00524533.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH",phs000007.v33.p14,phv00523877.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523877,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00479146.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00477933.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477933,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00478494.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00172959.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172959,[],phs000007,pht002900,phv00172959,False,True,False,FFD35,Derived field: Fresh apples or pears,0.0,\phs000007\pht002900\phv00172959\FFD35\,pht002900.v3,\phs000007\pht002900\phv00172959\FFD35\,phv00172959,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Fresh apples or pears,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Fresh apples or pears,phs000007.v31,507a73c68bfc1a88df9fc619bee590bbc8bead596db3b3088e639b30050d273b,continuous,phv00172959.v3,phs000007,False,FFD35,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172959\FFD35\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00477370.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00158425.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158425,[],phs000007,pht002153,phv00158425,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht002153\phv00158425\FFD35\,pht002153.v1,\phs000007\pht002153\phv00158425\FFD35\,phv00158425,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,0da263a57a2b777e85af075c1ef10504757be2a0c780d8f430247444ed114a0e,continuous,phv00158425.v1,phs000007,False,FFD35,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158425\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00157622.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157622,[],phs000007,pht002151,phv00157622,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht002151\phv00157622\FFD35\,pht002151.v1,\phs000007\pht002151\phv00157622\FFD35\,phv00157622,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,d335099bb1dc844d6e38eee89f17e3e736afcd14b5b46aa6cb5448edf5da5f78,continuous,phv00157622.v1,phs000007,False,FFD35,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157622\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00157181.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157181,[],phs000007,pht002150,phv00157181,False,True,False,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",0.0,\phs000007\pht002150\phv00157181\FFD35\,pht002150.v4,\phs000007\pht002150\phv00157181\FFD35\,phv00157181,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v31,7aa3cde07888bf49c9480d7b5d8581711109fcadd81911e8b168a26df7104273,continuous,phv00157181.v4,phs000007,False,FFD35,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157181\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00070071.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070071,[],phs000007,pht000680,phv00070071,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000680\phv00070071\FFD35\,pht000680.v6,\phs000007\pht000680\phv00070071\FFD35\,phv00070071,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,b5b32557e575ead9473c9f8118efc8cabea341c2b7a92cfd62c7af4ab339ccb8,continuous,phv00070071.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070071\FFD35\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00069047.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069047,[],phs000007,pht000682,phv00069047,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000682\phv00069047\FFD35\,pht000682.v6,\phs000007\pht000682\phv00069047\FFD35\,phv00069047,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,ffd1bcdc4ca4468803e216eaac9261bde05107cef82d442e24b476ad4c3c8a26,continuous,phv00069047.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069047\FFD35\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00068478.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068478,[],phs000007,pht000681,phv00068478,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000681\phv00068478\FFD35\,pht000681.v6,\phs000007\pht000681\phv00068478\FFD35\,phv00068478,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,f75476fafa4fd178a0b5b4bebe1fed721a70a643a345b00896dbd83897a8d86e,continuous,phv00068478.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068478\FFD35\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.149802891,vr_ffreq_ex06_1_0506d,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00162559.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162559,[],phs000007,pht002350,phv00162559,False,True,False,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",0.0,\phs000007\pht002350\phv00162559\FFD35\,pht002350.v5,\phs000007\pht002350\phv00162559\FFD35\,phv00162559,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v31,7d6e7d366ab08fea1fe269edd5cdb88a967ef1c9847c4eb98a0852ef84a9aea2,continuous,phv00162559.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162559\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00479148.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00524535.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,ORANGES,phs000007.v33.p14,phv00523879.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523879,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00478496.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00477935.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00477372.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00172961.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172961,[],phs000007,pht002900,phv00172961,False,True,False,FFD37,Derived field: Oranges,0.0,\phs000007\pht002900\phv00172961\FFD37\,pht002900.v3,\phs000007\pht002900\phv00172961\FFD37\,phv00172961,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Oranges,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Oranges,phs000007.v31,5d3de666c7f285281bc03a796427468fdd1c90234d0f6af2e418d100f843ce75,continuous,phv00172961.v3,phs000007,False,FFD37,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172961\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00162561.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162561,[],phs000007,pht002350,phv00162561,False,True,False,FFD37,DERIVED FIELD:ORANGES,0.0,\phs000007\pht002350\phv00162561\FFD37\,pht002350.v5,\phs000007\pht002350\phv00162561\FFD37\,phv00162561,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ORANGES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:ORANGES,phs000007.v31,6c58c2dd7f1f65cc135cfa5f3b1dfd33f1df56c981feb519282f551e2a59f9b7,continuous,phv00162561.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162561\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00068480.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068480,[],phs000007,pht000681,phv00068480,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000681\phv00068480\FFD37\,pht000681.v6,\phs000007\pht000681\phv00068480\FFD37\,phv00068480,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,1a1da8403c208fde67683962a2d4db07dfa4d41d23d40bc4873d580f75287f60,continuous,phv00068480.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068480\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00157624.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157624,[],phs000007,pht002151,phv00157624,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht002151\phv00157624\FFD37\,pht002151.v1,\phs000007\pht002151\phv00157624\FFD37\,phv00157624,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,51b2732b06a165aa20d1378aa92c7afc80493ec3ecf38f477ffba6753eec962f,continuous,phv00157624.v1,phs000007,False,FFD37,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157624\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00157183.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157183,[],phs000007,pht002150,phv00157183,False,True,False,FFD37,DERIVED FIELD:ORANGES,0.0,\phs000007\pht002150\phv00157183\FFD37\,pht002150.v4,\phs000007\pht002150\phv00157183\FFD37\,phv00157183,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ORANGES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:ORANGES,phs000007.v31,847ab14055d9703e776c5887e506436c6919367058d5084999b9086bcf9f6476,continuous,phv00157183.v4,phs000007,False,FFD37,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157183\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00070073.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070073,[],phs000007,pht000680,phv00070073,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000680\phv00070073\FFD37\,pht000680.v6,\phs000007\pht000680\phv00070073\FFD37\,phv00070073,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,34f8a47d18e191f948e0ecea476e10235f8eae87ea2c4a558300a2dd0805342f,continuous,phv00070073.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070073\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00069049.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069049,[],phs000007,pht000682,phv00069049,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000682\phv00069049\FFD37\,pht000682.v6,\phs000007\pht000682\phv00069049\FFD37\,phv00069049,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,517bc251ee53008c197243e45add8aece8edc295a15eb9fb5390845be2df12bd,continuous,phv00069049.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069049\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd37,ORANGES:(servings/week),1.741130092,vr_ffreq_ex06_1_0506d,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00158427.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158427,[],phs000007,pht002153,phv00158427,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht002153\phv00158427\FFD37\,pht002153.v1,\phs000007\pht002153\phv00158427\FFD37\,phv00158427,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,1b16d76a1a1d969df27e508d19be4323b57221c2f0294b6785cbe8f359af5333,continuous,phv00158427.v1,phs000007,False,FFD37,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158427\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00157185.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157185,[],phs000007,pht002150,phv00157185,False,True,False,FFD39,DERIVED FIELD:GRAPEFRUIT,0.0,\phs000007\pht002150\phv00157185\FFD39\,pht002150.v4,\phs000007\pht002150\phv00157185\FFD39\,phv00157185,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:GRAPEFRUIT,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:GRAPEFRUIT,phs000007.v31,08c807cf87a076477be4e73bc15b3f2dc8a789a716f7c186a2386a4ff2ec8dce,continuous,phv00157185.v4,phs000007,False,FFD39,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157185\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00070075.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070075,[],phs000007,pht000680,phv00070075,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000680\phv00070075\FFD39\,pht000680.v6,\phs000007\pht000680\phv00070075\FFD39\,phv00070075,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,4905d27461d4661075cb32ab6e27fb533cde88c8ae4a2cc6a0fc665ae91d6ef3,continuous,phv00070075.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070075\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00069051.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069051,[],phs000007,pht000682,phv00069051,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000682\phv00069051\FFD39\,pht000682.v6,\phs000007\pht000682\phv00069051\FFD39\,phv00069051,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,fc9c8cc1ff00628974402f8700c164600642ab0738a42d1f2bbed4b54f4fa739,continuous,phv00069051.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069051\FFD39\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00068482.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068482,[],phs000007,pht000681,phv00068482,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000681\phv00068482\FFD39\,pht000681.v6,\phs000007\pht000681\phv00068482\FFD39\,phv00068482,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,840b7ba2194d882d0cd81f970587975dde1f17c45eb16fcbfaa6cd9aaf73c63a,continuous,phv00068482.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068482\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00157626.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157626,[],phs000007,pht002151,phv00157626,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht002151\phv00157626\FFD39\,pht002151.v1,\phs000007\pht002151\phv00157626\FFD39\,phv00157626,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,f79273216d1e0524d4ff195ede70e35e5b65abec0087f00ea4d30a22f522bead,continuous,phv00157626.v1,phs000007,False,FFD39,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157626\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00477937.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,GRAPEFRUIT,phs000007.v33.p14,phv00523881.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00162563.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162563,[],phs000007,pht002350,phv00162563,False,True,False,FFD39,DERIVED FIELD:GRAPEFRUIT,0.0,\phs000007\pht002350\phv00162563\FFD39\,pht002350.v5,\phs000007\pht002350\phv00162563\FFD39\,phv00162563,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:GRAPEFRUIT,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:GRAPEFRUIT,phs000007.v31,5cab6cd836650095eda3a565a8262997c12faa11b3f5530c8851929977466d0f,continuous,phv00162563.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162563\FFD39\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00477374.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477374,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00478498.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478498,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd39,GRAPEFRUIT:(servings/week),1.281208936,vr_ffreq_ex06_1_0506d,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00158429.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158429,[],phs000007,pht002153,phv00158429,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht002153\phv00158429\FFD39\,pht002153.v1,\phs000007\pht002153\phv00158429\FFD39\,phv00158429,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,b4b9917596f47ce5eb4bff30d1b1b9f7e3511843f58d8ab831407e9120e99b1a,continuous,phv00158429.v1,phs000007,False,FFD39,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158429\FFD39\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00157188.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157188,[],phs000007,pht002150,phv00157188,False,True,False,FFD42,DERIVED FIELD:STRAWBERRIES,0.0,\phs000007\pht002150\phv00157188\FFD42\,pht002150.v4,\phs000007\pht002150\phv00157188\FFD42\,phv00157188,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:STRAWBERRIES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:STRAWBERRIES,phs000007.v31,bb85e714eaa5a97d832ecfca4e27324a5729d6c6228106db53fb9ebe068cbe67,continuous,phv00157188.v4,phs000007,False,FFD42,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157188\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00158432.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158432,[],phs000007,pht002153,phv00158432,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht002153\phv00158432\FFD42\,pht002153.v1,\phs000007\pht002153\phv00158432\FFD42\,phv00158432,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,b7faff465a85145aaa6e97cb7131e6c6cac05d4a64d706021aa6970b8f0e5556,continuous,phv00158432.v1,phs000007,False,FFD42,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158432\FFD42\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00162566.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162566,[],phs000007,pht002350,phv00162566,False,True,False,FFD42,DERIVED FIELD:STRAWBERRIES,0.0,\phs000007\pht002350\phv00162566\FFD42\,pht002350.v5,\phs000007\pht002350\phv00162566\FFD42\,phv00162566,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:STRAWBERRIES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:STRAWBERRIES,phs000007.v31,06d05af9e5af51f126488183a9e71a212ea1c5fa425afeebf06e6741e2428840,continuous,phv00162566.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162566\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00172966.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172966,[],phs000007,pht002900,phv00172966,False,True,False,FFD42,Derived field: Strawberries,0.0,\phs000007\pht002900\phv00172966\FFD42\,pht002900.v3,\phs000007\pht002900\phv00172966\FFD42\,phv00172966,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Strawberries,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Strawberries,phs000007.v31,9e2ebfc1ea0a49925eaa7488f45aac832be5787bf4dc452b6b2baa54a01594e7,continuous,phv00172966.v3,phs000007,False,FFD42,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172966\FFD42\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00157629.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157629,[],phs000007,pht002151,phv00157629,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht002151\phv00157629\FFD42\,pht002151.v1,\phs000007\pht002151\phv00157629\FFD42\,phv00157629,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,cb6c821f13dd71ed480777925d04a3eb7d21352495c7e653b596f7cd4de54c71,continuous,phv00157629.v1,phs000007,False,FFD42,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157629\FFD42\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00070078.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070078,[],phs000007,pht000680,phv00070078,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000680\phv00070078\FFD42\,pht000680.v6,\phs000007\pht000680\phv00070078\FFD42\,phv00070078,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,2636dfc9e391db6755b0e6f7a742a65151c0dcca24402a1cc222fb36ce5207b4,continuous,phv00070078.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070078\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00477940.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00068485.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068485,[],phs000007,pht000681,phv00068485,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000681\phv00068485\FFD42\,pht000681.v6,\phs000007\pht000681\phv00068485\FFD42\,phv00068485,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,ca0dc0fe34d29c3400f5873a333a77842a2caa6c454bd4f3debaefeb0e4f6db6,continuous,phv00068485.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068485\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00524540.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524540,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,STRAWBERRIES,phs000007.v33.p14,phv00523884.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523884,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00479153.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00478501.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00477377.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477377,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd42,STRAWBERRIES:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00069054.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069054,[],phs000007,pht000682,phv00069054,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000682\phv00069054\FFD42\,pht000682.v6,\phs000007\pht000682\phv00069054\FFD42\,phv00069054,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,70965e0ed39ff65323bd3ef32f8554e85aa5d9206505133605015dd83361df23,continuous,phv00069054.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069054\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00158433.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158433,[],phs000007,pht002153,phv00158433,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht002153\phv00158433\FFD43\,pht002153.v1,\phs000007\pht002153\phv00158433\FFD43\,phv00158433,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,a89fd3b021ddb4b0920f970ea19ff4edaf7be53f41fc16e43006dd7bb19c8fff,continuous,phv00158433.v1,phs000007,False,FFD43,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158433\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00162567.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162567,[],phs000007,pht002350,phv00162567,False,True,False,FFD43,DERIVED FIELD:BLUEBERRIES,0.0,\phs000007\pht002350\phv00162567\FFD43\,pht002350.v5,\phs000007\pht002350\phv00162567\FFD43\,phv00162567,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BLUEBERRIES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:BLUEBERRIES,phs000007.v31,f63608356643487d835a09edd883a638d716ce1ee2671d36b35f729a762bc326,continuous,phv00162567.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162567\FFD43\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00477378.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477378,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00070079.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070079,[],phs000007,pht000680,phv00070079,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000680\phv00070079\FFD43\,pht000680.v6,\phs000007\pht000680\phv00070079\FFD43\,phv00070079,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,0fb398f8265e21e9e3804e11fd2fe592a6d9b2710f4f703ac125b893a87c13f0,continuous,phv00070079.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070079\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00157189.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157189,[],phs000007,pht002150,phv00157189,False,True,False,FFD43,DERIVED FIELD:BLUEBERRIES,0.0,\phs000007\pht002150\phv00157189\FFD43\,pht002150.v4,\phs000007\pht002150\phv00157189\FFD43\,phv00157189,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BLUEBERRIES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BLUEBERRIES,phs000007.v31,e7f3e4cc5af4ba7b4c3ba3a516155d495ab31c772b9d8555e7f595824151dbda,continuous,phv00157189.v4,phs000007,False,FFD43,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157189\FFD43\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00157630.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157630,[],phs000007,pht002151,phv00157630,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht002151\phv00157630\FFD43\,pht002151.v1,\phs000007\pht002151\phv00157630\FFD43\,phv00157630,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,544da6c0b1b7079c8ba1469a58a13d4dcd4044104986deb047ab9704c7833131,continuous,phv00157630.v1,phs000007,False,FFD43,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157630\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00524541.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00069055.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069055,[],phs000007,pht000682,phv00069055,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000682\phv00069055\FFD43\,pht000682.v6,\phs000007\pht000682\phv00069055\FFD43\,phv00069055,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,7184844bdd999f98cd03b10632835165928708f83c5edd3789c979fc41947e7e,continuous,phv00069055.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069055\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00479154.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00478502.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00477941.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477941,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00172967.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172967,[],phs000007,pht002900,phv00172967,False,True,False,FFD43,Derived field: Blueberries,0.0,\phs000007\pht002900\phv00172967\FFD43\,pht002900.v3,\phs000007\pht002900\phv00172967\FFD43\,phv00172967,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Blueberries,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Blueberries,phs000007.v31,267b0a2f42fe0f8dab728a0505ec3e043b3c96d4fd26e9ff35fdfcb09da86f9a,continuous,phv00172967.v3,phs000007,False,FFD43,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172967\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,BLUEBERRIES,phs000007.v33.p14,phv00523885.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523885,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd43,BLUEBERRIES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00068486.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068486,[],phs000007,pht000681,phv00068486,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000681\phv00068486\FFD43\,pht000681.v6,\phs000007\pht000681\phv00068486\FFD43\,phv00068486,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,2fabeab54eddeffb1ae94f01e01ca4b7f05d7a82fc58036b9eb699f517aafe30,continuous,phv00068486.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068486\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,PEACHES,phs000007.v33.p14,phv00523886.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00478503.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00477942.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00477379.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00162568.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162568,[],phs000007,pht002350,phv00162568,False,True,False,FFD44,DERIVED FIELD:PEACHES,0.0,\phs000007\pht002350\phv00162568\FFD44\,pht002350.v5,\phs000007\pht002350\phv00162568\FFD44\,phv00162568,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PEACHES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:PEACHES,phs000007.v31,b48ce5bfb5ab70173ac13318e45821cf8ed0d7d4bacc9ee41f9e0ae92e872f20,continuous,phv00162568.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162568\FFD44\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00158434.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158434,[],phs000007,pht002153,phv00158434,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht002153\phv00158434\FFD44\,pht002153.v1,\phs000007\pht002153\phv00158434\FFD44\,phv00158434,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,12604115fd3dcc7df43db0321bd98319f27b26b5f60e9b4b2dacbdf21f1eab28,continuous,phv00158434.v1,phs000007,False,FFD44,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158434\FFD44\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00157190.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157190,[],phs000007,pht002150,phv00157190,False,True,False,FFD44,DERIVED FIELD:PEACHES,0.0,\phs000007\pht002150\phv00157190\FFD44\,pht002150.v4,\phs000007\pht002150\phv00157190\FFD44\,phv00157190,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PEACHES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:PEACHES,phs000007.v31,99adf506a301984f6f6e06a989fa3660d55569935391a69b6254a2d4947173e5,continuous,phv00157190.v4,phs000007,False,FFD44,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157190\FFD44\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00070080.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070080,[],phs000007,pht000680,phv00070080,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000680\phv00070080\FFD44\,pht000680.v6,\phs000007\pht000680\phv00070080\FFD44\,phv00070080,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,a028759f1f18804f7c128f472ffefc791b9e13c69cc541fc4554ec8d4dea9b6f,continuous,phv00070080.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070080\FFD44\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00157631.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157631,[],phs000007,pht002151,phv00157631,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht002151\phv00157631\FFD44\,pht002151.v1,\phs000007\pht002151\phv00157631\FFD44\,phv00157631,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,971ce6dae2f68385b2e318e615719456d63567ae9307378966dfd905c98364eb,continuous,phv00157631.v1,phs000007,False,FFD44,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157631\FFD44\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00068487.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068487,[],phs000007,pht000681,phv00068487,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000681\phv00068487\FFD44\,pht000681.v6,\phs000007\pht000681\phv00068487\FFD44\,phv00068487,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,7440717452cb6022f3ceb460f5d0cba64c05bc4f956fa2cb2cad01119ecfc429,continuous,phv00068487.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068487\FFD44\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex06_1_0506d.ffd44,PEACHES:(servings/week),0.427069645,vr_ffreq_ex06_1_0506d,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00069056.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069056,[],phs000007,pht000682,phv00069056,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000682\phv00069056\FFD44\,pht000682.v6,\phs000007\pht000682\phv00069056\FFD44\,phv00069056,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,9d3e193c0bb392c7e9b72656700995cb6c24480353607a719d1b6b16248f6031,continuous,phv00069056.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069056\FFD44\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00477380.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477380,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00070081.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070081,[],phs000007,pht000680,phv00070081,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000680\phv00070081\FFD45\,pht000680.v6,\phs000007\pht000680\phv00070081\FFD45\,phv00070081,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,f152c4f4e35af3d2cc5ff7aad6fb4dbf71374c9dcdd509d0af54e547a62287b5,continuous,phv00070081.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070081\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00172970.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172970,[],phs000007,pht002900,phv00172970,False,True,False,FFD45,Derived field: Tomatoes,0.0,\phs000007\pht002900\phv00172970\FFD45\,pht002900.v3,\phs000007\pht002900\phv00172970\FFD45\,phv00172970,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Tomatoes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Tomatoes,phs000007.v31,1fa3ac8d065ec7c9ff113935ce43c41c958b7e3994fad9bde9bcd565b4b41d75,continuous,phv00172970.v3,phs000007,False,FFD45,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172970\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00162569.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162569,[],phs000007,pht002350,phv00162569,False,True,False,FFD45,DERIVED FIELD:TOMATOES,0.0,\phs000007\pht002350\phv00162569\FFD45\,pht002350.v5,\phs000007\pht002350\phv00162569\FFD45\,phv00162569,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:TOMATOES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:TOMATOES,phs000007.v31,3328a3c3558a2d24b37256a7811ceebb0efefeac51048de2678e3f15bc66e7e9,continuous,phv00162569.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162569\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00158435.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158435,[],phs000007,pht002153,phv00158435,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht002153\phv00158435\FFD45\,pht002153.v1,\phs000007\pht002153\phv00158435\FFD45\,phv00158435,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,b82cf8684c5650e4425f296dad0b94a3f30d61bf029788f89c97c5c1aa24cda7,continuous,phv00158435.v1,phs000007,False,FFD45,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158435\FFD45\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00157632.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157632,[],phs000007,pht002151,phv00157632,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht002151\phv00157632\FFD45\,pht002151.v1,\phs000007\pht002151\phv00157632\FFD45\,phv00157632,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,b0c687d3629ad8960d165a8bf0fea5a15c42c310432e03f9bb4c1a2738115261,continuous,phv00157632.v1,phs000007,False,FFD45,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157632\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00157191.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157191,[],phs000007,pht002150,phv00157191,False,True,False,FFD45,DERIVED FIELD:TOMATOES,0.0,\phs000007\pht002150\phv00157191\FFD45\,pht002150.v4,\phs000007\pht002150\phv00157191\FFD45\,phv00157191,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:TOMATOES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:TOMATOES,phs000007.v31,b207b482b4d1f5cf3269c6671c39100305f476f67c325cc28bab8b30785c830c,continuous,phv00157191.v4,phs000007,False,FFD45,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157191\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00068488.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068488,[],phs000007,pht000681,phv00068488,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000681\phv00068488\FFD45\,pht000681.v6,\phs000007\pht000681\phv00068488\FFD45\,phv00068488,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,49c22d64388f6d3ec1e0dd15aa375d8dd32a5e491017a2ea744ea74ff922d139,continuous,phv00068488.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068488\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,TOMATOES,phs000007.v33.p14,phv00523887.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523887,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00477943.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477943,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00478504.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00479157.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00069057.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069057,[],phs000007,pht000682,phv00069057,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000682\phv00069057\FFD45\,pht000682.v6,\phs000007\pht000682\phv00069057\FFD45\,phv00069057,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,8a75c323aebca500d8e7649b84cdee4720cb5669cdca3598fce9ee7b269f6564,continuous,phv00069057.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069057\FFD45\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd45,TOMATOES:(servings/week),0.262812089,vr_ffreq_ex06_1_0506d,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00524544.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00524548.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00157196.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157196,[],phs000007,pht002150,phv00157196,False,True,False,FFD50,DERIVED FIELD:STRING BEANS,0.0,\phs000007\pht002150\phv00157196\FFD50\,pht002150.v4,\phs000007\pht002150\phv00157196\FFD50\,phv00157196,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:STRING BEANS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:STRING BEANS,phs000007.v31,a83eee7efcd8a10f33691b0759b782b2efe2419e5de57ee2b63621ba7c56e938,continuous,phv00157196.v4,phs000007,False,FFD50,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157196\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00157637.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157637,[],phs000007,pht002151,phv00157637,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht002151\phv00157637\FFD50\,pht002151.v1,\phs000007\pht002151\phv00157637\FFD50\,phv00157637,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,cf91096c6470eaadcd30b261c20f16a1f92a9336f994f3226360cac622e3d43d,continuous,phv00157637.v1,phs000007,False,FFD50,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157637\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00158440.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158440,[],phs000007,pht002153,phv00158440,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht002153\phv00158440\FFD50\,pht002153.v1,\phs000007\pht002153\phv00158440\FFD50\,phv00158440,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,1d04e1b6e328f9eae2f732ee426442916120799a436095043c4d3c95d16928af,continuous,phv00158440.v1,phs000007,False,FFD50,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158440\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00162574.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162574,[],phs000007,pht002350,phv00162574,False,True,False,FFD50,DERIVED FIELD:STRING BEANS,0.0,\phs000007\pht002350\phv00162574\FFD50\,pht002350.v5,\phs000007\pht002350\phv00162574\FFD50\,phv00162574,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:STRING BEANS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:STRING BEANS,phs000007.v31,4849b1351afa10ff1ed74ca0538b324a392b65ad7a83cb52801ce961ac72d295,continuous,phv00162574.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162574\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00172974.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172974,[],phs000007,pht002900,phv00172974,False,True,False,FFD50,Derived field: String beans,0.0,\phs000007\pht002900\phv00172974\FFD50\,pht002900.v3,\phs000007\pht002900\phv00172974\FFD50\,phv00172974,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: String beans,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: String beans,phs000007.v31,f87ab435242561b1b5ada61f8906e38e75093be7e4a02b4af1c3615bc07e8c22,continuous,phv00172974.v3,phs000007,False,FFD50,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172974\FFD50\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00477385.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00477948.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477948,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00478509.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00479161.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,STRING BEANS,phs000007.v33.p14,phv00523892.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523892,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00068493.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068493,[],phs000007,pht000681,phv00068493,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000681\phv00068493\FFD50\,pht000681.v6,\phs000007\pht000681\phv00068493\FFD50\,phv00068493,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,56e1e12043ae2a69522b6e018874d1942935687f11a670b23e5b6926435167f8,continuous,phv00068493.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068493\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00070086.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070086,[],phs000007,pht000680,phv00070086,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000680\phv00070086\FFD50\,pht000680.v6,\phs000007\pht000680\phv00070086\FFD50\,phv00070086,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,84f7a7ba0f212c7dbcf56af94ff6428d5937ed31acc77428f7603b2e08166543,continuous,phv00070086.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070086\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd50,STRING BEANS:(servings/week),0.361366623,vr_ffreq_ex06_1_0506d,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00069062.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069062,[],phs000007,pht000682,phv00069062,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000682\phv00069062\FFD50\,pht000682.v6,\phs000007\pht000682\phv00069062\FFD50\,phv00069062,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,f0dc0add95b628cbd4a7ac255f00da3e129ac459328be8ac1f5f41c28ec5c13e,continuous,phv00069062.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069062\FFD50\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00477949.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00478510.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00479165.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479165,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,BROCCOLI,phs000007.v33.p14,phv00523893.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523893,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00524552.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00070087.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070087,[],phs000007,pht000680,phv00070087,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000680\phv00070087\FFD51\,pht000680.v6,\phs000007\pht000680\phv00070087\FFD51\,phv00070087,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,cf7370be2f3840917db3f6bd2783d5da234639518229b2fb80834dec4d3b2de1,continuous,phv00070087.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070087\FFD51\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00069063.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069063,[],phs000007,pht000682,phv00069063,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000682\phv00069063\FFD51\,pht000682.v6,\phs000007\pht000682\phv00069063\FFD51\,phv00069063,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,a23f44f1fd7384636b5661c9a4cc99dbefd29763a6db141dfd3a274918b5417d,continuous,phv00069063.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069063\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00172978.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172978,[],phs000007,pht002900,phv00172978,False,True,False,FFD51,Derived field: Broccoli,0.0,\phs000007\pht002900\phv00172978\FFD51\,pht002900.v3,\phs000007\pht002900\phv00172978\FFD51\,phv00172978,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Broccoli,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Broccoli,phs000007.v31,3ebc64624a678a15e47fbe8f8a868aba9fdc700710de162f5dfd7cf5dc6a592d,continuous,phv00172978.v3,phs000007,False,FFD51,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172978\FFD51\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00477386.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477386,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00157197.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157197,[],phs000007,pht002150,phv00157197,False,True,False,FFD51,DERIVED FIELD:BROCCOLI,0.0,\phs000007\pht002150\phv00157197\FFD51\,pht002150.v4,\phs000007\pht002150\phv00157197\FFD51\,phv00157197,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BROCCOLI,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BROCCOLI,phs000007.v31,45ba13a51baf5bda63ab3ac5d42b4b3e162316a259762b71ed14019466ebed80,continuous,phv00157197.v4,phs000007,False,FFD51,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157197\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00068494.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068494,[],phs000007,pht000681,phv00068494,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000681\phv00068494\FFD51\,pht000681.v6,\phs000007\pht000681\phv00068494\FFD51\,phv00068494,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,291c9d7100faa621eb275149f8d784f08ef8c88b4febea3445a100e5df63f5bf,continuous,phv00068494.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068494\FFD51\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00158441.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158441,[],phs000007,pht002153,phv00158441,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht002153\phv00158441\FFD51\,pht002153.v1,\phs000007\pht002153\phv00158441\FFD51\,phv00158441,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,4792c53e7c57e1bcb0750728912bd5f1d7d5f1efb2d3a21ec3cac3395d526fd6,continuous,phv00158441.v1,phs000007,False,FFD51,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158441\FFD51\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00157638.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157638,[],phs000007,pht002151,phv00157638,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht002151\phv00157638\FFD51\,pht002151.v1,\phs000007\pht002151\phv00157638\FFD51\,phv00157638,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,de2b51d239c95a984df1265baff74dc2c1c47f91a380ea037a8c8dd81c4bc71f,continuous,phv00157638.v1,phs000007,False,FFD51,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157638\FFD51\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd51,BROCCOLI:(servings/week),0.821287779,vr_ffreq_ex06_1_0506d,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00162575.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162575,[],phs000007,pht002350,phv00162575,False,True,False,FFD51,DERIVED FIELD:BROCCOLI,0.0,\phs000007\pht002350\phv00162575\FFD51\,pht002350.v5,\phs000007\pht002350\phv00162575\FFD51\,phv00162575,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BROCCOLI,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BROCCOLI,phs000007.v31,870ef8113c078eb92e1b5fb0203ca7745f1dafdc4525e396725fce09efec7a5d,continuous,phv00162575.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162575\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00524554.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524554,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00479167.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00478511.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478511,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00477950.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00477387.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW,phs000007.v33.p14,phv00523894.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00162576.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162576,[],phs000007,pht002350,phv00162576,False,True,False,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,0.0,\phs000007\pht002350\phv00162576\FFD52\,pht002350.v5,\phs000007\pht002350\phv00162576\FFD52\,phv00162576,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v31,97cec4836fc02aba136a9125ef56d31e73a7fbd4d75eac8eca490f5636deb132,continuous,phv00162576.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162576\FFD52\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00172980.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172980,[],phs000007,pht002900,phv00172980,False,True,False,FFD52,Derived field: Cabbage or coleslaw,0.0,\phs000007\pht002900\phv00172980\FFD52\,pht002900.v3,\phs000007\pht002900\phv00172980\FFD52\,phv00172980,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cabbage or coleslaw,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Cabbage or coleslaw,phs000007.v31,06cfac9f4da85e7e45719dcb2022ea99bcc086f06b77bc3963293a70f4cf1d71,continuous,phv00172980.v3,phs000007,False,FFD52,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172980\FFD52\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00069064.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069064,[],phs000007,pht000682,phv00069064,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000682\phv00069064\FFD52\,pht000682.v6,\phs000007\pht000682\phv00069064\FFD52\,phv00069064,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,cf8857fc06af4c0123408aa9ab2fd0b292ec35c3538984f21c77010428813eaf,continuous,phv00069064.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069064\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00070088.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070088,[],phs000007,pht000680,phv00070088,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000680\phv00070088\FFD52\,pht000680.v6,\phs000007\pht000680\phv00070088\FFD52\,phv00070088,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,d508df34728162c1b94c95c31b34ec3b8c7438d87cfed748e7e62b023a845f8d,continuous,phv00070088.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070088\FFD52\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00068495.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068495,[],phs000007,pht000681,phv00068495,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000681\phv00068495\FFD52\,pht000681.v6,\phs000007\pht000681\phv00068495\FFD52\,phv00068495,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,ad7e052fece32c3e38c2daf3fbb8e5349e705dd965198c5372a10dc754670126,continuous,phv00068495.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068495\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00157639.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157639,[],phs000007,pht002151,phv00157639,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht002151\phv00157639\FFD52\,pht002151.v1,\phs000007\pht002151\phv00157639\FFD52\,phv00157639,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,11b9f3d5bbdce60cbfa540f1fa9f98f5678b0a954f28a5d244496731f2377e44,continuous,phv00157639.v1,phs000007,False,FFD52,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157639\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00158442.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158442,[],phs000007,pht002153,phv00158442,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht002153\phv00158442\FFD52\,pht002153.v1,\phs000007\pht002153\phv00158442\FFD52\,phv00158442,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,446db1372beffc7901dc16c591af20abaa07060684690a3a01ddabed8a2f0670,continuous,phv00158442.v1,phs000007,False,FFD52,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158442\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd52,CABBAGE/COLE SLAW:(servings/week),0.295663601,vr_ffreq_ex06_1_0506d,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00157198.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157198,[],phs000007,pht002150,phv00157198,False,True,False,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,0.0,\phs000007\pht002150\phv00157198\FFD52\,pht002150.v4,\phs000007\pht002150\phv00157198\FFD52\,phv00157198,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v31,dd6610ddbe7198ba9272242f4d78dfd3111491e32c13f7a10002b8afb230a6b3,continuous,phv00157198.v4,phs000007,False,FFD52,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157198\FFD52\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00068496.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068496,[],phs000007,pht000681,phv00068496,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000681\phv00068496\FFD53\,pht000681.v6,\phs000007\pht000681\phv00068496\FFD53\,phv00068496,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,c797023b1983998de1df8431ae263feead8b75d3382e8d22f95aabbf6c32cf70,continuous,phv00068496.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068496\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00069065.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069065,[],phs000007,pht000682,phv00069065,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000682\phv00069065\FFD53\,pht000682.v6,\phs000007\pht000682\phv00069065\FFD53\,phv00069065,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,a5cf1bba050adbeea31a34555817e059f3adaa9a2a0c3c4764096e8bfe2faa37,continuous,phv00069065.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069065\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00157199.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157199,[],phs000007,pht002150,phv00157199,False,True,False,FFD53,DERIVED FIELD:CAULIFLOWER,0.0,\phs000007\pht002150\phv00157199\FFD53\,pht002150.v4,\phs000007\pht002150\phv00157199\FFD53\,phv00157199,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CAULIFLOWER,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",7.0,DERIVED FIELD:CAULIFLOWER,phs000007.v31,40efa697d6705e09d311f9b044bf8d235f99adfab79d29c949b9287713207cd3,continuous,phv00157199.v4,phs000007,False,FFD53,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157199\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00157640.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157640,[],phs000007,pht002151,phv00157640,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht002151\phv00157640\FFD53\,pht002151.v1,\phs000007\pht002151\phv00157640\FFD53\,phv00157640,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,445428a75b31d1b9aedbcf3866891ce1f5bec89e5cbb6edc51458a67be5e7b9a,continuous,phv00157640.v1,phs000007,False,FFD53,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157640\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00158443.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158443,[],phs000007,pht002153,phv00158443,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht002153\phv00158443\FFD53\,pht002153.v1,\phs000007\pht002153\phv00158443\FFD53\,phv00158443,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,cfca728b76f5851c62f98d688a0194859e5621fa9c7dafbd09218d0ac8d47717,continuous,phv00158443.v1,phs000007,False,FFD53,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158443\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00162577.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162577,[],phs000007,pht002350,phv00162577,False,True,False,FFD53,DERIVED FIELD:CAULIFLOWER,0.0,\phs000007\pht002350\phv00162577\FFD53\,pht002350.v5,\phs000007\pht002350\phv00162577\FFD53\,phv00162577,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CAULIFLOWER,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:CAULIFLOWER,phs000007.v31,abda0e0d6258fe9d7d0e82061cc598bfef1c091779d86328e2e52d0326ccda6f,continuous,phv00162577.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162577\FFD53\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00172979.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172979,[],phs000007,pht002900,phv00172979,False,True,False,FFD53,Derived field: Cauliflower,0.0,\phs000007\pht002900\phv00172979\FFD53\,pht002900.v3,\phs000007\pht002900\phv00172979\FFD53\,phv00172979,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cauliflower,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Cauliflower,phs000007.v31,cb0ef961dfd3e000a3f6e81004f07d4c0331830408df128128212364e5bed8cb,continuous,phv00172979.v3,phs000007,False,FFD53,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172979\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00477388.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00477951.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477951,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00070089.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070089,[],phs000007,pht000680,phv00070089,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000680\phv00070089\FFD53\,pht000680.v6,\phs000007\pht000680\phv00070089\FFD53\,phv00070089,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,3cd6934364c3d820431bf827ee8550b4e721a0759f415b0733d30c043315ea43,continuous,phv00070089.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070089\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00479166.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,CAULIFLOWER,phs000007.v33.p14,phv00523895.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523895,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00524553.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd53,CAULIFLOWER:(servings/week),0.55847569,vr_ffreq_ex06_1_0506d,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00478512.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00524555.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524555,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS,phs000007.v33.p14,phv00523896.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523896,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00479168.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00478513.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00477389.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00172981.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172981,[],phs000007,pht002900,phv00172981,False,True,False,FFD54,Derived field: Brussels sprouts,0.0,\phs000007\pht002900\phv00172981\FFD54\,pht002900.v3,\phs000007\pht002900\phv00172981\FFD54\,phv00172981,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Brussels sprouts,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",5.5,Derived field: Brussels sprouts,phs000007.v31,7218ce474dbbd00786c59cb1d4ac31f57b11d91a968ac058676273fbfa31dc11,continuous,phv00172981.v3,phs000007,False,FFD54,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172981\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00477952.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477952,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00158444.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158444,[],phs000007,pht002153,phv00158444,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht002153\phv00158444\FFD54\,pht002153.v1,\phs000007\pht002153\phv00158444\FFD54\,phv00158444,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,f085da7393e28617a244219a1d3854787b0eaa0ea09f2e89ac58bb3fe023b917,continuous,phv00158444.v1,phs000007,False,FFD54,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158444\FFD54\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00157641.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157641,[],phs000007,pht002151,phv00157641,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht002151\phv00157641\FFD54\,pht002151.v1,\phs000007\pht002151\phv00157641\FFD54\,phv00157641,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,bb4901d7390dc06d02065d36c986d052603a05bc45984b7c326fa16d147f8e51,continuous,phv00157641.v1,phs000007,False,FFD54,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157641\FFD54\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00157200.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157200,[],phs000007,pht002150,phv00157200,False,True,False,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,0.0,\phs000007\pht002150\phv00157200\FFD54\,pht002150.v4,\phs000007\pht002150\phv00157200\FFD54\,phv00157200,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v31,5567910ac23179531f6fbdbec3cc49b78b09620a9ffa64a74e994441408a100a,continuous,phv00157200.v4,phs000007,False,FFD54,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157200\FFD54\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00070090.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070090,[],phs000007,pht000680,phv00070090,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000680\phv00070090\FFD54\,pht000680.v6,\phs000007\pht000680\phv00070090\FFD54\,phv00070090,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,cd421371c06af435e9fde2ff5d104101f0f36f605648d5c702064bbe540ff1e9,continuous,phv00070090.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070090\FFD54\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00069066.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069066,[],phs000007,pht000682,phv00069066,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000682\phv00069066\FFD54\,pht000682.v6,\phs000007\pht000682\phv00069066\FFD54\,phv00069066,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",5.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,f36a53141ea8625bc6e202fbac82932029bed2458a3c82b488bcf23960ec5c71,continuous,phv00069066.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069066\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00068497.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068497,[],phs000007,pht000681,phv00068497,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000681\phv00068497\FFD54\,pht000681.v6,\phs000007\pht000681\phv00068497\FFD54\,phv00068497,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,12239928bb2acd43cb8581a7495ce7b4603ad143000542118e4bd7887cde7d7f,continuous,phv00068497.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068497\FFD54\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd54,BRUSSELS SPROUTS:(servings/week),0.624178712,vr_ffreq_ex06_1_0506d,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00162578.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162578,[],phs000007,pht002350,phv00162578,False,True,False,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,0.0,\phs000007\pht002350\phv00162578\FFD54\,pht002350.v5,\phs000007\pht002350\phv00162578\FFD54\,phv00162578,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",5.5,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v31,5e32daf7455beffc25082fa76e8c170a5c6e418b1d8b484fd123bc27297de22f,continuous,phv00162578.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162578\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00477390.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477390,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00524556.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524556,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00479169.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00478514.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00477953.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00172982.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172982,[],phs000007,pht002900,phv00172982,False,True,False,FFD55,"Derived field: Carrots, raw",0.0,\phs000007\pht002900\phv00172982\FFD55\,pht002900.v3,\phs000007\pht002900\phv00172982\FFD55\,phv00172982,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Carrots, raw",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,"Derived field: Carrots, raw",phs000007.v31,fda37dbf84faee4d6df4e4d5cf1485cb0dc803c7df0df4a04fbbfa347e3ff735,continuous,phv00172982.v3,phs000007,False,FFD55,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172982\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW",phs000007.v33.p14,phv00523897.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523897,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00158445.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158445,[],phs000007,pht002153,phv00158445,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht002153\phv00158445\FFD55\,pht002153.v1,\phs000007\pht002153\phv00158445\FFD55\,phv00158445,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,2fd7dce9ba4bbd0fea758070c9a88590a19e90cf667c334d947ee6d9fd514e9c,continuous,phv00158445.v1,phs000007,False,FFD55,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158445\FFD55\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00157642.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157642,[],phs000007,pht002151,phv00157642,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht002151\phv00157642\FFD55\,pht002151.v1,\phs000007\pht002151\phv00157642\FFD55\,phv00157642,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,f58fc82f3f1554143a19923d0e8001b858e8e786a4ec3a9934c5967453e0dd92,continuous,phv00157642.v1,phs000007,False,FFD55,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157642\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00157201.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157201,[],phs000007,pht002150,phv00157201,False,True,False,FFD55,"DERIVED FIELD:CARROTS, RAW",0.0,\phs000007\pht002150\phv00157201\FFD55\,pht002150.v4,\phs000007\pht002150\phv00157201\FFD55\,phv00157201,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:CARROTS, RAW",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,"DERIVED FIELD:CARROTS, RAW",phs000007.v31,b98c75316e2e5b714703b168d59f6b5e482fc794cb5cdce124636573026224a9,continuous,phv00157201.v4,phs000007,False,FFD55,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157201\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00070091.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070091,[],phs000007,pht000680,phv00070091,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000680\phv00070091\FFD55\,pht000680.v6,\phs000007\pht000680\phv00070091\FFD55\,phv00070091,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,d8769b70a2f36938784500d0379066822fd9bb7d59d84aa6211b7361ec50c581,continuous,phv00070091.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070091\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00069067.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069067,[],phs000007,pht000682,phv00069067,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000682\phv00069067\FFD55\,pht000682.v6,\phs000007\pht000682\phv00069067\FFD55\,phv00069067,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,6b20a923a8b6152a28b8f15fcd1c73a2471f8444811798300e147d763082d39e,continuous,phv00069067.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069067\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00068498.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068498,[],phs000007,pht000681,phv00068498,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000681\phv00068498\FFD55\,pht000681.v6,\phs000007\pht000681\phv00068498\FFD55\,phv00068498,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,a7bc086dbbe03089b6f12e813cfff540588690338437ec8ea7afcbce515e28a6,continuous,phv00068498.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068498\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd55,"CARROTS, RAW:(servings/week)",1.248357424,vr_ffreq_ex06_1_0506d,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00162579.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162579,[],phs000007,pht002350,phv00162579,False,True,False,FFD55,"DERIVED FIELD:CARROTS, RAW",0.0,\phs000007\pht002350\phv00162579\FFD55\,pht002350.v5,\phs000007\pht002350\phv00162579\FFD55\,phv00162579,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:CARROTS, RAW",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,"DERIVED FIELD:CARROTS, RAW",phs000007.v31,11f78d08e08eac1a1f74904138ff0a0b8bb15ebd406d090b5de20293a1d4e20f,continuous,phv00162579.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162579\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00524557.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524557,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED",phs000007.v33.p14,phv00523898.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00478515.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478515,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00477954.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477954,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00477391.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477391,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00479170.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479170,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00162580.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162580,[],phs000007,pht002350,phv00162580,False,True,False,FFD56,"DERIVED FIELD:CARROTS, COOKED",0.0,\phs000007\pht002350\phv00162580\FFD56\,pht002350.v5,\phs000007\pht002350\phv00162580\FFD56\,phv00162580,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:CARROTS, COOKED",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,"DERIVED FIELD:CARROTS, COOKED",phs000007.v31,278f24b8e58a5c8c37f775f502348e518c1ee9332b816adbfcf0f47fc57be50b,continuous,phv00162580.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162580\FFD56\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00172983.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172983,[],phs000007,pht002900,phv00172983,False,True,False,FFD56,"Derived field: Carrots, cooked",0.0,\phs000007\pht002900\phv00172983\FFD56\,pht002900.v3,\phs000007\pht002900\phv00172983\FFD56\,phv00172983,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Carrots, cooked",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,"Derived field: Carrots, cooked",phs000007.v31,45db51aa8d48b74a1af7dc03f94b169780efb08217ebee107c7b4fb2d1b0f0b8,continuous,phv00172983.v3,phs000007,False,FFD56,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172983\FFD56\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00068499.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068499,[],phs000007,pht000681,phv00068499,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000681\phv00068499\FFD56\,pht000681.v6,\phs000007\pht000681\phv00068499\FFD56\,phv00068499,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,736876683a882cbc01b7cc1a4c8dfb7b548dd996bd814d4628da692172d0ebda,continuous,phv00068499.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068499\FFD56\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00069068.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069068,[],phs000007,pht000682,phv00069068,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000682\phv00069068\FFD56\,pht000682.v6,\phs000007\pht000682\phv00069068\FFD56\,phv00069068,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,bb2669b624bfc00386993e6ec457cfd3d6c9b7955f5c40be2fcac12906dd326e,continuous,phv00069068.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069068\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00158446.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158446,[],phs000007,pht002153,phv00158446,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht002153\phv00158446\FFD56\,pht002153.v1,\phs000007\pht002153\phv00158446\FFD56\,phv00158446,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,4890f1cea77c0f0299d867e5bce02f4504bf74f4b8853e8b33bd6a060ef5388a,continuous,phv00158446.v1,phs000007,False,FFD56,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158446\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00157202.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157202,[],phs000007,pht002150,phv00157202,False,True,False,FFD56,"DERIVED FIELD:CARROTS, COOKED",0.0,\phs000007\pht002150\phv00157202\FFD56\,pht002150.v4,\phs000007\pht002150\phv00157202\FFD56\,phv00157202,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:CARROTS, COOKED",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:CARROTS, COOKED",phs000007.v31,d6faf21f81af742354b33ba09bd21dc175a897130bebba29adf355285b36e265,continuous,phv00157202.v4,phs000007,False,FFD56,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157202\FFD56\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00157643.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157643,[],phs000007,pht002151,phv00157643,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht002151\phv00157643\FFD56\,pht002151.v1,\phs000007\pht002151\phv00157643\FFD56\,phv00157643,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,59addadb966beaf202762ddc65b9b721e49cf3aca866e803e06ea1cae70b2615,continuous,phv00157643.v1,phs000007,False,FFD56,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157643\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd56,"CARROTS, COOKED:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00070092.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070092,[],phs000007,pht000680,phv00070092,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000680\phv00070092\FFD56\,pht000680.v6,\phs000007\pht000680\phv00070092\FFD56\,phv00070092,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,d7b1f70b93ca35d4f7e60d1e76a873cbfe0e6edd48cd87d95ca252f7acbac50d,continuous,phv00070092.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070092\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00068500.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068500,[],phs000007,pht000681,phv00068500,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000681\phv00068500\FFD57\,pht000681.v6,\phs000007\pht000681\phv00068500\FFD57\,phv00068500,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,a06a658956629f68a23ad3547f0227dbebca79184b8379291911a347546267b4,continuous,phv00068500.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068500\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00069069.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069069,[],phs000007,pht000682,phv00069069,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000682\phv00069069\FFD57\,pht000682.v6,\phs000007\pht000682\phv00069069\FFD57\,phv00069069,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,e8ea423ee3f3404c7a7813ec74f2d67f5b28dd3bc3d3063336f0260204f4952c,continuous,phv00069069.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069069\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00070093.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070093,[],phs000007,pht000680,phv00070093,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000680\phv00070093\FFD57\,pht000680.v6,\phs000007\pht000680\phv00070093\FFD57\,phv00070093,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,f8df3d474f3bb45f62bf1e0b9e87ffa5f2e69c234dd80aa982985d7ee2f3bc2b,continuous,phv00070093.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070093\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00157203.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157203,[],phs000007,pht002150,phv00157203,False,True,False,FFD57,DERIVED FIELD:CORN,0.0,\phs000007\pht002150\phv00157203\FFD57\,pht002150.v4,\phs000007\pht002150\phv00157203\FFD57\,phv00157203,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CORN,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:CORN,phs000007.v31,e2062b6eb22a4c974e9896289b00839836a25f303d8b9ea45e34fb768d6d3085,continuous,phv00157203.v4,phs000007,False,FFD57,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157203\FFD57\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00158447.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158447,[],phs000007,pht002153,phv00158447,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht002153\phv00158447\FFD57\,pht002153.v1,\phs000007\pht002153\phv00158447\FFD57\,phv00158447,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,e6829bead50f94deb3aa9952a804ef8cc5ee2f706b3d490f50ef41255851d902,continuous,phv00158447.v1,phs000007,False,FFD57,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158447\FFD57\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00162581.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162581,[],phs000007,pht002350,phv00162581,False,True,False,FFD57,DERIVED FIELD:CORN,0.0,\phs000007\pht002350\phv00162581\FFD57\,pht002350.v5,\phs000007\pht002350\phv00162581\FFD57\,phv00162581,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CORN,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:CORN,phs000007.v31,0614160687a3313ef05b26c352e19470249ebfa6aed031a857f14fa3c6cea5d2,continuous,phv00162581.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162581\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00172984.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172984,[],phs000007,pht002900,phv00172984,False,True,False,FFD57,Derived field: Corn,0.0,\phs000007\pht002900\phv00172984\FFD57\,pht002900.v3,\phs000007\pht002900\phv00172984\FFD57\,phv00172984,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Corn,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",7.0,Derived field: Corn,phs000007.v31,809a84d7f3e0b93c5fb4d18b2b3c501f32a6fefb2a1c49a9e4d7aea12e893bd3,continuous,phv00172984.v3,phs000007,False,FFD57,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172984\FFD57\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00477392.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477392,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00477955.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477955,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00479171.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479171,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,CORN,phs000007.v33.p14,phv00523899.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523899,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00524558.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524558,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00157644.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157644,[],phs000007,pht002151,phv00157644,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht002151\phv00157644\FFD57\,pht002151.v1,\phs000007\pht002151\phv00157644\FFD57\,phv00157644,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,bd8b941a699e05044fa86faa10b6e1d2adca797c73eac6dc70415db246bc8010,continuous,phv00157644.v1,phs000007,False,FFD57,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157644\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd57,CORN:(servings/week),1.018396846,vr_ffreq_ex06_1_0506d,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00478516.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00172977.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172977,[],phs000007,pht002900,phv00172977,False,True,False,FFD58,Derived field: Peas or lima beans,0.0,\phs000007\pht002900\phv00172977\FFD58\,pht002900.v3,\phs000007\pht002900\phv00172977\FFD58\,phv00172977,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Peas or lima beans,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Peas or lima beans,phs000007.v31,d39c7ce3d5915495e9f8d8afb313a4a8c6d15e5e3f70ac5010e5c6c52aa814fa,continuous,phv00172977.v3,phs000007,False,FFD58,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172977\FFD58\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00477393.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477393,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00162582.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162582,[],phs000007,pht002350,phv00162582,False,True,False,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,0.0,\phs000007\pht002350\phv00162582\FFD58\,pht002350.v5,\phs000007\pht002350\phv00162582\FFD58\,phv00162582,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v31,983ee5bff3ca33ad16210490dd81d158c17372812a63d3c9987ba6d3c41b1d46,continuous,phv00162582.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162582\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00524551.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524551,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS,phs000007.v33.p14,phv00523900.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00158448.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158448,[],phs000007,pht002153,phv00158448,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht002153\phv00158448\FFD58\,pht002153.v1,\phs000007\pht002153\phv00158448\FFD58\,phv00158448,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,1bbdd0ac6c2b8c3955ba5372d3a906b3844169bb87b2dbeaa048ae80bc8ef505,continuous,phv00158448.v1,phs000007,False,FFD58,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158448\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00157204.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157204,[],phs000007,pht002150,phv00157204,False,True,False,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,0.0,\phs000007\pht002150\phv00157204\FFD58\,pht002150.v4,\phs000007\pht002150\phv00157204\FFD58\,phv00157204,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v31,c72dac18196d93101d5e44035fc54161384f6a458f8aca925876b1469bfeca55,continuous,phv00157204.v4,phs000007,False,FFD58,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157204\FFD58\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00157645.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157645,[],phs000007,pht002151,phv00157645,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht002151\phv00157645\FFD58\,pht002151.v1,\phs000007\pht002151\phv00157645\FFD58\,phv00157645,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,308944530ef756c3d42e359134015273d6556714d04e42fa10556f8d3c279b04,continuous,phv00157645.v1,phs000007,False,FFD58,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157645\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00069070.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069070,[],phs000007,pht000682,phv00069070,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000682\phv00069070\FFD58\,pht000682.v6,\phs000007\pht000682\phv00069070\FFD58\,phv00069070,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,d5fb5c929d521dffb94d5d5f6b8ee365663b53da11656f645239918f49782db1,continuous,phv00069070.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069070\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00068501.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068501,[],phs000007,pht000681,phv00068501,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000681\phv00068501\FFD58\,pht000681.v6,\phs000007\pht000681\phv00068501\FFD58\,phv00068501,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,68d04709df7414aa28159d5533e7bdccdd8e14fc43e5100ad0680a3f22736c8c,continuous,phv00068501.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068501\FFD58\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00479164.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00478517.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00477956.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477956,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd58,PEAS/LIMA BEANS:(servings/week),0.459921156,vr_ffreq_ex06_1_0506d,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00070094.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070094,[],phs000007,pht000680,phv00070094,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000680\phv00070094\FFD58\,pht000680.v6,\phs000007\pht000680\phv00070094\FFD58\,phv00070094,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,a2a695c13e200f8b29f32b356a2bf9e2d90452410d8e5d661a6286c75146457a,continuous,phv00070094.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070094\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00157205.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157205,[],phs000007,pht002150,phv00157205,False,True,False,FFD59,DERIVED FIELD:MIXED VEGETABLES,0.0,\phs000007\pht002150\phv00157205\FFD59\,pht002150.v4,\phs000007\pht002150\phv00157205\FFD59\,phv00157205,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:MIXED VEGETABLES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:MIXED VEGETABLES,phs000007.v31,7de5b25a574029827f171311dccbc97c2d744f48176aa5668c548ac972489d6f,continuous,phv00157205.v4,phs000007,False,FFD59,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157205\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00069071.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069071,[],phs000007,pht000682,phv00069071,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000682\phv00069071\FFD59\,pht000682.v6,\phs000007\pht000682\phv00069071\FFD59\,phv00069071,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,d3fbe03df0d6b2e47587f7019507d37ea882430591fa38464ecdd39637feefbd,continuous,phv00069071.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069071\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00070095.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070095,[],phs000007,pht000680,phv00070095,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000680\phv00070095\FFD59\,pht000680.v6,\phs000007\pht000680\phv00070095\FFD59\,phv00070095,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,5428a77a064104408d1b3ab5074e61a9987963394fa43e895cb95c2aa408050f,continuous,phv00070095.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070095\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00157646.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157646,[],phs000007,pht002151,phv00157646,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht002151\phv00157646\FFD59\,pht002151.v1,\phs000007\pht002151\phv00157646\FFD59\,phv00157646,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,bc58868a54bf6bd9918a4ab0707d59a35780f471fc673a52c87948f4b18abf96,continuous,phv00157646.v1,phs000007,False,FFD59,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157646\FFD59\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00068502.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068502,[],phs000007,pht000681,phv00068502,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000681\phv00068502\FFD59\,pht000681.v6,\phs000007\pht000681\phv00068502\FFD59\,phv00068502,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,fc3a55bc6ac54cc4933c2b168450c4b13cccf3c11fdfb218a882c119acf51b02,continuous,phv00068502.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068502\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00162583.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162583,[],phs000007,pht002350,phv00162583,False,True,False,FFD59,DERIVED FIELD:MIXED VEGETABLES,0.0,\phs000007\pht002350\phv00162583\FFD59\,pht002350.v5,\phs000007\pht002350\phv00162583\FFD59\,phv00162583,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:MIXED VEGETABLES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:MIXED VEGETABLES,phs000007.v31,d4e39edb3ef03bb566d00a9230e092592dafd96d8631f89cbd2d95bcefec249e,continuous,phv00162583.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162583\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00172985.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172985,[],phs000007,pht002900,phv00172985,False,True,False,FFD59,"Derived field: Mixed or stir fry veggies, veg soup",0.0,\phs000007\pht002900\phv00172985\FFD59\,pht002900.v3,\phs000007\pht002900\phv00172985\FFD59\,phv00172985,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Mixed or stir fry veggies, veg soup",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,"Derived field: Mixed or stir fry veggies, veg soup",phs000007.v31,98fbfe8c5afa1867495daa03897e9886dcb9d8036d834087948195cfed4235c6,continuous,phv00172985.v3,phs000007,False,FFD59,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172985\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00477957.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00478518.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478518,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00479172.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES,phs000007.v33.p14,phv00523901.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523901,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00524559.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00158449.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158449,[],phs000007,pht002153,phv00158449,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht002153\phv00158449\FFD59\,pht002153.v1,\phs000007\pht002153\phv00158449\FFD59\,phv00158449,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,fb0c84d812ce1109b41e7606c8feed73154ef69f2fc0fdd1b082e999482b20f3,continuous,phv00158449.v1,phs000007,False,FFD59,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158449\FFD59\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd59,MIXED VEGETABLES:(servings/week),0.722733246,vr_ffreq_ex06_1_0506d,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00477394.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477394,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00479162.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS,phs000007.v33.p14,phv00523902.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00524549.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00172975.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172975,[],phs000007,pht002900,phv00172975,False,True,False,FFD60,Derived field: Beans or lentils,0.0,\phs000007\pht002900\phv00172975\FFD60\,pht002900.v3,\phs000007\pht002900\phv00172975\FFD60\,phv00172975,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Beans or lentils,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Beans or lentils,phs000007.v31,22cf65021b682e348dbca12f3908fbdc8bbe6ac21aa8cfba62ed44732c83a7a2,continuous,phv00172975.v3,phs000007,False,FFD60,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172975\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00068503.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068503,[],phs000007,pht000681,phv00068503,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000681\phv00068503\FFD60\,pht000681.v6,\phs000007\pht000681\phv00068503\FFD60\,phv00068503,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,54c1ba1976ec6957298e421ff0446873450d40e8c0e07e3a9969b78e5bba08fd,continuous,phv00068503.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068503\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00069072.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069072,[],phs000007,pht000682,phv00069072,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000682\phv00069072\FFD60\,pht000682.v6,\phs000007\pht000682\phv00069072\FFD60\,phv00069072,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,5420e508f96c2a57952edfddd1639867ff1ec9376f2f46db57b55a3860de0971,continuous,phv00069072.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069072\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00070096.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070096,[],phs000007,pht000680,phv00070096,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000680\phv00070096\FFD60\,pht000680.v6,\phs000007\pht000680\phv00070096\FFD60\,phv00070096,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,b35eef95f8f3ad524bc2136655e3ef41efcd485df521cbc520099e5243c5b6f8,continuous,phv00070096.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070096\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00157206.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157206,[],phs000007,pht002150,phv00157206,False,True,False,FFD60,DERIVED FIELD:BEANS/LENTILS,0.0,\phs000007\pht002150\phv00157206\FFD60\,pht002150.v4,\phs000007\pht002150\phv00157206\FFD60\,phv00157206,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEANS/LENTILS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BEANS/LENTILS,phs000007.v31,8c16cdf3cf2679fda0b80d9876732e5c4f154023ba518e46439611864802c03f,continuous,phv00157206.v4,phs000007,False,FFD60,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157206\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00157647.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157647,[],phs000007,pht002151,phv00157647,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht002151\phv00157647\FFD60\,pht002151.v1,\phs000007\pht002151\phv00157647\FFD60\,phv00157647,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,0e9b93dddf7a7a56b2c7f06c9b63951fab261dc5896612678bbb77a89783e23a,continuous,phv00157647.v1,phs000007,False,FFD60,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157647\FFD60\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00158450.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158450,[],phs000007,pht002153,phv00158450,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht002153\phv00158450\FFD60\,pht002153.v1,\phs000007\pht002153\phv00158450\FFD60\,phv00158450,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,9f9cfcb9394eb2615832fcb58f5f762d7d50fb036221f470dc6177634734aa69,continuous,phv00158450.v1,phs000007,False,FFD60,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158450\FFD60\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00162584.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162584,[],phs000007,pht002350,phv00162584,False,True,False,FFD60,DERIVED FIELD:BEANS/LENTILS,0.0,\phs000007\pht002350\phv00162584\FFD60\,pht002350.v5,\phs000007\pht002350\phv00162584\FFD60\,phv00162584,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEANS/LENTILS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BEANS/LENTILS,phs000007.v31,f446172387a119f408d594bca86e730d62eb5dac8137b24753b535123c5c0aa2,continuous,phv00162584.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162584\FFD60\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00478519.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478519,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00477958.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477958,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd60,BEANS/LENTILS:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00477395.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00068504.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068504,[],phs000007,pht000681,phv00068504,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000681\phv00068504\FFD61\,pht000681.v6,\phs000007\pht000681\phv00068504\FFD61\,phv00068504,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,e8e21255a893f506c973ee06cfdcc0f23a03229ea8f44eb1f25938c14783dc97,continuous,phv00068504.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068504\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00069073.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069073,[],phs000007,pht000682,phv00069073,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000682\phv00069073\FFD61\,pht000682.v6,\phs000007\pht000682\phv00069073\FFD61\,phv00069073,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,df9bc8ab2583f5913f18160fbcf7e8151317b03424302bd5e641c9a6ca9a01ef,continuous,phv00069073.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069073\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00070097.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070097,[],phs000007,pht000680,phv00070097,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000680\phv00070097\FFD61\,pht000680.v6,\phs000007\pht000680\phv00070097\FFD61\,phv00070097,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,3f5f218d9f2c252c7438d053eb05a10a1b33cace783e56384c386a72a03f8fb6,continuous,phv00070097.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070097\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00157207.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157207,[],phs000007,pht002150,phv00157207,False,True,False,FFD61,DERIVED FIELD:WINTER SQUASH,0.0,\phs000007\pht002150\phv00157207\FFD61\,pht002150.v4,\phs000007\pht002150\phv00157207\FFD61\,phv00157207,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WINTER SQUASH,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:WINTER SQUASH,phs000007.v31,f4d1ce16952c0feccb0aecf1b959f340d811f64f3240ff84097ec82c0ccaf08d,continuous,phv00157207.v4,phs000007,False,FFD61,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157207\FFD61\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00157648.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157648,[],phs000007,pht002151,phv00157648,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht002151\phv00157648\FFD61\,pht002151.v1,\phs000007\pht002151\phv00157648\FFD61\,phv00157648,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,de00a8746e76f78240402ac8ccc0540d64f1c687beda14f44bbf11b79b7e7182,continuous,phv00157648.v1,phs000007,False,FFD61,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157648\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00158451.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158451,[],phs000007,pht002153,phv00158451,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht002153\phv00158451\FFD61\,pht002153.v1,\phs000007\pht002153\phv00158451\FFD61\,phv00158451,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,3596e43a0bbef8aa1fbacee850eee0c9c78b3433198e56a8a7eca37018ff46a1,continuous,phv00158451.v1,phs000007,False,FFD61,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158451\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00162585.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162585,[],phs000007,pht002350,phv00162585,False,True,False,FFD61,DERIVED FIELD:WINTER SQUASH,0.0,\phs000007\pht002350\phv00162585\FFD61\,pht002350.v5,\phs000007\pht002350\phv00162585\FFD61\,phv00162585,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WINTER SQUASH,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:WINTER SQUASH,phs000007.v31,5db4166ccdfe4953ac4a2ecacc93ebf7ecb30f61fc11d351872c8f30ed24493b,continuous,phv00162585.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162585\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00477396.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00477959.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00478520.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00479174.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,WINTER SQUASH,phs000007.v33.p14,phv00523903.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00524561.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd61,WINTER SQUASH:(servings/week),0.919842313,vr_ffreq_ex06_1_0506d,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00172987.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172987,[],phs000007,pht002900,phv00172987,False,True,False,FFD61,Derived field: Dark orange (winter) squash,0.0,\phs000007\pht002900\phv00172987\FFD61\,pht002900.v3,\phs000007\pht002900\phv00172987\FFD61\,phv00172987,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Dark orange (winter) squash,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",7.0,Derived field: Dark orange (winter) squash,phs000007.v31,54448615685e9436eca51ff3fe877fe82b1f3cf401be9a32a8418e48fc88c43c,continuous,phv00172987.v3,phs000007,False,FFD61,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172987\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00524562.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH,phs000007.v33.p14,phv00523904.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523904,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00479175.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00478521.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00477960.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477960,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00172988.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172988,[],phs000007,pht002900,phv00172988,False,True,False,FFD62,"Derived field: Eggplant, zuke, summer squash",0.0,\phs000007\pht002900\phv00172988\FFD62\,pht002900.v3,\phs000007\pht002900\phv00172988\FFD62\,phv00172988,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Eggplant, zuke, summer squash",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Eggplant, zuke, summer squash",phs000007.v31,6656956a9b6693e14de177fef347534eb98ce45c7f241ea649f559a48e19c732,continuous,phv00172988.v3,phs000007,False,FFD62,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172988\FFD62\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00477397.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477397,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00158452.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158452,[],phs000007,pht002153,phv00158452,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht002153\phv00158452\FFD62\,pht002153.v1,\phs000007\pht002153\phv00158452\FFD62\,phv00158452,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,a399f0beb7c9170cb6af5d4123c84f91a7446c58c2d6ce0cf619194662166aac,continuous,phv00158452.v1,phs000007,False,FFD62,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158452\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00157649.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157649,[],phs000007,pht002151,phv00157649,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht002151\phv00157649\FFD62\,pht002151.v1,\phs000007\pht002151\phv00157649\FFD62\,phv00157649,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,6269482d2fca438cd0bec650b3c1b985197fae16196922ace8ecaef91fbe5e3a,continuous,phv00157649.v1,phs000007,False,FFD62,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157649\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00157208.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157208,[],phs000007,pht002150,phv00157208,False,True,False,FFD62,DERIVED FIELD:SUMMER SQUASH,0.0,\phs000007\pht002150\phv00157208\FFD62\,pht002150.v4,\phs000007\pht002150\phv00157208\FFD62\,phv00157208,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:SUMMER SQUASH,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:SUMMER SQUASH,phs000007.v31,7df09dd4a28c02c76d796d7b4074bd16ce80738c42c03f0accb657dbe9f25027,continuous,phv00157208.v4,phs000007,False,FFD62,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157208\FFD62\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00070098.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070098,[],phs000007,pht000680,phv00070098,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000680\phv00070098\FFD62\,pht000680.v6,\phs000007\pht000680\phv00070098\FFD62\,phv00070098,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,053a7b1a627f145fdab486555727c36363c7dd4a572e161061ae7a80860a4fc9,continuous,phv00070098.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070098\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00069074.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069074,[],phs000007,pht000682,phv00069074,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000682\phv00069074\FFD62\,pht000682.v6,\phs000007\pht000682\phv00069074\FFD62\,phv00069074,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,93d4115ecb511b1d495fb98e73dc65b3289f850b176b1f62bc173139141b5638,continuous,phv00069074.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069074\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00162586.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162586,[],phs000007,pht002350,phv00162586,False,True,False,FFD62,DERIVED FIELD:SUMMER SQUASH,0.0,\phs000007\pht002350\phv00162586\FFD62\,pht002350.v5,\phs000007\pht002350\phv00162586\FFD62\,phv00162586,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:SUMMER SQUASH,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:SUMMER SQUASH,phs000007.v31,6700af01a61bf7225f6b29f1187034faae187d5a994d9110a787ec9fc84d770f,continuous,phv00162586.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162586\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd62,SUMMER SQUASH:(servings/week),0.492772668,vr_ffreq_ex06_1_0506d,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00068505.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068505,[],phs000007,pht000681,phv00068505,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000681\phv00068505\FFD62\,pht000681.v6,\phs000007\pht000681\phv00068505\FFD62\,phv00068505,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,c2846e318afd292fddc8271f53fc1e20aa033eadc35bbde4d9c6ac6262dc4fea,continuous,phv00068505.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068505\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00524560.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES,phs000007.v33.p14,phv00523905.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00478522.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00477961.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00477398.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00479173.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479173,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00162587.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162587,[],phs000007,pht002350,phv00162587,False,True,False,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,0.0,\phs000007\pht002350\phv00162587\FFD63\,pht002350.v5,\phs000007\pht002350\phv00162587\FFD63\,phv00162587,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v31,521f37ce3077109d7af6f998e9bf4c597b02db282136b1e4b806895ce3d0c9ac,continuous,phv00162587.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162587\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00172986.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172986,[],phs000007,pht002900,phv00172986,False,True,False,FFD63,Derived field: Yams or sweet potatoes,0.0,\phs000007\pht002900\phv00172986\FFD63\,pht002900.v3,\phs000007\pht002900\phv00172986\FFD63\,phv00172986,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Yams or sweet potatoes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Yams or sweet potatoes,phs000007.v31,0a92d71e6601289bd51bf2ea0e4f541b4c485f015bc85224d95b6923843130cd,continuous,phv00172986.v3,phs000007,False,FFD63,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172986\FFD63\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00068506.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068506,[],phs000007,pht000681,phv00068506,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000681\phv00068506\FFD63\,pht000681.v6,\phs000007\pht000681\phv00068506\FFD63\,phv00068506,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,17289f211fa6ab559db03ea8439d8896a69e60b16f8a6f183af78bdb68cc35df,continuous,phv00068506.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068506\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00069075.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069075,[],phs000007,pht000682,phv00069075,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000682\phv00069075\FFD63\,pht000682.v6,\phs000007\pht000682\phv00069075\FFD63\,phv00069075,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,4e4dd8e6d177f0ce4066daef20cc7e47c944675d1bce54d6e037ba253a4edc82,continuous,phv00069075.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069075\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00157650.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157650,[],phs000007,pht002151,phv00157650,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht002151\phv00157650\FFD63\,pht002151.v1,\phs000007\pht002151\phv00157650\FFD63\,phv00157650,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,0b4557405abd33e98d4fd2c15683e6c557211edda1481ef43da610b252e90f4d,continuous,phv00157650.v1,phs000007,False,FFD63,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157650\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00157209.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157209,[],phs000007,pht002150,phv00157209,False,True,False,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,0.0,\phs000007\pht002150\phv00157209\FFD63\,pht002150.v4,\phs000007\pht002150\phv00157209\FFD63\,phv00157209,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",7.0,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v31,ac44390d6dcff6c79cc28509edf006bb0c46c6661227714b48f81447ef03c005,continuous,phv00157209.v4,phs000007,False,FFD63,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157209\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00158453.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158453,[],phs000007,pht002153,phv00158453,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht002153\phv00158453\FFD63\,pht002153.v1,\phs000007\pht002153\phv00158453\FFD63\,phv00158453,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,5f97df77a12b9b81b3c5de79eeaa240cc608c52b1485e4fb556cdd9f4de5339c,continuous,phv00158453.v1,phs000007,False,FFD63,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158453\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd63,YAMS/SWEET POTATOES:(servings/week),0.164257556,vr_ffreq_ex06_1_0506d,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00070099.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070099,[],phs000007,pht000680,phv00070099,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000680\phv00070099\FFD63\,pht000680.v6,\phs000007\pht000680\phv00070099\FFD63\,phv00070099,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,c07402b614046a7895d1365cf1b934aab7d0dfd998b641a4d7dbf231e94df1c9,continuous,phv00070099.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070099\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00068507.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068507,[],phs000007,pht000681,phv00068507,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000681\phv00068507\FFD64\,pht000681.v6,\phs000007\pht000681\phv00068507\FFD64\,phv00068507,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,53f970a3465eb8e0038ce983ec6ce214218baf2c6588ac3a1926cf42759a7658,continuous,phv00068507.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068507\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00069076.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069076,[],phs000007,pht000682,phv00069076,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000682\phv00069076\FFD64\,pht000682.v6,\phs000007\pht000682\phv00069076\FFD64\,phv00069076,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,6446b3129f70214459f9834a386d9c9709f212e3e6fd7750007683c96e3ee8d9,continuous,phv00069076.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069076\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00070100.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070100,[],phs000007,pht000680,phv00070100,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000680\phv00070100\FFD64\,pht000680.v6,\phs000007\pht000680\phv00070100\FFD64\,phv00070100,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,4f5b026a8b6587b0a0d7c6d711fd826bf570a3e28602727d6325793e460fa74a,continuous,phv00070100.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070100\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00157651.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157651,[],phs000007,pht002151,phv00157651,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht002151\phv00157651\FFD64\,pht002151.v1,\phs000007\pht002151\phv00157651\FFD64\,phv00157651,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,1b9d485d7e3f26d502a460b4d4925cf2a84b368b487700101c314b953c861564,continuous,phv00157651.v1,phs000007,False,FFD64,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157651\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00158454.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158454,[],phs000007,pht002153,phv00158454,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht002153\phv00158454\FFD64\,pht002153.v1,\phs000007\pht002153\phv00158454\FFD64\,phv00158454,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",5.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,9bc5e963b97aaed3a028860e700b9b4fc8e14baf16927638d98c9c7adb53f5e5,continuous,phv00158454.v1,phs000007,False,FFD64,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158454\FFD64\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00162588.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162588,[],phs000007,pht002350,phv00162588,False,True,False,FFD64,"DERIVED FIELD:SPINACH, COOKED",0.0,\phs000007\pht002350\phv00162588\FFD64\,pht002350.v5,\phs000007\pht002350\phv00162588\FFD64\,phv00162588,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:SPINACH, COOKED",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,"DERIVED FIELD:SPINACH, COOKED",phs000007.v31,c01f51b69ef24cc7b8bf2bb8e28a0b92d2b56fbf8af11a667064e5b918e8c74c,continuous,phv00162588.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162588\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00172990.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172990,[],phs000007,pht002900,phv00172990,False,True,False,FFD64,"Derived field: Spinach, cooked",0.0,\phs000007\pht002900\phv00172990\FFD64\,pht002900.v3,\phs000007\pht002900\phv00172990\FFD64\,phv00172990,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Spinach, cooked",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Spinach, cooked",phs000007.v31,e903c962a40b5d367fc5f593203836a1ec12433c5f6e3345562c44bf5f4f9c56,continuous,phv00172990.v3,phs000007,False,FFD64,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172990\FFD64\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00524564.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED",phs000007.v33.p14,phv00523906.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00479177.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479177,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00478523.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478523,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00157210.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157210,[],phs000007,pht002150,phv00157210,False,True,False,FFD64,"DERIVED FIELD:SPINACH, COOKED",0.0,\phs000007\pht002150\phv00157210\FFD64\,pht002150.v4,\phs000007\pht002150\phv00157210\FFD64\,phv00157210,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:SPINACH, COOKED",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:SPINACH, COOKED",phs000007.v31,8047b37ec1f15d4dc06b8f64622e890a967b05a589f1ce8cb93311d6d1664f7e,continuous,phv00157210.v4,phs000007,False,FFD64,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157210\FFD64\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00477399.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd64,"SPINACH, COOKED:(servings/week)",0.328515112,vr_ffreq_ex06_1_0506d,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00477962.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00477963.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477963,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00524565.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW",phs000007.v33.p14,phv00523907.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00479178.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479178,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00478524.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00477400.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00172991.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172991,[],phs000007,pht002900,phv00172991,False,True,False,FFD65,"Derived field: Spinach, raw as in salad",0.0,\phs000007\pht002900\phv00172991\FFD65\,pht002900.v3,\phs000007\pht002900\phv00172991\FFD65\,phv00172991,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Spinach, raw as in salad",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Spinach, raw as in salad",phs000007.v31,f59d8e486eb5a7a96e053f29fc2107a701a4b0c178ac5d0281d474900b0f431a,continuous,phv00172991.v3,phs000007,False,FFD65,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172991\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00162589.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162589,[],phs000007,pht002350,phv00162589,False,True,False,FFD65,"DERIVED FIELD:SPINACH, RAW",0.0,\phs000007\pht002350\phv00162589\FFD65\,pht002350.v5,\phs000007\pht002350\phv00162589\FFD65\,phv00162589,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:SPINACH, RAW",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,"DERIVED FIELD:SPINACH, RAW",phs000007.v31,62b58079698dae97ec3566c9cf8a03d995fd116acf261329a0a6e0e73acd4b51,continuous,phv00162589.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162589\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00158455.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158455,[],phs000007,pht002153,phv00158455,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht002153\phv00158455\FFD65\,pht002153.v1,\phs000007\pht002153\phv00158455\FFD65\,phv00158455,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,61a3db996133c7da38c9b3a6efa6945bdcc211120db94d96a58dfc110444bd17,continuous,phv00158455.v1,phs000007,False,FFD65,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158455\FFD65\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00157652.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157652,[],phs000007,pht002151,phv00157652,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht002151\phv00157652\FFD65\,pht002151.v1,\phs000007\pht002151\phv00157652\FFD65\,phv00157652,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,d8ec89122ccc73d30693ee90496c1587c1616024c47f7531a7e2d87e357991f5,continuous,phv00157652.v1,phs000007,False,FFD65,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157652\FFD65\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00157211.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157211,[],phs000007,pht002150,phv00157211,False,True,False,FFD65,"DERIVED FIELD:SPANACH, RAW",0.0,\phs000007\pht002150\phv00157211\FFD65\,pht002150.v4,\phs000007\pht002150\phv00157211\FFD65\,phv00157211,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:SPANACH, RAW",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:SPANACH, RAW",phs000007.v31,2f871eceeba619088d0c8b3cb54d62f4f724b66eef1f3718aabbbb91863c87e6,continuous,phv00157211.v4,phs000007,False,FFD65,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157211\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00070101.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070101,[],phs000007,pht000680,phv00070101,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000680\phv00070101\FFD65\,pht000680.v6,\phs000007\pht000680\phv00070101\FFD65\,phv00070101,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,dbf0eeaa427e42eaac2b57801c520ac2c2158fd35d9e32942df6f232e11e5157,continuous,phv00070101.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070101\FFD65\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00069077.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069077,[],phs000007,pht000682,phv00069077,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000682\phv00069077\FFD65\,pht000682.v6,\phs000007\pht000682\phv00069077\FFD65\,phv00069077,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,a76c3aeed715b63e603c4432deab97429359c4dd5246c70f79740db1b0a19d39,continuous,phv00069077.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069077\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd65,"SPANACH, RAW:(servings/week)",0.788436268,vr_ffreq_ex06_1_0506d,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00068508.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068508,[],phs000007,pht000681,phv00068508,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000681\phv00068508\FFD65\,pht000681.v6,\phs000007\pht000681\phv00068508\FFD65\,phv00068508,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,6c1fea3b8d7ed56b2db19101c5eeb3817ce1b50d380bf0720f31f7e78c27614e,continuous,phv00068508.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068508\FFD65\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00477401.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00070102.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070102,[],phs000007,pht000680,phv00070102,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000680\phv00070102\FFD66\,pht000680.v6,\phs000007\pht000680\phv00070102\FFD66\,phv00070102,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,953f32f891be03c06b7bfd549b0aa8413ee1182396c37c02705b18ace5f9a4c5,continuous,phv00070102.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070102\FFD66\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00157212.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157212,[],phs000007,pht002150,phv00157212,False,True,False,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,0.0,\phs000007\pht002150\phv00157212\FFD66\,pht002150.v4,\phs000007\pht002150\phv00157212\FFD66\,phv00157212,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v31,ad63cb388276d3bce94f16ca4cdaa2b81b6205818a180f7cb4b6b52743d9eac3,continuous,phv00157212.v4,phs000007,False,FFD66,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157212\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00172989.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172989,[],phs000007,pht002900,phv00172989,False,True,False,FFD66,"Derived field: Kale, mustard greens, or chard",0.0,\phs000007\pht002900\phv00172989\FFD66\,pht002900.v3,\phs000007\pht002900\phv00172989\FFD66\,phv00172989,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Kale, mustard greens, or chard",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Kale, mustard greens, or chard",phs000007.v31,b662569bf255aff19a7f12b491ee2390542b532ba9bfbe6151887b826a6619ce,continuous,phv00172989.v3,phs000007,False,FFD66,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172989\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00162590.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162590,[],phs000007,pht002350,phv00162590,False,True,False,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,0.0,\phs000007\pht002350\phv00162590\FFD66\,pht002350.v5,\phs000007\pht002350\phv00162590\FFD66\,phv00162590,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v31,610e5817467e6b721e07e180b2e379e4adaae87874e3f9e4b2f09a5118b69d2a,continuous,phv00162590.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162590\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00069078.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069078,[],phs000007,pht000682,phv00069078,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000682\phv00069078\FFD66\,pht000682.v6,\phs000007\pht000682\phv00069078\FFD66\,phv00069078,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,895da685f06b312046e76109f07869a20eb01c5118c30002caf2c6df18d27ac6,continuous,phv00069078.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069078\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00068509.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068509,[],phs000007,pht000681,phv00068509,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000681\phv00068509\FFD66\,pht000681.v6,\phs000007\pht000681\phv00068509\FFD66\,phv00068509,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,e95297759f893a046c6bc0444f1b880c70c8e42f87786a13a0dc1edfb5705ff2,continuous,phv00068509.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068509\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00478525.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00157653.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157653,[],phs000007,pht002151,phv00157653,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht002151\phv00157653\FFD66\,pht002151.v1,\phs000007\pht002151\phv00157653\FFD66\,phv00157653,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,bed40fa5f1109e3483e4b4ac4b6e70ccec09e28dff3621edbe46aab96037121b,continuous,phv00157653.v1,phs000007,False,FFD66,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157653\FFD66\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00479176.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00523908.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523908,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00524563.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00477964.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477964,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd66,KALE/MUSTARD/CHARD:(servings/week),0.85413929,vr_ffreq_ex06_1_0506d,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00158456.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158456,[],phs000007,pht002153,phv00158456,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht002153\phv00158456\FFD66\,pht002153.v1,\phs000007\pht002153\phv00158456\FFD66\,phv00158456,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,d7434517d10787da707965c7bd7dce658ab0e29121b8594c9c20127f9856a3e2,continuous,phv00158456.v1,phs000007,False,FFD66,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158456\FFD66\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00157654.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157654,[],phs000007,pht002151,phv00157654,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002151\phv00157654\FFD67\,pht002151.v1,\phs000007\pht002151\phv00157654\FFD67\,phv00157654,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,26b81f9fc52ca93d107953f4379184b5b3da216fc378773501c8c9bba26c962b,continuous,phv00157654.v1,phs000007,False,FFD67,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157654\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00162591.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162591,[],phs000007,pht002350,phv00162591,False,True,False,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002350\phv00162591\FFD67\,pht002350.v5,\phs000007\pht002350\phv00162591\FFD67\,phv00162591,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v31,86ad60b9e2906b5c7c21ebc32abd573e36f4926b0b5f7bfffc481987adae74b2,continuous,phv00162591.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162591\FFD67\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00172992.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172992,[],phs000007,pht002900,phv00172992,False,True,False,FFD67,Derived field: Iceberg or head lettuce,0.0,\phs000007\pht002900\phv00172992\FFD67\,pht002900.v3,\phs000007\pht002900\phv00172992\FFD67\,phv00172992,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Iceberg or head lettuce,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Iceberg or head lettuce,phs000007.v31,ea644fcf610f5b55bfc6eddfa4f3ffcf694657ac7f5b668b3c555f4ddfef0a9e,continuous,phv00172992.v3,phs000007,False,FFD67,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172992\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00477402.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00524566.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00477965.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477965,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00478526.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00479179.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479179,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00158457.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158457,[],phs000007,pht002153,phv00158457,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002153\phv00158457\FFD67\,pht002153.v1,\phs000007\pht002153\phv00158457\FFD67\,phv00158457,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,a58abe26e724f8d2ad60984b8d8f28b133728f10a651f837ab1507e73484540b,continuous,phv00158457.v1,phs000007,False,FFD67,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158457\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00157213.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157213,[],phs000007,pht002150,phv00157213,False,True,False,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002150\phv00157213\FFD67\,pht002150.v4,\phs000007\pht002150\phv00157213\FFD67\,phv00157213,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v31,79e28ff3524265bd3140333592b809f85537acbf8476a4a16ffcc8038155c4a9,continuous,phv00157213.v4,phs000007,False,FFD67,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157213\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00523909.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523909,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00069079.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069079,[],phs000007,pht000682,phv00069079,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000682\phv00069079\FFD67\,pht000682.v6,\phs000007\pht000682\phv00069079\FFD67\,phv00069079,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,a6091a5ac877fb96c5a7dd7df7ff6b19777758739e53b14837a29eb466643473,continuous,phv00069079.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069079\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00070103.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070103,[],phs000007,pht000680,phv00070103,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000680\phv00070103\FFD67\,pht000680.v6,\phs000007\pht000680\phv00070103\FFD67\,phv00070103,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,9240923b42cf7216b966a88918c6a3222c2f50c1410408fb63dc8c0249ab08c6,continuous,phv00070103.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070103\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),0.886990802,vr_ffreq_ex06_1_0506d,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00068510.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068510,[],phs000007,pht000681,phv00068510,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000681\phv00068510\FFD67\,pht000681.v6,\phs000007\pht000681\phv00068510\FFD67\,phv00068510,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,1bfd1ecb0be59afe4d581f46d17f423ddd0bb50b0c5b8bba41412616c4912d4b,continuous,phv00068510.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068510\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00524567.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00479180.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479180,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00478527.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00477966.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00477403.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00523910.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523910,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00162592.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162592,[],phs000007,pht002350,phv00162592,False,True,False,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002350\phv00162592\FFD68\,pht002350.v5,\phs000007\pht002350\phv00162592\FFD68\,phv00162592,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v31,a52bc8e36e90832c9fb2abc46fd06f20c5ef80a9f2e93cf788dec45b07ab905f,continuous,phv00162592.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162592\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00158458.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158458,[],phs000007,pht002153,phv00158458,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002153\phv00158458\FFD68\,pht002153.v1,\phs000007\pht002153\phv00158458\FFD68\,phv00158458,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,5dcca273dfb8b32c3d9880174b0c457327612e7326b9b86d4731dd0cd1c228c0,continuous,phv00158458.v1,phs000007,False,FFD68,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158458\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00157655.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157655,[],phs000007,pht002151,phv00157655,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002151\phv00157655\FFD68\,pht002151.v1,\phs000007\pht002151\phv00157655\FFD68\,phv00157655,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,c24d77b776c22c463e6802c39ffdbf19dd47251a2db58c494a166e3089c3dde0,continuous,phv00157655.v1,phs000007,False,FFD68,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157655\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00157214.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157214,[],phs000007,pht002150,phv00157214,False,True,False,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002150\phv00157214\FFD68\,pht002150.v4,\phs000007\pht002150\phv00157214\FFD68\,phv00157214,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v31,e4852498f78ceaebf7bfadb9a59e62293877c6692075a202bd084a5d4e7bd35f,continuous,phv00157214.v4,phs000007,False,FFD68,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157214\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00070104.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070104,[],phs000007,pht000680,phv00070104,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000680\phv00070104\FFD68\,pht000680.v6,\phs000007\pht000680\phv00070104\FFD68\,phv00070104,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,5da9532c506bba51e6763356f533eaf99faa127ff688cb42455ca224d1c6e42b,continuous,phv00070104.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070104\FFD68\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00068511.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068511,[],phs000007,pht000681,phv00068511,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000681\phv00068511\FFD68\,pht000681.v6,\phs000007\pht000681\phv00068511\FFD68\,phv00068511,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,2808f2fd9eb168a0ac95d64579739c674b2bf314fe0c96251320acef6cd5e03d,continuous,phv00068511.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068511\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00069080.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069080,[],phs000007,pht000682,phv00069080,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000682\phv00069080\FFD68\,pht000682.v6,\phs000007\pht000682\phv00069080\FFD68\,phv00069080,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,caa50582aa19f0e3da5c0c67c48a0f52c64775f09b8d7c24a4b609b642bc958d,continuous,phv00069080.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069080\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00172993.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172993,[],phs000007,pht002900,phv00172993,False,True,False,FFD68,Derived field: Romaine or leaf lettuce,0.0,\phs000007\pht002900\phv00172993\FFD68\,pht002900.v3,\phs000007\pht002900\phv00172993\FFD68\,phv00172993,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Romaine or leaf lettuce,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Romaine or leaf lettuce,phs000007.v31,d95e969756be25b5a3becb473e8e21f5cc231cd23eecfa99e376bd6c9de746d9,continuous,phv00172993.v3,phs000007,False,FFD68,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172993\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00478528.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00477967.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00477404.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477404,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00172994.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172994,[],phs000007,pht002900,phv00172994,False,True,False,FFD69,Derived field: Celery,0.0,\phs000007\pht002900\phv00172994\FFD69\,pht002900.v3,\phs000007\pht002900\phv00172994\FFD69\,phv00172994,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Celery,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Celery,phs000007.v31,51d4243542240481b6652047a631ad0441cdd2f5de98e14b4f3f1e8cd38c319c,continuous,phv00172994.v3,phs000007,False,FFD69,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172994\FFD69\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00070105.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070105,[],phs000007,pht000680,phv00070105,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000680\phv00070105\FFD69\,pht000680.v6,\phs000007\pht000680\phv00070105\FFD69\,phv00070105,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,97dce0675aa98d83d8cb7c5ce3f0d399058efe18b0ec993a1fc9d6d50549e08e,continuous,phv00070105.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070105\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00157656.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157656,[],phs000007,pht002151,phv00157656,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht002151\phv00157656\FFD69\,pht002151.v1,\phs000007\pht002151\phv00157656\FFD69\,phv00157656,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,6aa14f4feb2b7adfd4e8a81a36d4c44fdadd955416d0705e9249942cf7410812,continuous,phv00157656.v1,phs000007,False,FFD69,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157656\FFD69\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00157215.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157215,[],phs000007,pht002150,phv00157215,False,True,False,FFD69,DERIVED FIELD:CELERY,0.0,\phs000007\pht002150\phv00157215\FFD69\,pht002150.v4,\phs000007\pht002150\phv00157215\FFD69\,phv00157215,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CELERY,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:CELERY,phs000007.v31,b8ccc88babbce2b8c812958b186ca3b2405ca13fdf0d8a55f4e5ab45e275d034,continuous,phv00157215.v4,phs000007,False,FFD69,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157215\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00069081.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069081,[],phs000007,pht000682,phv00069081,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000682\phv00069081\FFD69\,pht000682.v6,\phs000007\pht000682\phv00069081\FFD69\,phv00069081,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,fbdc6a3d855c7c854e4003c35d4388ceb14825eca21c5e9f0cc25402c8ddd340,continuous,phv00069081.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069081\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00068512.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068512,[],phs000007,pht000681,phv00068512,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000681\phv00068512\FFD69\,pht000681.v6,\phs000007\pht000681\phv00068512\FFD69\,phv00068512,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,73f127691462e2698f3f921e3069eb54d3874ac74d16a9b4ff256ec2c4df986a,continuous,phv00068512.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068512\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,CELERY,phs000007.v33.p14,phv00523911.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523911,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00162593.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162593,[],phs000007,pht002350,phv00162593,False,True,False,FFD69,DERIVED FIELD:CELERY,0.0,\phs000007\pht002350\phv00162593\FFD69\,pht002350.v5,\phs000007\pht002350\phv00162593\FFD69\,phv00162593,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CELERY,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:CELERY,phs000007.v31,1e75db7947066afd6dc25fdb47e4ee951774760d3d6de0c0a725d60646528d9f,continuous,phv00162593.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162593\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00524568.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00479181.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd69,CELERY:(servings/week),0.657030223,vr_ffreq_ex06_1_0506d,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00158459.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158459,[],phs000007,pht002153,phv00158459,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht002153\phv00158459\FFD69\,pht002153.v1,\phs000007\pht002153\phv00158459\FFD69\,phv00158459,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,787fae1356da14ce2717ba9bc83606bb759d1c564876279a249134da6bda174a,continuous,phv00158459.v1,phs000007,False,FFD69,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158459\FFD69\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00069082.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069082,[],phs000007,pht000682,phv00069082,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000682\phv00069082\FFD70\,pht000682.v6,\phs000007\pht000682\phv00069082\FFD70\,phv00069082,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,56a7ea219f0c8bff963b062cc1381ac987d4ffa8123dc3f5c26ec89ea1506509,continuous,phv00069082.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069082\FFD70\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,BEETS,phs000007.v33.p14,phv00523912.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00478529.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00477968.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477968,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00477405.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00068513.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068513,[],phs000007,pht000681,phv00068513,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000681\phv00068513\FFD70\,pht000681.v6,\phs000007\pht000681\phv00068513\FFD70\,phv00068513,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,b082b13e50368e0b395eab9c0bc28a23a26be93f105bb67c2d905ba892fda682,continuous,phv00068513.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068513\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00158460.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158460,[],phs000007,pht002153,phv00158460,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht002153\phv00158460\FFD70\,pht002153.v1,\phs000007\pht002153\phv00158460\FFD70\,phv00158460,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,19d7f6fd8021557ba66d317fe42643a620610f78ac67c52c0c6a26d03c79c3f1,continuous,phv00158460.v1,phs000007,False,FFD70,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158460\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00157657.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157657,[],phs000007,pht002151,phv00157657,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht002151\phv00157657\FFD70\,pht002151.v1,\phs000007\pht002151\phv00157657\FFD70\,phv00157657,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",5.5,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,d8c6b82746829e259f6a0230840dc8f4fddee3f1e958bc7c56f2dbe1b56b0519,continuous,phv00157657.v1,phs000007,False,FFD70,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157657\FFD70\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00157216.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157216,[],phs000007,pht002150,phv00157216,False,True,False,FFD70,DERIVED FIELD:BEETS,0.0,\phs000007\pht002150\phv00157216\FFD70\,pht002150.v4,\phs000007\pht002150\phv00157216\FFD70\,phv00157216,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEETS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BEETS,phs000007.v31,a71e3fe69d43a2389803c92b163bcdaf2a2091715c6bf179b9bf3563ef246c1e,continuous,phv00157216.v4,phs000007,False,FFD70,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157216\FFD70\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00070106.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070106,[],phs000007,pht000680,phv00070106,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000680\phv00070106\FFD70\,pht000680.v6,\phs000007\pht000680\phv00070106\FFD70\,phv00070106,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,19ae5d3f51ab792e3c0525c4ef3b91fcb6f1ca988b688ced8f54c38f469c77fb,continuous,phv00070106.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070106\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex06_1_0506d.ffd70,BEETS:(servings/week),0.328515112,vr_ffreq_ex06_1_0506d,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00162594.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162594,[],phs000007,pht002350,phv00162594,False,True,False,FFD70,DERIVED FIELD:BEETS,0.0,\phs000007\pht002350\phv00162594\FFD70\,pht002350.v5,\phs000007\pht002350\phv00162594\FFD70\,phv00162594,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEETS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:BEETS,phs000007.v31,4231ab911dd40cb07ec8b6c105cd03bee8b22db5522583e4a4c9bae4baf8df8c,continuous,phv00162594.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162594\FFD70\,0.0,7.0
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00524306.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,NUT_SODIUM,SODIUM (mg),phs000007.v33.p14,phv00523566.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00478925.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00478295.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00477732.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00477169.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00172710.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172710,[],phs000007,pht002900,phv00172710,False,True,False,nut_sodium,Derived field: Nutrient value - Sodium,126.66,\phs000007\pht002900\phv00172710\nut_sodium\,pht002900.v3,\phs000007\pht002900\phv00172710\nut_sodium\,phv00172710,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",13366.82,Derived field: Nutrient value - Sodium,phs000007.v31,68d785367c86ee78301adc5c779187c8eba109ea98361f86f864fb9ef510d817,continuous,phv00172710.v3,phs000007,False,nut_sodium,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172710\nut_sodium\,126.66,13366.82
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,NUT_SODIUM,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00162361.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162361,[],phs000007,pht002350,phv00162361,False,True,False,NUT_SODIUM,Derived field: Nutrient value - Sodium,425.99,\phs000007\pht002350\phv00162361\NUT_SODIUM\,pht002350.v5,\phs000007\pht002350\phv00162361\NUT_SODIUM\,phv00162361,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7612.38,Derived field: Nutrient value - Sodium,phs000007.v31,94ac8cd1d9e667e298011f9595840d4dbedec1fee20e14db425e9cbe8b9c13b3,continuous,phv00162361.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162361\NUT_SODIUM\,425.99,7612.38
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00157001.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157001,[],phs000007,pht002150,phv00157001,False,True,False,nut_sodium,Derived field: Nutrient value - Sodium,85.35,\phs000007\pht002150\phv00157001\nut_sodium\,pht002150.v4,\phs000007\pht002150\phv00157001\nut_sodium\,phv00157001,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17980.62,Derived field: Nutrient value - Sodium,phs000007.v31,8b33f55e0b8a304e8da943cb2b56dadc201260b2ba9070c6d0f6850b38af9798,continuous,phv00157001.v4,phs000007,False,nut_sodium,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157001\nut_sodium\,85.35,17980.62
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00070229.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070229,[],phs000007,pht000680,phv00070229,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",444.16,\phs000007\pht000680\phv00070229\NUT_SODIUM\,pht000680.v6,\phs000007\pht000680\phv00070229\NUT_SODIUM\,phv00070229,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",6597.83,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,442fd0e55191f1622ddefc57e4d0e7558d2afdc85061e2577001c6c530e9f0a1,continuous,phv00070229.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070229\NUT_SODIUM\,444.16,6597.83
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00068636.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068636,[],phs000007,pht000681,phv00068636,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",479.43,\phs000007\pht000681\phv00068636\NUT_SODIUM\,pht000681.v6,\phs000007\pht000681\phv00068636\NUT_SODIUM\,phv00068636,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",8770.78,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,191a66abf141be5f7100fa3a18f62b3dfaf4c1a319a9878bf317957094e52cbb,continuous,phv00068636.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068636\NUT_SODIUM\,479.43,8770.78
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex06_1_0506d.nut_sodium,SODIUM (mg),-,vr_ffreq_ex06_1_0506d,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00068753.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068753,[],phs000007,pht000682,phv00068753,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",403.14,\phs000007\pht000682\phv00068753\NUT_SODIUM\,pht000682.v6,\phs000007\pht000682\phv00068753\NUT_SODIUM\,phv00068753,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",6832.04,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,3112a109d93d50ed77f1b7c576b1e1ba8c86d6d076a845c71a60360748296e54,continuous,phv00068753.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068753\NUT_SODIUM\,403.14,6832.04
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00162638.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162638,[],phs000007,pht002350,phv00162638,False,True,True,FFD114,DERIVED FIELD:BEER,0.0,\phs000007\pht002350\phv00162638\FFD114\,pht002350.v5,\phs000007\pht002350\phv00162638\FFD114\,phv00162638,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEER,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:BEER,phs000007.v31,74ee6d0f73cf34948f09457f252223dad0d03e4dc382a2c5fe2b91f954109e53,continuous,phv00162638.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162638\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00157260.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157260,[],phs000007,pht002150,phv00157260,False,True,True,FFD114,DERIVED FIELD:BEER,0.0,\phs000007\pht002150\phv00157260\FFD114\,pht002150.v4,\phs000007\pht002150\phv00157260\FFD114\,phv00157260,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEER,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:BEER,phs000007.v31,1118bc50ecaeb49589a59c25a024075be4cc7458ecb63b14ddb616e3f69868c2,continuous,phv00157260.v4,phs000007,True,FFD114,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157260\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00069126.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069126,[],phs000007,pht000682,phv00069126,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000682\phv00069126\FFD114\,pht000682.v6,\phs000007\pht000682\phv00069126\FFD114\,phv00069126,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,d5d06579c9061e6db756dab3172c8f8517fda42d0debb340782ad9e2e9d9d0d5,continuous,phv00069126.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069126\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00068557.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068557,[],phs000007,pht000681,phv00068557,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000681\phv00068557\FFD114\,pht000681.v6,\phs000007\pht000681\phv00068557\FFD114\,phv00068557,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,2f5c7f194789f77b15a689d5a5d03bbad1c60dbcdaff4de3c60f8598d1b5f4ed,continuous,phv00068557.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068557\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00477449.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477449,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00478012.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478012,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00157701.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157701,[],phs000007,pht002151,phv00157701,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht002151\phv00157701\FFD114\,pht002151.v1,\phs000007\pht002151\phv00157701\FFD114\,phv00157701,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,db27c49de9785eb38f148d802411e8b2bc26c542168bf5bda70211687573da43,continuous,phv00157701.v1,phs000007,True,FFD114,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157701\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00158504.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158504,[],phs000007,pht002153,phv00158504,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht002153\phv00158504\FFD114\,pht002153.v1,\phs000007\pht002153\phv00158504\FFD114\,phv00158504,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,1fa60c508b1e22d5cdc4ba2e835fc8f1e0db73876d430eb57e2fc517c65bd441,continuous,phv00158504.v1,phs000007,True,FFD114,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158504\FFD114\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD:BEER,phs000007.v33.p14,phv00478573.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478573,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,BEER,phs000007.v33.p14,phv00523956.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523956,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd114,BEER:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd114,Framingham Cohort,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v33.p14,phv00070150.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070150,[],phs000007,pht000680,phv00070150,False,True,True,FFD114,DERIVED FIELD: SERVINGS PER WEEK - BEER,0.0,\phs000007\pht000680\phv00070150\FFD114\,pht000680.v6,\phs000007\pht000680\phv00070150\FFD114\,phv00070150,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - BEER,phs000007.v31,a8be256ad6889d7f59f2c2bd2cb0336a203ea36e1eb6cdb0670f1b0af84ef7e0,continuous,phv00070150.v5,phs000007,True,FFD114,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070150\FFD114\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00068558.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068558,[],phs000007,pht000681,phv00068558,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000681\phv00068558\FFD115\,pht000681.v6,\phs000007\pht000681\phv00068558\FFD115\,phv00068558,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,30381d4eece831ff8f24a0c4007caf7d8f2a0834cbb3f09f0d81c56b0267c531,continuous,phv00068558.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068558\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00069127.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069127,[],phs000007,pht000682,phv00069127,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000682\phv00069127\FFD115\,pht000682.v6,\phs000007\pht000682\phv00069127\FFD115\,phv00069127,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,169fa874ef35e15aa15bb07ab4dff68ff88cf9f224074d786ff989f530f67d25,continuous,phv00069127.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069127\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00157702.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157702,[],phs000007,pht002151,phv00157702,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht002151\phv00157702\FFD115\,pht002151.v1,\phs000007\pht002151\phv00157702\FFD115\,phv00157702,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,f30e3c10c7bae7590edb3e8df039d3ea985c28fddbb4861f5b5ddbc8a3404388,continuous,phv00157702.v1,phs000007,True,FFD115,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157702\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00477450.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477450,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00173043.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173043,[],phs000007,pht002900,phv00173043,False,True,True,FFD115,Derived field: Red wine,0.0,\phs000007\pht002900\phv00173043\FFD115\,pht002900.v3,\phs000007\pht002900\phv00173043\FFD115\,phv00173043,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Red wine,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Red wine,phs000007.v31,897a7be1929114f6ed54b574021b25666d849a4d22959a574ea27206994d0c97,continuous,phv00173043.v3,phs000007,True,FFD115,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173043\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00070151.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070151,[],phs000007,pht000680,phv00070151,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht000680\phv00070151\FFD115\,pht000680.v6,\phs000007\pht000680\phv00070151\FFD115\,phv00070151,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,69702aad592a2eb281b7d6ce28bd9df95cd53b9cdc10e1d51589933e8d60f9e1,continuous,phv00070151.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070151\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00478013.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478013,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,RED WINE,phs000007.v33.p14,phv00523957.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00479230.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,RED WINE: (servings/week),phs000007.v33.p14,phv00524617.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524617,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v33.p14,phv00158505.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158505,[],phs000007,pht002153,phv00158505,False,True,True,FFD115,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,0.0,\phs000007\pht002153\phv00158505\FFD115\,pht002153.v1,\phs000007\pht002153\phv00158505\FFD115\,phv00158505,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - RED WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - RED WINE,phs000007.v31,dd388c0334e96b8393d50833cc20d838f5fe1f77e27e8e7117d4f2ff4e48a108,continuous,phv00158505.v1,phs000007,True,FFD115,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158505\FFD115\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00157261.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157261,[],phs000007,pht002150,phv00157261,False,True,True,FFD115,DERIVED FIELD:RED WINE,0.0,\phs000007\pht002150\phv00157261\FFD115\,pht002150.v4,\phs000007\pht002150\phv00157261\FFD115\,phv00157261,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:RED WINE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:RED WINE,phs000007.v31,2c43cec98c258ef0aa247d9c43f8ca1e613f4347d8040c8117a38b3f3641b91d,continuous,phv00157261.v4,phs000007,True,FFD115,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157261\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00478574.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478574,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd115,RED WINE:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd115,Framingham Cohort,FFD115,DERIVED FIELD:RED WINE,phs000007.v33.p14,phv00162639.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162639,[],phs000007,pht002350,phv00162639,False,True,True,FFD115,DERIVED FIELD:RED WINE,0.0,\phs000007\pht002350\phv00162639\FFD115\,pht002350.v5,\phs000007\pht002350\phv00162639\FFD115\,phv00162639,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:RED WINE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:RED WINE,phs000007.v31,4512c778ea2a9ba4f8593401fc38269b3d3a3e79bf66eedc26d9e2b372a8d884,continuous,phv00162639.v5,phs000007,True,FFD115,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162639\FFD115\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00479231.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479231,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00162640.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162640,[],phs000007,pht002350,phv00162640,False,True,True,FFD116,DERIVED FIELD:WHITE WINE,0.0,\phs000007\pht002350\phv00162640\FFD116\,pht002350.v5,\phs000007\pht002350\phv00162640\FFD116\,phv00162640,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WHITE WINE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:WHITE WINE,phs000007.v31,4b2b26d975530b9fd54a7a0cb655102eb52a70873527946dc549d199704c39e6,continuous,phv00162640.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162640\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00478575.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478575,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,WHITE WINE,phs000007.v33.p14,phv00523958.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523958,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00477451.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477451,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00173044.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173044,[],phs000007,pht002900,phv00173044,False,True,True,FFD116,Derived field: White wine,0.0,\phs000007\pht002900\phv00173044\FFD116\,pht002900.v3,\phs000007\pht002900\phv00173044\FFD116\,phv00173044,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: White wine,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: White wine,phs000007.v31,1aa6adbb069211b5c40ff56d4fe2decd00202e5a413b47975e876dd5bdd48169,continuous,phv00173044.v3,phs000007,True,FFD116,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173044\FFD116\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,WHITE WINE: (servings/week),phs000007.v33.p14,phv00524618.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524618,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00157703.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157703,[],phs000007,pht002151,phv00157703,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht002151\phv00157703\FFD116\,pht002151.v1,\phs000007\pht002151\phv00157703\FFD116\,phv00157703,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,a885769bad8325ebdb79d9cb7dfa93a798ce9b5fd9cb08c3c3a93b8a7222a17c,continuous,phv00157703.v1,phs000007,True,FFD116,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157703\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00158506.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158506,[],phs000007,pht002153,phv00158506,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht002153\phv00158506\FFD116\,pht002153.v1,\phs000007\pht002153\phv00158506\FFD116\,phv00158506,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,d6855fba30973760015639ce6c196448935d635187aa61f9d858766e6c1fcc12,continuous,phv00158506.v1,phs000007,True,FFD116,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158506\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00068559.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068559,[],phs000007,pht000681,phv00068559,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000681\phv00068559\FFD116\,pht000681.v6,\phs000007\pht000681\phv00068559\FFD116\,phv00068559,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,d72036b8d78f24b0c061b986c695c63408529f6be85e2054d92dd8d3c09efe6c,continuous,phv00068559.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068559\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00478014.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478014,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00070152.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070152,[],phs000007,pht000680,phv00070152,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000680\phv00070152\FFD116\,pht000680.v6,\phs000007\pht000680\phv00070152\FFD116\,phv00070152,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,34b6e947e3b63e1a934f323d8a2ade05f53b107a0f5084ed188c047abc864b02,continuous,phv00070152.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070152\FFD116\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD:WHITE WINE,phs000007.v33.p14,phv00157262.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157262,[],phs000007,pht002150,phv00157262,False,True,True,FFD116,DERIVED FIELD:WHITE WINE,0.0,\phs000007\pht002150\phv00157262\FFD116\,pht002150.v4,\phs000007\pht002150\phv00157262\FFD116\,phv00157262,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WHITE WINE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:WHITE WINE,phs000007.v31,0306be86fbae2fbe9196c0caffdd16133664e3519a4b8fbf736148659032a4c1,continuous,phv00157262.v4,phs000007,True,FFD116,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157262\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd116,WHITE WINE:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd116,Framingham Cohort,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v33.p14,phv00069128.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069128,[],phs000007,pht000682,phv00069128,False,True,True,FFD116,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,0.0,\phs000007\pht000682\phv00069128\FFD116\,pht000682.v6,\phs000007\pht000682\phv00069128\FFD116\,phv00069128,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - WHITE WINE,phs000007.v31,c94b6312f826e7d34a7b702feec5cff066ab4fabbb1d2c95c8b8c7148f21a81e,continuous,phv00069128.v5,phs000007,True,FFD116,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069128\FFD116\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00524619.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524619,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,LIQUOR,phs000007.v33.p14,phv00523959.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00479232.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479232,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00478576.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478576,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00478015.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00478015,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00477452.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477452,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,LIQUOR: (servings/week),phs000007.v33.p14,phv00173045.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00173045,[],phs000007,pht002900,phv00173045,False,True,True,FFD117,Derived field: Liquor,0.0,\phs000007\pht002900\phv00173045\FFD117\,pht002900.v3,\phs000007\pht002900\phv00173045\FFD117\,phv00173045,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Liquor,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Liquor,phs000007.v31,021d8fb2f95c3a1698b3cbc57414e6153098f78614d3d501b3e57b48d9d31002,continuous,phv00173045.v3,phs000007,True,FFD117,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00173045\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00162641.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162641,[],phs000007,pht002350,phv00162641,False,True,True,FFD117,DERIVED FIELD:LIQUOR,0.0,\phs000007\pht002350\phv00162641\FFD117\,pht002350.v5,\phs000007\pht002350\phv00162641\FFD117\,phv00162641,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:LIQUOR,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:LIQUOR,phs000007.v31,955fc37c2f93e97ac55b75b42d3bc8012d25f322fa3f344e1982b63b627251c6,continuous,phv00162641.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162641\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD:LIQUOR,phs000007.v33.p14,phv00157263.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157263,[],phs000007,pht002150,phv00157263,False,True,True,FFD117,DERIVED FIELD:LIQUOR,0.0,\phs000007\pht002150\phv00157263\FFD117\,pht002150.v4,\phs000007\pht002150\phv00157263\FFD117\,phv00157263,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:LIQUOR,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:LIQUOR,phs000007.v31,336361869c80c7dbfd84d5bc508ca544aedecfb5dd661ae1e84d020554ea35d1,continuous,phv00157263.v4,phs000007,True,FFD117,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157263\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00070153.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070153,[],phs000007,pht000680,phv00070153,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000680\phv00070153\FFD117\,pht000680.v6,\phs000007\pht000680\phv00070153\FFD117\,phv00070153,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,b1cadde8c2c5c63783d184f016570935bacaa9594d8d2dfef19b1f5c225226bc,continuous,phv00070153.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070153\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00069129.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069129,[],phs000007,pht000682,phv00069129,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000682\phv00069129\FFD117\,pht000682.v6,\phs000007\pht000682\phv00069129\FFD117\,phv00069129,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,53d53d04d2fd499ed4520c93bb5010ac90cc3d721584c9020e3fc5dab639510e,continuous,phv00069129.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069129\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00068560.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068560,[],phs000007,pht000681,phv00068560,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht000681\phv00068560\FFD117\,pht000681.v6,\phs000007\pht000681\phv00068560\FFD117\,phv00068560,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,54f73fea724c26925c19695c838792a5a6cd22350f364c20e83e6806d98852cb,continuous,phv00068560.v5,phs000007,True,FFD117,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068560\FFD117\,0.0,42.0
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00158507.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158507,[],phs000007,pht002153,phv00158507,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht002153\phv00158507\FFD117\,pht002153.v1,\phs000007\pht002153\phv00158507\FFD117\,phv00158507,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,5648cac741e364f2065b6f7a6cc5f0a0395d7e8db218264652d46b51e01de1f5,continuous,phv00158507.v1,phs000007,True,FFD117,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158507\FFD117\,0.0,31.5
ALCOHOL,Alcohol (servings per week),896811007,C56075,ARICFraminghamMESAREGARDS,0.46,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd117,LIQUOR:(servings/week),0.037188546,vr_ffreq_ex08_1_0615d_v1,ffd117,Framingham Cohort,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v33.p14,phv00157704.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157704,[],phs000007,pht002151,phv00157704,False,True,True,FFD117,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,0.0,\phs000007\pht002151\phv00157704\FFD117\,pht002151.v1,\phs000007\pht002151\phv00157704\FFD117\,phv00157704,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - LIQUOR,phs000007.v31,0fd1578c5c436e32fc736d2458cef4ddf9231278746a07f72980df7f28cd014d,continuous,phv00157704.v1,phs000007,True,FFD117,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157704\FFD117\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00157176.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157176,[],phs000007,pht002150,phv00157176,False,True,False,FFD30,DERIVED FIELD:RAISINS,0.0,\phs000007\pht002150\phv00157176\FFD30\,pht002150.v4,\phs000007\pht002150\phv00157176\FFD30\,phv00157176,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:RAISINS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:RAISINS,phs000007.v31,2d080857ade314a03e8901fca5a691becc0d3de98e8c48c37b1cd698b1ee13ea,continuous,phv00157176.v4,phs000007,False,FFD30,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157176\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00157617.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157617,[],phs000007,pht002151,phv00157617,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht002151\phv00157617\FFD30\,pht002151.v1,\phs000007\pht002151\phv00157617\FFD30\,phv00157617,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,45537ab4ad44589e914f23a9399ba1939637bf681dd6844778b6b161c860f0b0,continuous,phv00157617.v1,phs000007,False,FFD30,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157617\FFD30\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00158420.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158420,[],phs000007,pht002153,phv00158420,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht002153\phv00158420\FFD30\,pht002153.v1,\phs000007\pht002153\phv00158420\FFD30\,phv00158420,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,f99797221f56d569434cb40309bc140df8d3241a5e29099117c70be2e33ab2c0,continuous,phv00158420.v1,phs000007,False,FFD30,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158420\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00070066.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070066,[],phs000007,pht000680,phv00070066,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000680\phv00070066\FFD30\,pht000680.v6,\phs000007\pht000680\phv00070066\FFD30\,phv00070066,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,f09a6599e8c1cf8c64abb6d7ccdfe4302a2fdecc5f25ce148fd91c0916600f3b,continuous,phv00070066.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070066\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00162554.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162554,[],phs000007,pht002350,phv00162554,False,True,False,FFD30,DERIVED FIELD:RAISINS,0.0,\phs000007\pht002350\phv00162554\FFD30\,pht002350.v5,\phs000007\pht002350\phv00162554\FFD30\,phv00162554,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:RAISINS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:RAISINS,phs000007.v31,6c1c26cf8f68e8dbf3e476b63162f6493658000a4fe0a934c0878b8e0e8dd5f7,continuous,phv00162554.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162554\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,RAISINS,phs000007.v33.p14,phv00523872.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523872,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00068473.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068473,[],phs000007,pht000681,phv00068473,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000681\phv00068473\FFD30\,pht000681.v6,\phs000007\pht000681\phv00068473\FFD30\,phv00068473,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,be49de00223c4ec07aa8c093ba00a8874c07cb9ac4aadf651f4985d3093e5cac,continuous,phv00068473.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068473\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00478489.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478489,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00477928.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477928,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD:RAISINS,phs000007.v33.p14,phv00477365.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477365,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00172953.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172953,[],phs000007,pht002900,phv00172953,False,True,False,FFD30,Derived field: Raisins or grapes,0.0,\phs000007\pht002900\phv00172953\FFD30\,pht002900.v3,\phs000007\pht002900\phv00172953\FFD30\,phv00172953,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Raisins or grapes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Raisins or grapes,phs000007.v31,d5c1a07452f1953a5e6e83cbd6dc46795b03b83fe9d208e3ce3dd33c3c8b015f,continuous,phv00172953.v3,phs000007,False,FFD30,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172953\FFD30\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00524527.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v33.p14,phv00069042.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069042,[],phs000007,pht000682,phv00069042,False,True,False,FFD30,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,0.0,\phs000007\pht000682\phv00069042\FFD30\,pht000682.v6,\phs000007\pht000682\phv00069042\FFD30\,phv00069042,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - RAISINS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - RAISINS,phs000007.v31,2f8ce696e225dfc8e7a37e1cf0112cbd192bd9dd41d7b8ce0a15d05431ba4961,continuous,phv00069042.v5,phs000007,False,FFD30,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069042\FFD30\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd30,RAISINS:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd30,Framingham Cohort,FFD30,RAISINS: (servings/week),phs000007.v33.p14,phv00479140.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479140,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00068474.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068474,[],phs000007,pht000681,phv00068474,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000681\phv00068474\FFD31\,pht000681.v6,\phs000007\pht000681\phv00068474\FFD31\,phv00068474,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,6f83b7cc15bf1b18636fedac7f39d308601e8992454dfc8bf7598411edfe668d,continuous,phv00068474.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068474\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00070067.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070067,[],phs000007,pht000680,phv00070067,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000680\phv00070067\FFD31\,pht000680.v6,\phs000007\pht000680\phv00070067\FFD31\,phv00070067,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,c48bd4cbbd2518e68a4ebca54ac41b908f136adb0ebd6d951a90bf195f16028a,continuous,phv00070067.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070067\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00157177.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157177,[],phs000007,pht002150,phv00157177,False,True,False,FFD31,DERIVED FIELD:PRUNES,0.0,\phs000007\pht002150\phv00157177\FFD31\,pht002150.v4,\phs000007\pht002150\phv00157177\FFD31\,phv00157177,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PRUNES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:PRUNES,phs000007.v31,543e9ab69eb1ed8d6ba460f1e636195d2adee5f946444aefe45ea30935ab09e8,continuous,phv00157177.v4,phs000007,False,FFD31,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157177\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00157618.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157618,[],phs000007,pht002151,phv00157618,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht002151\phv00157618\FFD31\,pht002151.v1,\phs000007\pht002151\phv00157618\FFD31\,phv00157618,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,e1b32985c3cafcbaeac7e41d65a31b8726ee5de8022bf4cd28d3995639ad5b78,continuous,phv00157618.v1,phs000007,False,FFD31,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157618\FFD31\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00158421.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158421,[],phs000007,pht002153,phv00158421,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht002153\phv00158421\FFD31\,pht002153.v1,\phs000007\pht002153\phv00158421\FFD31\,phv00158421,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,9d829a254ae2697ca62a229c302f3ecc0d82110b50d947e6955f21d2668fe7a1,continuous,phv00158421.v1,phs000007,False,FFD31,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158421\FFD31\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00162555.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162555,[],phs000007,pht002350,phv00162555,False,True,False,FFD31,DERIVED FIELD:PRUNES,0.0,\phs000007\pht002350\phv00162555\FFD31\,pht002350.v5,\phs000007\pht002350\phv00162555\FFD31\,phv00162555,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PRUNES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:PRUNES,phs000007.v31,19cbe3fcd263200f95d070d348366b41e300ac3a28a4609875b69106f6764388,continuous,phv00162555.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162555\FFD31\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00477366.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477366,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00477929.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477929,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD:PRUNES,phs000007.v33.p14,phv00478490.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478490,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,PRUNES,phs000007.v33.p14,phv00523873.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523873,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd31,PRUNES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd31,Framingham Cohort,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v33.p14,phv00069043.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069043,[],phs000007,pht000682,phv00069043,False,True,False,FFD31,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,0.0,\phs000007\pht000682\phv00069043\FFD31\,pht000682.v6,\phs000007\pht000682\phv00069043\FFD31\,phv00069043,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PRUNES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - PRUNES,phs000007.v31,217cd5c97101248ff7264b0315cdd2e3466c731e192474269dd3eebb4eb0e959,continuous,phv00069043.v5,phs000007,False,FFD31,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069043\FFD31\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00479143.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479143,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00477930.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477930,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00477367.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477367,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00172956.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172956,[],phs000007,pht002900,phv00172956,False,True,False,FFD32,Derived field: Bananas,0.0,\phs000007\pht002900\phv00172956\FFD32\,pht002900.v3,\phs000007\pht002900\phv00172956\FFD32\,phv00172956,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Bananas,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Bananas,phs000007.v31,976af2eb6db825a29af00e1f704be42fb3a4070bdcabf4a90fb29851da7072a2,continuous,phv00172956.v3,phs000007,False,FFD32,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172956\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00070068.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070068,[],phs000007,pht000680,phv00070068,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000680\phv00070068\FFD32\,pht000680.v6,\phs000007\pht000680\phv00070068\FFD32\,phv00070068,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,a2cd8145b51cad6b3b9427ac6b6f9f1261dfdfdecac6817370388bea6e4aa229,continuous,phv00070068.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070068\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00158422.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158422,[],phs000007,pht002153,phv00158422,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht002153\phv00158422\FFD32\,pht002153.v1,\phs000007\pht002153\phv00158422\FFD32\,phv00158422,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,516b994d306a118bd3861d65af73848e910daf6431dbba6bde1e794caa6403d3,continuous,phv00158422.v1,phs000007,False,FFD32,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158422\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00157619.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157619,[],phs000007,pht002151,phv00157619,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht002151\phv00157619\FFD32\,pht002151.v1,\phs000007\pht002151\phv00157619\FFD32\,phv00157619,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,f2df173e3f9ae6b20d2f7e95b28bc28d5be064c6d3c36c93647e96147ad10399,continuous,phv00157619.v1,phs000007,False,FFD32,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157619\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00157178.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157178,[],phs000007,pht002150,phv00157178,False,True,False,FFD32,DERIVED FIELD:BANANAS,0.0,\phs000007\pht002150\phv00157178\FFD32\,pht002150.v4,\phs000007\pht002150\phv00157178\FFD32\,phv00157178,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BANANAS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BANANAS,phs000007.v31,2345889d9d90803c638ec75abcc0d49e793ded46823ca3c79cce40b1bd6900cf,continuous,phv00157178.v4,phs000007,False,FFD32,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157178\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,BANANAS,phs000007.v33.p14,phv00523874.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523874,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00068475.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068475,[],phs000007,pht000681,phv00068475,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000681\phv00068475\FFD32\,pht000681.v6,\phs000007\pht000681\phv00068475\FFD32\,phv00068475,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,d68c6d4d0406eb63cabbf69e87e0cc9990cc9c66da76f6931ece5e13ae08ac99,continuous,phv00068475.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068475\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00162556.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162556,[],phs000007,pht002350,phv00162556,False,True,False,FFD32,DERIVED FIELD:BANANAS,0.0,\phs000007\pht002350\phv00162556\FFD32\,pht002350.v5,\phs000007\pht002350\phv00162556\FFD32\,phv00162556,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BANANAS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BANANAS,phs000007.v31,1c4ff3408fda6d4fc1fdc0bc17c095dceba5d0d12ec7bdcb94fcbf3a30045722,continuous,phv00162556.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162556\FFD32\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,BANANAS: (servings/week),phs000007.v33.p14,phv00524530.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524530,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD:BANANAS,phs000007.v33.p14,phv00478491.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478491,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd32,BANANAS:(servings/week),1.115656378,vr_ffreq_ex08_1_0615d_v1,ffd32,Framingham Cohort,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v33.p14,phv00069044.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069044,[],phs000007,pht000682,phv00069044,False,True,False,FFD32,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,0.0,\phs000007\pht000682\phv00069044\FFD32\,pht000682.v6,\phs000007\pht000682\phv00069044\FFD32\,phv00069044,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BANANAS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - BANANAS,phs000007.v31,376dd521f3f1d7a3f03337dc6567a8f78edef583e49340a32bea9142df664032,continuous,phv00069044.v5,phs000007,False,FFD32,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069044\FFD32\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00157620.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157620,[],phs000007,pht002151,phv00157620,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht002151\phv00157620\FFD33\,pht002151.v1,\phs000007\pht002151\phv00157620\FFD33\,phv00157620,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,5aaca17896fbd32741da0675ddabd821f9e66ae9e774d0c056e70ce89dde2302,continuous,phv00157620.v1,phs000007,False,FFD33,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157620\FFD33\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00524531.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524531,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,CANTALOUPE,phs000007.v33.p14,phv00523875.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523875,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00479144.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479144,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00477931.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477931,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00477368.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477368,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00478492.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478492,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00162557.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162557,[],phs000007,pht002350,phv00162557,False,True,False,FFD33,DERIVED FIELD:CANTALOUPE,0.0,\phs000007\pht002350\phv00162557\FFD33\,pht002350.v5,\phs000007\pht002350\phv00162557\FFD33\,phv00162557,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CANTALOUPE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:CANTALOUPE,phs000007.v31,aa1f34f9cbcb31b6356c3e404f549806f38e91d733a939d03a00322d3ad69f2a,continuous,phv00162557.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162557\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00068476.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068476,[],phs000007,pht000681,phv00068476,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000681\phv00068476\FFD33\,pht000681.v6,\phs000007\pht000681\phv00068476\FFD33\,phv00068476,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,3f6ca7b0ff2bdc23cd5887c75f52503b8f4d62fdd61b2259f2e0afa026614a5c,continuous,phv00068476.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068476\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00069045.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069045,[],phs000007,pht000682,phv00069045,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000682\phv00069045\FFD33\,pht000682.v6,\phs000007\pht000682\phv00069045\FFD33\,phv00069045,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,6ccb8b8957767e011560b3dd7d05974cc852fc011363380dfae40e8c1500dc3c,continuous,phv00069045.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069045\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00070069.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070069,[],phs000007,pht000680,phv00070069,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht000680\phv00070069\FFD33\,pht000680.v6,\phs000007\pht000680\phv00070069\FFD33\,phv00070069,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,343e5aad482555ea3af002918d6bbaf9cabd25d83ba5b64cd8e42e0649b062b2,continuous,phv00070069.v5,phs000007,False,FFD33,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070069\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD:CANTALOUPE,phs000007.v33.p14,phv00157179.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157179,[],phs000007,pht002150,phv00157179,False,True,False,FFD33,DERIVED FIELD:CANTALOUPE,0.0,\phs000007\pht002150\phv00157179\FFD33\,pht002150.v4,\phs000007\pht002150\phv00157179\FFD33\,phv00157179,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CANTALOUPE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:CANTALOUPE,phs000007.v31,53bf60ccb09476213d4c0b17c108c21b2b5ad8097e009fd5f4cb0280547bed43,continuous,phv00157179.v4,phs000007,False,FFD33,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157179\FFD33\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,CANTALOUPE: (servings/week),phs000007.v33.p14,phv00172957.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172957,[],phs000007,pht002900,phv00172957,False,True,False,FFD33,Derived field: Cantaloupe,0.0,\phs000007\pht002900\phv00172957\FFD33\,pht002900.v3,\phs000007\pht002900\phv00172957\FFD33\,phv00172957,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cantaloupe,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Cantaloupe,phs000007.v31,5583becf69ba14da6f104cd78c493737ffd21fc69eca2e7fc0f3ba600116e6ce,continuous,phv00172957.v3,phs000007,False,FFD33,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172957\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd33,CANTALOUPE:(servings/week),1.301599108,vr_ffreq_ex08_1_0615d_v1,ffd33,Framingham Cohort,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v33.p14,phv00158423.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158423,[],phs000007,pht002153,phv00158423,False,True,False,FFD33,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,0.0,\phs000007\pht002153\phv00158423\FFD33\,pht002153.v1,\phs000007\pht002153\phv00158423\FFD33\,phv00158423,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - CANTALOUPE,phs000007.v31,3ae3c6805679ff084e90bc9ecc5fccb5a5535d0e07a3b491c99f10292b9bbec7,continuous,phv00158423.v1,phs000007,False,FFD33,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158423\FFD33\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00478493.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478493,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00162558.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162558,[],phs000007,pht002350,phv00162558,False,True,False,FFD34,DERIVED FIELD:WATERMELON,0.0,\phs000007\pht002350\phv00162558\FFD34\,pht002350.v5,\phs000007\pht002350\phv00162558\FFD34\,phv00162558,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WATERMELON,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:WATERMELON,phs000007.v31,3ed7e5236a23088be0f1e3abd84040d3c831cd76286f1fee7e4190f23fde6ab2,continuous,phv00162558.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162558\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00477369.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477369,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00157180.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157180,[],phs000007,pht002150,phv00157180,False,True,False,FFD34,DERIVED FIELD:WATERMELON,0.0,\phs000007\pht002150\phv00157180\FFD34\,pht002150.v4,\phs000007\pht002150\phv00157180\FFD34\,phv00157180,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WATERMELON,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:WATERMELON,phs000007.v31,ee5e015faa58e773bcf8cc48c03b18606cff5c8292bbf61d6ba1e61b685cc6ec,continuous,phv00157180.v4,phs000007,False,FFD34,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157180\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD:WATERMELON,phs000007.v33.p14,phv00477932.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477932,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00068477.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068477,[],phs000007,pht000681,phv00068477,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000681\phv00068477\FFD34\,pht000681.v6,\phs000007\pht000681\phv00068477\FFD34\,phv00068477,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,950d4fe76954abffcd38ae8ac5390a8a9bb6dd70a10ef25dc56099a233701a12,continuous,phv00068477.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068477\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00070070.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070070,[],phs000007,pht000680,phv00070070,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000680\phv00070070\FFD34\,pht000680.v6,\phs000007\pht000680\phv00070070\FFD34\,phv00070070,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,89768909f3e72b5e62236000f4d6d4d45dd495d935db8a9c4702b773d1630cb9,continuous,phv00070070.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070070\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00069046.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069046,[],phs000007,pht000682,phv00069046,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht000682\phv00069046\FFD34\,pht000682.v6,\phs000007\pht000682\phv00069046\FFD34\,phv00069046,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,16ece4d2ee001070614d0a5974ead7d3b2f13cdf412fc221fed2e0b5ba7c3f96,continuous,phv00069046.v5,phs000007,False,FFD34,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069046\FFD34\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00158424.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158424,[],phs000007,pht002153,phv00158424,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht002153\phv00158424\FFD34\,pht002153.v1,\phs000007\pht002153\phv00158424\FFD34\,phv00158424,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,64206c630afb53c5e5cbf27fde6f51667b52504ed40838de10291f5baf866bf2,continuous,phv00158424.v1,phs000007,False,FFD34,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158424\FFD34\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,WATERMELON,phs000007.v33.p14,phv00523876.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523876,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd34,WATERMELON:(servings/week),1.822238751,vr_ffreq_ex08_1_0615d_v1,ffd34,Framingham Cohort,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v33.p14,phv00157621.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157621,[],phs000007,pht002151,phv00157621,False,True,False,FFD34,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,0.0,\phs000007\pht002151\phv00157621\FFD34\,pht002151.v1,\phs000007\pht002151\phv00157621\FFD34\,phv00157621,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - WATERMELON,phs000007.v31,5fd21372dfa6ffe0b9b2b3275644ef8f340a6521f7e467fe8e916abbb3770b57,continuous,phv00157621.v1,phs000007,False,FFD34,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157621\FFD34\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00068478.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068478,[],phs000007,pht000681,phv00068478,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000681\phv00068478\FFD35\,pht000681.v6,\phs000007\pht000681\phv00068478\FFD35\,phv00068478,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,f75476fafa4fd178a0b5b4bebe1fed721a70a643a345b00896dbd83897a8d86e,continuous,phv00068478.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068478\FFD35\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00069047.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069047,[],phs000007,pht000682,phv00069047,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000682\phv00069047\FFD35\,pht000682.v6,\phs000007\pht000682\phv00069047\FFD35\,phv00069047,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,ffd1bcdc4ca4468803e216eaac9261bde05107cef82d442e24b476ad4c3c8a26,continuous,phv00069047.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069047\FFD35\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00158425.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158425,[],phs000007,pht002153,phv00158425,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht002153\phv00158425\FFD35\,pht002153.v1,\phs000007\pht002153\phv00158425\FFD35\,phv00158425,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,0da263a57a2b777e85af075c1ef10504757be2a0c780d8f430247444ed114a0e,continuous,phv00158425.v1,phs000007,False,FFD35,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158425\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH",phs000007.v33.p14,phv00523877.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523877,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00479146.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479146,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00478494.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478494,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00477933.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477933,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00172959.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172959,[],phs000007,pht002900,phv00172959,False,True,False,FFD35,Derived field: Fresh apples or pears,0.0,\phs000007\pht002900\phv00172959\FFD35\,pht002900.v3,\phs000007\pht002900\phv00172959\FFD35\,phv00172959,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Fresh apples or pears,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Fresh apples or pears,phs000007.v31,507a73c68bfc1a88df9fc619bee590bbc8bead596db3b3088e639b30050d273b,continuous,phv00172959.v3,phs000007,False,FFD35,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172959\FFD35\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00162559.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162559,[],phs000007,pht002350,phv00162559,False,True,False,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",0.0,\phs000007\pht002350\phv00162559\FFD35\,pht002350.v5,\phs000007\pht002350\phv00162559\FFD35\,phv00162559,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v31,7d6e7d366ab08fea1fe269edd5cdb88a967ef1c9847c4eb98a0852ef84a9aea2,continuous,phv00162559.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162559\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00157622.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157622,[],phs000007,pht002151,phv00157622,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht002151\phv00157622\FFD35\,pht002151.v1,\phs000007\pht002151\phv00157622\FFD35\,phv00157622,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,d335099bb1dc844d6e38eee89f17e3e736afcd14b5b46aa6cb5448edf5da5f78,continuous,phv00157622.v1,phs000007,False,FFD35,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157622\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00157181.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157181,[],phs000007,pht002150,phv00157181,False,True,False,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",0.0,\phs000007\pht002150\phv00157181\FFD35\,pht002150.v4,\phs000007\pht002150\phv00157181\FFD35\,phv00157181,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v31,7aa3cde07888bf49c9480d7b5d8581711109fcadd81911e8b168a26df7104273,continuous,phv00157181.v4,phs000007,False,FFD35,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157181\FFD35\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v33.p14,phv00070071.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070071,[],phs000007,pht000680,phv00070071,False,True,False,FFD35,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",0.0,\phs000007\pht000680\phv00070071\FFD35\,pht000680.v6,\phs000007\pht000680\phv00070071\FFD35\,phv00070071,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,"DERIVED FIELD: SERVINGS PER WEEK - APPLES/PEARS, FRESH",phs000007.v31,b5b32557e575ead9473c9f8118efc8cabea341c2b7a92cfd62c7af4ab339ccb8,continuous,phv00070071.v5,phs000007,False,FFD35,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070071\FFD35\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"APPLES/PEARS, FRESH: (servings/week)",phs000007.v33.p14,phv00524533.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524533,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd35,"APPLES/PEARS, FRESH:(servings/week)",1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd35,Framingham Cohort,FFD35,"DERIVED FIELD:APPLES/PEARS, FRESH",phs000007.v33.p14,phv00477370.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477370,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00524535.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524535,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,ORANGES,phs000007.v33.p14,phv00523879.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523879,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00479148.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479148,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00478496.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478496,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00068480.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068480,[],phs000007,pht000681,phv00068480,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000681\phv00068480\FFD37\,pht000681.v6,\phs000007\pht000681\phv00068480\FFD37\,phv00068480,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,1a1da8403c208fde67683962a2d4db07dfa4d41d23d40bc4873d580f75287f60,continuous,phv00068480.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068480\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00070073.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070073,[],phs000007,pht000680,phv00070073,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000680\phv00070073\FFD37\,pht000680.v6,\phs000007\pht000680\phv00070073\FFD37\,phv00070073,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,34f8a47d18e191f948e0ecea476e10235f8eae87ea2c4a558300a2dd0805342f,continuous,phv00070073.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070073\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00157183.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157183,[],phs000007,pht002150,phv00157183,False,True,False,FFD37,DERIVED FIELD:ORANGES,0.0,\phs000007\pht002150\phv00157183\FFD37\,pht002150.v4,\phs000007\pht002150\phv00157183\FFD37\,phv00157183,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ORANGES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:ORANGES,phs000007.v31,847ab14055d9703e776c5887e506436c6919367058d5084999b9086bcf9f6476,continuous,phv00157183.v4,phs000007,False,FFD37,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157183\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00157624.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157624,[],phs000007,pht002151,phv00157624,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht002151\phv00157624\FFD37\,pht002151.v1,\phs000007\pht002151\phv00157624\FFD37\,phv00157624,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,51b2732b06a165aa20d1378aa92c7afc80493ec3ecf38f477ffba6753eec962f,continuous,phv00157624.v1,phs000007,False,FFD37,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157624\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00158427.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158427,[],phs000007,pht002153,phv00158427,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht002153\phv00158427\FFD37\,pht002153.v1,\phs000007\pht002153\phv00158427\FFD37\,phv00158427,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,1b16d76a1a1d969df27e508d19be4323b57221c2f0294b6785cbe8f359af5333,continuous,phv00158427.v1,phs000007,False,FFD37,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158427\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v33.p14,phv00069049.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069049,[],phs000007,pht000682,phv00069049,False,True,False,FFD37,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,0.0,\phs000007\pht000682\phv00069049\FFD37\,pht000682.v6,\phs000007\pht000682\phv00069049\FFD37\,phv00069049,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ORANGES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - ORANGES,phs000007.v31,517bc251ee53008c197243e45add8aece8edc295a15eb9fb5390845be2df12bd,continuous,phv00069049.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069049\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00162561.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162561,[],phs000007,pht002350,phv00162561,False,True,False,FFD37,DERIVED FIELD:ORANGES,0.0,\phs000007\pht002350\phv00162561\FFD37\,pht002350.v5,\phs000007\pht002350\phv00162561\FFD37\,phv00162561,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ORANGES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:ORANGES,phs000007.v31,6c58c2dd7f1f65cc135cfa5f3b1dfd33f1df56c981feb519282f551e2a59f9b7,continuous,phv00162561.v5,phs000007,False,FFD37,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162561\FFD37\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,ORANGES: (servings/week),phs000007.v33.p14,phv00172961.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172961,[],phs000007,pht002900,phv00172961,False,True,False,FFD37,Derived field: Oranges,0.0,\phs000007\pht002900\phv00172961\FFD37\,pht002900.v3,\phs000007\pht002900\phv00172961\FFD37\,phv00172961,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Oranges,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Oranges,phs000007.v31,5d3de666c7f285281bc03a796427468fdd1c90234d0f6af2e418d100f843ce75,continuous,phv00172961.v3,phs000007,False,FFD37,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172961\FFD37\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00477372.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477372,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd37,ORANGES:(servings/week),1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd37,Framingham Cohort,FFD37,DERIVED FIELD:ORANGES,phs000007.v33.p14,phv00477935.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477935,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00477937.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477937,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00477374.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477374,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00162563.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162563,[],phs000007,pht002350,phv00162563,False,True,False,FFD39,DERIVED FIELD:GRAPEFRUIT,0.0,\phs000007\pht002350\phv00162563\FFD39\,pht002350.v5,\phs000007\pht002350\phv00162563\FFD39\,phv00162563,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:GRAPEFRUIT,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:GRAPEFRUIT,phs000007.v31,5cab6cd836650095eda3a565a8262997c12faa11b3f5530c8851929977466d0f,continuous,phv00162563.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162563\FFD39\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00158429.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158429,[],phs000007,pht002153,phv00158429,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht002153\phv00158429\FFD39\,pht002153.v1,\phs000007\pht002153\phv00158429\FFD39\,phv00158429,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,b4b9917596f47ce5eb4bff30d1b1b9f7e3511843f58d8ab831407e9120e99b1a,continuous,phv00158429.v1,phs000007,False,FFD39,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158429\FFD39\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00157626.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157626,[],phs000007,pht002151,phv00157626,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht002151\phv00157626\FFD39\,pht002151.v1,\phs000007\pht002151\phv00157626\FFD39\,phv00157626,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,f79273216d1e0524d4ff195ede70e35e5b65abec0087f00ea4d30a22f522bead,continuous,phv00157626.v1,phs000007,False,FFD39,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157626\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00070075.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070075,[],phs000007,pht000680,phv00070075,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000680\phv00070075\FFD39\,pht000680.v6,\phs000007\pht000680\phv00070075\FFD39\,phv00070075,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,4905d27461d4661075cb32ab6e27fb533cde88c8ae4a2cc6a0fc665ae91d6ef3,continuous,phv00070075.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070075\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00069051.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069051,[],phs000007,pht000682,phv00069051,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000682\phv00069051\FFD39\,pht000682.v6,\phs000007\pht000682\phv00069051\FFD39\,phv00069051,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,fc9c8cc1ff00628974402f8700c164600642ab0738a42d1f2bbed4b54f4fa739,continuous,phv00069051.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069051\FFD39\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00478498.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478498,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v33.p14,phv00068482.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068482,[],phs000007,pht000681,phv00068482,False,True,False,FFD39,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,0.0,\phs000007\pht000681\phv00068482\FFD39\,pht000681.v6,\phs000007\pht000681\phv00068482\FFD39\,phv00068482,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - GRAPEFRUIT,phs000007.v31,840b7ba2194d882d0cd81f970587975dde1f17c45eb16fcbfaa6cd9aaf73c63a,continuous,phv00068482.v5,phs000007,False,FFD39,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068482\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,DERIVED FIELD:GRAPEFRUIT,phs000007.v33.p14,phv00157185.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157185,[],phs000007,pht002150,phv00157185,False,True,False,FFD39,DERIVED FIELD:GRAPEFRUIT,0.0,\phs000007\pht002150\phv00157185\FFD39\,pht002150.v4,\phs000007\pht002150\phv00157185\FFD39\,phv00157185,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:GRAPEFRUIT,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:GRAPEFRUIT,phs000007.v31,08c807cf87a076477be4e73bc15b3f2dc8a789a716f7c186a2386a4ff2ec8dce,continuous,phv00157185.v4,phs000007,False,FFD39,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157185\FFD39\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd39,GRAPEFRUIT:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd39,Framingham Cohort,FFD39,GRAPEFRUIT,phs000007.v33.p14,phv00523881.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523881,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00477940.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477940,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00477377.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477377,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00524540.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524540,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00479153.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479153,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,STRAWBERRIES: (servings/week),phs000007.v33.p14,phv00172966.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172966,[],phs000007,pht002900,phv00172966,False,True,False,FFD42,Derived field: Strawberries,0.0,\phs000007\pht002900\phv00172966\FFD42\,pht002900.v3,\phs000007\pht002900\phv00172966\FFD42\,phv00172966,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Strawberries,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Strawberries,phs000007.v31,9e2ebfc1ea0a49925eaa7488f45aac832be5787bf4dc452b6b2baa54a01594e7,continuous,phv00172966.v3,phs000007,False,FFD42,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172966\FFD42\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00478501.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478501,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00162566.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162566,[],phs000007,pht002350,phv00162566,False,True,False,FFD42,DERIVED FIELD:STRAWBERRIES,0.0,\phs000007\pht002350\phv00162566\FFD42\,pht002350.v5,\phs000007\pht002350\phv00162566\FFD42\,phv00162566,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:STRAWBERRIES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:STRAWBERRIES,phs000007.v31,06d05af9e5af51f126488183a9e71a212ea1c5fa425afeebf06e6741e2428840,continuous,phv00162566.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162566\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,STRAWBERRIES,phs000007.v33.p14,phv00523884.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523884,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00157629.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157629,[],phs000007,pht002151,phv00157629,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht002151\phv00157629\FFD42\,pht002151.v1,\phs000007\pht002151\phv00157629\FFD42\,phv00157629,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,cb6c821f13dd71ed480777925d04a3eb7d21352495c7e653b596f7cd4de54c71,continuous,phv00157629.v1,phs000007,False,FFD42,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157629\FFD42\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD:STRAWBERRIES,phs000007.v33.p14,phv00157188.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157188,[],phs000007,pht002150,phv00157188,False,True,False,FFD42,DERIVED FIELD:STRAWBERRIES,0.0,\phs000007\pht002150\phv00157188\FFD42\,pht002150.v4,\phs000007\pht002150\phv00157188\FFD42\,phv00157188,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:STRAWBERRIES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:STRAWBERRIES,phs000007.v31,bb85e714eaa5a97d832ecfca4e27324a5729d6c6228106db53fb9ebe068cbe67,continuous,phv00157188.v4,phs000007,False,FFD42,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157188\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00070078.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070078,[],phs000007,pht000680,phv00070078,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000680\phv00070078\FFD42\,pht000680.v6,\phs000007\pht000680\phv00070078\FFD42\,phv00070078,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,2636dfc9e391db6755b0e6f7a742a65151c0dcca24402a1cc222fb36ce5207b4,continuous,phv00070078.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070078\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00069054.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069054,[],phs000007,pht000682,phv00069054,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000682\phv00069054\FFD42\,pht000682.v6,\phs000007\pht000682\phv00069054\FFD42\,phv00069054,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,70965e0ed39ff65323bd3ef32f8554e85aa5d9206505133605015dd83361df23,continuous,phv00069054.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069054\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00068485.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068485,[],phs000007,pht000681,phv00068485,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht000681\phv00068485\FFD42\,pht000681.v6,\phs000007\pht000681\phv00068485\FFD42\,phv00068485,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,ca0dc0fe34d29c3400f5873a333a77842a2caa6c454bd4f3debaefeb0e4f6db6,continuous,phv00068485.v5,phs000007,False,FFD42,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068485\FFD42\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd42,STRAWBERRIES:(servings/week),1.264410562,vr_ffreq_ex08_1_0615d_v1,ffd42,Framingham Cohort,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v33.p14,phv00158432.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158432,[],phs000007,pht002153,phv00158432,False,True,False,FFD42,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,0.0,\phs000007\pht002153\phv00158432\FFD42\,pht002153.v1,\phs000007\pht002153\phv00158432\FFD42\,phv00158432,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRAWBERRIES,phs000007.v31,b7faff465a85145aaa6e97cb7131e6c6cac05d4a64d706021aa6970b8f0e5556,continuous,phv00158432.v1,phs000007,False,FFD42,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158432\FFD42\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00524541.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524541,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,BLUEBERRIES,phs000007.v33.p14,phv00523885.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523885,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00479154.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479154,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00478502.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478502,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00477941.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477941,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,BLUEBERRIES: (servings/week),phs000007.v33.p14,phv00172967.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172967,[],phs000007,pht002900,phv00172967,False,True,False,FFD43,Derived field: Blueberries,0.0,\phs000007\pht002900\phv00172967\FFD43\,pht002900.v3,\phs000007\pht002900\phv00172967\FFD43\,phv00172967,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Blueberries,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Blueberries,phs000007.v31,267b0a2f42fe0f8dab728a0505ec3e043b3c96d4fd26e9ff35fdfcb09da86f9a,continuous,phv00172967.v3,phs000007,False,FFD43,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172967\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00162567.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162567,[],phs000007,pht002350,phv00162567,False,True,False,FFD43,DERIVED FIELD:BLUEBERRIES,0.0,\phs000007\pht002350\phv00162567\FFD43\,pht002350.v5,\phs000007\pht002350\phv00162567\FFD43\,phv00162567,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BLUEBERRIES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:BLUEBERRIES,phs000007.v31,f63608356643487d835a09edd883a638d716ce1ee2671d36b35f729a762bc326,continuous,phv00162567.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162567\FFD43\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00477378.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477378,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00157630.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157630,[],phs000007,pht002151,phv00157630,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht002151\phv00157630\FFD43\,pht002151.v1,\phs000007\pht002151\phv00157630\FFD43\,phv00157630,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,544da6c0b1b7079c8ba1469a58a13d4dcd4044104986deb047ab9704c7833131,continuous,phv00157630.v1,phs000007,False,FFD43,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157630\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD:BLUEBERRIES,phs000007.v33.p14,phv00157189.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157189,[],phs000007,pht002150,phv00157189,False,True,False,FFD43,DERIVED FIELD:BLUEBERRIES,0.0,\phs000007\pht002150\phv00157189\FFD43\,pht002150.v4,\phs000007\pht002150\phv00157189\FFD43\,phv00157189,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BLUEBERRIES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BLUEBERRIES,phs000007.v31,e7f3e4cc5af4ba7b4c3ba3a516155d495ab31c772b9d8555e7f595824151dbda,continuous,phv00157189.v4,phs000007,False,FFD43,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157189\FFD43\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00070079.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070079,[],phs000007,pht000680,phv00070079,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000680\phv00070079\FFD43\,pht000680.v6,\phs000007\pht000680\phv00070079\FFD43\,phv00070079,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,0fb398f8265e21e9e3804e11fd2fe592a6d9b2710f4f703ac125b893a87c13f0,continuous,phv00070079.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070079\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00069055.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069055,[],phs000007,pht000682,phv00069055,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000682\phv00069055\FFD43\,pht000682.v6,\phs000007\pht000682\phv00069055\FFD43\,phv00069055,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,7184844bdd999f98cd03b10632835165928708f83c5edd3789c979fc41947e7e,continuous,phv00069055.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069055\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00068486.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068486,[],phs000007,pht000681,phv00068486,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht000681\phv00068486\FFD43\,pht000681.v6,\phs000007\pht000681\phv00068486\FFD43\,phv00068486,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,2fabeab54eddeffb1ae94f01e01ca4b7f05d7a82fc58036b9eb699f517aafe30,continuous,phv00068486.v5,phs000007,False,FFD43,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068486\FFD43\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd43,BLUEBERRIES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd43,Framingham Cohort,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v33.p14,phv00158433.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158433,[],phs000007,pht002153,phv00158433,False,True,False,FFD43,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,0.0,\phs000007\pht002153\phv00158433\FFD43\,pht002153.v1,\phs000007\pht002153\phv00158433\FFD43\,phv00158433,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BLUEBERRIES,phs000007.v31,a89fd3b021ddb4b0920f970ea19ff4edaf7be53f41fc16e43006dd7bb19c8fff,continuous,phv00158433.v1,phs000007,False,FFD43,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158433\FFD43\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00477942.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477942,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00477379.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00162568.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162568,[],phs000007,pht002350,phv00162568,False,True,False,FFD44,DERIVED FIELD:PEACHES,0.0,\phs000007\pht002350\phv00162568\FFD44\,pht002350.v5,\phs000007\pht002350\phv00162568\FFD44\,phv00162568,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PEACHES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:PEACHES,phs000007.v31,b48ce5bfb5ab70173ac13318e45821cf8ed0d7d4bacc9ee41f9e0ae92e872f20,continuous,phv00162568.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162568\FFD44\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00158434.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158434,[],phs000007,pht002153,phv00158434,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht002153\phv00158434\FFD44\,pht002153.v1,\phs000007\pht002153\phv00158434\FFD44\,phv00158434,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,12604115fd3dcc7df43db0321bd98319f27b26b5f60e9b4b2dacbdf21f1eab28,continuous,phv00158434.v1,phs000007,False,FFD44,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158434\FFD44\,0.0,7.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00157631.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157631,[],phs000007,pht002151,phv00157631,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht002151\phv00157631\FFD44\,pht002151.v1,\phs000007\pht002151\phv00157631\FFD44\,phv00157631,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,971ce6dae2f68385b2e318e615719456d63567ae9307378966dfd905c98364eb,continuous,phv00157631.v1,phs000007,False,FFD44,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157631\FFD44\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00069056.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069056,[],phs000007,pht000682,phv00069056,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000682\phv00069056\FFD44\,pht000682.v6,\phs000007\pht000682\phv00069056\FFD44\,phv00069056,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,9d3e193c0bb392c7e9b72656700995cb6c24480353607a719d1b6b16248f6031,continuous,phv00069056.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069056\FFD44\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00070080.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070080,[],phs000007,pht000680,phv00070080,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000680\phv00070080\FFD44\,pht000680.v6,\phs000007\pht000680\phv00070080\FFD44\,phv00070080,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,a028759f1f18804f7c128f472ffefc791b9e13c69cc541fc4554ec8d4dea9b6f,continuous,phv00070080.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070080\FFD44\,0.0,31.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v33.p14,phv00068487.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068487,[],phs000007,pht000681,phv00068487,False,True,False,FFD44,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,0.0,\phs000007\pht000681\phv00068487\FFD44\,pht000681.v6,\phs000007\pht000681\phv00068487\FFD44\,phv00068487,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PEACHES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEACHES,phs000007.v31,7440717452cb6022f3ceb460f5d0cba64c05bc4f956fa2cb2cad01119ecfc429,continuous,phv00068487.v5,phs000007,False,FFD44,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068487\FFD44\,0.0,17.5
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00478503.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478503,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,DERIVED FIELD:PEACHES,phs000007.v33.p14,phv00157190.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157190,[],phs000007,pht002150,phv00157190,False,True,False,FFD44,DERIVED FIELD:PEACHES,0.0,\phs000007\pht002150\phv00157190\FFD44\,pht002150.v4,\phs000007\pht002150\phv00157190\FFD44\,phv00157190,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PEACHES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:PEACHES,phs000007.v31,99adf506a301984f6f6e06a989fa3660d55569935391a69b6254a2d4947173e5,continuous,phv00157190.v4,phs000007,False,FFD44,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157190\FFD44\,0.0,42.0
FRUITS,Fruits (servings per week),-,C10056,ARICFraminghamREGARDS,2.65,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd44,PEACHES:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd44,Framingham Cohort,FFD44,PEACHES,phs000007.v33.p14,phv00523886.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523886,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00068488.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068488,[],phs000007,pht000681,phv00068488,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000681\phv00068488\FFD45\,pht000681.v6,\phs000007\pht000681\phv00068488\FFD45\,phv00068488,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,49c22d64388f6d3ec1e0dd15aa375d8dd32a5e491017a2ea744ea74ff922d139,continuous,phv00068488.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068488\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00069057.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069057,[],phs000007,pht000682,phv00069057,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000682\phv00069057\FFD45\,pht000682.v6,\phs000007\pht000682\phv00069057\FFD45\,phv00069057,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,8a75c323aebca500d8e7649b84cdee4720cb5669cdca3598fce9ee7b269f6564,continuous,phv00069057.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069057\FFD45\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00524544.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524544,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00158435.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158435,[],phs000007,pht002153,phv00158435,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht002153\phv00158435\FFD45\,pht002153.v1,\phs000007\pht002153\phv00158435\FFD45\,phv00158435,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,b82cf8684c5650e4425f296dad0b94a3f30d61bf029788f89c97c5c1aa24cda7,continuous,phv00158435.v1,phs000007,False,FFD45,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158435\FFD45\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00162569.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162569,[],phs000007,pht002350,phv00162569,False,True,False,FFD45,DERIVED FIELD:TOMATOES,0.0,\phs000007\pht002350\phv00162569\FFD45\,pht002350.v5,\phs000007\pht002350\phv00162569\FFD45\,phv00162569,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:TOMATOES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:TOMATOES,phs000007.v31,3328a3c3558a2d24b37256a7811ceebb0efefeac51048de2678e3f15bc66e7e9,continuous,phv00162569.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162569\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00172970.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172970,[],phs000007,pht002900,phv00172970,False,True,False,FFD45,Derived field: Tomatoes,0.0,\phs000007\pht002900\phv00172970\FFD45\,pht002900.v3,\phs000007\pht002900\phv00172970\FFD45\,phv00172970,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Tomatoes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Tomatoes,phs000007.v31,1fa3ac8d065ec7c9ff113935ce43c41c958b7e3994fad9bde9bcd565b4b41d75,continuous,phv00172970.v3,phs000007,False,FFD45,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172970\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00477380.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477380,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00477943.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477943,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00478504.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478504,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,TOMATOES: (servings/week),phs000007.v33.p14,phv00479157.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479157,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,TOMATOES,phs000007.v33.p14,phv00523887.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523887,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00070081.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070081,[],phs000007,pht000680,phv00070081,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht000680\phv00070081\FFD45\,pht000680.v6,\phs000007\pht000680\phv00070081\FFD45\,phv00070081,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,f152c4f4e35af3d2cc5ff7aad6fb4dbf71374c9dcdd509d0af54e547a62287b5,continuous,phv00070081.v5,phs000007,False,FFD45,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070081\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v33.p14,phv00157632.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157632,[],phs000007,pht002151,phv00157632,False,True,False,FFD45,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,0.0,\phs000007\pht002151\phv00157632\FFD45\,pht002151.v1,\phs000007\pht002151\phv00157632\FFD45\,phv00157632,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - TOMATOES,phs000007.v31,b0c687d3629ad8960d165a8bf0fea5a15c42c310432e03f9bb4c1a2738115261,continuous,phv00157632.v1,phs000007,False,FFD45,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157632\FFD45\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd45,TOMATOES:(servings/week),0.483451097,vr_ffreq_ex08_1_0615d_v1,ffd45,Framingham Cohort,FFD45,DERIVED FIELD:TOMATOES,phs000007.v33.p14,phv00157191.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157191,[],phs000007,pht002150,phv00157191,False,True,False,FFD45,DERIVED FIELD:TOMATOES,0.0,\phs000007\pht002150\phv00157191\FFD45\,pht002150.v4,\phs000007\pht002150\phv00157191\FFD45\,phv00157191,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:TOMATOES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:TOMATOES,phs000007.v31,b207b482b4d1f5cf3269c6671c39100305f476f67c325cc28bab8b30785c830c,continuous,phv00157191.v4,phs000007,False,FFD45,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157191\FFD45\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00477948.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477948,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00478509.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478509,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00158440.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158440,[],phs000007,pht002153,phv00158440,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht002153\phv00158440\FFD50\,pht002153.v1,\phs000007\pht002153\phv00158440\FFD50\,phv00158440,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,1d04e1b6e328f9eae2f732ee426442916120799a436095043c4d3c95d16928af,continuous,phv00158440.v1,phs000007,False,FFD50,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158440\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,STRING BEANS,phs000007.v33.p14,phv00523892.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523892,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00524548.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524548,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00479161.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479161,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00477385.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477385,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00157196.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157196,[],phs000007,pht002150,phv00157196,False,True,False,FFD50,DERIVED FIELD:STRING BEANS,0.0,\phs000007\pht002150\phv00157196\FFD50\,pht002150.v4,\phs000007\pht002150\phv00157196\FFD50\,phv00157196,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:STRING BEANS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:STRING BEANS,phs000007.v31,a83eee7efcd8a10f33691b0759b782b2efe2419e5de57ee2b63621ba7c56e938,continuous,phv00157196.v4,phs000007,False,FFD50,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157196\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD:STRING BEANS,phs000007.v33.p14,phv00162574.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162574,[],phs000007,pht002350,phv00162574,False,True,False,FFD50,DERIVED FIELD:STRING BEANS,0.0,\phs000007\pht002350\phv00162574\FFD50\,pht002350.v5,\phs000007\pht002350\phv00162574\FFD50\,phv00162574,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:STRING BEANS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:STRING BEANS,phs000007.v31,4849b1351afa10ff1ed74ca0538b324a392b65ad7a83cb52801ce961ac72d295,continuous,phv00162574.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162574\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00157637.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157637,[],phs000007,pht002151,phv00157637,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht002151\phv00157637\FFD50\,pht002151.v1,\phs000007\pht002151\phv00157637\FFD50\,phv00157637,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,cf91096c6470eaadcd30b261c20f16a1f92a9336f994f3226360cac622e3d43d,continuous,phv00157637.v1,phs000007,False,FFD50,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157637\FFD50\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00070086.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070086,[],phs000007,pht000680,phv00070086,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000680\phv00070086\FFD50\,pht000680.v6,\phs000007\pht000680\phv00070086\FFD50\,phv00070086,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,84f7a7ba0f212c7dbcf56af94ff6428d5937ed31acc77428f7603b2e08166543,continuous,phv00070086.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070086\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00069062.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069062,[],phs000007,pht000682,phv00069062,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000682\phv00069062\FFD50\,pht000682.v6,\phs000007\pht000682\phv00069062\FFD50\,phv00069062,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,f0dc0add95b628cbd4a7ac255f00da3e129ac459328be8ac1f5f41c28ec5c13e,continuous,phv00069062.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069062\FFD50\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v33.p14,phv00068493.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068493,[],phs000007,pht000681,phv00068493,False,True,False,FFD50,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,0.0,\phs000007\pht000681\phv00068493\FFD50\,pht000681.v6,\phs000007\pht000681\phv00068493\FFD50\,phv00068493,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - STRING BEANS,phs000007.v31,56e1e12043ae2a69522b6e018874d1942935687f11a670b23e5b6926435167f8,continuous,phv00068493.v5,phs000007,False,FFD50,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068493\FFD50\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd50,STRING BEANS:(servings/week),0.929713648,vr_ffreq_ex08_1_0615d_v1,ffd50,Framingham Cohort,FFD50,STRING BEANS: (servings/week),phs000007.v33.p14,phv00172974.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172974,[],phs000007,pht002900,phv00172974,False,True,False,FFD50,Derived field: String beans,0.0,\phs000007\pht002900\phv00172974\FFD50\,pht002900.v3,\phs000007\pht002900\phv00172974\FFD50\,phv00172974,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: String beans,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: String beans,phs000007.v31,f87ab435242561b1b5ada61f8906e38e75093be7e4a02b4af1c3615bc07e8c22,continuous,phv00172974.v3,phs000007,False,FFD50,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172974\FFD50\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00478510.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478510,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00479165.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479165,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,BROCCOLI,phs000007.v33.p14,phv00523893.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523893,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00477949.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477949,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00524552.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524552,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00477386.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477386,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00158441.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158441,[],phs000007,pht002153,phv00158441,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht002153\phv00158441\FFD51\,pht002153.v1,\phs000007\pht002153\phv00158441\FFD51\,phv00158441,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,4792c53e7c57e1bcb0750728912bd5f1d7d5f1efb2d3a21ec3cac3395d526fd6,continuous,phv00158441.v1,phs000007,False,FFD51,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158441\FFD51\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00162575.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162575,[],phs000007,pht002350,phv00162575,False,True,False,FFD51,DERIVED FIELD:BROCCOLI,0.0,\phs000007\pht002350\phv00162575\FFD51\,pht002350.v5,\phs000007\pht002350\phv00162575\FFD51\,phv00162575,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BROCCOLI,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BROCCOLI,phs000007.v31,870ef8113c078eb92e1b5fb0203ca7745f1dafdc4525e396725fce09efec7a5d,continuous,phv00162575.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162575\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00068494.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068494,[],phs000007,pht000681,phv00068494,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000681\phv00068494\FFD51\,pht000681.v6,\phs000007\pht000681\phv00068494\FFD51\,phv00068494,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,291c9d7100faa621eb275149f8d784f08ef8c88b4febea3445a100e5df63f5bf,continuous,phv00068494.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068494\FFD51\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00157638.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157638,[],phs000007,pht002151,phv00157638,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht002151\phv00157638\FFD51\,pht002151.v1,\phs000007\pht002151\phv00157638\FFD51\,phv00157638,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,de2b51d239c95a984df1265baff74dc2c1c47f91a380ea037a8c8dd81c4bc71f,continuous,phv00157638.v1,phs000007,False,FFD51,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157638\FFD51\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD:BROCCOLI,phs000007.v33.p14,phv00157197.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157197,[],phs000007,pht002150,phv00157197,False,True,False,FFD51,DERIVED FIELD:BROCCOLI,0.0,\phs000007\pht002150\phv00157197\FFD51\,pht002150.v4,\phs000007\pht002150\phv00157197\FFD51\,phv00157197,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BROCCOLI,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:BROCCOLI,phs000007.v31,45ba13a51baf5bda63ab3ac5d42b4b3e162316a259762b71ed14019466ebed80,continuous,phv00157197.v4,phs000007,False,FFD51,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157197\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00070087.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070087,[],phs000007,pht000680,phv00070087,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000680\phv00070087\FFD51\,pht000680.v6,\phs000007\pht000680\phv00070087\FFD51\,phv00070087,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,cf7370be2f3840917db3f6bd2783d5da234639518229b2fb80834dec4d3b2de1,continuous,phv00070087.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070087\FFD51\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v33.p14,phv00069063.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069063,[],phs000007,pht000682,phv00069063,False,True,False,FFD51,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,0.0,\phs000007\pht000682\phv00069063\FFD51\,pht000682.v6,\phs000007\pht000682\phv00069063\FFD51\,phv00069063,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - BROCCOLI,phs000007.v31,a23f44f1fd7384636b5661c9a4cc99dbefd29763a6db141dfd3a274918b5417d,continuous,phv00069063.v5,phs000007,False,FFD51,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069063\FFD51\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd51,BROCCOLI:(servings/week),0.892525102,vr_ffreq_ex08_1_0615d_v1,ffd51,Framingham Cohort,FFD51,BROCCOLI: (servings/week),phs000007.v33.p14,phv00172978.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172978,[],phs000007,pht002900,phv00172978,False,True,False,FFD51,Derived field: Broccoli,0.0,\phs000007\pht002900\phv00172978\FFD51\,pht002900.v3,\phs000007\pht002900\phv00172978\FFD51\,phv00172978,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Broccoli,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Broccoli,phs000007.v31,3ebc64624a678a15e47fbe8f8a868aba9fdc700710de162f5dfd7cf5dc6a592d,continuous,phv00172978.v3,phs000007,False,FFD51,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172978\FFD51\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00524554.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524554,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW,phs000007.v33.p14,phv00523894.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523894,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00479167.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479167,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00478511.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478511,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00477950.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477950,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00477387.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477387,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,CABBAGE/COLE SLAW: (servings/week),phs000007.v33.p14,phv00172980.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172980,[],phs000007,pht002900,phv00172980,False,True,False,FFD52,Derived field: Cabbage or coleslaw,0.0,\phs000007\pht002900\phv00172980\FFD52\,pht002900.v3,\phs000007\pht002900\phv00172980\FFD52\,phv00172980,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cabbage or coleslaw,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Cabbage or coleslaw,phs000007.v31,06cfac9f4da85e7e45719dcb2022ea99bcc086f06b77bc3963293a70f4cf1d71,continuous,phv00172980.v3,phs000007,False,FFD52,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172980\FFD52\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00162576.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162576,[],phs000007,pht002350,phv00162576,False,True,False,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,0.0,\phs000007\pht002350\phv00162576\FFD52\,pht002350.v5,\phs000007\pht002350\phv00162576\FFD52\,phv00162576,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v31,97cec4836fc02aba136a9125ef56d31e73a7fbd4d75eac8eca490f5636deb132,continuous,phv00162576.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162576\FFD52\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00157639.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157639,[],phs000007,pht002151,phv00157639,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht002151\phv00157639\FFD52\,pht002151.v1,\phs000007\pht002151\phv00157639\FFD52\,phv00157639,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,11b9f3d5bbdce60cbfa540f1fa9f98f5678b0a954f28a5d244496731f2377e44,continuous,phv00157639.v1,phs000007,False,FFD52,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157639\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v33.p14,phv00157198.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157198,[],phs000007,pht002150,phv00157198,False,True,False,FFD52,DERIVED FIELD:CABBAGE/COLE SLAW,0.0,\phs000007\pht002150\phv00157198\FFD52\,pht002150.v4,\phs000007\pht002150\phv00157198\FFD52\,phv00157198,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:CABBAGE/COLE SLAW,phs000007.v31,dd6610ddbe7198ba9272242f4d78dfd3111491e32c13f7a10002b8afb230a6b3,continuous,phv00157198.v4,phs000007,False,FFD52,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157198\FFD52\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00070088.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070088,[],phs000007,pht000680,phv00070088,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000680\phv00070088\FFD52\,pht000680.v6,\phs000007\pht000680\phv00070088\FFD52\,phv00070088,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,d508df34728162c1b94c95c31b34ec3b8c7438d87cfed748e7e62b023a845f8d,continuous,phv00070088.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070088\FFD52\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00069064.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069064,[],phs000007,pht000682,phv00069064,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000682\phv00069064\FFD52\,pht000682.v6,\phs000007\pht000682\phv00069064\FFD52\,phv00069064,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,cf8857fc06af4c0123408aa9ab2fd0b292ec35c3538984f21c77010428813eaf,continuous,phv00069064.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069064\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00068495.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068495,[],phs000007,pht000681,phv00068495,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht000681\phv00068495\FFD52\,pht000681.v6,\phs000007\pht000681\phv00068495\FFD52\,phv00068495,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,ad7e052fece32c3e38c2daf3fbb8e5349e705dd965198c5372a10dc754670126,continuous,phv00068495.v5,phs000007,False,FFD52,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068495\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd52,CABBAGE/COLE SLAW:(servings/week),0.409074005,vr_ffreq_ex08_1_0615d_v1,ffd52,Framingham Cohort,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v33.p14,phv00158442.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158442,[],phs000007,pht002153,phv00158442,False,True,False,FFD52,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,0.0,\phs000007\pht002153\phv00158442\FFD52\,pht002153.v1,\phs000007\pht002153\phv00158442\FFD52\,phv00158442,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CABBAGE/COLE SLAW,phs000007.v31,446db1372beffc7901dc16c591af20abaa07060684690a3a01ddabed8a2f0670,continuous,phv00158442.v1,phs000007,False,FFD52,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158442\FFD52\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00524553.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524553,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,CAULIFLOWER,phs000007.v33.p14,phv00523895.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523895,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00479166.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479166,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00478512.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478512,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00477951.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477951,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00477388.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477388,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,CAULIFLOWER: (servings/week),phs000007.v33.p14,phv00172979.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172979,[],phs000007,pht002900,phv00172979,False,True,False,FFD53,Derived field: Cauliflower,0.0,\phs000007\pht002900\phv00172979\FFD53\,pht002900.v3,\phs000007\pht002900\phv00172979\FFD53\,phv00172979,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Cauliflower,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Cauliflower,phs000007.v31,cb0ef961dfd3e000a3f6e81004f07d4c0331830408df128128212364e5bed8cb,continuous,phv00172979.v3,phs000007,False,FFD53,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172979\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00069065.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069065,[],phs000007,pht000682,phv00069065,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000682\phv00069065\FFD53\,pht000682.v6,\phs000007\pht000682\phv00069065\FFD53\,phv00069065,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,a5cf1bba050adbeea31a34555817e059f3adaa9a2a0c3c4764096e8bfe2faa37,continuous,phv00069065.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069065\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00158443.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158443,[],phs000007,pht002153,phv00158443,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht002153\phv00158443\FFD53\,pht002153.v1,\phs000007\pht002153\phv00158443\FFD53\,phv00158443,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,cfca728b76f5851c62f98d688a0194859e5621fa9c7dafbd09218d0ac8d47717,continuous,phv00158443.v1,phs000007,False,FFD53,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158443\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00157640.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157640,[],phs000007,pht002151,phv00157640,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht002151\phv00157640\FFD53\,pht002151.v1,\phs000007\pht002151\phv00157640\FFD53\,phv00157640,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,445428a75b31d1b9aedbcf3866891ce1f5bec89e5cbb6edc51458a67be5e7b9a,continuous,phv00157640.v1,phs000007,False,FFD53,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157640\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00157199.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157199,[],phs000007,pht002150,phv00157199,False,True,False,FFD53,DERIVED FIELD:CAULIFLOWER,0.0,\phs000007\pht002150\phv00157199\FFD53\,pht002150.v4,\phs000007\pht002150\phv00157199\FFD53\,phv00157199,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CAULIFLOWER,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",7.0,DERIVED FIELD:CAULIFLOWER,phs000007.v31,40efa697d6705e09d311f9b044bf8d235f99adfab79d29c949b9287713207cd3,continuous,phv00157199.v4,phs000007,False,FFD53,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157199\FFD53\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00070089.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070089,[],phs000007,pht000680,phv00070089,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000680\phv00070089\FFD53\,pht000680.v6,\phs000007\pht000680\phv00070089\FFD53\,phv00070089,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,3cd6934364c3d820431bf827ee8550b4e721a0759f415b0733d30c043315ea43,continuous,phv00070089.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070089\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v33.p14,phv00068496.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068496,[],phs000007,pht000681,phv00068496,False,True,False,FFD53,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,0.0,\phs000007\pht000681\phv00068496\FFD53\,pht000681.v6,\phs000007\pht000681\phv00068496\FFD53\,phv00068496,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CAULIFLOWER,phs000007.v31,c797023b1983998de1df8431ae263feead8b75d3382e8d22f95aabbf6c32cf70,continuous,phv00068496.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068496\FFD53\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd53,CAULIFLOWER:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd53,Framingham Cohort,FFD53,DERIVED FIELD:CAULIFLOWER,phs000007.v33.p14,phv00162577.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162577,[],phs000007,pht002350,phv00162577,False,True,False,FFD53,DERIVED FIELD:CAULIFLOWER,0.0,\phs000007\pht002350\phv00162577\FFD53\,pht002350.v5,\phs000007\pht002350\phv00162577\FFD53\,phv00162577,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CAULIFLOWER,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:CAULIFLOWER,phs000007.v31,abda0e0d6258fe9d7d0e82061cc598bfef1c091779d86328e2e52d0326ccda6f,continuous,phv00162577.v5,phs000007,False,FFD53,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162577\FFD53\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00524555.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524555,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00477389.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477389,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS,phs000007.v33.p14,phv00523896.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523896,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00479168.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479168,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00478513.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478513,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00477952.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477952,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,BRUSSELS SPROUTS: (servings/week),phs000007.v33.p14,phv00172981.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172981,[],phs000007,pht002900,phv00172981,False,True,False,FFD54,Derived field: Brussels sprouts,0.0,\phs000007\pht002900\phv00172981\FFD54\,pht002900.v3,\phs000007\pht002900\phv00172981\FFD54\,phv00172981,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Brussels sprouts,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",5.5,Derived field: Brussels sprouts,phs000007.v31,7218ce474dbbd00786c59cb1d4ac31f57b11d91a968ac058676273fbfa31dc11,continuous,phv00172981.v3,phs000007,False,FFD54,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172981\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00070090.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070090,[],phs000007,pht000680,phv00070090,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000680\phv00070090\FFD54\,pht000680.v6,\phs000007\pht000680\phv00070090\FFD54\,phv00070090,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,cd421371c06af435e9fde2ff5d104101f0f36f605648d5c702064bbe540ff1e9,continuous,phv00070090.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070090\FFD54\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00158444.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158444,[],phs000007,pht002153,phv00158444,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht002153\phv00158444\FFD54\,pht002153.v1,\phs000007\pht002153\phv00158444\FFD54\,phv00158444,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,f085da7393e28617a244219a1d3854787b0eaa0ea09f2e89ac58bb3fe023b917,continuous,phv00158444.v1,phs000007,False,FFD54,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158444\FFD54\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00157641.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157641,[],phs000007,pht002151,phv00157641,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht002151\phv00157641\FFD54\,pht002151.v1,\phs000007\pht002151\phv00157641\FFD54\,phv00157641,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,bb4901d7390dc06d02065d36c986d052603a05bc45984b7c326fa16d147f8e51,continuous,phv00157641.v1,phs000007,False,FFD54,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157641\FFD54\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00157200.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157200,[],phs000007,pht002150,phv00157200,False,True,False,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,0.0,\phs000007\pht002150\phv00157200\FFD54\,pht002150.v4,\phs000007\pht002150\phv00157200\FFD54\,phv00157200,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v31,5567910ac23179531f6fbdbec3cc49b78b09620a9ffa64a74e994441408a100a,continuous,phv00157200.v4,phs000007,False,FFD54,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157200\FFD54\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00069066.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069066,[],phs000007,pht000682,phv00069066,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000682\phv00069066\FFD54\,pht000682.v6,\phs000007\pht000682\phv00069066\FFD54\,phv00069066,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",5.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,f36a53141ea8625bc6e202fbac82932029bed2458a3c82b488bcf23960ec5c71,continuous,phv00069066.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069066\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v33.p14,phv00068497.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068497,[],phs000007,pht000681,phv00068497,False,True,False,FFD54,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,0.0,\phs000007\pht000681\phv00068497\FFD54\,pht000681.v6,\phs000007\pht000681\phv00068497\FFD54\,phv00068497,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BRUSSELS SPROUTS,phs000007.v31,12239928bb2acd43cb8581a7495ce7b4603ad143000542118e4bd7887cde7d7f,continuous,phv00068497.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068497\FFD54\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd54,BRUSSELS SPROUTS:(servings/week),0.669393827,vr_ffreq_ex08_1_0615d_v1,ffd54,Framingham Cohort,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v33.p14,phv00162578.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162578,[],phs000007,pht002350,phv00162578,False,True,False,FFD54,DERIVED FIELD:BRUSSELS SPROUTS,0.0,\phs000007\pht002350\phv00162578\FFD54\,pht002350.v5,\phs000007\pht002350\phv00162578\FFD54\,phv00162578,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BRUSSELS SPROUTS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",5.5,DERIVED FIELD:BRUSSELS SPROUTS,phs000007.v31,5e32daf7455beffc25082fa76e8c170a5c6e418b1d8b484fd123bc27297de22f,continuous,phv00162578.v5,phs000007,False,FFD54,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162578\FFD54\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00477953.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477953,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00478514.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478514,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00479169.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW",phs000007.v33.p14,phv00523897.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523897,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00524556.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524556,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00162579.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162579,[],phs000007,pht002350,phv00162579,False,True,False,FFD55,"DERIVED FIELD:CARROTS, RAW",0.0,\phs000007\pht002350\phv00162579\FFD55\,pht002350.v5,\phs000007\pht002350\phv00162579\FFD55\,phv00162579,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:CARROTS, RAW",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,"DERIVED FIELD:CARROTS, RAW",phs000007.v31,11f78d08e08eac1a1f74904138ff0a0b8bb15ebd406d090b5de20293a1d4e20f,continuous,phv00162579.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162579\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"CARROTS, RAW: (servings/week)",phs000007.v33.p14,phv00172982.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172982,[],phs000007,pht002900,phv00172982,False,True,False,FFD55,"Derived field: Carrots, raw",0.0,\phs000007\pht002900\phv00172982\FFD55\,pht002900.v3,\phs000007\pht002900\phv00172982\FFD55\,phv00172982,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Carrots, raw",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,"Derived field: Carrots, raw",phs000007.v31,fda37dbf84faee4d6df4e4d5cf1485cb0dc803c7df0df4a04fbbfa347e3ff735,continuous,phv00172982.v3,phs000007,False,FFD55,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172982\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00158445.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158445,[],phs000007,pht002153,phv00158445,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht002153\phv00158445\FFD55\,pht002153.v1,\phs000007\pht002153\phv00158445\FFD55\,phv00158445,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,2fd7dce9ba4bbd0fea758070c9a88590a19e90cf667c334d947ee6d9fd514e9c,continuous,phv00158445.v1,phs000007,False,FFD55,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158445\FFD55\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00477390.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477390,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00068498.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068498,[],phs000007,pht000681,phv00068498,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000681\phv00068498\FFD55\,pht000681.v6,\phs000007\pht000681\phv00068498\FFD55\,phv00068498,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,a7bc086dbbe03089b6f12e813cfff540588690338437ec8ea7afcbce515e28a6,continuous,phv00068498.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068498\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00069067.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069067,[],phs000007,pht000682,phv00069067,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000682\phv00069067\FFD55\,pht000682.v6,\phs000007\pht000682\phv00069067\FFD55\,phv00069067,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,6b20a923a8b6152a28b8f15fcd1c73a2471f8444811798300e147d763082d39e,continuous,phv00069067.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069067\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00157642.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157642,[],phs000007,pht002151,phv00157642,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht002151\phv00157642\FFD55\,pht002151.v1,\phs000007\pht002151\phv00157642\FFD55\,phv00157642,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,f58fc82f3f1554143a19923d0e8001b858e8e786a4ec3a9934c5967453e0dd92,continuous,phv00157642.v1,phs000007,False,FFD55,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157642\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v33.p14,phv00070091.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070091,[],phs000007,pht000680,phv00070091,False,True,False,FFD55,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",0.0,\phs000007\pht000680\phv00070091\FFD55\,pht000680.v6,\phs000007\pht000680\phv00070091\FFD55\,phv00070091,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, RAW",phs000007.v31,d8769b70a2f36938784500d0379066822fd9bb7d59d84aa6211b7361ec50c581,continuous,phv00070091.v5,phs000007,False,FFD55,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070091\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd55,"CARROTS, RAW:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd55,Framingham Cohort,FFD55,"DERIVED FIELD:CARROTS, RAW",phs000007.v33.p14,phv00157201.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157201,[],phs000007,pht002150,phv00157201,False,True,False,FFD55,"DERIVED FIELD:CARROTS, RAW",0.0,\phs000007\pht002150\phv00157201\FFD55\,pht002150.v4,\phs000007\pht002150\phv00157201\FFD55\,phv00157201,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:CARROTS, RAW",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,"DERIVED FIELD:CARROTS, RAW",phs000007.v31,b98c75316e2e5b714703b168d59f6b5e482fc794cb5cdce124636573026224a9,continuous,phv00157201.v4,phs000007,False,FFD55,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157201\FFD55\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00068499.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068499,[],phs000007,pht000681,phv00068499,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000681\phv00068499\FFD56\,pht000681.v6,\phs000007\pht000681\phv00068499\FFD56\,phv00068499,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,736876683a882cbc01b7cc1a4c8dfb7b548dd996bd814d4628da692172d0ebda,continuous,phv00068499.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068499\FFD56\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00069068.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069068,[],phs000007,pht000682,phv00069068,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000682\phv00069068\FFD56\,pht000682.v6,\phs000007\pht000682\phv00069068\FFD56\,phv00069068,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,bb2669b624bfc00386993e6ec457cfd3d6c9b7955f5c40be2fcac12906dd326e,continuous,phv00069068.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069068\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00070092.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070092,[],phs000007,pht000680,phv00070092,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht000680\phv00070092\FFD56\,pht000680.v6,\phs000007\pht000680\phv00070092\FFD56\,phv00070092,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,d7b1f70b93ca35d4f7e60d1e76a873cbfe0e6edd48cd87d95ca252f7acbac50d,continuous,phv00070092.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070092\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00157202.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157202,[],phs000007,pht002150,phv00157202,False,True,False,FFD56,"DERIVED FIELD:CARROTS, COOKED",0.0,\phs000007\pht002150\phv00157202\FFD56\,pht002150.v4,\phs000007\pht002150\phv00157202\FFD56\,phv00157202,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:CARROTS, COOKED",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:CARROTS, COOKED",phs000007.v31,d6faf21f81af742354b33ba09bd21dc175a897130bebba29adf355285b36e265,continuous,phv00157202.v4,phs000007,False,FFD56,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157202\FFD56\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00157643.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157643,[],phs000007,pht002151,phv00157643,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht002151\phv00157643\FFD56\,pht002151.v1,\phs000007\pht002151\phv00157643\FFD56\,phv00157643,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,59addadb966beaf202762ddc65b9b721e49cf3aca866e803e06ea1cae70b2615,continuous,phv00157643.v1,phs000007,False,FFD56,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157643\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v33.p14,phv00158446.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158446,[],phs000007,pht002153,phv00158446,False,True,False,FFD56,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",0.0,\phs000007\pht002153\phv00158446\FFD56\,pht002153.v1,\phs000007\pht002153\phv00158446\FFD56\,phv00158446,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,"DERIVED FIELD: SERVINGS PER WEEK - CARROTS, COOKED",phs000007.v31,4890f1cea77c0f0299d867e5bce02f4504bf74f4b8853e8b33bd6a060ef5388a,continuous,phv00158446.v1,phs000007,False,FFD56,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158446\FFD56\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00162580.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162580,[],phs000007,pht002350,phv00162580,False,True,False,FFD56,"DERIVED FIELD:CARROTS, COOKED",0.0,\phs000007\pht002350\phv00162580\FFD56\,pht002350.v5,\phs000007\pht002350\phv00162580\FFD56\,phv00162580,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:CARROTS, COOKED",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,"DERIVED FIELD:CARROTS, COOKED",phs000007.v31,278f24b8e58a5c8c37f775f502348e518c1ee9332b816adbfcf0f47fc57be50b,continuous,phv00162580.v5,phs000007,False,FFD56,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162580\FFD56\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00172983.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172983,[],phs000007,pht002900,phv00172983,False,True,False,FFD56,"Derived field: Carrots, cooked",0.0,\phs000007\pht002900\phv00172983\FFD56\,pht002900.v3,\phs000007\pht002900\phv00172983\FFD56\,phv00172983,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Carrots, cooked",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,"Derived field: Carrots, cooked",phs000007.v31,45db51aa8d48b74a1af7dc03f94b169780efb08217ebee107c7b4fb2d1b0f0b8,continuous,phv00172983.v3,phs000007,False,FFD56,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172983\FFD56\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00477391.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477391,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00477954.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477954,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00479170.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479170,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED",phs000007.v33.p14,phv00523898.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523898,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"CARROTS, COOKED: (servings/week)",phs000007.v33.p14,phv00524557.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524557,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd56,"CARROTS, COOKED:(servings/week)",1.375976199,vr_ffreq_ex08_1_0615d_v1,ffd56,Framingham Cohort,FFD56,"DERIVED FIELD:CARROTS, COOKED",phs000007.v33.p14,phv00478515.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478515,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00157644.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157644,[],phs000007,pht002151,phv00157644,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht002151\phv00157644\FFD57\,pht002151.v1,\phs000007\pht002151\phv00157644\FFD57\,phv00157644,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,bd8b941a699e05044fa86faa10b6e1d2adca797c73eac6dc70415db246bc8010,continuous,phv00157644.v1,phs000007,False,FFD57,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157644\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00158447.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158447,[],phs000007,pht002153,phv00158447,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht002153\phv00158447\FFD57\,pht002153.v1,\phs000007\pht002153\phv00158447\FFD57\,phv00158447,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,e6829bead50f94deb3aa9952a804ef8cc5ee2f706b3d490f50ef41255851d902,continuous,phv00158447.v1,phs000007,False,FFD57,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158447\FFD57\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00069069.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069069,[],phs000007,pht000682,phv00069069,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000682\phv00069069\FFD57\,pht000682.v6,\phs000007\pht000682\phv00069069\FFD57\,phv00069069,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,e8ea423ee3f3404c7a7813ec74f2d67f5b28dd3bc3d3063336f0260204f4952c,continuous,phv00069069.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069069\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00068500.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068500,[],phs000007,pht000681,phv00068500,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000681\phv00068500\FFD57\,pht000681.v6,\phs000007\pht000681\phv00068500\FFD57\,phv00068500,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,a06a658956629f68a23ad3547f0227dbebca79184b8379291911a347546267b4,continuous,phv00068500.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068500\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00524558.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524558,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,CORN,phs000007.v33.p14,phv00523899.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523899,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00478516.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478516,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00477955.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477955,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00479171.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479171,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,CORN: (servings/week),phs000007.v33.p14,phv00172984.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172984,[],phs000007,pht002900,phv00172984,False,True,False,FFD57,Derived field: Corn,0.0,\phs000007\pht002900\phv00172984\FFD57\,pht002900.v3,\phs000007\pht002900\phv00172984\FFD57\,phv00172984,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Corn,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",7.0,Derived field: Corn,phs000007.v31,809a84d7f3e0b93c5fb4d18b2b3c501f32a6fefb2a1c49a9e4d7aea12e893bd3,continuous,phv00172984.v3,phs000007,False,FFD57,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172984\FFD57\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00162581.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162581,[],phs000007,pht002350,phv00162581,False,True,False,FFD57,DERIVED FIELD:CORN,0.0,\phs000007\pht002350\phv00162581\FFD57\,pht002350.v5,\phs000007\pht002350\phv00162581\FFD57\,phv00162581,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CORN,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:CORN,phs000007.v31,0614160687a3313ef05b26c352e19470249ebfa6aed031a857f14fa3c6cea5d2,continuous,phv00162581.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162581\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00157203.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157203,[],phs000007,pht002150,phv00157203,False,True,False,FFD57,DERIVED FIELD:CORN,0.0,\phs000007\pht002150\phv00157203\FFD57\,pht002150.v4,\phs000007\pht002150\phv00157203\FFD57\,phv00157203,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CORN,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:CORN,phs000007.v31,e2062b6eb22a4c974e9896289b00839836a25f303d8b9ea45e34fb768d6d3085,continuous,phv00157203.v4,phs000007,False,FFD57,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157203\FFD57\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v33.p14,phv00070093.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070093,[],phs000007,pht000680,phv00070093,False,True,False,FFD57,DERIVED FIELD: SERVINGS PER WEEK - CORN,0.0,\phs000007\pht000680\phv00070093\FFD57\,pht000680.v6,\phs000007\pht000680\phv00070093\FFD57\,phv00070093,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CORN,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - CORN,phs000007.v31,f8df3d474f3bb45f62bf1e0b9e87ffa5f2e69c234dd80aa982985d7ee2f3bc2b,continuous,phv00070093.v5,phs000007,False,FFD57,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070093\FFD57\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd57,CORN:(servings/week),1.413164745,vr_ffreq_ex08_1_0615d_v1,ffd57,Framingham Cohort,FFD57,DERIVED FIELD:CORN,phs000007.v33.p14,phv00477392.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477392,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00477956.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477956,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00524551.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524551,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS,phs000007.v33.p14,phv00523900.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523900,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00479164.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479164,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00478517.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478517,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,PEAS/LIMA BEANS: (servings/week),phs000007.v33.p14,phv00172977.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172977,[],phs000007,pht002900,phv00172977,False,True,False,FFD58,Derived field: Peas or lima beans,0.0,\phs000007\pht002900\phv00172977\FFD58\,pht002900.v3,\phs000007\pht002900\phv00172977\FFD58\,phv00172977,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Peas or lima beans,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Peas or lima beans,phs000007.v31,d39c7ce3d5915495e9f8d8afb313a4a8c6d15e5e3f70ac5010e5c6c52aa814fa,continuous,phv00172977.v3,phs000007,False,FFD58,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172977\FFD58\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00477393.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477393,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00158448.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158448,[],phs000007,pht002153,phv00158448,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht002153\phv00158448\FFD58\,pht002153.v1,\phs000007\pht002153\phv00158448\FFD58\,phv00158448,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,1bbdd0ac6c2b8c3955ba5372d3a906b3844169bb87b2dbeaa048ae80bc8ef505,continuous,phv00158448.v1,phs000007,False,FFD58,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158448\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00157645.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157645,[],phs000007,pht002151,phv00157645,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht002151\phv00157645\FFD58\,pht002151.v1,\phs000007\pht002151\phv00157645\FFD58\,phv00157645,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,308944530ef756c3d42e359134015273d6556714d04e42fa10556f8d3c279b04,continuous,phv00157645.v1,phs000007,False,FFD58,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157645\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00157204.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157204,[],phs000007,pht002150,phv00157204,False,True,False,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,0.0,\phs000007\pht002150\phv00157204\FFD58\,pht002150.v4,\phs000007\pht002150\phv00157204\FFD58\,phv00157204,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v31,c72dac18196d93101d5e44035fc54161384f6a458f8aca925876b1469bfeca55,continuous,phv00157204.v4,phs000007,False,FFD58,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157204\FFD58\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00070094.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070094,[],phs000007,pht000680,phv00070094,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000680\phv00070094\FFD58\,pht000680.v6,\phs000007\pht000680\phv00070094\FFD58\,phv00070094,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,a2a695c13e200f8b29f32b356a2bf9e2d90452410d8e5d661a6286c75146457a,continuous,phv00070094.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070094\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00069070.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069070,[],phs000007,pht000682,phv00069070,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000682\phv00069070\FFD58\,pht000682.v6,\phs000007\pht000682\phv00069070\FFD58\,phv00069070,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,d5fb5c929d521dffb94d5d5f6b8ee365663b53da11656f645239918f49782db1,continuous,phv00069070.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069070\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v33.p14,phv00068501.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068501,[],phs000007,pht000681,phv00068501,False,True,False,FFD58,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,0.0,\phs000007\pht000681\phv00068501\FFD58\,pht000681.v6,\phs000007\pht000681\phv00068501\FFD58\,phv00068501,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - PEAS/LIMA BEANS,phs000007.v31,68d04709df7414aa28159d5533e7bdccdd8e14fc43e5100ad0680a3f22736c8c,continuous,phv00068501.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068501\FFD58\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd58,PEAS/LIMA BEANS:(servings/week),0.520639643,vr_ffreq_ex08_1_0615d_v1,ffd58,Framingham Cohort,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v33.p14,phv00162582.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162582,[],phs000007,pht002350,phv00162582,False,True,False,FFD58,DERIVED FIELD:PEAS/LIMA BEANS,0.0,\phs000007\pht002350\phv00162582\FFD58\,pht002350.v5,\phs000007\pht002350\phv00162582\FFD58\,phv00162582,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:PEAS/LIMA BEANS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:PEAS/LIMA BEANS,phs000007.v31,983ee5bff3ca33ad16210490dd81d158c17372812a63d3c9987ba6d3c41b1d46,continuous,phv00162582.v5,phs000007,False,FFD58,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162582\FFD58\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES,phs000007.v33.p14,phv00523901.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523901,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00479172.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00478518.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478518,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00477394.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477394,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00172985.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172985,[],phs000007,pht002900,phv00172985,False,True,False,FFD59,"Derived field: Mixed or stir fry veggies, veg soup",0.0,\phs000007\pht002900\phv00172985\FFD59\,pht002900.v3,\phs000007\pht002900\phv00172985\FFD59\,phv00172985,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Mixed or stir fry veggies, veg soup",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,"Derived field: Mixed or stir fry veggies, veg soup",phs000007.v31,98fbfe8c5afa1867495daa03897e9886dcb9d8036d834087948195cfed4235c6,continuous,phv00172985.v3,phs000007,False,FFD59,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172985\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00157205.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157205,[],phs000007,pht002150,phv00157205,False,True,False,FFD59,DERIVED FIELD:MIXED VEGETABLES,0.0,\phs000007\pht002150\phv00157205\FFD59\,pht002150.v4,\phs000007\pht002150\phv00157205\FFD59\,phv00157205,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:MIXED VEGETABLES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",31.5,DERIVED FIELD:MIXED VEGETABLES,phs000007.v31,7de5b25a574029827f171311dccbc97c2d744f48176aa5668c548ac972489d6f,continuous,phv00157205.v4,phs000007,False,FFD59,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157205\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00158449.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158449,[],phs000007,pht002153,phv00158449,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht002153\phv00158449\FFD59\,pht002153.v1,\phs000007\pht002153\phv00158449\FFD59\,phv00158449,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,fb0c84d812ce1109b41e7606c8feed73154ef69f2fc0fdd1b082e999482b20f3,continuous,phv00158449.v1,phs000007,False,FFD59,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158449\FFD59\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00157646.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157646,[],phs000007,pht002151,phv00157646,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht002151\phv00157646\FFD59\,pht002151.v1,\phs000007\pht002151\phv00157646\FFD59\,phv00157646,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,bc58868a54bf6bd9918a4ab0707d59a35780f471fc673a52c87948f4b18abf96,continuous,phv00157646.v1,phs000007,False,FFD59,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157646\FFD59\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00070095.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070095,[],phs000007,pht000680,phv00070095,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000680\phv00070095\FFD59\,pht000680.v6,\phs000007\pht000680\phv00070095\FFD59\,phv00070095,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,5428a77a064104408d1b3ab5074e61a9987963394fa43e895cb95c2aa408050f,continuous,phv00070095.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070095\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00069071.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069071,[],phs000007,pht000682,phv00069071,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000682\phv00069071\FFD59\,pht000682.v6,\phs000007\pht000682\phv00069071\FFD59\,phv00069071,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,d3fbe03df0d6b2e47587f7019507d37ea882430591fa38464ecdd39637feefbd,continuous,phv00069071.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069071\FFD59\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v33.p14,phv00068502.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068502,[],phs000007,pht000681,phv00068502,False,True,False,FFD59,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,0.0,\phs000007\pht000681\phv00068502\FFD59\,pht000681.v6,\phs000007\pht000681\phv00068502\FFD59\,phv00068502,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - MIXED VEGETABLES,phs000007.v31,fc3a55bc6ac54cc4933c2b168450c4b13cccf3c11fdfb218a882c119acf51b02,continuous,phv00068502.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068502\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00162583.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162583,[],phs000007,pht002350,phv00162583,False,True,False,FFD59,DERIVED FIELD:MIXED VEGETABLES,0.0,\phs000007\pht002350\phv00162583\FFD59\,pht002350.v5,\phs000007\pht002350\phv00162583\FFD59\,phv00162583,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:MIXED VEGETABLES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:MIXED VEGETABLES,phs000007.v31,d4e39edb3ef03bb566d00a9230e092592dafd96d8631f89cbd2d95bcefec249e,continuous,phv00162583.v5,phs000007,False,FFD59,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162583\FFD59\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,MIXED VEGETABLES: (servings/week),phs000007.v33.p14,phv00524559.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524559,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd59,MIXED VEGETABLES:(servings/week),1.487541837,vr_ffreq_ex08_1_0615d_v1,ffd59,Framingham Cohort,FFD59,DERIVED FIELD:MIXED VEGETABLES,phs000007.v33.p14,phv00477957.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477957,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00479162.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479162,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00068503.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068503,[],phs000007,pht000681,phv00068503,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000681\phv00068503\FFD60\,pht000681.v6,\phs000007\pht000681\phv00068503\FFD60\,phv00068503,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,54c1ba1976ec6957298e421ff0446873450d40e8c0e07e3a9969b78e5bba08fd,continuous,phv00068503.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068503\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00524549.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524549,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS,phs000007.v33.p14,phv00523902.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523902,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00070096.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070096,[],phs000007,pht000680,phv00070096,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000680\phv00070096\FFD60\,pht000680.v6,\phs000007\pht000680\phv00070096\FFD60\,phv00070096,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,b35eef95f8f3ad524bc2136655e3ef41efcd485df521cbc520099e5243c5b6f8,continuous,phv00070096.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070096\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00157206.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157206,[],phs000007,pht002150,phv00157206,False,True,False,FFD60,DERIVED FIELD:BEANS/LENTILS,0.0,\phs000007\pht002150\phv00157206\FFD60\,pht002150.v4,\phs000007\pht002150\phv00157206\FFD60\,phv00157206,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEANS/LENTILS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BEANS/LENTILS,phs000007.v31,8c16cdf3cf2679fda0b80d9876732e5c4f154023ba518e46439611864802c03f,continuous,phv00157206.v4,phs000007,False,FFD60,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157206\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00157647.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157647,[],phs000007,pht002151,phv00157647,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht002151\phv00157647\FFD60\,pht002151.v1,\phs000007\pht002151\phv00157647\FFD60\,phv00157647,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,0e9b93dddf7a7a56b2c7f06c9b63951fab261dc5896612678bbb77a89783e23a,continuous,phv00157647.v1,phs000007,False,FFD60,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157647\FFD60\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00069072.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069072,[],phs000007,pht000682,phv00069072,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht000682\phv00069072\FFD60\,pht000682.v6,\phs000007\pht000682\phv00069072\FFD60\,phv00069072,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,5420e508f96c2a57952edfddd1639867ff1ec9376f2f46db57b55a3860de0971,continuous,phv00069072.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069072\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00162584.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162584,[],phs000007,pht002350,phv00162584,False,True,False,FFD60,DERIVED FIELD:BEANS/LENTILS,0.0,\phs000007\pht002350\phv00162584\FFD60\,pht002350.v5,\phs000007\pht002350\phv00162584\FFD60\,phv00162584,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEANS/LENTILS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",31.5,DERIVED FIELD:BEANS/LENTILS,phs000007.v31,f446172387a119f408d594bca86e730d62eb5dac8137b24753b535123c5c0aa2,continuous,phv00162584.v5,phs000007,False,FFD60,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162584\FFD60\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,BEANS/LENTILS: (servings/week),phs000007.v33.p14,phv00172975.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172975,[],phs000007,pht002900,phv00172975,False,True,False,FFD60,Derived field: Beans or lentils,0.0,\phs000007\pht002900\phv00172975\FFD60\,pht002900.v3,\phs000007\pht002900\phv00172975\FFD60\,phv00172975,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Beans or lentils,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,Derived field: Beans or lentils,phs000007.v31,22cf65021b682e348dbca12f3908fbdc8bbe6ac21aa8cfba62ed44732c83a7a2,continuous,phv00172975.v3,phs000007,False,FFD60,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172975\FFD60\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00478519.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478519,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00477958.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477958,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD:BEANS/LENTILS,phs000007.v33.p14,phv00477395.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477395,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd60,BEANS/LENTILS:(servings/week),0.557828189,vr_ffreq_ex08_1_0615d_v1,ffd60,Framingham Cohort,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v33.p14,phv00158450.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158450,[],phs000007,pht002153,phv00158450,False,True,False,FFD60,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,0.0,\phs000007\pht002153\phv00158450\FFD60\,pht002153.v1,\phs000007\pht002153\phv00158450\FFD60\,phv00158450,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEANS/LENTILS,phs000007.v31,9f9cfcb9394eb2615832fcb58f5f762d7d50fb036221f470dc6177634734aa69,continuous,phv00158450.v1,phs000007,False,FFD60,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158450\FFD60\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00479174.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00478520.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00068504.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068504,[],phs000007,pht000681,phv00068504,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000681\phv00068504\FFD61\,pht000681.v6,\phs000007\pht000681\phv00068504\FFD61\,phv00068504,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,e8e21255a893f506c973ee06cfdcc0f23a03229ea8f44eb1f25938c14783dc97,continuous,phv00068504.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068504\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00070097.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070097,[],phs000007,pht000680,phv00070097,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000680\phv00070097\FFD61\,pht000680.v6,\phs000007\pht000680\phv00070097\FFD61\,phv00070097,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,3f5f218d9f2c252c7438d053eb05a10a1b33cace783e56384c386a72a03f8fb6,continuous,phv00070097.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070097\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00157207.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157207,[],phs000007,pht002150,phv00157207,False,True,False,FFD61,DERIVED FIELD:WINTER SQUASH,0.0,\phs000007\pht002150\phv00157207\FFD61\,pht002150.v4,\phs000007\pht002150\phv00157207\FFD61\,phv00157207,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:WINTER SQUASH,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:WINTER SQUASH,phs000007.v31,f4d1ce16952c0feccb0aecf1b959f340d811f64f3240ff84097ec82c0ccaf08d,continuous,phv00157207.v4,phs000007,False,FFD61,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157207\FFD61\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00157648.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157648,[],phs000007,pht002151,phv00157648,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht002151\phv00157648\FFD61\,pht002151.v1,\phs000007\pht002151\phv00157648\FFD61\,phv00157648,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,de00a8746e76f78240402ac8ccc0540d64f1c687beda14f44bbf11b79b7e7182,continuous,phv00157648.v1,phs000007,False,FFD61,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157648\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,WINTER SQUASH,phs000007.v33.p14,phv00523903.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523903,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00162585.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162585,[],phs000007,pht002350,phv00162585,False,True,False,FFD61,DERIVED FIELD:WINTER SQUASH,0.0,\phs000007\pht002350\phv00162585\FFD61\,pht002350.v5,\phs000007\pht002350\phv00162585\FFD61\,phv00162585,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:WINTER SQUASH,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:WINTER SQUASH,phs000007.v31,5db4166ccdfe4953ac4a2ecacc93ebf7ecb30f61fc11d351872c8f30ed24493b,continuous,phv00162585.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162585\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00172987.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172987,[],phs000007,pht002900,phv00172987,False,True,False,FFD61,Derived field: Dark orange (winter) squash,0.0,\phs000007\pht002900\phv00172987\FFD61\,pht002900.v3,\phs000007\pht002900\phv00172987\FFD61\,phv00172987,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Dark orange (winter) squash,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",7.0,Derived field: Dark orange (winter) squash,phs000007.v31,54448615685e9436eca51ff3fe877fe82b1f3cf401be9a32a8418e48fc88c43c,continuous,phv00172987.v3,phs000007,False,FFD61,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172987\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00069073.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069073,[],phs000007,pht000682,phv00069073,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht000682\phv00069073\FFD61\,pht000682.v6,\phs000007\pht000682\phv00069073\FFD61\,phv00069073,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,df9bc8ab2583f5913f18160fbcf7e8151317b03424302bd5e641c9a6ca9a01ef,continuous,phv00069073.v5,phs000007,False,FFD61,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069073\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v33.p14,phv00158451.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158451,[],phs000007,pht002153,phv00158451,False,True,False,FFD61,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,0.0,\phs000007\pht002153\phv00158451\FFD61\,pht002153.v1,\phs000007\pht002153\phv00158451\FFD61\,phv00158451,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - WINTER SQUASH,phs000007.v31,3596e43a0bbef8aa1fbacee850eee0c9c78b3433198e56a8a7eca37018ff46a1,continuous,phv00158451.v1,phs000007,False,FFD61,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158451\FFD61\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00477959.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477959,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,DERIVED FIELD:WINTER SQUASH,phs000007.v33.p14,phv00477396.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477396,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd61,WINTER SQUASH:(servings/week),1.227222016,vr_ffreq_ex08_1_0615d_v1,ffd61,Framingham Cohort,FFD61,WINTER SQUASH: (servings/week),phs000007.v33.p14,phv00524561.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524561,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00068505.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068505,[],phs000007,pht000681,phv00068505,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000681\phv00068505\FFD62\,pht000681.v6,\phs000007\pht000681\phv00068505\FFD62\,phv00068505,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,c2846e318afd292fddc8271f53fc1e20aa033eadc35bbde4d9c6ac6262dc4fea,continuous,phv00068505.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068505\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00069074.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069074,[],phs000007,pht000682,phv00069074,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000682\phv00069074\FFD62\,pht000682.v6,\phs000007\pht000682\phv00069074\FFD62\,phv00069074,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,93d4115ecb511b1d495fb98e73dc65b3289f850b176b1f62bc173139141b5638,continuous,phv00069074.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069074\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00070098.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070098,[],phs000007,pht000680,phv00070098,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht000680\phv00070098\FFD62\,pht000680.v6,\phs000007\pht000680\phv00070098\FFD62\,phv00070098,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,053a7b1a627f145fdab486555727c36363c7dd4a572e161061ae7a80860a4fc9,continuous,phv00070098.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070098\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00157649.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157649,[],phs000007,pht002151,phv00157649,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht002151\phv00157649\FFD62\,pht002151.v1,\phs000007\pht002151\phv00157649\FFD62\,phv00157649,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,6269482d2fca438cd0bec650b3c1b985197fae16196922ace8ecaef91fbe5e3a,continuous,phv00157649.v1,phs000007,False,FFD62,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157649\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v33.p14,phv00158452.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158452,[],phs000007,pht002153,phv00158452,False,True,False,FFD62,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,0.0,\phs000007\pht002153\phv00158452\FFD62\,pht002153.v1,\phs000007\pht002153\phv00158452\FFD62\,phv00158452,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - SUMMER SQUASH,phs000007.v31,a399f0beb7c9170cb6af5d4123c84f91a7446c58c2d6ce0cf619194662166aac,continuous,phv00158452.v1,phs000007,False,FFD62,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158452\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00162586.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162586,[],phs000007,pht002350,phv00162586,False,True,False,FFD62,DERIVED FIELD:SUMMER SQUASH,0.0,\phs000007\pht002350\phv00162586\FFD62\,pht002350.v5,\phs000007\pht002350\phv00162586\FFD62\,phv00162586,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:SUMMER SQUASH,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:SUMMER SQUASH,phs000007.v31,6700af01a61bf7225f6b29f1187034faae187d5a994d9110a787ec9fc84d770f,continuous,phv00162586.v5,phs000007,False,FFD62,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162586\FFD62\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00172988.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172988,[],phs000007,pht002900,phv00172988,False,True,False,FFD62,"Derived field: Eggplant, zuke, summer squash",0.0,\phs000007\pht002900\phv00172988\FFD62\,pht002900.v3,\phs000007\pht002900\phv00172988\FFD62\,phv00172988,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Eggplant, zuke, summer squash",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Eggplant, zuke, summer squash",phs000007.v31,6656956a9b6693e14de177fef347534eb98ce45c7f241ea649f559a48e19c732,continuous,phv00172988.v3,phs000007,False,FFD62,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172988\FFD62\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00477960.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477960,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00478521.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478521,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00479175.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479175,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH,phs000007.v33.p14,phv00523904.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523904,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,SUMMER SQUASH: (servings/week),phs000007.v33.p14,phv00524562.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524562,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00157208.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157208,[],phs000007,pht002150,phv00157208,False,True,False,FFD62,DERIVED FIELD:SUMMER SQUASH,0.0,\phs000007\pht002150\phv00157208\FFD62\,pht002150.v4,\phs000007\pht002150\phv00157208\FFD62\,phv00157208,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:SUMMER SQUASH,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:SUMMER SQUASH,phs000007.v31,7df09dd4a28c02c76d796d7b4074bd16ce80738c42c03f0accb657dbe9f25027,continuous,phv00157208.v4,phs000007,False,FFD62,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157208\FFD62\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd62,SUMMER SQUASH:(servings/week),0.260319822,vr_ffreq_ex08_1_0615d_v1,ffd62,Framingham Cohort,FFD62,DERIVED FIELD:SUMMER SQUASH,phs000007.v33.p14,phv00477397.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477397,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00158453.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158453,[],phs000007,pht002153,phv00158453,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht002153\phv00158453\FFD63\,pht002153.v1,\phs000007\pht002153\phv00158453\FFD63\,phv00158453,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,5f97df77a12b9b81b3c5de79eeaa240cc608c52b1485e4fb556cdd9f4de5339c,continuous,phv00158453.v1,phs000007,False,FFD63,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158453\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00157650.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157650,[],phs000007,pht002151,phv00157650,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht002151\phv00157650\FFD63\,pht002151.v1,\phs000007\pht002151\phv00157650\FFD63\,phv00157650,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,0b4557405abd33e98d4fd2c15683e6c557211edda1481ef43da610b252e90f4d,continuous,phv00157650.v1,phs000007,False,FFD63,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157650\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00157209.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157209,[],phs000007,pht002150,phv00157209,False,True,False,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,0.0,\phs000007\pht002150\phv00157209\FFD63\,pht002150.v4,\phs000007\pht002150\phv00157209\FFD63\,phv00157209,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",7.0,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v31,ac44390d6dcff6c79cc28509edf006bb0c46c6661227714b48f81447ef03c005,continuous,phv00157209.v4,phs000007,False,FFD63,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157209\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00070099.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070099,[],phs000007,pht000680,phv00070099,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000680\phv00070099\FFD63\,pht000680.v6,\phs000007\pht000680\phv00070099\FFD63\,phv00070099,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,c07402b614046a7895d1365cf1b934aab7d0dfd998b641a4d7dbf231e94df1c9,continuous,phv00070099.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070099\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00069075.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069075,[],phs000007,pht000682,phv00069075,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000682\phv00069075\FFD63\,pht000682.v6,\phs000007\pht000682\phv00069075\FFD63\,phv00069075,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,4e4dd8e6d177f0ce4066daef20cc7e47c944675d1bce54d6e037ba253a4edc82,continuous,phv00069075.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069075\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v33.p14,phv00068506.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068506,[],phs000007,pht000681,phv00068506,False,True,False,FFD63,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,0.0,\phs000007\pht000681\phv00068506\FFD63\,pht000681.v6,\phs000007\pht000681\phv00068506\FFD63\,phv00068506,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - YAMS/SWEET POTATOES,phs000007.v31,17289f211fa6ab559db03ea8439d8896a69e60b16f8a6f183af78bdb68cc35df,continuous,phv00068506.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068506\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00162587.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162587,[],phs000007,pht002350,phv00162587,False,True,False,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,0.0,\phs000007\pht002350\phv00162587\FFD63\,pht002350.v5,\phs000007\pht002350\phv00162587\FFD63\,phv00162587,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:YAMS/SWEET POTATOES,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v31,521f37ce3077109d7af6f998e9bf4c597b02db282136b1e4b806895ce3d0c9ac,continuous,phv00162587.v5,phs000007,False,FFD63,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162587\FFD63\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00172986.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172986,[],phs000007,pht002900,phv00172986,False,True,False,FFD63,Derived field: Yams or sweet potatoes,0.0,\phs000007\pht002900\phv00172986\FFD63\,pht002900.v3,\phs000007\pht002900\phv00172986\FFD63\,phv00172986,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Yams or sweet potatoes,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Yams or sweet potatoes,phs000007.v31,0a92d71e6601289bd51bf2ea0e4f541b4c485f015bc85224d95b6923843130cd,continuous,phv00172986.v3,phs000007,False,FFD63,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172986\FFD63\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00477398.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477398,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00477961.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477961,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,DERIVED FIELD:YAMS/SWEET POTATOES,phs000007.v33.p14,phv00478522.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478522,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00479173.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479173,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES: (servings/week),phs000007.v33.p14,phv00524560.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524560,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd63,YAMS/SWEET POTATOES:(servings/week),0.148754184,vr_ffreq_ex08_1_0615d_v1,ffd63,Framingham Cohort,FFD63,YAMS/SWEET POTATOES,phs000007.v33.p14,phv00523905.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523905,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED",phs000007.v33.p14,phv00523906.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523906,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00479177.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479177,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00478523.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478523,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00477962.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477962,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00477399.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00172990.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172990,[],phs000007,pht002900,phv00172990,False,True,False,FFD64,"Derived field: Spinach, cooked",0.0,\phs000007\pht002900\phv00172990\FFD64\,pht002900.v3,\phs000007\pht002900\phv00172990\FFD64\,phv00172990,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Spinach, cooked",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Spinach, cooked",phs000007.v31,e903c962a40b5d367fc5f593203836a1ec12433c5f6e3345562c44bf5f4f9c56,continuous,phv00172990.v3,phs000007,False,FFD64,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172990\FFD64\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00069076.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069076,[],phs000007,pht000682,phv00069076,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000682\phv00069076\FFD64\,pht000682.v6,\phs000007\pht000682\phv00069076\FFD64\,phv00069076,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,6446b3129f70214459f9834a386d9c9709f212e3e6fd7750007683c96e3ee8d9,continuous,phv00069076.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069076\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00070100.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070100,[],phs000007,pht000680,phv00070100,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000680\phv00070100\FFD64\,pht000680.v6,\phs000007\pht000680\phv00070100\FFD64\,phv00070100,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,4f5b026a8b6587b0a0d7c6d711fd826bf570a3e28602727d6325793e460fa74a,continuous,phv00070100.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070100\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00157210.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157210,[],phs000007,pht002150,phv00157210,False,True,False,FFD64,"DERIVED FIELD:SPINACH, COOKED",0.0,\phs000007\pht002150\phv00157210\FFD64\,pht002150.v4,\phs000007\pht002150\phv00157210\FFD64\,phv00157210,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:SPINACH, COOKED",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:SPINACH, COOKED",phs000007.v31,8047b37ec1f15d4dc06b8f64622e890a967b05a589f1ce8cb93311d6d1664f7e,continuous,phv00157210.v4,phs000007,False,FFD64,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157210\FFD64\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00157651.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157651,[],phs000007,pht002151,phv00157651,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht002151\phv00157651\FFD64\,pht002151.v1,\phs000007\pht002151\phv00157651\FFD64\,phv00157651,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,1b9d485d7e3f26d502a460b4d4925cf2a84b368b487700101c314b953c861564,continuous,phv00157651.v1,phs000007,False,FFD64,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157651\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"SPINACH, COOKED: (servings/week)",phs000007.v33.p14,phv00524564.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524564,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD:SPINACH, COOKED",phs000007.v33.p14,phv00162588.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162588,[],phs000007,pht002350,phv00162588,False,True,False,FFD64,"DERIVED FIELD:SPINACH, COOKED",0.0,\phs000007\pht002350\phv00162588\FFD64\,pht002350.v5,\phs000007\pht002350\phv00162588\FFD64\,phv00162588,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:SPINACH, COOKED",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,"DERIVED FIELD:SPINACH, COOKED",phs000007.v31,c01f51b69ef24cc7b8bf2bb8e28a0b92d2b56fbf8af11a667064e5b918e8c74c,continuous,phv00162588.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162588\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00158454.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158454,[],phs000007,pht002153,phv00158454,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht002153\phv00158454\FFD64\,pht002153.v1,\phs000007\pht002153\phv00158454\FFD64\,phv00158454,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",5.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,9bc5e963b97aaed3a028860e700b9b4fc8e14baf16927638d98c9c7adb53f5e5,continuous,phv00158454.v1,phs000007,False,FFD64,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158454\FFD64\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd64,"SPINACH, COOKED:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd64,Framingham Cohort,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v33.p14,phv00068507.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068507,[],phs000007,pht000681,phv00068507,False,True,False,FFD64,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",0.0,\phs000007\pht000681\phv00068507\FFD64\,pht000681.v6,\phs000007\pht000681\phv00068507\FFD64\,phv00068507,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, COOKED",phs000007.v31,53f970a3465eb8e0038ce983ec6ce214218baf2c6588ac3a1926cf42759a7658,continuous,phv00068507.v5,phs000007,False,FFD64,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068507\FFD64\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00477400.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477400,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00068508.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068508,[],phs000007,pht000681,phv00068508,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000681\phv00068508\FFD65\,pht000681.v6,\phs000007\pht000681\phv00068508\FFD65\,phv00068508,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,6c1fea3b8d7ed56b2db19101c5eeb3817ce1b50d380bf0720f31f7e78c27614e,continuous,phv00068508.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068508\FFD65\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00069077.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069077,[],phs000007,pht000682,phv00069077,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000682\phv00069077\FFD65\,pht000682.v6,\phs000007\pht000682\phv00069077\FFD65\,phv00069077,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,a76c3aeed715b63e603c4432deab97429359c4dd5246c70f79740db1b0a19d39,continuous,phv00069077.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069077\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00070101.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070101,[],phs000007,pht000680,phv00070101,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht000680\phv00070101\FFD65\,pht000680.v6,\phs000007\pht000680\phv00070101\FFD65\,phv00070101,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,dbf0eeaa427e42eaac2b57801c520ac2c2158fd35d9e32942df6f232e11e5157,continuous,phv00070101.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070101\FFD65\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00157211.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157211,[],phs000007,pht002150,phv00157211,False,True,False,FFD65,"DERIVED FIELD:SPANACH, RAW",0.0,\phs000007\pht002150\phv00157211\FFD65\,pht002150.v4,\phs000007\pht002150\phv00157211\FFD65\,phv00157211,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.","DERIVED FIELD:SPANACH, RAW",{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,"DERIVED FIELD:SPANACH, RAW",phs000007.v31,2f871eceeba619088d0c8b3cb54d62f4f724b66eef1f3718aabbbb91863c87e6,continuous,phv00157211.v4,phs000007,False,FFD65,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157211\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00157652.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157652,[],phs000007,pht002151,phv00157652,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht002151\phv00157652\FFD65\,pht002151.v1,\phs000007\pht002151\phv00157652\FFD65\,phv00157652,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,d8ec89122ccc73d30693ee90496c1587c1616024c47f7531a7e2d87e357991f5,continuous,phv00157652.v1,phs000007,False,FFD65,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157652\FFD65\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v33.p14,phv00158455.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158455,[],phs000007,pht002153,phv00158455,False,True,False,FFD65,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",0.0,\phs000007\pht002153\phv00158455\FFD65\,pht002153.v1,\phs000007\pht002153\phv00158455\FFD65\,phv00158455,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22","DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,"DERIVED FIELD: SERVINGS PER WEEK - SPINACH, RAW",phs000007.v31,61a3db996133c7da38c9b3a6efa6945bdcc211120db94d96a58dfc110444bd17,continuous,phv00158455.v1,phs000007,False,FFD65,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158455\FFD65\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00162589.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162589,[],phs000007,pht002350,phv00162589,False,True,False,FFD65,"DERIVED FIELD:SPINACH, RAW",0.0,\phs000007\pht002350\phv00162589\FFD65\,pht002350.v5,\phs000007\pht002350\phv00162589\FFD65\,phv00162589,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.","DERIVED FIELD:SPINACH, RAW",{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,"DERIVED FIELD:SPINACH, RAW",phs000007.v31,62b58079698dae97ec3566c9cf8a03d995fd116acf261329a0a6e0e73acd4b51,continuous,phv00162589.v5,phs000007,False,FFD65,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162589\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00172991.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172991,[],phs000007,pht002900,phv00172991,False,True,False,FFD65,"Derived field: Spinach, raw as in salad",0.0,\phs000007\pht002900\phv00172991\FFD65\,pht002900.v3,\phs000007\pht002900\phv00172991\FFD65\,phv00172991,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Spinach, raw as in salad",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Spinach, raw as in salad",phs000007.v31,f59d8e486eb5a7a96e053f29fc2107a701a4b0c178ac5d0281d474900b0f431a,continuous,phv00172991.v3,phs000007,False,FFD65,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172991\FFD65\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00477963.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477963,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"DERIVED FIELD:SPANACH, RAW",phs000007.v33.p14,phv00478524.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478524,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00479178.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479178,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW",phs000007.v33.p14,phv00523907.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523907,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd65,"SPANACH, RAW:(servings/week)",0.855336556,vr_ffreq_ex08_1_0615d_v1,ffd65,Framingham Cohort,FFD65,"SPANACH, RAW: (servings/week)",phs000007.v33.p14,phv00524565.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524565,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00524563.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524563,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00069078.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069078,[],phs000007,pht000682,phv00069078,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000682\phv00069078\FFD66\,pht000682.v6,\phs000007\pht000682\phv00069078\FFD66\,phv00069078,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,895da685f06b312046e76109f07869a20eb01c5118c30002caf2c6df18d27ac6,continuous,phv00069078.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069078\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00523908.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523908,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00479176.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479176,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00068509.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068509,[],phs000007,pht000681,phv00068509,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000681\phv00068509\FFD66\,pht000681.v6,\phs000007\pht000681\phv00068509\FFD66\,phv00068509,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,e95297759f893a046c6bc0444f1b880c70c8e42f87786a13a0dc1edfb5705ff2,continuous,phv00068509.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068509\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00478525.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478525,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00477964.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477964,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00477401.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477401,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,KALE/MUSTARD/CHARD: (servings/week),phs000007.v33.p14,phv00172989.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172989,[],phs000007,pht002900,phv00172989,False,True,False,FFD66,"Derived field: Kale, mustard greens, or chard",0.0,\phs000007\pht002900\phv00172989\FFD66\,pht002900.v3,\phs000007\pht002900\phv00172989\FFD66\,phv00172989,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.","Derived field: Kale, mustard greens, or chard",{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",17.5,"Derived field: Kale, mustard greens, or chard",phs000007.v31,b662569bf255aff19a7f12b491ee2390542b532ba9bfbe6151887b826a6619ce,continuous,phv00172989.v3,phs000007,False,FFD66,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172989\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00162590.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162590,[],phs000007,pht002350,phv00162590,False,True,False,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,0.0,\phs000007\pht002350\phv00162590\FFD66\,pht002350.v5,\phs000007\pht002350\phv00162590\FFD66\,phv00162590,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v31,610e5817467e6b721e07e180b2e379e4adaae87874e3f9e4b2f09a5118b69d2a,continuous,phv00162590.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162590\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00158456.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158456,[],phs000007,pht002153,phv00158456,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht002153\phv00158456\FFD66\,pht002153.v1,\phs000007\pht002153\phv00158456\FFD66\,phv00158456,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,d7434517d10787da707965c7bd7dce658ab0e29121b8594c9c20127f9856a3e2,continuous,phv00158456.v1,phs000007,False,FFD66,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158456\FFD66\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00157653.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157653,[],phs000007,pht002151,phv00157653,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht002151\phv00157653\FFD66\,pht002151.v1,\phs000007\pht002151\phv00157653\FFD66\,phv00157653,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",3.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,bed40fa5f1109e3483e4b4ac4b6e70ccec09e28dff3621edbe46aab96037121b,continuous,phv00157653.v1,phs000007,False,FFD66,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157653\FFD66\,0.0,3.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00157212.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157212,[],phs000007,pht002150,phv00157212,False,True,False,FFD66,DERIVED FIELD:KALE/MUSTARD/CHARD,0.0,\phs000007\pht002150\phv00157212\FFD66\,pht002150.v4,\phs000007\pht002150\phv00157212\FFD66\,phv00157212,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:KALE/MUSTARD/CHARD,phs000007.v31,ad63cb388276d3bce94f16ca4cdaa2b81b6205818a180f7cb4b6b52743d9eac3,continuous,phv00157212.v4,phs000007,False,FFD66,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157212\FFD66\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd66,KALE/MUSTARD/CHARD:(servings/week),1.450353291,vr_ffreq_ex08_1_0615d_v1,ffd66,Framingham Cohort,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v33.p14,phv00070102.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070102,[],phs000007,pht000680,phv00070102,False,True,False,FFD66,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,0.0,\phs000007\pht000680\phv00070102\FFD66\,pht000680.v6,\phs000007\pht000680\phv00070102\FFD66\,phv00070102,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - KALE/MUSTARD/CHARD,phs000007.v31,953f32f891be03c06b7bfd549b0aa8413ee1182396c37c02705b18ace5f9a4c5,continuous,phv00070102.v5,phs000007,False,FFD66,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070102\FFD66\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00523909.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523909,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00158457.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158457,[],phs000007,pht002153,phv00158457,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002153\phv00158457\FFD67\,pht002153.v1,\phs000007\pht002153\phv00158457\FFD67\,phv00158457,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,a58abe26e724f8d2ad60984b8d8f28b133728f10a651f837ab1507e73484540b,continuous,phv00158457.v1,phs000007,False,FFD67,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158457\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00524566.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00162591.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162591,[],phs000007,pht002350,phv00162591,False,True,False,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002350\phv00162591\FFD67\,pht002350.v5,\phs000007\pht002350\phv00162591\FFD67\,phv00162591,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",17.5,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v31,86ad60b9e2906b5c7c21ebc32abd573e36f4926b0b5f7bfffc481987adae74b2,continuous,phv00162591.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162591\FFD67\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00479179.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479179,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00069079.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069079,[],phs000007,pht000682,phv00069079,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000682\phv00069079\FFD67\,pht000682.v6,\phs000007\pht000682\phv00069079\FFD67\,phv00069079,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,a6091a5ac877fb96c5a7dd7df7ff6b19777758739e53b14837a29eb466643473,continuous,phv00069079.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069079\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00477965.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477965,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00070103.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070103,[],phs000007,pht000680,phv00070103,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000680\phv00070103\FFD67\,pht000680.v6,\phs000007\pht000680\phv00070103\FFD67\,phv00070103,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,9240923b42cf7216b966a88918c6a3222c2f50c1410408fb63dc8c0249ab08c6,continuous,phv00070103.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070103\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00157213.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157213,[],phs000007,pht002150,phv00157213,False,True,False,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002150\phv00157213\FFD67\,pht002150.v4,\phs000007\pht002150\phv00157213\FFD67\,phv00157213,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v31,79e28ff3524265bd3140333592b809f85537acbf8476a4a16ffcc8038155c4a9,continuous,phv00157213.v4,phs000007,False,FFD67,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157213\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00068510.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068510,[],phs000007,pht000681,phv00068510,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht000681\phv00068510\FFD67\,pht000681.v6,\phs000007\pht000681\phv00068510\FFD67\,phv00068510,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,1bfd1ecb0be59afe4d581f46d17f423ddd0bb50b0c5b8bba41412616c4912d4b,continuous,phv00068510.v5,phs000007,False,FFD67,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068510\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00478526.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478526,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00157654.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157654,[],phs000007,pht002151,phv00157654,False,True,False,FFD67,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,0.0,\phs000007\pht002151\phv00157654\FFD67\,pht002151.v1,\phs000007\pht002151\phv00157654\FFD67\,phv00157654,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",31.5,DERIVED FIELD: SERVINGS PER WEEK - ICEBERG/HEAD LETTUCE,phs000007.v31,26b81f9fc52ca93d107953f4379184b5b3da216fc378773501c8c9bba26c962b,continuous,phv00157654.v1,phs000007,False,FFD67,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157654\FFD67\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,ICEBERG/HEAD LETTUCE: (servings/week),phs000007.v33.p14,phv00172992.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172992,[],phs000007,pht002900,phv00172992,False,True,False,FFD67,Derived field: Iceberg or head lettuce,0.0,\phs000007\pht002900\phv00172992\FFD67\,pht002900.v3,\phs000007\pht002900\phv00172992\FFD67\,phv00172992,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Iceberg or head lettuce,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Iceberg or head lettuce,phs000007.v31,ea644fcf610f5b55bfc6eddfa4f3ffcf694657ac7f5b668b3c555f4ddfef0a9e,continuous,phv00172992.v3,phs000007,False,FFD67,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172992\FFD67\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd67,ICEBERG/HEAD LETTUCE:(servings/week),1.338787653,vr_ffreq_ex08_1_0615d_v1,ffd67,Framingham Cohort,FFD67,DERIVED FIELD:ICEBERG/HEAD LETTUCE,phs000007.v33.p14,phv00477402.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477402,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00069080.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069080,[],phs000007,pht000682,phv00069080,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000682\phv00069080\FFD68\,pht000682.v6,\phs000007\pht000682\phv00069080\FFD68\,phv00069080,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,caa50582aa19f0e3da5c0c67c48a0f52c64775f09b8d7c24a4b609b642bc958d,continuous,phv00069080.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069080\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00157214.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157214,[],phs000007,pht002150,phv00157214,False,True,False,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002150\phv00157214\FFD68\,pht002150.v4,\phs000007\pht002150\phv00157214\FFD68\,phv00157214,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v31,e4852498f78ceaebf7bfadb9a59e62293877c6692075a202bd084a5d4e7bd35f,continuous,phv00157214.v4,phs000007,False,FFD68,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157214\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00070104.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070104,[],phs000007,pht000680,phv00070104,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000680\phv00070104\FFD68\,pht000680.v6,\phs000007\pht000680\phv00070104\FFD68\,phv00070104,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",31.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,5da9532c506bba51e6763356f533eaf99faa127ff688cb42455ca224d1c6e42b,continuous,phv00070104.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070104\FFD68\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00524567.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524567,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00523910.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523910,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00479180.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479180,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00478527.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478527,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00157655.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157655,[],phs000007,pht002151,phv00157655,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002151\phv00157655\FFD68\,pht002151.v1,\phs000007\pht002151\phv00157655\FFD68\,phv00157655,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,c24d77b776c22c463e6802c39ffdbf19dd47251a2db58c494a166e3089c3dde0,continuous,phv00157655.v1,phs000007,False,FFD68,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157655\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00477966.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477966,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,ROMAINE/LEAF LETTUCE: (servings/week),phs000007.v33.p14,phv00172993.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172993,[],phs000007,pht002900,phv00172993,False,True,False,FFD68,Derived field: Romaine or leaf lettuce,0.0,\phs000007\pht002900\phv00172993\FFD68\,pht002900.v3,\phs000007\pht002900\phv00172993\FFD68\,phv00172993,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Romaine or leaf lettuce,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",42.0,Derived field: Romaine or leaf lettuce,phs000007.v31,d95e969756be25b5a3becb473e8e21f5cc231cd23eecfa99e376bd6c9de746d9,continuous,phv00172993.v3,phs000007,False,FFD68,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172993\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00158458.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158458,[],phs000007,pht002153,phv00158458,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002153\phv00158458\FFD68\,pht002153.v1,\phs000007\pht002153\phv00158458\FFD68\,phv00158458,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,5dcca273dfb8b32c3d9880174b0c457327612e7326b9b86d4731dd0cd1c228c0,continuous,phv00158458.v1,phs000007,False,FFD68,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158458\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00162592.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162592,[],phs000007,pht002350,phv00162592,False,True,False,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht002350\phv00162592\FFD68\,pht002350.v5,\phs000007\pht002350\phv00162592\FFD68\,phv00162592,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v31,a52bc8e36e90832c9fb2abc46fd06f20c5ef80a9f2e93cf788dec45b07ab905f,continuous,phv00162592.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162592\FFD68\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00068511.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068511,[],phs000007,pht000681,phv00068511,False,True,False,FFD68,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,0.0,\phs000007\pht000681\phv00068511\FFD68\,pht000681.v6,\phs000007\pht000681\phv00068511\FFD68\,phv00068511,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",17.5,DERIVED FIELD: SERVINGS PER WEEK - ROMAINE/LEAF LETTUCE,phs000007.v31,2808f2fd9eb168a0ac95d64579739c674b2bf314fe0c96251320acef6cd5e03d,continuous,phv00068511.v5,phs000007,False,FFD68,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068511\FFD68\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd68,ROMAINE/LEAF LETTUCE:(servings/week),0.706582373,vr_ffreq_ex08_1_0615d_v1,ffd68,Framingham Cohort,FFD68,DERIVED FIELD:ROMAINE/LEAF LETTUCE,phs000007.v33.p14,phv00477403.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477403,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,CELERY,phs000007.v33.p14,phv00523911.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523911,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00478528.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478528,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00477967.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477967,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00524568.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524568,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00172994.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172994,[],phs000007,pht002900,phv00172994,False,True,False,FFD69,Derived field: Celery,0.0,\phs000007\pht002900\phv00172994\FFD69\,pht002900.v3,\phs000007\pht002900\phv00172994\FFD69\,phv00172994,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Celery,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",31.5,Derived field: Celery,phs000007.v31,51d4243542240481b6652047a631ad0441cdd2f5de98e14b4f3f1e8cd38c319c,continuous,phv00172994.v3,phs000007,False,FFD69,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172994\FFD69\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,CELERY: (servings/week),phs000007.v33.p14,phv00479181.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00479181,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00158459.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158459,[],phs000007,pht002153,phv00158459,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht002153\phv00158459\FFD69\,pht002153.v1,\phs000007\pht002153\phv00158459\FFD69\,phv00158459,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",31.5,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,787fae1356da14ce2717ba9bc83606bb759d1c564876279a249134da6bda174a,continuous,phv00158459.v1,phs000007,False,FFD69,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158459\FFD69\,0.0,31.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00162593.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162593,[],phs000007,pht002350,phv00162593,False,True,False,FFD69,DERIVED FIELD:CELERY,0.0,\phs000007\pht002350\phv00162593\FFD69\,pht002350.v5,\phs000007\pht002350\phv00162593\FFD69\,phv00162593,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:CELERY,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",42.0,DERIVED FIELD:CELERY,phs000007.v31,1e75db7947066afd6dc25fdb47e4ee951774760d3d6de0c0a725d60646528d9f,continuous,phv00162593.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162593\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00068512.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068512,[],phs000007,pht000681,phv00068512,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000681\phv00068512\FFD69\,pht000681.v6,\phs000007\pht000681\phv00068512\FFD69\,phv00068512,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,73f127691462e2698f3f921e3069eb54d3874ac74d16a9b4ff256ec2c4df986a,continuous,phv00068512.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068512\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00069081.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069081,[],phs000007,pht000682,phv00069081,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000682\phv00069081\FFD69\,pht000682.v6,\phs000007\pht000682\phv00069081\FFD69\,phv00069081,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,fbdc6a3d855c7c854e4003c35d4388ceb14825eca21c5e9f0cc25402c8ddd340,continuous,phv00069081.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069081\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00477404.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477404,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD:CELERY,phs000007.v33.p14,phv00157215.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157215,[],phs000007,pht002150,phv00157215,False,True,False,FFD69,DERIVED FIELD:CELERY,0.0,\phs000007\pht002150\phv00157215\FFD69\,pht002150.v4,\phs000007\pht002150\phv00157215\FFD69\,phv00157215,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:CELERY,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",42.0,DERIVED FIELD:CELERY,phs000007.v31,b8ccc88babbce2b8c812958b186ca3b2405ca13fdf0d8a55f4e5ab45e275d034,continuous,phv00157215.v4,phs000007,False,FFD69,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157215\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00157656.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157656,[],phs000007,pht002151,phv00157656,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht002151\phv00157656\FFD69\,pht002151.v1,\phs000007\pht002151\phv00157656\FFD69\,phv00157656,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",17.5,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,6aa14f4feb2b7adfd4e8a81a36d4c44fdadd955416d0705e9249942cf7410812,continuous,phv00157656.v1,phs000007,False,FFD69,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157656\FFD69\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd69,CELERY:(servings/week),0.595016735,vr_ffreq_ex08_1_0615d_v1,ffd69,Framingham Cohort,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v33.p14,phv00070105.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070105,[],phs000007,pht000680,phv00070105,False,True,False,FFD69,DERIVED FIELD: SERVINGS PER WEEK - CELERY,0.0,\phs000007\pht000680\phv00070105\FFD69\,pht000680.v6,\phs000007\pht000680\phv00070105\FFD69\,phv00070105,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - CELERY,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",42.0,DERIVED FIELD: SERVINGS PER WEEK - CELERY,phs000007.v31,97dce0675aa98d83d8cb7c5ce3f0d399058efe18b0ec993a1fc9d6d50549e08e,continuous,phv00070105.v5,phs000007,False,FFD69,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070105\FFD69\,0.0,42.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00157216.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157216,[],phs000007,pht002150,phv00157216,False,True,False,FFD70,DERIVED FIELD:BEETS,0.0,\phs000007\pht002150\phv00157216\FFD70\,pht002150.v4,\phs000007\pht002150\phv00157216\FFD70\,phv00157216,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",DERIVED FIELD:BEETS,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17.5,DERIVED FIELD:BEETS,phs000007.v31,a71e3fe69d43a2389803c92b163bcdaf2a2091715c6bf179b9bf3563ef246c1e,continuous,phv00157216.v4,phs000007,False,FFD70,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157216\FFD70\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00477968.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477968,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00477405.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477405,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00162594.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162594,[],phs000007,pht002350,phv00162594,False,True,False,FFD70,DERIVED FIELD:BEETS,0.0,\phs000007\pht002350\phv00162594\FFD70\,pht002350.v5,\phs000007\pht002350\phv00162594\FFD70\,phv00162594,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",DERIVED FIELD:BEETS,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7.0,DERIVED FIELD:BEETS,phs000007.v31,4231ab911dd40cb07ec8b6c105cd03bee8b22db5522583e4a4c9bae4baf8df8c,continuous,phv00162594.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162594\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00158460.v1.p14,pht002153.v2.p14,ffreq0_22s,phv00158460,[],phs000007,pht002153,phv00158460,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht002153\phv00158460\FFD70\,pht002153.v1,\phs000007\pht002153\phv00158460\FFD70\,phv00158460,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 22",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,19d7f6fd8021557ba66d317fe42643a620610f78ac67c52c0c6a26d03c79c3f1,continuous,phv00158460.v1,phs000007,False,FFD70,FHS,Framingham Cohort,pht002153,ffreq0_22s,\phs000007\pht002153\phv00158460\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00157657.v1.p14,pht002151.v2.p14,ffreq0_20s,phv00157657,[],phs000007,pht002151,phv00157657,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht002151\phv00157657\FFD70\,pht002151.v1,\phs000007\pht002151\phv00157657\FFD70\,phv00157657,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Original Cohort Exam 20",5.5,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,d8c6b82746829e259f6a0230840dc8f4fddee3f1e958bc7c56f2dbe1b56b0519,continuous,phv00157657.v1,phs000007,False,FFD70,FHS,Framingham Cohort,pht002151,ffreq0_20s,\phs000007\pht002151\phv00157657\FFD70\,0.0,5.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00069082.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00069082,[],phs000007,pht000682,phv00069082,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000682\phv00069082\FFD70\,pht000682.v6,\phs000007\pht000682\phv00069082\FFD70\,phv00069082,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",17.5,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,56a7ea219f0c8bff963b062cc1381ac987d4ffa8123dc3f5c26ec89ea1506509,continuous,phv00069082.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00069082\FFD70\,0.0,17.5
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00068513.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068513,[],phs000007,pht000681,phv00068513,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000681\phv00068513\FFD70\,pht000681.v6,\phs000007\pht000681\phv00068513\FFD70\,phv00068513,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,b082b13e50368e0b395eab9c0bc28a23a26be93f105bb67c2d905ba892fda682,continuous,phv00068513.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068513\FFD70\,0.0,7.0
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,BEETS,phs000007.v33.p14,phv00523912.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523912,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD:BEETS,phs000007.v33.p14,phv00478529.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478529,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
VEGETABLES,Vegetables (servings per week),401070008,C10056,ARICFraminghamREGARDS,2.64,Framingham,vr_ffreq_ex08_1_0615d_v1.ffd70,BEETS:(servings/week),0.446262551,vr_ffreq_ex08_1_0615d_v1,ffd70,Framingham Cohort,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v33.p14,phv00070106.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070106,[],phs000007,pht000680,phv00070106,False,True,False,FFD70,DERIVED FIELD: SERVINGS PER WEEK - BEETS,0.0,\phs000007\pht000680\phv00070106\FFD70\,pht000680.v6,\phs000007\pht000680\phv00070106\FFD70\,phv00070106,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",DERIVED FIELD: SERVINGS PER WEEK - BEETS,{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",7.0,DERIVED FIELD: SERVINGS PER WEEK - BEETS,phs000007.v31,19ae5d3f51ab792e3c0525c4ef3b91fcb6f1ca988b688ced8f54c38f469c77fb,continuous,phv00070106.v5,phs000007,False,FFD70,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070106\FFD70\,0.0,7.0
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00172710.v5.p14,pht002900.v5.p14,vr_ffreq_ex02_3b_1345s,phv00172710,[],phs000007,pht002900,phv00172710,False,True,False,nut_sodium,Derived field: Nutrient value - Sodium,126.66,\phs000007\pht002900\phv00172710\nut_sodium\,pht002900.v3,\phs000007\pht002900\phv00172710\nut_sodium\,phv00172710,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire with Derived Variables, Generation 3 Exam 2. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions.",13366.82,Derived field: Nutrient value - Sodium,phs000007.v31,68d785367c86ee78301adc5c779187c8eba109ea98361f86f864fb9ef510d817,continuous,phv00172710.v3,phs000007,False,nut_sodium,FHS,Framingham Cohort,pht002900,vr_ffreq_ex02_3_0713s,\phs000007\pht002900\phv00172710\nut_sodium\,126.66,13366.82
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00070229.v7.p14,pht000680.v8.p14,ffreq1_5s,phv00070229,[],phs000007,pht000680,phv00070229,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",444.16,\phs000007\pht000680\phv00070229\NUT_SODIUM\,pht000680.v6,\phs000007\pht000680\phv00070229\NUT_SODIUM\,phv00070229,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 5",6597.83,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,442fd0e55191f1622ddefc57e4d0e7558d2afdc85061e2577001c6c530e9f0a1,continuous,phv00070229.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000680,ffreq1_5s,\phs000007\pht000680\phv00070229\NUT_SODIUM\,444.16,6597.83
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00157001.v5.p14,pht002150.v6.p14,vr_ffreq_ex01_3_0587s,phv00157001,[],phs000007,pht002150,phv00157001,False,True,False,nut_sodium,Derived field: Nutrient value - Sodium,85.35,\phs000007\pht002150\phv00157001\nut_sodium\,pht002150.v4,\phs000007\pht002150\phv00157001\nut_sodium\,phv00157001,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire (FFQ) and Derived Variables, Generation 3 Cohort Exam 1. Variables that have FFQ at the beginning of the description are those questions on the actual FFQ and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values.",17980.62,Derived field: Nutrient value - Sodium,phs000007.v31,8b33f55e0b8a304e8da943cb2b56dadc201260b2ba9070c6d0f6850b38af9798,continuous,phv00157001.v4,phs000007,False,nut_sodium,FHS,Framingham Cohort,pht002150,vr_ffreq_ex01_3_0587s,\phs000007\pht002150\phv00157001\nut_sodium\,85.35,17980.62
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,NUT_SODIUM,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00162361.v7.p14,pht002350.v7.p14,vr_ffreq_ex08_1_0615s,phv00162361,[],phs000007,pht002350,phv00162361,False,True,False,NUT_SODIUM,Derived field: Nutrient value - Sodium,425.99,\phs000007\pht002350\phv00162361\NUT_SODIUM\,pht002350.v5,\phs000007\pht002350\phv00162361\NUT_SODIUM\,phv00162361,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",Derived field: Nutrient value - Sodium,{},,"Food Frequency Questionnaire with Derived Variables, Offspring Cohort Exam 8. Variables that have FFQ at the beginning of the variable description are those questions on the actual FFQ questionnaire and answered by the participant. Variables that are described as derived fields were calculated using the answers to the FFQ questions. Variables beginning with NUT_ are calculated as 'per day' nutrient values. The following variables were used to create the derived nutrient fields and should not be used by the end user and were therefore deleted from the final dataset: MEASURE1, MEASURE2, MEASURE3, FRACT1, FRACT2, and FRACT3. Only valid FFQ data is included in this dataset. Valid FFQ data is defined as FFQs with less than 13 blanks and calorie intakes between 600-4199 kcal for men and between 600-3199 kcal for women. Dietary intakes have been assessed repeatedly for the original cohort and for the Offspring cohort since 1989 using the Harvard semi-quantitative food frequency questionnaire (FFQ) (Rimm et al. Am J Epidemiol 1992). The questionnaires were mailed to non-institutionalized participants before the examination and the participants were asked to bring the completed questionnaire with them to their appointment, at which time the FFQs were reviewed with the participant. The FFQ consists of a list of foods with a standard serving size and a selection of 9 frequency categories ranging from never or <1 serving/month to >= 6 servings/day. Participants were asked to report their frequency of consumption of each food item during the year prior to the examination. The FFQ also asked about the frequency and dose of vitamin and mineral supplements.",7612.38,Derived field: Nutrient value - Sodium,phs000007.v31,94ac8cd1d9e667e298011f9595840d4dbedec1fee20e14db425e9cbe8b9c13b3,continuous,phv00162361.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht002350,vr_ffreq_ex08_1_0615s,\phs000007\pht002350\phv00162361\NUT_SODIUM\,425.99,7612.38
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00068636.v7.p14,pht000681.v8.p14,ffreq1_6s,phv00068636,[],phs000007,pht000681,phv00068636,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",479.43,\phs000007\pht000681\phv00068636\NUT_SODIUM\,pht000681.v6,\phs000007\pht000681\phv00068636\NUT_SODIUM\,phv00068636,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 6",8770.78,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,191a66abf141be5f7100fa3a18f62b3dfaf4c1a319a9878bf317957094e52cbb,continuous,phv00068636.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000681,ffreq1_6s,\phs000007\pht000681\phv00068636\NUT_SODIUM\,479.43,8770.78
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v33.p14,phv00068753.v7.p14,pht000682.v8.p14,ffreq1_7s,phv00068753,[],phs000007,pht000682,phv00068753,False,True,False,NUT_SODIUM,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",403.14,\phs000007\pht000682\phv00068753\NUT_SODIUM\,pht000682.v6,\phs000007\pht000682\phv00068753\NUT_SODIUM\,phv00068753,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7","DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",{},,"Food Frequency Questionnaire Data for Willett Purple Form, Offspring Cohort Exam 7",6832.04,"DERIVED FIELD: NUTRIENT VALUE - SODIUM, (MG)",phs000007.v31,3112a109d93d50ed77f1b7c576b1e1ba8c86d6d076a845c71a60360748296e54,continuous,phv00068753.v5,phs000007,False,NUT_SODIUM,FHS,Framingham Cohort,pht000682,ffreq1_7s,\phs000007\pht000682\phv00068753\NUT_SODIUM\,403.14,6832.04
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00477732.v1.p14,pht010752.v2.p14,vr_ffreq_ex01_72_0975s,phv00477732,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00478295.v2.p14,pht010753.v2.p14,vr_ffreq_ex03_7_0973s,phv00478295,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00478925.v2.p14,pht010754.v2.p14,vr_ffreq_ex09_1b_1636s,phv00478925,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,NUT_SODIUM,SODIUM (mg),phs000007.v33.p14,phv00523566.v1.p14,pht012909.v1.p14,vr_ffreq_ex02_7_1301s,phv00523566,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Sodium mg,phs000007.v33.p14,phv00524306.v1.p14,pht012910.v1.p14,vr_ffreq_ex03_3b_1344s,phv00524306,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
SODIUM,Sodium intake (mg/day),1148504005,C54943,ARICFraminghamREGARDS,-,Framingham,vr_ffreq_ex08_1_0615d_v1.nut_sodium,Sodium mg,-,vr_ffreq_ex08_1_0615d_v1,nut_sodium,Framingham Cohort,nut_sodium,Derived field: Nutrient value - Sodium,phs000007.v33.p14,phv00477169.v1.p14,pht010751.v2.p14,vr_ffreq_ex01_2_0984s,phv00477169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod1,ATC CODE FOR MEDICATION OR FIRST DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod2,ATC CODE FOR SECOND DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod3,ATC CODE FOR THIRD DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex08_1_0280d.atc_cod4,ATC CODE FOR FOURTH DRUG IN COMPOUND,-,vr_meds_ex08_1_0280d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00479292.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479292,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00276903.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276903,"['A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A03AA07', 'A03BA03', 'A03FA01', 'A05AA02', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC07', 'A06AC08', 'A06AD', 'A07DA03', 'A07EC01', 'A07EC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11AA', 'A11AA03', 'A11CA', 'A11CA02', 'A11CC', 'A11CC04', 'A11CC05', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'C01DA', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03BA04', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA07', 'C09AA10', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA08', 'C10', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC03', 'D01AE12', 'D01BA02', 'D07AA02', 'D07AB09', 'D07AB19', 'D07AC04', 'D07AC08', 'D07AD01', 'D11AX10', 'D11AX11', 'D11AX14', 'G01AD01', 'G02CB01', 'G03AA08', 'G03CA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BE03', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AB07', 'H03AA01', 'H03AA02', 'H05AA01', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01MA02', 'J02AC01', 'J05AB09', 'J05AF08', 'L02BA01', 'L03AX13', 'L04AA17', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BX08', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'N02AA05', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX16', 'N04AA01', 'N04BC05', 'N04BX02', 'N05BA01', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N06AA01', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA02', 'N06BA11', 'N06DA02', 'N06DX01', 'N06DX02', 'N07BA02', 'N07BB03', 'P01BA02', 'R01AB07', 'R01AD08', 'R01AD09', 'R01BA02', 'R03AC02', 'R03AC12', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA07', 'R03BB04', 'R03BC01', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DB01', 'R06AA02', 'R06AA08', 'R06AB02', 'R06AB06', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AX22', 'S01BA04', 'S01BC05', 'S01CB05', 'S01EA05', 'S01EC01', 'S01EC03', 'S01ED01', 'S01ED02', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GX07', 'S01GX08', 'V03AE03', 'V04CB01']",phs000007,pht006019,phv00276903,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht006019\phv00276903\atc_cod1\,pht006019.v1,\phs000007\pht006019\phv00276903\atc_cod1\,phv00276903,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,38b3a181366b94d5f6d47db2728786c06064ac1320d6a3b87c9fbc48cfc5002d,categorical,phv00276903.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276903\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257922.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257922,"['A01AA01', 'A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA02', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AX13', 'A03BA03', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A06AG02', 'A07', 'A07AA02', 'A07AA09', 'A07BB', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA', 'A09AA02', 'A10A', 'A10AB01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11AA01', 'A11AA03', 'A11CA', 'A11CC', 'A11CC01', 'A11CC05', 'A11CC07', 'A11DA01', 'A11EA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC10', 'A12CE', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC06', 'B01AC07', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B03XA02', 'B03XA03', 'B05XA06', 'C01AA05', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AC01', 'C02CA04', 'C02DB02', 'C03', 'C03AA03', 'C03BA04', 'C03BA08', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC08', 'D02AE01', 'D03BA01', 'D04AA32', 'D04AB01', 'D04AB02', 'D05AX02', 'D06AX05', 'D06AX09', 'D06BX01', 'D07AA02', 'D07AA03', 'D07AB09', 'D07AC01', 'D07AD01', 'D08AX03', 'D10AF01', 'D11AX10', 'G01AD01', 'G01AX14', 'G03BA03', 'G03CA57', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD10', 'G04BE09', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AB02', 'H02AB07', 'H03AA', 'H03AA01', 'H03BB02', 'H04AA01', 'H05BA01', 'H05BX01', 'J01AA02', 'J01AA08', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EC01', 'J01EE01', 'J01FA10', 'J01FF01', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J07BB', 'L01XX05', 'L02AB01', 'L02AE02', 'L02BB03', 'L02BG03', 'L04AA13', 'L04AD01', 'L04AX03', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BE01', 'N02CX02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX16', 'N04BA02', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA04', 'N06BA11', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03BB04', 'R03CC02', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AB02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'S01AA17', 'S01AA19', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA07', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED03', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA05', 'S01GA01', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA18', 'S01XA20', 'S03BA02', 'V03AF03', 'V03AN01']",phs000007,pht005173,phv00257922,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005173\phv00257922\atc_cod1\,pht005173.v1,\phs000007\pht005173\phv00257922\atc_cod1\,phv00257922,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,e589a37b538d611cec94b142f5670f6677fd8ee01066c3039e428bacf2b2b800,categorical,phv00257922.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257922\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00479314.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479314,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00227300.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227300,"['A01AA01', 'A01AB18', 'A02A', 'A02AA02', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AB05', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A05AA02', 'A05BA03', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD11', 'A06AG', 'A06AG01', 'A07', 'A07AA02', 'A07AA09', 'A07AA51', 'A07DA01', 'A07DA03', 'A07EA06', 'A07EC01', 'A07EC02', 'A08AA01', 'A09AA02', 'A09AA04', 'A09AB02', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB06', 'A10AC01', 'A10AD02', 'A10AD04', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG03', 'A10BH01', 'A10BH03', 'A10BH05', 'A10BX02', 'A10BX03', 'A10BX04', 'A10BX07', 'A11AA', 'A11AA02', 'A11AA03', 'A11AA04', 'A11CA', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12AA20', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12BA51', 'A12CB', 'A12CC', 'A12CC01', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CC30', 'A12CD51', 'A12CE', 'A12CX', 'A14AA01', 'A16AA01', 'A16AA02', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC07', 'B01AC09', 'B01AC22', 'B01AC23', 'B01AE07', 'B01AF01', 'B02BA', 'B02BA01', 'B02BA02', 'B03A', 'B03AA03', 'B03AA07', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B03XA03', 'B05AA06', 'B05BA01', 'B05CB02', 'B05CX01', 'B05CX03', 'B05XA02', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01BD07', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05CA01', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09BA09', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AA08', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'C10BX03', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC14', 'D01AC15', 'D01AE04', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01BA02', 'D02BB01', 'D03AX05', 'D04AB01', 'D05AX02', 'D05BB02', 'D06AX05', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AC21', 'D07AD01', 'D07XB02', 'D07XC01', 'D08AG03', 'D10AD01', 'D10AF01', 'D10AF02', 'D10AX03', 'D11AX10', 'D11AX16', 'D11AX57', 'G01AX14', 'G02CB01', 'G03AA08', 'G03AB04', 'G03AB05', 'G03BA02', 'G03BA03', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03EA01', 'G03FA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BD11', 'G04BE01', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'H01BA02', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB06', 'H02AB07', 'H02AB08', 'H02AB09', 'H02AB10', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA02', 'H05BA01', 'H05BA03', 'H05BX01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CR02', 'J01CR50', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AB02', 'J02AC01', 'J04AB02', 'J04AC01', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AF08', 'J05AF10', 'L01BA01', 'L01BC02', 'L01BC06', 'L01BC07', 'L01XC07', 'L01XE01', 'L01XE03', 'L01XX05', 'L01XX32', 'L01XX35', 'L02AB01', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BB03', 'L02BG03', 'L02BG04', 'L02BG06', 'L02BX03', 'L03AA02', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA10', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AB02', 'L04AB05', 'L04AD01', 'L04AX01', 'L04AX03', 'L04AX04', 'M01AA01', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB55', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AA03', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX04', 'M09AX01', 'Medication not coded', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AG04', 'N02AX02', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04AA01', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD05', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX01', 'N06AX02', 'N06AX05', 'N06AX11', 'N06AX16', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07AX03', 'N07BA01', 'N07BA02', 'N07BA03', 'N07XX02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD11', 'R01AX03', 'R01AX06', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03AK07', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC03', 'R03CC02', 'R03DA04', 'R03DC03', 'R03DX07', 'R05CA02', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AA52', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD09', 'S01AX03', 'S01AX09', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA05', 'S01BA07', 'S01BA14', 'S01BA15', 'S01BC03', 'S01BC05', 'S01BC11', 'S01E', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01ED51', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA03', 'S01XA04', 'S01XA18', 'S01XA20', 'S02AA10', 'S02BA01', 'S03AA07', 'S03BA02', 'V01AA04', 'V03AB20', 'V03AB21', 'V03AB26', 'V03AE01', 'V03AE02', 'V03AF03', 'V03AN01', 'V06DC01', 'V10BX01']",phs000007,pht004810,phv00227300,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht004810\phv00227300\atc_cod1\,pht004810.v2,\phs000007\pht004810\phv00227300\atc_cod1\,phv00227300,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for medication or first drug in compound (character variable),phs000007.v31,019ad89d847f974967bfcfe48a60acb96d6e89eec02524882cacf2fe42c7638f,categorical,phv00227300.v2,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227300\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00177902.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177902,"['A01AA04', 'A01AB18', 'A01AB22', 'A01AB23', 'A02A', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB02', 'A03AX10', 'A03AX13', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AA01', 'A04AD01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD10', 'A06AD11', 'A06AG06', 'A06AX03', 'A07', 'A07BC01', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EA06', 'A07EC01', 'A07EC02', 'A07EC04', 'A07FA02', 'A08AA01', 'A08AA03', 'A08AB01', 'A09AA02', 'A09AA04', 'A09AC02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AB06', 'A10AC01', 'A10AD05', 'A10AE', 'A10AE01', 'A10AE04', 'A10AE05', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB09', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX02', 'A10BX04', 'A11A', 'A11AA', 'A11AA01', 'A11AA02', 'A11AA03', 'A11CA', 'A11CA02', 'A11CB', 'A11CC', 'A11CC01', 'A11CC04', 'A11CC05', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA', 'A12AA01', 'A12AA04', 'A12AA09', 'A12AX', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CB', 'A12CC', 'A12CC02', 'A12CC03', 'A12CC04', 'A12CC10', 'A12CD51', 'A12CE', 'A12CE01', 'A12CX', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB01', 'B01AC04', 'B01AC06', 'B02BA', 'B03A', 'B03AA02', 'B03AA03', 'B03AA07', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA03', 'B05AA06', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'C01AA05', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD07', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C01EB18', 'C02', 'C02AB', 'C02CA04', 'C02DC01', 'C03AA03', 'C03AA08', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB02', 'C04AD03', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AB12', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE14', 'D01AE15', 'D01AE16', 'D01AE22', 'D01BA02', 'D04AA32', 'D04AB01', 'D04AB03', 'D05AA', 'D05AX02', 'D05AX03', 'D05AX05', 'D06AX09', 'D06BB06', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AB19', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XC03', 'D08AG03', 'D10AB02', 'D10AD01', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX06', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD03', 'G02BA', 'G02CB01', 'G02CB03', 'G03A', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA04', 'G03DC02', 'G03EA01', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE04', 'G04BE08', 'G04BE09', 'G04BX01', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CA04', 'G04CB01', 'G04CB02', 'G04CX01', 'H02AA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB08', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'H05BX03', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA04', 'J01CE02', 'J01CE10', 'J01CR02', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD13', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA01', 'J01MA02', 'J01MA12', 'J01XA01', 'J01XD01', 'J01XE01', 'J01XX05', 'J01XX10', 'J02AB02', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB11', 'J05AE03', 'J05AE08', 'J05AF07', 'J05AH02', 'J05AX05', 'L01BA01', 'L01BC02', 'L01XC07', 'L01XE01', 'L02AA03', 'L02AE02', 'L02AE04', 'L02BA01', 'L02BG03', 'L02BG04', 'L02BG06', 'L03AB07', 'L03AX13', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AA21', 'L04AA23', 'L04AB02', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AB15', 'M01AC01', 'M01AC06', 'M01AE', 'M01AE01', 'M01AE02', 'M01AE09', 'M01AE11', 'M01AE12', 'M01AG01', 'M01AH01', 'M01AX01', 'M01AX05', 'M01AX25', 'M02AA15', 'M03', 'M03BA02', 'M03BA03', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M09AX01', 'Medication not coded', 'N01BB02', 'N02AA01', 'N02AA03', 'N02AA05', 'N02AB02', 'N02AC04', 'N02AE01', 'N02AX02', 'N02BA01', 'N02BA03', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CX02', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N03AX18', 'N04BA02', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX17', 'N06AX21', 'N06AX23', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BA11', 'N06BA12', 'N06BC01', 'N06BX12', 'N06DA02', 'N06DX02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB03', 'No medications listed', 'P01AB01', 'P01AX06', 'P01BA02', 'P01BC01', 'P01BC02', 'R01AA04', 'R01AA05', 'R01AA12', 'R01AC03', 'R01AC08', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AD12', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BA08', 'R03BB01', 'R03BB04', 'R03BC01', 'R03BC03', 'R03CA02', 'R03CC02', 'R03D', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AE09', 'R06AX02', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AB04', 'S01AX11', 'S01AX21', 'S01BA04', 'S01BA14', 'S01BC03', 'S01BC05', 'S01BC10', 'S01BC11', 'S01EA05', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01GA01', 'S01GX', 'S01GX08', 'S01GX09', 'S01KA02', 'S01XA18', 'S01XA20', 'S02AA03', 'S03BA02', 'V03AF03', 'V06DC01', 'V10BX01']",phs000007,pht003098,phv00177902,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht003098\phv00177902\atc_cod1\,pht003098.v5,\phs000007\pht003098\phv00177902\atc_cod1\,phv00177902,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,cb982369048562380ccb9a8ed9b8799d9f2ec51eb19f8545b3be6fcdc32e1fc3,categorical,phv00177902.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177902\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073779.v7.p14,pht000828.v8.p14,meds1_8s,phv00073779,"['A01AB13', 'A01AC01', 'A02A', 'A02AA01', 'A02AA02', 'A02AA04', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AB05', 'A03AE02', 'A03BA03', 'A03BB03', 'A03CA02', 'A03FA01', 'A04AA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AB07', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD', 'A06AD04', 'A06AD10', 'A06AD11', 'A06AD17', 'A07AA', 'A07AA11', 'A07BB', 'A07DA01', 'A07DA03', 'A07EA01', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB05', 'A10BB07', 'A10BB12', 'A10BF01', 'A10BG02', 'A10BG03', 'A10BH01', 'A10BX03', 'A10BX04', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11CC04', 'A11CC05', 'A11CC07', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA04', 'A11HA05', 'A11HA31', 'A11HA32', 'A12AA', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC01', 'A12CC05', 'A12CC09', 'A12CC10', 'A12CE', 'A16AA01', 'A16AA03', 'A16AA06', 'A16AX01', 'B01AA03', 'B01AB05', 'B01AC04', 'B01AC05', 'B01AC06', 'B01AC07', 'B02BA', 'B03AA03', 'B03AA07', 'B03AB07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB', 'B03BB01', 'B03XA02', 'B03XA03', 'B05BA01', 'B05XA06', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BA01', 'C01BA03', 'C01BC03', 'C01BC04', 'C01BD01', 'C01BD04', 'C01CA17', 'C01CA24', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02', 'C02AB01', 'C02AC01', 'C02CA01', 'C02CA04', 'C02DB02', 'C02DC01', 'C03AA03', 'C03AA04', 'C03BA04', 'C03BA08', 'C03BA11', 'C03CA01', 'C03CA02', 'C03CA04', 'C03CC01', 'C03DA01', 'C03DA04', 'C03DB01', 'C03DB02', 'C05AA01', 'C05AX02', 'C05BA04', 'C07AA03', 'C07AA05', 'C07AA06', 'C07AA07', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA04', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C09XA02', 'C10AA', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC02', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AE14', 'D01AE15', 'D01AE22', 'D01AE23', 'D04AA32', 'D04AB01', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB10', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC10', 'D07AC13', 'D07AC17', 'D07AD01', 'D08AG03', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AF01', 'D10AF02', 'D11AX10', 'D11AX14', 'D11AX16', 'G01AD01', 'G01AF04', 'G03AA05', 'G03AA08', 'G03AA11', 'G03AC06', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA04', 'G03CA57', 'G03CC04', 'G03DA04', 'G03DC02', 'G03XC01', 'G04BD02', 'G04BD04', 'G04BD07', 'G04BD08', 'G04BD09', 'G04BD10', 'G04BE03', 'G04BE08', 'G04BE09', 'G04BX06', 'G04CA01', 'G04CA02', 'G04CA03', 'G04CB01', 'G04CB02', 'G04CX01', 'H01BA02', 'H02AB02', 'H02AB04', 'H02AB07', 'H02AB09', 'H02AB10', 'H03AA', 'H03AA01', 'H03AA02', 'H03BA02', 'H03BB02', 'H05AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CR02', 'J01DB01', 'J01DC02', 'J01EA01', 'J01EC01', 'J01EC02', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01FA15', 'J01FF01', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XD01', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J04AB04', 'J04AK02', 'J05AB01', 'J05AB09', 'J05AB11', 'J05AE01', 'J05AE04', 'J05AF05', 'J05AF08', 'J05AG03', 'J06BB09', 'L01AX03', 'L01BA01', 'L01CD02', 'L01XE01', 'L01XX05', 'L02AA03', 'L02AB01', 'L02AE02', 'L02AE03', 'L02BA01', 'L02BB02', 'L02BB03', 'L02BG03', 'L02BG04', 'L03AA02', 'L03AX13', 'L04AA01', 'L04AA05', 'L04AA11', 'L04AA12', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX02', 'L04AX03', 'L04AX04', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AB08', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BA03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA03', 'M05BA04', 'M05BA06', 'M05BA07', 'M05BA08', 'M05BX01', 'M09AX01', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BA06', 'N02BA11', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC03', 'N02CC04', 'N02CC06', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N03AX16', 'N04BA01', 'N04BA02', 'N04BB01', 'N04BC04', 'N04BC05', 'N04BD01', 'N04BD02', 'N04BX02', 'N05AB04', 'N05AB06', 'N05AC02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA04', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA07', 'N05CD01', 'N05CD07', 'N05CF01', 'N05CF02', 'N05CH01', 'N05CH02', 'N05CM09', 'N05CM17', 'N06AA02', 'N06AA09', 'N06AA10', 'N06AA11', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AF03', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA07', 'N06BA09', 'N06BX12', 'N06DA02', 'N06DA03', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07AX01', 'N07BA01', 'N07BA02', 'N07BA03', 'N07BB01', 'N07BC02', 'P01AX06', 'P01BA02', 'P01BC01', 'R01AA05', 'R01AB01', 'R01AC03', 'R01AC07', 'R01AD02', 'R01AD04', 'R01AD05', 'R01AD08', 'R01AD09', 'R01AX03', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BA07', 'R03BB01', 'R03BB04', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R05CA03', 'R05CB01', 'R05DA03', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX21', 'S01AX22', 'S01BA03', 'S01BA04', 'S01BA07', 'S01BA14', 'S01BC03', 'S01BC05', 'S01EA05', 'S01EB01', 'S01EC01', 'S01EC03', 'S01EC04', 'S01ED01', 'S01ED02', 'S01ED05', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01FA04', 'S01GX07', 'S01GX09', 'S01XA03', 'S01XA18', 'S01XA20', 'S02AA03', 'S02AA14', 'S03BA02', 'V03AB26', 'V03AB32', 'V03AE02', 'V03AF03', 'V03AN01', 'V04CB01']",phs000007,pht000828,phv00073779,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000828\phv00073779\atc_cod1\,pht000828.v6,\phs000007\pht000828\phv00073779\atc_cod1\,phv00073779,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f047d29f1fd90d7a2dbb0e2fe3f2cbdbd626f0a5bfbd768aaeedbe06b6e68f8e,categorical,phv00073779.v5,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073779\atc_cod1\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00073748.v1.p14,pht000827.v2.p14,meds0_28s,phv00073748,"['A02A', 'A02AA04', 'A02AB', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03FA01', 'A05AA02', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD11', 'A06AG02', 'A07AA', 'A07BB', 'A07BC02', 'A07DA01', 'A07DA03', 'A07EC02', 'A09AA02', 'A10A', 'A10AB01', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A11AA', 'A11CC', 'A11CC04', 'A11DA01', 'A11E', 'A11EA', 'A11EB', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA31', 'A12AA04', 'A12AA09', 'A12AA12', 'A12BA', 'A12BA01', 'A12CB', 'A12CB01', 'A12CC', 'A12CC10', 'A12CE', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B01AC07', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03XA02', 'B05AA05', 'B05XB03', 'C01AA05', 'C01BA01', 'C01BC04', 'C01BD01', 'C01DA', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02AC01', 'C02CA04', 'C02DB02', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C05AA01', 'C07AA05', 'C07AA07', 'C07AA12', 'C07AB02', 'C07AB03', 'C07AB04', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA04', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA06', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AC01', 'C10AX06', 'C10AX09', 'D01A', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AE15', 'D02AB', 'D02AE01', 'D04AB07', 'D05AA', 'D06AX05', 'D06AX09', 'D06BA01', 'D06BX01', 'D07AA02', 'D07AB09', 'D07AC01', 'D07AD01', 'D10AF02', 'D11AX10', 'G01AF04', 'G03CA03', 'G03CA57', 'G03DB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04CA02', 'G04CA03', 'G04CB01', 'H01BA02', 'H02AB04', 'H02AB07', 'H03AA', 'H03AA01', 'H03AA03', 'H04AA01', 'H05AA02', 'H05BA01', 'J01AA02', 'J01CA04', 'J01CR02', 'J01DB01', 'J01EE01', 'J01FA01', 'J01MA12', 'J01XE01', 'J05AB01', 'J07BB', 'L01AA02', 'L02AE02', 'L02BA01', 'L02BG03', 'L04AA13', 'L04AX02', 'L04AX03', 'M01AB01', 'M01AB02', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03AB', 'M03BA02', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA01', 'M05BA04', 'M05BA07', 'N01AH01', 'N01BB02', 'N01BX04', 'N02AA05', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CX02', 'N03AA02', 'N03AA03', 'N03AE01', 'N03AF01', 'N03AG01', 'N03AX12', 'N04AC01', 'N04BA02', 'N04BC05', 'N05AB04', 'N05AD01', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05BA01', 'N05BA02', 'N05BA06', 'N05BA12', 'N05BE01', 'N05CD05', 'N05CF02', 'N05CF03', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX11', 'N06AX16', 'N06BX12', 'N06BX18', 'N06DA02', 'N06DA04', 'N06DX01', 'N06DX02', 'N07AB02', 'N07AX01', 'N07BA02', 'P01BA02', 'P01BC01', 'R01AC03', 'R01AD08', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC12', 'R03BA02', 'R03BA05', 'R03BB01', 'R03CC02', 'R03DA04', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AE05', 'R06AX13', 'R06AX26', 'S01AA03', 'S01AA17', 'S01AB04', 'S01AD02', 'S01BA04', 'S01BC03', 'S01BC05', 'S01CB03', 'S01EA05', 'S01EB01', 'S01EC03', 'S01EC04', 'S01EC05', 'S01ED01', 'S01ED03', 'S01ED04', 'S01ED05', 'S01EE01', 'S01EE03', 'S01XA03', 'S01XA20', 'S03AA07', 'S03BA02', 'V03AF03', 'V03AN01', 'V04CB01', 'V04CF01']",phs000007,pht000827,phv00073748,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000827\phv00073748\atc_cod1\,pht000827.v2,\phs000007\pht000827\phv00073748\atc_cod1\,phv00073748,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,f14b7dc6a900b25081bb4f825be7b75417acf4db7df901b976bd8fdbfc322f2f,categorical,phv00073748.v1,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073748\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound (character variable),phs000007.v33.p14,phv00257888.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257888,"['A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BB01', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX05', 'A03AX10', 'A03AX13', 'A03BA03', 'A03FA01', 'A06AA', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A07DA03', 'A07EC01', 'A07EC02', 'A08AA10', 'A09AA04', 'A10AB01', 'A10AB04', 'A10AC01', 'A10AE', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BG02', 'A10BG03', 'A10BX02', 'A11AA', 'A11AA01', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA05', 'A12AA', 'A12AA04', 'A12AA09', 'A12BA', 'A12BA01', 'A12CB', 'A12CC', 'A12CE', 'A12CX', 'A16AA01', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B03A', 'B03AA02', 'B03AA07', 'B03BA', 'B03BB01', 'B03XA02', 'B05BA01', 'B05XB01', 'C01AA05', 'C01BC03', 'C01DA02', 'C01DA08', 'C01DA14', 'C01EB09', 'C02AB', 'C02CA04', 'C03AA03', 'C03BA04', 'C03BA11', 'C03CA01', 'C03DA01', 'C03DB01', 'C03DB02', 'C07AA05', 'C07AA06', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C08CA01', 'C08CA02', 'C08CA05', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA08', 'C10AA01', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AD02', 'C10AX06', 'C10AX09', 'D01AC01', 'D01AE15', 'D03AX05', 'D05AX02', 'D06AX04', 'D06BX01', 'D07AA02', 'D07AC01', 'D07AC08', 'D07AC10', 'D07AD01', 'D10AD01', 'D10AF01', 'D10AX01', 'D11AX10', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03BA03', 'G03CA03', 'G03CA57', 'G03DA02', 'G03DA04', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE08', 'G04CA02', 'G04CA03', 'H01BA02', 'H02AA02', 'H02AB07', 'H03AA01', 'H03BB02', 'H05BA01', 'J01AA02', 'J01AA07', 'J01CA04', 'J01CE02', 'J01DB01', 'J01EE01', 'J01FA09', 'J01FA10', 'J01MA02', 'J02AC01', 'J05AB01', 'J05AE06', 'J05AF04', 'J05AF07', 'L02AA03', 'L03AB07', 'L04AA05', 'L04AA10', 'L04AA13', 'L04AB02', 'L04AX01', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AE01', 'M01AE02', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX05', 'M01AX25', 'M03', 'M04AA01', 'M04AC01', 'M05BA04', 'M05BA07', 'Medication not coded', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N02CC01', 'N02CC03', 'N02CC06', 'N02CX02', 'N03AA02', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AX11', 'N03AX12', 'N04BA02', 'N04BC06', 'N05BA01', 'N05BA04', 'N05BA06', 'N05BA12', 'N05CA07', 'N05CF02', 'N05CM17', 'N06AA09', 'N06AA10', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB10', 'N06AX05', 'N06AX16', 'N06BA04', 'N06BX12', 'N06DX02', 'N07BA02', 'No medications listed', 'P01BA02', 'P01BC01', 'R01AD05', 'R01AD09', 'R01BA02', 'R02AD02', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA05', 'R03BA06', 'R03BB01', 'R03CC02', 'R03DA04', 'R03DC03', 'R05CA03', 'R05DA03', 'R05DA09', 'R06A', 'R06AA02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01BA07', 'S01EA05', 'S01EC03', 'S01ED01', 'S01EE03', 'S01EE04']",phs000007,pht005172,phv00257888,True,False,False,atc_cod1,ATC code for medication or first drug in compound (character variable),,\phs000007\pht005172\phv00257888\atc_cod1\,pht005172.v3,\phs000007\pht005172\phv00257888\atc_cod1\,phv00257888,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for medication or first drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for medication or first drug in compound (character variable),phs000007.v31,ac327c01bd472d25f6acee0b5d203517ab287e72052e1281ecabba4bd9c54ee6,categorical,phv00257888.v3,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257888\atc_cod1\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod1,ATC code for medication or first drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod1,Framingham Cohort,atc_cod1,ATC code for medication or first drug in compound,phs000007.v33.p14,phv00066826.v8.p14,pht000676.v9.p14,meds3_1s,phv00066826,"['A01AA01', 'A01AB03', 'A02A', 'A02AB01', 'A02AC', 'A02AC01', 'A02BA01', 'A02BA02', 'A02BA03', 'A02BA04', 'A02BC01', 'A02BC02', 'A02BC03', 'A02BC04', 'A02BC05', 'A02BX02', 'A02BX05', 'A03AA07', 'A03AE02', 'A03BA03', 'A03BA04', 'A03FA01', 'A04AD01', 'A05BA03', 'A05BA06', 'A06A', 'A06AA', 'A06AA02', 'A06AB02', 'A06AB06', 'A06AC', 'A06AC01', 'A06AC06', 'A06AC07', 'A06AC08', 'A06AD17', 'A06AD19', 'A07AA09', 'A07BA01', 'A07DA01', 'A07DA03', 'A07EC01', 'A07EC02', 'A07EC04', 'A08AA01', 'A08AA10', 'A08AB01', 'A09AA02', 'A10A', 'A10AB01', 'A10AB04', 'A10AB05', 'A10AC01', 'A10AD01', 'A10AD04', 'A10AD05', 'A10AE01', 'A10AE04', 'A10BA02', 'A10BB01', 'A10BB07', 'A10BB12', 'A10BD03', 'A10BG02', 'A10BG03', 'A10BX03', 'A11AA', 'A11AA01', 'A11AA02', 'A11CA', 'A11CB', 'A11CC', 'A11E', 'A11EA', 'A11EB', 'A11EX', 'A11GA01', 'A11GB01', 'A11HA02', 'A11HA03', 'A11HA05', 'A11HA07', 'A11HA31', 'A12AA04', 'A12AA05', 'A12AA09', 'A12BA01', 'A12BA02', 'A12BA05', 'A12CA01', 'A12CB', 'A12CC', 'A12CC10', 'A12CE', 'A16AA03', 'A16AX01', 'B01AA03', 'B01AC04', 'B01AC06', 'B02BA', 'B03AA03', 'B03AA07', 'B03AE01', 'B03AE03', 'B03BA', 'B03BA01', 'B03BB01', 'B03BB51', 'B05XA01', 'B05XB01', 'B05XB03', 'B06AA11', 'C01AA05', 'C01BC04', 'C01CA24', 'C01DA02', 'C01DA14', 'C01EB09', 'C02AB01', 'C02AC01', 'C02AC02', 'C02CA04', 'C02DC01', 'C03AA03', 'C03CA01', 'C03CA02', 'C03DA01', 'C03DB01', 'C03DB02', 'C04AD03', 'C05AA11', 'C05BA04', 'C07AA05', 'C07AA12', 'C07AA23', 'C07AB02', 'C07AB03', 'C07AB07', 'C07AG01', 'C07AG02', 'C08CA01', 'C08CA02', 'C08CA03', 'C08CA05', 'C08CA07', 'C08DA01', 'C08DB01', 'C09AA01', 'C09AA02', 'C09AA03', 'C09AA05', 'C09AA06', 'C09AA07', 'C09AA09', 'C09AA10', 'C09AA13', 'C09CA01', 'C09CA03', 'C09CA04', 'C09CA06', 'C09CA07', 'C09CA08', 'C10AA01', 'C10AA02', 'C10AA03', 'C10AA04', 'C10AA05', 'C10AA07', 'C10AB04', 'C10AB05', 'C10AC01', 'C10AC04', 'C10AD02', 'C10AX06', 'C10AX08', 'C10AX09', 'D01AA01', 'D01AC01', 'D01AC03', 'D01AC08', 'D01AC15', 'D01AE12', 'D01AE13', 'D01AE14', 'D01AE15', 'D01AE18', 'D01AE23', 'D02BA01', 'D04AA32', 'D05AX02', 'D05AX05', 'D06AX04', 'D06AX05', 'D06AX09', 'D06BB11', 'D06BX01', 'D07AA02', 'D07AB08', 'D07AB09', 'D07AC01', 'D07AC03', 'D07AC04', 'D07AC08', 'D07AC13', 'D07AC17', 'D07AD01', 'D07XB02', 'D08AX03', 'D10AB02', 'D10AD01', 'D10AD03', 'D10AE01', 'D10AF01', 'D10AF02', 'D10AX01', 'D10AX03', 'D11AX01', 'D11AX10', 'D11AX15', 'G01AF04', 'G01AF15', 'G02CB01', 'G03AA01', 'G03AA05', 'G03AA06', 'G03AA07', 'G03AA08', 'G03AA09', 'G03AA11', 'G03AA12', 'G03AA13', 'G03AB03', 'G03AB04', 'G03AB05', 'G03AC03', 'G03AC06', 'G03AC08', 'G03AC09', 'G03BA02', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA53', 'G03CA57', 'G03CC04', 'G03DA02', 'G03DA03', 'G03DA04', 'G03DC02', 'G03FB06', 'G03GA01', 'G03GA05', 'G03GB02', 'G03XC01', 'G04BD04', 'G04BD07', 'G04BE03', 'G04BE09', 'G04BX06', 'G04CA02', 'G04CA03', 'G04CB01', 'H02AB04', 'H02AB07', 'H02AB09', 'H03AA', 'H03AA01', 'H03AA02', 'H03BB02', 'H05AA01', 'J01AA02', 'J01AA07', 'J01AA08', 'J01CA01', 'J01CA04', 'J01CE02', 'J01CF01', 'J01DB01', 'J01DB05', 'J01DC02', 'J01DD15', 'J01EC01', 'J01EE01', 'J01FA01', 'J01FA09', 'J01FA10', 'J01MA02', 'J01MA06', 'J01MA12', 'J01MA14', 'J01XE01', 'J01XX05', 'J02AC01', 'J02AC02', 'J05AB01', 'J05AB04', 'J05AB09', 'J05AB11', 'J05AE05', 'J05AF04', 'J05AF06', 'J05AG03', 'L01BB02', 'L01BC02', 'L02AA03', 'L02AB02', 'L02AE02', 'L02BA01', 'L02BG03', 'L03AB07', 'L03AB08', 'L04AA05', 'L04AA06', 'L04AA11', 'L04AA13', 'L04AA17', 'L04AX01', 'L04AX03', 'M01AB01', 'M01AB05', 'M01AC01', 'M01AC06', 'M01AE01', 'M01AE02', 'M01AE03', 'M01AE09', 'M01AE12', 'M01AH01', 'M01AH02', 'M01AH03', 'M01AX01', 'M01AX05', 'M01AX25', 'M03BA02', 'M03BB03', 'M03BC01', 'M03BX01', 'M03BX02', 'M03BX08', 'M04AA01', 'M04AB01', 'M04AC01', 'M05BA04', 'M05BA07', 'M05BA08', 'M09AX01', 'N01BA05', 'N02AA01', 'N02AA05', 'N02AB02', 'N02AB03', 'N02AC04', 'N02AX02', 'N02BA01', 'N02BE01', 'N02CA02', 'N02CC01', 'N02CC02', 'N02CC03', 'N02CC04', 'N02CC05', 'N02CC06', 'N02CC07', 'N03AA01', 'N03AA02', 'N03AA03', 'N03AB02', 'N03AE01', 'N03AF01', 'N03AF02', 'N03AG01', 'N03AG06', 'N03AX09', 'N03AX11', 'N03AX12', 'N03AX14', 'N03AX15', 'N04BA02', 'N04BB01', 'N04BC06', 'N05AB03', 'N05AB04', 'N05AE04', 'N05AH02', 'N05AH03', 'N05AH04', 'N05AN01', 'N05AX08', 'N05AX12', 'N05BA01', 'N05BA02', 'N05BA05', 'N05BA06', 'N05BA12', 'N05BB01', 'N05BE01', 'N05CA04', 'N05CA07', 'N05CD04', 'N05CD07', 'N05CF02', 'N05CF03', 'N05CM09', 'N05CM17', 'N06AA01', 'N06AA02', 'N06AA04', 'N06AA09', 'N06AA10', 'N06AA12', 'N06AB03', 'N06AB04', 'N06AB05', 'N06AB06', 'N06AB08', 'N06AB10', 'N06AX02', 'N06AX05', 'N06AX06', 'N06AX11', 'N06AX16', 'N06AX21', 'N06BA01', 'N06BA02', 'N06BA04', 'N06BA05', 'N06BA07', 'N06BA09', 'N06BC01', 'N06DX02', 'N07AA02', 'N07AB02', 'N07BA01', 'N07BA02', 'N07BC02', 'P01AB01', 'P01BA01', 'P01BA02', 'P01BC01', 'P03AC04', 'R01AA04', 'R01AA05', 'R01AC03', 'R01AD05', 'R01AD09', 'R01AD11', 'R01BA02', 'R01BA03', 'R03AA01', 'R03AC02', 'R03AC08', 'R03AC12', 'R03AC13', 'R03BA01', 'R03BA02', 'R03BA03', 'R03BA05', 'R03BA06', 'R03BB01', 'R03BC01', 'R03CB03', 'R03CC02', 'R03DA04', 'R03DC01', 'R03DC03', 'R03DX05', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R05DB01', 'R06A', 'R06AA02', 'R06AA04', 'R06AA09', 'R06AB01', 'R06AB02', 'R06AD02', 'R06AE05', 'R06AE07', 'R06AX13', 'R06AX26', 'R06AX27', 'S01AA03', 'S01AA11', 'S01AA12', 'S01AA17', 'S01AB04', 'S01AX11', 'S01AX13', 'S01BA07', 'S01BC03', 'S01CB02', 'S01EA02', 'S01EC03', 'S01ED01', 'S01EE01', 'S01EE03', 'S01EE04', 'S01FA01', 'S01GX02', 'S01GX04', 'S01GX07', 'S01GX09', 'S02AA03', 'S03AA01', 'S03BA02', 'V04CB01', 'V09DB04']",phs000007,pht000676,phv00066826,True,False,False,atc_cod1,ATC code for medication or first drug in compound,,\phs000007\pht000676\phv00066826\atc_cod1\,pht000676.v8,\phs000007\pht000676\phv00066826\atc_cod1\,phv00066826,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for medication or first drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for medication or first drug in compound,phs000007.v31,4199023ae35a5493ff18d448ec8235c232a01553cd8198a4a35e7831ecd1aad6,categorical,phv00066826.v7,phs000007,False,atc_cod1,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066826\atc_cod1\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073742.v1.p14,pht000827.v2.p14,meds0_28s,phv00073742,"['A02AA01', 'A02AA04', 'A03BA04', 'A03CA02', 'A06AB06', 'A07BC01', 'A10BA02', 'A11A', 'A11CA', 'A11CC', 'A11HA02', 'A12AA04', 'A12CC', 'B02BA', 'B03BB01', 'C01BA01', 'C03AA03', 'C09AA07', 'D07AB09', 'D10AB02', 'H03AA02', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03']",phs000007,pht000827,phv00073742,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000827\phv00073742\atc_cod2\,pht000827.v2,\phs000007\pht000827\phv00073742\atc_cod2\,phv00073742,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,a6bcd205336cdc9889c26132d79bd14ea573b812c8133e754775fd523b0de2ed,categorical,phv00073742.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073742\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00276897.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276897,"['A02AA', 'A02AA04', 'A02AC', 'A10BA02', 'A11CA01', 'A11CC', 'A11CC05', 'A11EA', 'A11HA02', 'A11HA03', 'A11HA31', 'A12CC', 'C03AA03', 'C03BA04', 'C08CA02', 'C09AA07', 'C10AA01', 'D05AX01', 'M01AE01', 'M01AX25', 'N02BA01', 'N02BE01', 'N06BC01', 'R01BA02', 'R03BA05', 'R03BB01', 'R05DA03', 'S01EC03']",phs000007,pht006019,phv00276897,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht006019\phv00276897\atc_cod2\,pht006019.v1,\phs000007\pht006019\phv00276897\atc_cod2\,phv00276897,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,f0ba63c433cee6550d1da00b864e5211a3570b71029f51e5e4238a8be801ab2a,categorical,phv00276897.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276897\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00066820.v8.p14,pht000676.v9.p14,meds3_1s,phv00066820,"['A02AA01', 'A02AA04', 'A02AC', 'A03AX10', 'A03BA04', 'A03BB03', 'A03CA02', 'A09AB04', 'A10BA02', 'A11CC', 'A11GA01', 'A12CB', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B02BA', 'B03BB', 'C03AA03', 'C04AB01', 'C08CA02', 'C09AA07', 'C09AA13', 'C10AA02', 'D07AC01', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DA04', 'H03AA02', 'M01AE02', 'M01AX05', 'M01AX25', 'N02AA05', 'N02AC04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX07', 'S01AA18', 'S01EC03', 'S02AA11', 'S03AA03']",phs000007,pht000676,phv00066820,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000676\phv00066820\atc_cod2\,pht000676.v8,\phs000007\pht000676\phv00066820\atc_cod2\,phv00066820,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,5044314eeb66fe9670b513abb27c52e8ad40a11e63a4844811161d57b5c4ab0b,categorical,phv00066820.v7,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066820\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00073773.v7.p14,pht000828.v8.p14,meds1_8s,phv00073773,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A03BA04', 'A03CA02', 'A06AB06', 'A06AB07', 'A09AB04', 'A10AB04', 'A10BA02', 'A10BB01', 'A10BG03', 'A11A', 'A11CA', 'A11CA01', 'A11CC', 'A11CC05', 'A11E', 'A11HA02', 'A11HA03', 'A12AA03', 'A12AA04', 'A12CC', 'A12CC04', 'A12CC10', 'A12CE', 'B01AC07', 'B02BA', 'B03BB', 'B03BB01', 'B05XA09', 'C01BA01', 'C01EB09', 'C02KB', 'C03AA03', 'C03BA04', 'C04AC01', 'C08CA02', 'C08DA01', 'C09AA07', 'C09AA10', 'C09AA13', 'C10AA01', 'C10AA05', 'C10AD02', 'D01AE12', 'D07AB09', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J05AF01', 'M01AE01', 'M01AX05', 'M01AX25', 'M03BA02', 'N01BB04', 'N02AA05', 'N02BA01', 'N02BE01', 'N06BC01', 'R01AA04', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AX13', 'S01AA18', 'S01EC03']",phs000007,pht000828,phv00073773,True,False,False,atc_cod2,ATC code for second drug in compound,,\phs000007\pht000828\phv00073773\atc_cod2\,pht000828.v6,\phs000007\pht000828\phv00073773\atc_cod2\,phv00073773,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for second drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for second drug in compound,phs000007.v31,3177fcb11a30df53ca1f7dbbf7dd9db38f910f5ffb0619f2cfe489501769a396,categorical,phv00073773.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073773\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00177903.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177903,"['A02AA04', 'A02AC', 'A02BB01', 'A03BA01', 'A03BB03', 'A06AB06', 'A09AB04', 'A10BH01', 'A11CA', 'A11CA01', 'A11CC', 'A11CC01', 'A11CC05', 'A11EA', 'A11GA01', 'A11HA02', 'A11HA03', 'A11HA07', 'A12', 'A12AA', 'A12CB', 'A12CC', 'A12CC04', 'A12CX', 'B01AC07', 'B02BA', 'B02BA02', 'B03A', 'B03BB', 'B03BB01', 'B05CB04', 'B05XB03', 'C01EB09', 'C03AA03', 'C03BA04', 'C05CA', 'C09AA07', 'C09CA03', 'C10AA01', 'C10AA02', 'C10AA05', 'C10AD02', 'D05AX02', 'D06AX07', 'D07AC01', 'D10AD01', 'G03BA03', 'G03CA01', 'G03CA03', 'G03CA57', 'G03DC02', 'H03AA02', 'J01XB02', 'M01AE01', 'M01AE02', 'M01AX05', 'M01AX25', 'M03BA02', 'N02BA01', 'N02BE01', 'N03AA02', 'N05CA01', 'N05CC04', 'N06BA02', 'N06BC01', 'P01BB01', 'R01AA04', 'R01B', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'V03AB15']",phs000007,pht003098,phv00177903,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht003098\phv00177903\atc_cod2\,pht003098.v5,\phs000007\pht003098\phv00177903\atc_cod2\,phv00177903,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for second drug in compound (character variable),phs000007.v31,6a89638dc159a333336547ae98b1e9751028d39998559343a1802aea0a0c1eaa,categorical,phv00177903.v5,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177903\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00227301.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227301,"['A02AA01', 'A02AA04', 'A02BB01', 'A03BA01', 'A10AB04', 'A10BA02', 'A10BH01', 'A10BH03', 'A11A', 'A11CC', 'A11CC05', 'A11EA', 'A11GA01', 'A12AA', 'A12BA', 'A12CB', 'A12CC', 'B02BA', 'B02BA02', 'B03BA', 'B03BB', 'B03BB01', 'C01EB09', 'C03AA03', 'C05CA', 'C09AA07', 'C09CA03', 'C09CA08', 'C10AA01', 'C10AA05', 'C10AX06', 'D06AX07', 'D07AB08', 'G03CA01', 'G03CA03', 'G04AB01', 'G04CB02', 'H03AA02', 'M01AE01', 'M01AE02', 'M01AX25', 'M09AX01', 'N01BB04', 'N02BA01', 'N02BE01', 'N05CA01', 'N06BA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R03AC02', 'R03AC13', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB05', 'S01AA18', 'S01BA04', 'S01EC03', 'S01ED01', 'S02AA10']",phs000007,pht004810,phv00227301,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht004810\phv00227301\atc_cod2\,pht004810.v2,\phs000007\pht004810\phv00227301\atc_cod2\,phv00227301,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for second drug in compound (character variable),phs000007.v31,e67f51604ac82088739fbea56c93ed9c855d57b4668ab4d70dd23b547a5bfcae,categorical,phv00227301.v2,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227301\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257889.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257889,"['A02AA04', 'A02AC', 'A02BB01', 'A09AB04', 'A11A', 'A11CA', 'A11CC', 'A12CC', 'A12CC04', 'A16AA01', 'B02BA', 'B03BB01', 'C03AA03', 'C10AA02', 'G03DC02', 'J05AE03', 'M01AX25', 'N02BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA04', 'R05DA09', 'R06A', 'R06AA02', 'R06AB02', 'S01EC03', 'S02AA11']",phs000007,pht005172,phv00257889,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005172\phv00257889\atc_cod2\,pht005172.v3,\phs000007\pht005172\phv00257889\atc_cod2\,phv00257889,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,229029cc3790b07ac150820030285bf66a9148819d39a4ce4831ba5b21188a4b,categorical,phv00257889.v3,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257889\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00257923.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257923,"['A02AA04', 'A03BA01', 'A06AB06', 'A06AB07', 'A09AB04', 'A11A', 'A11CC', 'A11CC05', 'A11HA02', 'A11HA03', 'A12', 'A12AA', 'A12AA04', 'A12BA', 'A12CC', 'A12CC04', 'B03BB01', 'C03AA03', 'C05CA', 'C09AA07', 'C10AA01', 'C10AA05', 'D07AB09', 'D07AC01', 'G04BX12', 'M01AX25', 'N02AA05', 'N02BE01', 'R01BA02', 'R03AC02', 'R03BA05', 'R03BB01', 'R05CA03', 'R05DA03', 'R05DA04', 'R05DA09', 'R06AA02', 'R06AB02', 'R06AB05', 'S01BA04', 'S01EC03', 'S01ED01']",phs000007,pht005173,phv00257923,True,False,False,atc_cod2,ATC code for second drug in compound (character variable),,\phs000007\pht005173\phv00257923\atc_cod2\,pht005173.v1,\phs000007\pht005173\phv00257923\atc_cod2\,phv00257923,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for second drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for second drug in compound (character variable),phs000007.v31,6465463f3dc02567176976302a3182df68aaff5f3338cb02c2e5f24b46a74d4e,categorical,phv00257923.v1,phs000007,False,atc_cod2,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257923\atc_cod2\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound,phs000007.v33.p14,phv00479286.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479286,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod2,ATC code for medication or second drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod2,Framingham Cohort,atc_cod2,ATC code for second drug in compound (character variable),phs000007.v33.p14,phv00479315.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479315,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073791.v7.p14,pht000828.v8.p14,meds1_8s,phv00073791,"['A02AC', 'A02AH', 'A11AA', 'A11CC', 'A11HA31', 'A12AA05', 'A12BA', 'A12CB', 'B02BA', 'B03BA01', 'G03CC06', 'N03AA02', 'N06BC01', 'R01AA04', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht000828,phv00073791,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000828\phv00073791\atc_cod3\,pht000828.v6,\phs000007\pht000828\phv00073791\atc_cod3\,phv00073791,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,c290c13d038f241844faf3f50b43cdef4b57629d99067f95efa6ead3a64511e5,categorical,phv00073791.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073791\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00073760.v1.p14,pht000827.v2.p14,meds0_28s,phv00073760,"['A11AA', 'A11CC', 'B03A', 'B03BA01', 'N02BA04', 'N03AA02', 'N06BC01', 'R01BA02', 'R02AB30']",phs000007,pht000827,phv00073760,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000827\phv00073760\atc_cod3\,pht000827.v2,\phs000007\pht000827\phv00073760\atc_cod3\,phv00073760,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,5996070ee2cfc15d6b7b271e8a7f6ce93ed44c639bd5623624be90f0a5b45e73,categorical,phv00073760.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073760\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00276915.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276915,"['A11CC', 'A11CC05', 'A11HA02', 'A12', 'A12CB', 'N06BC01']",phs000007,pht006019,phv00276915,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht006019\phv00276915\atc_cod3\,pht006019.v1,\phs000007\pht006019\phv00276915\atc_cod3\,phv00276915,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,486f1d7b99ccbee65d1134f7c6efa5777f317f9cb940a606dc35ac350c6a6957,categorical,phv00276915.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276915\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257890.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257890,"['A02AH', 'A11CC', 'A11CC05', 'B03BA01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA03', 'R05CA03', 'R06AA09', 'R06AC01']",phs000007,pht005172,phv00257890,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005172\phv00257890\atc_cod3\,pht005172.v3,\phs000007\pht005172\phv00257890\atc_cod3\,phv00257890,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,a3515581368c03bc0e43c0dea66ce79b0796b51859aa2201027870fbe92f0970,categorical,phv00257890.v3,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257890\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00227302.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227302,"['A11CC', 'A11CC05', 'A11EA', 'A11HA03', 'A12', 'A12BA', 'A12CB', 'B02BA', 'B03BB01', 'D01AE18', 'G03BA03', 'G03CC06', 'G04BE02', 'M09AX01', 'N02BA04', 'N06BC01', 'R01BA02', 'R02AB30', 'R06AA09']",phs000007,pht004810,phv00227302,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht004810\phv00227302\atc_cod3\,pht004810.v2,\phs000007\pht004810\phv00227302\atc_cod3\,phv00227302,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for third drug in compound (character variable),phs000007.v31,d2360aece7ae80fd29417728a2ed51f6bbf57d1de89ae18db34543e6c7a86505,categorical,phv00227302.v2,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227302\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00177904.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177904,"['A02AH', 'A11AA', 'A11CC', 'A11CC05', 'A11EA', 'A12', 'A12CB', 'A12CC', 'B02BA', 'B02BC07', 'B03AA02', 'B03BB01', 'D01AE18', 'D11AX11', 'G03BA03', 'G03CC06', 'M01AX25', 'M09AX01', 'N02BE01', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA', 'R01BA01', 'R01BA02', 'R01BA03', 'R02AB30', 'R06AA09', 'R06AC01']",phs000007,pht003098,phv00177904,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht003098\phv00177904\atc_cod3\,pht003098.v5,\phs000007\pht003098\phv00177904\atc_cod3\,phv00177904,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for third drug in compound (character variable),phs000007.v31,857b2111715cbe578c0f6670c5e93b0f3e14a3a369dab0cb6956b787033fed42,categorical,phv00177904.v5,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177904\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00066838.v8.p14,pht000676.v9.p14,meds3_1s,phv00066838,"['A02AH', 'A11AA', 'A11CC', 'A12CB', 'B02BA', 'G03CC06', 'N02AA08', 'N02BE01', 'N03AA02', 'N05CC04', 'N06BC01', 'R01AA04', 'R01BA02', 'R01BA03', 'R02AB30', 'R05CA03', 'R05DA04', 'R06AA02', 'R06AA09', 'R06AC01', 'S02BA01']",phs000007,pht000676,phv00066838,True,False,False,atc_cod3,ATC code for third drug in compound,,\phs000007\pht000676\phv00066838\atc_cod3\,pht000676.v8,\phs000007\pht000676\phv00066838\atc_cod3\,phv00066838,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for third drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for third drug in compound,phs000007.v31,48a4a40c7e2fd97ae529e7e71711a4175130d855a724040194c1935b3962e911,categorical,phv00066838.v7,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066838\atc_cod3\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00257924.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257924,"['A02AH', 'A11AA', 'A11CC', 'A11G', 'B03BA01', 'M09AX01', 'N02BA04', 'R01BA02', 'R05DA09']",phs000007,pht005173,phv00257924,True,False,False,atc_cod3,ATC code for third drug in compound (character variable),,\phs000007\pht005173\phv00257924\atc_cod3\,pht005173.v1,\phs000007\pht005173\phv00257924\atc_cod3\,phv00257924,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for third drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for third drug in compound (character variable),phs000007.v31,f6f51c0f2a8b755b94db7cd727e32f6d8a6f12caa7808136c523a43e99e3328f,categorical,phv00257924.v1,phs000007,False,atc_cod3,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257924\atc_cod3\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound (character variable),phs000007.v33.p14,phv00479316.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479316,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod3,ATC code for medication or third drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod3,Framingham Cohort,atc_cod3,ATC code for third drug in compound,phs000007.v33.p14,phv00479298.v1.p14,pht010755.v1.p14,vr_meds_ex03_3b_1071s,phv00479298,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
ASPIRIN,"Taking aspirin (0=No, 1=Yes)",387458008,C10463,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00066839.v8.p14,pht000676.v9.p14,meds3_1s,phv00066839,"['G03DA04', 'R01BA02', 'R05DA04', 'R06AB02']",phs000007,pht000676,phv00066839,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000676\phv00066839\atc_cod4\,pht000676.v8,\phs000007\pht000676\phv00066839\atc_cod4\,phv00066839,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication from Clinic Exam, Generation 3 Cohort Exam 1. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,c234136b05e8dd83cf0411b74b24e5cef1a4681aa2f39e37e8e96cdb43e7f844,categorical,phv00066839.v7,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000676,meds3_1s,\phs000007\pht000676\phv00066839\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073792.v7.p14,pht000828.v8.p14,meds1_8s,phv00073792,"['A11CC05', 'A11EA', 'B03AA07', 'G03DA04', 'R05DA04']",phs000007,pht000828,phv00073792,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000828\phv00073792\atc_cod4\,pht000828.v6,\phs000007\pht000828\phv00073792\atc_cod4\,phv00073792,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Offspring Cohort Exam 8. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,7537382b43bceba037c404ed9b56ceb41e54f9ec67995fa78fa9dace952edc39,categorical,phv00073792.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000828,meds1_8s,\phs000007\pht000828\phv00073792\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound,phs000007.v33.p14,phv00073761.v1.p14,pht000827.v2.p14,meds0_28s,phv00073761,['N06BC01'],phs000007,pht000827,phv00073761,True,False,False,atc_cod4,ATC code for fourth drug in compound,,\phs000007\pht000827\phv00073761\atc_cod4\,pht000827.v2,\phs000007\pht000827\phv00073761\atc_cod4\,phv00073761,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",ATC code for fourth drug in compound,{},,"World Health Organization's Anatomical Therapeutic Chemical (ATC) Coding for Medication, Original Cohort Exam 28. Data collected include ATC codes, chemical subgroup of drugs, medication name and use.",,ATC code for fourth drug in compound,phs000007.v31,8b96f41cd36b54447fc6a41fe82612c48f33c7f54a837ab92fd1099ec5db26b5,categorical,phv00073761.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht000827,meds0_28s,\phs000007\pht000827\phv00073761\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257925.v1.p14,pht005173.v1.p14,vr_meds_ex31_0_0763s,phv00257925,"['A12BA02', 'N06BC01']",phs000007,pht005173,phv00257925,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005173\phv00257925\atc_cod4\,pht005173.v1,\phs000007\pht005173\phv00257925\atc_cod4\,phv00257925,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Original Cohort Exams 29, 30 and 31. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,0a8c7e1183a8f959d24b1667d6ce74caf23f695654c1276e315194681a25fa26,categorical,phv00257925.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005173,vr_meds_ex31_0_0763s,\phs000007\pht005173\phv00257925\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00257891.v3.p14,pht005172.v3.p14,vr_meds_ex01_3b_0825s,phv00257891,['R01BA02'],phs000007,pht005172,phv00257891,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht005172\phv00257891\atc_cod4\,pht005172.v3,\phs000007\pht005172\phv00257891\atc_cod4\,phv00257891,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), New Offspring Spouse and Omni 2, Exam 1. Medications were reported by study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,00b4254fb1e4098aabec7c17565e0f745e291f8d5730e04ea67ee6d477269fe0,categorical,phv00257891.v3,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht005172,vr_meds_ex01_3b_0825s,\phs000007\pht005172\phv00257891\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00479317.v1.p14,pht010756.v1.p14,vr_meds_ex32_0_0880s,phv00479317,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
INSULIN,"Taking insulin (0=No, 1=Yes)",67866001,C20268,ARICFraminghamMESAREGARDS,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00177905.v6.p14,pht003098.v6.p14,vr_meds_2011_m_0675s,phv00177905,"['D08AH30', 'G03DA04']",phs000007,pht003098,phv00177905,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht003098\phv00177905\atc_cod4\,pht003098.v5,\phs000007\pht003098\phv00177905\atc_cod4\,phv00177905,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam, Generation 3 Exam 2, New Offspring Spouse Exam 2, and Omni 2 Exam 2. Participants were mailed a medication bag with a request to bring in all prescription and non-prescription medication to the clinic. The physician recorded all the medications during the clinic visit. These medications were then coded using the World Health Organization&#39;s Anatomical Therapeutic Chemical (ATC) classifications. Information about the ATC classification system can be found at http://www.whocc.no/atcddd/. See protocol document for more details.",,ATC code for fourth drug in compound (character variable),phs000007.v31,091cf52064da725fdcd082074b23529d07f4627e34978ef2abc10d03d00361df,categorical,phv00177905.v5,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht003098,vr_meds_2011_m_0675s,\phs000007\pht003098\phv00177905\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00227303.v4.p14,pht004810.v4.p14,vr_meds_ex09_1b_0879s,phv00227303,"['D08AH30', 'N06BC01']",phs000007,pht004810,phv00227303,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht004810\phv00227303\atc_cod4\,pht004810.v2,\phs000007\pht004810\phv00227303\atc_cod4\,phv00227303,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Offspring Exam 9 and Omni 1 Exam 4",,ATC code for fourth drug in compound (character variable),phs000007.v31,268c48d51d9f25c1d5a46f539808d7e26153aeab2726a61f008d89be22913fc8,categorical,phv00227303.v2,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht004810,vr_meds_ex09_1b_0879s,\phs000007\pht004810\phv00227303\atc_cod4\,,
NONSTATIN,"Taking non-statin medication (0=No, 1=Yes)",-,-,FraminghamMESA,1.24,Framingham,vr_meds_ex09_1b_0879d.atc_cod4,ATC code for medication or fourth drug in compound,-,vr_meds_ex09_1b_0879d,atc_cod4,Framingham Cohort,atc_cod4,ATC code for fourth drug in compound (character variable),phs000007.v33.p14,phv00276916.v2.p14,pht006019.v2.p14,vr_meds_ex03_7_0535s,phv00276916,['A11CC'],phs000007,pht006019,phv00276916,True,False,False,atc_cod4,ATC code for fourth drug in compound (character variable),,\phs000007\pht006019\phv00276916\atc_cod4\,pht006019.v1,\phs000007\pht006019\phv00276916\atc_cod4\,phv00276916,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",ATC code for fourth drug in compound (character variable),{},,"Medications Reported at Clinic Exam (ATC coded), Omni 1 Exam 3. This dataset includes medications reported as taken regularly in the past month by Omni 1 Exam 3 study participants, coded with WHO ATC medication codes.",,ATC code for fourth drug in compound (character variable),phs000007.v31,97efb597490a8a7324c6743f165f5bac2e6a06457c5acae44aa2a6e02e0ef8aa,categorical,phv00276916.v1,phs000007,False,atc_cod4,FHS,Framingham Cohort,pht006019,vr_meds_ex03_7_0535s,\phs000007\pht006019\phv00276916\atc_cod4\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Jackson Heart Study (JHS) Cohort,DATE,Date of Interview,phs000286.v7.p2,phv00400850.v2.p2,pht008725.v2.p2,afulong,phv00400850,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Exam date,phs000007.v33.p14,phv00523290.v1.p14,pht012900.v1.p14,t_ecgclinic_2011_a_0706s,phv00523290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date of the exam in which the digital clock drawing test occurred,phs000007.v33.p14,phv00522520.v1.p14,pht012896.v1.p14,t_clockdct_2018_a_1360s,phv00522520,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date participant underwent VCTE (date only),phs000007.v33.p14,phv00464425.v1.p14,pht010735.v1.p14,t_livrvcte_ex03_3b_1253s,phv00464425,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00065288.v2.p14,pht000608.v3.p14,t_mrcdwma_2006_1b_0909s,phv00065288,[],phs000007,pht000608,phv00065288,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",10293.0,\phs000007\pht000608\phv00065288\date\,pht000608.v2,\phs000007\pht000608\phv00065288\date\,phv00065288,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Wall Motion Abnormality, Offspring Cohort 2002 - 2006",12335.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,4bc588d6ef4a883f2289d30768df825594e5cce46e417e3615d61b75454229b5,continuous,phv00065288.v1,phs000007,True,date,FHS,Framingham Cohort,pht000608,cmrwma1_2006s,\phs000007\pht000608\phv00065288\date\,10293.0,12335.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00065269.v5.p14,pht000607.v6.p14,cmrplaq1_2006s,phv00065269,[],phs000007,pht000607,phv00065269,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000607\phv00065269\date\,pht000607.v4,\phs000007\pht000607\phv00065269\date\,phv00065269,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Plaque, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,80c6698cbe96dfb865a556e89c99a791c93a86ab178d7344a77edef0843ac467,continuous,phv00065269.v3,phs000007,True,date,FHS,Framingham Cohort,pht000607,cmrplaq1_2006s,\phs000007\pht000607\phv00065269\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Framingham Heart Study exam date (blood draw date),phs000007.v33.p14,phv00219227.v5.p14,pht004361.v5.p14,l_bamyl_ex02_3b_0818s,phv00219227,[],phs000007,pht004361,phv00219227,False,True,True,DATE,Framingham Heart Study exam date (blood draw date),1092.0,\phs000007\pht004361\phv00219227\DATE\,pht004361.v4,\phs000007\pht004361\phv00219227\DATE\,phv00219227,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",Framingham Heart Study exam date (blood draw date),{},,"Beta Amyloid, Generation 3 Exam 2 and Omni 2 Exam 2. One of the two pathological hallmarks of Alzheimer's Disease (AD) is the presence of amyloid-containing senile plaques; a key component of these plaques is insoluble forms of the beta-amyloid (AB) protein, specifically AB1-42 and AB1-40. Plasma concentrations of AB1-42 and AB1-40 levels were measured using a fluorimetric immunoassay, to evaluate the clinical correlates, and to assess the prognostic significance in AD and its precursor, mild cognitive impairment (MCI). The limit of detection for this assay is 12pg/ml for AB1-40 and 5pg/ml for AB1-42. All assays were run on a single lot.",3176.0,Framingham Heart Study exam date (blood draw date),phs000007.v31,fa14aa39db158f46e3e5f0806cf97e010fb1fcc3842c74586baaa0e458b1f2f6,continuous,phv00219227.v4,phs000007,True,DATE,FHS,Framingham Cohort,pht004361,l_bamyl_ex02_3b_0818s,\phs000007\pht004361\phv00219227\DATE\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021691.v8.p14,pht000080.v9.p14,crp1_2s,phv00021691,[],phs000007,pht000080,phv00021691,False,True,True,date,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",1996.0,\phs000007\pht000080\phv00021691\date\,pht000080.v7,\phs000007\pht000080\phv00021691\date\,phv00021691,"C-Reactive Protein, Offspring Cohort Exam 2","DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",{},,"C-Reactive Protein, Offspring Cohort Exam 2",4227.0,"DATE OF CRP MEASUREMENT, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,552331d5b12c464464b5863974458f2e5d9194b166a78a903ded6f8621ad30b3,continuous,phv00021691.v6,phs000007,True,date,FHS,Framingham Cohort,pht000080,crp1_2s,\phs000007\pht000080\phv00021691\date\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v33.p14,phv00021936.v8.p14,pht000092.v9.p14,homocys1_2s,phv00021936,[],phs000007,pht000092,phv00021936,False,True,True,date,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",1840.0,\phs000007\pht000092\phv00021936\date\,pht000092.v7,\phs000007\pht000092\phv00021936\date\,phv00021936,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2","TEST DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cysteine, Homocysteine, Cysteinylglycine, Offspring Cohort Exam 2",4227.0,"TEST DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,87078a6371ef4e8fd4e33fa5992e6795059c7aba0c2ff261c3b1aa1ac2cdf876,continuous,phv00021936.v6,phs000007,True,date,FHS,Framingham Cohort,pht000092,homocys1_2s,\phs000007\pht000092\phv00021936\date\,1840.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064606.v5.p14,pht000605.v6.p14,t_mrcdafat_2005_1b_0905s,phv00064606,[],phs000007,pht000605,phv00064606,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000605\phv00064606\date\,pht000605.v4,\phs000007\pht000605\phv00064606\date\,phv00064606,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Abdominal Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,8efa22508734beab3b933ff3628c8c81d2d1181ec8d30fdf55b688b122daabe3,continuous,phv00064606.v3,phs000007,True,date,FHS,Framingham Cohort,pht000605,cmrafat1_2006s,\phs000007\pht000605\phv00064606\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Date of Event,phs000007.v33.p14,phv00036471.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036471,[],phs000007,pht000309,phv00036471,False,True,True,DATE,Date of Event,-8824.0,\phs000007\pht000309\phv00036471\DATE\,pht000309.v14,\phs000007\pht000309\phv00036471\DATE\,phv00036471,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Date of Event,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",24989.0,Date of Event,phs000007.v31,bfe56119f76e1b1129ddc49832e08a5f3d613a9c5b67bb8b77a56ebb51cc48e4,continuous,phv00036471.v13,phs000007,True,DATE,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036471\DATE\,-8824.0,24989.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,DATE,Cardiac MRI scan date,phs000007.v33.p14,phv00064617.v5.p14,pht000606.v6.p14,t_mrcdefat_2005_1b_0906s,phv00064617,[],phs000007,pht000606,phv00064617,False,True,True,date,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",9914.0,\phs000007\pht000606\phv00064617\date\,pht000606.v4,\phs000007\pht000606\phv00064617\date\,phv00064617,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006","CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",{},,"Cardiac MRI Epicardial Fat, Offspring Cohort 2002 - 2006",12365.0,"CARDIAC MRI SCAN DATE, NUMBER OF DAYS SINCE EXAM 1",phs000007.v31,b1b5d3f503a0f6ac061312719b5b0fc5381a7fd95c82dfb3dc54baa5a440ef60,continuous,phv00064617.v3,phs000007,True,date,FHS,Framingham Cohort,pht000606,cmrefat1_2006s,\phs000007\pht000606\phv00064617\date\,9914.0,12365.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.date,DATE OF EVENT,0.016110843,vr_soe_2020_a_1340d,date,Framingham Cohort,date,Date Test Administered,phs000007.v33.p14,phv00056634.v7.p14,pht000395.v10.p14,t_sleephhs_1998_1b_1056s,phv00056634,[],phs000007,pht000395,phv00056634,False,True,True,date,Date Test Administered,7810.0,\phs000007\pht000395\phv00056634\date\,pht000395.v9,\phs000007\pht000395\phv00056634\date\,phv00056634,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",Date Test Administered,{},,"Sleep Heart Health Study Baseline, Offspring Cohort 1995 - 1998",9409.0,Date Test Administered,phs000007.v31,bea839e9ead7a860b147a376e439a4dc32ff131f775b7440c922f55a3b4205dc,continuous,phv00056634.v6,phs000007,True,date,FHS,Framingham Cohort,pht000395,sleep1_1998s,\phs000007\pht000395\phv00056634\date\,7810.0,9409.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 1],phs000280.v8.p2,phv00511359.v1.p2,pht004231.v3.p2,V1ECG,phv00511359,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 3],phs000280.v8.p2,phv00511399.v1.p2,pht004233.v3.p2,V3ECG,phv00511399,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 4],phs000280.v8.p2,phv00511419.v1.p2,pht004234.v3.p2,V4ECG,phv00511419,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event,phs000280.v8.p2,phv00511469.v1.p2,pht012807.v1.p2,AMY3,phv00511469,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,Event,Event [ECG data. Visit 2],phs000280.v8.p2,phv00511379.v1.p2,pht004232.v3.p2,V2ECG,phv00511379,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,Event [Ultrasound Raw Data. UBME. Visit 2],phs000280.v8.p2,phv00518230.v1.p2,pht012849.v1.p2,UBME,phv00518230,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Atherosclerosis Risk in Communities (ARIC) Cohort,EVENT,EVENT [Ultrasound Raw Data. UBMDALL. Visit 1],phs000280.v8.p2,phv00211151.v2.p2,pht004208.v3.p2,UBMDALL,phv00211151,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_soe_2020_a_1340d.event,EVENT NUMBER ON SEQUENCE OF EVENTS,-,vr_soe_2020_a_1340d,event,Framingham Cohort,EVENT,Event Number,phs000007.v33.p14,phv00036469.v15.p14,pht000309.v16.p14,vr_soe_2020_a_1340s,phv00036469,"['ABI (Atherothrombotic Infarction of brain)', 'AP, first episode only', 'Acute MI by autopsy, previously coded as 1 or 2', 'CHF, hospitalized', 'CHF, not hospitalized, diagnosed on basis of on exam or MD notes', 'CHF, questionable CHF at exam 1', 'CI, definite by both history and ECG', 'CVA, definite CVA, type unknown', 'Cerebral embolism', 'Death, CHD sudden, within 1 hour', 'Death, CHD, 1-23 hours, non sudden', 'Death, CHD, 24-47 hours, non sudden', 'Death, CHD, 48 hours or more, non sudden', 'Death, CVA', 'Death, Cancer', 'Death, cause unknown', 'Death, other CVD', 'Death, other causes', 'Definite CVA at exam 1, but questionable type', 'IC, first episode only', 'IC, questionable IC at exam 1', 'Intracerebral hemorrhage', 'MI recognized, with diagnostic ECG', 'MI recognized, without diagnostic ECG, with autopsy evidence, new event (see also code 9)', 'MI recognized, without diagnostic ECG, with enzymes and history', 'MI unrecognized, not silent', 'MI unrecognized, silent', 'Other CVA', 'Questionable CVA at exam 1', 'Questionable MI at exam 1', 'Subarachnoid hemorrhage', 'TIA (Transient Ischemic Attack) only the 1st TIA is coded', 'TIA with positive imaging']",phs000007,pht000309,phv00036469,True,False,False,EVENT,Event Number,,\phs000007\pht000309\phv00036469\EVENT\,pht000309.v14,\phs000007\pht000309\phv00036469\EVENT\,phv00036469,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",Event Number,{},,"Sequence of Cardiovascular Events (SOE) Endpoints (includes death), Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) reviewed through 2018. There is a more detailed coding manual at the bottom of the SOE protocol for this dataset. Each event is a separate record in this file. If a unique study participant has two or more events with the same date value, the order of events in the dataset does not necessarily reflect the natural order of events. This dataset is generated annually. Included are events reviewed on or before 12/2018. Events reviewed after 12/2018 will appear in the next annual update. Events can take up to two years to be reviewed after they become known. This file does not represent follow up through 12/2018. The corresponding survival file contains follow up information and lags one year behind. This dataset replaces dataset vr_soe_2016_a_1073s.",,Event Number,phs000007.v31,7b1ddd73286067a71631586e67b47c0c6521d2ba9eaf817ee603500e3d4ca161,categorical,phv00036469.v13,phs000007,False,EVENT,FHS,Framingham Cohort,pht000309,vr_soe_2018_a_1311s,\phs000007\pht000309\phv00036469\EVENT\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Women's Health Initiative,CVD,Cardiovascular disease ever,phs000200.v12.p3,phv00078531.v6.p3,pht000999.v6.p3,f30_rel2,phv00078531,"['No', 'Yes']",phs000200,pht000999,phv00078531,True,False,False,CVD,Cardiovascular disease ever,,\phs000200\pht000999\phv00078531\CVD\,pht000999.v6,\phs000200\pht000999\phv00078531\CVD\,phv00078531,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",Cardiovascular disease ever,{},,"Form 30 - Medical History Questionnaire -- hospitalization history; history of medical conditions; history of heart, circulatory, or coagulation problems; history of arthritis, gallbladder disease, thyroid disease, hypertension, angina, peripheral arterial disease and related procedures, colonoscopy or sigmoidoscopy, stool guaiac; history of cancers (site, age at diagnosis); recent history of falls or syncopal episodes; history of fractures (site, age, number). This self-administered questionnaire was required for all OS participants.",,Cardiovascular disease ever,phs000200.v12,3e3409401c7835ca9505e7ba14774febe4dd7f77e86e3e9ee3a2f3c0a6fea000,categorical,phv00078531.v6,phs000200,False,CVD,WHI,Women's Health Initiative,pht000999,f30_rel2,\phs000200\pht000999\phv00078531\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,CVD,Cardiovascular disease yes or no,phs000007.v33.p14,phv00256866.v1.p14,pht005147.v1.p14,l_rnapilot_ex08_1_0918s,phv00256866,"['No CVD', 'Yes, had CVD']",phs000007,pht005147,phv00256866,True,False,False,CVD,Cardiovascular disease yes or no,,\phs000007\pht005147\phv00256866\CVD\,pht005147.v1,\phs000007\pht005147\phv00256866\CVD\,phv00256866,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",Cardiovascular disease yes or no,{},,"Extra Cellular RNA: Plasma RNA Sequencing Results Pilot, Offspring Exam 8. The criteria for subject inclusion: 20 individuals with CVD, 20 individuals without CVD.",,Cardiovascular disease yes or no,phs000007.v31,58471a184fd91b8fddc93caf9f35dd362e57bee64988b8f120d83b2bb2a7168a,categorical,phv00256866.v1,phs000007,False,CVD,FHS,Framingham Cohort,pht005147,l_rnapilot_ex08_1_0918s,\phs000007\pht005147\phv00256866\CVD\,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvd,Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvd,Framingham Cohort,cvd,Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190817.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190817,"['No', 'Yes']",phs000007,pht003316,phv00190817,True,False,False,cvd,Cardiovascular Disease (CVD) status,,\phs000007\pht003316\phv00190817\cvd\,pht003316.v8,\phs000007\pht003316\phv00190817\cvd\,phv00190817,,Cardiovascular Disease (CVD) status,{},,,,Cardiovascular Disease (CVD) status,phs000007.v31,f49e0afca84acb6218a681a07c3484b0eb25b611eaa29770e220aa640fdb66c1,categorical,phv00190817.v8,phs000007,False,cvd,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190817\cvd\,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
BASE_CVD,Baseline CVD,-,-,ARICFraminghamMESA,0.65,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_survcvd_2019_a_1334d.cvddate,Date of Cardiovascular Disease (CVD) status,-,vr_survcvd_2019_a_1334d,cvddate,Framingham Cohort,cvddate,Date of Cardiovascular Disease (CVD) status,phs000007.v33.p14,phv00190823.v10.p14,pht003316.v10.p14,vr_survcvd_2019_a_1334s,phv00190823,[],phs000007,pht003316,phv00190823,False,True,True,cvddate,Date of Cardiovascular Disease (CVD) status,-8824.0,\phs000007\pht003316\phv00190823\cvddate\,pht003316.v8,\phs000007\pht003316\phv00190823\cvddate\,phv00190823,,Date of Cardiovascular Disease (CVD) status,{},,,25004.0,Date of Cardiovascular Disease (CVD) status,phs000007.v31,e889087dcbf80ce2d331618a75b804e3d38b359db50d4a542c0b400927f4f4fb,continuous,phv00190823.v8,phs000007,True,cvddate,FHS,Framingham Cohort,pht003316,vr_survcvd_2017_a_1194s,\phs000007\pht003316\phv00190823\cvddate\,-8824.0,25004.0
DEATH_IND,Death indicator,-,-,ARICFraminghamMESA,1.79,Framingham,vr_survdth_2019_a_1337d.datedth,Date of death,57.63052209,vr_survdth_2019_a_1337d,datedth,Framingham Cohort,DATEDTH,Date of death,phs000007.v33.p14,phv00190831.v10.p14,pht003317.v10.p14,vr_survdth_2019_a_1337s,phv00190831,[],phs000007,pht003317,phv00190831,False,True,True,DATEDTH,Date of death,1.0,\phs000007\pht003317\phv00190831\DATEDTH\,pht003317.v8,\phs000007\pht003317\phv00190831\DATEDTH\,phv00190831,,Date of death,{},,,24989.0,Date of death,phs000007.v31,45dad9f576087637b401d06d278c892f28cdd589205aa6c7d010bc0fad44d1cf,continuous,phv00190831.v8,phs000007,True,DATEDTH,FHS,Framingham Cohort,pht003317,vr_survdth_2017_a_1192s,\phs000007\pht003317\phv00190831\DATEDTH\,1.0,24989.0
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,Stroke,phs000200.v12.p3,phv00193803.v4.p3,pht003415.v4.p3,outc_strk_carotid_cad_rel4,phv00193803,['Yes'],phs000200,pht003415,phv00193803,True,False,False,STROKE,Stroke,,\phs000200\pht003415\phv00193803\STROKE\,pht003415.v4,\phs000200\pht003415\phv00193803\STROKE\,phv00193803,,Stroke,{},,,,Stroke,phs000200.v12,933c1e7e3a46016981cc2cb3cbac3e81139aa9dc32afe88c3173df65102bf22f,categorical,phv00193803.v4,phs000200,False,STROKE,WHI,Women's Health Initiative,pht003415,outc_strk_carotid_cad_rel4,\phs000200\pht003415\phv00193803\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,Stroke,phs000200.v12.p3,phv00193202.v4.p3,pht003407.v4.p3,outc_ct_os_rel4,phv00193202,"['No', 'Yes']",phs000200,pht003407,phv00193202,True,False,False,STROKE,Stroke,,\phs000200\pht003407\phv00193202\STROKE\,pht003407.v4,\phs000200\pht003407\phv00193202\STROKE\,phv00193202,,Stroke,{},,,,Stroke,phs000200.v12,7670d872dd458830bcc96d2960340ee3fe7fcf8eb43a1776876df48b8e231970,categorical,phv00193202.v4,phs000200,False,STROKE,WHI,Women's Health Initiative,pht003407,outc_ct_os_rel4,\phs000200\pht003407\phv00193202\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,Stroke,phs000200.v12.p3,phv00192522.v3.p3,pht003402.v4.p3,outc_cad_rel4,phv00192522,"['No', 'Yes']",phs000200,pht003402,phv00192522,True,False,False,STROKE,Stroke,,\phs000200\pht003402\phv00192522\STROKE\,pht003402.v4,\phs000200\pht003402\phv00192522\STROKE\,phv00192522,,Stroke,{},,,,Stroke,phs000200.v12,1b12ddfbbb253a55cf92a2a517896c47e5b7f65709d8ff40fb0625d1cf667ae7,categorical,phv00192522.v3,phs000200,False,STROKE,WHI,Women's Health Initiative,pht003402,outc_cad_rel4,\phs000200\pht003402\phv00192522\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,Stroke ever,phs000200.v12.p3,phv00078478.v6.p3,pht000998.v6.p3,f2_rel1,phv00078478,"['No', 'Yes']",phs000200,pht000998,phv00078478,True,False,False,STROKE,Stroke ever,,\phs000200\pht000998\phv00078478\STROKE\,pht000998.v6,\phs000200\pht000998\phv00078478\STROKE\,phv00078478,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",Stroke ever,{},,"Form 2 - Eligibility Screen -- name; mailing address; telephone numbers and best times to call; date of birth; residing in area for next three years; current involvement in other research studies; history of cancer (site, diagnosis in past 10 years); ethnicity; recruitment source; hormone use (present, in last three months); osteoporosis-related fracture and hormone use as treatment; hysterectomy history; last menstrual bleeding; number of meals prepared away from home; special diets (type); history of diabetes, deep vein thrombosis, pulmonary embolus, stroke, transient ischemic attack, myocardial infarction; history of sickle cell anemia, heart failure, liver disease, bleeding problem; loss of 15 pounds in last six months; renal failure requiring hemodialysis; other chronic illness; emotional or mental problems; ability to get to clinical center; interest in DM; interest in HRT (willingness to stop current hormone medications).",,Stroke ever,phs000200.v12,743df151decdf1c2a43a34ff4db572b956d5bce8fd7b424086927a18e8d32dc5,categorical,phv00078478.v6,phs000200,False,STROKE,WHI,Women's Health Initiative,pht000998,f2_rel1,\phs000200\pht000998\phv00078478\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Jackson Heart Study (JHS) Cohort,stroke,Incidence Stroke,phs000286.v7.p2,phv00402849.v1.p2,pht008756.v2.p2,incevtstroke,phv00402849,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,Stroke,phs000200.v12.p3,phv00193824.v4.p3,pht003416.v4.p3,outc_strk_carotid_rel4,phv00193824,['Yes'],phs000200,pht003416,phv00193824,True,False,False,STROKE,Stroke,,\phs000200\pht003416\phv00193824\STROKE\,pht003416.v4,\phs000200\pht003416\phv00193824\STROKE\,phv00193824,,Stroke,{},,,,Stroke,phs000200.v12,567b6395f716b1675e1951f04937ae85f9456df0c01aed4db579b812ede51e4c,categorical,phv00193824.v4,phs000200,False,STROKE,WHI,Women's Health Initiative,pht003416,outc_strk_carotid_rel4,\phs000200\pht003416\phv00193824\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Women's Health Initiative,STROKE,F136 Stroke,phs000200.v12.p3,phv00283705.v2.p3,pht006223.v2.p3,unc_hf_rel1,phv00283705,"['No/Not Recorded', 'Yes']",phs000200,pht006223,phv00283705,True,False,False,STROKE,F136 Stroke,,\phs000200\pht006223\phv00283705\STROKE\,pht006223.v2,\phs000200\pht006223\phv00283705\STROKE\,phv00283705,,F136 Stroke,{},,,,F136 Stroke,phs000200.v12,f625a52f4a1e352783c9a5f502ace25a17c3abf50d595636a3fbc1c12bf1c65e,categorical,phv00283705.v2,phs000200,False,STROKE,WHI,Women's Health Initiative,pht006223,unc_hf_rel1,\phs000200\pht006223\phv00283705\STROKE\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Jackson Heart Study (JHS) Cohort,Stroke,Definite/Probable Stroke,phs000286.v7.p2,phv00401072.v1.p2,pht008728.v2.p2,allevtstroke,phv00401072,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Hispanic Community Health Study /Study of Latinos (HCHS/SOL),STROKE,"Prevalent Stroke, self report",phs000810.v2.p2,phv00526214.v1.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,phv00526214,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,stroke,Prevalent stroke,phs000287.v7.p1,phv00197704.v1.p1,pht003699.v2.p1,SHHS1_PSG,phv00197704,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Framingham Cohort,stroke,Stroke status,phs000007.v33.p14,phv00276965.v5.p14,pht006023.v5.p14,vr_svstk_2019_a_1335s,phv00276965,"['No', 'Yes']",phs000007,pht006023,phv00276965,True,False,False,stroke,Stroke status,,\phs000007\pht006023\phv00276965\stroke\,pht006023.v3,\phs000007\pht006023\phv00276965\stroke\,phv00276965,,Stroke status,{},,,,Stroke status,phs000007.v31,5755ace962e5ba28a43c1012c81d9f59d73617f43f120ff1f3e6602a4bf29ed0,categorical,phv00276965.v3,phs000007,False,stroke,FHS,Framingham Cohort,pht006023,vr_svstk_2017_a_1196s,\phs000007\pht006023\phv00276965\stroke\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.stroke,Stroke status,-,vr_svstk_2019_a_1335d,stroke,Genetic Epidemiology of COPD (COPDGene),Stroke,Stroke,phs000179.v6.p2,phv00159619.v4.p2,pht002239.v4.p2,COPDGene_Subject_Phenotypes,phv00159619,"['No', 'Yes']",phs000179,pht002239,phv00159619,True,False,False,Stroke,Stroke,,\phs000179\pht002239\phv00159619\Stroke\,pht002239.v4,\phs000179\pht002239\phv00159619\Stroke\,phv00159619,"Subject ID, died center, age at enrolment, race, ethnic, gender, body weight, body height, BMI, systolic and diastolic blood pressure, measurement of several parameters during 6 minutes work, CT slicer, CT scanner, heart rate, oxygen saturation and therapy, medical history of back pain, cancer, cardio vascular diseases, diabetes, digestive system diseases, eye diseases, general health, musculoskeletal diseases, painful joint type, respiratory tract disease, smoking, and walking limbs, medication history of treatment with beta-agonist, theophylline, inhaled corticosteroid, Oral corticosteroids, ipratropium bromide, and tiotroprium bromide, respiratory disease, St. George's Respiratory Questionnaire, SF-36 Health Survey, spirometry, and VIDA of participants with or without chronic obstructive pulmonary disease and involved in the ""Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute"" project.",Stroke,{},,"Subject ID, died center, age at enrolment, race, ethnic, gender, body weight, body height, BMI, systolic and diastolic blood pressure, measurement of several parameters during 6 minutes work, CT slicer, CT scanner, heart rate, oxygen saturation and therapy, medical history of back pain, cancer, cardio vascular diseases, diabetes, digestive system diseases, eye diseases, general health, musculoskeletal diseases, painful joint type, respiratory tract disease, smoking, and walking limbs, medication history of treatment with beta-agonist, theophylline, inhaled corticosteroid, Oral corticosteroids, ipratropium bromide, and tiotroprium bromide, respiratory disease, St. George's Respiratory Questionnaire, SF-36 Health Survey, spirometry, and VIDA of participants with or without chronic obstructive pulmonary disease and involved in the ""Genetic Epidemiology of COPD (COPDGene) Funded by the National Heart, Lung, and Blood Institute"" project.",,Stroke,phs000179.v6,d8faa06705f8ca635673e0a044d0371058c4e6f1c0439022b309513a861656fd,categorical,phv00159619.v4,phs000179,False,Stroke,COPDGENE,Genetic Epidemiology of COPD (COPDGene),pht002239,COPDGene_Subject_Phenotypes,\phs000179\pht002239\phv00159619\Stroke\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstk_2019_a_1335d.strokedate,Date of stroke,-,vr_svstk_2019_a_1335d,strokedate,Framingham Cohort,strokedate,Date of stroke,phs000007.v33.p14,phv00276968.v5.p14,pht006023.v5.p14,vr_svstk_2019_a_1335s,phv00276968,[],phs000007,pht006023,phv00276968,False,True,True,strokedate,Date of stroke,-6952.0,\phs000007\pht006023\phv00276968\strokedate\,pht006023.v3,\phs000007\pht006023\phv00276968\strokedate\,phv00276968,,Date of stroke,{},,,25004.0,Date of stroke,phs000007.v31,b8b77b548699bca6a57966ac84b89bc9ec3c4a648e874867afb17c4a20735779,continuous,phv00276968.v3,phs000007,True,strokedate,FHS,Framingham Cohort,pht006023,vr_svstk_2017_a_1196s,\phs000007\pht006023\phv00276968\strokedate\,-6952.0,25004.0
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstktia_2019_a_1336d.stroke_tia,Stroke/TIA status,-,vr_svstktia_2019_a_1336d,stroke_tia,Framingham Cohort,stroke_tia,Stroke/TIA status,phs000007.v33.p14,phv00276971.v5.p14,pht006024.v5.p14,vr_svstktia_2019_a_1336s,phv00276971,"['No', 'Yes']",phs000007,pht006024,phv00276971,True,False,False,stroke_tia,Stroke/TIA status,,\phs000007\pht006024\phv00276971\stroke_tia\,pht006024.v3,\phs000007\pht006024\phv00276971\stroke_tia\,phv00276971,,Stroke/TIA status,{},,,,Stroke/TIA status,phs000007.v31,aa7bfafb54190eb7018f84f922d5d13ae618f8975d3fb039d4e4145304902dc9,categorical,phv00276971.v3,phs000007,False,stroke_tia,FHS,Framingham Cohort,pht006024,vr_svstktia_2017_a_1197s,\phs000007\pht006024\phv00276971\stroke_tia\,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstktia_2019_a_1336d.stroke_tia,Stroke/TIA status,-,vr_svstktia_2019_a_1336d,stroke_tia,Hispanic Community Health Study /Study of Latinos (HCHS/SOL),STROKE_TIA,"Prevalent Stroke or TIA, self report",phs000810.v2.p2,phv00526215.v1.p2,pht004715.v2.p2,HCHS_SOL_Cohort_Subject_Phenotypes,phv00526215,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BASE_STROKE,"Baseline Stroke/TIA(0=No, 1=TIA, 2=Stroke)",-,-,ARICFraminghamREGARDS,-,Framingham,vr_svstktia_2019_a_1336d.stroketiadate,Date of stroke/TIA,-,vr_svstktia_2019_a_1336d,stroketiadate,Framingham Cohort,stroketiadate,Date of stroke/TIA,phs000007.v33.p14,phv00276974.v5.p14,pht006024.v5.p14,vr_svstktia_2019_a_1336s,phv00276974,[],phs000007,pht006024,phv00276974,False,True,True,stroketiadate,Date of stroke/TIA,-7931.0,\phs000007\pht006024\phv00276974\stroketiadate\,pht006024.v3,\phs000007\pht006024\phv00276974\stroketiadate\,phv00276974,,Date of stroke/TIA,{},,,25004.0,Date of stroke/TIA,phs000007.v31,fc71af13af878bf0ebe358a7ff5f5e04e8da61397148eb3e0c0cd2ec5a0925cb,continuous,phv00276974.v3,phs000007,True,stroketiadate,FHS,Framingham Cohort,pht006024,vr_svstktia_2017_a_1197s,\phs000007\pht006024\phv00276974\stroketiadate\,-7931.0,25004.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age1,"Age (years), Exam 1",-,vr_wkthru_ex09_1_1001d,age1,Framingham Cohort,age1,Age at Exam 1,phs000007.v33.p14,phv00177930.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177930,[],phs000007,pht003099,phv00177930,False,True,False,age1,Age at Exam 1,5.0,\phs000007\pht003099\phv00177930\age1\,pht003099.v6,\phs000007\pht003099\phv00177930\age1\,phv00177930,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 1,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",83.0,Age at Exam 1,phs000007.v31,bf465997b87a17c1ae36ace6f15b1bc628f95ba08d284ef4ff0b4a00c3603025,continuous,phv00177930.v6,phs000007,False,age1,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177930\age1\,5.0,83.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age1,"Age (years), Exam 1",-,vr_wkthru_ex09_1_1001d,age1,Framingham Cohort,AGE1,Age at Exam 1,phs000007.v33.p14,phv00277020.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277020,[],phs000007,pht006026,phv00277020,False,True,False,AGE1,Age at Exam 1,19.0,\phs000007\pht006026\phv00277020\AGE1\,pht006026.v3,\phs000007\pht006026\phv00277020\AGE1\,phv00277020,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",Age at Exam 1,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",83.0,Age at Exam 1,phs000007.v31,57df28e0443c85767bf780cfbba972b2ecc1b34e177d02927dc4db352fa5c10d,continuous,phv00277020.v3,phs000007,False,AGE1,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277020\AGE1\,19.0,83.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age1,"Age (years), Exam 1",-,vr_wkthru_ex09_1_1001d,age1,Framingham Cohort,AGE1,Age at Exam 1,phs000007.v33.p14,phv00277077.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277077,[],phs000007,pht006027,phv00277077,False,True,False,AGE1,Age at Exam 1,5.0,\phs000007\pht006027\phv00277077\AGE1\,pht006027.v2,\phs000007\pht006027\phv00277077\AGE1\,phv00277077,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 1,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",70.0,Age at Exam 1,phs000007.v31,1bbc790a893afd68c02ba99e13c2459fe75c32282981b0189ee2c90a6b89aa2b,continuous,phv00277077.v2,phs000007,False,AGE1,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277077\AGE1\,5.0,70.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age1,"Age (years), Exam 1",-,vr_wkthru_ex09_1_1001d,age1,Framingham Cohort,AGE1,Age at Exam 1,phs000007.v33.p14,phv00369654.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369654,[],phs000007,pht007777,phv00369654,False,True,False,AGE1,Age at Exam 1,28.0,\phs000007\pht007777\phv00369654\AGE1\,pht007777.v2,\phs000007\pht007777\phv00369654\AGE1\,phv00369654,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 1,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",74.0,Age at Exam 1,phs000007.v31,a331208483a5ed4a0108b24ab0e9604081985952af54af1e490c3e1ac3e78adb,continuous,phv00369654.v1,phs000007,False,AGE1,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369654\AGE1\,28.0,74.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age1,"Age (years), Exam 1",-,vr_wkthru_ex09_1_1001d,age1,Framingham Cohort,age1,Age at Exam 1,phs000007.v33.p14,phv00423875.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423875,[],phs000007,pht009761,phv00423875,False,True,False,age1,Age at Exam 1,27.0,\phs000007\pht009761\phv00423875\age1\,pht009761.v1,\phs000007\pht009761\phv00423875\age1\,phv00423875,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Age at Exam 1,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",78.0,Age at Exam 1,phs000007.v31,f2da03fa92facc87af4a954b2c084688468aae90729e9b679e2e8a8f34dc6b57,continuous,phv00423875.v1,phs000007,False,age1,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423875\age1\,27.0,78.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Framingham Cohort,AGE2,Age at Exam 2,phs000007.v33.p14,phv00277021.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277021,[],phs000007,pht006026,phv00277021,False,True,False,AGE2,Age at Exam 2,24.0,\phs000007\pht006026\phv00277021\AGE2\,pht006026.v3,\phs000007\pht006026\phv00277021\AGE2\,phv00277021,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",Age at Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",85.0,Age at Exam 2,phs000007.v31,7344c4a9bfbc396850637eb7c3b3407b234a9b60942eba352de0549c68a50b1d,continuous,phv00277021.v3,phs000007,False,AGE2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277021\AGE2\,24.0,85.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Framingham Cohort,age2,Age at Exam 2,phs000007.v33.p14,phv00177932.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177932,[],phs000007,pht003099,phv00177932,False,True,False,age2,Age at Exam 2,17.0,\phs000007\pht003099\phv00177932\age2\,pht003099.v6,\phs000007\pht003099\phv00177932\age2\,phv00177932,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 2,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",85.0,Age at Exam 2,phs000007.v31,48abed4e8eeed319d1a25f95cdb1a1b65dc9aa5ce1d43fe6be801448a58dc50d,continuous,phv00177932.v6,phs000007,False,age2,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177932\age2\,17.0,85.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Framingham Cohort,AGE2,Age at Exam 2,phs000007.v33.p14,phv00277078.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277078,[],phs000007,pht006027,phv00277078,False,True,False,AGE2,Age at Exam 2,17.0,\phs000007\pht006027\phv00277078\AGE2\,pht006027.v2,\phs000007\pht006027\phv00277078\AGE2\,phv00277078,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",77.0,Age at Exam 2,phs000007.v31,09264b9328f5fb314d5ab0e06121642f7c8beea85ad696fb3489557d98eeb4e6,continuous,phv00277078.v2,phs000007,False,AGE2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277078\AGE2\,17.0,77.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Framingham Cohort,AGE2,Age at Exam 2,phs000007.v33.p14,phv00369655.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369655,[],phs000007,pht007777,phv00369655,False,True,False,AGE2,Age at Exam 2,31.0,\phs000007\pht007777\phv00369655\AGE2\,pht007777.v2,\phs000007\pht007777\phv00369655\AGE2\,phv00369655,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",65.0,Age at Exam 2,phs000007.v31,63992bfc5123776bc4df7cca9534d4fad707c96eec5b75c800557bc35c5a3a07,continuous,phv00369655.v1,phs000007,False,AGE2,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369655\AGE2\,31.0,65.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Framingham Cohort,age2,Age at Exam 2,phs000007.v33.p14,phv00423876.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423876,[],phs000007,pht009761,phv00423876,False,True,False,age2,Age at Exam 2,33.0,\phs000007\pht009761\phv00423876\age2\,pht009761.v1,\phs000007\pht009761\phv00423876\age2\,phv00423876,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Age at Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",83.0,Age at Exam 2,phs000007.v31,f19af91f68272c63883da839013f86f4a3e5d618e22607e63a511365532e6b9d,continuous,phv00423876.v1,phs000007,False,age2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423876\age2\,33.0,83.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age2,"Age (years), Exam 2",24.77947073,vr_wkthru_ex09_1_1001d,age2,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AGE2,AGE (BASELINE) IN 2-YEAR CATEGORIES,phs000287.v7.p1,phv00100836.v2.p1,pht001466.v2.p1,CHS_Event16,phv00100836,"['65 - 66', '67 - 68', '69 - 70', '71 - 72', '73 - 74', '75 - 76', '77 - 78', '79 - 80', '81 - 82', '83 - 84', '85 - 86', '87 - 89', '90+']",phs000287,pht001466,phv00100836,True,False,False,AGE2,AGE (BASELINE) IN 2-YEAR CATEGORIES,,\phs000287\pht001466\phv00100836\AGE2\,pht001466.v2,\phs000287\pht001466\phv00100836\AGE2\,phv00100836,,AGE (BASELINE) IN 2-YEAR CATEGORIES,{},,,,AGE (BASELINE) IN 2-YEAR CATEGORIES,phs000287.v7,1a36e51beaf313f93e570a8251fea917e8ae258f1109ef300776e9a455d21bce,categorical,phv00100836.v2,phs000287,False,AGE2,CHS,Cardiovascular Health Study (CHS) Cohort,pht001466,CHS_Event16,\phs000287\pht001466\phv00100836\AGE2\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age3,"Age (years), Exam 3",24.57898958,vr_wkthru_ex09_1_1001d,age3,Framingham Cohort,age3,Age at Exam 3,phs000007.v33.p14,phv00423877.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423877,[],phs000007,pht009761,phv00423877,False,True,False,age3,Age at Exam 3,39.0,\phs000007\pht009761\phv00423877\age3\,pht009761.v1,\phs000007\pht009761\phv00423877\age3\,phv00423877,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Age at Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",89.0,Age at Exam 3,phs000007.v31,cb1ea18ff2bc8e59b82bca9049724a4cf10b4a006a8330f6511762329dbf5211,continuous,phv00423877.v1,phs000007,False,age3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423877\age3\,39.0,89.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age3,"Age (years), Exam 3",24.57898958,vr_wkthru_ex09_1_1001d,age3,Framingham Cohort,AGE3,Age at Exam 3,phs000007.v33.p14,phv00369656.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369656,[],phs000007,pht007777,phv00369656,False,True,False,AGE3,Age at Exam 3,32.0,\phs000007\pht007777\phv00369656\AGE3\,pht007777.v2,\phs000007\pht007777\phv00369656\AGE3\,phv00369656,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",67.0,Age at Exam 3,phs000007.v31,c6834d092b235586096628f72f4350ac80888ed95cd7955125f5b49e1c94d62f,continuous,phv00369656.v1,phs000007,False,AGE3,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369656\AGE3\,32.0,67.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age3,"Age (years), Exam 3",24.57898958,vr_wkthru_ex09_1_1001d,age3,Framingham Cohort,AGE3,Age at Exam 3,phs000007.v33.p14,phv00277079.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277079,[],phs000007,pht006027,phv00277079,False,True,False,AGE3,Age at Exam 3,18.0,\phs000007\pht006027\phv00277079\AGE3\,pht006027.v2,\phs000007\pht006027\phv00277079\AGE3\,phv00277079,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",77.0,Age at Exam 3,phs000007.v31,90ca700ab943a27e564e4538c23491807e8f68eb2e1266ae40e318aff6126587,continuous,phv00277079.v2,phs000007,False,AGE3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277079\AGE3\,18.0,77.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age3,"Age (years), Exam 3",24.57898958,vr_wkthru_ex09_1_1001d,age3,Framingham Cohort,age3,Age at Exam 3,phs000007.v33.p14,phv00177934.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177934,[],phs000007,pht003099,phv00177934,False,True,False,age3,Age at Exam 3,18.0,\phs000007\pht003099\phv00177934\age3\,pht003099.v6,\phs000007\pht003099\phv00177934\age3\,phv00177934,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 3,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",93.0,Age at Exam 3,phs000007.v31,7fc6b0c54340282c4f79104eb6203f67e0b1144fa84897f78e7ba794d8e7d00a,continuous,phv00177934.v6,phs000007,False,age3,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177934\age3\,18.0,93.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age3,"Age (years), Exam 3",24.57898958,vr_wkthru_ex09_1_1001d,age3,Framingham Cohort,AGE3,Age at Exam 3,phs000007.v33.p14,phv00520288.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520288,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age4,"Age (years), Exam 4",21.77225341,vr_wkthru_ex09_1_1001d,age4,Framingham Cohort,age4,Age at Exam 4,phs000007.v33.p14,phv00423878.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423878,[],phs000007,pht009761,phv00423878,False,True,False,age4,Age at Exam 4,44.0,\phs000007\pht009761\phv00423878\age4\,pht009761.v1,\phs000007\pht009761\phv00423878\age4\,phv00423878,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Age at Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",88.0,Age at Exam 4,phs000007.v31,23beb542a238144e5fc43d4b084ba0f4689d89672862166695e17ba58be8091c,continuous,phv00423878.v1,phs000007,False,age4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423878\age4\,44.0,88.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age4,"Age (years), Exam 4",21.77225341,vr_wkthru_ex09_1_1001d,age4,Framingham Cohort,AGE4,Age at Exam 4,phs000007.v33.p14,phv00277080.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277080,[],phs000007,pht006027,phv00277080,False,True,False,AGE4,Age at Exam 4,22.0,\phs000007\pht006027\phv00277080\AGE4\,pht006027.v2,\phs000007\pht006027\phv00277080\AGE4\,phv00277080,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",81.0,Age at Exam 4,phs000007.v31,e5cedbb605042150c5f0c3d95f126101eae01743bad202336edb55feb044343d,continuous,phv00277080.v2,phs000007,False,AGE4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277080\AGE4\,22.0,81.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age4,"Age (years), Exam 4",21.77225341,vr_wkthru_ex09_1_1001d,age4,Framingham Cohort,AGE4,Age at Exam 4,phs000007.v33.p14,phv00369657.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369657,[],phs000007,pht007777,phv00369657,False,True,False,AGE4,Age at Exam 4,34.0,\phs000007\pht007777\phv00369657\AGE4\,pht007777.v2,\phs000007\pht007777\phv00369657\AGE4\,phv00369657,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",69.0,Age at Exam 4,phs000007.v31,2ad775bbc3ef5bb2bf9cf1564baeabf52283e39cc4408899568f7666fc04bee2,continuous,phv00369657.v1,phs000007,False,AGE4,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369657\AGE4\,34.0,69.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age4,"Age (years), Exam 4",21.77225341,vr_wkthru_ex09_1_1001d,age4,Framingham Cohort,age4,Age at Exam 4,phs000007.v33.p14,phv00177936.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177936,[],phs000007,pht003099,phv00177936,False,True,False,age4,Age at Exam 4,22.0,\phs000007\pht003099\phv00177936\age4\,pht003099.v6,\phs000007\pht003099\phv00177936\age4\,phv00177936,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 4,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",88.0,Age at Exam 4,phs000007.v31,120c8e35a9af9bc13cc31689e6468d1e091faecbda2337cd52e21a2d2134711e,continuous,phv00177936.v6,phs000007,False,age4,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177936\age4\,22.0,88.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Framingham Cohort,age5,Age at Exam 5,phs000007.v33.p14,phv00177938.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177938,[],phs000007,pht003099,phv00177938,False,True,False,age5,Age at Exam 5,26.0,\phs000007\pht003099\phv00177938\age5\,pht003099.v6,\phs000007\pht003099\phv00177938\age5\,phv00177938,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 5,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",84.0,Age at Exam 5,phs000007.v31,f8c7c8d08cd71f154ecb9af5a9be8b1ca60dbfd1a4aba58ab2bab9b3832d45c7,continuous,phv00177938.v6,phs000007,False,age5,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177938\age5\,26.0,84.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age5,Q3) HOW OLD ARE YOU?,phs000209.v13.p3,phv00176078.v1.p3,pht003091.v3.p3,MESA_Exam5Main,phv00176078,"['CORRECT', 'MISSED BY 1-3 YEARS', 'MISSED BY >3 YEARS', 'NOT ATT/DISABLED']",phs000209,pht003091,phv00176078,True,False,False,age5,Q3) HOW OLD ARE YOU?,,\phs000209\pht003091\phv00176078\age5\,pht003091.v3,\phs000209\pht003091\phv00176078\age5\,phv00176078,,Q3) HOW OLD ARE YOU?,{},,,,Q3) HOW OLD ARE YOU?,phs000209.v13,7262c0817f21c03458251078547241b4660f5944680677f9b99cdc01e0acf83e,categorical,phv00176078.v1,phs000209,False,age5,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003091,MESA_Exam5Main,\phs000209\pht003091\phv00176078\age5\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,age5,Q3) HOW OLD ARE YOU?,phs000209.v13.p3,phv00174655.v1.p3,pht003086.v3.p3,MESA_AirNRExam5Main,phv00174655,"['CORRECT', 'MISSED BY 1-3 YEARS']",phs000209,pht003086,phv00174655,True,False,False,age5,Q3) HOW OLD ARE YOU?,,\phs000209\pht003086\phv00174655\age5\,pht003086.v3,\phs000209\pht003086\phv00174655\age5\,phv00174655,,Q3) HOW OLD ARE YOU?,{},,,,Q3) HOW OLD ARE YOU?,phs000209.v13,5360fbba04b19224930a476d12ed786280c27bb41d6ca94e43f07a3b0e66f15f,categorical,phv00174655.v1,phs000209,False,age5,MESA,Multi-Ethnic Study of Atherosclerosis (MESA) Cohort,pht003086,MESA_AirNRExam5Main,\phs000209\pht003086\phv00174655\age5\,,
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Framingham Cohort,AGE5,Age at Exam 5,phs000007.v33.p14,phv00277081.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277081,[],phs000007,pht006027,phv00277081,False,True,False,AGE5,Age at Exam 5,26.0,\phs000007\pht006027\phv00277081\AGE5\,pht006027.v2,\phs000007\pht006027\phv00277081\AGE5\,phv00277081,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",84.0,Age at Exam 5,phs000007.v31,91a0536e7b9c65c535cf702aae40976086abe3ca9806da761221893f51b975f6,continuous,phv00277081.v2,phs000007,False,AGE5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277081\AGE5\,26.0,84.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Cardiovascular Health Study (CHS) Cohort: an NHLBI-funded observational study of risk factors for cardiovascular disease in adults 65 years or older,AGE5,Age at bl in 5 groups,phs000287.v7.p1,phv00100309.v1.p1,pht001452.v1.p1,BASEBOTH,phv00100309,[],phs000287,pht001452,phv00100309,False,True,False,AGE5,Age at bl in 5 groups,1.0,\phs000287\pht001452\phv00100309\AGE5\,pht001452.v1,\phs000287\pht001452\phv00100309\AGE5\,phv00100309,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),Age at bl in 5 groups,{},,CARe_CHS_BASELINE - Medical history (OLD and NEW cohort),5.0,Age at bl in 5 groups,phs000287.v7,8f23d841c7d092204b29072e4f993d7a3da1d5b79781e54fc8c47802fe2e15cf,continuous,phv00100309.v1,phs000287,False,AGE5,CHS,Cardiovascular Health Study (CHS) Cohort,pht001452,BASEBOTH,\phs000287\pht001452\phv00100309\AGE5\,1.0,5.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age5,"Age (years), Exam 5",26.06255012,vr_wkthru_ex09_1_1001d,age5,Framingham Cohort,AGE5,Age at Exam 5,phs000007.v33.p14,phv00369658.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369658,[],phs000007,pht007777,phv00369658,False,True,False,AGE5,Age at Exam 5,37.0,\phs000007\pht007777\phv00369658\AGE5\,pht007777.v2,\phs000007\pht007777\phv00369658\AGE5\,phv00369658,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",70.0,Age at Exam 5,phs000007.v31,83883122cdd1f46c93d08cf59b7da5b0832f0528e18e69f085cf65e7d8c78df1,continuous,phv00369658.v1,phs000007,False,AGE5,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369658\AGE5\,37.0,70.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age6,"Age (years), Exam 6",31.61587811,vr_wkthru_ex09_1_1001d,age6,Framingham Cohort,AGE6,Age at Exam 6,phs000007.v33.p14,phv00277082.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277082,[],phs000007,pht006027,phv00277082,False,True,False,AGE6,Age at Exam 6,29.0,\phs000007\pht006027\phv00277082\AGE6\,pht006027.v2,\phs000007\pht006027\phv00277082\AGE6\,phv00277082,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",86.0,Age at Exam 6,phs000007.v31,034f6e121b32a48cdc6c758cdd8304a006673541ca8abfb298e015619f141d81,continuous,phv00277082.v2,phs000007,False,AGE6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277082\AGE6\,29.0,86.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age6,"Age (years), Exam 6",31.61587811,vr_wkthru_ex09_1_1001d,age6,Framingham Cohort,age6,Age at Exam 6,phs000007.v33.p14,phv00177940.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177940,[],phs000007,pht003099,phv00177940,False,True,False,age6,Age at Exam 6,29.0,\phs000007\pht003099\phv00177940\age6\,pht003099.v6,\phs000007\pht003099\phv00177940\age6\,phv00177940,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 6,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",86.0,Age at Exam 6,phs000007.v31,845ddf1e41babc1f35f2096cbe973e1d1af6f79a05797994f7a020a20b4aaa5c,continuous,phv00177940.v6,phs000007,False,age6,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177940\age6\,29.0,86.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age6,"Age (years), Exam 6",31.61587811,vr_wkthru_ex09_1_1001d,age6,Framingham Cohort,AGE6,Age at Exam 6,phs000007.v33.p14,phv00369659.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369659,[],phs000007,pht007777,phv00369659,False,True,False,AGE6,Age at Exam 6,38.0,\phs000007\pht007777\phv00369659\AGE6\,pht007777.v2,\phs000007\pht007777\phv00369659\AGE6\,phv00369659,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",72.0,Age at Exam 6,phs000007.v31,94e370de3a6203779dcc706bfd60b8a905b224410dc059ec064ad5525f6efa67,continuous,phv00369659.v1,phs000007,False,AGE6,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369659\AGE6\,38.0,72.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age7,"Age (years), Exam 7",30.3127506,vr_wkthru_ex09_1_1001d,age7,Framingham Cohort,AGE7,Age at Exam 7,phs000007.v33.p14,phv00369660.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369660,[],phs000007,pht007777,phv00369660,False,True,False,AGE7,Age at Exam 7,40.0,\phs000007\pht007777\phv00369660\AGE7\,pht007777.v2,\phs000007\pht007777\phv00369660\AGE7\,phv00369660,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",74.0,Age at Exam 7,phs000007.v31,cd5a7ebc845b143bb1aff07ec2d15e55c91ab425f97f433869eb008b3cc79909,continuous,phv00369660.v1,phs000007,False,AGE7,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369660\AGE7\,40.0,74.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age7,"Age (years), Exam 7",30.3127506,vr_wkthru_ex09_1_1001d,age7,Framingham Cohort,AGE7,Age at Exam 7,phs000007.v33.p14,phv00277083.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277083,[],phs000007,pht006027,phv00277083,False,True,False,AGE7,Age at Exam 7,33.0,\phs000007\pht006027\phv00277083\AGE7\,pht006027.v2,\phs000007\pht006027\phv00277083\AGE7\,phv00277083,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",90.0,Age at Exam 7,phs000007.v31,ae1cbc58fea155ccce16c5c74e6ab39e290175f3a41861ad9ed94bbc20609df2,continuous,phv00277083.v2,phs000007,False,AGE7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277083\AGE7\,33.0,90.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age7,"Age (years), Exam 7",30.3127506,vr_wkthru_ex09_1_1001d,age7,Framingham Cohort,age7,Age at Exam 7,phs000007.v33.p14,phv00177942.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177942,[],phs000007,pht003099,phv00177942,False,True,False,age7,Age at Exam 7,33.0,\phs000007\pht003099\phv00177942\age7\,pht003099.v6,\phs000007\pht003099\phv00177942\age7\,phv00177942,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 7,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",90.0,Age at Exam 7,phs000007.v31,7c40896006dc582d3f5432931bc2142ce97ed7c4bdcbe4f15bb073576463e193,continuous,phv00177942.v6,phs000007,False,age7,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177942\age7\,33.0,90.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age8,"Age (years), Exam 8",40.1563753,vr_wkthru_ex09_1_1001d,age8,Framingham Cohort,AGE8,Age at Exam 8,phs000007.v33.p14,phv00369661.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369661,[],phs000007,pht007777,phv00369661,False,True,False,AGE8,Age at Exam 8,42.0,\phs000007\pht007777\phv00369661\AGE8\,pht007777.v2,\phs000007\pht007777\phv00369661\AGE8\,phv00369661,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",76.0,Age at Exam 8,phs000007.v31,b0a2bee12a334c736223363a71d3a4e6571880a4e6e73719b96c9d0add912be1,continuous,phv00369661.v1,phs000007,False,AGE8,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369661\AGE8\,42.0,76.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age8,"Age (years), Exam 8",40.1563753,vr_wkthru_ex09_1_1001d,age8,Framingham Cohort,age8,Age at Exam 8,phs000007.v33.p14,phv00177944.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177944,[],phs000007,pht003099,phv00177944,False,True,False,age8,Age at Exam 8,40.0,\phs000007\pht003099\phv00177944\age8\,pht003099.v6,\phs000007\pht003099\phv00177944\age8\,phv00177944,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 8,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",93.0,Age at Exam 8,phs000007.v31,31c6527b3b2f2252a4443fb356a40373183308c2c9609f72fa85827b9463b1bf,continuous,phv00177944.v6,phs000007,False,age8,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177944\age8\,40.0,93.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age8,"Age (years), Exam 8",40.1563753,vr_wkthru_ex09_1_1001d,age8,Framingham Cohort,AGE8,Age at Exam 8,phs000007.v33.p14,phv00277084.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277084,[],phs000007,pht006027,phv00277084,False,True,False,AGE8,Age at Exam 8,40.0,\phs000007\pht006027\phv00277084\AGE8\,pht006027.v2,\phs000007\pht006027\phv00277084\AGE8\,phv00277084,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",93.0,Age at Exam 8,phs000007.v31,e60c05a5ca27addb7cfe4256be7dd6d2b3121f5fbb210496d719722d3f009ace,continuous,phv00277084.v2,phs000007,False,AGE8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277084\AGE8\,40.0,93.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age9,"Age (years), Exam 9",51.88452285,vr_wkthru_ex09_1_1001d,age9,Framingham Cohort,AGE9,Age at Exam 9,phs000007.v33.p14,phv00369662.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369662,[],phs000007,pht007777,phv00369662,False,True,False,AGE9,Age at Exam 9,44.0,\phs000007\pht007777\phv00369662\AGE9\,pht007777.v2,\phs000007\pht007777\phv00369662\AGE9\,phv00369662,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Age at Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",78.0,Age at Exam 9,phs000007.v31,f1ce3b62af6f7c249ed44ac5d8e56c538975489e84d6743ae268fdaef5a0dfaa,continuous,phv00369662.v1,phs000007,False,AGE9,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369662\AGE9\,44.0,78.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age9,"Age (years), Exam 9",51.88452285,vr_wkthru_ex09_1_1001d,age9,Framingham Cohort,AGE9,Age at Exam 9,phs000007.v33.p14,phv00277085.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277085,[],phs000007,pht006027,phv00277085,False,True,False,AGE9,Age at Exam 9,46.0,\phs000007\pht006027\phv00277085\AGE9\,pht006027.v2,\phs000007\pht006027\phv00277085\AGE9\,phv00277085,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Age at Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",98.0,Age at Exam 9,phs000007.v31,8ac05bd581977eaa964650b4a806ed8eade30e456142925bbad8ef2745a5a659,continuous,phv00277085.v2,phs000007,False,AGE9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277085\AGE9\,46.0,98.0
AGE,Age,424144002,C00008,ARICFraminghamMESAREGARDS,1.3,Framingham,vr_wkthru_ex09_1_1001d.age9,"Age (years), Exam 9",51.88452285,vr_wkthru_ex09_1_1001d,age9,Framingham Cohort,age9,Age at Exam 9,phs000007.v33.p14,phv00177946.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177946,[],phs000007,pht003099,phv00177946,False,True,False,age9,Age at Exam 9,44.0,\phs000007\pht003099\phv00177946\age9\,pht003099.v6,\phs000007\pht003099\phv00177946\age9\,phv00177946,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Age at Exam 9,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",98.0,Age at Exam 9,phs000007.v31,8e3b5e0a5d3b23f64a2b4e6a485b05659b40099ab93f2700415e37b1ad76431a,continuous,phv00177946.v6,phs000007,False,age9,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177946\age9\,44.0,98.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",4.250200481,vr_wkthru_ex09_1_1001d,bg1,Framingham Cohort,bg1,"Blood glucose, Exam 1 (includes fasting and non-fasting)",phs000007.v33.p14,phv00423879.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423879,[],phs000007,pht009761,phv00423879,False,True,False,bg1,"Blood glucose, Exam 1 (includes fasting and non-fasting)",52.0,\phs000007\pht009761\phv00423879\bg1\,pht009761.v1,\phs000007\pht009761\phv00423879\bg1\,phv00423879,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Blood glucose, Exam 1 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",356.0,"Blood glucose, Exam 1 (includes fasting and non-fasting)",phs000007.v31,cfa3470c2564e9793e8f260db6c6d6b73ed00d89d494777384ee22488d481471,continuous,phv00423879.v1,phs000007,False,bg1,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423879\bg1\,52.0,356.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",4.250200481,vr_wkthru_ex09_1_1001d,bg1,Framingham Cohort,BG1,"Blood glucose, Exam 1",phs000007.v33.p14,phv00369718.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369718,[],phs000007,pht007777,phv00369718,False,True,False,BG1,"Blood glucose, Exam 1",39.0,\phs000007\pht007777\phv00369718\BG1\,pht007777.v2,\phs000007\pht007777\phv00369718\BG1\,phv00369718,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 1",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",420.0,"Blood glucose, Exam 1",phs000007.v31,b16c63d05669a31f381cd6cb65f426dbb539c5a7d7e55004b22a65bc015456da,continuous,phv00369718.v1,phs000007,False,BG1,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369718\BG1\,39.0,420.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",4.250200481,vr_wkthru_ex09_1_1001d,bg1,Framingham Cohort,BG1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",phs000007.v33.p14,phv00277022.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277022,[],phs000007,pht006026,phv00277022,False,True,False,BG1,"Blood glucose, Exam 1 (includes fasting and non-fasting)",54.0,\phs000007\pht006026\phv00277022\BG1\,pht006026.v3,\phs000007\pht006026\phv00277022\BG1\,phv00277022,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.","Blood glucose, Exam 1 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",404.0,"Blood glucose, Exam 1 (includes fasting and non-fasting)",phs000007.v31,bab827994950e3578374396b6a968fab6ca35fcb29d9a3d7c92cc91eaf0febcc,continuous,phv00277022.v3,phs000007,False,BG1,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277022\BG1\,54.0,404.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",4.250200481,vr_wkthru_ex09_1_1001d,bg1,Framingham Cohort,BG1,"Blood glucose, Exam 1",phs000007.v33.p14,phv00080784.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080784,[],phs000007,pht000040,phv00080784,False,True,False,BG1,"Blood glucose, Exam 1",39.0,\phs000007\pht000040\phv00080784\BG1\,pht000040.v5,\phs000007\pht000040\phv00080784\BG1\,phv00080784,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 1",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",420.0,"Blood glucose, Exam 1",phs000007.v31,cee35a97172da01bbfcc26a66e255b2068d21e56508e66c6fbba2af97cb0a2d8,continuous,phv00080784.v2,phs000007,False,BG1,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080784\BG1\,39.0,420.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg1,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 1",4.250200481,vr_wkthru_ex09_1_1001d,bg1,Framingham Cohort,BG1,"Blood glucose, Exam 1 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277086.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277086,[],phs000007,pht006027,phv00277086,False,True,False,BG1,"Blood glucose, Exam 1 (includes fasting and non-fasting)",60.0,\phs000007\pht006027\phv00277086\BG1\,pht006027.v2,\phs000007\pht006027\phv00277086\BG1\,phv00277086,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 1 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",390.0,"Blood glucose, Exam 1 (includes fasting and non-fasting)",phs000007.v31,168e2bac5d77199fd12da33d7e264bb7ff32af5d045fa2cc51188504c5f228f2,continuous,phv00277086.v2,phs000007,False,BG1,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277086\BG1\,60.0,390.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,bg2,Framingham Cohort,BG2,"Blood glucose, Exam 2",phs000007.v33.p14,phv00080785.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080785,[],phs000007,pht000040,phv00080785,False,True,False,BG2,"Blood glucose, Exam 2",33.0,\phs000007\pht000040\phv00080785\BG2\,pht000040.v5,\phs000007\pht000040\phv00080785\BG2\,phv00080785,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 2",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",524.0,"Blood glucose, Exam 2",phs000007.v31,f18fb2d08f8a1d3a1a5538ffe14842e782756a909f27d96a336151944cddc89d,continuous,phv00080785.v2,phs000007,False,BG2,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080785\BG2\,33.0,524.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,bg2,Framingham Cohort,BG2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",phs000007.v33.p14,phv00277023.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277023,[],phs000007,pht006026,phv00277023,False,True,False,BG2,"Blood glucose, Exam 2 (includes fasting and non-fasting)",50.0,\phs000007\pht006026\phv00277023\BG2\,pht006026.v3,\phs000007\pht006026\phv00277023\BG2\,phv00277023,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.","Blood glucose, Exam 2 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",365.0,"Blood glucose, Exam 2 (includes fasting and non-fasting)",phs000007.v31,d4300ea867f44e0bf4c4cc82f5a130ece74757b6e11fc7ddd412eceeb4c3b15e,continuous,phv00277023.v3,phs000007,False,BG2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277023\BG2\,50.0,365.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,bg2,Framingham Cohort,BG2,"Blood glucose, Exam 2 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277087.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277087,[],phs000007,pht006027,phv00277087,False,True,False,BG2,"Blood glucose, Exam 2 (includes fasting and non-fasting)",50.0,\phs000007\pht006027\phv00277087\BG2\,pht006027.v2,\phs000007\pht006027\phv00277087\BG2\,phv00277087,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 2 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",339.0,"Blood glucose, Exam 2 (includes fasting and non-fasting)",phs000007.v31,d7bba1c2ff6c82f76482558bc02cc2ed8e694bcf4f5c576472bc93659083de37,continuous,phv00277087.v2,phs000007,False,BG2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277087\BG2\,50.0,339.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,bg2,Framingham Cohort,BG2,"Blood glucose, Exam 2",phs000007.v33.p14,phv00369719.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369719,[],phs000007,pht007777,phv00369719,False,True,False,BG2,"Blood glucose, Exam 2",33.0,\phs000007\pht007777\phv00369719\BG2\,pht007777.v2,\phs000007\pht007777\phv00369719\BG2\,phv00369719,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",524.0,"Blood glucose, Exam 2",phs000007.v31,663a1ccd4d60511412b7d2b7ce19f6f93776f838c90c4ab778b3ab872b9cbaff,continuous,phv00369719.v1,phs000007,False,BG2,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369719\BG2\,33.0,524.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg2,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,bg2,Framingham Cohort,bg2,"Blood glucose, Exam 2 (includes fasting and non-fasting)",phs000007.v33.p14,phv00423880.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423880,[],phs000007,pht009761,phv00423880,False,True,False,bg2,"Blood glucose, Exam 2 (includes fasting and non-fasting)",51.0,\phs000007\pht009761\phv00423880\bg2\,pht009761.v1,\phs000007\pht009761\phv00423880\bg2\,phv00423880,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Blood glucose, Exam 2 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",403.0,"Blood glucose, Exam 2 (includes fasting and non-fasting)",phs000007.v31,b14cac0b0001f41defba73c555e7850fa2ed1db5766f2b0c3d3060f89d764f36,continuous,phv00423880.v1,phs000007,False,bg2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423880\bg2\,51.0,403.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",27.12510024,vr_wkthru_ex09_1_1001d,bg3,Framingham Cohort,BG3,"Blood glucose, Exam 3",phs000007.v33.p14,phv00080786.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080786,[],phs000007,pht000040,phv00080786,False,True,False,BG3,"Blood glucose, Exam 3",40.0,\phs000007\pht000040\phv00080786\BG3\,pht000040.v5,\phs000007\pht000040\phv00080786\BG3\,phv00080786,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 3",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",386.0,"Blood glucose, Exam 3",phs000007.v31,a3a2ae34949b349ade80b58b02e6f9cb2103687a18e7089a7f7b0937efb5df24,continuous,phv00080786.v2,phs000007,False,BG3,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080786\BG3\,40.0,386.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",27.12510024,vr_wkthru_ex09_1_1001d,bg3,Framingham Cohort,BG3,"Blood glucose, Exam 3 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277088.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277088,[],phs000007,pht006027,phv00277088,False,True,False,BG3,"Blood glucose, Exam 3 (includes fasting and non-fasting)",47.0,\phs000007\pht006027\phv00277088\BG3\,pht006027.v2,\phs000007\pht006027\phv00277088\BG3\,phv00277088,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 3 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",387.0,"Blood glucose, Exam 3 (includes fasting and non-fasting)",phs000007.v31,ef8b020e27247abfd8476dc1d3300f76da63b3fb12259fca336570768c669049,continuous,phv00277088.v2,phs000007,False,BG3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277088\BG3\,47.0,387.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",27.12510024,vr_wkthru_ex09_1_1001d,bg3,Framingham Cohort,BG3,"Blood glucose, Exam 3",phs000007.v33.p14,phv00369720.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369720,[],phs000007,pht007777,phv00369720,False,True,False,BG3,"Blood glucose, Exam 3",40.0,\phs000007\pht007777\phv00369720\BG3\,pht007777.v2,\phs000007\pht007777\phv00369720\BG3\,phv00369720,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 3",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",386.0,"Blood glucose, Exam 3",phs000007.v31,c7a9c67039dacc217d1b51935a5e969c980be9c4572b37f66c262d3e9e2bb7e1,continuous,phv00369720.v1,phs000007,False,BG3,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369720\BG3\,40.0,386.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",27.12510024,vr_wkthru_ex09_1_1001d,bg3,Framingham Cohort,bg3,"Blood glucose, Exam 3 (includes fasting and non-fasting)",phs000007.v33.p14,phv00423881.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423881,[],phs000007,pht009761,phv00423881,False,True,False,bg3,"Blood glucose, Exam 3 (includes fasting and non-fasting)",68.0,\phs000007\pht009761\phv00423881\bg3\,pht009761.v1,\phs000007\pht009761\phv00423881\bg3\,phv00423881,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Blood glucose, Exam 3 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",319.0,"Blood glucose, Exam 3 (includes fasting and non-fasting)",phs000007.v31,6fd3f3251fe600374213a007cd00f75ede506c61227e3fe2ed708779ca0dc698,continuous,phv00423881.v1,phs000007,False,bg3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423881\bg3\,68.0,319.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",27.12510024,vr_wkthru_ex09_1_1001d,bg3,Framingham Cohort,BG3,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 3",phs000007.v33.p14,phv00520290.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520290,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg4,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 4",23.61668003,vr_wkthru_ex09_1_1001d,bg4,Framingham Cohort,BG4,"Blood glucose, Exam 4 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277089.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277089,[],phs000007,pht006027,phv00277089,False,True,False,BG4,"Blood glucose, Exam 4 (includes fasting and non-fasting)",42.0,\phs000007\pht006027\phv00277089\BG4\,pht006027.v2,\phs000007\pht006027\phv00277089\BG4\,phv00277089,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 4 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",362.0,"Blood glucose, Exam 4 (includes fasting and non-fasting)",phs000007.v31,ec8ae8a08473bfe8e52fb6b3dc6a47428331e9f2e0f27af127dc484f6c3786e0,continuous,phv00277089.v2,phs000007,False,BG4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277089\BG4\,42.0,362.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg4,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 4",23.61668003,vr_wkthru_ex09_1_1001d,bg4,Framingham Cohort,BG4,"Blood glucose, Exam 4",phs000007.v33.p14,phv00369721.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369721,[],phs000007,pht007777,phv00369721,False,True,False,BG4,"Blood glucose, Exam 4",37.0,\phs000007\pht007777\phv00369721\BG4\,pht007777.v2,\phs000007\pht007777\phv00369721\BG4\,phv00369721,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 4",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",483.0,"Blood glucose, Exam 4",phs000007.v31,cffc3102c08df33939703f682bb9d085703b2b5d2e9fd9944d1c8a7b1ac10e68,continuous,phv00369721.v1,phs000007,False,BG4,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369721\BG4\,37.0,483.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg4,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 4",23.61668003,vr_wkthru_ex09_1_1001d,bg4,Framingham Cohort,BG4,"Blood glucose, Exam 4",phs000007.v33.p14,phv00080787.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080787,[],phs000007,pht000040,phv00080787,False,True,False,BG4,"Blood glucose, Exam 4",37.0,\phs000007\pht000040\phv00080787\BG4\,pht000040.v5,\phs000007\pht000040\phv00080787\BG4\,phv00080787,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 4",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",483.0,"Blood glucose, Exam 4",phs000007.v31,daf3ea6eae5b05d5f62387468b93dedaf149becdd8b59dc3c7b20075ac0cbf41,continuous,phv00080787.v2,phs000007,False,BG4,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080787\BG4\,37.0,483.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg4,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 4",23.61668003,vr_wkthru_ex09_1_1001d,bg4,Framingham Cohort,bg4,"Blood glucose, Exam 4 (includes fasting and non-fasting)",phs000007.v33.p14,phv00423882.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423882,[],phs000007,pht009761,phv00423882,False,True,False,bg4,"Blood glucose, Exam 4 (includes fasting and non-fasting)",60.0,\phs000007\pht009761\phv00423882\bg4\,pht009761.v1,\phs000007\pht009761\phv00423882\bg4\,phv00423882,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Blood glucose, Exam 4 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",295.0,"Blood glucose, Exam 4 (includes fasting and non-fasting)",phs000007.v31,d33fb2002759b03fa06886493f08f39f6f4a893eeb62794f9b4a0057e74021ab,continuous,phv00423882.v1,phs000007,False,bg4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423882\bg4\,60.0,295.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg5,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 5",26.66399358,vr_wkthru_ex09_1_1001d,bg5,Framingham Cohort,BG5,"Blood glucose, Exam 5 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277090.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277090,[],phs000007,pht006027,phv00277090,False,True,False,BG5,"Blood glucose, Exam 5 (includes fasting and non-fasting)",47.0,\phs000007\pht006027\phv00277090\BG5\,pht006027.v2,\phs000007\pht006027\phv00277090\BG5\,phv00277090,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 5 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",456.0,"Blood glucose, Exam 5 (includes fasting and non-fasting)",phs000007.v31,eeb6ad7b78c57d9f4a4eac6150fbe72b3a324d11164306294a59ea875c3b317d,continuous,phv00277090.v2,phs000007,False,BG5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277090\BG5\,47.0,456.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg6,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 6",32.55813953,vr_wkthru_ex09_1_1001d,bg6,Framingham Cohort,BG6,"Blood glucose, Exam 6",phs000007.v33.p14,phv00080788.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080788,[],phs000007,pht000040,phv00080788,False,True,False,BG6,"Blood glucose, Exam 6",39.0,\phs000007\pht000040\phv00080788\BG6\,pht000040.v5,\phs000007\pht000040\phv00080788\BG6\,phv00080788,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 6",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",420.0,"Blood glucose, Exam 6",phs000007.v31,a785cad90669169fb8f34ac041b9e6742d80f5d7f10dba81f4814caaf98c2585,continuous,phv00080788.v2,phs000007,False,BG6,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080788\BG6\,39.0,420.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg6,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 6",32.55813953,vr_wkthru_ex09_1_1001d,bg6,Framingham Cohort,BG6,"Blood glucose, Exam 6 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277091.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277091,[],phs000007,pht006027,phv00277091,False,True,False,BG6,"Blood glucose, Exam 6 (includes fasting and non-fasting)",57.0,\phs000007\pht006027\phv00277091\BG6\,pht006027.v2,\phs000007\pht006027\phv00277091\BG6\,phv00277091,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 6 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",360.0,"Blood glucose, Exam 6 (includes fasting and non-fasting)",phs000007.v31,4e128c00bb0befbe52c31619c3dbb42fabcb8ad5cc7831b6dd88f2512b145ec4,continuous,phv00277091.v2,phs000007,False,BG6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277091\BG6\,57.0,360.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg6,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 6",32.55813953,vr_wkthru_ex09_1_1001d,bg6,Framingham Cohort,BG6,"Blood glucose, Exam 6",phs000007.v33.p14,phv00369722.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369722,[],phs000007,pht007777,phv00369722,False,True,False,BG6,"Blood glucose, Exam 6",39.0,\phs000007\pht007777\phv00369722\BG6\,pht007777.v2,\phs000007\pht007777\phv00369722\BG6\,phv00369722,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 6",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",420.0,"Blood glucose, Exam 6",phs000007.v31,2a66af240620397a50bebbe9c881d64da02c73e5696a9ee7b085caf62cf92e73,continuous,phv00369722.v1,phs000007,False,BG6,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369722\BG6\,39.0,420.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg7,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 7",34.38251804,vr_wkthru_ex09_1_1001d,bg7,Framingham Cohort,BG7,"Blood glucose, Exam 7 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277092.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277092,[],phs000007,pht006027,phv00277092,False,True,False,BG7,"Blood glucose, Exam 7 (includes fasting and non-fasting)",61.0,\phs000007\pht006027\phv00277092\BG7\,pht006027.v2,\phs000007\pht006027\phv00277092\BG7\,phv00277092,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 7 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",467.0,"Blood glucose, Exam 7 (includes fasting and non-fasting)",phs000007.v31,260252a547212c0b6d40efefa1ff16838ac79438c94e3cdbd43c7e4a0c77314b,continuous,phv00277092.v2,phs000007,False,BG7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277092\BG7\,61.0,467.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg8,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 8",42.54210104,vr_wkthru_ex09_1_1001d,bg8,Framingham Cohort,BG8,"Blood glucose, Exam 8",phs000007.v33.p14,phv00369723.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369723,[],phs000007,pht007777,phv00369723,False,True,False,BG8,"Blood glucose, Exam 8",29.0,\phs000007\pht007777\phv00369723\BG8\,pht007777.v2,\phs000007\pht007777\phv00369723\BG8\,phv00369723,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 8",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",362.0,"Blood glucose, Exam 8",phs000007.v31,1cb3e0f0b00a7f43c61d751553cf13b16d59a713f687f4bc4e1d78d38db6dc27,continuous,phv00369723.v1,phs000007,False,BG8,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369723\BG8\,29.0,362.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg8,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 8",42.54210104,vr_wkthru_ex09_1_1001d,bg8,Framingham Cohort,BG8,"Blood glucose, Exam 8",phs000007.v33.p14,phv00080789.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080789,[],phs000007,pht000040,phv00080789,False,True,False,BG8,"Blood glucose, Exam 8",29.0,\phs000007\pht000040\phv00080789\BG8\,pht000040.v5,\phs000007\pht000040\phv00080789\BG8\,phv00080789,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 8",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",362.0,"Blood glucose, Exam 8",phs000007.v31,4698e6b3eb139410eb676046b04c869eeef9c0365db6c01844cbb3858eafa730,continuous,phv00080789.v2,phs000007,False,BG8,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080789\BG8\,29.0,362.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg8,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 8",42.54210104,vr_wkthru_ex09_1_1001d,bg8,Framingham Cohort,BG8,"Blood glucose, Exam 8 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277093.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277093,[],phs000007,pht006027,phv00277093,False,True,False,BG8,"Blood glucose, Exam 8 (includes fasting and non-fasting)",36.0,\phs000007\pht006027\phv00277093\BG8\,pht006027.v2,\phs000007\pht006027\phv00277093\BG8\,phv00277093,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 8 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",339.0,"Blood glucose, Exam 8 (includes fasting and non-fasting)",phs000007.v31,856daec1d1ae42b82f61dfbfe55b7e395c1266a04206eada97dfa6c6bdac1578,continuous,phv00277093.v2,phs000007,False,BG8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277093\BG8\,36.0,339.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg9,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 9",54.87169206,vr_wkthru_ex09_1_1001d,bg9,Framingham Cohort,BG9,"Blood glucose, Exam 9",phs000007.v33.p14,phv00369724.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369724,[],phs000007,pht007777,phv00369724,False,True,False,BG9,"Blood glucose, Exam 9",44.0,\phs000007\pht007777\phv00369724\BG9\,pht007777.v2,\phs000007\pht007777\phv00369724\BG9\,phv00369724,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Blood glucose, Exam 9",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",423.0,"Blood glucose, Exam 9",phs000007.v31,49c4210770b991c2195410fef64440c95f815624732da975f1989400eb2709c1,continuous,phv00369724.v1,phs000007,False,BG9,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369724\BG9\,44.0,423.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg9,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 9",54.87169206,vr_wkthru_ex09_1_1001d,bg9,Framingham Cohort,BG9,"Blood glucose, Exam 9",phs000007.v33.p14,phv00080790.v2.p14,pht000040.v5.p14,vr_diab_ex28_0_0601s,phv00080790,[],phs000007,pht000040,phv00080790,False,True,False,BG9,"Blood glucose, Exam 9",44.0,\phs000007\pht000040\phv00080790\BG9\,pht000040.v5,\phs000007\pht000040\phv00080790\BG9\,phv00080790,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.","Blood glucose, Exam 9",{},,"Diabetes Mellitus Status, Original Cohort Exams 1 - 28. Variables include blood glucose levels, current treatment for diabetes, and diabetes mellitus status. Blood glucose was not measured at exams 5, 7, 11, 12, 24, and 25. Therefore, there is no measure of diabetes mellitus status at these exams.",423.0,"Blood glucose, Exam 9",phs000007.v31,837e68eb9e6e88ac5a6d5cb72fc84f48c7bc9d4fae27901d9aa68a639ec639b4,continuous,phv00080790.v2,phs000007,False,BG9,FHS,Framingham Cohort,pht000040,vr_diab_ex28_0_0601s,\phs000007\pht000040\phv00080790\BG9\,44.0,423.0
BG,Blood glucose (mg/dL) (fasting and non-fasting),-,-,Framingham,1.31,Framingham,vr_wkthru_ex09_1_1001d.bg9,"Blood glucose (mg/dL) (includes fasting and non-fasting), Exam 9",54.87169206,vr_wkthru_ex09_1_1001d,bg9,Framingham Cohort,BG9,"Blood glucose, Exam 9 (includes fasting and non-fasting)",phs000007.v33.p14,phv00277094.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277094,[],phs000007,pht006027,phv00277094,False,True,False,BG9,"Blood glucose, Exam 9 (includes fasting and non-fasting)",53.0,\phs000007\pht006027\phv00277094\BG9\,pht006027.v2,\phs000007\pht006027\phv00277094\BG9\,phv00277094,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Blood glucose, Exam 9 (includes fasting and non-fasting)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",277.0,"Blood glucose, Exam 9 (includes fasting and non-fasting)",phs000007.v31,bbe20414b1f995924c21842b2ffb9ee18c12dfe835514605e9d666631988ba56,continuous,phv00277094.v2,phs000007,False,BG9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277094\BG9\,53.0,277.0
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat2,"Creatinine (mg/dL), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,creat2,Framingham Cohort,CREAT2,"Creatinine (mg/dL), Exam 2",phs000007.v33.p14,phv00277031.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277031,[],phs000007,pht006026,phv00277031,False,True,False,CREAT2,"Creatinine, Exam 2",0.31,\phs000007\pht006026\phv00277031\CREAT2\,pht006026.v3,\phs000007\pht006026\phv00277031\CREAT2\,phv00277031,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.","Creatinine, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",2.65,"Creatinine, Exam 2",phs000007.v31,ddda48eb35027a414b48769e1c128641aaa48f5cbe4073e184e85b1058bc110e,continuous,phv00277031.v3,phs000007,False,CREAT2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277031\CREAT2\,0.31,2.65
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat2,"Creatinine (mg/dL), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,creat2,Framingham Cohort,CREAT2,"Creatinine, Exam 2",phs000007.v33.p14,phv00277122.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277122,[],phs000007,pht006027,phv00277122,False,True,False,CREAT2,"Creatinine, Exam 2",0.3,\phs000007\pht006027\phv00277122\CREAT2\,pht006027.v2,\phs000007\pht006027\phv00277122\CREAT2\,phv00277122,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",9.8,"Creatinine, Exam 2",phs000007.v31,dac961f29bff6d7cf43dd55fd6f859179922d75e5322dece365750b949bc6af1,continuous,phv00277122.v2,phs000007,False,CREAT2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277122\CREAT2\,0.3,9.8
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat2,"Creatinine (mg/dL), Exam 2",27.7265437,vr_wkthru_ex09_1_1001d,creat2,Framingham Cohort,CREAT2,"Creatinine, Exam 2",phs000007.v33.p14,phv00423895.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423895,[],phs000007,pht009761,phv00423895,False,True,False,CREAT2,"Creatinine, Exam 2",0.44,\phs000007\pht009761\phv00423895\CREAT2\,pht009761.v1,\phs000007\pht009761\phv00423895\CREAT2\,phv00423895,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Creatinine, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",3.29,"Creatinine, Exam 2",phs000007.v31,cece116bea1cc18fa97b8e19b9333bf2016d2cc4d2dec3ed3a1f37d0fe780400,continuous,phv00423895.v1,phs000007,False,CREAT2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423895\CREAT2\,0.44,3.29
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat5,"Creatinine (mg/dL), Exam 5",38.09141941,vr_wkthru_ex09_1_1001d,creat5,Framingham Cohort,CREAT5,"Creatinine, Exam 5",phs000007.v33.p14,phv00277123.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277123,[],phs000007,pht006027,phv00277123,False,True,False,CREAT5,"Creatinine, Exam 5",0.17,\phs000007\pht006027\phv00277123\CREAT5\,pht006027.v2,\phs000007\pht006027\phv00277123\CREAT5\,phv00277123,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 5",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",7.01,"Creatinine, Exam 5",phs000007.v31,265e9dfa3ad0de8a86a870157c228eb65496c461ba95be537b02da164195e471,continuous,phv00277123.v2,phs000007,False,CREAT5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277123\CREAT5\,0.17,7.01
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat6,"Creatinine (mg/dL), Exam 6",33.05934242,vr_wkthru_ex09_1_1001d,creat6,Framingham Cohort,CREAT6,"Creatinine, Exam 6",phs000007.v33.p14,phv00277124.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277124,[],phs000007,pht006027,phv00277124,False,True,False,CREAT6,"Creatinine, Exam 6",0.32,\phs000007\pht006027\phv00277124\CREAT6\,pht006027.v2,\phs000007\pht006027\phv00277124\CREAT6\,phv00277124,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 6",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",4.56,"Creatinine, Exam 6",phs000007.v31,267ea238446b1c2d9a483c81f3ada3504cc65a0403e4ecca487fc32cc7ae9638,continuous,phv00277124.v2,phs000007,False,CREAT6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277124\CREAT6\,0.32,4.56
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat7,"Creatinine (mg/dL), Exam 7",34.60304731,vr_wkthru_ex09_1_1001d,creat7,Framingham Cohort,CREAT7,"Creatinine, Exam 7",phs000007.v33.p14,phv00277125.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277125,[],phs000007,pht006027,phv00277125,False,True,False,CREAT7,"Creatinine, Exam 7",0.4,\phs000007\pht006027\phv00277125\CREAT7\,pht006027.v2,\phs000007\pht006027\phv00277125\CREAT7\,phv00277125,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 7",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",8.91,"Creatinine, Exam 7",phs000007.v31,33f0101d4296b511bda1569c5258d80d56eeda4211a62c7416ac240fef746c87,continuous,phv00277125.v2,phs000007,False,CREAT7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277125\CREAT7\,0.4,8.91
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat8,"Creatinine (mg/dL), Exam 8",42.78267843,vr_wkthru_ex09_1_1001d,creat8,Framingham Cohort,CREAT8,"Creatinine, Exam 8",phs000007.v33.p14,phv00277126.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277126,[],phs000007,pht006027,phv00277126,False,True,False,CREAT8,"Creatinine, Exam 8",0.33,\phs000007\pht006027\phv00277126\CREAT8\,pht006027.v2,\phs000007\pht006027\phv00277126\CREAT8\,phv00277126,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 8",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",6.79,"Creatinine, Exam 8",phs000007.v31,c99e1ccc5e72c6905ef6e6a7d1cff1a227859cdd50852816e1f9ac2f0ca2c8f1,continuous,phv00277126.v2,phs000007,False,CREAT8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277126\CREAT8\,0.33,6.79
CREAT,Creatinine (mg/dL),15373003,C57972,ARICFraminghamMESAREGARDS,0.95,Framingham,vr_wkthru_ex09_1_1001d.creat9,"Creatinine (mg/dL), Exam 9",55.13231756,vr_wkthru_ex09_1_1001d,creat9,Framingham Cohort,CREAT9,"Creatinine, Exam 9",phs000007.v33.p14,phv00277127.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277127,[],phs000007,pht006027,phv00277127,False,True,False,CREAT9,"Creatinine, Exam 9",0.39,\phs000007\pht006027\phv00277127\CREAT9\,pht006027.v2,\phs000007\pht006027\phv00277127\CREAT9\,phv00277127,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Creatinine, Exam 9",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",3.69,"Creatinine, Exam 9",phs000007.v31,c7591e209763297587bf4fc743a9395877afa0344a1e0980bbdac02d3a66a727,continuous,phv00277127.v2,phs000007,False,CREAT9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277127\CREAT9\,0.39,3.69
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,date2,Date of Exam 2,phs000007.v33.p14,phv00423962.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423962,[],phs000007,pht009761,phv00423962,False,True,True,date2,Date of Exam 2,446.0,\phs000007\pht009761\phv00423962\date2\,pht009761.v1,\phs000007\pht009761\phv00423962\date2\,phv00423962,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",2534.0,Date of Exam 2,phs000007.v31,8c65f4867921e9e2ed770124f5e077f33c39ef69c6176049f9a584f93f3a96bc,continuous,phv00423962.v1,phs000007,True,date2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423962\date2\,446.0,2534.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Exam date for Exam 2,phs000007.v33.p14,phv00277064.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277064,[],phs000007,pht006026,phv00277064,False,True,True,DATE2,Date of Exam 2,1092.0,\phs000007\pht006026\phv00277064\DATE2\,pht006026.v3,\phs000007\pht006026\phv00277064\DATE2\,phv00277064,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",3176.0,Date of Exam 2,phs000007.v31,8bd04140b011bb430a6a1e8d51030e19117dcaa9376044e70e73376d2c7d0160,continuous,phv00277064.v3,phs000007,True,DATE2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277064\DATE2\,1092.0,3176.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Date of Exam 2,phs000007.v33.p14,phv00277264.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277264,[],phs000007,pht006027,phv00277264,False,True,True,DATE2,Date of Exam 2,1996.0,\phs000007\pht006027\phv00277264\DATE2\,pht006027.v2,\phs000007\pht006027\phv00277264\DATE2\,phv00277264,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",4227.0,Date of Exam 2,phs000007.v31,e33fb366dcd2f63bf7f14e366bcaad8cf38f77e28f5192a06b06c7e8a0a8355b,continuous,phv00277264.v2,phs000007,True,DATE2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277264\DATE2\,1996.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Date of Exam 2,phs000007.v33.p14,phv00370159.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370159,[],phs000007,pht007777,phv00370159,False,True,True,DATE2,Date of Exam 2,333.0,\phs000007\pht007777\phv00370159\DATE2\,pht007777.v2,\phs000007\pht007777\phv00370159\DATE2\,phv00370159,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",1552.0,Date of Exam 2,phs000007.v31,cf5002a630537a545045ee683d6527a23b28410614d0729acd8b5a8e7c165bd5,continuous,phv00370159.v1,phs000007,True,DATE2,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370159\DATE2\,333.0,1552.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,date2,Date of Exam 2,phs000007.v33.p14,phv00423962.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423962,[],phs000007,pht009761,phv00423962,False,True,True,date2,Date of Exam 2,446.0,\phs000007\pht009761\phv00423962\date2\,pht009761.v1,\phs000007\pht009761\phv00423962\date2\,phv00423962,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",2534.0,Date of Exam 2,phs000007.v31,8c65f4867921e9e2ed770124f5e077f33c39ef69c6176049f9a584f93f3a96bc,continuous,phv00423962.v1,phs000007,True,date2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423962\date2\,446.0,2534.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Exam date for Exam 2,phs000007.v33.p14,phv00277064.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277064,[],phs000007,pht006026,phv00277064,False,True,True,DATE2,Date of Exam 2,1092.0,\phs000007\pht006026\phv00277064\DATE2\,pht006026.v3,\phs000007\pht006026\phv00277064\DATE2\,phv00277064,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",3176.0,Date of Exam 2,phs000007.v31,8bd04140b011bb430a6a1e8d51030e19117dcaa9376044e70e73376d2c7d0160,continuous,phv00277064.v3,phs000007,True,DATE2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277064\DATE2\,1092.0,3176.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Date of Exam 2,phs000007.v33.p14,phv00277264.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277264,[],phs000007,pht006027,phv00277264,False,True,True,DATE2,Date of Exam 2,1996.0,\phs000007\pht006027\phv00277264\DATE2\,pht006027.v2,\phs000007\pht006027\phv00277264\DATE2\,phv00277264,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",4227.0,Date of Exam 2,phs000007.v31,e33fb366dcd2f63bf7f14e366bcaad8cf38f77e28f5192a06b06c7e8a0a8355b,continuous,phv00277264.v2,phs000007,True,DATE2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277264\DATE2\,1996.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,date2,Exam date for Exam 2,phs000007.v33.p14,phv00177985.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177985,[],phs000007,pht003099,phv00177985,False,True,True,date2,Exam date for Exam 2,333.0,\phs000007\pht003099\phv00177985\date2\,pht003099.v6,\phs000007\pht003099\phv00177985\date2\,phv00177985,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 2,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",4227.0,Exam date for Exam 2,phs000007.v31,61568eed67655ff1b03a60dfcf4f2549b0ae05bd39a738c1b0b1db9f9bbef5fa,continuous,phv00177985.v6,phs000007,True,date2,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177985\date2\,333.0,4227.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,date2,Exam date for Exam 2,phs000007.v33.p14,phv00177985.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177985,[],phs000007,pht003099,phv00177985,False,True,True,date2,Exam date for Exam 2,333.0,\phs000007\pht003099\phv00177985\date2\,pht003099.v6,\phs000007\pht003099\phv00177985\date2\,phv00177985,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 2,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",4227.0,Exam date for Exam 2,phs000007.v31,61568eed67655ff1b03a60dfcf4f2549b0ae05bd39a738c1b0b1db9f9bbef5fa,continuous,phv00177985.v6,phs000007,True,date2,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177985\date2\,333.0,4227.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date2,Date of Exam 2,24.77947073,vr_wkthru_ex09_1_1001d,date2,Framingham Cohort,DATE2,Date of Exam 2,phs000007.v33.p14,phv00370159.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370159,[],phs000007,pht007777,phv00370159,False,True,True,DATE2,Date of Exam 2,333.0,\phs000007\pht007777\phv00370159\DATE2\,pht007777.v2,\phs000007\pht007777\phv00370159\DATE2\,phv00370159,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 2,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",1552.0,Date of Exam 2,phs000007.v31,cf5002a630537a545045ee683d6527a23b28410614d0729acd8b5a8e7c165bd5,continuous,phv00370159.v1,phs000007,True,DATE2,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370159\DATE2\,333.0,1552.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Exam date for Exam 3,phs000007.v33.p14,phv00520311.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,date3,Date of Exam 3,phs000007.v33.p14,phv00423963.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423963,[],phs000007,pht009761,phv00423963,False,True,True,date3,Date of Exam 3,3082.0,\phs000007\pht009761\phv00423963\date3\,pht009761.v1,\phs000007\pht009761\phv00423963\date3\,phv00423963,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",4863.0,Date of Exam 3,phs000007.v31,07ace3f8d4a2c2a996c8439e8966574815818c1b5e3e1c0ccf8000dde44a0172,continuous,phv00423963.v1,phs000007,True,date3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423963\date3\,3082.0,4863.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Exam date for Exam 3,phs000007.v33.p14,phv00520311.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520311,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,date3,Date of Exam 3,phs000007.v33.p14,phv00423963.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423963,[],phs000007,pht009761,phv00423963,False,True,True,date3,Date of Exam 3,3082.0,\phs000007\pht009761\phv00423963\date3\,pht009761.v1,\phs000007\pht009761\phv00423963\date3\,phv00423963,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",4863.0,Date of Exam 3,phs000007.v31,07ace3f8d4a2c2a996c8439e8966574815818c1b5e3e1c0ccf8000dde44a0172,continuous,phv00423963.v1,phs000007,True,date3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423963\date3\,3082.0,4863.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Date of Exam 3,phs000007.v33.p14,phv00370160.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370160,[],phs000007,pht007777,phv00370160,False,True,True,DATE3,Date of Exam 3,1080.0,\phs000007\pht007777\phv00370160\DATE3\,pht007777.v2,\phs000007\pht007777\phv00370160\DATE3\,phv00370160,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",1888.0,Date of Exam 3,phs000007.v31,2755316d45cb85d6e06a8c28e1022e763b5646a14e477b2550b858700e256daa,continuous,phv00370160.v1,phs000007,True,DATE3,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370160\DATE3\,1080.0,1888.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Date of Exam 3,phs000007.v33.p14,phv00277265.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277265,[],phs000007,pht006027,phv00277265,False,True,True,DATE3,Date of Exam 3,3319.0,\phs000007\pht006027\phv00277265\DATE3\,pht006027.v2,\phs000007\pht006027\phv00277265\DATE3\,phv00277265,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",5627.0,Date of Exam 3,phs000007.v31,5efe7d41e69305878495a0e9982b314531e221a31c9d7fd692eca6dc1e7125fc,continuous,phv00277265.v2,phs000007,True,DATE3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277265\DATE3\,3319.0,5627.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,date3,Exam date for Exam 3,phs000007.v33.p14,phv00177986.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177986,[],phs000007,pht003099,phv00177986,False,True,True,date3,Exam date for Exam 3,1080.0,\phs000007\pht003099\phv00177986\date3\,pht003099.v6,\phs000007\pht003099\phv00177986\date3\,phv00177986,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 3,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",6219.0,Exam date for Exam 3,phs000007.v31,238aeb98002e2621518bc177f335d7f37e13dd8f6801ec08c09827d8054e5ce2,continuous,phv00177986.v6,phs000007,True,date3,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177986\date3\,1080.0,6219.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Date of Exam 3,phs000007.v33.p14,phv00370160.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370160,[],phs000007,pht007777,phv00370160,False,True,True,DATE3,Date of Exam 3,1080.0,\phs000007\pht007777\phv00370160\DATE3\,pht007777.v2,\phs000007\pht007777\phv00370160\DATE3\,phv00370160,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",1888.0,Date of Exam 3,phs000007.v31,2755316d45cb85d6e06a8c28e1022e763b5646a14e477b2550b858700e256daa,continuous,phv00370160.v1,phs000007,True,DATE3,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370160\DATE3\,1080.0,1888.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,DATE3,Date of Exam 3,phs000007.v33.p14,phv00277265.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277265,[],phs000007,pht006027,phv00277265,False,True,True,DATE3,Date of Exam 3,3319.0,\phs000007\pht006027\phv00277265\DATE3\,pht006027.v2,\phs000007\pht006027\phv00277265\DATE3\,phv00277265,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 3,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",5627.0,Date of Exam 3,phs000007.v31,5efe7d41e69305878495a0e9982b314531e221a31c9d7fd692eca6dc1e7125fc,continuous,phv00277265.v2,phs000007,True,DATE3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277265\DATE3\,3319.0,5627.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date3,Date of Exam 3,24.57898958,vr_wkthru_ex09_1_1001d,date3,Framingham Cohort,date3,Exam date for Exam 3,phs000007.v33.p14,phv00177986.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177986,[],phs000007,pht003099,phv00177986,False,True,True,date3,Exam date for Exam 3,1080.0,\phs000007\pht003099\phv00177986\date3\,pht003099.v6,\phs000007\pht003099\phv00177986\date3\,phv00177986,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 3,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",6219.0,Exam date for Exam 3,phs000007.v31,238aeb98002e2621518bc177f335d7f37e13dd8f6801ec08c09827d8054e5ce2,continuous,phv00177986.v6,phs000007,True,date3,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177986\date3\,1080.0,6219.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,date4,Exam date for Exam 4,phs000007.v33.p14,phv00177987.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177987,[],phs000007,pht003099,phv00177987,False,True,True,date4,Exam date for Exam 4,1827.0,\phs000007\pht003099\phv00177987\date4\,pht003099.v6,\phs000007\pht003099\phv00177987\date4\,phv00177987,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 4,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",7055.0,Exam date for Exam 4,phs000007.v31,ed10a5c9d86c189238dd7afc5ac7c45abb36fccc66dba85ca07e6b2cb54b6969,continuous,phv00177987.v6,phs000007,True,date4,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177987\date4\,1827.0,7055.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,DATE4,Date of Exam 4,phs000007.v33.p14,phv00277266.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277266,[],phs000007,pht006027,phv00277266,False,True,True,DATE4,Date of Exam 4,4326.0,\phs000007\pht006027\phv00277266\DATE4\,pht006027.v2,\phs000007\pht006027\phv00277266\DATE4\,phv00277266,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",6991.0,Date of Exam 4,phs000007.v31,b540f3aa22bf0196b2bdd29748ff2ba3986c629e2ad36d02a609a60a5ac45b3e,continuous,phv00277266.v2,phs000007,True,DATE4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277266\DATE4\,4326.0,6991.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,date4,Date of Exam 4,phs000007.v33.p14,phv00423964.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423964,[],phs000007,pht009761,phv00423964,False,True,True,date4,Date of Exam 4,4802.0,\phs000007\pht009761\phv00423964\date4\,pht009761.v1,\phs000007\pht009761\phv00423964\date4\,phv00423964,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",7055.0,Date of Exam 4,phs000007.v31,3517742ac686d37615ebadee25791ca129994bbb2ca3a0e36027f913a9a494e8,continuous,phv00423964.v1,phs000007,True,date4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423964\date4\,4802.0,7055.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,DATE4,Date of Exam 4,phs000007.v33.p14,phv00370161.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370161,[],phs000007,pht007777,phv00370161,False,True,True,DATE4,Date of Exam 4,1827.0,\phs000007\pht007777\phv00370161\DATE4\,pht007777.v2,\phs000007\pht007777\phv00370161\DATE4\,phv00370161,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",2626.0,Date of Exam 4,phs000007.v31,0e90245b52b4cdd5b49a79a8c7089a4fdacd71ed08c64596ac61378166faaded,continuous,phv00370161.v1,phs000007,True,DATE4,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370161\DATE4\,1827.0,2626.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,date4,Exam date for Exam 4,phs000007.v33.p14,phv00177987.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177987,[],phs000007,pht003099,phv00177987,False,True,True,date4,Exam date for Exam 4,1827.0,\phs000007\pht003099\phv00177987\date4\,pht003099.v6,\phs000007\pht003099\phv00177987\date4\,phv00177987,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 4,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",7055.0,Exam date for Exam 4,phs000007.v31,ed10a5c9d86c189238dd7afc5ac7c45abb36fccc66dba85ca07e6b2cb54b6969,continuous,phv00177987.v6,phs000007,True,date4,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177987\date4\,1827.0,7055.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,DATE4,Date of Exam 4,phs000007.v33.p14,phv00277266.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277266,[],phs000007,pht006027,phv00277266,False,True,True,DATE4,Date of Exam 4,4326.0,\phs000007\pht006027\phv00277266\DATE4\,pht006027.v2,\phs000007\pht006027\phv00277266\DATE4\,phv00277266,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",6991.0,Date of Exam 4,phs000007.v31,b540f3aa22bf0196b2bdd29748ff2ba3986c629e2ad36d02a609a60a5ac45b3e,continuous,phv00277266.v2,phs000007,True,DATE4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277266\DATE4\,4326.0,6991.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,DATE4,Date of Exam 4,phs000007.v33.p14,phv00370161.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370161,[],phs000007,pht007777,phv00370161,False,True,True,DATE4,Date of Exam 4,1827.0,\phs000007\pht007777\phv00370161\DATE4\,pht007777.v2,\phs000007\pht007777\phv00370161\DATE4\,phv00370161,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",2626.0,Date of Exam 4,phs000007.v31,0e90245b52b4cdd5b49a79a8c7089a4fdacd71ed08c64596ac61378166faaded,continuous,phv00370161.v1,phs000007,True,DATE4,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370161\DATE4\,1827.0,2626.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date4,Date of Exam 4,21.77225341,vr_wkthru_ex09_1_1001d,date4,Framingham Cohort,date4,Date of Exam 4,phs000007.v33.p14,phv00423964.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423964,[],phs000007,pht009761,phv00423964,False,True,True,date4,Date of Exam 4,4802.0,\phs000007\pht009761\phv00423964\date4\,pht009761.v1,\phs000007\pht009761\phv00423964\date4\,phv00423964,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",Date of Exam 4,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",7055.0,Date of Exam 4,phs000007.v31,3517742ac686d37615ebadee25791ca129994bbb2ca3a0e36027f913a9a494e8,continuous,phv00423964.v1,phs000007,True,date4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423964\date4\,4802.0,7055.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,date5,Exam date for Exam 5,phs000007.v33.p14,phv00177988.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177988,[],phs000007,pht003099,phv00177988,False,True,True,date5,Exam date for Exam 5,2530.0,\phs000007\pht003099\phv00177988\date5\,pht003099.v6,\phs000007\pht003099\phv00177988\date5\,phv00177988,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 5,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",8354.0,Exam date for Exam 5,phs000007.v31,f7dd80993f264b442d60f819b27826354d78e374368392b76348924bd1c9ab20,continuous,phv00177988.v6,phs000007,True,date5,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177988\date5\,2530.0,8354.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,DATE5,Date of Exam 5,phs000007.v33.p14,phv00277267.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277267,[],phs000007,pht006027,phv00277267,False,True,True,DATE5,Date of Exam 5,5902.0,\phs000007\pht006027\phv00277267\DATE5\,pht006027.v2,\phs000007\pht006027\phv00277267\DATE5\,phv00277267,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",8354.0,Date of Exam 5,phs000007.v31,ea384e75de20412b72dc7ac5ed5754ae6704cfb3262d84cd1d6854862fee8534,continuous,phv00277267.v2,phs000007,True,DATE5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277267\DATE5\,5902.0,8354.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,DATE5,Date of Exam 5,phs000007.v33.p14,phv00370162.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370162,[],phs000007,pht007777,phv00370162,False,True,True,DATE5,Date of Exam 5,2530.0,\phs000007\pht007777\phv00370162\DATE5\,pht007777.v2,\phs000007\pht007777\phv00370162\DATE5\,phv00370162,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",3291.0,Date of Exam 5,phs000007.v31,f904e7a9dd5be0a3f6c719725e0d49b1ee4711b9389ead0c58b7179e032e912b,continuous,phv00370162.v1,phs000007,True,DATE5,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370162\DATE5\,2530.0,3291.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,DATE5,Date of Exam 5,phs000007.v33.p14,phv00370162.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370162,[],phs000007,pht007777,phv00370162,False,True,True,DATE5,Date of Exam 5,2530.0,\phs000007\pht007777\phv00370162\DATE5\,pht007777.v2,\phs000007\pht007777\phv00370162\DATE5\,phv00370162,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",3291.0,Date of Exam 5,phs000007.v31,f904e7a9dd5be0a3f6c719725e0d49b1ee4711b9389ead0c58b7179e032e912b,continuous,phv00370162.v1,phs000007,True,DATE5,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370162\DATE5\,2530.0,3291.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,DATE5,Date of Exam 5,phs000007.v33.p14,phv00277267.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277267,[],phs000007,pht006027,phv00277267,False,True,True,DATE5,Date of Exam 5,5902.0,\phs000007\pht006027\phv00277267\DATE5\,pht006027.v2,\phs000007\pht006027\phv00277267\DATE5\,phv00277267,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 5,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",8354.0,Date of Exam 5,phs000007.v31,ea384e75de20412b72dc7ac5ed5754ae6704cfb3262d84cd1d6854862fee8534,continuous,phv00277267.v2,phs000007,True,DATE5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277267\DATE5\,5902.0,8354.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date5,Date of Exam 5,26.06255012,vr_wkthru_ex09_1_1001d,date5,Framingham Cohort,date5,Exam date for Exam 5,phs000007.v33.p14,phv00177988.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177988,[],phs000007,pht003099,phv00177988,False,True,True,date5,Exam date for Exam 5,2530.0,\phs000007\pht003099\phv00177988\date5\,pht003099.v6,\phs000007\pht003099\phv00177988\date5\,phv00177988,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 5,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",8354.0,Exam date for Exam 5,phs000007.v31,f7dd80993f264b442d60f819b27826354d78e374368392b76348924bd1c9ab20,continuous,phv00177988.v6,phs000007,True,date5,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177988\date5\,2530.0,8354.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,DATE6,Date of Exam 6,phs000007.v33.p14,phv00370163.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370163,[],phs000007,pht007777,phv00370163,False,True,True,DATE6,Date of Exam 6,2961.0,\phs000007\pht007777\phv00370163\DATE6\,pht007777.v2,\phs000007\pht007777\phv00370163\DATE6\,phv00370163,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",4018.0,Date of Exam 6,phs000007.v31,d96d2866496f64f13dad24a5c724661050473fb64830e56deaf0bf3f30b6be66,continuous,phv00370163.v1,phs000007,True,DATE6,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370163\DATE6\,2961.0,4018.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,DATE6,Date of Exam 6,phs000007.v33.p14,phv00277268.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277268,[],phs000007,pht006027,phv00277268,False,True,True,DATE6,Date of Exam 6,7181.0,\phs000007\pht006027\phv00277268\DATE6\,pht006027.v2,\phs000007\pht006027\phv00277268\DATE6\,phv00277268,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",9754.0,Date of Exam 6,phs000007.v31,50720bf4dc17da4964a0c38c1e046286e6de294ed524d0b0640318d7dba87799,continuous,phv00277268.v2,phs000007,True,DATE6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277268\DATE6\,7181.0,9754.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,DATE6,Date of Exam 6,phs000007.v33.p14,phv00277268.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277268,[],phs000007,pht006027,phv00277268,False,True,True,DATE6,Date of Exam 6,7181.0,\phs000007\pht006027\phv00277268\DATE6\,pht006027.v2,\phs000007\pht006027\phv00277268\DATE6\,phv00277268,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",9754.0,Date of Exam 6,phs000007.v31,50720bf4dc17da4964a0c38c1e046286e6de294ed524d0b0640318d7dba87799,continuous,phv00277268.v2,phs000007,True,DATE6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277268\DATE6\,7181.0,9754.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,DATE6,Date of Exam 6,phs000007.v33.p14,phv00370163.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370163,[],phs000007,pht007777,phv00370163,False,True,True,DATE6,Date of Exam 6,2961.0,\phs000007\pht007777\phv00370163\DATE6\,pht007777.v2,\phs000007\pht007777\phv00370163\DATE6\,phv00370163,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 6,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",4018.0,Date of Exam 6,phs000007.v31,d96d2866496f64f13dad24a5c724661050473fb64830e56deaf0bf3f30b6be66,continuous,phv00370163.v1,phs000007,True,DATE6,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370163\DATE6\,2961.0,4018.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,date6,Exam date for Exam 6,phs000007.v33.p14,phv00177989.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177989,[],phs000007,pht003099,phv00177989,False,True,True,date6,Exam date for Exam 6,2961.0,\phs000007\pht003099\phv00177989\date6\,pht003099.v6,\phs000007\pht003099\phv00177989\date6\,phv00177989,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 6,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",9754.0,Exam date for Exam 6,phs000007.v31,c81dc6e599ced81996543a5e39ff06569e99ab1fce497d6ca9d3fda4b63c5111,continuous,phv00177989.v6,phs000007,True,date6,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177989\date6\,2961.0,9754.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date6,Date of Exam 6,31.61587811,vr_wkthru_ex09_1_1001d,date6,Framingham Cohort,date6,Exam date for Exam 6,phs000007.v33.p14,phv00177989.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177989,[],phs000007,pht003099,phv00177989,False,True,True,date6,Exam date for Exam 6,2961.0,\phs000007\pht003099\phv00177989\date6\,pht003099.v6,\phs000007\pht003099\phv00177989\date6\,phv00177989,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 6,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",9754.0,Exam date for Exam 6,phs000007.v31,c81dc6e599ced81996543a5e39ff06569e99ab1fce497d6ca9d3fda4b63c5111,continuous,phv00177989.v6,phs000007,True,date6,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177989\date6\,2961.0,9754.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,DATE7,Date of Exam 7,phs000007.v33.p14,phv00277269.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277269,[],phs000007,pht006027,phv00277269,False,True,True,DATE7,Date of Exam 7,8442.0,\phs000007\pht006027\phv00277269\DATE7\,pht006027.v2,\phs000007\pht006027\phv00277269\DATE7\,phv00277269,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",10965.0,Date of Exam 7,phs000007.v31,a1f74c6571ecd708c346d2088bd3d613b64f70825a86e6f2c728e21ee2c2d135,continuous,phv00277269.v2,phs000007,True,DATE7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277269\DATE7\,8442.0,10965.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,date7,Exam date for Exam 7,phs000007.v33.p14,phv00177990.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177990,[],phs000007,pht003099,phv00177990,False,True,True,date7,Exam date for Exam 7,4023.0,\phs000007\pht003099\phv00177990\date7\,pht003099.v6,\phs000007\pht003099\phv00177990\date7\,phv00177990,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 7,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",10965.0,Exam date for Exam 7,phs000007.v31,b48a0250cfad46ee69230bc2f9594481aef8327e9ed1a889ec979c7e14207dff,continuous,phv00177990.v6,phs000007,True,date7,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177990\date7\,4023.0,10965.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,DATE7,Date of Exam 7,phs000007.v33.p14,phv00370164.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370164,[],phs000007,pht007777,phv00370164,False,True,True,DATE7,Date of Exam 7,4023.0,\phs000007\pht007777\phv00370164\DATE7\,pht007777.v2,\phs000007\pht007777\phv00370164\DATE7\,phv00370164,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",4765.0,Date of Exam 7,phs000007.v31,eb66dccd84b7c91aa8bbc12de4cc6d4ca428d664c0f1e883834708ccbe2d79d3,continuous,phv00370164.v1,phs000007,True,DATE7,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370164\DATE7\,4023.0,4765.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,date7,Exam date for Exam 7,phs000007.v33.p14,phv00177990.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177990,[],phs000007,pht003099,phv00177990,False,True,True,date7,Exam date for Exam 7,4023.0,\phs000007\pht003099\phv00177990\date7\,pht003099.v6,\phs000007\pht003099\phv00177990\date7\,phv00177990,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 7,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",10965.0,Exam date for Exam 7,phs000007.v31,b48a0250cfad46ee69230bc2f9594481aef8327e9ed1a889ec979c7e14207dff,continuous,phv00177990.v6,phs000007,True,date7,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177990\date7\,4023.0,10965.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,DATE7,Date of Exam 7,phs000007.v33.p14,phv00370164.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370164,[],phs000007,pht007777,phv00370164,False,True,True,DATE7,Date of Exam 7,4023.0,\phs000007\pht007777\phv00370164\DATE7\,pht007777.v2,\phs000007\pht007777\phv00370164\DATE7\,phv00370164,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",4765.0,Date of Exam 7,phs000007.v31,eb66dccd84b7c91aa8bbc12de4cc6d4ca428d664c0f1e883834708ccbe2d79d3,continuous,phv00370164.v1,phs000007,True,DATE7,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370164\DATE7\,4023.0,4765.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date7,Date of Exam 7,30.3127506,vr_wkthru_ex09_1_1001d,date7,Framingham Cohort,DATE7,Date of Exam 7,phs000007.v33.p14,phv00277269.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277269,[],phs000007,pht006027,phv00277269,False,True,True,DATE7,Date of Exam 7,8442.0,\phs000007\pht006027\phv00277269\DATE7\,pht006027.v2,\phs000007\pht006027\phv00277269\DATE7\,phv00277269,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 7,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",10965.0,Date of Exam 7,phs000007.v31,a1f74c6571ecd708c346d2088bd3d613b64f70825a86e6f2c728e21ee2c2d135,continuous,phv00277269.v2,phs000007,True,DATE7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277269\DATE7\,8442.0,10965.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,date8,Exam date for Exam 8,phs000007.v33.p14,phv00177991.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177991,[],phs000007,pht003099,phv00177991,False,True,True,date8,Exam date for Exam 8,4652.0,\phs000007\pht003099\phv00177991\date8\,pht003099.v6,\phs000007\pht003099\phv00177991\date8\,phv00177991,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 8,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",13237.0,Exam date for Exam 8,phs000007.v31,da1c75c0c5767bcc09ec2e2c61bae6a3a0cf3027f0a44de1f335bd20e0866684,continuous,phv00177991.v6,phs000007,True,date8,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177991\date8\,4652.0,13237.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,DATE8,Date of Exam 8,phs000007.v33.p14,phv00277270.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277270,[],phs000007,pht006027,phv00277270,False,True,True,DATE8,Date of Exam 8,10885.0,\phs000007\pht006027\phv00277270\DATE8\,pht006027.v2,\phs000007\pht006027\phv00277270\DATE8\,phv00277270,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",13237.0,Date of Exam 8,phs000007.v31,d1ade63ca9a5093d416b81b441986555054956ccd37c2c26a10215fa69cfc4d3,continuous,phv00277270.v2,phs000007,True,DATE8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277270\DATE8\,10885.0,13237.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,DATE8,Date of Exam 8,phs000007.v33.p14,phv00370165.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370165,[],phs000007,pht007777,phv00370165,False,True,True,DATE8,Date of Exam 8,4652.0,\phs000007\pht007777\phv00370165\DATE8\,pht007777.v2,\phs000007\pht007777\phv00370165\DATE8\,phv00370165,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",5525.0,Date of Exam 8,phs000007.v31,c06e31c18fe0b2260b451161c66b95452ffeebf14ceea30244f3cbff95b2f8f2,continuous,phv00370165.v1,phs000007,True,DATE8,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370165\DATE8\,4652.0,5525.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,DATE8,Date of Exam 8,phs000007.v33.p14,phv00370165.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370165,[],phs000007,pht007777,phv00370165,False,True,True,DATE8,Date of Exam 8,4652.0,\phs000007\pht007777\phv00370165\DATE8\,pht007777.v2,\phs000007\pht007777\phv00370165\DATE8\,phv00370165,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",5525.0,Date of Exam 8,phs000007.v31,c06e31c18fe0b2260b451161c66b95452ffeebf14ceea30244f3cbff95b2f8f2,continuous,phv00370165.v1,phs000007,True,DATE8,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370165\DATE8\,4652.0,5525.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,date8,Exam date for Exam 8,phs000007.v33.p14,phv00177991.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177991,[],phs000007,pht003099,phv00177991,False,True,True,date8,Exam date for Exam 8,4652.0,\phs000007\pht003099\phv00177991\date8\,pht003099.v6,\phs000007\pht003099\phv00177991\date8\,phv00177991,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 8,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",13237.0,Exam date for Exam 8,phs000007.v31,da1c75c0c5767bcc09ec2e2c61bae6a3a0cf3027f0a44de1f335bd20e0866684,continuous,phv00177991.v6,phs000007,True,date8,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177991\date8\,4652.0,13237.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date8,Date of Exam 8,40.1563753,vr_wkthru_ex09_1_1001d,date8,Framingham Cohort,DATE8,Date of Exam 8,phs000007.v33.p14,phv00277270.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277270,[],phs000007,pht006027,phv00277270,False,True,True,DATE8,Date of Exam 8,10885.0,\phs000007\pht006027\phv00277270\DATE8\,pht006027.v2,\phs000007\pht006027\phv00277270\DATE8\,phv00277270,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 8,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",13237.0,Date of Exam 8,phs000007.v31,d1ade63ca9a5093d416b81b441986555054956ccd37c2c26a10215fa69cfc4d3,continuous,phv00277270.v2,phs000007,True,DATE8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277270\DATE8\,10885.0,13237.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,date9,Exam date for Exam 9,phs000007.v33.p14,phv00177992.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177992,[],phs000007,pht003099,phv00177992,False,True,True,date9,Exam date for Exam 9,5465.0,\phs000007\pht003099\phv00177992\date9\,pht003099.v6,\phs000007\pht003099\phv00177992\date9\,phv00177992,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 9,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",15553.0,Exam date for Exam 9,phs000007.v31,a36d626af4d979c1eb82f1bf523df43cf53f2d89c3a87ec296dd8e7a227be7ac,continuous,phv00177992.v6,phs000007,True,date9,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177992\date9\,5465.0,15553.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,DATE9,Date of Exam 9,phs000007.v33.p14,phv00370166.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370166,[],phs000007,pht007777,phv00370166,False,True,True,DATE9,Date of Exam 9,5465.0,\phs000007\pht007777\phv00370166\DATE9\,pht007777.v2,\phs000007\pht007777\phv00370166\DATE9\,phv00370166,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",6223.0,Date of Exam 9,phs000007.v31,cc570a4af3eae52d4ce07dd6cb8b895d53dc71576d1ec483297309283df1472a,continuous,phv00370166.v1,phs000007,True,DATE9,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370166\DATE9\,5465.0,6223.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,DATE9,Date of Exam 9,phs000007.v33.p14,phv00370166.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00370166,[],phs000007,pht007777,phv00370166,False,True,True,DATE9,Date of Exam 9,5465.0,\phs000007\pht007777\phv00370166\DATE9\,pht007777.v2,\phs000007\pht007777\phv00370166\DATE9\,phv00370166,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",Date of Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",6223.0,Date of Exam 9,phs000007.v31,cc570a4af3eae52d4ce07dd6cb8b895d53dc71576d1ec483297309283df1472a,continuous,phv00370166.v1,phs000007,True,DATE9,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00370166\DATE9\,5465.0,6223.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,DATE9,Date of Exam 9,phs000007.v33.p14,phv00277271.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277271,[],phs000007,pht006027,phv00277271,False,True,True,DATE9,Date of Exam 9,13127.0,\phs000007\pht006027\phv00277271\DATE9\,pht006027.v2,\phs000007\pht006027\phv00277271\DATE9\,phv00277271,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",15553.0,Date of Exam 9,phs000007.v31,8dbde3f197528cb016ea8be3dd691846e3a461ce12da80ac0a36d9ad2f88a02f,continuous,phv00277271.v2,phs000007,True,DATE9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277271\DATE9\,13127.0,15553.0
HXHRTD,History of heart disease,56265001,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,0.43,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,date9,Exam date for Exam 9,phs000007.v33.p14,phv00177992.v8.p14,pht003099.v8.p14,vr_dates_2019_a_1175s,phv00177992,[],phs000007,pht003099,phv00177992,False,True,True,date9,Exam date for Exam 9,5465.0,\phs000007\pht003099\phv00177992\date9\,pht003099.v6,\phs000007\pht003099\phv00177992\date9\,phv00177992,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",Exam date for Exam 9,{},,"Clinic Exam Dates, Sex, Age at Exam, Original Exam 1 - Exam 32, Offspring Exam 1 - Exam 9, Generation 3 Exam 1 - Exam 3, New Offspring Spouse Exam 1 - Exam 3, Omni 1 Exam 1 - Exam 4, and Omni 2 Exam 1 - Exam 3. The time interval is from 1948 through 2019. The age at each clinic exam was calculated using the clinic exam date and the date of birth. Clinic exam dates were calculated using the number of days between exam 1 and subsequent exams.",15553.0,Exam date for Exam 9,phs000007.v31,a36d626af4d979c1eb82f1bf523df43cf53f2d89c3a87ec296dd8e7a227be7ac,continuous,phv00177992.v6,phs000007,True,date9,FHS,Framingham Cohort,pht003099,vr_dates_2019_a_1175s,\phs000007\pht003099\phv00177992\date9\,5465.0,15553.0
HXCVD,History of cardiovascular disease,49601007,C21869; C17477; C17479,ARICFraminghamMESAREGARDS,1.12,Framingham,vr_wkthru_ex09_1_1001d.date9,Date of Exam 9,51.88452285,vr_wkthru_ex09_1_1001d,date9,Framingham Cohort,DATE9,Date of Exam 9,phs000007.v33.p14,phv00277271.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277271,[],phs000007,pht006027,phv00277271,False,True,True,DATE9,Date of Exam 9,13127.0,\phs000007\pht006027\phv00277271\DATE9\,pht006027.v2,\phs000007\pht006027\phv00277271\DATE9\,phv00277271,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",Date of Exam 9,{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",15553.0,Date of Exam 9,phs000007.v31,8dbde3f197528cb016ea8be3dd691846e3a461ce12da80ac0a36d9ad2f88a02f,continuous,phv00277271.v2,phs000007,True,DATE9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277271\DATE9\,13127.0,15553.0
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh1,"Definite left ventricular hypertrophy, Exam 1",0.040096231,vr_wkthru_ex09_1_1001d,dlvh1,Framingham Cohort,DLVH1,"Definite left ventricular hypertrophy, Exam 1",phs000007.v33.p14,phv00423906.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423906,"['No', 'Yes']",phs000007,pht009761,phv00423906,True,False,False,DLVH1,"Definite left ventricular hypertrophy, Exam 1",,\phs000007\pht009761\phv00423906\DLVH1\,pht009761.v1,\phs000007\pht009761\phv00423906\DLVH1\,phv00423906,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Definite left ventricular hypertrophy, Exam 1",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",,"Definite left ventricular hypertrophy, Exam 1",phs000007.v31,b9f861849eccdef9ce30cb4f246018c2e7878d15a466ccac18d64d7db703bfc4,categorical,phv00423906.v1,phs000007,False,DLVH1,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423906\DLVH1\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh1,"Definite left ventricular hypertrophy, Exam 1",0.040096231,vr_wkthru_ex09_1_1001d,dlvh1,Framingham Cohort,DLVH1,"Definite left ventricular hypertrophy, Exam 1",phs000007.v33.p14,phv00369871.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369871,"['No', 'Yes']",phs000007,pht007777,phv00369871,True,False,False,DLVH1,"Definite left ventricular hypertrophy, Exam 1",,\phs000007\pht007777\phv00369871\DLVH1\,pht007777.v2,\phs000007\pht007777\phv00369871\DLVH1\,phv00369871,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 1",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 1",phs000007.v31,6bab31fd3ec05e34ccf9fdd0330749b556fd59d2b8840d0ea335f9454f6abb58,categorical,phv00369871.v1,phs000007,False,DLVH1,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369871\DLVH1\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh1,"Definite left ventricular hypertrophy, Exam 1",0.040096231,vr_wkthru_ex09_1_1001d,dlvh1,Framingham Cohort,DLVH1,"Definite left ventricular hypertrophy, Exam 1",phs000007.v33.p14,phv00277036.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277036,"['No', 'Yes']",phs000007,pht006026,phv00277036,True,False,False,DLVH1,"Definite left ventricular hypertrophy, Exam 1",,\phs000007\pht006026\phv00277036\DLVH1\,pht006026.v3,\phs000007\pht006026\phv00277036\DLVH1\,phv00277036,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.","Definite left ventricular hypertrophy, Exam 1",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",,"Definite left ventricular hypertrophy, Exam 1",phs000007.v31,9616bde4166760e874f3188dfa527980db6e33a924678978c685c65e91a16056,categorical,phv00277036.v3,phs000007,False,DLVH1,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277036\DLVH1\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh1,"Definite left ventricular hypertrophy, Exam 1",0.040096231,vr_wkthru_ex09_1_1001d,dlvh1,Framingham Cohort,DLVH1,"Definite left ventricular hypertrophy, Exam 1",phs000007.v33.p14,phv00277146.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277146,"['No', 'Yes']",phs000007,pht006027,phv00277146,True,False,False,DLVH1,"Definite left ventricular hypertrophy, Exam 1",,\phs000007\pht006027\phv00277146\DLVH1\,pht006027.v2,\phs000007\pht006027\phv00277146\DLVH1\,phv00277146,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 1",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 1",phs000007.v31,23bd15c345d957dcedbed50f77c3d7008e05180bdb02359b6b9aaaba01e5a50c,categorical,phv00277146.v2,phs000007,False,DLVH1,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277146\DLVH1\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh2,"Definite left ventricular hypertrophy, Exam 2",25.02004812,vr_wkthru_ex09_1_1001d,dlvh2,Framingham Cohort,DLVH2,"Definite left ventricular hypertrophy, Exam 2",phs000007.v33.p14,phv00277037.v4.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00277037,"['No', 'Yes']",phs000007,pht006026,phv00277037,True,False,False,DLVH2,"Definite left ventricular hypertrophy, Exam 2",,\phs000007\pht006026\phv00277037\DLVH2\,pht006026.v3,\phs000007\pht006026\phv00277037\DLVH2\,phv00277037,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.","Definite left ventricular hypertrophy, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Generation 3, New Offspring Spouse, and Omni 2, Exam 1 - Exam 2. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams.",,"Definite left ventricular hypertrophy, Exam 2",phs000007.v31,accc0fb5e30e5a485d31d55973882802856c9f62a2857be03900f0c0260dbf43,categorical,phv00277037.v3,phs000007,False,DLVH2,FHS,Framingham Cohort,pht006026,vr_wkthru_ex02_3b_0464s,\phs000007\pht006026\phv00277037\DLVH2\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh2,"Definite left ventricular hypertrophy, Exam 2",25.02004812,vr_wkthru_ex09_1_1001d,dlvh2,Framingham Cohort,DLVH2,"Definite left ventricular hypertrophy, Exam 2",phs000007.v33.p14,phv00277147.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277147,"['N o', 'Yes']",phs000007,pht006027,phv00277147,True,False,False,DLVH2,"Definite left ventricular hypertrophy, Exam 2",,\phs000007\pht006027\phv00277147\DLVH2\,pht006027.v2,\phs000007\pht006027\phv00277147\DLVH2\,phv00277147,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 2",phs000007.v31,ab5b9a952361a9ebc2c1d9db9d47cf80b8b2e69e4728549e912c2702be434cfa,categorical,phv00277147.v2,phs000007,False,DLVH2,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277147\DLVH2\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh2,"Definite left ventricular hypertrophy, Exam 2",25.02004812,vr_wkthru_ex09_1_1001d,dlvh2,Framingham Cohort,DLVH2,"Definite left ventricular hypertrophy, Exam 2",phs000007.v33.p14,phv00423907.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423907,"['No', 'Yes']",phs000007,pht009761,phv00423907,True,False,False,DLVH2,"Definite left ventricular hypertrophy, Exam 2",,\phs000007\pht009761\phv00423907\DLVH2\,pht009761.v1,\phs000007\pht009761\phv00423907\DLVH2\,phv00423907,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Definite left ventricular hypertrophy, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",,"Definite left ventricular hypertrophy, Exam 2",phs000007.v31,afebf5866232275fd6a15824920164eabcac13bdb8b981e3ffa900d7747414a8,categorical,phv00423907.v1,phs000007,False,DLVH2,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423907\DLVH2\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh2,"Definite left ventricular hypertrophy, Exam 2",25.02004812,vr_wkthru_ex09_1_1001d,dlvh2,Framingham Cohort,DLVH2,"Definite left ventricular hypertrophy, Exam 2",phs000007.v33.p14,phv00369872.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369872,"['No', 'Yes']",phs000007,pht007777,phv00369872,True,False,False,DLVH2,"Definite left ventricular hypertrophy, Exam 2",,\phs000007\pht007777\phv00369872\DLVH2\,pht007777.v2,\phs000007\pht007777\phv00369872\DLVH2\,phv00369872,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 2",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 2",phs000007.v31,79e8ba8535d24b6eb8d0f27df644d5e95a60e92615c499827a3f0fb723fd497c,categorical,phv00369872.v1,phs000007,False,DLVH2,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369872\DLVH2\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh3,"Definite left ventricular hypertrophy, Exam 3",24.67923015,vr_wkthru_ex09_1_1001d,dlvh3,Framingham Cohort,DLVH3,"Definite left ventricular hypertrophy, Exam 3",phs000007.v33.p14,phv00423908.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423908,['No'],phs000007,pht009761,phv00423908,True,False,False,DLVH3,"Definite left ventricular hypertrophy, Exam 3",,\phs000007\pht009761\phv00423908\DLVH3\,pht009761.v1,\phs000007\pht009761\phv00423908\DLVH3\,phv00423908,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Definite left ventricular hypertrophy, Exam 3",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",,"Definite left ventricular hypertrophy, Exam 3",phs000007.v31,61814c24668042cb8917598448182795f9bca59254f587fd8e83b1475ce2b090,categorical,phv00423908.v1,phs000007,False,DLVH3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423908\DLVH3\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh3,"Definite left ventricular hypertrophy, Exam 3",24.67923015,vr_wkthru_ex09_1_1001d,dlvh3,Framingham Cohort,DLVH3,"Definite left ventricular hypertrophy, Exam 3",phs000007.v33.p14,phv00520297.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520297,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh3,"Definite left ventricular hypertrophy, Exam 3",24.67923015,vr_wkthru_ex09_1_1001d,dlvh3,Framingham Cohort,DLVH3,"Definite left ventricular hypertrophy, Exam 3",phs000007.v33.p14,phv00277148.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277148,"['No', 'Yes']",phs000007,pht006027,phv00277148,True,False,False,DLVH3,"Definite left ventricular hypertrophy, Exam 3",,\phs000007\pht006027\phv00277148\DLVH3\,pht006027.v2,\phs000007\pht006027\phv00277148\DLVH3\,phv00277148,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 3",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 3",phs000007.v31,2605d0f530eb5991cccd1cd7b9cdfaab788cd7eb9def1ed14b4ef0a2f98c6b4c,categorical,phv00277148.v2,phs000007,False,DLVH3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277148\DLVH3\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh3,"Definite left ventricular hypertrophy, Exam 3",24.67923015,vr_wkthru_ex09_1_1001d,dlvh3,Framingham Cohort,DLVH3,"Definite left ventricular hypertrophy, Exam 3",phs000007.v33.p14,phv00369873.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369873,"['No', 'Yes']",phs000007,pht007777,phv00369873,True,False,False,DLVH3,"Definite left ventricular hypertrophy, Exam 3",,\phs000007\pht007777\phv00369873\DLVH3\,pht007777.v2,\phs000007\pht007777\phv00369873\DLVH3\,phv00369873,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 3",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 3",phs000007.v31,98bbee527a5f36d6001bfc63af1a69931a17ebd5e1e8848128f73a1a4066aca9,categorical,phv00369873.v1,phs000007,False,DLVH3,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369873\DLVH3\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh4,"Definite left ventricular hypertrophy, Exam 4",22.45388933,vr_wkthru_ex09_1_1001d,dlvh4,Framingham Cohort,DLVH4,"Definite left ventricular hypertrophy, Exam 4",phs000007.v33.p14,phv00423909.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423909,"['No', 'Yes']",phs000007,pht009761,phv00423909,True,False,False,DLVH4,"Definite left ventricular hypertrophy, Exam 4",,\phs000007\pht009761\phv00423909\DLVH4\,pht009761.v1,\phs000007\pht009761\phv00423909\DLVH4\,phv00423909,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Definite left ventricular hypertrophy, Exam 4",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",,"Definite left ventricular hypertrophy, Exam 4",phs000007.v31,93bc002b3831e63444c402732505106f72162f6e493d30e49869cea693aca1c1,categorical,phv00423909.v1,phs000007,False,DLVH4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423909\DLVH4\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh4,"Definite left ventricular hypertrophy, Exam 4",22.45388933,vr_wkthru_ex09_1_1001d,dlvh4,Framingham Cohort,DLVH4,"Definite left ventricular hypertrophy, Exam 4",phs000007.v33.p14,phv00277149.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277149,"['No', 'Yes']",phs000007,pht006027,phv00277149,True,False,False,DLVH4,"Definite left ventricular hypertrophy, Exam 4",,\phs000007\pht006027\phv00277149\DLVH4\,pht006027.v2,\phs000007\pht006027\phv00277149\DLVH4\,phv00277149,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 4",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 4",phs000007.v31,498ecfdd5a285535b3fce9604a04b87655f131d848e10be411039cf1dae1e646,categorical,phv00277149.v2,phs000007,False,DLVH4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277149\DLVH4\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh4,"Definite left ventricular hypertrophy, Exam 4",22.45388933,vr_wkthru_ex09_1_1001d,dlvh4,Framingham Cohort,DLVH4,"Definite left ventricular hypertrophy, Exam 4",phs000007.v33.p14,phv00369874.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369874,"['No', 'Yes']",phs000007,pht007777,phv00369874,True,False,False,DLVH4,"Definite left ventricular hypertrophy, Exam 4",,\phs000007\pht007777\phv00369874\DLVH4\,pht007777.v2,\phs000007\pht007777\phv00369874\DLVH4\,phv00369874,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 4",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 4",phs000007.v31,62e082ebdfe7b93a066e143adfb8f60c11876f9865a037e4f4d38a3b539b440c,categorical,phv00369874.v1,phs000007,False,DLVH4,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369874\DLVH4\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh5,"Definite left ventricular hypertrophy, Exam 5",27.36567763,vr_wkthru_ex09_1_1001d,dlvh5,Framingham Cohort,DLVH5,"Definite left ventricular hypertrophy, Exam 5",phs000007.v33.p14,phv00369875.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369875,"['No', 'Yes']",phs000007,pht007777,phv00369875,True,False,False,DLVH5,"Definite left ventricular hypertrophy, Exam 5",,\phs000007\pht007777\phv00369875\DLVH5\,pht007777.v2,\phs000007\pht007777\phv00369875\DLVH5\,phv00369875,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 5",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 5",phs000007.v31,e4792a7b480912ebe62c4964f7abee9fc62b8e968fca474965f77e9277d5932f,categorical,phv00369875.v1,phs000007,False,DLVH5,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369875\DLVH5\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh5,"Definite left ventricular hypertrophy, Exam 5",27.36567763,vr_wkthru_ex09_1_1001d,dlvh5,Framingham Cohort,DLVH5,"Definite left ventricular hypertrophy, Exam 5",phs000007.v33.p14,phv00277150.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277150,"['No', 'Yes']",phs000007,pht006027,phv00277150,True,False,False,DLVH5,"Definite left ventricular hypertrophy, Exam 5",,\phs000007\pht006027\phv00277150\DLVH5\,pht006027.v2,\phs000007\pht006027\phv00277150\DLVH5\,phv00277150,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 5",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 5",phs000007.v31,948d66f022f3932dd9784f589dada7986ede24afed34d8873df7b471e173f83f,categorical,phv00277150.v2,phs000007,False,DLVH5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277150\DLVH5\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh6,"Definite left ventricular hypertrophy, Exam 6",32.59823577,vr_wkthru_ex09_1_1001d,dlvh6,Framingham Cohort,DLVH6,"Definite left ventricular hypertrophy, Exam 6",phs000007.v33.p14,phv00369876.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369876,"['No', 'Yes']",phs000007,pht007777,phv00369876,True,False,False,DLVH6,"Definite left ventricular hypertrophy, Exam 6",,\phs000007\pht007777\phv00369876\DLVH6\,pht007777.v2,\phs000007\pht007777\phv00369876\DLVH6\,phv00369876,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 6",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 6",phs000007.v31,1b908bc39bbb25b187c085e30e624ecc558031ec28e7cb056cb04cc5ff790016,categorical,phv00369876.v1,phs000007,False,DLVH6,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369876\DLVH6\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh6,"Definite left ventricular hypertrophy, Exam 6",32.59823577,vr_wkthru_ex09_1_1001d,dlvh6,Framingham Cohort,DLVH6,"Definite left ventricular hypertrophy, Exam 6",phs000007.v33.p14,phv00277151.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277151,"['No', 'Yes']",phs000007,pht006027,phv00277151,True,False,False,DLVH6,"Definite left ventricular hypertrophy, Exam 6",,\phs000007\pht006027\phv00277151\DLVH6\,pht006027.v2,\phs000007\pht006027\phv00277151\DLVH6\,phv00277151,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 6",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 6",phs000007.v31,58543765e875d059f4784bf636916a20bea8f4e998c9c249e5a96553333f7ff8,categorical,phv00277151.v2,phs000007,False,DLVH6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277151\DLVH6\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh7,"Definite left ventricular hypertrophy, Exam 7",31.77626303,vr_wkthru_ex09_1_1001d,dlvh7,Framingham Cohort,DLVH7,"Definite left ventricular hypertrophy, Exam 7",phs000007.v33.p14,phv00369877.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369877,"['No', 'Yes']",phs000007,pht007777,phv00369877,True,False,False,DLVH7,"Definite left ventricular hypertrophy, Exam 7",,\phs000007\pht007777\phv00369877\DLVH7\,pht007777.v2,\phs000007\pht007777\phv00369877\DLVH7\,phv00369877,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 7",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 7",phs000007.v31,af0b496435a0efac04f85766e45127a3f8498dba0db30bdf9d63be032fc3108b,categorical,phv00369877.v1,phs000007,False,DLVH7,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369877\DLVH7\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh7,"Definite left ventricular hypertrophy, Exam 7",31.77626303,vr_wkthru_ex09_1_1001d,dlvh7,Framingham Cohort,DLVH7,"Definite left ventricular hypertrophy, Exam 7",phs000007.v33.p14,phv00277152.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277152,"['No', 'Yes']",phs000007,pht006027,phv00277152,True,False,False,DLVH7,"Definite left ventricular hypertrophy, Exam 7",,\phs000007\pht006027\phv00277152\DLVH7\,pht006027.v2,\phs000007\pht006027\phv00277152\DLVH7\,phv00277152,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 7",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 7",phs000007.v31,4fabc96a34e3802dacb16b81a6be1aec50f0bec49fb5f6c7608df69ca61fadd9,categorical,phv00277152.v2,phs000007,False,DLVH7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277152\DLVH7\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh8,"Definite left ventricular hypertrophy, Exam 8",42.16118685,vr_wkthru_ex09_1_1001d,dlvh8,Framingham Cohort,DLVH8,"Definite left ventricular hypertrophy, Exam 8",phs000007.v33.p14,phv00277153.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277153,"['No', 'Yes']",phs000007,pht006027,phv00277153,True,False,False,DLVH8,"Definite left ventricular hypertrophy, Exam 8",,\phs000007\pht006027\phv00277153\DLVH8\,pht006027.v2,\phs000007\pht006027\phv00277153\DLVH8\,phv00277153,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 8",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 8",phs000007.v31,a075df7500ff287cf1c3cbd9c7b56c850526308870dcae4bdddf9bbf22b50765,categorical,phv00277153.v2,phs000007,False,DLVH8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277153\DLVH8\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh8,"Definite left ventricular hypertrophy, Exam 8",42.16118685,vr_wkthru_ex09_1_1001d,dlvh8,Framingham Cohort,DLVH8,"Definite left ventricular hypertrophy, Exam 8",phs000007.v33.p14,phv00369878.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369878,"['No', 'Yes']",phs000007,pht007777,phv00369878,True,False,False,DLVH8,"Definite left ventricular hypertrophy, Exam 8",,\phs000007\pht007777\phv00369878\DLVH8\,pht007777.v2,\phs000007\pht007777\phv00369878\DLVH8\,phv00369878,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 8",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 8",phs000007.v31,270ea4c05bbbc2833282861be72ef0b57bf6d4f1091659c6b5bbbcc79e7f04e2,categorical,phv00369878.v1,phs000007,False,DLVH8,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369878\DLVH8\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh9,"Definite left ventricular hypertrophy, Exam 9",53.8893344,vr_wkthru_ex09_1_1001d,dlvh9,Framingham Cohort,DLVH9,"Definite left ventricular hypertrophy, Exam 9",phs000007.v33.p14,phv00277154.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277154,"['No', 'Yes']",phs000007,pht006027,phv00277154,True,False,False,DLVH9,"Definite left ventricular hypertrophy, Exam 9",,\phs000007\pht006027\phv00277154\DLVH9\,pht006027.v2,\phs000007\pht006027\phv00277154\DLVH9\,phv00277154,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Definite left ventricular hypertrophy, Exam 9",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",,"Definite left ventricular hypertrophy, Exam 9",phs000007.v31,cecc769576a64bf0014ce4224c45508d1fdb650408357887044897cf17f4bd17,categorical,phv00277154.v2,phs000007,False,DLVH9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277154\DLVH9\,,
LVH,Left ventricular hypertrophy on ECG,55827005,C10735,ARICFraminghamMESAREGARDS,1.29,Framingham,vr_wkthru_ex09_1_1001d.dlvh9,"Definite left ventricular hypertrophy, Exam 9",53.8893344,vr_wkthru_ex09_1_1001d,dlvh9,Framingham Cohort,DLVH9,"Definite left ventricular hypertrophy, Exam 9",phs000007.v33.p14,phv00369879.v1.p14,pht007777.v3.p14,vr_wkthru_ex32_0_0997s,phv00369879,"['No', 'Yes']",phs000007,pht007777,phv00369879,True,False,False,DLVH9,"Definite left ventricular hypertrophy, Exam 9",,\phs000007\pht007777\phv00369879\DLVH9\,pht007777.v2,\phs000007\pht007777\phv00369879\DLVH9\,phv00369879,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.","Definite left ventricular hypertrophy, Exam 9",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. Workthru), Original Cohort, Exam 1 - Exam 32.",,"Definite left ventricular hypertrophy, Exam 9",phs000007.v31,446aa771558dc733a11b1a6ce47d46322ad48727cd93c05c2295dec1e5ed503d,categorical,phv00369879.v1,phs000007,False,DLVH9,FHS,Framingham Cohort,pht007777,vr_wkthru_ex32_0_0997s,\phs000007\pht007777\phv00369879\DLVH9\,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg3,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 3",29.17000802,vr_wkthru_ex09_1_1001d,fasting_bg3,Framingham Cohort,FASTING_BG3,"Fasting blood glucose, Exam 3 (>= 8 hours)",phs000007.v33.p14,phv00423912.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423912,[],phs000007,pht009761,phv00423912,False,True,False,FASTING_BG3,"Fasting blood glucose, Exam 3 (>= 8 hours)",68.0,\phs000007\pht009761\phv00423912\FASTING_BG3\,pht009761.v1,\phs000007\pht009761\phv00423912\FASTING_BG3\,phv00423912,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Fasting blood glucose, Exam 3 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",319.0,"Fasting blood glucose, Exam 3 (>= 8 hours)",phs000007.v31,ba99a3fbd7e1988f57f3fc8325d8cd27fffdabd83a90b6178f27dac181ac492d,continuous,phv00423912.v1,phs000007,False,FASTING_BG3,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423912\FASTING_BG3\,68.0,319.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg3,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 3",29.17000802,vr_wkthru_ex09_1_1001d,fasting_bg3,Framingham Cohort,FASTING_BG3,"Fasting blood glucose, Exam 3 (>= 8 hours)",phs000007.v33.p14,phv00277155.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277155,[],phs000007,pht006027,phv00277155,False,True,False,FASTING_BG3,"Fasting blood glucose, Exam 3 (>= 8 hours)",47.0,\phs000007\pht006027\phv00277155\FASTING_BG3\,pht006027.v2,\phs000007\pht006027\phv00277155\FASTING_BG3\,phv00277155,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 3 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",387.0,"Fasting blood glucose, Exam 3 (>= 8 hours)",phs000007.v31,65212afc0f81582a9700c63b5dab99b2e8e51dd048068a646c89cf76f6195deb,continuous,phv00277155.v2,phs000007,False,FASTING_BG3,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277155\FASTING_BG3\,47.0,387.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg3,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 3",29.17000802,vr_wkthru_ex09_1_1001d,fasting_bg3,Framingham Cohort,FASTING_BG3,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 3",phs000007.v33.p14,phv00520299.v1.p14,pht006026.v5.p14,vr_wkthru_ex03_3b_1191s,phv00520299,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg4,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 4",26.98476343,vr_wkthru_ex09_1_1001d,fasting_bg4,Framingham Cohort,FASTING_BG4,"Fasting blood glucose, Exam 4 (>= 8 hours)",phs000007.v33.p14,phv00423913.v2.p14,pht009761.v2.p14,vr_wkthru_ex04_7_0917s,phv00423913,[],phs000007,pht009761,phv00423913,False,True,False,FASTING_BG4,"Fasting blood glucose, Exam 4 (>= 8 hours)",60.0,\phs000007\pht009761\phv00423913\FASTING_BG4\,pht009761.v1,\phs000007\pht009761\phv00423913\FASTING_BG4\,phv00423913,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.","Fasting blood glucose, Exam 4 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Omni 1 Exam 1 - Exam 4.",289.0,"Fasting blood glucose, Exam 4 (>= 8 hours)",phs000007.v31,aa57a9e0425389976774227ea3302bb4749e6581cb407830613e82a1bfed58a4,continuous,phv00423913.v1,phs000007,False,FASTING_BG4,FHS,Framingham Cohort,pht009761,vr_wkthru_ex04_7_0917s,\phs000007\pht009761\phv00423913\FASTING_BG4\,60.0,289.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg4,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 4",26.98476343,vr_wkthru_ex09_1_1001d,fasting_bg4,Framingham Cohort,FASTING_BG4,"Fasting blood glucose, Exam 4 (>= 8 hours)",phs000007.v33.p14,phv00277156.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277156,[],phs000007,pht006027,phv00277156,False,True,False,FASTING_BG4,"Fasting blood glucose, Exam 4 (>= 8 hours)",42.0,\phs000007\pht006027\phv00277156\FASTING_BG4\,pht006027.v2,\phs000007\pht006027\phv00277156\FASTING_BG4\,phv00277156,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 4 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",362.0,"Fasting blood glucose, Exam 4 (>= 8 hours)",phs000007.v31,2d8b240925df95a8f1c560bd5b99a7b0f154ce78bbd8480fc3830c0df60b614a,continuous,phv00277156.v2,phs000007,False,FASTING_BG4,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277156\FASTING_BG4\,42.0,362.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg5,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 5",27.5862069,vr_wkthru_ex09_1_1001d,fasting_bg5,Framingham Cohort,FASTING_BG5,"Fasting blood glucose, Exam 5 (>= 8 hours)",phs000007.v33.p14,phv00277157.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277157,[],phs000007,pht006027,phv00277157,False,True,False,FASTING_BG5,"Fasting blood glucose, Exam 5 (>= 8 hours)",48.0,\phs000007\pht006027\phv00277157\FASTING_BG5\,pht006027.v2,\phs000007\pht006027\phv00277157\FASTING_BG5\,phv00277157,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 5 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",411.0,"Fasting blood glucose, Exam 5 (>= 8 hours)",phs000007.v31,3ffe8b2b09617308abee1265e6d0ef5d65c8185527a2034a6ede1d698087bdc5,continuous,phv00277157.v2,phs000007,False,FASTING_BG5,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277157\FASTING_BG5\,48.0,411.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg6,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 6",33.72093023,vr_wkthru_ex09_1_1001d,fasting_bg6,Framingham Cohort,FASTING_BG6,"Fasting blood glucose, Exam 6 (>= 8 hours)",phs000007.v33.p14,phv00277158.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277158,[],phs000007,pht006027,phv00277158,False,True,False,FASTING_BG6,"Fasting blood glucose, Exam 6 (>= 8 hours)",64.0,\phs000007\pht006027\phv00277158\FASTING_BG6\,pht006027.v2,\phs000007\pht006027\phv00277158\FASTING_BG6\,phv00277158,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 6 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",360.0,"Fasting blood glucose, Exam 6 (>= 8 hours)",phs000007.v31,e7ec2fe42d06a5df57ba5e309a3c70a00e366319e5d1946c17d1473f0bfa96b4,continuous,phv00277158.v2,phs000007,False,FASTING_BG6,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277158\FASTING_BG6\,64.0,360.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg7,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 7",35.56535686,vr_wkthru_ex09_1_1001d,fasting_bg7,Framingham Cohort,FASTING_BG7,"Fasting blood glucose, Exam 7 (>= 8 hours)",phs000007.v33.p14,phv00277159.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277159,[],phs000007,pht006027,phv00277159,False,True,False,FASTING_BG7,"Fasting blood glucose, Exam 7 (>= 8 hours)",61.0,\phs000007\pht006027\phv00277159\FASTING_BG7\,pht006027.v2,\phs000007\pht006027\phv00277159\FASTING_BG7\,phv00277159,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 7 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",367.0,"Fasting blood glucose, Exam 7 (>= 8 hours)",phs000007.v31,70c9cbca9a1bba4a1dfc4c2f4588245133f8b4ea7a21cd183e6c1d14a3807f8c,continuous,phv00277159.v2,phs000007,False,FASTING_BG7,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277159\FASTING_BG7\,61.0,367.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg8,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 8",43.68484362,vr_wkthru_ex09_1_1001d,fasting_bg8,Framingham Cohort,FASTING_BG8,"Fasting blood glucose, Exam 8 (>= 8 hours)",phs000007.v33.p14,phv00277160.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277160,[],phs000007,pht006027,phv00277160,False,True,False,FASTING_BG8,"Fasting blood glucose, Exam 8 (>= 8 hours)",36.0,\phs000007\pht006027\phv00277160\FASTING_BG8\,pht006027.v2,\phs000007\pht006027\phv00277160\FASTING_BG8\,phv00277160,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 8 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",339.0,"Fasting blood glucose, Exam 8 (>= 8 hours)",phs000007.v31,4ba0dc2f9fb51c771ce86a733213b603e9b4284eab2aa53978b56f712fbca971,continuous,phv00277160.v2,phs000007,False,FASTING_BG8,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277160\FASTING_BG8\,36.0,339.0
FASTING_BG,Fasting blood glucose (>: 8 hours) (mg/dL),271062006,C54941,FraminghamMESA,1.53,Framingham,vr_wkthru_ex09_1_1001d.fasting_bg9,"Fasting (>= 8 hours) blood glucose (mg/dL), Exam 9",55.87409783,vr_wkthru_ex09_1_1001d,fasting_bg9,Framingham Cohort,FASTING_BG9,"Fasting blood glucose, Exam 9 (>= 8 hours)",phs000007.v33.p14,phv00277161.v4.p14,pht006027.v4.p14,vr_wkthru_ex09_1_1001s,phv00277161,[],phs000007,pht006027,phv00277161,False,True,False,FASTING_BG9,"Fasting blood glucose, Exam 9 (>= 8 hours)",53.0,\phs000007\pht006027\phv00277161\FASTING_BG9\,pht006027.v2,\phs000007\pht006027\phv00277161\FASTING_BG9\,phv00277161,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.","Fasting blood glucose, Exam 9 (>= 8 hours)",{},,"Frequently Used Cardiovascular Risk Factors (a.k.a. ""Workthru""), Offspring, Exam 1 - Exam 9. This purpose of this dataset is to: 1) Abstract and rename frequently used variables across exams for ease of use; 2) Standardize units across exams; 3) Standardize calculated variables across exams; 4) Incorporate variable value corrections reported over several years.",277.0,"Fasting blood glucose, Exam 9 (>= 8 hours)",phs000007.v31,c7d4550b4c1059e5ef06b87f6d5a2e5df13a3e84fe6d93764839974f3ee80e8b,continuous,phv00277161.v2,phs000007,False,FASTING_BG9,FHS,Framingham Cohort,pht006027,vr_wkthru_ex09_1_1001s,\phs000007\pht006027\phv00277161\FASTING_BG9\,53.0,277.0
